<SEC-DOCUMENT>0001140361-25-013294.txt : 20250410
<SEC-HEADER>0001140361-25-013294.hdr.sgml : 20250410
<ACCEPTANCE-DATETIME>20250410170230
ACCESSION NUMBER:		0001140361-25-013294
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		25
CONFORMED PERIOD OF REPORT:	20250529
FILED AS OF DATE:		20250410
DATE AS OF CHANGE:		20250410

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Acadia Healthcare Company, Inc.
		CENTRAL INDEX KEY:			0001520697
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35331
		FILM NUMBER:		25829110

	BUSINESS ADDRESS:	
		STREET 1:		6100 TOWER CIRCLE
		STREET 2:		SUITE 1000
		CITY:			FRANKLIN
		STATE:			TN
		ZIP:			37067
		BUSINESS PHONE:		615-861-6000

	MAIL ADDRESS:	
		STREET 1:		6100 TOWER CIRCLE
		STREET 2:		SUITE 1000
		CITY:			FRANKLIN
		STATE:			TN
		ZIP:			37067
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>ny20042551x1_def14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Apr 10 21:02:13 UTC 2025 -->
<html xmlns:achc="http://acadiahealthcare.com/20250529" xmlns:compsci="http://compsciresources.com" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-types="http://xbrl.us/us-types/2009-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title> </title>
    <!-- Licensed to: Broadridge Document created using Broadridge PROfile 25.3.1.5296 Copyright 1995 - 2025 Broadridge -->

<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>
  </div><p style="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNITED STATES<br/>
      SECURITIES AND EXCHANGE COMMISSION<br/>
      WASHINGTON, DC 20549</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SCHEDULE 14A<br/>
    (Rule 14a-101)</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="-sec-ix-hidden: hidden-fact-0">SCHEDULE 14A</span> INFORMATION</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proxy Statement Pursuant to Section 14(a) of the Securities<br/>
      Exchange Act of 1934 (Amendment No.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;)</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table border="0" cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 200pt;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed by the Registrant</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 200pt;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed by a Party other than the Registrant</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check the appropriate box:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"/>
        <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary Proxy Statement</span></td>
      </tr>

  </table><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"/>
        <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Confidential, for use of the Commission Only (as permitted by Rule 14a-6(e)(2))</b></span></td>
      </tr>

  </table><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"/>
        <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive Proxy Statement</span></td>
      </tr>

  </table><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"/>
        <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive Additional Materials</span></td>
      </tr>

  </table><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"/>
        <td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting Material under &#167;240.14a-12</span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-112"><b>ACADIA HEALTHCARE COMPANY, INC.</b></ix:nonNumeric><br/> (Name of Registrant as Specified in its Charter)</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <br/>
    </span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>
  </div><!-- Field: Rule-Page --><div>
  </div><div style="margin-top: 3pt; margin-bottom: 3pt; text-align: CENTER;">
    <div style="font-size: 1pt; border-top: Black 1pt solid; width: 30%; margin-left: auto; margin-right: auto;">&#160;</div>
  </div><div>
  </div><!-- Field: /Rule-Page --><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment of Filing Fee (Check all boxes that apply):</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 3pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0in; font: 10pt Times New Roman,Times,serif;"/>
        <td style="width: 0.25in; font: 10pt Times New Roman,Times,serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
        <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No fee required.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 3pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0in; font: 10pt Times New Roman,Times,serif;"/>
        <td style="width: 0.25in; font: 10pt Times New Roman,Times,serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
        <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee paid previously with preliminary materials.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 3pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0in; font: 10pt Times New Roman,Times,serif;"/>
        <td style="width: 0.25in; font: 10pt Times New Roman,Times,serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
        <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</span></td>
      </tr>

  </table><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"><img alt="" src="ny20042551x1_image01.jpg"/></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>6100 Tower Circle, Suite 1000</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/>
      <span style="text-transform: uppercase"><b>Franklin, Tennessee 37067</b></span></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">April 10, 2025</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO OUR STOCKHOLDERS:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You are cordially invited to attend the 2025 Annual Meeting of Stockholders
      (the &#8220;Annual Meeting&#8221;) of Acadia Healthcare Company, Inc., to be held on Thursday, May 29, 2025, at 8:00 a.m. (Central Time), at our executive offices located at 6100 Tower Circle, Suite 1000, Franklin, Tennessee 37067. The matters to be acted upon
      at the Annual Meeting are more fully described in the accompanying Proxy Statement and related materials.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with rules adopted by the Securities and Exchange Commission,
      we are mailing to many of our stockholders a Notice of Internet Availability of Proxy Materials instead of a paper copy of the Proxy Statement and our 2024 Annual Report to Stockholders. The Notice of Internet Availability of Proxy Materials contains
      instructions on how stockholders can access the proxy documents over the internet as well as how stockholders can receive a paper copy of our proxy materials, including the Proxy Statement, the 2024 Annual Report to Stockholders and a form of proxy
      card.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It is important that your shares be represented at the Annual Meeting.
      Whether or not you plan to attend the Annual Meeting, please vote by proxy as soon as possible by following the instructions located in the Notice of Internet Availability of Proxy Materials sent to you or in the Proxy Statement. If you attend the
      Annual Meeting, you may withdraw your proxy and vote your shares personally.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We look forward to your attendance at the Annual Meeting.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 65%; font: 10pt Times New Roman, Times, Serif; text-align: justify"/>
        <td style="width: 35%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><img alt="" src="ny20042551x1_image02.jpg"/></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher H. Hunter</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Chief Executive Officer and Director</i></span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>YOUR VOTE IS IMPORTANT.</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PLEASE COMPLETE, DATE, SIGN AND RETURN THE ENCLOSED PROXY CARD<br/>
      AS PROMPTLY AS POSSIBLE.</b></span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"><img alt="" src="ny20042551x1_image01.jpg"/></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>6100 Tower Circle, Suite 1000</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/>
      <span style="text-transform: uppercase"><b>Franklin, Tennessee 37067</b></span></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS<br/>
      To Be Held May 29, 2025</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO OUR STOCKHOLDERS:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The 2025 Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) of Acadia
      Healthcare Company, Inc. will be held on Thursday, May 29, 2025, at 8:00 a.m. (Central Time), <span style="background-color: white">at our executive offices located at 6100 Tower Circle, Suite 1000, Franklin, Tennessee 37067</span>.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Annual Meeting is being convened for the following purposes:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To elect four nominees as Class II directors;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To approve an amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive
            Compensation Plan;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To approve, on a non-binding advisory basis, the compensation of our named executive officers;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To approve, on a non-binding advisory basis, the frequency of a non-binding advisory vote on the
            compensation of our named executive officers;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To ratify the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm
            for the fiscal year ending December 31, 2025; and</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To transact any other business that properly comes before the Annual Meeting or any adjournments or
            postponements thereof.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The matters to be acted upon at the Annual Meeting are more fully described
      in the Proxy Statement and related materials. Please read the materials carefully.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Board of Directors has fixed the close of business on April 1, 2025 as
      the record date for determining stockholders entitled to notice of and to vote at the Annual Meeting or any adjournments or postponements thereof.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 65%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: April 10, 2025</span></td>
        <td style="width: 35%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By order of the Board of Directors,</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><img alt="" src="ny20042551x1_image02.jpg"/></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher H. Hunter</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Chief Executive Officer and Director</i></span></td>
      </tr>

  </table><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>IMPORTANT</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHETHER OR NOT YOU PLAN TO ATTEND THE ANNUAL MEETING, TO ASSURE THE
        PRESENCE OF A QUORUM, PLEASE COMPLETE, DATE, SIGN AND RETURN THE ENCLOSED PROXY CARD AS PROMPTLY AS POSSIBLE. IF YOU ATTEND THE MEETING AND WISH TO VOTE YOUR SHARES PERSONALLY, YOU MAY DO SO AT ANY TIME BEFORE THE PROXY IS EXERCISED.</b><span style="clear: both; display: block;"><br/></span>
    </span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><!--PROfilePageNumberReset%LCR%1%%%--><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE OF CONTENTS </b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif">

      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 90%; text-indent: -0.25in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a001">PROXY
              STATEMENT</a></span></td>
        <td style="width: 10%; text-align: right; padding-top: 12pt; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="text-indent: -0.25in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a002">INFORMATION
              CONCERNING SOLICITATION AND VOTING</a></span></td>
        <td style="text-align: right; padding-top: 12pt; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="text-indent: -0.25in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a003">PROPOSAL 1: ELECTION
              OF DIRECTORS</a></span></td>
        <td style="text-align: right; padding-top: 12pt; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="text-indent: -0.25in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a004">PROPOSAL 2: APPROVAL
              OF AMENDMENT TO ACADIA HEALTHCARE COMPANY, INC. AMENDED AND RESTATED INCENTIVE COMPENSATION PLAN</a></span></td>
        <td style="text-align: right; padding-top: 12pt; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="text-indent: -0.25in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a005">PROPOSAL 3:
              NON-BINDING ADVISORY VOTE ON EXECUTIVE COMPENSATION</a></span></td>
        <td style="text-align: right; padding-top: 12pt; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</span></td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="text-indent: -0.25in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a006">PROPOSAL 4:
              NON-BINDING ADVISORY VOTE ON THE FREQUENCY OF THE NON-BINDING ADVISORY VOTE ON EXECUTIVE COMPENSATION</a></span></td>
        <td style="text-align: right; padding-top: 12pt; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="text-indent: -0.25in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a007">PROPOSAL 5:
              RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></span></td>
        <td style="text-align: right; padding-top: 12pt; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="text-indent: -0.25in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a008">CORPORATE GOVERNANCE</a></span></td>
        <td style="text-align: right; padding-top: 12pt; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="text-indent: -0.25in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a009">MANAGEMENT</a></span></td>
        <td style="text-align: right; padding-top: 12pt; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</span></td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="text-indent: -0.25in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a010">SECURITY OWNERSHIP
              OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</a></span></td>
        <td style="text-align: right; padding-top: 12pt; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</span></td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="text-indent: -0.25in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a011">COMPENSATION
              DISCUSSION AND ANALYSIS</a></span></td>
        <td style="text-align: right; padding-top: 12pt; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</span></td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="text-indent: -0.25in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a012">COMPENSATION
              COMMITTEE REPORT</a></span></td>
        <td style="text-align: right; padding-top: 12pt; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</span></td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="text-indent: -0.25in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a013">EXECUTIVE
              COMPENSATION</a></span></td>
        <td style="text-align: right; padding-top: 12pt; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</span></td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="text-indent: -0.25in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a014">DIRECTOR
              COMPENSATION</a></span></td>
        <td style="text-align: right; padding-top: 12pt; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</span></td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="text-indent: -0.25in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a015">AUDIT AND RISK
              COMMITTEE REPORT</a></span></td>
        <td style="text-align: right; padding-top: 12pt; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">63</span></td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="text-indent: -0.25in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a016">CERTAIN
              RELATIONSHIPS AND RELATED PERSON TRANSACTIONS</a></span></td>
        <td style="text-align: right; padding-top: 12pt; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="text-indent: -0.25in; padding-top: 12pt; padding-bottom: 0pt; padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a017">GENERAL INFORMATION</a></span></td>
        <td style="text-align: right; padding-top: 12pt; padding-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</span></td>
      </tr>
      <tr style="vertical-align: top; text-align: justify">
        <td style="padding-top: 12pt; padding-left: 0.25in; text-indent: -0.25in;"><a href="#a018">APPENDIX A: Amendment to Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan</a></td>
        <td style="text-align: right; vertical-align: bottom">A-1</td>
      </tr>
      <tr style="vertical-align: top; text-align: justify">
        <td style="padding-top: 12pt; padding-left: 0.25in; text-indent: -0.25in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#a019">APPENDIX B: Acadia Healthcare Company, Inc. Amended and Restated Incentive
              Compensation Plan</a></span></td>
        <td style="text-align: right; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B-1</span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span>&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Note to Readers</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless the context otherwise requires, all references in this Proxy
      Statement to &#8220;Acadia,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; or &#8220;our&#8221; mean Acadia Healthcare Company, Inc. and its consolidated subsidiaries. Acadia Healthcare Company, Inc. is a holding company whose direct and indirect subsidiaries own and operate behavioral
      healthcare facilities and conduct healthcare and management operations. The terms &#8220;facilities,&#8221; &#8220;centers,&#8221; &#8220;clinics,&#8221; and &#8220;hospitals&#8221; refer to entities owned, operated, or managed by subsidiaries of Acadia Healthcare Company, Inc. References herein
      to &#8220;Acadia employees&#8221; or to &#8220;our employees&#8221; refer to employees of subsidiaries of Acadia Healthcare Company, Inc.</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;">i</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><!--PROfilePageNumberReset%Num%1%%%--><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"><img alt="" src="ny20042551x1_image01.jpg"/></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: Red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>6100 Tower Circle, Suite 1000</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/>
      <span style="text-transform: uppercase"><b>Franklin, Tennessee 37067</b></span></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><div><a id="a001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROXY STATEMENT</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Proxy Statement is furnished in connection with the solicitation by
      the Board of Directors (the &#8220;Board&#8221; or &#8220;Board of Directors&#8221;) of Acadia Healthcare Company, Inc. (the &#8220;Company&#8221;) of proxies to be voted at the 2025 Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;), to be held at our executive offices located at
      6100 Tower Circle, Suite 1000, Franklin, Tennessee 37067, on Thursday, May 29, 2025, at 8:00 a.m. (Central Time), for the purposes set forth in the accompanying notice, and at any adjournments or postponements thereof. This Proxy Statement and the
      accompanying proxy are first being mailed or made available to stockholders on or about April 10, 2025.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><div><a id="a002"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">INFORMATION CONCERNING SOLICITATION AND VOTING</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Record Date</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The close of business on April 1, 2025 has been fixed as the record date
      for the determination of stockholders entitled to vote at the Annual Meeting. As of such date, we had 180,000,000 authorized shares of common stock, $0.01 par value per share (&#8220;Common Stock&#8221;), of which 92,127,804 shares were outstanding and entitled
      to vote, and 10,000,000 authorized shares of preferred stock, $0.01 par value per share, of which no shares were outstanding. Common Stock is our only outstanding class of voting stock. Each share of Common Stock will have one vote on each matter to
      be voted upon at the Annual Meeting.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quorum Requirements</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A majority of the shares of Common Stock entitled to vote, represented in
      person or by proxy, is required to constitute a quorum. Abstentions and broker non-votes will be counted for purposes of determining the presence of a quorum at the Annual Meeting. If a quorum is not present at the time of the Annual Meeting, the
      stockholders entitled to vote, present in person or represented by proxy, shall have the power to adjourn the Annual Meeting until a quorum shall be present or represented by proxy. The Annual Meeting may be adjourned from time to time, whether or
      not a quorum is present, by the affirmative vote of a majority of the votes present and entitled to be cast at the Annual Meeting.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Voting Procedures</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Whether you hold shares directly as the stockholder of record or through a
      broker, trustee or other nominee, as the beneficial owner, you may direct how your shares are voted without attending the Annual Meeting. If you hold shares in street name, you must vote by giving instructions to your broker or nominee. You should
      follow the voting instructions on any form that you receive from your broker or nominee. The availability of telephone and Internet voting for shares held in street name will depend on your broker&#8217;s or nominee&#8217;s voting process. Please refer to the
      instructions in the materials provided in the Notice of Internet Availability of Proxy Materials or proxy card provided to you for information on the available voting methods.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If a proxy is properly given prior to or at the Annual Meeting and not
      properly revoked, it will be voted in accordance with the instructions, if any, given by the stockholder. Subject to the requirements described below, if no instructions are given, each proxy will be voted:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR </b>the election as directors of the nominees described in this Proxy Statement;</span></td>
      </tr>

  </table><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;">1</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR </b>the approval of an amendment to the Acadia Healthcare Company, Inc. Amended and Restated
            Incentive Compensation Plan;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR </b>the approval, on a non-binding advisory basis, of the compensation of our executive
            officers named in the section below entitled &#8220;EXECUTIVE COMPENSATION <span style="font-weight: normal;">&#8211;</span> Summary Compensation Table&#8221; (the &#8220;Named Executive Officers&#8221;);</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR </b>the approval, on a non-binding advisory basis, of a frequency of every year for future
            non-binding advisory votes on the compensation of our Named Executive Officers;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR </b>ratification of the appointment of Ernst &amp; Young LLP as our independent registered
            public accounting firm for the fiscal year ending December 31, 2025; and</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with the recommendation of the Board on any other proposal that may properly come before
            the Annual Meeting or any adjournments or postponements thereof.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The persons named as proxies were selected by our Board of Directors.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Without your instructions, your broker or nominee is permitted to use its
      own discretion and vote your shares on certain routine matters (such as Proposal 5), but is not permitted to use its discretion and vote your shares on non-routine matters (such as Proposals 1, 2, 3 and 4). We urge you to give voting instructions to
      your broker or nominee on all proposals. Shares that are not permitted to be voted by your broker or nominee are called &#8220;broker non-votes.&#8221; Broker non-votes are not considered votes for or against a proposal and, therefore, will have no direct impact
      on any proposal. If you abstain from voting on Proposal 1, your abstention will have no effect on the outcome of the election. If you abstain from voting on Proposals 2, 3, 4 or 5, your abstention will have the same legal effect as a vote against
      these proposals.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders who give proxies have the right to revoke them at any time
      before they are voted by delivering a written request to Brian P. Farley, Esq., Executive Vice President, General Counsel and Secretary, at 6100 Tower Circle, Suite 1000, Franklin, Tennessee 37067, prior to the Annual Meeting or by submitting another
      proxy at a later date. The giving of the proxy will not affect the right of a stockholder to attend the Annual Meeting and vote in person.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Miscellaneous</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will bear the cost of printing, mailing and other expenses in connection
      with this solicitation of proxies and will also reimburse brokers and other persons holding shares of Common Stock in their names or in the names of nominees for their expenses in forwarding the proxy materials to the beneficial owners of such
      shares. Certain of our directors, officers and employees may, without any additional compensation, solicit proxies in person or by telephone.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our management is not aware of any matters other than those described in
      this Proxy Statement that may be presented for action at the Annual Meeting. If any other matters properly come before the Annual Meeting, it is intended that the proxies will be voted with respect thereto in accordance with the judgment of the
      person or persons voting such proxies subject to the direction of our Board of Directors.</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;">2</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div><a id="a003"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROPOSAL 1: ELECTION OF DIRECTORS</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Introduction</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Amended and Restated Certificate of Incorporation, as amended
      (&#8220;Certificate of Incorporation&#8221;), provides that our Board of Directors shall be divided into three classes, subject to a declassification plan to fully phase out director classification by the Company&#8217;s 2029 annual meeting of stockholders, as further
      described below. All classes of directors currently have three-year terms. The terms of our Class II directors expire at the Annual Meeting.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As set forth in our Certificate of Incorporation, for our annual meeting of
      stockholders in 2025 and 2026, the classes of directors whose terms expire at those meetings will be nominated for re-election for three-year terms, respectively; for our annual meeting of stockholders in 2027, the class of directors whose terms
      expire at such meeting will be nominated for re-election for a two-year term; for our annual meeting of stockholders in 2028, the class of directors whose terms expire at such meeting will be nominated for re-election for a one-year term; and our
      Board of Directors will be fully declassified, with all directors standing for annual election, beginning with our annual meeting of stockholders in 2029. The following table illustrates how our classified Board of Directors will be phased out
      pursuant to our Certificate of Incorporation, assuming no change in the number of our directors.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="width: 22%; border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Annual Meeting</b></span></td>
        <td style="width: 32%; border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of Directors to be Elected</b></span></td>
        <td style="width: 46%; border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Term of Directors Elected<br/>
            &#160;(Year of Expiration)</b></span></td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
        <td style="border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td>
        <td style="border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
        <td style="border-top: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">three-year term<br/>
            (expires 2028)</span></td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
        <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td>
        <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
        <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">three-year term<br/>
            (expires 2029)</span></td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
        <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2027</span></td>
        <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td>
        <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">two-year term<br/>
            (expires 2029)</span></td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
        <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2028</span></td>
        <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
        <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">one-year term<br/>
            (expires 2029)</span></td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
        <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2029</span></td>
        <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td>
        <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">one-year term<br/>
            (expires 2030)</span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Board of Directors has nominated the individuals named below under the
      caption &#8220;Class II Nominees&#8221; for election as directors to serve until the annual meeting of stockholders in 2028 and their successors have been elected and take office or until their earlier death, resignation or removal. Each nominee has consented to
      be a candidate and to serve if elected. Proxies cannot be voted for a greater number of persons than the nominees named.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Qualification of Directors</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As described below, our Board of Directors is composed of individuals from
      differing backgrounds and experiences. As reflected in the table set forth below, we believe that each of our continuing directors possesses unique qualifications, skills and attributes that complement the performance of the Board of Directors as a
      whole. The experience that each has obtained from his or her professional background, as set forth below, has qualified him or her to serve on our Board of Directors.</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;">3</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table highlights key skills, experiences and qualifications
      of our continuing directors in areas deemed valuable for execution of our long-term strategy. Such skills matrix is intended to set forth notable areas of strength, and the absence of a mark does not mean that a particular director lacks the
      corresponding skill, experience, or qualification.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 40%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; border-right: Black 1pt solid; text-align: left; padding-right: 5pt; padding-left: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Skill or Experience</b></span></td>
        <td style="width: 6%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mr. Bernhard</b></span></td>
        <td style="width: 6%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mr. Bissell</b></span></td>
        <td style="width: 6%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mr. Fucci</b></span></td>
        <td style="width: 6%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ms. Gregg</b></span></td>
        <td style="width: 6%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mr. Grieco</b></span></td>
        <td style="width: 6%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dr. Harris</b></span></td>
        <td style="width: 6%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mr. Hunter</b></span></td>
        <td style="width: 6%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mr. Kelly</b></span></td>
        <td style="width: 6%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mr. Miquelon</b></span></td>
        <td style="width: 6%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 5.75pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Mr. Waud</b></span></td>
      </tr>
      <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
        <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 5pt; padding-left: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Health Care Industry</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
      </tr>
      <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
        <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 5pt; padding-left: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quality/Patient Management</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
      </tr>
      <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
        <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 5pt; padding-left: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Real Estate/Project Management</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
      </tr>
      <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
        <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 5pt; padding-left: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board and Governance</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
      </tr>
      <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
        <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 5pt; padding-left: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Management</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
      </tr>
      <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
        <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 5pt; padding-left: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit/Finance and Legal/Risk
            Management</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
      </tr>
      <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
        <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 5pt; padding-left: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">M&amp;A and Strategic Initiatives</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
      </tr>
      <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
        <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 5pt; padding-left: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information Technology/Digital</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
      </tr>
      <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
        <td style="border-right: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 5pt; padding-left: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government/Regulatory/ Public
            Policy</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#10003;</span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class II Nominees</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table shows the names, ages and principal occupations of each
      of the nominees designated by our Board of Directors to become directors and the year in which each nominee was first appointed or elected to the Board of Directors:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 26%; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></p>
        </td>
        <td style="width: 8%; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></p>
        </td>
        <td style="width: 57%; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal Occupation/Other Directorships</b></span></p>
        </td>
        <td style="width: 9%; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director</b></span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Since</b></span></p>
        </td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 3pt; padding-left: 3pt">&#160;</td>
        <td style="text-align: center; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt"/>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"/>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jason R. Bernhard</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Bernhard is the Global Chief Operating Officer, Financial
            Advisory; Managing Director, and a Vice Chairman of Investment Banking at Lazard, Inc. where he has served for more than 25 years. In addition, he was formerly Global Co-Head of Lazard&#8217;s Healthcare Investment Banking group. Our Board believes
            that Mr. Bernhard is qualified to serve as a director because of, among other things, his extensive corporate finance background and his general business and financial acumen.</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 3pt; padding-left: 3pt">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 3pt; padding-left: 3pt">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt">&#160;</td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">William F. Grieco</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">71</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since March 2018, Mr. Grieco has served as Chief Compliance
            Officer of NX Development Corporation, the U.S. life sciences affiliate of Tokyo-based SBI Holdings, Inc., and since May 2021, has served as Senior Vice President and General Counsel. Also, since 2008, Mr. Grieco has served as the Managing
            Director of Arcadia Strategies, LLC, a legal and business consulting organization servicing healthcare, science and technology companies. From 2003 to 2008, he served as Senior Vice President and General Counsel of American Science and
            Engineering, Inc., an x-ray inspection technology company. From 2001 to 2002, he served as Senior Vice President and General Counsel of IDX Systems Corporation, a healthcare information technology company. Previously, from 1995 to 1999, he was
            Senior Vice President and General Counsel for Fresenius Medical Care North America, a dialysis service and products company. Prior to that, Mr. Grieco was a partner in the Healthcare Department at Choate, Hall &amp; Stewart, a general service
            law firm. Mr. Grieco previously served on the board of directors of PHC, Inc. Our Board believes that Mr. Grieco is qualified to serve as a director because of, among other things, his extensive knowledge of and experience in the healthcare
            industry and his general business and financial acumen.</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2011</span></td>
      </tr>

  </table><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;">4</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><!--PROfilePageNumberReset%Num%5%%%--><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 26%; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></p>
        </td>
        <td style="width: 8%; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></p>
        </td>
        <td style="width: 57%; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal Occupation/Other Directorships</b></span></p>
        </td>
        <td style="width: 9%; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director</b></span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Since</b></span></p>
        </td>
      </tr>
      <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt">&#160;</td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 26%; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">R. David Kelly</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 8%; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 57%; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since 2011, Mr. Kelly has served as the founder and
            managing partner of StraightLine Realty Partners, an alternative investment platform based in Dallas, Texas. Mr. Kelly has also been a founder of multiple real estate and investment companies, including Croesus and Company, Serra Real Estate
            Capital, LLC, Circuit Avenue Advisors and Atwood Management. He previously served as a founding partner of Carleton Residential Properties from 1996 to 2011. Mr. Kelly currently serves as a director or trustee of Invesco Commercial Real Estate
            Finance Trust, Inc., the Children&#8217;s Medical Center (Dallas) Foundation, and the Dallas Police and Fire Pension Fund. Mr. Kelly has served on major institutional investor boards, including serving as trustee and Chairman of the Teacher
            Retirement System of Texas from 2007-2017, as well as multiple endowment, financial services and real estate boards. Our Board believes that Mr. Kelly is qualified to serve as a director because of, among other things, his extensive corporate
            finance and real estate background and his general business and financial acumen.</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 9%; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 3pt; padding-left: 3pt">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 3pt; padding-left: 3pt">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt">&#160;</td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reeve B. Waud</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">61</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Waud founded the Company in 2005 and, most recently, has
            served as the Chairman of the Board since December 2018. Mr. Waud previously served as the Lead Director of the Board from April 2012 to December 2018. Mr. Waud formed Waud Capital Partners, L.L.C. (&#8220;WCP&#8221;) in 1993 and has served as the Managing
            Partner of WCP since that time. Prior to founding WCP, Mr. Waud was an investment professional at Golder, Thoma, Cressey, Rauner, Inc. (&#8220;GTCR&#8221;), a private equity investment group based in Chicago, Illinois. Before joining GTCR, Mr. Waud was in
            the Corporate Finance Group of Salomon Brothers Inc and was a founding member of its Venture Capital Group. He serves on the board of directors of the Northwestern Memorial HealthCare Foundation. In addition, he is a trustee and member of the
            finance committee of the Art Institute of Chicago. Mr. Waud has served on various for profit and non-profit boards, including the Northwestern Memorial HealthCare finance committee, the John G. Shedd Aquarium, the Economic Club of Chicago, the
            Illinois State Police Merit Board, and St. Paul&#8217;s School in Concord, New Hampshire. Our Board believes that Mr. Waud is qualified to serve as a director because of, among other things, his extensive knowledge of and experience in the healthcare
            industry and his general business and financial acumen. Mr. Waud was originally designated as a director by WCP.</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2005</span></td>
      </tr>

  </table><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&#160;</p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Required Vote</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Certificate of Incorporation provides that, in an uncontested election,
      a nominee is elected if a majority of the votes cast by the holders of the shares of Common Stock entitled to vote in the election at a meeting at which a quorum is present are cast in favor of such nominee&#8217;s election. In contested elections,
      directors are elected by a plurality of the votes cast. Our Certificate of Incorporation does not provide for cumulative voting, and, accordingly, the stockholders do not have cumulative voting rights with respect to the election of directors.
      Consequently, each stockholder may cast one vote per share of Common Stock held of record for each nominee. Abstentions and broker non-votes will have no effect on the outcome of the election. If a nominee becomes unavailable for election, shares
      covered by a proxy will be voted for a substitute nominee selected by our Board of Directors.</span></p><div>
  </div><p style="margin: 0pt 0px; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 0px;"><br/>
  </p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Board of Directors recommends that the stockholders vote FOR each
        of the Class II nominees.</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.2in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">5</span></div>
    <div class="BRPFPageBreak" style="page-break-after: always;">
      <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Continuing Directors</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each of the persons named below will continue to serve as a director until
      the annual meeting of stockholders in the year indicated and a successor is elected and takes office or until his or her earlier death, resignation or removal. Stockholders are not voting on the election of the Class I directors or Class III
      directors. The following table shows the names, ages, principal occupations and other directorships of each continuing director and the year in which each was first appointed or elected to our Board or that of our predecessor, Acadia Healthcare
      Company, LLC:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 25%; font: 10pt Times New Roman, Times, Serif">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt; text-align: center; border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></p>
        </td>
        <td style="width: 7%; font: 10pt Times New Roman, Times, Serif">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt; text-align: center; border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></p>
        </td>
        <td style="width: 59%; font: 10pt Times New Roman, Times, Serif">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt; text-align: center; border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal Occupation/Other Directorships</b></span></p>
        </td>
        <td style="width: 9%; font: 10pt Times New Roman, Times, Serif">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director</b></span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt; text-align: center; border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Since</b></span></p>
        </td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 3pt; padding-left: 3pt">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"><br/>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 3pt; padding-left: 3pt"><br/>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"><br/>
        </td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class III<br/>
            Term Expiring in 2026</b></span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"><br/>
        </td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt"><br/>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"><br/>
        </td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 3pt; padding-left: 3pt">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"><br/>
        </td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt"><br/>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"><br/>
        </td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael J. Fucci</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior to his retirement in September 2020, Mr. Fucci served as
            Chairman Emeritus of Deloitte U.S. He previously served as Executive Chairman of Deloitte U.S. from 2015 to 2019, Chief Operating Officer of Deloitte Consulting from 2009 to 2015 and held various management positions since 2003. Mr. Fucci also
            served as a member on both the Deloitte U.S. and Deloitte Global Boards of Directors. While at Deloitte U.S., he established and co-chaired the Board Leadership Forum, a coalition of Fortune 500 board chairs and lead directors. Mr. Fucci
            currently serves on the board of directors of Flotek Industries, Inc. (NYSE: FTK). <span style="background-color: white">Our Board believes that Mr. Fucci is qualified to serve as a director because of, among other things, his extensive
              corporate finance background, corporate governance experience, deep experience around talent strategy and his general business and financial acumen.</span></span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 3pt; padding-left: 3pt">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt">&#160;</td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt">&#160;</td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patrice A. Harris, M.D., M.A.</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr. Harris is a board-certified psychiatrist and the Co-Founder
            and Chief Executive Officer of eMed Digital Healthcare, a digital healthcare company. She is also an Adjunct Professor of Psychiatry and Behavioral Sciences at Emory University School of Medicine, and an Adjunct Clinical Assistant Professor in
            Psychiatry and Behavioral Sciences at Morehouse School of Medicine. Dr. Harris is a Fellow of the American Psychiatric Association (&#8220;APA&#8221;). She previously served as the President of the American Medical Association (&#8220;AMA&#8221;) from 2019 to 2020,
            and Chair of the AMA&#8217;s Opioid Task Force from 2014 to 2021. Dr. Harris previously served on the Board of Trustees of the APA. Dr. Harris currently serves on the board of directors of United Bankshares, Inc. (NASDAQ: UBSI). O<span style="background-color: white">ur Board believes that Dr. Harris is qualified to serve as a director because of, among other things, her extensive healthcare experience, particularly in the psychiatric and behavioral healthcare fields.</span></span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td>
      </tr>

  </table><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">6</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 25%; font: 10pt Times New Roman, Times, Serif">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt; text-align: center; border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></p>
        </td>
        <td style="width: 7%; font: 10pt Times New Roman, Times, Serif">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt; text-align: center; border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></p>
        </td>
        <td style="width: 59%; font: 10pt Times New Roman, Times, Serif">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt; text-align: center; border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal Occupation/Other Directorships</b></span></p>
        </td>
        <td style="width: 9%; font: 10pt Times New Roman, Times, Serif">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director</b></span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt; text-align: center; border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Since</b></span></p>
        </td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 3pt; padding-left: 3pt">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt">&#160;</td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt">&#160;</td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wade D. Miquelon</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Miquelon is currently founder and partner in Playmore Holdings, LLC, a beauty,
              health and leisure investment and operations company. Prior to his retirement in May 2023, Mr. Miquelon served as the President, Chief Executive Officer and a member of the board of directors of JOANN Inc. (NASDAQ: JOAN) (&#8220;Jo-Ann&#8221;), the
              nation&#8217;s leading fabric and craft specialty retailer (which filed for Chapter 11 bankruptcy in March 2024 and January 2025). Prior to that, he served as the Chief Financial Officer and Executive Vice President of Jo-Ann. Prior to joining
              Jo-Ann, he served as Chief Financial Officer, Executive Vice President and President International for Walgreen Co. from June 2008 to August of 2014. From 2006 to 2008, he was Executive Vice President and Chief Financial Officer at Tyson
              Foods, Inc. Prior to that, Mr. Miquelon served Procter and Gamble in several positions of increasing responsibility in the U.S., Asia and Europe. Mr. Miquelon serves on the advisory board of Vorto, an AI-based supply chain company. He has
              served on various for profit and non-profit boards including Jo-Ann, Alliance Boots, the Chicago Lyric Opera, the John G. Shedd Aquarium and the National 4-H Council. Our Board believes that Mr. Miquelon is qualified to serve as a director
              because of, among other things, his extensive knowledge and background in public accounting and finance.</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2012</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Class I<br/>
            Term Expiring in 2027</b></span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"/>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"/>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 3pt; padding-left: 3pt">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"/>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"/>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E. Perot Bissell</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">65</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Bissell currently serves as an Advisory Partner at Egis
            Capital Partners, LLC (&#8220;Egis Capital&#8221;), a private equity firm that invests in the security and protection industries. From 2016 to 2023, Mr. Bissell was a Managing Partner of Egis Capital. Mr. Bissell served as the Chairman and Chief Executive
            Officer of Next Generation Energy Logistics, LLC, an energy logistics development company, from 2013 to 2015. Before that, Mr. Bissell served as the Vice Chairman of Pilot Logistics Services, a provider of drilling and exploration support
            services, from September 2012 until July 2013. From 2006 to 2012, he served as Chief Executive Officer for Maxum Petroleum, Inc., an independent energy logistics company. Prior to that, Mr. Bissell was a Partner of Northwest Capital
            Appreciation, Inc., a merchant banking and private equity firm, and before that, the Co-Managing Partner and Chief Financial Officer of SLP Capital, a specialty finance company. Mr. Bissell currently serves on the board of directors of Palmdale
            Solutions, LLC, an energy logistics platform, and Clear Object, Inc., a provider of AI video solutions for preventative maintenance for mission critical equipment and infrastructure. Mr. Bissell previously served on the board of directors of
            First Reserve Sustainable Growth Corp. (NASDAQ: FRSG) from 2021 to 2023. Our Board believes that Mr. Bissell is qualified to serve as a director because of, among other things, his extensive corporate finance background and his general business
            and financial acumen.</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2013</span></td>
      </tr>

  </table><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">7</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 25%; font: 10pt Times New Roman, Times, Serif">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt; text-align: center; border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></p>
        </td>
        <td style="width: 7%; font: 10pt Times New Roman, Times, Serif">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt; text-align: center; border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></p>
        </td>
        <td style="width: 59%; font: 10pt Times New Roman, Times, Serif">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt; text-align: center; border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal Occupation/Other Directorships</b></span></p>
        </td>
        <td style="width: 9%; font: 10pt Times New Roman, Times, Serif">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director</b></span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3pt; text-align: center; border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Since</b></span></p>
        </td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 3pt; padding-left: 3pt; width: 25%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt; width: 7%">&#160;</td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt; width: 59%">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt; width: 9%">&#160;</td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vicky B. Gregg</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since November 2014, Ms. Gregg has served as Co-Founder and
            Partner of Guidon Partners, an investor and consultant for an array of privately held healthcare companies. She served as Chief Executive Officer of BlueCross BlueShield of Tennessee from January 2003 through the end of 2012. Ms. Gregg
            currently serves on the board of directors of Quest Diagnostics Incorporated (NYSE: DGX), Erlanger Health, and Capital Vision Services, LLC d/b/a MyEyeDr. Our Board believes that Ms. Gregg is qualified to serve as a director because of, among
            other things, her extensive healthcare background and her general business and financial acumen.</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2016</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 3pt; padding-left: 3pt">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 3pt; padding-left: 3pt">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt">&#160;</td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher H. Hunter</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since April 11, 2022, Mr. Hunter has served as our Chief
            Executive Officer. From January 2014 through August 2021, Mr. Hunter served in senior leadership positions at Humana, most recently as President of Humana&#8217;s Group, Military &amp; Specialty and previously as Humana&#8217;s Chief Strategy Officer. Mr.
            Hunter served as President, Provider Markets, for TriZetto Corporation prior to joining Humana. Mr. Hunter serves on the board of directors of the University of North Carolina-Chapel Hill Honors Program. Our Board believes that Mr. Hunter is
            qualified to serve as a director because of, among other things, his extensive healthcare background and his general business and financial acumen.</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-right: 3pt; padding-left: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td>
      </tr>

  </table><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">8</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div><a id="a004"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROPOSAL 2: APPROVAL OF AMENDMENT TO <span style="text-transform: uppercase">Acadia Healthcare Company, Inc. Amended and Restated</span> INCENTIVE COMPENSATION PLAN</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Background </b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Acadia Healthcare Company, Inc. Amended and Restated Incentive
      Compensation Plan, last amended and restated in 2023 (the &#8220;Incentive Plan&#8221;), provides for grants of stock options, stock appreciation rights (&#8220;SARs&#8221;), restricted stock and other stock-based and cash-based awards. Directors, officers and other
      employees of the Company, as well as other persons performing consulting or advisory services for the Company, are eligible for grants under the Incentive Plan. The purpose of the Incentive Plan is to provide incentives that will attract, retain and
      reward high performing officers, directors, employees and consultants by providing them with a proprietary interest in our long-term success or compensation based on their performance in fulfilling their responsibilities to the Company.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of April 1, 2025, there were outstanding under the Incentive Plan:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 80%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; margin-left: 30pt">

      <tr style="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 86%; padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Stock Options Outstanding</span></td>
        <td style="width: 14%; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">655,686</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Unvested Restricted Stock Outstanding</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,829,245</span></td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Unvested Restricted Stock Units Outstanding</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">201,868</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Common Stock Outstanding</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">92,127,804</span></td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-Average Exercise Price of Stock Options
            Outstanding</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$57.44</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-Average Remaining Duration of Stock Options
            Outstanding</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.20</span></td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-left: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Shares Available for Grant under Incentive Plan</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,202,970</span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The closing price of a share of our Common Stock on The NASDAQ Global
      Select Market on April 1, 2025 was $29.93. The Incentive Plan is the Company&#8217;s only equity compensation plan.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposal </b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 2025, the Compensation Committee and the Board of Directors
      approved and adopted an amendment to the Incentive Plan (the &#8220;Amendment&#8221;), subject to stockholder approval. If approved, the Amendment would increase the aggregate number of shares of our Common Stock that may be issued or used for purposes of awards
      granted under the Incentive Plan by 2,475,000 shares, which would increase the aggregate number of shares available for issuance or use under the Incentive Plan from 12,700,000 shares to 15,175,000 shares. Increasing the number of shares of Common
      Stock available for issuance or use under the Incentive Plan would enable the Company to effectively use the Incentive Plan going forward in attracting, retaining and rewarding talented officers, directors, employees and consultants. The Incentive
      Plan is not being amended in any other respect.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholders are being asked to approve the Amendment at the Annual
      Meeting. The full text of the Amendment is included in <i>Appendix A</i> to this Proxy Statement.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description of the Incentive Plan </b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set forth below is a summary of the material terms of the Incentive Plan.
      The summary is qualified in its entirety by reference to the full text of the Incentive Plan, which is included in <i>Appendix B</i> to this Proxy Statement.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Administration</i>. The Incentive Plan is administered by the
      Compensation Committee. Under the Incentive Plan, the Compensation Committee has the power to:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 27pt; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 27pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Grant awards under the Incentive Plan and determine the recipients, type of awards, form, amount and
            other terms and conditions of awards, including the number of shares of Common Stock in each award;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 27pt; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 27pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Construe and interpret the terms and provisions of the Incentive Plan or any award agreement;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 27pt; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 27pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amend the terms of outstanding awards;</span></td>
      </tr>

  </table><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">9</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 27pt; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 27pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Administer the Incentive Plan and adopt such rules, forms, instruments and guidelines for administering
            the Incentive Plan as it deems necessary or proper;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 27pt; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 27pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Make all other determinations in connection with the Incentive Plan and the awards; and</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 27pt; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 27pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delegate authority under the Incentive Plan.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Available Shares.</i> On and after the effective date of the Amendment,
      the aggregate number of shares of our Common Stock which may be issued or used for reference purposes under the Incentive Plan or with respect to which awards may be granted may not exceed 15,175,000 shares. The number of shares available for
      issuance under the Incentive Plan may be subject to adjustment in the event of a reorganization, stock split, merger or similar change in the corporate structure or the number of outstanding shares of our Common Stock. In the event of any of these
      occurrences, we may make any appropriate adjustments to, among other things, the number and kind of shares, options or other property available for issuance under the Incentive Plan or covered by outstanding awards. The shares available for issuance
      under the Incentive Plan may be either authorized and unissued shares of our Common Stock or shares of Common Stock held in or acquired for our treasury. In general, if awards under the Incentive Plan are for any reason cancelled, or expire or
      terminate unexercised, the shares covered by such awards may again be available for the grant of awards under the Incentive Plan.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Maximum Awards.</i> The maximum number of shares of our Common Stock
      subject to any performance award granted to any one participant during any fiscal year is 750,000 shares, and the maximum number of shares of our Common Stock for all awards granted to any one participant during any fiscal year is 1,500,000 shares.
      The maximum value of a cash payment made under a performance award with respect to any fiscal year is $10,000,000.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Eligibility for Participation.</i> Members of our Board of Directors,
      as well as our employees and consultants, are eligible to receive awards under the Incentive Plan. The number of persons eligible to participate in the Incentive Plan as of April 1, 2025 is estimated to be approximately 25,500 employees, officers,
      consultants and advisors, as a class, and nine non-employee directors.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Award Agreement.</i> Awards granted under the Incentive Plan will
      generally be evidenced by award agreements, which need not be identical, that provide additional terms, conditions, restrictions or limitations covering the grant of the award, including additional terms providing for the acceleration of
      exercisability or vesting of awards in the event of a change of control or conditions regarding the participant&#8217;s employment, as determined by the Compensation Committee.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock Options.</i> The Compensation Committee may grant nonqualified
      options to purchase shares of our Common Stock to eligible employees and eligible non-employees, and incentive options to purchase shares of our Common Stock only to eligible employees. The Compensation Committee will determine the number of shares
      of our Common Stock subject to each option, the term of each option, which may not exceed ten years (or five years in the case of an incentive stock option granted to a 10% or greater stockholder), the exercise price, the vesting schedule (if any)
      and the other material terms of each option. No incentive stock option or nonqualified stock option may have an exercise price less than the fair market value of a share of our Common Stock at the time of grant or, in the case of an incentive stock
      option granted to a 10% or greater stockholder, 110% of such fair market value. Options will be exercisable at such time or times and subject to such terms and conditions as determined by the Compensation Committee at grant and the exercisability of
      such options may be accelerated by the Compensation Committee.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock Appreciation Rights.</i> The Compensation Committee may grant
      SARs either with a stock option, which may be exercised only at such times and to the extent the related option is exercisable (a &#8220;Tandem SAR&#8221;), or independent of a stock option (a &#8220;Non-Tandem SAR&#8221;). A SAR is a right to receive a payment in shares of
      our Common Stock or cash, as determined by the Compensation Committee, equal in value to the excess of the fair market value of one share of our Common Stock on the date of exercise over the exercise price per share established in connection with the
      grant of the SAR. The term of each SAR may not exceed ten years. The exercise price per share covered by an SAR will be the exercise price per share of the related option in the case of a Tandem SAR and will be the fair market value of our Common
      Stock on the date of grant in the case of a Non-Tandem SAR. The Compensation Committee may also grant limited SARs, either as Tandem SARs or Non-Tandem SARs, which may become exercisable only upon the occurrence of a change in control, as defined in
      the Incentive Plan, or such other event as the Compensation Committee may designate at the time of grant or thereafter.</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">10</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted Stock.</i> The Compensation Committee may award shares of
      restricted stock. Except with respect to dividends or as otherwise provided by the Compensation Committee upon the award of restricted stock, the recipient generally will have the rights of a stockholder with respect to the shares, including the
      right to vote the shares of restricted stock and, conditioned upon full vesting of shares of restricted stock, the right to tender such shares, subject to the conditions and restrictions generally applicable to restricted stock or specifically set
      forth in the recipient&#8217;s restricted stock agreement. I<span style="background-color: white">n no event will dividends or dividend equivalents be granted with respect to unvested shares of restricted stock, except that the Compensation Committee may
        provide in the applicable award agreement at the time of grant that the payment of dividends shall be deferred until, and conditioned upon, vesting of the shares of restricted stock. </span>Recipients of restricted stock will generally be required
      to enter into a restricted stock agreement with us that states the restrictions to which the shares are subject, which may include satisfaction of pre-established performance goals, and the criteria or date or dates on which such restrictions will
      lapse. If the grant of restricted stock or the lapse of the relevant restrictions is based on the attainment of performance goals, the Compensation Committee will establish for each recipient the applicable performance goals, formulae or standards
      and the applicable vesting percentages with reference to the attainment of such goals or satisfaction of such formulae or standards while the outcome of the performance goals are substantially uncertain. Such performance goals may incorporate
      provisions for disregarding, or adjusting for, changes in accounting methods, corporate transactions, including dispositions and acquisitions, and other similar events or circumstances.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other Stock-Based Awards.</i> The Compensation Committee may, subject
      to limitations under applicable law, make a grant of such other stock-based awards, including nonmanagement director compensation paid at the election of a director in shares of our Common Stock in lieu of cash, stock equivalent units and restricted
      stock units that are payable in cash or denominated or payable in or valued by shares of our Common Stock or factors that influence the value of such shares. The Compensation Committee may determine the terms and conditions of any such other awards,
      which may include the achievement of certain minimum performance goals and a minimum vesting period.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other Cash-Based Awards.</i> The Compensation Committee may grant
      awards payable in cash. Cash-based awards shall be in such form, and dependent on such conditions, as the Compensation Committee shall determine, including being subject to the satisfaction of vesting conditions or awarded purely as a bonus and not
      subject to restrictions or conditions. If a cash-based award is subject to vesting conditions, the Compensation Committee may accelerate the vesting of such award in its discretion.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Performance Awards.</i> The Compensation Committee may grant a
      performance award to a participant payable upon the attainment of specific performance goals. If the performance award is payable in cash, it may be paid upon the attainment of the relevant performance goals either in cash or in shares of restricted
      stock, based on the then current fair market value of such shares, as determined by the Compensation Committee. Based on service, performance or other factors or criteria, the Compensation Committee may, at or after grant, accelerate the vesting of
      all or any part of any performance award.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Change in Control.</i> In connection with a change in control, as
      defined in the Incentive Plan, the Compensation Committee may accelerate vesting of outstanding awards under the Incentive Plan. In addition, such awards may be, in the discretion of the Compensation Committee:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 42.5pt; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 18pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumed and continued or substituted in accordance with applicable law; or</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 42.5pt; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 18pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchased by us for an amount equal to the excess of the price of a share of our Common Stock paid in a
            change in control over the exercise price of the awards.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Compensation Committee may also provide for accelerated vesting or
      lapse of restrictions of an award at any time.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stockholder Rights.</i> Except as otherwise provided in the applicable
      award agreement and with respect to an award of restricted stock, a participant will have no rights as a stockholder with respect to shares of our Common Stock covered by any award until the participant becomes the record holder of such shares. I<span style="background-color: white">n no event will dividends or dividend equivalents be granted with respect to unvested awards, except that the Compensation Committee may provide in the applicable award agreement at the time of grant that the payment
        of dividends shall be deferred until, and conditioned upon, vesting of the award.</span></span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">11</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Amendment and Termination.</i> Notwithstanding any other provision of
      the Incentive Plan, generally our Board of Directors may at any time amend any or all of the provisions of the Incentive Plan, or suspend or terminate it entirely, retroactively or otherwise; provided, however, that, unless otherwise required by law
      or specifically provided in the Incentive Plan, the rights of a participant with respect to awards granted prior to such amendment, suspension or termination may not be adversely affected without the consent of such participant. Repricing of options
      and SARs (including the cash buyout of underwater options and SARs) without stockholder approval is prohibited.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transferability. </i>Awards granted under the Incentive Plan generally
      are nontransferable, other than by will or the laws of descent and distribution, except that the Compensation Committee may provide for the transferability of nonqualified stock options at the time of grant or thereafter to certain family members.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recoupment of Awards.</i> The Incentive Plan provides that awards
      granted under the Incentive Plan are subject to any right that we might have (i) under any recoupment policy or (ii) regarding the clawback of &#8220;incentive-based compensation&#8221; under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;),
      and under any applicable rules and regulations promulgated by the Securities and Exchange Commission (the &#8220;SEC&#8221;).</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Federal Income Tax Consequences </b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under present federal income tax law, participants will generally realize
      ordinary income equal to the amount of a cash award under the Incentive Plan in the year of receipt. With respect to equity awards (other than options) under the Incentive Plan, participants will generally recognize ordinary income based on the
      market value of our Common Stock at the time it becomes vested or earned under an award; however, with respect to an award of restricted stock, participants can make an election under Section 83(b) of the Internal Revenue Code of 1986, as amended
      (the &#8220;Code&#8221;), to be taxed on the value of the Common Stock at the time the award is granted. In either case, the individual is also subject to capital gains treatment on the subsequent sale of the Common Stock acquired through an award. For this
      purpose, the individual&#8217;s basis in the Common Stock is its fair market value at the time the Common Stock subject to the award becomes vested. If an election under Section 83(b) is made, basis is determined at the time the Common Stock was
      transferred. With respect to nonqualified stock options, a participant will recognize ordinary income when the option is exercised, equal to the difference between the exercise price and the fair market value of our Common Stock at the time of
      exercise. A participant who exercises an incentive stock option generally will not recognize any ordinary income, provided the participant holds the Common Stock for at least two years from the time of grant of the option and one year from the time
      of exercise.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will generally be entitled to a corresponding federal income tax
      deduction at the time the participant recognizes ordinary income. However, Section 162(m) of the Code generally limits federal income tax deductions for compensation paid to a &#8220;covered employee&#8221; in any taxable year to $1 million. A person is a
      covered employee if such person was the Company&#8217;s Chief Executive Officer or Chief Financial Officer, was one of the Company&#8217;s three other most highly compensated officers for the fiscal year, or was a covered employee in a prior year.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Incentive Plan is intended to comply with Section 409A of the Code to
      the extent that such section would apply to any award under the Incentive Plan. Section 409A of the Code governs the taxation of deferred compensation. Any participant that is granted an award that is deemed to be deferred compensation, such as a
      grant of restricted stock units that does not qualify for an exemption from Section 409A of the Code, and does not comply with Section 409A of the Code, could be subject to taxation on the award as soon as the award is no longer subject to a
      substantial risk of forfeiture and an additional 20% tax (and a further additional tax based upon an amount of interest determined under Section 409A of the Code) on the value of the award.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Required Vote </b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The affirmative vote of the holders of a majority of the shares of Common
      Stock present in person or represented by proxy at the Annual Meeting and entitled to vote on the matter is needed to approve the Amendment. Under Delaware law, an abstention will have the same legal effect as a vote against approval of the
      Amendment, and broker non-votes will have no effect on the outcome of the approval of the Amendment.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The Board of Directors recommends that the stockholders vote FOR approval of the
        Amendment. </b></span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">12</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table provides information as of December 31, 2024 with
      respect to compensation plans (including individual compensation arrangements) under which shares of Common Stock are authorized for issuance:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 32%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plan Category</span></td>
        <td style="width: 2%; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"/>
        <td style="width: 20%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of Securities to be Issued
            upon Exercise of Outstanding Options, Warrants and Rights</span></td>
        <td style="width: 2%; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"/>
        <td style="width: 20%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-Average Exercise Price
            of Outstanding Options, Warrants and Rights</span></td>
        <td style="width: 2%; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"/>
        <td style="width: 22%; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of Securities Remaining
            Available for Future Issuance under Equity Compensation<br/>
            Plans<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></span></td>
      </tr>
      <tr style="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
        <td style="vertical-align: top; font: 10pt Times New Roman,Times,serif; text-align: left; padding-right: 5pt; padding-left: 5pt;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity Compensation Plans Approved by
            Stockholders<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></span></td>
        <td style="vertical-align: top; font: 10pt Times New Roman,Times,serif; text-align: right;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
        <td style="line-height: normal; vertical-align: bottom; padding-top: 0px; padding-right: 30pt; padding-left: 0px; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: right;"><span style="font-family: Times New Roman, Times, Serif;">2,131,957<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></span></td>
        <td style="vertical-align: top; font: 10pt Times New Roman,Times,serif; text-align: right;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
        <td style="vertical-align: bottom; font: 10pt Times New Roman,Times,serif; text-align: right; padding-right: 40pt;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$57.45</span></td>
        <td style="vertical-align: top; font: 10pt Times New Roman,Times,serif; text-align: right;"/>
        <td style="font: 10pt Times New Roman,Times,serif; text-align: right; padding-right: 40pt;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,053,112</span></td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-right: 5pt; padding-left: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity Compensation Plans Not Approved by
            Stockholders</span></td>
        <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
        <td style="vertical-align: bottom; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 40pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
        <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
        <td style="vertical-align: bottom; text-align: right; font: 10pt Times New Roman, Times, Serif; padding-right: 40pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
        <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: right"/>
        <td style="vertical-align: bottom; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 40pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
      </tr>
      <tr style="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
        <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; padding-right: 5pt; padding-left: 5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
        <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
        <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 40pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,131,957</span></td>
        <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 40pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
        <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
        <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 40pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,053,112</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><!-- Field: Rule-Page --><div>
  </div><div style="margin-top: 3pt; margin-bottom: 3pt; text-align: LEFT;">
    <div style="font-size: 1pt; border-top: Black 1pt solid; width: 20%">&#160;</div>
  </div><div>
  </div><!-- Field: /Rule-Page --><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excludes shares to be issued upon exercise of outstanding options and vesting of outstanding restricted
            stock units.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents securities issued or available for issuance under the Incentive Plan.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 291,518 shares that may be issued upon vesting of outstanding restricted stock units that vest
            over three years, assuming that maximum performance goals are attained in all three years.</span></td>
      </tr>

  </table><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">13</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div><a id="a005"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROPOSAL 3: NON-BINDING ADVISORY VOTE ON EXECUTIVE COMPENSATION</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The Dodd-Frank Wall Street Reform and Consumer
      Protection Act of 2010 (the &#8220;Dodd-Frank Act&#8221;) enables our stockholders to vote to approve, on a non-binding advisory basis, the compensation of our Named Executive Officers as described below in the sections entitled &#8220;COMPENSATION DISCUSSION AND
      ANALYSIS&#8221; and &#8220;EXECUTIVE COMPENSATION.&#8221; Because your vote is advisory, it will not be binding on the Board of Directors or the Compensation Committee, override any decision made by the Board of Directors or the Compensation Committee or create or
      imply any additional fiduciary duty of the Board of Directors or the Compensation Committee. The Compensation Committee will, however, review the voting results and take them into consideration when making future decisions regarding executive
      compensation. </span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Our executive compensation program is vital to our
      ability to attract, motivate and retain a highly experienced team of executives. We believe that the program is structured in a manner that supports our company and our business objectives. </span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">In accordance with Section 14A of the Exchange Act, we
      are asking our stockholders to indicate their support for the compensation of our Named Executive Officers disclosed in this Proxy Statement. This proposal, commonly known as a &#8220;say-on-pay&#8221; proposal, gives our stockholders the opportunity to express
      their views on the compensation of our Named Executive Officers. This vote is not intended to address any specific item of compensation, but rather the overall compensation of our Named Executive Officers and the philosophy, policies and practices
      described in this Proxy Statement. Accordingly, we ask our stockholders to vote FOR the following resolution at the Annual Meeting: </span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">RESOLVED, that the Company&#8217;s stockholders approve, on a
      non-binding advisory basis, the compensation of the Named Executive Officers as disclosed in the Company&#8217;s Proxy Statement for the 2025 Annual Meeting of stockholders pursuant to Item 402 of Regulation S-K, including the sections entitled
      &#8220;COMPENSATION DISCUSSION AND ANALYSIS&#8221; and &#8220;EXECUTIVE COMPENSATION.&#8221; </span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Although the results of this advisory vote are not
      binding on the Board of Directors or the Compensation Committee, the Compensation Committee will review the voting results and take them into consideration when making future decisions regarding executive compensation.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Board of Directors recommends that stockholders vote FOR the resolution to approve,
      on a</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">non-binding advisory basis, the compensation of our Named Executive Officers.</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">14</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div><a id="a006"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROPOSAL 4: NON-BINDING ADVISORY VOTE ON THE FREQUENCY<br/>
      OF THE NON-BINDING ADVISORY VOTE ON EXECUTIVE COMPENSATION</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The Dodd-Frank Act requires us to include, at least
      once every six years, a non-binding advisory vote regarding the frequency of the non-binding advisory vote on executive compensation. In casting their advisory vote, stockholders may choose among four options: </span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">A vote every year;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">A vote every two years;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">A vote every three years; or</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">To abstain from voting. </span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The last time the Company&#8217;s stockholders cast a
      frequency vote was at the 2019 annual meeting of stockholders. The stockholders voted in favor of a frequency of every year. Based on these results and the reasons described below, the Board of Directors has determined that a non-binding advisory
      vote on executive compensation that occurs every year is the most appropriate option for us at this time. The Board of Directors believes that an advisory vote every year will be the most effective timeframe for us to respond to stockholders&#8217;
      feedback and provide us with sufficient time to engage with stockholders to understand and respond to the vote results. Setting a one-year period will enhance stockholder communication by providing a clear, simple means for us to obtain information
      on investor sentiment about our executive compensation philosophy. </span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Although the results of this advisory vote are not
      binding on the Board of Directors or the Compensation Committee, the Board of Directors and the Compensation Committee will review the voting results and will respect the expressed desire of the Company&#8217;s stockholders by implementing the option, if
      any, that receives an affirmative vote of the holders of a majority of the shares of Common Stock present in person or represented by proxy at the Annual Meeting and entitled to vote on the matter. If no option receives a majority, the Board will
      select the annual option to be in effect until the next non-binding advisory vote on the frequency of the non-binding advisory vote on executive compensation.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Board of Directors recommends that stockholders vote for a frequency of every year
      for future non-binding stockholder advisory votes on the compensation of our Named Executive Officers.</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">15</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div><a id="a007"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROPOSAL 5: RATIFICATION OF APPOINTMENT OF<br/>
      INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Audit and Risk Committee of the Board of Directors has appointed Ernst
      &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. Representatives of Ernst &amp; Young LLP are expected to be present at the Annual Meeting and will have an opportunity to make a
      statement if they desire and will be available to respond to appropriate questions. Although ratification is not required by our Amended and Restated Bylaws, as amended (&#8220;Bylaws&#8221;), or otherwise, our Board of Directors is submitting the selection of
      Ernst &amp; Young LLP to our stockholders for ratification as a matter of good corporate practice.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fees</b></span></p><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents fees for professional services rendered by
      Ernst &amp; Young LLP for the audit of our annual financial statements for the years ended December 31, 2024 and 2023, and fees incurred for other services rendered by Ernst &amp; Young LLP for such years:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 80%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; margin-left: 0.6in">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 39%; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"/>
        <td style="width: 20%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></p>
        </td>
        <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
        <td style="width: 20%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></p>
        </td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit Fees<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></span></td>
        <td style="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-right: 40pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3,858,800</span></td>
        <td>&#160;</td>
        <td style="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-right: 40pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3,576,657</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit-Related Fees</span></td>
        <td style="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-right: 40pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
        <td>&#160;</td>
        <td style="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-right: 40pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax Fees<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></span></td>
        <td style="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-right: 40pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,522,641</span></td>
        <td>&#160;</td>
        <td style="text-align: right; font: 10pt Times New Roman, Times, Serif; padding-right: 40pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">967,223</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All Other Fees</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; padding-right: 40pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></p>
        </td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid; padding-right: 40pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></p>
        </td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 18.65pt; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Fees</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; padding-right: 40pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$5,381,441</span></p>
        </td>
        <td style="padding-bottom: 2.5pt">&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 2.5pt double; padding-right: 40pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4,543,880</span></p>
        </td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>
  </div><!-- Field: Rule-Page --><div>
  </div><div style="margin-top: 3pt; margin-bottom: 3pt; text-align: LEFT;">
    <div style="font-size: 1pt; border-top: Black 1pt solid; width: 20%">&#160;</div>
  </div><div>
  </div><!-- Field: /Rule-Page --><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 3pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Primarily for the audit of our annual financial statements and the review of our quarterly financial
            statements, and services provided in connection with acquisition due diligence. Also includes travel and lodging costs incurred in connection with the rendering of audit services.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Primarily for tax compliance services and other tax planning and tax advice services.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pre-approval of Auditor Services</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The charter of the Audit and Risk Committee provides that the Audit and
      Risk Committee must pre-approve all auditing and non-auditing services to be provided by our auditor. In addition, the Audit and Risk Committee shall have the sole authority to approve any compensation to our auditor for any approved audit or
      non-audit services. For 2024, all services provided by Ernst &amp; Young LLP were pre-approved by the Audit and Risk Committee. All non-audit services were reviewed by the Audit and Risk Committee, and the Audit and Risk Committee concluded that the
      provision of such services by Ernst &amp; Young LLP was compatible with the maintenance of that firm&#8217;s independence in the conduct of its auditing functions.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Required Vote</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The affirmative vote of the holders of a majority of the shares of Common
      Stock present in person or represented by proxy at the Annual Meeting and entitled to vote on the matter is needed to ratify the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending
      December 31, 2025. Under Delaware law, an abstention will have the same legal effect as a vote against the ratification of Ernst &amp; Young LLP, and broker non-votes will have no effect on the outcome of the ratification of the independent
      registered public accounting firm. If the appointment is not ratified, the matter will be referred to the Audit and Risk Committee for further review.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Audit and Risk Committee and the Board of Directors recommend that the stockholders
      vote FOR ratification of the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">16</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div><a id="a008"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CORPORATE GOVERNANCE</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independence of the Board of Directors</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Our Board annually reviews the independence of all of
      our directors and affirmatively makes a determination as to the independence of each director based on whether such director satisfies the definition of &#8220;independent director&#8221; as set forth in the applicable rules of The NASDAQ Stock Market. We had
      nine independent directors in 2024. Our Board has determined that all of our directors are independent directors other than Mr. Hunter. Our independent directors meet in executive sessions as required by the applicable rules of The NASDAQ Stock
      Market.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Code of Conduct and Code of Ethics for Senior Financial Officers</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">Our Board of Directors has adopted a Code of Conduct
      which is applicable to all of our officers, employees and directors, including our Chief Executive Officer, Chief Financial Officer, the principal accounting officer or controller and all persons performing similar functions (together, the &#8220;Senior
      Financial Officers&#8221;). In addition, our Board has adopted a Code of Ethics that applies to the Senior Financial Officers. Both the Code of Conduct and the Code of Ethics are available on our website at <i>www.acadiahealthcare.com</i> under the
      webpage &#8220;Investors &#8211; Corporate Governance.&#8221;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Committees of the Board of Directors</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Board of Directors has established five standing committees <span style="font-weight: normal;">&#8211;</span> a Compensation Committee, an Audit and Risk Committee, a Nominating and Governance Committee, a Quality and Compliance Committee and a Finance Committee, each of which is described below.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Compensation Committee </i></b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Board of Directors has appointed a Compensation Committee to assist it
      with executive compensation matters. The primary responsibilities and duties of the Compensation Committee are:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing and approving for the Chief Executive Officer and other executive officers (a) the annual
            base salary level, (b) bonus and other annual incentives, (c) equity compensation, (d) employment agreements, severance arrangements and change in control arrangements, and (e) any other benefits, compensation, compensation policies or
            arrangements;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing and making recommendations to the Board regarding the compensation policy for such other
            officers as directed by the Board;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparing a report to be included in the annual report or proxy statement that describes: (a) the
            criteria on which compensation paid to the Chief Executive Officer for the last completed fiscal year is based; (b) the relationship of such compensation to our performance; and (c) the Compensation Committee&#8217;s executive compensation policies
            applicable to executive officers; and</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overseeing the administration and approval of our current equity-based compensation plans and making
            recommendations to our Board of Directors with respect to amendments to the plans, changes in the number of shares reserved for issuance thereunder and other equity-based compensation plans proposed for adoption.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2024, the Compensation Committee was composed of Ms. Gregg, and
      Messrs. Fucci and Miquelon, with Mr. Miquelon serving as Chairman. During 2024, the Compensation Committee held seven meetings. The Compensation Committee has a written charter that is available on our website at <i>www.acadiahealthcare.com</i>
      under the webpage &#8220;Investors <span style="font-weight: normal;">&#8211;</span> Corporate Governance.&#8221;</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">17</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Audit and Risk Committee</i></b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Board of Directors has appointed an Audit and Risk Committee to assist
      it in fulfilling its oversight responsibilities for our financial reports, systems of internal control over financial reporting and accounting policies, procedures and practices. The primary responsibilities and duties of the Audit and Risk Committee
      are:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Appointing, retaining, evaluating and, when appropriate, replacing our independent registered public
            accounting firm, whose duty it is to audit our financial statements and our internal control over financial reporting for the fiscal year in which it is appointed;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Determining the compensation to be paid to our independent registered public accounting firm (subject
            to ratification by our stockholders) and, in its sole discretion, approving all audit and engagement fees and terms and pre-approve all auditing and non-auditing services of our independent registered public accounting firm;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing and discussing our system of internal control over financial reporting, audit procedures, the
            adequacy and effectiveness of our disclosure controls and procedures and our enterprise risk assessment and risk management system with management, our independent registered public accounting firm and our internal auditors;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing the internal audit function of the Company, including the independence of its reporting
            obligations and the adequacy of the internal audit budget and staffing;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing and discussing with management and our independent registered public accounting firm the
            audited financial statements to be included in our Annual Report on Form 10-K, the quarterly financial statements to be included in our Quarterly Reports on Form 10-Q, our disclosures under &#8220;Management&#8217;s Discussion and Analysis of Financial
            Condition and Results of Operations&#8221; and the selection, application and disclosure of critical accounting policies used in our financial statements;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing and discussing with management the Company&#8217;s major financial and enterprise risk exposures
            including the Company&#8217;s accounting and financial reporting policies, risk management protocols, compliance programs and the measures management has taken to mitigate risk;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing and discussing with management the Company&#8217;s process to identify, monitor and mitigate
            enterprise risk exposures;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing and discussing with management all existing related-party transactions and approving any
            proposed related-party transactions to ensure that they are in our best interest;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing and discussing with management the quarterly earnings press releases and financial
            information and earnings guidance provided to analysts and rating agencies;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Establishing and overseeing procedures for receiving, retaining and treating complaints received by the
            Company regarding accounting, internal accounting controls or auditing matters; and</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing and reassessing the performance of the Audit and Risk Committee and the adequacy of the Audit
            and Risk Committee charter adopted by our Board of Directors and recommending proposed changes to the Board.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2024, the Audit and Risk Committee was composed of Messrs. Bissell,
      Fucci, Grieco and Kelly, with Mr. Grieco serving as Chairman. Mr. Kelly was appointed to the Audit and Risk Committee on February 22, 2024. Our Board of Directors has determined that each of Messrs. Bissell, Fucci, Grieco and Kelly is an &#8220;audit
      committee financial expert&#8221; as defined in rules promulgated by the SEC under the Exchange Act, and that each member of the Audit and Risk Committee meets the financial literacy requirements under the Sarbanes-Oxley Act of 2002 (the &#8220;Sarbanes-Oxley
      Act&#8221;) and rules and regulations of NASDAQ and the SEC. Our Board has determined that each of Messrs. Bissell, Fucci and Grieco satisfies the independence requirements for audit committee members set forth in the applicable rules of The NASDAQ Stock
      Market. During 2024, the Audit and Risk Committee held five meetings. The Audit and Risk Committee has a written charter available on our website, <i>www.acadiahealthcare.com</i> under the webpage &#8220;Investors <span style="font-weight: normal;">&#8211;</span>
      Corporate Governance.&#8221;</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">18</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Nominating and Governance Committee</i></b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Board of Directors has appointed a Nominating and Governance Committee
      (the &#8220;Nominating Committee&#8221;) to assist it with director nominations matters. The primary responsibilities and duties of the Nominating Committee are:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identifying, recruiting and recommending individuals qualified to serve on the Board;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing the qualifications and performance of incumbent directors to determine whether to recommend
            them as nominees for re-election;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing and considering candidates who may be properly suggested by any director or executive office
            of the Company, or by any stockholder of the Company;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Periodically reviewing the composition of the Board, including size of the Board and the minimum
            qualifications for director nominees;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Seeking to have qualified director candidates with a diversity of experience, professions, skills and
            backgrounds included by the Company in each pool of candidates from which Board nominees are chosen;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Establishing procedures to evaluate the performance of the Board, its committees and its members;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing succession planning for the Company&#8217;s senior executive officers; and</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carrying out such other responsibilities delegated by the Board relating to the director nominations
            process and procedures.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2024, the Nominating Committee was composed of Ms. Gregg and Messrs.
      Bissell, Grieco and Kelly, with Mr. Bissell serving as Chairman. During 2024, the Nominating Committee held five meetings. The Nominating Committee has a written charter available on our website, <i>www.acadiahealthcare.com</i> under the webpage
      &#8220;Investors <span style="font-weight: normal;">&#8211;</span> Corporate Governance.&#8221;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Quality and Compliance Committee</i></b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Board of Directors has appointed a Quality and Compliance Committee
      (the &#8220;Compliance Committee&#8221;) to oversee regulatory compliance risks, including risks associated with healthcare related requirements. The primary responsibilities and duties of the Compliance Committee are:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing and providing oversight of matters relating to compliance with Federal health care program
            requirements, obligations under the Company&#8217;s corporate integrity agreement and other legal and regulatory requirements;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Periodically meeting with and reviewing reports regarding compliance matters from the Company&#8217;s Chief
            Compliance Officer;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing and overseeing the performance of the Company&#8217;s Chief Compliance Officer and the compliance
            department;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing significant areas of healthcare compliance risk, including (i) coding, billing,
            documentation, claims submission and reimbursement, (ii) licensure and accreditation requirements, (iii) clinical quality of care, (iv) physician recruitment and contracting, and (v) privacy and security of health information;</span></td>
      </tr>

  </table><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">19</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overseeing procedures for the receipt, retention and treatment of complaints regarding compliance with
            applicable legal and regulatory requirements and the Company&#8217;s compliance policies;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing significant licensure, certification, accreditation and quality standards matters; and</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carrying out such other responsibilities delegated by the Board relating to regulatory compliance.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2024, the Compliance Committee was composed of Ms. Gregg, Dr. Harris
      and Mr. Grieco, with Ms. Gregg serving as Chairman. Debra K. Osteen, a former director, served on the committee until May 23, 2024. During 2024, the Compliance Committee held four meetings. The Compliance Committee has a written charter available on
      our website, <i>www.acadiahealthcare.com</i> under the webpage &#8220;Investors <span style="font-weight: normal;">&#8211;</span> Corporate Governance.&#8221;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Finance Committee</i></b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Board of Directors has appointed a Finance Committee (the &#8220;Finance
      Committee&#8221;) to oversee and review the Company&#8217;s significant strategic transactions and financing matters. The primary responsibilities and duties of the Finance Committee are:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Overseeing our strategic transactions;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing and evaluating our (i) capital structure and proposed changes thereto, including significant
            new issuances, purchases, or redemptions of our securities, (ii) plans for allocation and disbursement of capital expenditures, (iii) credit rating, activities with credit rating agencies, and key financial ratios, (iv) long-term financial
            strategy and financial needs, (v) major activities with respect to mergers, acquisition and divestitures, and (vi) plans to manage insurance and asset risk;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reviewing and approving certain capital expenditures, contractual obligations and financial commitments
            per delegated authority from our Board; and</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carrying out such other responsibilities delegated by the Board relating to long-term finance and
            strategic transaction matters.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2024, the Finance Committee was composed of Messrs. Bernhard,
      Bissell, Fucci, Miquelon and Waud, with Mr. Waud serving as Chairman. During 2024, the Finance Committee did not meet.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Meetings of our Board of Directors and Committees</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2024, our Board of Directors held a total of five meetings. Each
      director attended 75% or more of the meetings of our Board and the committees of our Board of Directors on which such director served.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nomination of Directors</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nominations By the Nominating Committee</i></span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors may be nominated by our Nominating Committee, Board, executive
      officers or by our stockholders in accordance with our Bylaws, Certificate of Incorporation, applicable laws and any guidelines developed by the Nominating Committee or the Board. The Nominating Committee is responsible for identifying individuals
      qualified to become members of the Board and its committees, and recommending candidates for the Board&#8217;s selection as director nominees for election at the annual or other properly convened meeting of the stockholders in accordance with our Bylaws
      and applicable laws and regulations. The Nominating Committee meets to discuss and evaluate the qualities and skills of each candidate, both on an individual basis and taking into account the overall composition and needs of the Board. The Nominating
      Committee considers each identified candidate&#8217;s qualifications, which include the nominee&#8217;s experience, business acumen, education, integrity, character, commitment, diligence, conflicts of interest and ability to exercise sound business judgment. We
      generally seek nominees with a broad diversity of experience, professions, skills and backgrounds. We do not currently pay a fee to any third party to identify or assist in identifying or evaluating potential nominees.</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">20</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Nominations By Our Stockholders</i></b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Bylaws govern stockholder nominations of directors. To make a director
      nomination at the 2026 annual meeting, a stockholder of record entitled to vote at the annual meeting must deliver a written notice (containing certain information specified in our Bylaws as discussed below) to Brian P. Farley, Esq., Executive Vice
      President, General Counsel and Secretary, at Acadia Healthcare Company, Inc., 6100 Tower Circle, Suite 1000, Franklin, Tennessee 37067 between the close of business on January 29, 2026 and the close of business on February 28, 2026. If the date of
      the 2026 annual meeting is more than 30 days before or more than 70 days after May 29, 2026, the stockholder&#8217;s notice must be so delivered not earlier than the close of business on the 120th day prior to such annual meeting and not later than the
      close of business on the later of the 90th day prior to such annual meeting or the tenth day following the day on which public announcement of the date of such meeting is first made by the Company. To make a director nomination to be voted on at a
      special meeting of stockholders called for the purpose of electing directors, a stockholder of record entitled to vote in such election must deliver written notice to our secretary at the address above no earlier than the close of business on the
      120th day prior to such special meeting and no later than the close of business on the later of the 90th day prior to such special meeting or the tenth day following the day on which we first publicly announce the date of the special meeting and the
      nominees proposed by the Board to be elected at such meeting.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For a stockholder nomination to be deemed proper, the notice must contain
      certain information specified in our Bylaws, including information as to the director nominee(s) proposed by the stockholder, the name and address of the stockholder, the class and number of shares of our capital stock beneficially owned by the
      stockholder, a description of all arrangements or understandings between the stockholder and any other persons (including each proposed nominee(s) if applicable) in connection with the proposed nominations, and a representation that such stockholder
      intends to appear in person or by proxy at the meeting to bring such business or nominate the person(s) named in the notice.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition to satisfying the foregoing requirements under our Bylaws, to
      comply with the universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than our director nominees must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act no
      later than March 30, 2026.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Majority Voting for Uncontested Director Elections; Director Resignation Policy</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Certificate of Incorporation and Bylaws provide for a majority voting
      standard for uncontested director elections. In contested elections, directors are elected by a plurality of the votes cast. The Board also adopted a Director Resignation Policy requiring a nominee for director to submit a written offer of
      resignation to the Board in the event such nominee does not receive a majority of the votes cast in an uncontested election of directors. The Director Resignation Policy addresses the continuation in office of a &#8220;holdover&#8221; director, so that an
      incumbent director who does not receive the requisite affirmative majority of the votes cast for his or her re-election must tender his or her resignation to the Board. In the event a nominee submits a written officer of resignation to the Board, the
      Nominating and Governance Committee will promptly consider the director&#8217;s offer of resignation and recommend to the Board whether to accept the resignation or reject it. The Board will act on such recommendation within 90 days following receipt of
      the recommendation.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Communicating with the Board</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All stockholder communications with our Board of Directors should be
      directed to Brian P. Farley, Esq., Executive Vice President, General Counsel and Secretary, at Acadia Healthcare Company, Inc., 6100 Tower Circle, Suite 1000, Franklin, Tennessee 37067, and should prominently indicate on the outside of the envelope
      that it is intended for our Board of Directors or for an individual director. Each communication intended for our Board of Directors and received by Mr. Farley will not be opened but will be promptly forwarded unopened to the Chairman of the Audit
      and Risk Committee following its clearance through normal security procedures.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attendance by Members of the Board of Directors at the Annual Meeting of Stockholders</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">We encourage each member of our Board of Directors to
      attend the annual meeting of stockholders. Each director attended the 2024 annual meeting of stockholders in person.</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">21</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board Leadership Structure</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">The Board of Directors does not have a formal policy
      on whether the roles of Chief Executive Officer and Chairman of the Board of Directors should be separate. The Company currently has separate individuals serve in those positions. Reeve B. Waud serves as the Chairman of the Board and Christopher H.
      Hunter is our Chief Executive Officer. Mr. Hunter is also a member of the Board. The Board of Directors has carefully considered its leadership structure and believes at this time that the Company and its stockholders are best served by having the
      positions of Chairman of the Board and Chief Executive Officer filled by different individuals. This allows the Chief Executive Officer to, among other things, focus on the Company&#8217;s day-to-day business, while allowing the Chairman to lead the Board
      of Directors in its fundamental role of providing advice and oversight of management. In addition, our independent directors bring experience, oversight and expertise from outside our Company and industry, while the Chief Executive Officer brings
      Company-specific experience and expertise. The Board of Directors recognizes that depending on future circumstances, other leadership models may become more appropriate. Accordingly, the Board of Directors will continue to periodically review its
      leadership structure.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Board Diversity Matrix</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based upon voluntary self-identification by each member of our Board of
      Directors, the table below sets forth the diversity composition of our Board of Directors as of April 1, 2025.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 70%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; margin-left: auto; margin-right: auto;">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Board Diversity Matrix (as of April 1, 2025)*</b></span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Number of Directors</span></td>
        <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
        <td style="width: 44%; font: 10pt Times New Roman, Times, Serif; text-align: left"/>
        <td style="width: 28%; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Female</b></span></td>
        <td style="width: 28%; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Male</b></span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Part I: Gender Identity</b></span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"/>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Part II: Demographic Background</b></span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">White</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
        <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">African American or Black</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
        <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*&#8194;&#8202;Inapplicable categories omitted.</span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risk Oversight</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Board is responsible for overseeing our risk management process. The
      Board fulfills its responsibility by delegating many of these functions to its committees. Under its charter, the Audit and Risk Committee is responsible for meeting periodically with management to review our major financial risks and the steps
      management has taken to monitor and control such risks. The Audit and Risk Committee also oversees our financial reporting and internal controls and compliance programs.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Board receives reports on risk management from our senior officers, the
      Compliance Committee and the Chairman of the Audit and Risk Committee. Also, our Executive Vice President, General Counsel and Secretary provides a summary of our outstanding material litigation and governmental investigations to our Board at each
      Board meeting. Additionally, our Board regularly engages in discussions of the most significant risks that we are facing and how these risks are being managed. Our Board of Directors believes that the work undertaken by the Audit and Risk Committee
      and Compliance Committee, together with the oversight provided by the full Board of Directors, enables the Board to oversee our risk management function effectively.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Corporate Social Responsibility and Sustainability</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Board and its committees oversee our enterprise-wide commitment to
      social responsibility and sustainability matters. In fulfilling its oversight responsibilities, the Board and its committees collaborate with management on the Company&#8217;s strategy, policies, programs and reporting related to social responsibility and
      sustainability matters.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation Committee Interlocks and Insider Participation</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2024, the Compensation Committee consisted of Ms. Gregg, and Messrs.
      Fucci and Miquelon, none of whom has at any time been one of our officers or employees. None of our executive officers serves, or in the past year served, as a member of the board of directors or compensation committee of any entity that has or had
      one or more of its executive officers serving on our Board or Compensation Committee.</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">22</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Policy on Reporting of Concerns Regarding Accounting Matters</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Audit and Risk Committee has adopted a policy on the reporting of
      concerns regarding accounting, internal accounting controls or auditing matters. We have established a compliance hotline called ValuesLine (800-500-0333), which is administered by a third party, as a hotline for the receipt, retention and treatment
      of complaints from employees or others regarding accounting, internal accounting controls and auditing matters. Information received through the hotline is conveyed directly to our Chief Compliance Officer. Complaints relating to accounting, internal
      accounting controls or auditing matters will then be directed to the Chairman of the Audit and Risk Committee. Any complaint may be made anonymously if the claimant so desires, and all claimants will be provided confidentiality in the handling of the
      complaint.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Procedure for Approval of Transactions with Related Persons</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have established policies and other procedures regarding approval of
      transactions between the Company and any employee, officer, director, and certain of their family members and other related persons, including those required to be reported under Item 404 of Regulation S-K promulgated under the Securities Act of
      1933, as amended (the &#8220;Securities Act&#8221;). These policies and procedures are generally not in writing, but are evidenced by principles set forth in our Code of Conduct or adhered to by our Board. As set forth in the Audit and Risk Committee Charter,
      the Audit and Risk Committee reviews and approves all related person transactions after reviewing such transaction for potential conflicts of interests and improprieties. Accordingly, all such related person transactions are submitted to the Audit
      and Risk Committee for ongoing review and oversight. Generally speaking, we enter into related person transactions only on terms that we believe are at least as favorable to the Company as those that we could obtain from an unrelated third party.</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">23</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div><a id="a009"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>MANAGEMENT</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Executive Officers</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Below are the names and ages (as of April 1, 2025) of our executive officers, and a brief
      account of the business experience of the executive officers who are not members of our Board.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></p>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Age</b></span></p>
        </td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></p>
        </td>
      </tr>
      <tr style="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
        <td style="vertical-align: top; padding-left: 17.65pt; font: 10pt Times New Roman, Times, Serif; text-indent: -17.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher H. Hunter</span></td>
        <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: justify"/>
        <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</span></td>
        <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: justify"/>
        <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="vertical-align: top; padding-left: 17.65pt; font: 10pt Times New Roman, Times, Serif; text-indent: -17.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Heather Dixon</span></td>
        <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
        <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</span></td>
        <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
        <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td>
      </tr>
      <tr style="background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
        <td style="vertical-align: top; padding-left: 17.65pt; font: 10pt Times New Roman, Times, Serif; text-indent: -17.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian P. Farley</span></td>
        <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
        <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</span></td>
        <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
        <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Vice President, General Counsel and Secretary</span></td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="vertical-align: top; padding-left: 17.65pt; font: 10pt Times New Roman, Times, Serif; text-indent: -17.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasser Khan, M.D.</span></td>
        <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: justify"/>
        <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</span></td>
        <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: justify"/>
        <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Operating Officer</span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The term of each executive officer runs until his successor is appointed and qualified, or
      until his earlier death, resignation or removal.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Heather Dixon</i> joined the Company in July 2023 and has served as our Chief Financial
      Officer since that time. Before joining the Company, Ms. Dixon served as the Chief Financial Officer of Everside Health since June 2021. Prior to that, Ms. Dixon served as the Senior Vice President, Global Controller and Chief Accounting Officer of
      Walgreens Boots Alliance, Inc. (NASDAQ: WBA) from March 2019 to May 2021. From August 2016 to March 2019, Ms. Dixon served in various roles at Aetna, a subsidiary of CVS Health Corporation (NYSE: CVS) (&#8220;CVS Health&#8221;), including Assistant Controller
      and later as Vice President, Controller and Chief Accounting Officer. Ms. Dixon has served as an independent board member of Addus HomeCare (NASDAQ: ADUS) since March 2023.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Brian P. Farley</i> joined the Company in July 2023 and has served as our Executive Vice
      President, General Counsel and Secretary since that time. Before joining the Company, Mr. Farley served as the Chief Legal Officer and Corporate Secretary for GoHealth, Inc. (NASDAQ: GOCO) since June 2020. Prior to that, Mr. Farley served in various
      roles at Veradigm Inc. (formerly known as Allscripts Healthcare Solutions, Inc.), a healthcare technology company, including most recently as Executive Vice President, General Counsel and Chief Administrative Officer from May 2013 to June 2020.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Dr. Nasser Khan</i> joined the Company as Operations Group President for the Company&#8217;s
      comprehensive treatment center business line in September 2022 and became our Chief Operating Officer in June 2024. Prior to joining the Company, Dr. Khan served as the Senior Vice President, Operations at Shields Health Solutions, a national
      provider of specialty pharmacy services to health systems and a subsidiary of Walgreens Boots Alliance, Inc. (NASDAQ: WBA), from July 2020 to August 2022. Prior to that, Dr. Khan served as Head of Program &amp; Chief Medical Officer at Biograph Inc.,
      a healthcare technology company, from May 2017 to June 2020.</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">24</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div><a id="a010"></a></div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below sets forth information with respect to ownership of our
      Common Stock as of April 1, 2025, by:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each person who we know to be the beneficial owner of more than 5% of the outstanding shares of Common
            Stock;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each of our directors and nominees;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each of our Named Executive Officers; and</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All of our directors and executive officers as a group.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To our knowledge, unless otherwise indicated, each stockholder listed below
      has sole voting and investment power with respect to the shares beneficially owned. All computations are based on 92,127,804 shares of Common Stock outstanding on April 1, 2025, unless otherwise indicated.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 90%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; margin-left: auto; margin-right: auto;">

      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="vertical-align: bottom; width: 53%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name of Beneficial Owner<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></b></span></p>
        </td>
        <td style="width: 1%; padding-bottom: 1pt">&#160;</td>
        <td style="vertical-align: bottom; width: 23%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amount and Nature of Beneficial Ownership<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></b></span></p>
        </td>
        <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1pt"/>
        <td style="vertical-align: bottom; width: 12%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percent of Class</b></span></p>
        </td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wellington Management Group LLC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></span></td>
        <td>&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,658,253</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.7%</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Vanguard Group<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup></span></td>
        <td>&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,861,427</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.6%</span></td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BlackRock, Inc.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup></span></td>
        <td>&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,180,827</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.9%</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FMR LLC<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup></span></td>
        <td>&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,230,631</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.8%</span></td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">T. Rowe Price Associates, Inc.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup></span></td>
        <td>&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,121,895</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.6%</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher H. Hunter<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(8)</sup></span></td>
        <td>&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">132,761</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Heather Dixon<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(9)</sup></span></td>
        <td>&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78,676</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian P. Farley<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(10)</sup></span></td>
        <td>&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,416</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nasser Khan, M.D.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(11)</sup></span></td>
        <td>&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,995</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
      </tr>
      <tr style="font: 10pt Times New Roman, Times, Serif">
        <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">John S. Hollinsworth<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(12)</sup></span></td>
        <td>&#160;</td>
        <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">113,376</span></td>
        <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reeve B. Waud<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(13)</sup></span></td>
        <td>&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">695,298</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jason R. Bernhard<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(14)</sup></span></td>
        <td>&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,389</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">E. Perot Bissell<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(14)</sup></span></td>
        <td>&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38,623</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael J. Fucci<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(14)</sup></span></td>
        <td>&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,789</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vicky B. Gregg<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(14)</sup></span></td>
        <td>&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29,265</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">William F. Grieco<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(14)</sup></span></td>
        <td>&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">78,454</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patrice A. Harris, M.D., M.A.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(15)</sup></span></td>
        <td>&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,551</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">R. David Kelly<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(16)</sup></span></td>
        <td>&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,072</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wade D. Miquelon<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(14)</sup></span></td>
        <td>&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">48,488</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All directors and executive officers as a group (13 persons)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(17)</sup></span></td>
        <td>&#160;</td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,211,777</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"/>
        <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-right: 20pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.3%</span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>
  </div><!-- Field: Rule-Page --><div>
  </div><div style="margin-top: 3pt; margin-bottom: 3pt; text-align: LEFT;">
    <div style="font-size: 1pt; border-top: Black 1pt solid; width: 20%">&#160;</div>
  </div><div>
  </div><!-- Field: /Rule-Page --><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0"/>
        <td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>*</b></span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less than 1%</span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless otherwise indicated, the address of each beneficial owner is c/o Acadia Healthcare Company,
            Inc., 6100 Tower Circle, Suite 1000, Franklin, Tennessee 37067.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under SEC rules, the number of shares shown as beneficially owned includes shares of Common Stock (i)
            issuable upon the vesting of restricted stock units, and (ii) subject to options that currently are exercisable or will be exercisable, in each case within 60 days of April 1, 2025. Such shares are deemed to be outstanding for the purpose of
            computing the &#8220;percent of class&#8221; for that individual, but are not deemed outstanding for the purpose of computing the percentage of any other person.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information is based solely on the Schedule 13G/A filed by Wellington Management Group LLP
            (&#8220;Wellington&#8221;) with the SEC on November 8, 2024. Wellington reported that it possessed shared dispositive power with respect to all of the shares. The address for Wellington is 280 Congress Street, Boston, Massachusetts 02210.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information is based solely on the Schedule 13G/A filed by The Vanguard Group (&#8220;Vanguard&#8221;) with the SEC
            on February 13, 2024. Vanguard reported that it possessed (i) sole dispositive power with respect to 8,733,284 shares and (ii) shared dispositive power with respect to 128,143 shares. The address for Vanguard is 100 Vanguard Blvd., Malvern,
            Pennsylvania 19355.</span></td>
      </tr>

  </table><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">25</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information is based solely on the Schedule 13G/A filed by BlackRock, Inc. (&#8220;BlackRock&#8221;) with the SEC
            on January 25, 2024. BlackRock reported that it possessed (i) sole voting power with respect to 7,981,620 shares and (ii) sole dispositive power with respect to all of the shares. The address for BlackRock is 50 Hudson Yards, New York, New York
            10001.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information is based solely on the Schedule 13G filed by FMR LLC (&#8220;FMR&#8221;) with the SEC on February 11,
            2025. FMR reported that it possessed (i) sole voting power with respect to 6,225,094 shares and (ii) sole dispositive power with respect to all of the shares. The address for FMR is 245 Summer Street, Boston, Massachusetts 02210.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information is based solely on the Schedule 13G/A filed by T. Rowe Price Associates, Inc. (&#8220;Price
            Associates&#8221;) with the SEC on November 14, 2024. Price Associates reported that it possesses (i) sole voting power with respect to 6,107,600 shares, and (ii) sole dispositive power with respect to all of the shares. These securities are owned by
            various individual and institutional investors for which Price Associates serves as an investment adviser with power to direct investments and/or sole power to vote the securities. For the purposes of the reporting requirements of the Exchange
            Act, Price Associates is deemed to be the beneficial owner of such securities; however, Price Associates expressly disclaims that it is, in fact, the beneficial owner of such securities. The address for Price Associates is 101 E. Pratt Street,
            Baltimore, Maryland 21201.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 57,245 shares of time-vesting restricted stock and 37,393 earned shares of performance-vesting
            restricted stock.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 40,131 shares of time-vesting restricted stock and 33,219 earned shares of performance-vesting
            restricted stock.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 23,945 shares of time-vesting restricted stock and 7,210 earned shares of performance-vesting
            restricted stock.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 20,582 shares of time-vesting restricted stock and options to purchase 675 shares of Common
            Stock.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information is based solely on reports filed with the SEC, subject to factoring in time-vesting
            restricted stock forfeited by such executive in connection with his retirement from the Company in 2024.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 4,669 shares of time-vesting restricted stock. The 695,298 shares of Common Stock are owned of
            record as follows: (i) 225,519 shares by the Halcyon Exempt Family Trust (the &#8220;Halcyon Trust&#8221;); (ii) 37,493 shares by Waud Capital Partners, L.L.C.; (iii) 155,930 shares by the Reeve B. Waud Jr. 2012 Family Trust (the &#8220;2012 RBW Jr Family
            Trust&#8221;); (iv) 155,930 shares by the Cecily R.M. Waud 2012 Family Trust (the &#8220;2012 CRMW Family Trust&#8221;); (v) 43,643 shares by the Cornelius Byron Waud 2002 Trust (the &#8220;2002 CBW Family Trust&#8221;), (vi) 34,500 shares by the Corinna Reeve Waud 2002
            Trust (&#8220;2002 CRW Family Trust&#8221;) and (vii) 42,283 shares directly held by Mr. Waud.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Waud may be deemed to beneficially own the shares of Common
      Stock reported herein by virtue of (A) his being the investment advisor of the Halcyon Trust of which Mr. Waud&#8217;s children are beneficiaries, (B) his being the sole manager of WCP LLC, (C) his being the investment advisor of the 2012 RBW Jr Family
      Trust and the 2012 CRMW Family Trust of which Mr. Waud&#8217;s grandchildren are beneficiaries, and (D) his being appointed as the co-trustee of the 2002 CBW Family Trust and the 2002 CRW Family Trust of which Mr. Waud&#8217;s parents are beneficiaries.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(14)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 4,669 shares of time-vesting restricted stock.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 3,839 shares of time-vesting restricted stock.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes 4,594 shares of time-vesting restricted stock.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(17)</span></td>
        <td style="text-align: left; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excludes shares shown as beneficially owned by Mr. Hollinsworth, who retired as an executive officer of
            the Company in 2024. Includes 183,019 shares of time-vesting restricted stock, 77,822 earned shares of performance-vesting restricted stock and options to purchase 675 shares of Common Stock.</span></td>
      </tr>

  </table><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">26</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delinquent Section 16(a) Reports</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 16(a) of the Exchange Act requires our directors, executive
      officers and persons who beneficially own more than 10% of our Common Stock to file with the SEC initial reports of ownership and reports of changes in ownership of our Common Stock. These officers, directors and greater than 10% stockholders are
      required by SEC rules to furnish us with copies of all Section 16(a) reports they file. There are specific due dates for these reports, and we are required to report in this Proxy Statement any failure to file reports in a timely manner as required
      during 2024. Based upon a review of these filings and written representations from our directors and executive officers, we believe that all reports required to be filed with the SEC pursuant to Section 16(a) during 2024 were filed in a timely manner
      except (i) Nasser Khan, M.D. filed a report on Form 4 on November 8, 2024 with respect to an award of restricted stock on September 30, 2024 and (ii) R. David Kelly filed a report on Form 4 on May 31, 2024 with respect to an award of restricted stock
      on May 23, 2024.</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">27</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div><a id="a011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><b>COMPENSATION DISCUSSION AND ANALYSIS</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Compensation Discussion and Analysis provides a detailed description of our executive compensation philosophy and programs, the compensation
    arrangements that we have with our Named Executive Officers, and the alignment of our executive compensation programs with Company performance.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Table of Contents</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%">

      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 90%; padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in;">Named Executive Officers</td>
        <td style="width: 10%; text-align: right; padding-top: 0in; padding-bottom: 0pt">28</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in;">Executive Summary</td>
        <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">28</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in;">Compensation Process and Philosophy</td>
        <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">30</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in;">Executive Officer Transition</td>
        <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">32</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in;">Components of Executive Compensation</td>
        <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">32</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in;">Cash Retention Awards</td>
        <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">41</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in;">Compensation Clawback Policy</td>
        <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">41</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in;">Deferred Compensation Plan</td>
        <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">42</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in;">Equity Award Grant Practices</td>
        <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">42</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in;">Risk Assessment</td>
        <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">42</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in;">Tax Implications of Executive Compensation</td>
        <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">42</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in;">Stock Ownership Guidelines, Insider Trading Policy, Hedging and Pledging</td>
        <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">43</td>
      </tr>
      <tr style="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
        <td style="padding-top: 0in; padding-bottom: 0pt; padding-left: 0.25in;">Termination and Change-in-Control Arrangements</td>
        <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">43</td>
      </tr>

  </table><div>
  </div><p style="margin: 0pt 0">&#160;</p><div>
  </div><p style="margin: 0pt 0"><b>Named Executive Officers</b></p><div>
  </div><p style="margin: 0pt 0">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Named Executive Officers for 2024 were:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; width: 95%; border-collapse: collapse; margin-left: 0.5in">

      <tr style="vertical-align: bottom">
        <td style="white-space: nowrap; width: 25%">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 1pt solid">Name</p>
        </td>
        <td style="width: 3%">&#160;</td>
        <td style="width: 66%">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 1pt solid">Title</p>
        </td>
      </tr>
      <tr style="background-color: #CCEEFF">
        <td style="vertical-align: top; padding-left: 12pt; text-align: justify; text-indent: -12pt">Christopher H. Hunter</td>
        <td style="vertical-align: bottom; text-align: justify">&#160;</td>
        <td style="vertical-align: bottom; text-align: justify">Chief Executive Officer and Director</td>
      </tr>
      <tr>
        <td style="vertical-align: top; padding-left: 12pt; text-align: justify; text-indent: -12pt">Heather Dixon</td>
        <td style="vertical-align: bottom; text-align: justify">&#160;</td>
        <td style="vertical-align: bottom; text-align: justify">Chief Financial Officer</td>
      </tr>
      <tr style="background-color: #CCEEFF">
        <td style="vertical-align: top; padding-left: 12pt; text-align: justify; text-indent: -12pt">Brian P. Farley</td>
        <td style="vertical-align: bottom; text-align: justify">&#160;</td>
        <td style="vertical-align: bottom; text-align: justify">Executive Vice President, General Counsel and Secretary</td>
      </tr>
      <tr>
        <td style="vertical-align: top; padding-left: 12pt; text-align: justify; text-indent: -12pt">Nasser Khan, M.D.</td>
        <td style="vertical-align: bottom; text-align: justify">&#160;</td>
        <td style="vertical-align: bottom; text-align: justify">Chief Operating Officer</td>
      </tr>
      <tr style="background-color: #CCEEFF">
        <td style="vertical-align: top; padding-left: 12pt; text-align: justify; text-indent: -12pt">John S. Hollinsworth</td>
        <td style="vertical-align: bottom; text-align: justify">&#160;</td>
        <td style="vertical-align: bottom; text-align: justify">Former Executive Vice President of Operations</td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Executive Summary</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Acadia is the leading publicly traded pure-play provider of behavioral healthcare services in the United States. Our business strategy is to become
    the indispensable behavioral healthcare provider for the high-acuity and complex needs patient population. We are committed to providing the communities we serve with high-quality, cost-effective behavioral healthcare services, while growing our
    business, increasing profitability and creating long-term value for our stockholders.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Acadia has a history of motivating leaders through the use of performance-based pay with challenging annual and long-term incentives and a record of
    alignment with stockholders&#8217; interests as a result of incentive designs and executive equity ownership. As described in greater detail below, our executive compensation program seeks to:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.5in">(i)</td>
        <td>attract and retain superior executives by providing the opportunity to earn competitive compensation packages,</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.5in">(ii)</td>
        <td>align the pay of our executive officers with Company performance, and</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.5in">(iii)</td>
        <td>recognize and reward senior management&#8217;s individual and collective efforts relating to the financial performance of the Company and creation of stockholder value.</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">As a result of challenges experienced in 2024, our executive officers realized below-target payouts under cash and equity incentive programs,
    demonstrating the alignment of our executive compensation program with our financial and operating performance, and the returns experienced by our stockholders. We remain committed to providing quality patient care at our facilities and supporting our
    long-term strategic objectives. We believe that the Company is well positioned to address the challenges facing it and to grow by focusing on its five growth pathways: expansions of existing facilities, joint venture partnerships, de novo facilities,
    acquisitions and expansion across our continuum of care. The Company expects each of these growth pathways to contribute to additional stockholder value creation in the future.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">28</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Summary of 2024 Company Performance</i></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-weight: normal">Results for 2024 include:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left">Adjusted EPS (as defined below) for purposes of our 2024 non-equity incentive awards was $3.32 compared to our target level Adjusted EPS of $3.54.</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left">Adjusted EBITDA (as defined below) for purposes of our 2024 equity and non-equity incentive awards was approximately $711.3 million compared to our target level Adjusted EBITDA of $751.4 million.</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left">Revenue for 2024 for purposes of our 2024 equity incentive awards was approximately $3,154.0 million compared to our target level revenue of $3,212.7 million.</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left">During 2024, we added 776 beds to our operations, consisting of 312 beds added at existing facilities and 464 beds added through the opening of four wholly-owned de novo facilities and one joint venture facility, ending
          the year with over 11,850 beds in 262 behavioral healthcare facilities in 39 states and Puerto Rico. During 2024, we also opened nine comprehensive treatment centers.</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">A reconciliation of non-GAAP financial measures can be found at the end of this Proxy Statement.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Pay for Performance</i></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Compensation paid to executive officers for 2024 reflects the alignment of pay with the Company&#8217;s performance, as more fully described in this
    Compensation Discussion and Analysis:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left"><b>Below-Target Payment of 2024 Non-Equity Incentive Compensation. </b>The Adjusted EBITDA and Adjusted EPS measures set forth in our non-equity incentive compensation plan for 2024 were achieved at 73.3% and 68.9% of
          target, respectively, which, along with the Compensation Committee&#8217;s evaluation of the achievement of certain non-financial goals, resulted in the payment of below-target (76.0%) cash bonuses to our Named Executive Officers as described below in
          the section entitled &#8220;Components of Executive Compensation &#8211; Annual Non-Equity Incentive Compensation.&#8221;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left"><b>Vesting of Certain Equity Awards at Below-Target Levels.</b> Based on actual 2024 Adjusted EPS, Adjusted EBITDA and revenue performance in relation to targets, as applicable, the first tranche of the
          performance-vesting restricted stock units granted in 2024 were earned at a below-target level (82.1%, subject to adjustment based on the relative TSR modifier), the second tranche of the performance-vesting restricted stock units granted in 2023
          were earned at a below-target level (75.9%), and the third tranche of the performance-vesting restricted stock units granted in 2022 were earned at a below-target level (42.3%), as described below in the section entitled &#8220;Components of Executive
          Compensation &#8211; Equity-Based Compensation.&#8221;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">See &#8220;EXECUTIVE COMPENSATION &#8211; Pay Versus Performance&#8221; for more information about the compensation to our Named Executive Officers in comparison to
    certain financial performance measures of the Company.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Stockholder Approval of Executive Compensation on an Advisory Basis</i></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-weight: normal">At our 2024 Annual Meeting of Stockholders in May 2024, we held an advisory vote to approve the compensation of our Named Executive
      Officers as disclosed in our Proxy Statement dated April 9, 2024 related to the annual meeting. Stockholders of the Company expressed strong support for the compensation of our Named Executive Officers, with approximately 98% of the votes cast
      supporting the Company&#8217;s executive compensation. </span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">29</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Executive Compensation Highlights</i></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-weight: normal">Following review and discussions with our independent compensation consultant, Pay Governance LLC (&#8220;Pay Governance&#8221;), about our
      executive compensation program and that of our peer companies, our executive compensation program included the following features for 2024:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left"><b>Modest Increases to Total Direct Compensation for our Named Executive Officers &#8212; </b>Modest 2% or 3% increases to the base salary of each of our Named Executive Officers for 2024 which resulted in corresponding
          increases in their total direct compensation, except for Dr. Khan who was appointed as an executive officer in 2024, and for Mr. Hollinsworth who retired from the Company in 2024.</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left"><b>Introduction of Relative TSR to Performance-Based Equity Incentive Awards &#8212; </b>Adopted a three-year relative TSR payout modifier on our 2024 performance-vesting restricted stock unit awards. Three-year TSR will be
          evaluated relative to the companies listed in the S&amp;P Composite 1500 Index within the GICS Healthcare Providers and Services Industry Group, plus any companies in the 2024 Peer Group (as defined below) not otherwise included (collectively,
          the &#8220;TSR Peer Group&#8221;).</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left"><b>For Named Executive Officers, Modified our Approach to Allocate Half of Equity Value to Performance-Vesting Restricted Stock Unit Awards &#8212; </b>50% of overall long-term incentive value for each Named Executive
          Officer was delivered as performance-vesting restricted stock units and 50% as time-vesting restricted stock awards in 2024. The Compensation Committee believes that allocating 50% of long-term incentive value to performance-vesting restricted
          stock units and 50% as time-vesting restricted stock awards aligns the Named Executive Officers&#8217; compensation with achievement of the Company&#8217;s long-term growth strategy and better aligns with the highly competitive labor market for talented
          executives.</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left"><b>For Named Executive Officer Performance-Vesting Restricted Stock Units, Goals Set at Grant for Performance Measured Each Year of the 2024-2026 Performance and Vesting Period &#8212; </b>For each of our Named Executive
          Officers, the performance-vesting restricted stock units granted in 2024 will vest only if the Company meets or exceeds established Adjusted EBITDA and revenue goals for each year of the 2024-2026 period, rather than measuring performance solely
          on a performance period three years out from grant. The Compensation Committee believes that structuring the awards to vest based on the Company&#8217;s actual Adjusted EBITDA and revenue compared to Adjusted EBITDA and revenue goals set
          contemporaneously with the grant date for the years ending December 31, 2024, 2025 and 2026 better aligns the Named Executive Officers&#8217; compensation with achievement of the Company&#8217;s long-term growth strategy.</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left"><b>Maintained Certain Non-Financial Goals as a Component of the Annual Non-Equity Incentive Awards &#8212; </b>Maintained non-financial goals focused on (i) employee safety and patient safety and outcomes and (ii)
          initiatives to help enhance our technology capabilities as qualitative measures for determining annual cash incentive awards. The Compensation Committee determined the continuation of such non-financial goals as an incentive plan metric better
          aligns the Named Executive Officers&#8217; compensation with the Company&#8217;s mission and values and facilitates long-term stockholder value creation.</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-weight: normal">See &#8220;EXECUTIVE COMPENSATION &#8211; Summary Compensation Table&#8221; for more information about the compensation paid to our Named Executive
      Officers.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Compensation Process and Philosophy</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The Compensation Committee is responsible for discharging our Board of Directors&#8217; responsibilities relating to the oversight, administration and
    approval of our compensation plans, policies and programs for our executive officers and directors. The primary responsibilities and duties of the Compensation Committee are described above in the section entitled &#8220;CORPORATE GOVERNANCE &#8211; Committees of
    the Board of Directors &#8211; Compensation Committee.&#8221;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">30</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Our executive compensation program seeks to:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left">Link the interests of management with those of our stockholders by encouraging stock ownership and aligning performance equity awards with key performance indicators aligned with long-term stockholder returns;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left">Attract and retain superior executives by providing the opportunity to earn total compensation packages that are competitive within the healthcare industry;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left">Recognize and reward senior management&#8217;s individual and collective efforts relating to the financial performance of the Company and creation of stockholder value through salary, annual cash incentives and long-term
          stock-based incentives; and</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left">Manage compensation based on an individual&#8217;s level of skill, knowledge, effort and responsibility.</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The Compensation Committee believes that the compensation of our executive officers should provide a competitive level of total compensation
    necessary to attract and retain talented and experienced executives, and motivate them to contribute to our success. The Compensation Committee has a pay-for-performance philosophy that works to align the interests of management with the interests of
    stockholders through the use of incentive compensation and an approach that puts a majority of the compensation of our Named Executive Officers at risk if the Company does not perform. </p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Our Compensation Committee reviews and approves, in advance, employment and similar arrangements or payments to be made to any executive officer.
    Historically, our Chief Executive Officer provided the Compensation Committee with input regarding the performance of and compensation recommendations for other executive officers based on his direct knowledge of their contributions during the year.
    Our Chief Executive Officer does not play any role with respect to the deliberations and determinations about his own compensation. Our Chief Executive Officer considers internal pay equity issues, individual contribution and performance, competitive
    pressures and our financial performance in making his recommendations to the Compensation Committee.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Our Compensation Committee believes that our executive compensation program should be internally consistent and equitable in order to achieve our
    compensation goals. The Compensation Committee relies on its collective judgment together with the information provided to it by management, the analyses and goals described above and the recommendations of our Chief Executive Officer. The Compensation
    Committee also considers the qualifications, length of service, experience, consistency of performance, position, responsibilities, individual performance and available competitive alternatives of our executives, their existing compensation and our
    financial resources, performance and prospects in determining appropriate levels of compensation for our executives.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Executive Compensation Practices</i></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-weight: normal">Highlighted below are some of the key elements of our compensation program that the Compensation Committee believes evidence strong
      corporate governance and alignment of our executive compensation with long-term stockholder interests.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-weight: normal"><span style="text-decoration:underline">What We Do</span></span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in"><span style=" font-weight: normal">&#10003;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">Significant amount of pay is performance-based and not guaranteed</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in"><span style=" font-weight: normal">&#10003;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">Engage stockholders and seek feedback on our executive compensation program</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in"><span style=" font-weight: normal">&#10003;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">Apply stringent share ownership and share retention policies</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in"><span style=" font-weight: normal">&#10003;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">Use peer market data for benchmarking and calibration </span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in"><span style=" font-weight: normal">&#10003;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">Consult with an independent compensation consultant </span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in"><span style=" font-weight: normal">&#10003;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">Utilize double trigger severance agreements upon a change in control </span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in"><span style=" font-weight: normal">&#10003;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">Conduct an annual risk assessment of our compensation program</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in"><span style=" font-weight: normal">&#10003;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">Have a Compensation Committee composed entirely of independent directors</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in"><span style=" font-weight: normal">&#10003;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-weight: normal">Separate Chief Executive Officer and Chairman of the Board</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">31</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-weight: normal"><span style="text-decoration:underline">What We Don&#8217;t Do</span></span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in"><span style="font-weight: normal">X</span></td>
        <td><span style="font-weight: normal">No supplemental executive retirement plans </span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in"><span style="font-weight: normal">X</span></td>
        <td><span style="font-weight: normal">No stock option repricing or exchanges without stockholder approval </span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in"><span style="font-weight: normal">X</span></td>
        <td><span style="font-weight: normal">No tax gross-ups related to change in control or otherwise</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in"><span style="font-weight: normal">X</span></td>
        <td><span style="font-weight: normal">No excessive perquisites</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in"><span style="font-weight: normal">X</span></td>
        <td><span style="font-weight: normal">No hedging and pledging</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b><i>Role of Compensation Consultant</i></b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Since 2018, the Compensation Committee has retained Pay Governance to advise it with respect to the Company&#8217;s executive compensation program. The
    Compensation Committee has considered the relationships that Pay Governance has had with the Company, the members of the Compensation Committee and our executive officers, and has taken into account the factors required by NASDAQ to be considered when
    assessing a consultant&#8217;s independence. For 2024, after considering such relationships and factors, the Compensation Committee determined that the work of Pay Governance did not raise any conflicts of interest. Outside of their direct engagement by the
    Compensation Committee as independent compensation consultants to the Compensation Committee with respect to executive compensation matters, Pay Governance did not provide other services to the Company in 2024. In late 2024, the Compensation Committee
    began to transition advisory work to Willis Towers Watson (&#8220;WTW&#8221;). WTW did not advise the Compensation Committee on 2024 executive compensation.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b><i>Peer Group Comparison</i></b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-weight: normal">In late 2023, for purposes of setting 2024 compensation for our executive officers, Pay Governance assisted the Compensation
      Committee in establishing a peer group of publicly traded healthcare companies generally similarly sized and with similar service offerings to us (the &#8220;2024 Peer Group&#8221;). The 2024 Peer Group consisted of the following companies:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 94%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 0.55in">

      <tr style="vertical-align: top">
        <td style="width: 50%; padding-right: 5.4pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in">&#9679;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span>Amedisys, Inc.</td>
        <td style="width: 50%; padding-right: 5.4pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in">&#9679;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span>Option Care Health, Inc.</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in">&#9679;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span>AMN Healthcare Services, Inc.</td>
        <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in">&#9679;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span>Pediatrix Medical Group, Inc.</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in">&#9679;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span>Brookdale Senior Living Inc.</td>
        <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in">&#9679;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span>Select Medical Holdings Corporation</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in">&#9679;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span>Chemed Corporation</td>
        <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in">&#9679;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span>Surgery Partners, Inc.</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in">&#9679;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span>Encompass Health Corporation </td>
        <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in">&#9679;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span>Universal Health Services, Inc.</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="padding-right: 5.4pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in">&#9679;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span>The Ensign Group, Inc.</td>
        <td style="padding-right: 5.4pt; text-align: justify; text-indent: 0in">&#160;</td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-weight: normal">The 2024 Peer Group was established using similar criteria for selection of the prior year&#8217;s peer group selected by our Compensation
      Committee, specifically: industry, market capitalization, revenue and revenue growth, and adjusting for mergers and acquisition activity among peers. </span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Executive Officer Transition</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">John S. Hollinsworth retired as the Company&#8217;s Executive Vice President of Operations effective June 30, 2024, but continued to provide transition
    advisory services through December 31, 2024. Dr. Khan was appointed to serve as the Company&#8217;s Chief Operating Officer effective June 30, 2024. See &#8220;EXECUTIVE COMPENSATION &#8211; Potential Payments Upon Termination or Change in Control under the Employment
    Agreements&#8221; for more information about the terms of the Employment Agreements for Dr. Khan. See &#8220;EXECUTIVE COMPENSATION &#8211; Potential Payments Upon Termination or Change in Control under the Employment Agreements &#8211; Mr. Hollinsworth&#8217;s Payments related to
    his Retirement&#8221; for more information about the compensation or benefits received by Mr. Hollinsworth related to his transition from the Company.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Components of Executive Compensation</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-weight: normal">The components of our compensation program for executive officers include base salary, performance-based cash and equity incentive
      compensation, and time-based equity awards. </span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">32</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The following table summarizes the elements of our current compensation program for our Named Executive Officers and provides information about each
    element:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">

      <tr>
        <td style="white-space: nowrap; vertical-align: bottom; width: 19%; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Category of </b></span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Compensation</b></span></p>
        </td>
        <td style="vertical-align: bottom; width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="vertical-align: bottom; width: 18%; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Elements of </b></span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt"><b>Compensation</b></span></p>
        </td>
        <td style="vertical-align: top; width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="vertical-align: bottom; width: 14%; border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 9pt"><b>Metrics Used</b></span></td>
        <td style="vertical-align: top; width: 1%; padding-bottom: 0.75pt; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
        <td style="vertical-align: bottom; width: 46%; border-bottom: Black 1pt solid; padding-bottom: 0.75pt; text-align: center"><span style="font-size: 9pt"><b>Rationale for Compensation</b></span></td>
      </tr>
      <tr>
        <td style="padding-left: 12pt; text-align: center; text-indent: -12pt"><span style="font-size: 9pt"><b>Base Compensation</b></span></td>
        <td style="vertical-align: bottom; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 9pt">Base Salary</span></td>
        <td style="vertical-align: top; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 9pt">N/A</span></td>
        <td style="vertical-align: top; padding-top: 3pt; padding-bottom: 0.75pt; padding-left: 23.75pt; text-align: left; text-indent: -0.25in"><span style="font-size: 9pt">&#160;</span></td>
        <td style="vertical-align: bottom">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.75pt; text-align: left; text-indent: -0.25in"><span style="font-size: 9pt">&#8226;&#160;&#160;&#160;&#160;Attract, retain, and motivate key executive talent</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: left; text-indent: -0.25in"><span style="font-size: 9pt">&#8226;&#160;&#160;&#160;&#160;Provide income security</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: left; text-indent: -0.25in"><span style="font-size: 9pt">&#8226;&#160;&#160;&#160;&#160;Recognizes different levels of responsibility</span></p>
        </td>
      </tr>
      <tr>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="vertical-align: top; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="vertical-align: top; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
      </tr>
      <tr>
        <td style="padding-left: 12pt; text-align: center; text-indent: -12pt"><span style="font-size: 9pt"><b>Short-Term Incentives</b></span></td>
        <td style="vertical-align: bottom; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 9pt">Annual Cash Payment</span></td>
        <td style="vertical-align: top; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt">Adjusted EBITDA</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt">Adjusted EPS</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt">Non-Financial Goals</span></p>
        </td>
        <td style="vertical-align: top; padding-top: 3pt; padding-left: 23.75pt; text-align: left; text-indent: -0.25in"><span style="font-size: 9pt">&#160;</span></td>
        <td style="vertical-align: top">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.75pt; text-align: left; text-indent: -0.25in"><span style="font-size: 9pt">&#8226;&#160;&#160;&#160;&#160;Motivate and reward annual financial performance results</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.75pt; text-align: left; text-indent: -0.25in"><span style="font-size: 9pt">&#8226;&#160;&#160;&#160;&#160;Encourages focus on Company&#8217;s mission and values</span></p>
        </td>
      </tr>
      <tr>
        <td style="padding-left: 12pt; text-align: center; text-indent: -12pt"><span style="font-size: 9pt">&#160;</span></td>
        <td style="vertical-align: bottom; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
        <td style="vertical-align: top; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
        <td style="vertical-align: top; padding-left: 23.75pt; text-align: left; text-indent: -0.25in"><span style="font-size: 9pt">&#160;</span></td>
        <td style="vertical-align: bottom; padding-left: 23.75pt; text-align: left; text-indent: -0.25in"><span style="font-size: 9pt">&#160;</span></td>
      </tr>
      <tr>
        <td style="padding-left: 12pt; text-align: center; text-indent: -12pt"><span style="font-size: 9pt"><b>Long-Term Incentives</b></span></td>
        <td style="vertical-align: bottom; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt">Time-Vesting and</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt">Performance-Vesting</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt">Equity Grants</span></p>
        </td>
        <td style="vertical-align: top; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt">Adjusted EBITDA</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt">Revenue</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt">Relative TSR</span></p>
        </td>
        <td style="vertical-align: top; padding-top: 3pt; padding-left: 23.75pt; text-align: left; text-indent: -0.25in"><span style="font-size: 9pt">&#160;</span></td>
        <td style="vertical-align: bottom">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.75pt; text-align: left; text-indent: -0.25in"><span style="font-size: 9pt">&#8226;&#160;&#160;&#160;&#160;Attract, retain, and motivate key executive talent</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: left; text-indent: -0.25in"><span style="font-size: 9pt">&#8226;&#160;&#160;&#160;&#160;Align interests of executives and stockholders</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: left; text-indent: -0.25in"><span style="font-size: 9pt">&#8226;&#160;&#160;&#160;&#160;Motivate and reward long-term financial performance and stockholder returns</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: left; text-indent: -0.25in"><span style="font-size: 9pt">&#8226;&#160;&#160;&#160;&#160;Encourage executive stock ownership</span></p>
        </td>
      </tr>
      <tr>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="vertical-align: top; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="vertical-align: top; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
      </tr>
      <tr>
        <td style="padding-left: 12pt; text-align: center; text-indent: -12pt"><span style="font-size: 9pt"><b>Benefits</b></span></td>
        <td style="vertical-align: bottom; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="vertical-align: bottom">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt">Retirement Benefits</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt">Personal Benefits</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt">Severance&#160;&amp; Change in</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 9pt">Control Benefits</span></p>
        </td>
        <td style="vertical-align: top; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 9pt">N/A</span></td>
        <td style="vertical-align: top; padding-top: 3pt; padding-left: 23.75pt; text-align: left; text-indent: -0.25in"><span style="font-size: 9pt">&#160;</span></td>
        <td>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 23.75pt; text-align: left; text-indent: -0.25in"><span style="font-size: 9pt">&#8226;&#160;&#160;&#160;&#160;Attract and retain key executive talent</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: left; text-indent: -0.25in"><span style="font-size: 9pt">&#8226;&#160;&#160;&#160;&#160;Enhance executive productivity</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: left; text-indent: -0.25in"><span style="font-size: 9pt">&#8226;&#160;&#160;&#160;&#160;Provide opportunity for financial security in retirement</span></p>
        </td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-weight: normal">As illustrated in the charts below and consistent with our pay-for-performance philosophy, 86% of Mr. Hunter&#8217;s total direct
      compensation for 2024 and, on average, 77% of the other non-CEO Named Executive Officers&#8217; (other than Mr. Hollinsworth) total direct compensation for 2024 was performance-based pay, with emphasis on long-term performance and stockholder value
      creation. For the purposes of these charts, total direct compensation includes base salary, actual non-equity incentive compensation and the grant date fair value of our annual equity grants made in 2024, and is exclusive of any applicable retention
      bonuses. The stock award portion of these charts assume that target performance goals for performance-vesting restricted stock units issued in 2024 are attained during the 2024 performance period in accordance with ASC 718. See &#8220;EXECUTIVE
      COMPENSATION &#8211; Summary Compensation Table&#8221; for more information about the compensation paid to our Named Executive Officers. </span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>
  </div><table border="0" cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; width: 50%; border-collapse: collapse; margin-left: auto; margin-right: auto;">

      <tr style="vertical-align: top">
        <td>
          <p style="margin: 0pt 30pt 0pt 0px; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: right;"><b>2024 CEO TOTAL</b></p>
          <p style="font: 10pt Times New Roman,Times,serif; margin: 0pt 0px; text-align: right;"><b>DIRECT COMPENSATION MIX</b></p>
        </td>
        <td style="width: 85pt;">&#160;</td>
        <td style="width: 330pt;">
          <p style="margin: 0pt 0px 0pt 55pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left;"><b>2024 ALL OTHER NEOS</b></p>
          <p style="font: 10pt Times New Roman,Times,serif; margin: 0pt 0px; text-align: left;"><b>AVERAGE TOTAL DIRECT COMPENSATION MIX</b></p>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td colspan="2">&#160;</td>
        <td style="width: 330pt;">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td colspan="3" style="text-align: center;"><img alt="" src="ny20042551x1_image03.jpg" style="height: 203; width: 550"/>&#160;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">33</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Base Salary </i></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Our Compensation Committee generally reviews each Named Executive Officer&#8217;s base salary annually, and considers adjustments to each Named Executive
    Officer&#8217;s base salary for the following year. The base salaries under the employment agreements for our Named Executive Officers are subject to an annual review and potential increase in the sole discretion of the Compensation Committee.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">In setting base salaries for 2024, the Compensation Committee reviewed the composition of the relevant peer group and discussed peer group
    information with the Compensation Committee&#8217;s independent compensation consultant. For setting 2024 base salaries, Mr. Hunter provided the Compensation Committee with an evaluation of the individual performance and roles and responsibilities of each
    executive officer other than himself.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The base salaries for the Named Executive Officers effective as of January 1, 2023 and 2024 were as follows:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 98%; font: 10pt Times New Roman, Times, Serif; margin-left: auto; margin-right: auto;">

      <tr style="vertical-align: bottom">
        <td style="text-align: center; border-bottom: Black 1pt solid">Name</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Base Salary <br/>
          As of January 1, 2023</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Base Salary <br/>
          As of January 1, 2024</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="border-bottom: Black 1pt solid; text-align: center">Percentage <br/>
          Increase</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 22%; text-align: justify; padding-left: 5.4pt">Christopher H. Hunter</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 15%; text-align: right">$1,000,000</td>
        <td style="width: 10%; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 15%; text-align: right">$1,020,000</td>
        <td style="width: 10%; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 25%; text-align: center">2.0%</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: justify; padding-left: 5.4pt">Heather Dixon</td>
        <td>&#160;</td>
        <td style="text-align: right">690,000</td>
        <td style="text-align: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup>&#160;</td>
        <td>&#160;</td>
        <td style="text-align: right">710,700</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: center">3.0%</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 5.4pt">Brian P. Farley</td>
        <td>&#160;</td>
        <td style="text-align: right">550,000</td>
        <td style="text-align: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup>&#160;</td>
        <td>&#160;</td>
        <td style="text-align: right">566,500</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: center">3.0%</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: justify; padding-left: 5.4pt">Nasser Khan, M.D.</td>
        <td>&#160;</td>
        <td style="text-align: right">N/A</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: right">515,000</td>
        <td style="text-align: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup>&#160;</td>
        <td>&#160;</td>
        <td style="text-align: center">N/A</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 5.4pt">John S. Hollinsworth</td>
        <td>&#160;</td>
        <td style="text-align: right">652,030</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: right">652,030</td>
        <td style="text-align: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup>&#160;</td>
        <td>&#160;</td>
        <td style="text-align: center">0.0%</td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><div>
  </div><!-- Field: Rule-Page --><div>
  </div><div style="margin-top: 0; margin-bottom: 0; text-align: LEFT;">
    <div style="font-size: 1pt; border-top: Black 1pt solid; width: 18%">&#160;</div>
  </div><div>
  </div><!-- Field: /Rule-Page --><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-size: 9pt">(1) As of July 10, 2023, the effective date of her appointment as our Chief Financial Officer.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-size: 9pt">(2) As of July 26, 2023, the effective date of his appointment as our Executive Vice President, General Counsel and
      Secretary.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-size: 9pt">(3) As of June 30, 2024, the effective date of his appointment as our Chief Operating Officer.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-size: 9pt">(4) Mr. Hollinsworth retired as our Executive Vice President of Operations effective June 30, 2024.</span> </p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">See &#8220;EXECUTIVE COMPENSATION &#8211; Summary Compensation Table&#8221; for more information about the base salaries paid to our Named Executive Officers.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Annual Non-Equity Incentive Compensation</i></b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Annual non-equity incentive awards paid to our Named Executive Officers are a reward for the realization of established performance objectives. Our
    Compensation Committee annually adopts a cash bonus plan pursuant to the Company&#8217;s incentive compensation plan for each Named Executive Officer. The Compensation Committee generally meets in February or March to review whether and the extent to which
    performance objectives have been achieved for the prior year. All non-equity incentive awards are subject to the review and approval of the Compensation Committee, which has the discretion to adjust any and all such awards.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><i>2024 Awards</i></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Annual non-equity incentive compensation payable to our Named Executive Officers for 2024 was based 80% on the Company-wide measures Adjusted EBITDA
    and Adjusted EPS and 20% on achieving certain non-financial goals, with each of Adjusted EBITDA and Adjusted EPS determining 40% of the total incentive award. For 2024, the non-financial goals focused on the Compensation Committee&#8217;s assessments of (i)
    employee safety and patient safety and outcomes and (ii) initiatives to help enhance our technology capabilities. The Compensation Committee used these measures for determining annual cash incentive awards because they are important measures of our
    performance and the performance of our management, they drive our success and growth and they are key criteria by which management plans and analyzes our business. Adjusted EBITDA and Adjusted EPS are non-GAAP financial measures and subject to further
    adjustments compared to the same measures disclosed in or derived from the Company&#8217;s Annual Report on Form 10-K, press releases or other financial records. A reconciliation of these non-GAAP financial measures can be found at the end of this Proxy
    Statement.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">34</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The table below sets forth the threshold, target and maximum cash incentive award for 2024 (as a percentage of base salary) for each of the Named
    Executive Officers.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif; margin-left: auto; margin-right: auto;">

      <tr style="vertical-align: bottom">
        <td style="text-align: center; border-bottom: Black 1pt solid">Name</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="text-align: center; border-bottom: Black 1pt solid">Threshold<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="text-align: center; border-bottom: Black 1pt solid">Target</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="text-align: center; border-bottom: Black 1pt solid">Maximum</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 52%; text-align: left">Christopher H. Hunter</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 15%; text-align: center">62.5%</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 15%; text-align: center">125%</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 15%; text-align: center">250%</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left">Heather Dixon</td>
        <td>&#160;</td>
        <td style="text-align: center">42.5%</td>
        <td>&#160;</td>
        <td style="text-align: center">85%</td>
        <td>&#160;</td>
        <td style="text-align: center">170%</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left">Brian P. Farley</td>
        <td>&#160;</td>
        <td style="text-align: center">42.5%</td>
        <td>&#160;</td>
        <td style="text-align: center">85%</td>
        <td>&#160;</td>
        <td style="text-align: center">170%</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: justify; text-indent: -12pt; padding-left: 12pt">Nasser Khan, M.D.</td>
        <td>&#160;</td>
        <td style="text-align: center">42.5%</td>
        <td>&#160;</td>
        <td style="text-align: center">85%</td>
        <td>&#160;</td>
        <td style="text-align: center">170%</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; text-indent: -12pt; padding-left: 12pt">John S. Hollinsworth</td>
        <td>&#160;</td>
        <td style="text-align: center">42.5%</td>
        <td>&#160;</td>
        <td style="text-align: center">85%</td>
        <td>&#160;</td>
        <td style="text-align: center">170%</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td>&#160;</td>
        <td>&#160;</td>
        <td style="text-align: center">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: center">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: center">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td colspan="7"><!-- Field: Rule-Page -->
          <div style="margin-top: 0; margin-bottom: 5pt; text-align: LEFT;">
            <div style="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&#160;</div>
          </div>
          <!-- Field: /Rule-Page --> </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td colspan="7">(1) As described below, Named Executive Officers may receive an aggregate of less than the threshold percentage of their base salary listed above if performance exceeds the threshold level of one or more, but not all, of the
          applicable performance measures.</td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 85.5pt; text-align: left">&#160;&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">These target and maximum percentages are no less than the target and maximum percentages that each executive is eligible to earn (as a percentage of base salary)
    pursuant to the employment agreements entered into with each applicable executive.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The table below summarizes the performance measures and actual results applicable to our 2024 non-equity incentive awards. Straight-line
    interpolation is used to determine awards for performance between goal levels. Payout ranges reflect a percentage of a Named Executive Officer&#8217;s base salary.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom">
        <td style="font-size: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Weighting</span></td>
        <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 9pt">Threshold</span></td>
        <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Target</span></td>
        <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">Maximum</span></td>
        <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 9pt">Actual</span></td>
        <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 9pt">% of<br/>
            Target</span></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td colspan="17" style="text-align: center"><span style="font-size: 9pt">(amounts in millions, other than EPS)</span></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold; text-decoration: underline; text-align: justify; text-indent: -12pt; padding-left: 12pt"><span style="font-size: 9pt">Performance Metric</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="width: 38%; text-align: left; text-indent: 15.8pt; padding-left: 5.4pt"><span style="font-size: 9pt">Adjusted EBITDA</span></td>
        <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 8%; text-align: center"><span style="font-size: 9pt">40%</span></td>
        <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 7%; text-align: right"><span style="font-size: 9pt">$676.2</span></td>
        <td style="width: 3%; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 7%; text-align: right"><span style="font-size: 9pt">$751.3</span></td>
        <td style="width: 3%"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 7%; text-align: right"><span style="font-size: 9pt">$864.0</span></td>
        <td style="width: 3%"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 7%; text-align: right"><span style="font-size: 9pt">$711.3</span></td>
        <td style="width: 3%; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 8%; text-align: center"><span style="font-size: 9pt">94.7%</span></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="text-align: left; text-indent: 15.8pt; padding-left: 5.4pt"><span style="font-size: 9pt">Adjusted EPS</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 9pt">40%</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">$3.20</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">$3.54</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">$4.08</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">$3.32</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 9pt">93.8%</span></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="text-align: left; text-indent: 0.25in; padding-left: 5.4pt"><span style="font-size: 9pt">Non-Financial Goals</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 9pt">20%</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 9pt">95.0%</span></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold; text-align: justify; text-indent: -12pt; padding-left: 12pt"><span style="font-size: 9pt">Performance Range (as % of Target measure)</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">90%</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">100%</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">115%</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold; text-align: justify; text-indent: -12pt; padding-left: 12pt"><span style="font-size: 9pt">Payout Range (CEO)</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">62.5%</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">125.0%</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">250.0%</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="font-weight: bold; text-align: justify; text-indent: -12pt; padding-left: 12pt"><span style="font-size: 9pt">Payout Range (other NEOs)</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">42.5%</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">85.0%</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">170.0%</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">For 2024, the non-financial goals focused on the Compensation Committee&#8217;s assessments of (i) employee safety and patient safety and outcomes and (ii)
    initiatives to help enhance our technology capabilities. The employee safety and patient safety and outcomes goal was measured based on patient experience evaluation results at our facilities, implementation of our selected electronic patient
    monitoring platform in certain of our facilities, and implementation of our personal safety alert devices for employees in certain of our facilities. The information technology (&#8220;IT&#8221;) initiatives goal was measured based on development of enterprise,
    full coverage networks at certain of our facilities and the completion of an enterprise cyber security maturity assessment.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">In February 2025, the Compensation Committee evaluated the extent to which the performance goals for the 2024 annual non-equity incentive awards had
    been achieved. As a result of 2024 performance, the payout for our Named Executive Officers as a percentage of target was 76.0%. Pursuant <span style="background-color: white">to the terms of a Separation and Consulting Agreement with the Company,
      upon his retirement as Executive Vice President of Operations, </span>Mr.&#160;Hollinsworth remained eligible to earn a prorated portion of his 2024 annual non-equity incentive award subject to actual achievement of the 2024 performance goals.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">35</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The table below sets forth the cash incentive payments earned by each of the Named Executive Officers with respect to their 2024 annual non-equity
    incentive award.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom">
        <td style="text-align: center; border-bottom: Black 1pt solid">Name</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="text-align: center; border-bottom: Black 1pt solid">EBITDA <br/>
          Component</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="text-align: center; border-bottom: Black 1pt solid">% of<br/>
          Target</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="text-align: center; border-bottom: Black 1pt solid">EPS <br/>
          Component</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="text-align: center; border-bottom: Black 1pt solid">% of<br/>
          Target</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="text-align: center; border-bottom: Black 1pt solid">Non-Financial Component</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="text-align: center; border-bottom: Black 1pt solid">% of<br/>
          Target</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="text-align: center; border-bottom: Black 1pt solid">Total Cash Incentive<br/>
          Payment</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="text-align: center; border-bottom: Black 1pt solid">% of<br/>
          Target</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 28%; text-align: left; padding-left: 5.4pt">Christopher H. Hunter</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 8%; text-align: right; padding-right: 10pt">&#160;$373,926</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 8%; text-align: center">73.3</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 8%; text-align: right; padding-right: 10pt">&#160;$351,525</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 8%; text-align: center">68.9</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 8%; text-align: right; padding-right: 10pt">&#160;$241,868</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 8%; text-align: center">95.0</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 8%; text-align: right; padding-right: 10pt">$967,319</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 8%; text-align: center">76.0</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-left: 5.4pt">Heather Dixon</td>
        <td>&#160;</td>
        <td style="text-align: right; padding-right: 10pt">177,166</td>
        <td>&#160;</td>
        <td style="text-align: center">73.3</td>
        <td>&#160;</td>
        <td style="text-align: right; padding-right: 10pt">166,553</td>
        <td>&#160;</td>
        <td style="text-align: center">68.9</td>
        <td>&#160;</td>
        <td style="text-align: right; padding-right: 10pt">113,781</td>
        <td>&#160;</td>
        <td style="text-align: center">95.0</td>
        <td>&#160;</td>
        <td style="text-align: right; padding-right: 10pt">457,500</td>
        <td>&#160;</td>
        <td style="text-align: center">76.0</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-left: 5.4pt">Brian P. Farley</td>
        <td>&#160;</td>
        <td style="text-align: right; padding-right: 10pt">141,219</td>
        <td>&#160;</td>
        <td style="text-align: center">73.3</td>
        <td>&#160;</td>
        <td style="text-align: right; padding-right: 10pt">132,759</td>
        <td>&#160;</td>
        <td style="text-align: center">68.9</td>
        <td>&#160;</td>
        <td style="text-align: right; padding-right: 10pt">90,290</td>
        <td>&#160;</td>
        <td style="text-align: center">95.0</td>
        <td>&#160;</td>
        <td style="text-align: right; padding-right: 10pt">364,268</td>
        <td>&#160;</td>
        <td style="text-align: center">76.0</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-left: 5.4pt"><span style="font-size: 10pt">Nasser Khan, M.D.<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></span></td>
        <td>&#160;</td>
        <td style="text-align: right; padding-right: 10pt">65,089</td>
        <td>&#160;</td>
        <td style="text-align: center">73.3</td>
        <td>&#160;</td>
        <td style="text-align: right; padding-right: 10pt">61,190</td>
        <td>&#160;</td>
        <td style="text-align: center">68.9</td>
        <td>&#160;</td>
        <td style="text-align: right; padding-right: 10pt">41,724</td>
        <td>&#160;</td>
        <td style="text-align: center">95.0</td>
        <td>&#160;</td>
        <td style="text-align: right; padding-right: 10pt">168,003</td>
        <td>&#160;</td>
        <td style="text-align: center">76.0</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-left: 5.4pt"><span style="font-size: 10pt">John S. Hollinsworth<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></span></td>
        <td>&#160;</td>
        <td style="text-align: right; padding-right: 10pt">81,047</td>
        <td>&#160;</td>
        <td style="text-align: center">73.3</td>
        <td>&#160;</td>
        <td style="text-align: right; padding-right: 10pt">76,192</td>
        <td>&#160;</td>
        <td style="text-align: center">68.9</td>
        <td>&#160;</td>
        <td style="text-align: right; padding-right: 10pt">51,789</td>
        <td>&#160;</td>
        <td style="text-align: center">95.0</td>
        <td>&#160;</td>
        <td style="text-align: right; padding-right: 10pt">209,028</td>
        <td>&#160;</td>
        <td style="text-align: center">76.0</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><!-- Field: Rule-Page --><div>
  </div><div style="margin-top: 0; margin-bottom: 3pt; text-align: LEFT;">
    <div style="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&#160;</div>
  </div><div>
  </div><!-- Field: /Rule-Page --><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><span style="font-size: 9pt">(1) The amount payable to Dr. Khan is a pro rata amount (50.7%) based on the date of his appointment as our Chief
      Operating Officer.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-size: 9pt">(2) The amount payable to Mr. Hollinsworth is a pro rata amount (50.0%) based on the date of his retirement as our Executive Vice President
      of Operations.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b><i>Equity-Based Compensation</i></b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Our Compensation Committee believes that time-vesting restricted stock and performance-vesting restricted stock units are key components to the
    compensation of our executive officers, and providing a mix of these different types of equity awards is consistent with market practice for executive officers in our peer group. The Compensation Committee believes that time-vesting restricted stock
    and performance-vesting restricted stock units provide a substantial incentive to our Named Executive Officers by allowing them to directly participate in any increase in our long-term value. These incentives are intended to reward, motivate and retain
    the services of our Named Executive Officers. The Compensation Committee believes that a mix of equity awards aligns the interests of our Named Executive Officers with those of our stockholders and is consistent with our pay-for-performance philosophy.
    Equity-based awards are typically granted under the Company&#8217;s incentive compensation plan during the second quarter of each year.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><i>Equity Awards Granted in 2024</i></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white">With respect to our equity awards granted in 2024, the allocation among performance-vesting restricted stock units (50% of
    the total equity award) and time-vesting restricted stock (50% of the total equity award) was not based on a formula approach but reflected the Compensation Committee&#8217;s view that one-half of the equity-based incentives should be performance-based and
    at risk.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Effective June 26, 2024, the Compensation Committee approved annual grants of the following number of performance-vesting restricted stock units (subject to the
    achievement of certain performance goals and continued employment) and shares of time-vesting restricted stock under the Incentive Plan to our Named Executive Officers (other than Mr. Hollinsworth).</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 96%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.25in">

      <tr style="vertical-align: bottom">
        <td style="text-align: center; border-bottom: Black 1pt solid">Name</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Performance-Vesting <br/>
          Restricted Stock Units</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">Time-Vesting<br/>
          Restricted Stock</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="3" style="text-align: center; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">Grant Date Fair Value<br/>
            of Stock Awards<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></p>
        </td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 34%; text-align: left; padding-left: 5.4pt">Christopher H. Hunter</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 15%; text-align: right">37,516</td>
        <td style="width: 5%; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 15%; text-align: right">37,516</td>
        <td style="width: 5%; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left"/>
        <td style="width: 15%; text-align: right">$&#160;&#160;5,099,925</td>
        <td style="width: 5%; text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-left: 5.4pt">Heather Dixon</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">15,447</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">15,447</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">2,099,865</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-left: 5.4pt">Brian P. Farley</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">10,445</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">10,445</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">1,419,893</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-left: 5.4pt">Nasser Khan, M.D.</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">5,884</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">5,884</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">799,871</td>
        <td style="text-align: left">&#160;</td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p><div>
  </div><!-- Field: Rule-Page --><div>
  </div><div style="margin-left: 0.25in; margin-top: 3pt; margin-bottom: 3pt; text-align: LEFT;">
    <div style="font-size: 1pt; border-top: Black 1pt solid; width: 20%">&#160;</div>
  </div><div>
  </div><!-- Field: /Rule-Page --><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left"><span style="font-size: 9pt">(1) Reflects the aggregate grant date fair value of such time-vesting restricted stock and performance-vesting restricted stock
      units, computed in accordance with ASC 718, and pursuant to the terms of such awards, calculated by using the average of the trailing twenty-day closing price of the Company&#8217;s stock as of the grant date. The awards are described in more detail in the
      &#8220;EXECUTIVE COMPENSATION <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#8211;</span> Grants of Plan-Based Awards&#8221; section below.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: 0in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: 0in"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">36</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: 0in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The Named Executive Officers must be employed by the Company at the time the performance-vesting restricted stock units and/or time-vesting
    restricted stock vest in order to receive the shares of Common Stock underlying each award, except in the case of certain terminations of employment as discussed under the heading &#8220;<span style="text-transform: uppercase">Executive Compensation</span> &#8211;
    Potential Payments Upon Termination or Change in Control under the Employment Agreements.&#8221; An executive who retires prior to issuance may receive a pro rata share of any earned awards based on the date of retirement. Pursuant <span style="background-color: white">to the terms of that certain Separation and Consulting Agreement with the Company, upon his retirement as Executive Vice President of Operations, </span>Mr.&#160;Hollinsworth&#8217;s previously earned but unvested
    performance-vesting restricted stock units remained outstanding and eligible to vest at the conclusion of their applicable full performance period, but <span style="background-color: white">Mr. Hollinsworth forfeited his rights to all other
      outstanding equity awards, including the portions of any outstanding </span>performance-vesting restricted stock units subject to 2024 or later performance goals<span style="background-color: white">.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><i>Performance-Vesting Restricted Stock Units</i>. For the Named Executive Officers, the performance-vesting restricted stock units granted effective
    June 26, 2024 are earned <span style="background-color: white">in three equal annual installments&#160;</span>based upon the achievement of a specified performance level of Adjusted EBITDA and revenue for 2024, 2025, and 2026, and adjusted at the end of
    the full three-year period in accordance with the three-year TSR modifier. On June 26, 2024, t<span style="background-color: white">he Compensation Committee established the performance objectives for each of 2024, 2025 and 2026 for purposes of the
      vesting of restricted stock units. </span>The Compensation Committee believes that Adjusted EBITDA and revenue are the appropriate financial measures for determining vesting of performance-vesting restricted stock unit awards because each is an
    important measure of our performance and the performance of our management, each drives our success and growth, and each is a key criterion by which management plans and analyzes our business.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The Compensation Committee has established Adjusted EBITDA and revenue as the core long-term metrics for purposes of performance-vesting equity
    awards for our Named Executive Officers and for 2024 delivered one-half of equity awards as performance based, with 50% of awards being performance-vesting restricted stock units and 50% of awards being time-vesting restricted stock. In addition,
    performance-vesting equity awards are subject to the following parameters:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.25in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>Financial performance is measured annually, with Adjusted EBITDA and revenue goals for each of the three years in the performance period set at the time of grant for each year of the three-year term of the award.</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.25in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>A TSR modifier that measures the Company&#8217;s TSR performance relative to a group of industry comparators over the full three-year performance period was added.</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.25in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>Shares earned based on Adjusted EBITDA and revenue results are issued at the end of the three-year term of the award, subject to adjustment based on the new relative TSR modifier. The Compensation Committee believes that issuance of shares at
          the end of the three-year term in combination with the application of a three-year relative TSR modifier increases the long-term orientation of the compensation program.</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.25in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>The number of shares accumulated during the term are increased or decreased by up to 25% at the end of the three-year term based on our three-year TSR relative to that of the TSR Peer Group. If our absolute TSR is negative, the TSR modifier is
          capped at 100% and cannot increase the share payout.</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The number of shares of Common Stock that may be issued upon vesting of the performance-vesting restricted stock units ranges from 0% to 200% of the
    total number of units set forth above in accordance with a formula based on our Adjusted EBITDA and revenue, equally-weighted between such measures, and adjusted in accordance with the TSR modifier. Unearned performance awards in the performance period
    are forfeited.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">For 2024, the threshold award (as a percentage of the number of performance-vesting restricted stock units eligible for vesting based on the
    applicable performance period) for each applicable Named Executive Officer was 50%, the target award was 100% and the maximum award was 200%.&#160;Subject to remaining vesting and the three-year TSR modifier, the actual number of shares of Common Stock
    earned each year is based on performance relative to the specified Adjusted EBITDA and revenue for the corresponding year.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">37</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">For purposes of our 2024 awards of performance-vesting restricted stock units, our target level Adjusted EBITDA was $751.39 million and our target
    level revenue was $3,212.7 million. The table below sets forth the number of shares of Common Stock that each applicable Named Executive Officer was eligible to earn for 2024 (as a percentage of the number of performance-vesting restricted stock units
    eligible to be earned based on 2024 performance), subject to continued employment throughout the full three-year performance and vesting period, based upon the Company&#8217;s actual Adjusted EBITDA and revenue for 2024. All shares earned are subject to
    adjustment at the end of the three-year term based on the TSR modifier.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; width: 80%; margin-left: auto; margin-right: auto;">

      <tr style="vertical-align: bottom">
        <td rowspan="2" style="border-bottom: Black 1pt solid; text-align: center">Metric</td>
        <td rowspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighting</td>
        <td>&#160;</td>
        <td colspan="2" style="white-space: nowrap; text-align: center">Threshold</td>
        <td>&#160;</td>
        <td colspan="2" style="white-space: nowrap; text-align: center">Target </td>
        <td>&#160;</td>
        <td colspan="2" style="white-space: nowrap; text-align: center">Maximum</td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="border-bottom: Black 1pt solid">&#160;</td>
        <td colspan="2" style="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center">(50% - 100%)</td>
        <td style="border-bottom: Black 1pt solid">&#160;</td>
        <td colspan="2" style="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center">(100% - 200%)</td>
        <td style="border-bottom: Black 1pt solid">&#160;</td>
        <td colspan="2" style="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center">(200%)</td>
      </tr>
      <tr style="background-color: #CCEEFF">
        <td style="vertical-align: top; width: 19%; text-align: center">Adjusted EBITDA</td>
        <td style="vertical-align: top; text-align: center">50%</td>
        <td style="vertical-align: bottom">&#160;</td>
        <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
        <td style="white-space: nowrap; vertical-align: top; width: 22%; text-align: center">$676.25m - $751.39m</td>
        <td style="vertical-align: top">&#160;</td>
        <td style="white-space: nowrap; vertical-align: top">&#160;</td>
        <td style="white-space: nowrap; vertical-align: top; width: 23%; text-align: center">$751.39m - $864.1m</td>
        <td style="vertical-align: top">&#160;</td>
        <td style="white-space: nowrap; vertical-align: top">&#160;</td>
        <td style="vertical-align: top; width: 20%; text-align: center">$864.1m or Greater</td>
      </tr>
      <tr>
        <td style="vertical-align: top; text-align: center">Revenue</td>
        <td style="vertical-align: top; text-align: center">50%</td>
        <td style="vertical-align: bottom; text-align: left">&#160;</td>
        <td style="white-space: nowrap; vertical-align: bottom; text-align: right">&#160;</td>
        <td style="white-space: nowrap; vertical-align: top; text-align: center">$2,891.4m - $3,212.7m</td>
        <td style="vertical-align: top; text-align: center">&#160;</td>
        <td style="white-space: nowrap; vertical-align: top; text-align: center">&#160;</td>
        <td style="white-space: nowrap; vertical-align: top; text-align: center">$3,212.7m - $3,694.6m</td>
        <td style="vertical-align: top; text-align: center">&#160;</td>
        <td style="white-space: nowrap; vertical-align: top; text-align: center">&#160;</td>
        <td style="vertical-align: top; text-align: center">$3,694.6m or Greater</td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">In February 2025, the Compensation Committee evaluated the extent to which the 2024 performance goals for the 2024 performance-vesting restricted
    stock unit awards had been achieved. The Compensation Committee determined that actual Adjusted EBITDA for 2024 was $711.3 million and actual revenue for 2024 was $3,154.0 million, resulting in approximately 73.3% and 90.9% of each portion of the 2024
    performance-vesting restricted stock unit annual award being earned with respect to such measure as reflected in the table below (all of these earned shares are subject to continued time-based vesting through the full three-year period and adjustment
    at the end of the three-year term based on the TSR modifier):</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom">
        <td style="text-align: center; border-bottom: Black 1pt solid">Name</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2024 Performance-Vesting Restricted Stock Unit Grant</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">Target Shares<br/>
            Subject to</p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">2024 Performance<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></p>
        </td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Shares Allocated to each Measure</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Shares Earned per Adjusted EBITDA</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Shares Earned per Revenue</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Total Shares Earned for <br/>
          2024 Performance</td>
        <td style="padding-bottom: 1pt">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 22%; text-align: left; padding-left: 5.4pt">Christopher H. Hunter</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 10%; text-align: right">37,516</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 10%; text-align: right">12,505</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 10%; text-align: right">6,253</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 10%; text-align: right">4,584</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 10%; text-align: right">5,681</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 10%; text-align: right">10,265</td>
        <td style="width: 1%; text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-left: 5.4pt">Heather Dixon</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">15,447</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">5,149</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">2,575</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">1,888</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">2,339</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">4,227</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-left: 5.4pt">Brian P. Farley</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">10,445</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">3,482</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">1,743</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">1,278</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">1,583</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">2,861</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; text-indent: 0; padding-left: 5.4pt">Nasser Khan, M.D.</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">5,884</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">1,961</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">981</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">719</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">891</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">1,610</td>
        <td style="text-align: left">&#160;</td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>
  </div><!-- Field: Rule-Page --><div>
  </div><div style="margin-top: 0; margin-bottom: 3pt; text-align: LEFT;">
    <div style="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&#160;</div>
  </div><div>
  </div><!-- Field: /Rule-Page --><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-size: 9pt">(1) Amounts reflect one-third of the grant.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">Mr. Hollinsworth did not receive a 2024 performance-vesting restricted stock unit award due to his retirement from the Company in 2024.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><i>Time-Vesting Restricted Stock</i>. The time-vesting restricted stock granted in 2024 vests 25% per year on the four successive anniversaries of
    the date of grant.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><i>2023 Performance-Vesting Restricted Stock Unit Awards Earned</i></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">On May 9, 2023, the Compensation Committee approved grants of the following number of performance-vesting restricted stock units under the Incentive
    Plan to our Named Executive Officers listed below, except that the awards granted to Ms. Dixon and Mr. Farley occurred on July 25, 2023 and July 26, 2023, respectively, in connection with their appointment as executive officers of the Company:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 60%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: auto; margin-right: auto;">

      <tr style="vertical-align: bottom">
        <td style="width: 51%; padding-right: 5.4pt; padding-left: 5.4pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.75pt solid">Name</p>
        </td>
        <td style="width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; border-bottom: Black 0.75pt solid; margin-bottom: 0pt;">2023 Performance-Vesting Restricted Stock Units</p>
        </td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Christopher H. Hunter</td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">51,871</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Heather Dixon</td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">46,077</td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Brian P. Farley </td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">10,000</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">John S. Hollinsworth</td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">16,021</td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">38</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The performance-vesting restricted stock units granted in 2023 are earned in three equal annual installments based upon the achievement of specified
    performance levels of Adjusted EPS and Adjusted EBITDA for 2023, 2024, and 2025. On May 9, 2023 or such other grant dates, the Compensation Committee established the performance objectives for each of 2023, 2024 and 2025 for purposes of the vesting of
    restricted stock units.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The number of shares of Common Stock that may be issued upon vesting of the 2023 performance-vesting restricted stock units ranges from 0% to 200% of
    the total number of units set forth above in accordance with a formula based on our Adjusted EPS and Adjusted EBITDA, equally-weighted between such measures. None of the performance-vesting restricted stock units granted in 2023 will vest for
    performance below 90.0% of the specified Adjusted EPS. Unearned performance awards in the performance period are forfeited.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">For 2024 performance under the 2023 performance-vesting restricted stock unit awards, the threshold award (as a percentage of the number of
    performance-vesting restricted stock units eligible for vesting based on 2024 performance) for each applicable Named Executive Officer was 50%, the target award was 100% and the maximum award was 200%.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">For purposes of our 2023 awards of performance-vesting restricted stock units, our target level Adjusted EPS for 2024 was $3.62 and target level
    Adjusted EBITDA was $720.7 million. The table below sets forth the number of shares of Common Stock that each applicable Named Executive Officer was eligible to earn for 2024 performance under the 2023 performance-vesting restricted stock unit awards
    (as a percentage of the number of performance-vesting restricted stock units eligible for vesting based on 2024 performance), subject to continued employment throughout the performance period, based upon the Company&#8217;s actual Adjusted EPS and Adjusted
    EBITDA for 2024.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; width: 80%; margin-left: auto; margin-right: auto;">

      <tr style="vertical-align: bottom">
        <td rowspan="2" style="border-bottom: Black 1pt solid; text-align: center">Metric</td>
        <td rowspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighting</td>
        <td>&#160;</td>
        <td colspan="2" style="white-space: nowrap; text-align: center">Threshold</td>
        <td>&#160;</td>
        <td colspan="2" style="white-space: nowrap; text-align: center">Target </td>
        <td>&#160;</td>
        <td colspan="2" style="white-space: nowrap; text-align: center">Maximum</td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="border-bottom: Black 1pt solid">&#160;</td>
        <td colspan="2" style="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center">(50% - 100%)</td>
        <td style="border-bottom: Black 1pt solid">&#160;</td>
        <td colspan="2" style="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center">(100% - 200%)</td>
        <td style="border-bottom: Black 1pt solid">&#160;</td>
        <td colspan="2" style="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center">(200%)</td>
      </tr>
      <tr style="background-color: #CCEEFF">
        <td style="vertical-align: top; width: 19%; text-align: center">Adjusted EPS</td>
        <td style="vertical-align: top; text-align: center">50%</td>
        <td style="vertical-align: bottom">&#160;</td>
        <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
        <td style="white-space: nowrap; vertical-align: top; width: 22%; text-align: center">$3.25 - $3.62</td>
        <td style="vertical-align: top">&#160;</td>
        <td style="white-space: nowrap; vertical-align: top">&#160;</td>
        <td style="white-space: nowrap; vertical-align: top; width: 23%; text-align: center">$3.62 - $3.81</td>
        <td style="vertical-align: top">&#160;</td>
        <td style="white-space: nowrap; vertical-align: top">&#160;</td>
        <td style="vertical-align: top; width: 20%; text-align: center">$3.81 or Greater</td>
      </tr>
      <tr>
        <td style="vertical-align: top; text-align: center">Adjusted EBITDA</td>
        <td style="vertical-align: top; text-align: center">50%</td>
        <td style="vertical-align: bottom; text-align: left">&#160;</td>
        <td style="white-space: nowrap; vertical-align: bottom; text-align: right">&#160;</td>
        <td style="white-space: nowrap; vertical-align: top; text-align: center">$653.3m - $720.7m</td>
        <td style="vertical-align: top; text-align: center">&#160;</td>
        <td style="white-space: nowrap; vertical-align: top; text-align: center">&#160;</td>
        <td style="white-space: nowrap; vertical-align: top; text-align: center">$720.7m - $791.2m</td>
        <td style="vertical-align: top; text-align: center">&#160;</td>
        <td style="white-space: nowrap; vertical-align: top; text-align: center">&#160;</td>
        <td style="vertical-align: top; text-align: center">$791.2m or Greater</td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">In February 2025, the Compensation Committee evaluated the extent to which the 2024 performance goals for the 2023 performance-vesting restricted
    stock unit awards had been achieved. The Compensation Committee determined that actual Adjusted EPS for 2024 was $3.32 and actual Adjusted EBITDA for 2024 was $711.3 million, resulting in approximately 58.3% and 93.5% of each portion of the 2023
    performance-vesting restricted stock unit annual award being earned with respect to such measure as reflected in the table below (all of these earned shares are subject to continued time-based vesting through the full three-year period):</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom">
        <td style="text-align: center; border-bottom: Black 1pt solid">Name</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2023 Performance-Vesting Restricted Stock Unit Grant</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">Target Shares<br/>
            Subject to</p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">2024 Performance<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></p>
        </td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Shares Allocated to each Measure</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Shares Earned per Adjusted EPS</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Shares Earned per Adjusted EBITDA</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Total Shares Earned for <br/>
          2024 Performance</td>
        <td style="padding-bottom: 1pt">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 22%; text-align: left; padding-left: 5.4pt">Christopher H. Hunter</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 10%; text-align: right">51,871</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 10%; text-align: right">17,290</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 10%; text-align: right">8,645</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 10%; text-align: right">5,043</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 10%; text-align: right">8,081</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 10%; text-align: right">13,124</td>
        <td style="width: 1%; text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-left: 5.4pt">Heather Dixon</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">46,077</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">15,359</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">7,680</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">4,480</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">7,179</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">11,659</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-left: 5.4pt">Brian P. Farley</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">10,000</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">3,333</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">1,667</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">972</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">1,558</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">2,530</td>
        <td style="text-align: left">&#160;</td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>
  </div><!-- Field: Rule-Page --><div>
  </div><div style="margin-top: 0; margin-bottom: 3pt; text-align: LEFT;">
    <div style="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&#160;</div>
  </div><div>
  </div><!-- Field: /Rule-Page --><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-size: 9pt">(1) Amounts reflect one-third of the grant.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Mr. Hollinsworth did not earn any shares related to the 2024 performance period pursuant to the 2023 performance-vesting restricted stock unit award due to his
    retirement from the Company in 2024.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">39</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><i>2022 Performance-Vesting Restricted Stock Unit Awards Earned</i></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">On April 11, 2022, the Compensation Committee approved grants of the following number of performance-vesting restricted stock units under the
    Incentive Plan to our Named Executive Officers listed below:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 50%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: auto; margin-right: auto;">

      <tr style="vertical-align: bottom">
        <td style="width: 51%; padding-right: 5.4pt; padding-left: 5.4pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.75pt solid">Name</p>
        </td>
        <td style="width: 49%; padding-left: 5.4pt; text-align: center">
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; border-bottom: Black 0.75pt solid; margin-bottom: 0pt;">2022 Performance-Vesting Restricted Stock Units</p>
        </td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Christopher H. Hunter</td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">47,323</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">John S. Hollinsworth</td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">15,128</td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The performance-vesting restricted stock units granted in 2022 are earned in three equal annual installments based upon the achievement of specified
    performance levels of Adjusted EPS and Adjusted EBITDA for 2022, 2023, and 2024. On May 12, 2022, the Compensation Committee established the performance objectives for each of 2022, 2023 and 2024 for purposes of the vesting of restricted stock units.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The number of shares of Common Stock that may be issued upon vesting of the 2022 performance-vesting restricted stock units ranges from 0% to 200% of
    the total number of units set forth above in accordance with a formula based on our Adjusted EPS and Adjusted EBITDA, equally-weighted between such measures. None of the performance-vesting restricted stock units granted in 2022 will vest for
    performance below 90.0% of the specified Adjusted EPS. Unearned performance awards in the performance period are forfeited.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">For 2024 performance under the 2022 performance-vesting restricted stock unit awards, the threshold award (as a percentage of the number of
    performance-vesting restricted stock units eligible for vesting based on 2022 performance) for each applicable Named Executive Officer was 50%, the target award was 100% and the maximum award was 200%.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">For purposes of our 2022 awards of performance-vesting restricted stock units, our target level Adjusted EPS for 2024 was $3.76 and target level
    Adjusted EBITDA was $733.9 million. The table below sets forth the number of shares of Common Stock that each applicable Named Executive Officer was eligible to earn for 2024 performance under the 2022 performance-vesting restricted stock unit awards
    (as a percentage of the number of performance-vesting restricted stock units eligible for vesting based on 2024 performance), subject to continued employment throughout the performance period, based upon the Company&#8217;s actual Adjusted EPS and Adjusted
    EBITDA for 2024.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; width: 80%; margin-left: auto; margin-right: auto;">

      <tr style="vertical-align: bottom">
        <td rowspan="2" style="border-bottom: Black 1pt solid; text-align: center">Metric</td>
        <td rowspan="2" style="border-bottom: Black 1pt solid; text-align: center">Weighting</td>
        <td>&#160;</td>
        <td colspan="2" style="white-space: nowrap; text-align: center">Threshold</td>
        <td>&#160;</td>
        <td colspan="2" style="white-space: nowrap; text-align: center">Target </td>
        <td>&#160;</td>
        <td colspan="2" style="white-space: nowrap; text-align: center">Maximum</td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="border-bottom: Black 1pt solid">&#160;</td>
        <td colspan="2" style="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center">(50% - 100%)</td>
        <td style="border-bottom: Black 1pt solid">&#160;</td>
        <td colspan="2" style="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center">(100% - 200%)</td>
        <td style="border-bottom: Black 1pt solid">&#160;</td>
        <td colspan="2" style="white-space: nowrap; border-bottom: Black 1pt solid; text-align: center">(200%)</td>
      </tr>
      <tr style="background-color: #CCEEFF">
        <td style="vertical-align: top; width: 19%; text-align: center">Adjusted EPS</td>
        <td style="vertical-align: top; text-align: center">50%</td>
        <td style="vertical-align: bottom">&#160;</td>
        <td style="white-space: nowrap; vertical-align: bottom">&#160;</td>
        <td style="white-space: nowrap; vertical-align: bottom; width: 22%; text-align: center">$3.38 - $3.76</td>
        <td style="vertical-align: top">&#160;</td>
        <td style="white-space: nowrap; vertical-align: top">&#160;</td>
        <td style="white-space: nowrap; vertical-align: top; width: 23%; text-align: center">$3.76 - $4.32</td>
        <td style="vertical-align: top">&#160;</td>
        <td style="white-space: nowrap; vertical-align: top">&#160;</td>
        <td style="vertical-align: top; width: 20%; text-align: center">$4.32 or Greater</td>
      </tr>
      <tr>
        <td style="vertical-align: top; text-align: center">Adjusted EBITDA</td>
        <td style="vertical-align: top; text-align: center">50%</td>
        <td style="vertical-align: bottom; text-align: left">&#160;</td>
        <td style="white-space: nowrap; vertical-align: bottom; text-align: right">&#160;</td>
        <td style="white-space: nowrap; vertical-align: top; text-align: center">$660.5m - $733.9m</td>
        <td style="vertical-align: top; text-align: center">&#160;</td>
        <td style="white-space: nowrap; vertical-align: top; text-align: center">&#160;</td>
        <td style="white-space: nowrap; vertical-align: bottom; text-align: center">$733.9m - $844.0m</td>
        <td style="vertical-align: top; text-align: center">&#160;</td>
        <td style="white-space: nowrap; vertical-align: top; text-align: center">&#160;</td>
        <td style="vertical-align: top; text-align: center">$844.0m or Greater</td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">In February 2025, the Compensation Committee evaluated the extent to which the 2024 performance goals for the 2022 performance-vesting restricted
    stock unit awards had been achieved. The Compensation Committee determined that actual Adjusted EBITDA for 2024 was $711.3 million, resulting in approximately 84.6% of such portion of the 2022 performance-vesting restricted stock unit annual award
    being earned with respect to such measure as reflected in the table below. No shares were earned under the Adjusted EPS component of such award, as the actual Adjusted EPS for 2024 ($3.32) was below the threshold amount under such award.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom">
        <td style="text-align: center; border-bottom: Black 1pt solid">Name</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">2022 Performance-Vesting Restricted Stock Unit Grant</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">Target Shares<br/>
            Subject to</p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">2024 Performance<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></p>
        </td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Shares Allocated to each Measure</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Shares Earned per Adjusted EPS</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Shares Earned per Adjusted EBITDA</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Total Shares Earned for <br/>
          2024 Performance</td>
        <td style="padding-bottom: 1pt">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 22%; text-align: left; padding-left: 5.4pt">Christopher H. Hunter</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 10%; text-align: right">47,323</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 10%; text-align: right">15,775</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 10%; text-align: right">7,887</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 10%; text-align: right">0</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 10%; text-align: right">6,672</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 10%; text-align: right">6,672</td>
        <td style="width: 1%; text-align: left">&#160;</td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>
  </div><!-- Field: Rule-Page --><div>
  </div><div style="margin-top: 0; margin-bottom: 3pt; text-align: LEFT;">
    <div style="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&#160;</div>
  </div><div>
  </div><!-- Field: /Rule-Page --><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-size: 9pt">(1) Amounts reflect one-third of the grant.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">40</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">Mr. Hollinsworth did not earn any shares related to the 2024 performance period pursuant to the 2022 performance-vesting restricted stock unit award
    due to his retirement from the Company in 2024.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b><i>Perquisites and other Benefits</i></b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">We provide our Named Executive Officers with modest perquisites (less than $10,000 on an annual basis) that our Compensation Committee believes are
    reasonable and consistent with our overall executive compensation program. Our Compensation Committee believes that such perquisites help us to retain our executive personnel and allows them to operate more effectively.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Our Named Executive Officers are eligible for health and welfare benefits available to eligible Company employees during active employment under the
    same terms and conditions, and are eligible for certain enhanced health benefits made available to other senior executives of the Company. These benefits include medical, dental, vision, short-term and long-term disability and group-term life insurance
    coverage. The Named Executive Officers also participate in a separate insurance plan that provides long-term care benefits to the executives and their spouses. Our general policies applicable to all employees govern paid vacation and other time off for
    our Named Executive Officers.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Cash Retention Awards</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">In December 2024, the Board of Directors recognized that the Company was being asked to respond to unprecedented governmental inquiries and concluded
    that responding to such inquiries would require an extensive time commitment from management and specifically from the Company&#8217;s executive officers. The Board also concluded that it would be in the best interest of stockholders for the executive
    officers to lead the Company through these response efforts while continuing to operate the business. The Board similarly determined that it would be detrimental to stockholders if an executive officer left the Company before it fully responded to the
    inquiries. Therefore, the Board, upon recommendation of the Compensation Committee, which had conferred with the Committee&#8217;s independent compensation consultants and legal counsel, authorized one-time cash retention awards for certain members of
    management, including the executive officers. These one-time cash retention opportunities were established in January 2025 and generally provide for cash payments to executives on March 31, 2026, subject to continued employment other than as a result
    of a termination without Cause by the Company or resignation by the executive officer for Good Reason. The amount of the cash retention awards for each executive officer is as follows:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 50%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: auto; margin-right: auto;">

      <tr>
        <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.75pt solid">Name</p>
        </td>
        <td colspan="2" style="vertical-align: top; padding-left: 5.4pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.75pt solid">Retention Award Amount</p>
        </td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; width: 47%">Christopher H. Hunter</td>
        <td style="padding-left: 5.4pt; text-align: right; width: 38%">$1,785,000</td>
        <td style="width: 15%">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Heather Dixon</td>
        <td style="padding-left: 5.4pt; text-align: right">1,066,050</td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Brian P. Farley</td>
        <td style="padding-left: 5.4pt; text-align: right">991,375</td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">Nasser Khan, M.D.</td>
        <td style="padding-left: 5.4pt; text-align: right">643,750</td>
        <td>&#160;</td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Compensation Clawback Policy</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">If the Company is required to restate its financial statements as a result of misconduct, Section 304 of the Sarbanes-Oxley Act requires the Chief
    Executive Officer and the Chief Financial Officer to reimburse the Company for: (i) any bonus or other incentive-based or equity-based compensation received during the 12 months following the public issuance of the financial statements; and (ii) any
    profits realized from the sale of Company securities during those 12 months. On February 26, 2015, the Compensation Committee adopted and approved a compensation clawback policy applicable to performance-based equity awards issued to executive officers
    during and after 2015. Under the clawback policy, if a Named Executive Officer is determined by the Board to have engaged in fraud or misconduct contributing to restatement of the Company&#8217;s financial statements, the Board shall take appropriate action
    to address such events, including requiring (i) reimbursement of any equity securities that vested during the preceding three year period, including any proceeds from the sale of such securities, and (ii) cancellation of all unvested equity securities
    during such three-year period.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">41</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Furthermore, effective October 26, 2023, the Board of Directors adopted and approved the Policy Regarding the Mandatory Recovery of Compensation (the
    &#8220;Clawback Policy&#8221;), a copy of which is filed with our Annual Report on Form 10-K for the year ended December 31, 2023. The Clawback Policy is designed to comply with Section 10D of the Exchange Act, Exchange Act Rule 10D-1, and NASDAQ Stock Market
    Listing Rule 5608. Under the Clawback Policy, if we are required to prepare a restatement of previously issued financial statements of the Company due to the material noncompliance of the Company with any financial reporting requirement under federal
    securities laws, the Company will recover any incentive-based compensation received by any current or former executive officer after the effective date of the policy and during the three-year period preceding the date on which the Company is required
    to prepare the restatement that is in excess of what would have been paid or earned by such executive officer had the financial results been properly reported.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Deferred Compensation Plan</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">On February 28, 2013, our Board adopted and approved the Acadia Healthcare Company, Inc. Deferred Compensation Plan, effective February 1, 2013 (the
    &#8220;Deferred Compensation Plan&#8221;). The Deferred Compensation Plan is designed to provide tax-deferred compensation for our eligible employees, including executive officers. Deferred compensation plans are common in our industry and help in the recruitment
    and retention of top executive talent.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Under the Deferred Compensation Plan, participants may defer up to 50% of their annual base compensation and up to 100% of any performance-based
    compensation. Participants are fully vested in their deferral accounts as to amounts they elect to defer. No employer matching contributions are made to the Deferred Compensation Plan. Participants will be able to select from several fund choices and
    their deferred compensation account will increase or decrease in value in accordance with the performance of the funds selected. Participants may receive a distribution from the Deferred Compensation Plan upon a qualifying distribution event such as
    separation from service, disability, death, change in control or an unforeseeable emergency. Following a participant&#8217;s separation from the Company for any reason, the participant&#8217;s vested interest in the account is paid to the participant (or the
    participant&#8217;s beneficiary in the event of the participant&#8217;s death) either in a lump sum or up to ten annual installments, as elected by the participant. The Deferred Compensation Plan is intended to be an unfunded plan administered and maintained by
    the Company primarily for the purpose of providing deferred compensation benefits to participants.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><ix:nonNumeric contextRef="c0" continuedAt="_AwardTmgMnpiDiscTextBlock-c0_cont_1" escape="true" name="ecd:AwardTmgMnpiDiscTextBlock" id="ixv-6210"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Equity Award Grant Practices</b></p></ix:nonNumeric><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>
  </div><ix:continuation id="_AwardTmgMnpiDiscTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company does not generally grant stock options to its employees. <ix:nonNumeric contextRef="c0" escape="true" name="ecd:AwardTmgHowMnpiCnsdrdTextBlock" id="ixv-18027"><ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="ecd:AwardTmgMnpiCnsdrdFlag" id="ixv-18028">The Compensation Committee did not take material nonpublic information into account when determining the timing and terms of equity awards in 2024</ix:nonNumeric>, and <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="ecd:MnpiDiscTimedForCompValFlag" id="ixv-18029">the Company does not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation</ix:nonNumeric>.</ix:nonNumeric></p></ix:continuation><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Risk Assessment</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">In addition to overseeing the Company&#8217;s executive compensation program, the Compensation Committee considers the risk profile of the Company&#8217;s
    compensation policies and practices for all employees. The Compensation Committee has concluded that the Company&#8217;s compensation program does not encourage excessive or inappropriate risk taking and determined that such program is not reasonably likely
    to have a material adverse impact on the Company. See &#8220;CORPORATE GOVERNANCE &#8211; Risk Oversight&#8221; for more information about the Board&#8217;s role in our risk management process.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Tax Implications of Executive Compensation</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 162(m) of the Internal Revenue Code (&#8220;Section 162(m)&#8221;) generally limits to $1 million per year income tax deductions available to publicly
    held corporations for compensation paid to the corporation&#8217;s CEO, CFO, certain other NEOs, and certain former NEOs (each a &#8220;Covered Executive&#8221;). As a result, most compensation in excess of $1 million paid to our Covered Executives is not deductible.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">42</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The Compensation Committee has considered the effect of Section 162(m) on the Company&#8217;s executive compensation program. The Compensation Committee
    exercises discretion in setting base salaries, structuring incentive compensation awards and in determining payments in relation to levels of achievement of performance goals. The Compensation Committee believes that the total compensation program for
    Covered Executives should be managed in accordance with the objectives outlined in the Company&#8217;s compensation philosophy and in the best overall interests of the Company&#8217;s stockholders. Accordingly, some of the compensation paid by the Company may not
    be deductible because such compensation exceeds the limitations for deductibility under Section 162(m).</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Stock Ownership Guidelines, <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" id="ixv-18030">Insider Trading Policy</ix:nonNumeric>, Hedging and Pledging</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">In March 2012, the Board of Directors adopted stock ownership guidelines for non-management directors. The guidelines require that each
    non-management director hold an investment position in our Common Stock equal in value to five times the annual cash retainer (exclusive of any Board committee retainers) paid to non-management directors. The guidelines provide for a five-year
    transition period during which directors can attain the required ownership. As of December 31, 2024, all of our non-management directors not in a transition period satisfied the applicable stock ownership guidelines.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">In December 2014, the Board of Directors adopted stock ownership guidelines for certain designated officers. The guidelines require that the Named
    Executive Officers hold an investment position in our Common Stock equal to the following multiples of annual base salary:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 75%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: auto; margin-right: auto;">

      <tr>
        <td style="vertical-align: bottom; width: 40%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: left; text-indent: 0in"><span style="text-decoration:underline">Position</span></td>
        <td style="vertical-align: top; width: 60%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">Fair Market Value of Stock Holdings</p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">as a Multiple of Base Salary</p>
        </td>
      </tr>
      <tr style="vertical-align: top">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left; text-indent: 0in">Chief Executive Officer</td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; text-indent: 0in">5x</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: left; text-indent: 0in">Other Named Executive Officers</td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; text-indent: 0in">3x</td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The guidelines provide for a five-year transition period during which executive officers can attain the required ownership. If an executive officer
    becomes subject to a greater ownership threshold due to an increase in the amount of his or her annual base salary, the executive officer must satisfy the greater ownership threshold within the later of the original five-year transition period or two
    years from the effective date of the increase in annual base salary. As of December 31, 2024, all of our Named Executive Officers not in a transition period satisfied the applicable stock ownership guidelines.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Pursuant to the stock ownership guidelines applicable to non-management directors and executive officers, ownership of the following shares of Common
    Stock (&#8220;Qualified Shares&#8221;) are counted toward the satisfaction of the applicable ownership requirements: (i) shares owned directly by the non-management director or the executive officer; (ii) shares owned indirectly (e.g. by a spouse or in trust);
    (iii) restricted shares, including restricted shares that have been granted but that have not vested; (iv) shares issuable upon the settlement of vested performance-vesting restricted stock units; and (v) shares obtained through stock option exercises.
    For the avoidance of doubt, shares that underlie unexercised options, whether or not vested, will not be deemed to be Qualified Shares.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">We maintain an insider trading policy that governs transactions in our securities by directors, officers and other employees. Among other provisions,
    the policy prohibits &#8220;short-selling&#8221; of any equity security of the Company and any hedging transactions. Directors and officers are also prohibited from holding our securities in a margin account or otherwise pledging our securities as collateral for a
    loan.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Termination and Change-in-Control Arrangements</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Under the terms of the compensation plans and employment agreements with the Named Executive Officers, the Named Executive Officers are entitled to
    payments and benefits upon the occurrence of specified events including termination of employment. The specific terms of these arrangements are discussed under the heading &#8220;<span style="text-transform: uppercase">Executive Compensation</span> &#8211;
    Potential Payments Upon Termination or Change in Control under the Employment Agreements.&#8221; The Compensation Committee believes that these arrangements are appropriate and necessary to attract and retain talented senior executives. The Compensation
    Committee believes that the potential payments and benefits provide security and encourage retention in the event of an actual or potential change in control, such as a sale or &#8220;hostile&#8221; takeover. The absence of such arrangements could impact our
    ability to hire talented executives and an executive&#8217;s willingness to work through a merger or sale transaction which could be beneficial to our stockholders. </p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">43</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>
  </div><div><a id="a012"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>COMPENSATION COMMITTEE REPORT</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis required by SEC Regulation S-K, Item 402(b) with
    management. Based on such review and discussions, the Compensation Committee recommended to the Board of Directors that the Compensation Discussion and Analysis be included in this Proxy Statement.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">

      <tr style="vertical-align: top; text-align: left">
        <td style="width: 50%">&#160;</td>
        <td style="width: 50%">COMPENSATION COMMITTEE:</td>
      </tr>
      <tr style="vertical-align: top; text-align: left">
        <td>&#160;</td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top; text-align: left">
        <td>&#160;</td>
        <td>Wade D. Miquelon, Chairman</td>
      </tr>
      <tr style="vertical-align: top; text-align: left">
        <td>&#160;</td>
        <td>Michael J. Fucci</td>
      </tr>
      <tr style="vertical-align: top; text-align: left">
        <td>&#160;</td>
        <td>Vicky B. Gregg</td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">44</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="margin: 0">&#160;</p><div>
  </div><p style="margin: 0"></p><div>
  </div><div><a id="a013"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><b>EXECUTIVE COMPENSATION</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Summary Compensation Table</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The following summary compensation table reflects the compensation paid or accrued by us with respect to each of the Named Executive Officers:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom">
        <td style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">Name and <br/>
            Principal Position</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Year</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">Salary</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">Bonus<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup>&#160;&#160;&#160;</span></p>
        </td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">Stock Awards<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup>&#160;&#160;</span></p>
        </td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">Non-Equity Incentive Plan Compensation<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup>&#160;&#160;</span></p>
        </td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">All Other Compensation<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup>&#160;&#160;</span></p>
        </td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">Total</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="font-style: italic; text-align: left; padding-left: 5.4pt; vertical-align: top"><span style="font-size: 8pt"><span style="font-style: normal;">Christopher H. Hunter</span> <br/>
            Chief Executive Officer</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt">2024</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt">2023</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt">2022</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left; vertical-align: top"><span style="font-size: 8pt">&#160;</span>$</td>
        <td style="text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -4.5pt;"><span style="font-size: 8pt"> 1,020,000</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -4.5pt;"><span style="font-size: 8pt">1,000,000</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -4.5pt;"><span style="font-size: 8pt">1,000,000</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left; vertical-align: top"><span style="font-size: 8pt">&#160;</span>$</td>
        <td style="text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -4.3pt;"><span style="font-size: 8pt"> &#8211;</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -4.3pt;"><span style="font-size: 8pt">&#8211;</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -4.3pt;"><span style="font-size: 8pt">&#8211;</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left; vertical-align: top"><span style="font-size: 8pt">&#160;</span>$</td>
        <td style="text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -4.3pt;"><span style="font-size: 8pt"> 5,099,925</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -4.3pt;"><span style="font-size: 8pt">4,749,977</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -4.3pt;"><span style="font-size: 8pt">4,500,022</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left; vertical-align: top"><span style="font-size: 8pt">&#160;</span>$</td>
        <td style="text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt"> 967,319</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">1,653,667</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">915,202</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left; vertical-align: top"><span style="font-size: 8pt">&#160;</span>$</td>
        <td style="text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt"> 1,923</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">962</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">&#8211;</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left; vertical-align: top"><span style="font-size: 8pt">&#160;</span>$</td>
        <td style="text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt 0pt 0; text-indent: -5pt;"><span style="font-size: 8pt"> 7,089,167</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt 0pt 0; text-indent: -5pt;"><span style="font-size: 8pt">7,404,606</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.5pt 0pt 0; text-indent: -5pt;"><span style="font-size: 8pt">6,415,224</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="font-style: italic; text-align: left; padding-left: 5.4pt; vertical-align: top">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">Heather Dixon<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup>&#160;&#160;</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt"><i>Chief Financial Officer</i></span></p>
        </td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt">2024</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt">2023</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">710,700</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">305,192</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right">
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">300,000</span></p>
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#8211;</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">2,099,865</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">6,000,004</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">457,500</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">372,007</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#8211;</span></p>
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#8211;</span></p>
        </td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">3,568,065</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">6,677,203</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="font-style: italic; text-align: left; padding-left: 5.4pt; vertical-align: top">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">Brian P. Farley<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup>&#160;&#160;</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt"><i>Executive Vice President, General Counsel and Secretary</i></span></p>
        </td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center; vertical-align: top">
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 8pt">2024</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 8pt">2023</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right; vertical-align: top">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 8pt">566,500</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 8pt">217,885</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right; vertical-align: top"><span style="font-size: 8pt">400,000<br/>
            &#8211;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right; vertical-align: top">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 8pt">1,419,893</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 8pt">2,126,880</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right; vertical-align: top">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 8pt">364,268</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 8pt">269,416</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right; vertical-align: top">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 8pt">58,991</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 8pt">50,403</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right; vertical-align: top">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 8pt">2,809,652</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 8pt">2,664,584</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="width: 24%; font-style: italic; text-align: left; padding-left: 5.4pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">Nasser Khan, M.D. <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup>&#160;&#160;</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt"><i>Chief Operating Officer</i></span></p>
        </td>
        <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 8%; text-align: center; vertical-align: top"><span style="font-size: 8pt">2024</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 8%; text-align: right; vertical-align: top"><span style="font-size: 8pt">448,035</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 8%; text-align: right; vertical-align: top"><span style="font-size: 8pt">98,437</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 8%; text-align: right; vertical-align: top"><span style="font-size: 8pt">1,198,831</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 8%; text-align: right; vertical-align: top"><span style="font-size: 8pt">168,003</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 8%; text-align: right; vertical-align: top"><span style="font-size: 8pt">8,250</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 8%; text-align: right; vertical-align: top"><span style="font-size: 8pt">1,921,556</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="font-style: italic; text-align: left; padding-left: 5.4pt; vertical-align: top"><span style="font-size: 8pt"><span style="font-style: normal;">John S. Hollinsworth</span> <br/>
            Former Executive Vice President of Operations</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt">2024</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt">2023</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 8pt">2022</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">386,015</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">652,030</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">633,039</span></p>
        </td>
        <td style="text-align: left; vertical-align: top"><span style="font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(8)</sup></span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">&#8211;</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">&#8211;</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">&#8211;</span></p>
        </td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">&#8211;</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">1,467,073</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">1,793,884</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">209,028</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">733,204</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">678,287</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">59,597</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">10,960</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">9,331</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">654,640</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">2,863,267</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">3,114,541</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>
  </div><!-- Field: Rule-Page --><div>
  </div><div style="margin-top: 0; margin-bottom: 3pt; text-align: LEFT;">
    <div style="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&#160;</div>
  </div><div>
  </div><!-- Field: /Rule-Page --><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(1)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">Reflects each applicable Named Executive Officer&#8217;s retention bonus pursuant to the terms of his or her Employment Agreement.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(2)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">Reflects the aggregate grant date fair value of time-vesting restricted stock and performance-vesting restricted stock units granted to each applicable Named Executive Officer pursuant to
            the Incentive Plan, computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718, &#8220;Stock Compensation,&#8221; or ASC 718. The awards are described in more detail in the Grants of Plan-Based Awards
            section below. See Note 17 to the Consolidated Financial Statements contained in the Company&#8217;s 2024 Annual Report on Form 10-K for assumptions relevant to the valuation of stock awards. With respect to annual grants of performance-vesting
            restricted stock units, the units vest over three years and the amounts for a given year assume that the performance goals are attained during a respective annual performance period in accordance with ASC 718.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><span style="font-size: 8pt">The amounts relating to performance-vesting restricted stock unit awards for 2024 represent the sum of the grant date fair value
      of the target number of shares that may be earned pursuant to the target amount of the 2024 performance-vesting restricted stock unit award.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><span style="font-size: 8pt">The amounts relating to performance-vesting restricted stock unit awards for 2023 represent the sum of the grant date fair value
      of the target number of shares that may be earned pursuant to the target amount of the 2023 performance-vesting restricted stock unit award.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><span style="font-size: 8pt">The amounts relating to performance-vesting restricted stock unit awards for 2022 represent the sum of the grant date fair value
      of the target number of shares that may be earned pursuant to (a) the target amount of the 2022 performance-vesting restricted stock unit award, and (b) the third tranche of the 2020 performance-vesting restricted stock unit award, as applicable to
      each Named Executive Officer.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><span style="font-size: 8pt">Assuming that the maximum performance goals are attained during a respective annual performance period in accordance with ASC 718
      for the applicable tranche of the performance-vesting restricted stock units granted in 2024, 2023 and 2022, (i) the aggregate grant date fair value of the annual grants of performance-vesting restricted stock units would have been, and (ii) the
      aggregate grant date fair value of the total stock awards (including awards of both time-vesting restricted stock and performance-vesting restricted stock units) would have been:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom">
        <td style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">Name</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Year</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">2024 RSU <br/>
            Awards</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">2023 RSU <br/>
            Awards</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">2022 RSU <br/>
            Awards</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">2020 RSU <br/>
            Awards</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">Total RSU <br/>
            Awards</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">Total Stock <br/>
            Awards</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="vertical-align: top; width: 24%; padding: 0px 0px 0px 5.4pt; text-align: left;"><span style="font-size: 8pt">Christopher H. Hunter</span></td>
        <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 8%; text-align: center">
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 8pt">2024</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 8pt">2023</span></p>
        </td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; text-align: left; vertical-align: top"><span style="font-size: 8pt">$</span></td>
        <td style="width: 8%; text-align: right">
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">5,099,925</span></p>
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#8211;</span></p>
        </td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; text-align: left; vertical-align: top"><span style="font-size: 8pt">$</span></td>
        <td style="width: 8%; text-align: right">
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#8211;</span></p>
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">7,125,001</span></p>
        </td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; text-align: left; vertical-align: top"><span style="font-size: 8pt">$</span></td>
        <td style="width: 8%; text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">&#8211;</span></p>
        </td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; text-align: left; vertical-align: top"><span style="font-size: 8pt">$</span></td>
        <td style="width: 8%; text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">&#8211;</span></p>
        </td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; text-align: left; vertical-align: top"><span style="font-size: 8pt">$</span></td>
        <td style="width: 8%; text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">5,099,925</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">7,125,001</span></p>
        </td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; text-align: left; vertical-align: top"><span style="font-size: 8pt">$</span></td>
        <td style="width: 8%; text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">7,649,888</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">8,312,478</span></p>
        </td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: right; padding-left: 5.4pt"/>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 8pt">2022</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">7,000,018</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">7,000,018</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">8,000,031</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-left: 5.4pt; vertical-align: top"><span style="font-size: 8pt">Heather Dixon</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center">
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 8pt">2024</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 8pt">2023</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right">
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">2,099,865</span></p>
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#8211;</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right">
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#8211;</span></p>
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">7,000,018</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#8211;</span></p>
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#8211;</span></p>
        </td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#8211;</span></p>
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#8211;</span></p>
        </td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">2,099,865</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">7,000,018</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">3,149,798</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">9,500,013</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-left: 5.4pt; vertical-align: top"><span style="font-size: 8pt">Brian P. Farley</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center">
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 8pt">2024</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 8pt">2023</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right">
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">1,419,893</span></p>
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#8211;</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right">
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#8211;</span></p>
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">1,519,200</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#8211;</span></p>
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#8211;</span></p>
        </td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#8211;</span></p>
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#8211;</span></p>
        </td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">1,419,893</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">1,519,200</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">2,129,840</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">2,886,480</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-left: 5.4pt"><span style="font-size: 8pt">Nasser Khan, M.D.</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 8pt">2024</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">799,871</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">799,971</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">1,598,767</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-left: 5.4pt; vertical-align: top"><span style="font-size: 8pt">John S. Hollinsworth</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center">
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 8pt">2024</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 8pt">2023</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#8211;</span></p>
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#8211;</span></p>
        </td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right">
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#8211;</span></p>
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">2,200,645</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#8211;</span></p>
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#8211;</span></p>
        </td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right">
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#8211;</span></p>
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">2,200,645</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right">
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#8211;</span></p>
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">2,567,396</span></p>
        </td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: right; padding-left: 5.4pt"/>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 8pt">2022</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">2,237,734</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">604,073</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">2,841,807</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">3,214,787</span></td>
        <td style="text-align: left"><span style="font-size: 7pt">&#160;</span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">45</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><span style="font-size: 8pt">See the section above entitled &#8220;COMPENSATION DISCUSSION AND ANALYSIS &#8211; Components of Executive Compensation &#8211; Equity-Based
      Compensation&#8221; for more information about the time-vesting restricted stock and performance-vesting restricted stock units.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(3)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">Reflects cash awards earned during the years indicated under the Incentive Plan. See the section above entitled &#8220;COMPENSATION DISCUSSION AND ANALYSIS &#8211; Components of Executive Compensation &#8211;
            Annual Non<b>&#8211;</b>Equity Incentive Compensation&#8221; for more information.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(4)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">Represents certain long-term care insurance benefits and 401(k) plan matching contributions by the Company to each Named Executive Officer. For Mr. Farley, amounts include relocation
            benefits of $50,741. For Mr. Hollinsworth, amounts shown in this column for 2024 include unused paid time off of $50,156, accrued through his retirement date.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(5)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">Ms. Dixon was appointed Chief Financial Officer effective July 10, 2023.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(6)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">Mr. Farley was appointed Executive Vice President, General Counsel and Secretary effective July 26, 2023.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(7)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">Dr. Khan was appointed Chief Operating Officer effective June 30, 2024 and previously served as Operations Group President for the Company&#8217;s comprehensive treatment center business line.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(8)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">Includes $59,996 paid to Mr. Hollinsworth in his capacity as a consultant to the Company following his retirement as Executive Vice President of Operations effective June 30, 2024.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><b>Grants of Plan-Based Awards</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth certain information regarding plan-based awards granted to the Named Executive Officers during 2024:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 100%; font: 8pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom">
        <td style="font-size: 10pt; text-align: center; padding-bottom: 1pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"></p>
        </td>
        <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-size: 10pt; text-align: center; padding-bottom: 1pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;"></p>
        </td>
        <td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td colspan="1" rowspan="2" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid;"><span style="font-size: 8pt">Grant</span>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 8pt">Date</span></p>
        </td>
        <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td colspan="10" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">&#160;</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">&#160;<span style="font-size: 8pt">Estimated Possible Payouts Under Non-<br/>
            Equity Incentive Plan Awards<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup>&#160;&#160;</span></p>
        </td>
        <td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td colspan="10" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">&#160;</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">&#160;</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">&#160;</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">&#160;</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">&#160;</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">Estimated Future Payouts Under</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">Equity Incentive Plan Awards<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup>&#160;&#160;</span></p>
        </td>
        <td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td colspan="2" rowspan="2" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">All Other <br/>
              Stock <br/>
              Awards: <br/>
              Number of <br/>
              Shares of <br/>
              Stock or <br/>
              Units<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup>&#160;&#160;</span></p>
        </td>
        <td style="padding-bottom: 1pt; font-size: 10pt"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-size: 10pt; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td colspan="2" rowspan="2" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt">Grant Date Fair <br/>
              Value of Stock <br/>
              and Option <br/>
              Awards<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup>&#160;&#160;</span></p>
        </td>
        <td style="padding-bottom: 1pt; font-size: 10pt">
          <p style="margin-top: 0; margin-bottom: 0"></p>
          <p style="margin-top: 0; margin-bottom: 0">&#160;</p>
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#160;</span></p>
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#160;</span></p>
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#160;</span></p>
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#160;</span></p>
          <p style="margin-top: 0; margin-bottom: 0"></p>
          <p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 8pt">&#160;</span></p>
        </td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">Name</span>
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;"></p>
        </td>
        <td style="font-size: 10pt; padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">Type</span>
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;"></p>
        </td>
        <td style="padding-bottom: 1pt; font-size: 10pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-size: 10pt; padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-size: 10pt; text-align: center; padding-bottom: 1pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 8pt">&#160;</span></p>
        </td>
        <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-size: 8pt">Threshold</span></td>
        <td colspan="2" style="font-size: 10pt; text-align: center; padding-bottom: 1pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;"></p>
        </td>
        <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-size: 8pt">Target</span></td>
        <td colspan="2" style="font-size: 10pt; text-align: center; padding-bottom: 1pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;"></p>
        </td>
        <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-size: 8pt">Maximum</span></td>
        <td colspan="2" style="font-size: 10pt; text-align: center; padding-bottom: 1pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;"></p>
        </td>
        <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center"><span style="font-size: 8pt">Threshold</span></td>
        <td colspan="2" style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Target</span></td>
        <td colspan="2" style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Maximum</span></td>
        <td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 13%; padding: 0px 0px 0px 5.4pt; text-align: left;"><span style="font-size: 8pt">Christopher H. Hunter</span></td>
        <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 6%; text-align: center"><span style="font-size: 8pt">Bonus</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 6%; text-align: center; padding-left: 5.4pt"><span style="font-size: 8pt">N/A</span></td>
        <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td>
        <td style="width: 6%; text-align: right"><span style="font-size: 8pt">637,000</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td>
        <td style="width: 6%; text-align: right"><span style="font-size: 8pt">1,275,000</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td>
        <td style="width: 6%; text-align: right"><span style="font-size: 8pt">2,550,000</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 6%; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 6%; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 6%; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 6%; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td>
        <td style="width: 6%; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: center; padding-left: 5.4pt"/>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 8pt">RSA</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center; padding-left: 5.4pt"><span style="font-size: 8pt">6/26/24</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">37,516</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">2,549,963</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: center; padding-left: 5.4pt"/>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 8pt">RSU</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center; padding-left: 5.4pt"><span style="font-size: 8pt">6/26/24</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">18,758</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">37,516</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">75,032</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">2,549,963</span></td>
        <td style="text-align: left"><span style="font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup>&#160;&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: justify; padding-left: 5.4pt"><span style="font-size: 8pt">Heather Dixon</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 8pt">Bonus</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center; padding-left: 5.4pt"><span style="font-size: 8pt">N/A</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">302,048</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">604,095</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">1,208,190</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="text-align: center; padding-left: 5.4pt"/>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 8pt">RSA</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center; padding-left: 5.4pt"><span style="font-size: 8pt">6/26/24</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">15,447</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">1,049,933</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: center; padding-left: 5.4pt"/>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 8pt">RSU</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center; padding-left: 5.4pt"><span style="font-size: 8pt">6/26/24</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">7,724</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">15,447</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">30,894</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">1,049,933</span></td>
        <td style="text-align: left"><span style="font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup>&#160;&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 5.4pt"><span style="font-size: 8pt">Brian P. Farley</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 8pt">Bonus</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center; padding-left: 5.4pt"><span style="font-size: 8pt">N/A</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">240,763</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">481,525</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">963,050</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: center; padding-left: 5.4pt"/>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 8pt">RSA</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center; padding-left: 5.4pt"><span style="font-size: 8pt">6/26/24</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">10,445</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">709,947</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: center; padding-left: 5.4pt"/>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 8pt">RSU</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center; padding-left: 5.4pt"><span style="font-size: 8pt">6/26/24</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">5,223</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">10,445</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">20,890</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">709,947</span></td>
        <td style="text-align: left"><span style="font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup>&#160;&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: justify; padding-left: 5.4pt"><span style="font-size: 8pt">Nasser Khan, M.D.</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 8pt">Bonus</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center; padding-left: 5.4pt"><span style="font-size: 8pt">N/A</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">218,875</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">437,750</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">875,500</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="text-align: center; padding-left: 5.4pt"/>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 8pt">RSA</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center; padding-left: 5.4pt"><span style="font-size: 8pt">6/26/24</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">5,884</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">399,935</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: center; padding-left: 5.4pt"/>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 8pt">RSA</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center; padding-left: 5.4pt"><span style="font-size: 8pt">3/29/24</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">4,997</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">398,960</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="text-align: center; padding-left: 5.4pt"/>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 8pt">RSU</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center; padding-left: 5.4pt"><span style="font-size: 8pt">6/26/24</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">2,942</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">5,884</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">11,768</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">399,935</span></td>
        <td style="text-align: left"><span style="font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup>&#160;&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="padding: 0px 0px 0px 5.4pt; text-align: left;"><span style="font-size: 8pt">John S. Hollinsworth</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 8pt">Bonus</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center; padding-left: 5.4pt"><span style="font-size: 8pt">N/A</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">277,113</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">554,226</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 8pt">1,108,451</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: center; padding-left: 5.4pt"/>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 8pt">RSA</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center; padding-left: 5.4pt"><span style="font-size: 8pt">N/A</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: center; padding-left: 5.4pt"/>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center"><span style="font-size: 8pt">RSU</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td><span style="font-size: 8pt">&#160;</span></td>
        <td style="text-align: center; padding-left: 5.4pt"><span style="font-size: 8pt">N/A</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 8pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 8pt">&#160;</span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><!-- Field: Rule-Page --><div>
  </div><div style="margin-top: 0; margin-bottom: 3pt; text-align: LEFT;">
    <div style="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&#160;</div>
  </div><div>
  </div><!-- Field: /Rule-Page --><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(1)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">The estimated payouts shown reflect non-equity incentive awards granted under the Incentive Plan, where receipt is contingent upon the achievement of specified performance goals. The amounts
            in the &#8220;Threshold&#8221; column assume threshold performance for all of the specified performance goals. See the section above entitled &#8220;COMPENSATION DISCUSSION AND ANALYSIS &#8211; Components of Executive Compensation &#8211; Annual Non-Equity Incentive
            Compensation&#8221; for more information about the awards.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(2)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">Reflects the number of shares of Common Stock issuable upon vesting of performance-vesting restricted stock units granted under the Incentive Plan. The performance-vesting restricted stock
            units granted in 2024 to all applicable Named Executive Officers are earned based upon the achievement of certain performance goals in 2024, 2025 and 2026, continued employment and subject to adjustment at the end of the three-year term based
            on the TSR modifier. See the section above entitled &#8220;COMPENSATION DISCUSSION AND ANALYSIS &#8211; Components of Executive Compensation &#8211; Equity-Based Compensation&#8221; for more information about the performance-vesting restricted stock units.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(3)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">Reflects shares of time-vesting restricted stock granted to all Named Executive Officers under the Incentive Plan, which will vest in four equal annual installments commencing one year after
            the date of grant.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(4)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">Reflects the aggregate grant date fair value computed in accordance with ASC 718, and pursuant to the terms of the equity awards calculated by using the average of the trailing twenty-day
            closing price of the Company&#8217;s stock as of the grant date.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(5)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">The amounts shown reflect the grant date fair value of the target number of shares subject to the 2024 annual award of performance-vesting restricted stock units assuming that target
            performance goals are attained during the performance period in accordance with ASC 718, continued employment throughout the performance period, and no adjustment as a result of the TSR modifier. For additional information, see the section
            above entitled &#8220;COMPENSATION DISCUSSION AND ANALYSIS &#8211; Components of Executive Compensation &#8211; Equity-Based Compensation <span style="font-family: Times New Roman, Times, Serif"><b>&#8211;</b></span> Equity Awards Granted in 2024.&#8221;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">46</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Outstanding Equity Awards at Fiscal Year-End</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The following table provides certain information with respect to the Named Executive Officers regarding outstanding equity awards as of December 31,
    2024 that represent potential amounts that may be realized in the future:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom">
        <td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt"/>
        <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt;">&#160;</span></td>
        <td colspan="9" style="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt;">Option Awards</span></td>
        <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt;">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt;">&#160;</span></td>
        <td colspan="12" style="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt;">Stock Awards</span></td>
        <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt;">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="font-family: Times New Roman, Times, Serif; text-align: center">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"></p>
        </td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 8pt;">&#160;</span></p>
        </td>
        <td colspan="3" style="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;">&#160;</p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;">&#160;</p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt;"><span style="font-size: 8pt;">Number of Securities Underlying Unexercised Options<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup>&#160;&#160;</span></p>
        </td>
        <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt;">&#160;</span></td>
        <td colspan="2" rowspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt;">Option Exercise Price</span></td>
        <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt;">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt;">&#160;</span></td>
        <td rowspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt;">Option Expiration Date</span></td>
        <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt;">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt;">&#160;</span></td>
        <td colspan="2" rowspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt;">Number of Shares or Units of Stock That Have Not Vested</span>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"></p>
        </td>
        <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt;">&#160;</span></td>
        <td colspan="2" rowspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt;">Market Value of Shares or Units of Stock Held that Have Not Vested<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup>&#160;&#160;</span></td>
        <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt;">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt;">&#160;</span></td>
        <td colspan="2" rowspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt;">Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That
            Have Not Vested</span>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"></p>
        </td>
        <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td colspan="2" rowspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other
            Rights That Have Not Vested<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup>&#160;&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">Name</span></td>
        <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-size: 8pt;">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt;">(Exercisable)</span></td>
        <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"><span style="font-size: 8pt;">&#160;</span></td>
        <td style="border-bottom: Black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(Unexercisable)</span></td>
        <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 19%; text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Christopher H. Hunter</span></td>
        <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td>
        <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">6,761</span></td>
        <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup>&#160;&#160;</span></td>
        <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td>
        <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">268,074</span></td>
        <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</span></td>
        <td style="width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">15,775</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">(4)</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">625,479</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">12,968</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup>&#160;&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">514,181</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">34,581</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup>&#160;&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,371,137</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">37,516</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup>&#160;&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,487,509</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">37,516</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(8)</sup>&#160;&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,487,509</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">24,269</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(9)</sup>&#160;&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">962,266</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">40,748</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(10)</sup>&#160;&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,615,658</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Heather Dixon</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">24,684</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(11)</sup>&#160;&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">978,721</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">30,718</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup>&#160;&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,217,969</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">15,447</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup>&#160;&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">612,474</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">15,447</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(8)</sup>&#160;&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">612,474</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">21,560</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(9)</sup>&#160;&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">854,854</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Brian P. Farley</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">13,500</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(12)</sup>&#160;&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">525,275</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">6,666</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup>&#160;&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">264,307</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">10,445</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup>&#160;&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">414,144</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">10,445</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(8)</sup>&#160;&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">414,144</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,680</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(9)</sup>&#160;&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">185,562</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">Nasser Khan, M.D.</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,025</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">72.51</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3/1/33</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">6,000</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(13)</sup>&#160;&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">237,900</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,750</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(14)</sup>&#160;&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">148,688</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,800</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(15)</sup>&#160;&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">71,370</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,997</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(16)</sup>&#160;&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">198,131</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5,884</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup>&#160;&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">233,301</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">5,884</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(8)</sup>&#160;&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">233,301</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">John S. Hollinsworth</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">7,496</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(9)</sup>&#160;&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">297,216</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 4.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">13,025</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(10)</sup>&#160;&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">516,441</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt">&#160;</span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>
  </div><!-- Field: Rule-Page --><div>
  </div><div style="margin-top: 0; margin-bottom: 3pt; text-align: LEFT;">
    <div style="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&#160;</div>
  </div><div>
  </div><!-- Field: /Rule-Page --><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(1)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">The amounts shown reflect stock options granted under the Incentive Plan.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(2)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">Based on the closing sales price of our Common Stock of $39.65 on The NASDAQ Global Select Market on December 31, 2024.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(3)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">One-half of these shares of time-vesting restricted stock vest on each of April 11, 2025 and April 11, 2026.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(4)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">Reflects the aggregate target number of shares that will vest upon the achievement of certain performance goals established for the annual award of performance-vesting restricted stock units
            granted in 2022 under the Incentive Plan and continued employment. See the section above entitled &#8220;COMPENSATION DISCUSSION AND ANALYSIS &#8211; Components of Executive Compensation &#8211; Equity-Based Compensation&#160;<span style="font-family: Times New Roman, Times, Serif"><b><span style="font-family: Times New Roman,Times,serif; font-weight: normal;">&#8211;</span> </b></span>2022 Performance-Vesting Restricted Stock Unit Awards Earned&#8221; for more information about the performance-vesting
            restricted stock units.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(5)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">One-third of these shares of time-vesting restricted stock vest on each of May 9, 2025, May 9, 2026 and May 9, 2027.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">47</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(6)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">Reflects the aggregate target number of shares that will vest upon the achievement of certain performance goals established for the annual award of performance-vesting restricted stock units
            granted in 2023 under the Incentive Plan and continued employment. See the section above entitled &#8220;COMPENSATION DISCUSSION AND ANALYSIS &#8211; Components of Executive Compensation &#8211; Equity-Based Compensation </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&#8211;</span><span style="font-size: 8pt"><span style="font-family: Times New Roman, Times, Serif"><b> </b></span>Equity Awards Granted in 2023&#8221; for more information about the
            performance-vesting restricted stock units.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(7)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">One-fourth of these shares of time-vesting restricted stock vest on each of June 26, 2025, June 26, 2026, June 26, 2027 and June 26, 2028.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(8)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">Reflects the aggregate target number of shares that will vest upon the achievement of certain performance goals established for the annual award of performance-vesting restricted stock units
            granted in 2024 under the Incentive Plan and continued employment. See the section above entitled &#8220;COMPENSATION DISCUSSION AND ANALYSIS &#8211; Components of Executive Compensation &#8211; Equity-Based Compensation&#160;<span style="font-family: Times New Roman, Times, Serif"><b><span style="font-size: 10pt; font-weight: normal;">&#8211;</span> </b></span>Equity Awards Granted in 2024&#8221; for more information about the performance-vesting restricted stock units.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(9)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">Reflects the earned but unvested portion of performance-vesting restricted stock units granted in 2023 that will vest in 2026 following the Company&#8217;s certification of the final performance
            period subject to such award.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(10)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">Reflects the earned but unvested portion of performance-vesting restricted stock units granted in 2022 that will vest in 2025 following the Company&#8217;s certification of the final performance
            period subject to such award.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(11)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">One-third of these shares of time-vesting restricted stock vest on each of July 25, 2025, July 25, 2026 and July 25, 2027.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(12)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">One-third of these shares of time-vesting restricted stock vest on each of July 26, 2025, July 26, 2026 and July 26, 2027.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(13)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">One-half of these shares of time-vesting restricted stock vest on each of September 30, 2025 and September 30, 2026.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(14)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">One-third of these shares of time-vesting restricted stock vest on each of November 7, 2025, November 7, 2026 and November 7, 2027.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(15)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">One-third of these shares of time-vesting restricted stock vest on each of March 1, 2025, March 1, 2026 and March 1, 2027.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(16)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">One-third of these shares of time-vesting restricted stock vest on each of March 29, 2025, March 29, 2026 and March 29, 2027.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in"><b>Option Exercises and Stock Vested</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The following table shows the amounts received by the Named Executive Officers upon the exercise of stock options or the vesting of time-vesting
    restricted stock and performance-vesting restricted stock units during 2024:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 65%; font: 9pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom">
        <td style="font-size: 10pt; text-align: center; padding-bottom: 1pt">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"></p>
        </td>
        <td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
        <td colspan="6" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 9pt">Option Awards</span></p>
        </td>
        <td style="padding-bottom: 1pt; font-size: 10pt">&#160;</td>
        <td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
        <td colspan="6" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 9pt">Stock Awards</span></p>
        </td>
        <td style="padding-bottom: 1pt; font-size: 10pt">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 9pt">Name</span></p>
        </td>
        <td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 9pt">Number of Shares Acquired on Exercise</span></p>
        </td>
        <td style="padding-bottom: 1pt; font-size: 10pt">&#160;</td>
        <td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 9pt">Value Realized on Exercise</span></p>
        </td>
        <td style="padding-bottom: 1pt; font-size: 10pt">&#160;</td>
        <td style="font-size: 10pt; padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="font-size: 10pt; text-align: center; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 9pt">Number of Shares Acquired on Vesting</span></p>
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"></p>
        </td>
        <td style="padding-bottom: 1pt; font-size: 10pt">&#160;</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Value Realized on Vesting</td>
        <td style="padding-bottom: 1pt">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 32%; padding: 0px 0px 0px 5.4pt; text-align: left;">Christopher H. Hunter</td>
        <td style="width: 1%; font-family: Times New Roman, Times, Serif">&#160;</td>
        <td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="width: 14%; font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td>
        <td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">$</td>
        <td style="width: 14%; text-align: right">&#8211;</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 14%; text-align: right">4,322</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">$</td>
        <td style="width: 14%; text-align: right">285,511</td>
        <td style="width: 1%; text-align: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup>&#160;&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 5.4pt">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">3,380</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">256,204</td>
        <td style="text-align: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup>&#160;&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: justify; padding-left: 5.4pt">Heather Dixon</td>
        <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">8,228</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">545,352</td>
        <td style="text-align: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup>&#160;&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 5.4pt">Brian P. Farley</td>
        <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">4,500</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">292,770</td>
        <td style="text-align: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup>&#160;&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: justify; padding-left: 5.4pt">Nasser Khan, M.D.</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">675</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">8,241</td>
        <td style="text-align: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"><sup style="vertical-align: text-top; line-height: 1;">(5)</sup>&#160;&#160;</sup>&#160;&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">1,250</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">53,113</td>
        <td style="text-align: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup>&#160;&#160;</td>
      </tr>
      <tr style="vertical-align: bottom">
        <td style="text-align: justify; padding-left: 5.4pt">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">3,000</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">189,840</td>
        <td style="text-align: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup>&#160;&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 5.4pt">John S. Hollinsworth</td>
        <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">33,718</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">2,813,093</td>
        <td style="text-align: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(8)</sup>&#160;&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 5.4pt">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">1,335</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">88,190</td>
        <td style="text-align: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup>&#160;&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 5.4pt">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">1,260</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">95,508</td>
        <td style="text-align: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup>&#160;&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 5.4pt">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">1,405</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">98,715</td>
        <td style="text-align: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(9)</sup>&#160;&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 5.4pt">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">7,124</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">544,915</td>
        <td style="text-align: left"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(10)</sup>&#160;&#160;</td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>
  </div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>
  </div><!-- Field: Rule-Page --><div>
  </div><div style="margin-top: 0; margin-bottom: 3pt; text-align: LEFT;">
    <div style="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&#160;</div>
  </div><div>
  </div><!-- Field: /Rule-Page --><div>
  </div><p style="margin-top: 0; margin-bottom: 0"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 9pt">(1)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">Based on the closing sales price of our Common Stock of $66.06 on the NASDAQ Global Select Market on May 8, 2024, the first business day immediately prior to the date that the shares of
            time-vesting restricted stock vested.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 9pt">(2)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">Based on the closing sales price of our Common Stock of $75.80 on the NASDAQ Global Select Market on April 10, 2024, the first business day immediately prior to the date that the shares of
            time-vesting restricted stock vested.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 9pt">(3)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">Based on the closing sales price of our Common Stock of $66.28 on the NASDAQ Global Select Market on July 24, 2024, the first business day immediately prior to the date that the shares of
            time-vesting restricted stock vested.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">48</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 9pt">(4)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">Based on the closing sales price of our Common Stock of $65.06 on the NASDAQ Global Select Market on July 25, 2024, the first business day immediately prior to the date that the shares of
            time-vesting restricted stock vested.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 9pt">(5)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">Based on the closing sales price of our Common Stock of $84.72 on The NASDAQ Global Select Market on March 6, 2024, the date that the options were exercised, less the option exercise price
            of $72.51.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 9pt">(6)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">Based on the closing sales price of our Common Stock of $42.49 on the NASDAQ Global Select Market on November 6, 2024, the first business day immediately prior to the date that the shares of
            time-vesting restricted stock vested.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 9pt">(7)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">Based on the closing sales price of our Common Stock of $63.28 on the NASDAQ Global Select Market on September 27, 2024, the first business day immediately prior to the date that the shares
            of time-vesting restricted stock vested.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 9pt">(8)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">Based on the closing sales price of our Common Stock of $83.43 on The NASDAQ Global Select Market on February 28, 2024, the date that the performance-vesting restricted stock units vested.
            See the section entitled &#8220;COMPENSATION DISCUSSION AND ANALYSIS &#8211; Components of Executive Compensation &#8211; Equity-Based Compensation &#8211; 2021 Annual Awards&#8221; in our Proxy Statement dated April 8, 2022 for more information about the
            performance-vesting restricted stock units.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 9pt">(9)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">Based on the closing sales price of our Common Stock of $70.26 on The NASDAQ Global Select Market on April 22, 2024, the first business day immediately prior to the date that the shares of
            time-vesting restricted stock vested.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 9pt">(10)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">Based on the closing sales price of our Common Stock of $76.49 on The NASDAQ Global Select Market on March 22, 2024, the first business day immediately prior to the date that the shares of
            time-vesting restricted stock vested.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Nonqualified Deferred Compensation </b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The following table shows the activity during 2024 and the aggregate balances held by each of our Named Executive Officers at December 31, 2024 under
    the Deferred Compensation Plan.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom">
        <td style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 9pt">Name</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">
          <div style="padding: 0in 0in 1pt">
            <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 9pt">Executive Contributions</span></p>
            <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 9pt">in 2024($)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup>&#160;&#160;</span></p>
          </div>
        </td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 9pt">Company Contributions in 2024($)</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 9pt">Aggregate Earnings in 2024($)</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 9pt">Aggregate Withdrawals / Distributions($)</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 9pt">Aggregate Balance at December 31, 2024($)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup>&#160;&#160;</span></p>
        </td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-left: 5.4pt"><span style="font-size: 9pt">Christopher H. Hunter</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">$</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">$</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">$</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">$</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">$</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-left: 5.4pt"><span style="font-size: 9pt">Heather Dixon</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-left: 5.4pt"><span style="font-size: 9pt">Brian P. Farley</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-left: 5.4pt"><span style="font-size: 9pt">Nasser Khan, M.D.</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 30%; text-align: left; text-indent: 0; padding-left: 5.4pt"><span style="font-size: 9pt">John S. Hollinsworth</span></td>
        <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 11%; text-align: right"><span style="font-size: 9pt">50,644</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 1%; font-family: Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 11%; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 11%; text-align: right"><span style="font-size: 9pt">16,527</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 1%; font-family: Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 11%; font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="width: 1%; font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 11%; text-align: right"><span style="font-size: 9pt">192,599</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></p><div>
  </div><!-- Field: Rule-Page --><div>
  </div><div style="margin-top: 0; margin-bottom: 3pt; text-align: LEFT;">
    <div style="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&#160;</div>
  </div><div>
  </div><!-- Field: /Rule-Page --><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"/>
        <td style="width: 0.5in; text-align: left"><span style="font-size: 9pt">(1)</span></td>
        <td><span style="font-size: 9pt">These amounts are included in the Summary Compensation Table above.</span></td>
      </tr>

  </table><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"/>
        <td style="width: 0.5in; text-align: left"><span style="font-size: 9pt">(2)</span></td>
        <td><span style="font-size: 9pt">All amounts other than 2024 earnings are included in the Summary Compensation Table above.</span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 9.35pt">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Under the plan, participants may defer up to 50% of their annual base compensation and up to 100% of any performance-based compensation. Participants
    are fully vested in their deferral accounts as to amounts they elect to defer. No employer matching contributions are made to the Deferred Compensation Plan. Participants will be able to select from several fund choices and their deferred compensation
    account will increase or decrease in value in accordance with the performance of the funds selected. Participants may receive a distribution from the Deferred Compensation Plan upon a qualifying distribution event such as separation from service,
    disability, death, change in control or an unforeseeable emergency or on a specified date selected by a participant. Following a participant&#8217;s separation from the Company for any reason, the participant&#8217;s vested interest in the account is paid to the
    participant (or the participant&#8217;s beneficiary in the event of the participant&#8217;s death) either in a lump sum or up to ten annual installments, as elected by the participant. The Deferred Compensation Plan is intended to be an unfunded plan administered
    and maintained by the Company primarily for the purpose of providing deferred compensation benefits to participants.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">49</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Potential Payments Upon Termination or Change in Control under the Employment Agreements </b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">We entered into an employment agreement with Mr. Hunter effective April 11, 2022, with Ms. Dixon effective July 10, 2023, with Mr. Farley effective
    July 26, 2023, and with Mr. Khan effective June 30, 2024 (collectively, the &#8220;Employment Agreements&#8221;). A summary of the Employment Agreements for each applicable Named Executive Officer is provided below. For more information about the compensation or
    benefits received by Mr. Hollinsworth related to his transition from the Company, see &#8220;&#8211; Mr. Hollinsworth&#8217;s Payments related to his Retirement&#8221; below.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><i>Compensation and Benefits</i></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The base salaries under the Employment Agreements are subject to an annual increase in the sole discretion of our Board. In addition to base salary,
    under the Employment Agreements the executives are entitled to participate, in their sole discretion, in all of our employee benefit programs for which senior executive employees are generally eligible. Each executive is also reimbursed for reasonable
    expenses incurred in connection with services performed under each executive&#8217;s Employment Agreement.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><i>Non-Competition and Non-Solicitation</i></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">During the term of each Employment Agreement and for 12 months thereafter (in the case of Ms. Dixon, Mr. Farley and Dr. Khan) or 24 months thereafter
    (in the case of Mr. Hunter), each such executive is prohibited from (i)&#160;directly or indirectly managing, controlling, consulting, rendering services for or participating, engaging or owning an interest in any business which derives 25% of its gross
    revenue from the business of providing behavioral healthcare and/or related services and (ii)&#160;directly or indirectly managing, controlling, rendering services for or participating or consulting with any unit, division, segment or subsidiary of any
    other business that engages in or otherwise competes with (or was organized for the purpose of engaging in or competing with) the business of providing behavioral healthcare and/or related services (subject to certain exceptions), in each case within
    any geographical area in which we engage in such businesses. During the term of each Employment Agreement and for 12 months thereafter (in the case of Ms. Dixon, Mr. Farley and Dr. Khan) or 24 months thereafter (in the case of Mr. Hunter), each such
    executive is prohibited from directly or indirectly soliciting or hiring any employee or independent contractor of ours or directly or indirectly soliciting any customer, supplier, licensee, licensor or other business relation of ours. For Mr. Hunter,
    his non-compete and non-solicitation periods are reduced to 18 months if he is terminated without &#8220;Cause&#8221; or resigns with &#8220;Good Reason&#8221; during the period beginning 3 months prior to and 18 months following a &#8220;Change in Control&#8221; of the Company (the
    &#8220;Change in Control Period&#8221;). In addition, the executives are subject to customary confidentiality and non-disparagement obligations both during and following their employment with the Company.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i>Retention Bonus</i></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Under the Employment Agreements for Ms. Dixon and Mr. Farley, each received a retention bonus equal to $300,000 and $400,000, respectively, for
    continued service through March 31, 2024.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Severance</i></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Employment Agreements, if the executive is terminated without &#8220;Cause&#8221; or resigns with &#8220;Good Reason,&#8221; such executive is generally
    entitled to receive (subject to the satisfaction of certain conditions):</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>Such executive&#8217;s base salary through the termination date;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>Any accrued but unpaid cash bonus with respect to a completed performance period, and, for Ms. Dixon and Mr. Farley, any unpaid retention bonus;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">50</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>Any unused and unpaid time off and sick pay accrued through the termination date, any incurred but unreimbursed business expenses as of the termination date, and all other payments, benefits or fringe benefits pursuant to any applicable
          compensation arrangement as of the termination date;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>For Mr. Hunter, an amount equal to one and a half (1.5) times, and two (2) times, his base salary and target cash bonus as in effect on the termination date, depending on whether such termination occurs outside, or during, the Change of Control
          Period, respectively;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>For Ms. Dixon, Mr. Farley and Dr. Khan, an amount equal to such executive&#8217;s base salary and target cash bonus as in effect on the termination date;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>For Ms. Dixon, Mr. Farley and Dr. Khan, a prorated cash bonus amount for the calendar year in which the termination occurs, determined as if all of the subjective performance objectives for such year have been achieved at the target level;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>An amount equal to the after-tax cost of the premiums for continued health and dental insurance for the executive and/or his or her dependents in accordance with COBRA for a specified period;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>For Mr. Hunter, either full accelerated vesting of a prorated portion of outstanding performance-vesting equity awards (with outstanding performance conditions deemed satisfied at target levels) or delay of vesting and forfeiture of a prorated
          portion of outstanding performance-vesting equity awards, depending on whether such termination occurs outside, or during, the Change of Control Period, respectively; and</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>For Ms. Dixon, Mr. Farley and Dr. Khan, full and immediate vesting of the time-vesting components of such executive&#8217;s outstanding annual equity and equity-based awards, and delay of vesting and forfeiture of such executive&#8217;s outstanding annual
          equity and equity-based awards that are subject to performance-vesting criteria (all such payments collectively, the &#8220;Termination Payments&#8221;).</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;Cause&#8221; (as defined in the Employment Agreement for Mr. Hunter) means the occurrence of one or more of the following with respect to the
    applicable executive; provided that no determination of &#8220;Cause&#8221; may be made under certain circumstances until Mr. Hunter has been given written notice detailing the specific Cause event and a period of thirty (30) business days following receipt of
    such notice to cure such event:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>the arrest and indictment for, conviction of or plea of nolo contendere to a felony or other crime involving moral turpitude or the conviction of any crime involving misappropriation, embezzlement or fraud with respect to the Company or any of
          its subsidiaries or any of their customers, suppliers or other business relations;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>willful conduct outside the scope of his duties and responsibilities under his Employment Agreement that causes the Company or any of its subsidiaries substantial public disgrace or disrepute or demonstrable economic harm;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>repeated failure to perform duties consistent with his Employment Agreement as reasonably directed by the Board;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>any willful act or knowing omission of aiding or abetting a competitor of the Company or any of its subsidiaries to the disadvantage or detriment of the Company or any of its subsidiaries;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>material breach of fiduciary duty or gross negligence in the performance of his duties to the Company or any of its subsidiaries;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>intentional misconduct in the performance of his duties to the Company or any of its subsidiaries;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">51</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>an administrative or other proceeding arising as a result of his action that results in his suspension or debarment from participation in any contracts with, or programs of, the United States or any of the fifty states or any agency or
          department thereof, or any finding of a governmental agency that he personally has engaged in misconduct in connection with his employment by the Company;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>any other material breach by him of his Employment Agreement or material breach of any other agreement between him and the Company or any of its subsidiaries or any written policy of the Company or any of its subsidiaries; or</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>failure by him to, or notification from him of his intent not to, relocate to the greater Nashville, Tennessee area as requested by the Board.</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;Cause&#8221; (as defined in the Employment Agreements for Ms. Dixon, Mr. Farley and Dr. Khan) means the occurrence of one or more of the following with
    respect to the applicable executive:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>the conviction of or plea of nolo contendere to a felony or other crime involving moral turpitude or the conviction of any crime involving misappropriation, embezzlement or fraud with respect to the Company or any of its subsidiaries or any of
          their customers, suppliers or other business relations;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>conduct outside the scope of such executive&#8217;s duties and responsibilities under such Employment Agreement that causes the Company or any of its subsidiaries substantial public disgrace or disrepute or economic harm;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>repeated failure to perform duties consistent with such Employment Agreement as reasonably directed by the Board;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>any act or knowing omission aiding or abetting a competitor, supplier or customer of the Company or any of its subsidiaries to the disadvantage or detriment of the Company or any of its subsidiaries;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>breach of fiduciary duty, gross negligence or willful misconduct with respect to the Company or any of its subsidiaries;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>an administrative or other proceeding resulting in the suspension or debarment of such executive from participation in any contracts with, or programs of, the United States or any individual state or any agency or department thereof; or</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td>any other material breach by such executive of such Employment Agreement or any other agreement between such executive and us, which is not cured to the reasonable satisfaction of the Board within thirty (30)&#160;days after written notice thereof
          to such executive.</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#8220;Good Reason&#8221; (as defined in the Employment Agreements) means if the applicable executive resigns his or her employment with the Company as a result
    of one or more of the following actions (in each case taken without the executive&#8217;s written consent): (i)&#160;a reduction in such executive&#8217;s base salary; (ii)&#160;a material diminution of such executive&#8217;s job duties or responsibilities inconsistent with the
    executive&#8217;s position; (iii)&#160;any other material breach by the Company of such Employment Agreement; or (iv)&#160;a relocation of the Company&#8217;s principal executive offices and corporate headquarters outside of a 30-mile radius of Nashville, Tennessee, or in
    the case of Ms. Dixon and Mr. Farley, Franklin, Tennessee, or, in the case of Dr. Khan, a required relocation of his principal place of employment pursuant to his Employment Agreement; provided that, none of the events described in clauses (i)&#160;through
    (iv)&#160;shall constitute Good Reason unless such executive shall have notified us in writing describing the event which constitutes Good Reason within ninety (90)&#160;days after the occurrence of such event and then only if we shall have failed to cure such
    event within thirty (30)&#160;days after our receipt of such written notice and such executive elects to terminate his or her employment as a result at the end of such thirty (30)&#160;day period.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">52</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">If an executive that is party to an Employment Agreement dies or becomes disabled, such executive is entitled to the Termination Payments; provided,
    that in the case of Mr. Hunter, his payment with respect to the annual cash bonus shall be a prorated cash bonus amount for the calendar year in which the termination occurs and he shall forfeit all outstanding equity awards other than a prorated
    portion of outstanding performance-vesting equity awards subject to the performance period preceding the termination date, and in the case of Ms. Dixon, Mr. Farley and Dr. Khan, such executive shall forfeit all outstanding equity awards. In the event
    that an executive becomes disabled not due to death, such executive is entitled to receive continued installment payments of such executive&#8217;s base salary as in effect on the termination date for a specified period of time.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">If we terminate an executive under an Employment Agreement for Cause or if any such executive resigns without Good Reason, such executive is only
    entitled to receive his or her unpaid base salary through the termination date and any bonus amount to which such executive is entitled by reference to the calendar year that ended on or prior to the termination date, and in the case of Mr. Hunter, all
    other payments, benefits or fringe benefits pursuant to any applicable compensation arrangement as of the termination date. Upon any termination of employment under an Employment Agreement, whether voluntary or otherwise, such executive has the option
    to elect to continue health insurance coverage until the earlier of (A) such time as the executive is eligible to participate in another health plan or (B) the executive becomes eligible for Medicare.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The tables below show the amounts that each Named Executive Officer employed as of December 31, 2024 would have received assuming that the Named
    Executive Officer&#8217;s employment was terminated or he or she died or became disabled effective December 31, 2024. As of December 31, 2024, none of the Named Executive Officers were entitled to any compensation or benefits for resignation or retirement,
    other than in the case of Mr. Hollinsworth, shares of Common Stock previously earned and to be issued upon vesting of the performance-vesting restricted stock units awarded in 2022 and 2023. Furthermore, the Employment Agreements (other than the
    Employment Agreement for Mr. Hunter) do not distinguish a termination following a change in control from a termination in another context. Therefore, a termination following a change in control will entitle a Named Executive Officer to severance
    benefits only if the Named Executive Officer&#8217;s employment is otherwise terminated without Cause by the Company or by the Named Executive Officer for Good Reason.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 9pt"><i>Mr. Hunter</i></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif; margin-left: auto; margin-right: auto;">

      <tr style="vertical-align: bottom">
        <td style="text-align: left; padding-left: 5.75pt; border-bottom: Black 1pt solid"><span style="font-size: 9pt">Executive Benefits and Payments upon Termination</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 9pt">Involuntary Termination without Cause (outside of CoC Period)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup>&#160;&#160;&#160;</span></p>
        </td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 9pt">Involuntary Termination without Cause (during CoC Period)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup>&#160;&#160;&#160;</span></p>
        </td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 9pt">Death or Disability</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 55%; text-align: justify; padding-left: 5.75pt"><span style="font-size: 9pt">Base Salary</span></td>
        <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 9pt">$</span></td>
        <td style="width: 12%; text-align: right"><span style="font-size: 9pt">1,530,000</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 9pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup>&#160;&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 9pt">$</span></td>
        <td style="width: 12%; text-align: right"><span style="font-size: 9pt">2,040,000</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 9pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup>&#160;&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 9pt">$</span></td>
        <td style="width: 12%; text-align: right"><span style="font-size: 9pt">510,000</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 9pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup>&#160;&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: justify; padding-left: 5.75pt"><span style="font-size: 9pt">Non-Equity Incentive Plan Compensation<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup>&#160;&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">3,187,500</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">3,825,000</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">1,275,000</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 5.75pt"><span style="font-size: 9pt">Time-Vesting Restricted Stock (unvested)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup>&#160;&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">2,269,764</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: justify; padding-left: 5.75pt"><span style="font-size: 9pt">Insurance Benefits</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">52,788</span></td>
        <td style="text-align: left"><span style="font-size: 9pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup>&#160;&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">70,383</span></td>
        <td style="text-align: left"><span style="font-size: 9pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup>&#160;&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">17,596</span></td>
        <td style="text-align: left"><span style="font-size: 9pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(8)</sup>&#160;&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 5.75pt"><span style="font-size: 9pt">Accrued Vacation<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(9)</sup>&#160;&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">78,461</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">78,461</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">78,461</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 9pt"><i>Ms. Dixon </i></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif; margin-left: auto; margin-right: auto;">

      <tr style="vertical-align: bottom">
        <td style="text-align: left; border-bottom: Black 1pt solid; padding-left: 5.75pt"><span style="font-size: 9pt">Executive Benefits and Payments upon Termination</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; white-space: nowrap;">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 9pt">Involuntary<br/>
              Termination <br/>
              without Cause<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></span></p>
        </td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 9pt">Death or <br/>
            Disability</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 70%; text-align: justify; padding-left: 5.75pt"><span style="font-size: 9pt">Base Salary</span></td>
        <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 9pt">$</span></td>
        <td style="width: 12%; text-align: right"><span style="font-size: 9pt">690,000</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 9pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup>&#160;&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 9pt">$</span></td>
        <td style="width: 12%; text-align: right"><span style="font-size: 9pt">345,000</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 9pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup>&#160;&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: justify; padding-left: 5.75pt"><span style="font-size: 9pt">Non-Equity Incentive Plan Compensation<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup>&#160;&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">1,208,190</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">604,095</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 5.75pt"><span style="font-size: 9pt">Time-Vesting Restricted Stock (unvested)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup>&#160;&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">1,591,194</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: justify; padding-left: 5.75pt"><span style="font-size: 9pt">Insurance Benefits</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">26,561</span></td>
        <td style="text-align: left"><span style="font-size: 9pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup>&#160;&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">13,281</span></td>
        <td style="text-align: left"><span style="font-size: 9pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(8)</sup>&#160;&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 5.75pt"><span style="font-size: 9pt">Accrued Vacation<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(9)</sup>&#160;&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">54,669</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">54,669</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 9pt"><i>Mr. Farley</i></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif; margin-left: auto; margin-right: auto;">

      <tr style="vertical-align: bottom">
        <td style="text-align: left; border-bottom: Black 1pt solid; padding-left: 5.75pt"><span style="font-size: 9pt">Executive Benefits and Payments upon Termination</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; white-space: nowrap;">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 9pt">Involuntary<br/>
              Termination <br/>
              without Cause<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></span></p>
        </td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 9pt">Death or <br/>
            Disability</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 70%; text-align: justify; padding-left: 5.75pt"><span style="font-size: 9pt">Base Salary</span></td>
        <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 9pt">$</span></td>
        <td style="width: 12%; text-align: right"><span style="font-size: 9pt">550,000</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 9pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup>&#160;&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 9pt">$</span></td>
        <td style="width: 12%; text-align: right"><span style="font-size: 9pt">275,000</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 9pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup>&#160;&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: justify; padding-left: 5.75pt"><span style="font-size: 9pt">Non-Equity Incentive Plan Compensation<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup>&#160;&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">963,050</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">481,525</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 5.75pt"><span style="font-size: 9pt">Time-Vesting Restricted Stock (unvested)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup>&#160;&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">949,419</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: justify; padding-left: 5.75pt"><span style="font-size: 9pt">Insurance Benefits</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">35,192</span></td>
        <td style="text-align: left"><span style="font-size: 9pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup>&#160;&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">17,596</span></td>
        <td style="text-align: left"><span style="font-size: 9pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(8)</sup>&#160;&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 5.75pt"><span style="font-size: 9pt">Accrued Vacation<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(9)</sup>&#160;&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">43,578</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">43,578</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">53</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 9pt"><i>Dr. Khan</i></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif; margin-left: auto; margin-right: auto;">

      <tr style="vertical-align: bottom">
        <td style="text-align: left; border-bottom: Black 1pt solid; padding-left: 5.75pt"><span style="font-size: 9pt">Executive Benefits and Payments upon Termination</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; white-space: nowrap;">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><span style="font-size: 9pt">Involuntary<br/>
              Termination <br/>
              without Cause<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></span></p>
        </td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 9pt">Death or <br/>
            Disability</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 9pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 70%; text-align: justify; padding-left: 5.75pt"><span style="font-size: 9pt">Base Salary</span></td>
        <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 9pt">$</span></td>
        <td style="width: 12%; text-align: right"><span style="font-size: 9pt">515,000</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 9pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup>&#160;&#160;</span></td>
        <td style="width: 1%"><span style="font-size: 9pt">&#160;</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 9pt">$</span></td>
        <td style="width: 12%; text-align: right"><span style="font-size: 9pt">326,015</span></td>
        <td style="width: 1%; text-align: left"><span style="font-size: 9pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup>&#160;&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: justify; padding-left: 5.75pt"><span style="font-size: 9pt">Non-Equity Incentive Plan Compensation<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup>&#160;&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">875,500</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">437,750</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 5.75pt"><span style="font-size: 9pt">Time-Vesting Restricted Stock (unvested)<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup>&#160;&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">889,389</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: justify; padding-left: 5.75pt"><span style="font-size: 9pt">Insurance Benefits</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup>&#160;&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-size: 9pt">&#8211;</span></td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left"><span style="font-size: 9pt"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(8)</sup>&#160;&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: justify; padding-left: 5.75pt"><span style="font-size: 9pt">Accrued Vacation<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(9)</sup>&#160;&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">37,180</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
        <td style="text-align: right"><span style="font-size: 9pt">37,180</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">&#160;</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>
  </div><!-- Field: Rule-Page --><div>
  </div><div style="margin-top: 0; margin-bottom: 3pt; text-align: LEFT;">
    <div style="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&#160;</div>
  </div><div>
  </div><!-- Field: /Rule-Page --><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.25in"><span style="font-size: 9pt">(1)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">The amounts shown would have been payable if we terminated the Named Executive Officer&#8217;s employment without Cause (as defined in his or her Employment Agreement) or if the Named Executive
            Officer resigned his or her employment for Good Reason (as defined in his or her Employment Agreement), provided that the Named Executive Officer had not breached the non-competition, non-solicitation, confidentiality and proprietary
            information provisions of his or her Employment Agreement.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.25in"><span style="font-size: 9pt">(2)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">The amounts shown would have been payable if we terminated Mr. Hunter&#8217;s employment without Cause (as defined in his Employment Agreement) or if Mr. Hunter resigned his employment for Good
            Reason (as defined in his Employment Agreement) during the Change of Control Period (as defined in his Employment Agreement), provided that Mr. Hunter had not breached the non-competition, non-solicitation, confidentiality and proprietary
            information provisions of his Employment Agreement.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.25in"><span style="font-size: 9pt">(3)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">The amount shown reflects, for Mr. Hunter, one and a half (1.5) and two (2) times his base salary depending on whether such termination occurs outside, or during, the Change of Control
            Period, respectively, for Ms. Dixon, Mr. Farley and Dr. Khan, twelve months of his or her base salary, in each case such base salary as in effect on December 31, 2024 pursuant to the terms of the Employment Agreements (assuming that he or she
            is not in violation of the restrictive covenants set forth in his or her Employment Agreement or his General Release, if applicable). Pursuant to the Employment Agreements, base salary amounts are payable in regular installments over the course
            of the applicable severance period.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.25in"><span style="font-size: 9pt">(4)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">The amount shown reflects the Named Executive Officer&#8217;s base salary as in effect on December 31, 2024 payable for a period of six months in the event of disability pursuant to the terms of
            his or her Employment Agreement.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.25in"><span style="font-size: 9pt">(5)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">The amount shown reflects the cash incentive award for 2024 of 125% of the base salary for Mr. Hunter, two (2) times 85% of the base salary for Ms. Dixon, Mr. Farley and Dr. Khan, assuming
            achievement of the performance goals at the target level, pursuant to the terms of the Employment Agreements and each of their non-equity incentive compensation plans for 2024. In addition, Mr. Hunter is entitled to an additional payment of one
            and a half (1.5) times and two (2) times his target annual cash bonus depending on whether such termination occurs outside, or during, the Change of Control Period, respectively.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.25in"><span style="font-size: 9pt">(6)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">The amount shown reflects the value of all unvested time-vesting restricted stock not intended to qualify as performance-based compensation for each Named Executive Officer (other than Mr.
            Hunter), which may immediately vest pursuant to the terms of his or her Employment Agreement depending on the type of termination, based on a market value of $39.65 per share as of December 31, 2024. Pursuant to the terms of his Employment
            Agreement, Mr. Hunter is only entitled to vest in unvested time-vesting restricted stock if such termination occurs within three months of a Change of Control. See &#8220;EXECUTIVE COMPENSATION &#8211; Outstanding Equity Awards at Fiscal Year-End.&#8221;
            Pursuant to each Named Executive Officer&#8217;s Employment Agreement, unvested performance-vesting restricted stock unit awards intended to qualify as performance-based compensation are not immediately forfeited at termination but remain subject to
            forfeiture restrictions related to pre-established performance goals until the results of the related goals have been satisfied. As of December 31, 2024, all unvested performance-vesting restricted stock units of each Named Executive Officer
            would remain subject to pre-established performance goals and would vest in future years based on future performance. See &#8220;EXECUTIVE COMPENSATION &#8211; Outstanding Equity Awards at Fiscal Year-End&#8221; for potential amounts that may be realized in the
            future with respect to each Named Executive Officer&#8217;s unvested performance-vesting restricted stock units as of December 31, 2024.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.25in"><span style="font-size: 9pt">(7)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">The amount shown reflects the cost of the premiums for continued health, dental and vision insurance for the Named Executive Officer or his or her dependents, in accordance with COBRA, for a
            period of 18 or 24 months for Mr. Hunter depending on whether such termination occurs outside, or during, the Change of Control Period, respectively, and 12 months for Ms. Dixon, Mr. Farley and Dr. Khan, pursuant to the terms of the Employment
            Agreements.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">54</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.25in"><span style="font-size: 9pt">(8)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">The amount shown reflects the cost of the premiums for continued health, dental and vision insurance for the Named Executive Officer or his or her dependents, in accordance with COBRA, for a
            period of six months pursuant to the terms of his or her Employment Agreement.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.25in"><span style="font-size: 9pt">(9)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">The amount shown reflects unused paid time off, pursuant to the terms of the Named Executive Officer&#8217;s Employment Agreement and our paid time off policies.</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><i>Mr. Hollinsworth&#8217;s Payments related to his Retirement</i></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Mr. Hollinsworth retired as the Company&#8217;s Executive Vice President of Operations effective June 30, 2024, but continued to provide transition
    advisory services through December 31, 2024. <span style="background-color: white">In connection with such retirement and pursuant to the terms of a Separation and Consulting Agreement with the Company, Mr.&#160;Hollinsworth received (a) approximately
      $50,156 for unused paid time off accrued through his retirement date, and (b) approximately $59,996 of consulting fees post-retirement in 2024. In addition, Mr.&#160;Hollinsworth&#160;remained eligible to earn a prorated portion of his 2024 annual non-equity
      incentive award subject to actual achievement of the 2024 performance goals. Under the terms of such Separation and Consulting Agreement, Mr. Hollinsworth forfeited his rights to any additional compensation, severance or other benefits, including all
      other outstanding equity and non-equity incentive awards; provided that, in accordance with the terms and conditions of the Incentive Plan and the applicable award agreement, the earned but unvested portion of all outstanding performance-vesting
      restricted stock units remain eligible to vest following the Company&#8217;s certification of all outstanding performance periods subject to each award. </span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>2022, 2023 and 2024 Performance-Vesting Equity Awards</i></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">As described in &#8220;COMPENSATION DISCUSSION AND ANALYSIS &#8211; Components of Executive Compensation &#8211; Equity-Based Compensation,&#8221; shares earned under
    performance-vesting restricted stock unit awards made in 2022, 2023 and 2024 are generally accumulated and released at the end of the applicable three-year term of the award, and for such awards made in 2024, subject to adjustment based on the relative
    TSR modifier. Given the longer payout for such awards, awards for an executive whose employment is terminated during the performance period due to death, disability, retirement, or without cause or for good reason may vest at the end of the performance
    period, subject to the Company&#8217;s achievement of the performance goals.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="text-transform: uppercase"><b>P</b></span><b>ay Ratio</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">As required by Section 953(b) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(u) of Regulation S-K, we are providing
    the following information about the relationship of the annual total compensation of our employees and the annual total compensation of Mr. Hunter, our Chief Executive Officer:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#8226;</td>
        <td style="text-align: left">the median of the annual total compensation of all employees of the Company was $48,375; and</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#8226;</td>
        <td style="text-align: left">the annual total compensation of our Chief Executive Officer, as reported in the Summary Compensation Table included elsewhere in this Proxy Statement, was $7,089,167.</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Based on this information, for 2024, the ratio of the annual total compensation of Mr. Hunter, our Chief Executive Officer, to the median of the
    annual total compensation of all employees was 147 to 1.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">For purposes of the foregoing pay ratio disclosure, we were required to identify the median employee of all employees of the Company, without regard
    to their location, compensation arrangements or employment status (full-time versus part-time) and then determine the annual total compensation that &#8220;median employee&#8221; earned during 2024. To identify the median of the annual total compensation of all
    our employees, as well as to determine the annual total compensation of our median employee in 2024, we took the following steps:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Pursuant to applicable regulations, we are required to identify our median employee only once every three years. Accordingly, for purposes of
    determining the median annual total compensation of employees and the resulting pay ratio for 2024, we have used the 2024 compensation of the median employee that we identified as of December 31, 2024. We determined that, as of December&#160;31, 2024, our
    employee population consisted of approximately 25,500 individuals working at the Company and its consolidated subsidiaries in the United States and Puerto Rico (as reported in Item 1, <i>Business</i>, in our Annual Report on Form 10-K for the year
    ended December 31, 2024). This population consisted of our full-time, part-time and temporary employees paid during the year ended December 31, 2024. The inclusion of part-time and temporary employees substantially reduces the median of the annual
    total compensation of all of our employees.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">55</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">We prepared a list of employees at December&#160;31, 2024 from our payroll records and evaluated total compensation. Total compensation includes salary,
    stock awards and non-equity incentive plan compensation. Compensation for full-time and part-time employees who commenced employment after January&#160;1, 2024 was annualized. Compensation for temporary employees was not annualized.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The SEC rules for identifying the median employee and calculating the pay ratio allow companies to apply various methodologies and assumptions and,
    as a result, the pay ratio reported by us may not be comparable to the pay ratio reported by other companies, including those within our peer group and industry.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><ix:nonNumeric contextRef="c0" continuedAt="_PvpTableTextBlock-c0_cont_1" escape="true" name="ecd:PvpTableTextBlock" id="ixv-12515"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Pay Versus Performance</b></p></ix:nonNumeric><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>
  </div><ix:continuation continuedAt="_PvpTableTextBlock-c0_cont_2" id="_PvpTableTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The following table sets forth certain information regarding compensation actually paid to our Named Executive Officers during the past five fiscal
    years compared to certain measures of our financial performance:</p></ix:continuation><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></p><div>
  </div><ix:continuation continuedAt="_PvpTableTextBlock-c0_cont_3" id="_PvpTableTextBlock-c0_cont_2"><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="color: rgb(33, 37, 41); text-align: center; padding-bottom: 2px;"/> <td colspan="8" rowspan="1" style="color: rgb(33, 37, 41); border-bottom: 2px solid rgb(0, 0, 0); text-align: center; vertical-align: bottom;"><span style="font-size: 8pt;">&#160;&#160;Summary Comp. Table Total <br/> for CEO</span></td> <td style="padding-bottom: 2px; color: rgb(33, 37, 41);"><span style="font-size: 8pt">&#160;</span></td> <td colspan="7" rowspan="1" style="color: rgb(33, 37, 41); text-align: center; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><span style="font-size: 8pt;">&#160;</span> <p style="font: 10pt Times New Roman,Times,serif; margin: 0pt 0px; color: rgb(33, 37, 41);"><span style="font-size: 8pt;">&#160;</span></p> <p style="font: 10pt Times New Roman,Times,serif; margin: 0pt 0px; color: rgb(33, 37, 41);"><span style="font-size: 8pt;">Comp. Actually Paid</span></p> <p style="font: 10pt Times New Roman,Times,serif; margin: 0pt 0px; color: rgb(33, 37, 41);"><span style="font-size: 8pt;">to CEO<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup>&#160;&#160;</span></p> </td> <td style="padding-bottom: 2px; color: rgb(33, 37, 41);"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); padding-bottom: 2px;"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" rowspan="2" style="color: rgb(33, 37, 41); text-align: center; border-bottom: 2px solid rgb(0, 0, 0);"><span style="font-size: 8pt; color: #212529">Average Summary Comp. Table Total for Non-CEO NEOs<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 2px; color: rgb(33, 37, 41);"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); padding-bottom: 2px;"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" rowspan="2" style="color: rgb(33, 37, 41); text-align: center; border-bottom: 2px solid rgb(0, 0, 0);"><span style="font-size: 8pt; color: #212529">Average Comp. Actually Paid to Non-CEO NEOs<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 2px; color: rgb(33, 37, 41);"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); padding-bottom: 2px;"><span style="font-size: 8pt">&#160;</span></td> <td colspan="6" style="color: rgb(33, 37, 41); text-align: center; border-bottom: 2px solid rgb(0, 0, 0);"><span style="font-size: 8pt">Value of Initial Fixed $100 Investment Based On:</span></td> <td style="padding-bottom: 2px; color: rgb(33, 37, 41);"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); padding-bottom: 2px;"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" rowspan="2" style="color: rgb(33, 37, 41); text-align: center; border-bottom: 2px solid rgb(0, 0, 0);"><span style="font-size: 8pt">Net Income (Loss) <br/> (in thousands)</span></td> <td style="padding-bottom: 2px; color: rgb(33, 37, 41);"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); padding-bottom: 2px;"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" rowspan="2" style="color: rgb(33, 37, 41); text-align: center; border-bottom: 2px solid rgb(0, 0, 0);"><span style="font-size: 8pt; color: #212529">Adjusted EPS<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 2px; color: rgb(33, 37, 41);"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Year</span></td> <td colspan="4" rowspan="1" style="padding-bottom: 1pt; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);"><span style="font-size: 8pt">&#160;&#160;</span><span style="font-size: 8pt; color: rgb(33, 37, 41);">Christopher H. Hunter<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 1pt; color: #212529; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="border-bottom: 2px solid rgb(0, 0, 0); color: rgb(33, 37, 41); text-align: center;"><span style="font-size: 8pt; color: #212529">Debra K. Osteen<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 1pt; color: #212529; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td colspan="4" rowspan="1" style="color: rgb(33, 37, 41); padding-bottom: 1pt; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);"><span style="font-size: 8pt">&#160;</span><span style="font-size: 8pt; color: #212529">Christopher H. Hunter<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup>&#160;&#160;</span><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="border-bottom: 2px solid rgb(0, 0, 0); color: rgb(33, 37, 41); text-align: center;"><span style="font-size: 8pt; color: #212529">Debra K. Osteen<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 1pt; color: #212529; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="border-bottom: 2px solid rgb(0, 0, 0); color: rgb(33, 37, 41); text-align: center;"><span style="font-size: 8pt; color: #212529">TSR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 1pt; color: #212529; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="border-bottom: 2px solid rgb(0, 0, 0); color: rgb(33, 37, 41); text-align: center;"><span style="font-size: 8pt; color: #212529">Peer Group TSR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 1pt; color: #212529; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 9%; color: #212529; text-align: center"><span style="font-size: 8pt">2024</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 6%; color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd" id="ixv-18031">7,089,167</ix:nonFraction></span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 6%; color: #212529; text-align: right"><span style="font-size: 8pt; color: #212529">&#160;N/A</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 6%; color: #212529; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoActuallyPaidCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18032">241,669</ix:nonFraction></span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">)</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 6%; text-align: right"><span style="font-size: 8pt; color: #212529">N/A</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 6%; color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" unitRef="usd" id="ixv-18033">2,238,478</ix:nonFraction></span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 6%; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" sign="-" unitRef="usd" id="ixv-18034">19,323</ix:nonFraction></span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">)</span></td> <td style="width: 1%; color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 6%; color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ecd:TotalShareholderRtnAmt" scale="0" unitRef="usd" id="ixv-18035">119</ix:nonFraction></span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 6%; color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" unitRef="usd" id="ixv-18036">126</ix:nonFraction></span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 6%; color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c0" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" unitRef="usd" id="ixv-18037">264,484</ix:nonFraction></span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 6%; color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ecd:CoSelectedMeasureAmt" scale="0" unitRef="usdPershares" id="ixv-18038">3.32</ix:nonFraction></span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: #212529; text-align: center"><span style="font-size: 8pt">2023</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd" id="ixv-18039">7,404,606</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt; color: #212529">&#160;N/A</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoActuallyPaidCompAmt" scale="0" unitRef="usd" id="ixv-18040">8,352,752</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt; color: #212529">N/A</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" unitRef="usd" id="ixv-18041">3,289,184</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" unitRef="usd" id="ixv-18042">1,079,088</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ecd:TotalShareholderRtnAmt" scale="0" unitRef="usd" id="ixv-18043">234</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" unitRef="usd" id="ixv-18044">124</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c3" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" sign="-" unitRef="usd" id="ixv-18045">15,661</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">)</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c3" decimals="2" format="ixt:num-dot-decimal" name="ecd:CoSelectedMeasureAmt" scale="0" unitRef="usdPershares" id="ixv-18046">3.51</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: #212529; text-align: center"><span style="font-size: 8pt">2022</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd" id="ixv-18047">6,415,224</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd" id="ixv-18048">2,620,043</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoActuallyPaidCompAmt" scale="0" unitRef="usd" id="ixv-18049">8,482,132</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoActuallyPaidCompAmt" scale="0" unitRef="usd" id="ixv-18050">17,102,308</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" unitRef="usd" id="ixv-18051">3,040,751</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" unitRef="usd" id="ixv-18052">9,817,787</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ecd:TotalShareholderRtnAmt" scale="0" unitRef="usd" id="ixv-18053">248</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" unitRef="usd" id="ixv-18054">118</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c6" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" unitRef="usd" id="ixv-18055">280,033</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c6" decimals="2" format="ixt:num-dot-decimal" name="ecd:CoSelectedMeasureAmt" scale="0" unitRef="usdPershares" id="ixv-18056">3.19</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: #212529; text-align: center"><span style="font-size: 8pt">2021</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt; color: #212529">N/A</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd" id="ixv-18057">9,853,107</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt; color: #212529">N/A</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoActuallyPaidCompAmt" scale="0" unitRef="usd" id="ixv-18058">29,812,731</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" unitRef="usd" id="ixv-18059">3,656,112</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" unitRef="usd" id="ixv-18060">8,870,858</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="ecd:TotalShareholderRtnAmt" scale="0" unitRef="usd" id="ixv-18061">183</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" unitRef="usd" id="ixv-18062">147</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c8" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" unitRef="usd" id="ixv-18063">195,562</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c8" decimals="2" format="ixt:num-dot-decimal" name="ecd:CoSelectedMeasureAmt" scale="0" unitRef="usdPershares" id="ixv-18064">2.70</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: #212529; text-align: center"><span style="font-size: 8pt">2020</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt; color: #212529">N/A</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd" id="ixv-18065">5,131,395</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt; color: #212529">N/A</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoActuallyPaidCompAmt" scale="0" unitRef="usd" id="ixv-18066">17,648,915</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" unitRef="usd" id="ixv-18067">2,604,425</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" unitRef="usd" id="ixv-18068">6,550,425</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="ecd:TotalShareholderRtnAmt" scale="0" unitRef="usd" id="ixv-18069">151</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" unitRef="usd" id="ixv-18070">134</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c10" decimals="-3" format="ixt:num-dot-decimal" name="us-gaap:ProfitLoss" scale="3" sign="-" unitRef="usd" id="ixv-18071">669,199</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">)</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c10" decimals="2" format="ixt:num-dot-decimal" name="ecd:CoSelectedMeasureAmt" scale="0" unitRef="usdPershares" id="ixv-18072">2.81</ix:nonFraction></span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> </tr> </table></ix:continuation><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></p><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><!-- Field: Rule-Page --><div>
  </div><div style="margin-top: 0; margin-bottom: 3pt; text-align: LEFT;">
    <div style="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&#160;</div>
  </div><div>
  </div><!-- Field: /Rule-Page --><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><ix:continuation continuedAt="_PvpTableTextBlock-c0_cont_4" id="_PvpTableTextBlock-c0_cont_3"><ix:nonNumeric contextRef="c0" continuedAt="_NamedExecutiveOfficersFnTextBlock-c0_cont_1" escape="true" name="ecd:NamedExecutiveOfficersFnTextBlock" id="ixv-13080"><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"> <tr style="vertical-align: top"> <td style="width: 0"/> <td style="width: 0.5in"><span style="font-size: 8pt">(1)</span></td> <td style="text-align: left"><span style="font-size: 8pt"><ix:nonNumeric contextRef="c11" name="ecd:PeoName" id="ixv-18073"><ix:nonNumeric contextRef="c3" name="ecd:PeoName" id="ixv-18074"><ix:nonNumeric contextRef="c0" name="ecd:PeoName" id="ixv-18075">Mr. Hunter</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> was appointed Chief Executive Officer effective April 11, 2022.</span></td> </tr> </table></ix:nonNumeric></ix:continuation><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><ix:continuation continuedAt="_PvpTableTextBlock-c0_cont_5" id="_PvpTableTextBlock-c0_cont_4"><ix:continuation continuedAt="_NamedExecutiveOfficersFnTextBlock-c0_alt_0_cont_2" id="_NamedExecutiveOfficersFnTextBlock-c0_cont_1"><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"> <tr style="vertical-align: top"> <td style="width: 0"/> <td style="width: 0.5in"><span style="font-size: 8pt">(2)</span></td> <td style="text-align: left"><span style="font-size: 8pt"><ix:nonNumeric contextRef="c10" name="ecd:PeoName" id="ixv-18076"><ix:nonNumeric contextRef="c8" name="ecd:PeoName" id="ixv-18077"><ix:nonNumeric contextRef="c12" name="ecd:PeoName" id="ixv-18078">Ms. Osteen</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> retired as Chief Executive Officer effective April 11, 2022.</span></td> </tr> </table></ix:continuation></ix:continuation><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><ix:continuation continuedAt="_PvpTableTextBlock-c0_cont_6" id="_PvpTableTextBlock-c0_cont_5"><ix:nonNumeric contextRef="c0" continuedAt="_AdjToPeoCompFnTextBlock-c0_alt_0_cont_1" escape="true" name="ecd:AdjToPeoCompFnTextBlock" id="ixv-13106"><ix:nonNumeric contextRef="c0" continuedAt="_AdjToNonPeoNeoCompFnTextBlock-c0_alt_0_cont_1" escape="true" name="ecd:AdjToNonPeoNeoCompFnTextBlock" id="ixv-13107"><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"> <tr style="vertical-align: top"> <td style="width: 0"/> <td style="width: 0.5in"><span style="font-size: 8pt">(3)</span></td> <td style="text-align: left"><span style="font-size: 8pt">To calculate Compensation Actually Paid (&#8220;CAP&#8221;), the following amounts were deducted from and added to Summary Compensation Table (&#8220;SCT&#8221;) total compensation:</span></td> </tr> </table></ix:nonNumeric></ix:nonNumeric></ix:continuation><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><ix:continuation continuedAt="_PvpTableTextBlock-c0_cont_7" id="_PvpTableTextBlock-c0_cont_6"><ix:continuation continuedAt="_AdjToPeoCompFnTextBlock-c0_alt_0_cont_2" id="_AdjToPeoCompFnTextBlock-c0_alt_0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in"><span style="font-size: 8pt"><b>CEO SCT Table to CAP Reconciliation: </b></span></p></ix:continuation></ix:continuation><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in">&#160;</p><div>
  </div><ix:continuation continuedAt="_PvpTableTextBlock-c0_cont_8" id="_PvpTableTextBlock-c0_cont_7"><ix:continuation continuedAt="_AdjToPeoCompFnTextBlock-c0_alt_1_cont_3" id="_AdjToPeoCompFnTextBlock-c0_alt_0_cont_2"><table border="0" cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: 1pt solid Black; text-align: left; width: 20%; vertical-align: bottom;"><span style="font-size: 8pt;">Name</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="border-bottom: 1pt solid Black; text-align: center; width: 9%;"><span style="font-size: 8pt">Year</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="text-align: center; border-bottom: 1pt solid Black;"><span style="font-size: 8pt">SCT Total</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="text-align: center; border-bottom: 1pt solid Black;"><span style="font-size: 8pt">Deductions from SCT Total<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(a)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="text-align: center; border-bottom: 1pt solid Black;"><span style="font-size: 8pt">Additions to SCT Total<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(b)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="text-align: center; border-bottom: 1pt solid Black;"><span style="font-size: 8pt">CAP</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 20%; text-align: left; vertical-align: top;"><span style="font-size: 8pt;">Christopher H. Hunter</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 9%; text-align: center;"><span style="font-size: 8pt">2024</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 14%; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd" id="ixv-18079">7,089,167</ix:nonFraction></span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 14%; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c13" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18080">5,099,925</ix:nonFraction></span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 14%; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18081">2,230,911</ix:nonFraction></span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">)</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 14%; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoActuallyPaidCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18082">241,669</ix:nonFraction></span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">)</span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; width: 20%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center; width: 9%;"><span style="font-size: 8pt">2023</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd" id="ixv-18083">7,404,606</ix:nonFraction></span></td> <td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18084">4,749,977</ix:nonFraction></span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18085">5,698,123</ix:nonFraction></span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoActuallyPaidCompAmt" scale="0" unitRef="usd" id="ixv-18086">8,352,752</ix:nonFraction></span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; width: 20%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center; width: 9%;"><span style="font-size: 8pt">2022</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd" id="ixv-18087">6,415,224</ix:nonFraction></span></td> <td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18088">4,500,022</ix:nonFraction></span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c18" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18089">6,566,930</ix:nonFraction></span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoActuallyPaidCompAmt" scale="0" unitRef="usd" id="ixv-18090">8,482,132</ix:nonFraction></span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; width: 20%; vertical-align: middle;"><span style="font-size: 8pt;">Debra K. Osteen</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center; width: 9%;"><span style="font-size: 8pt">2024</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c19" decimals="0" format="ixt:fixed-zero" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd" id="ixv-18091">&#8211;</ix:nonFraction></span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:fixed-zero" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18092">&#8211;</ix:nonFraction></span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c21" decimals="0" format="ixt:fixed-zero" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18093">&#8211;</ix:nonFraction></span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c19" decimals="0" format="ixt:fixed-zero" name="ecd:PeoActuallyPaidCompAmt" scale="0" unitRef="usd" id="ixv-18094">&#8211;</ix:nonFraction></span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom"> <td style="text-align: center; width: 20%;"/> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center; width: 9%;"><span style="font-size: 8pt">2023</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c22" decimals="0" format="ixt:fixed-zero" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd" id="ixv-18095">&#8211;</ix:nonFraction></span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c23" decimals="0" format="ixt:fixed-zero" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18096">&#8211;</ix:nonFraction></span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c24" decimals="0" format="ixt:fixed-zero" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18097">&#8211;</ix:nonFraction></span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c22" decimals="0" format="ixt:fixed-zero" name="ecd:PeoActuallyPaidCompAmt" scale="0" unitRef="usd" id="ixv-18098">&#8211;</ix:nonFraction></span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; width: 20%;"/> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center; width: 9%;"><span style="font-size: 8pt">2022</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd" id="ixv-18099">2,620,043</ix:nonFraction></span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c25" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18100">1,059,857</ix:nonFraction></span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c26" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18101">15,542,122</ix:nonFraction></span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoActuallyPaidCompAmt" scale="0" unitRef="usd" id="ixv-18102">17,102,308</ix:nonFraction></span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom"> <td style="text-align: center; width: 20%;"/> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center; width: 9%;"><span style="font-size: 8pt">2021</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd" id="ixv-18103">9,853,107</ix:nonFraction></span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18104">6,989,753</ix:nonFraction></span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c28" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18105">26,949,377</ix:nonFraction></span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoActuallyPaidCompAmt" scale="0" unitRef="usd" id="ixv-18106">29,812,731</ix:nonFraction></span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; width: 20%;"/> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center; width: 9%;"><span style="font-size: 8pt">2020</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd" id="ixv-18107">5,131,395</ix:nonFraction></span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c29" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18108">2,789,779</ix:nonFraction></span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c30" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18109">15,307,298</ix:nonFraction></span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); text-align: right; width: 14%;"><span style="font-size: 8pt"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoActuallyPaidCompAmt" scale="0" unitRef="usd" id="ixv-18110">17,648,915</ix:nonFraction></span></td> <td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> </tr> </table></ix:continuation></ix:continuation><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in">&#160;</p><div>
  </div><ix:continuation continuedAt="_PvpTableTextBlock-c0_cont_9" id="_PvpTableTextBlock-c0_cont_8"><ix:continuation continuedAt="_AdjToNonPeoNeoCompFnTextBlock-c0_alt_0_cont_2" id="_AdjToNonPeoNeoCompFnTextBlock-c0_alt_0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in"><span style="font-size: 8pt"><b>Average Non-CEO NEOs SCT Table to CAP Reconciliation:</b></span></p></ix:continuation></ix:continuation><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><ix:continuation continuedAt="_PvpTableTextBlock-c0_cont_10" id="_PvpTableTextBlock-c0_cont_9"><ix:continuation continuedAt="_AdjToNonPeoNeoCompFnTextBlock-c0_alt_1_cont_3" id="_AdjToNonPeoNeoCompFnTextBlock-c0_alt_0_cont_2"><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Year</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">SCT Total</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">Deductions from SCT Total<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(a)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">Additions to SCT Total<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(b)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">CAP</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 15%; background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 14%; text-align: center"><span style="font-size: 8pt">2024</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 14%; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" unitRef="usd" id="ixv-18111">2,238,478</ix:nonFraction></span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 14%; text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c31" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18112">1,179,647</ix:nonFraction></span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 14%; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c32" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18113">1,078,154</ix:nonFraction></span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">)</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 14%; text-align: right"><span style="font-size: 8pt">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" sign="-" unitRef="usd" id="ixv-18114">19,323</ix:nonFraction></span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">)</span></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center"><span style="font-size: 8pt">2023</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" unitRef="usd" id="ixv-18115">3,289,184</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c33" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18116">2,503,492</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c34" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18117">293,396</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" unitRef="usd" id="ixv-18118">1,079,088</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center"><span style="font-size: 8pt">2022</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" unitRef="usd" id="ixv-18119">3,040,751</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c35" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18120">1,720,243</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c36" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18121">8,497,279</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" unitRef="usd" id="ixv-18122">9,817,787</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center"><span style="font-size: 8pt">2021</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" unitRef="usd" id="ixv-18123">3,656,112</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c37" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18124">1,963,594</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c38" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18125">7,178,340</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" unitRef="usd" id="ixv-18126">8,870,858</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center"><span style="font-size: 8pt">2020</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" unitRef="usd" id="ixv-18127">2,604,425</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c39" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18128">1,116,717</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c40" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18129">5,062,717</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" unitRef="usd" id="ixv-18130">6,550,425</ix:nonFraction></span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> </tr> </table></ix:continuation></ix:continuation><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">56</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p><div>
  </div><!-- Field: Rule-Page --><div>
  </div><div style="margin-top: 0; margin-bottom: 3pt; text-align: LEFT;">
    <div style="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&#160;</div>
  </div><div>
  </div><!-- Field: /Rule-Page --><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p><div>
  </div><ix:continuation continuedAt="_PvpTableTextBlock-c0_cont_11" id="_PvpTableTextBlock-c0_cont_10"><ix:continuation continuedAt="_AdjToPeoCompFnTextBlock-c0_alt_1_cont_4" id="_AdjToPeoCompFnTextBlock-c0_alt_1_cont_3"><ix:continuation continuedAt="_AdjToNonPeoNeoCompFnTextBlock-c0_alt_1_cont_4" id="_AdjToNonPeoNeoCompFnTextBlock-c0_alt_1_cont_3"><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 0in"/> <td style="width: 0.5in"><span style="font-size: 8pt">(a)</span></td> <td style="text-align: left"><span style="font-size: 8pt">Represents the grant date fair value of equity-based awards granted each year calculated in accordance with ASC 718.</span></td> </tr> </table></ix:continuation></ix:continuation></ix:continuation><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><ix:continuation continuedAt="_PvpTableTextBlock-c0_cont_12" id="_PvpTableTextBlock-c0_cont_11"><ix:continuation continuedAt="_AdjToPeoCompFnTextBlock-c0_alt_1_cont_5" id="_AdjToPeoCompFnTextBlock-c0_alt_1_cont_4"><ix:continuation continuedAt="_AdjToNonPeoNeoCompFnTextBlock-c0_alt_1_cont_5" id="_AdjToNonPeoNeoCompFnTextBlock-c0_alt_1_cont_4"><ix:nonNumeric contextRef="c0" continuedAt="_EqtyAwrdsAdjFnTextBlock-c0_cont_1" escape="true" name="ecd:EqtyAwrdsAdjFnTextBlock" id="ixv-13809"><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 0in"/> <td style="width: 0.5in"><span style="font-size: 8pt">(b)</span></td> <td style="text-align: left"><span style="font-size: 8pt">Reflects the value of equity calculated in accordance with the SEC methodology for determining CAP for each year shown. The equity component of CAP is further detailed in the table below. For performance-vesting restricted stock unit awards, fair value amounts have been computed consistent with the methodology used in the Company&#8217;s Consolidated Financial Statements as of December 31, 2020, 2021, 2022, 2023 and 2024, respectively.</span></td> </tr> </table></ix:nonNumeric></ix:continuation></ix:continuation></ix:continuation><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><ix:continuation continuedAt="_PvpTableTextBlock-c0_cont_13" id="_PvpTableTextBlock-c0_cont_12"><ix:continuation continuedAt="_AdjToPeoCompFnTextBlock-c0_alt_2_cont_6" id="_AdjToPeoCompFnTextBlock-c0_alt_1_cont_5"><ix:continuation continuedAt="_AdjToNonPeoNeoCompFnTextBlock-c0_alt_2_cont_6" id="_AdjToNonPeoNeoCompFnTextBlock-c0_alt_1_cont_5"><ix:continuation continuedAt="_EqtyAwrdsAdjFnTextBlock-c0_cont_2" id="_EqtyAwrdsAdjFnTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in"><span style="font-size: 8pt"><b>Equity Component of CAP: </b></span></p></ix:continuation></ix:continuation></ix:continuation></ix:continuation><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><ix:continuation continuedAt="_PvpTableTextBlock-c0_cont_14" id="_PvpTableTextBlock-c0_cont_13"><ix:continuation continuedAt="_EqtyAwrdsAdjFnTextBlock-c0_cont_3" id="_EqtyAwrdsAdjFnTextBlock-c0_cont_2"><ix:continuation continuedAt="_AdjToPeoCompFnTextBlock-c0_alt_2_cont_7" id="_AdjToPeoCompFnTextBlock-c0_alt_2_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><span style="font-size: 8pt"><span style="text-decoration:underline">Christopher H. Hunter</span></span></p></ix:continuation></ix:continuation></ix:continuation><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&#160;</p><div>
  </div><ix:continuation continuedAt="_PvpTableTextBlock-c0_cont_15" id="_PvpTableTextBlock-c0_cont_14"><ix:continuation continuedAt="_EqtyAwrdsAdjFnTextBlock-c0_cont_4" id="_EqtyAwrdsAdjFnTextBlock-c0_cont_3"><ix:continuation continuedAt="_AdjToPeoCompFnTextBlock-c0_alt_2_cont_8" id="_AdjToPeoCompFnTextBlock-c0_alt_2_cont_7"><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 65%; font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Year</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"> <div>Fair Value of</div> <div> Current Year Equity Awards at Year-End</div> </td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Change in Value of Prior Years&#8217; Awards Unvested at Year-End</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Change in Value of Prior Years&#8217; Awards That Vested in the Year</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"> <div>Equity Value</div> <div> Included in CAP</div> </td> <td style="padding-bottom: 1pt">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 19%; text-align: center">2024</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right"><ix:nonFraction contextRef="c41" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18131">2,975,019</ix:nonFraction></td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right">(<ix:nonFraction contextRef="c42" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18132">5,148,737</ix:nonFraction></td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 17%; text-align: right">(<ix:nonFraction contextRef="c43" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18133">57,192</ix:nonFraction></td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right">(<ix:nonFraction contextRef="c14" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18134">2,230,911</ix:nonFraction></td> <td style="width: 1%; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2023</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c44" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18135">6,050,233</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(<ix:nonFraction contextRef="c45" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18136">321,521</ix:nonFraction></td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(<ix:nonFraction contextRef="c46" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18137">30,589</ix:nonFraction></td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18138">5,698,123</ix:nonFraction></td> <td style="text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2022</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c47" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18139">6,566,930</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c48" decimals="0" format="ixt:fixed-zero" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18140">&#8211;</ix:nonFraction></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c49" decimals="0" format="ixt:fixed-zero" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18141">&#8211;</ix:nonFraction></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c18" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18142">6,566,930</ix:nonFraction></td> <td style="text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2021</td> <td style="text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c50" decimals="0" format="ixt:fixed-zero" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18143">&#8211;</ix:nonFraction></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c51" decimals="0" format="ixt:fixed-zero" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18144">&#8211;</ix:nonFraction></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c52" decimals="0" format="ixt:fixed-zero" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18145">&#8211;</ix:nonFraction></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c53" decimals="0" format="ixt:fixed-zero" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18146">&#8211;</ix:nonFraction></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2020</td> <td style="text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c54" decimals="0" format="ixt:fixed-zero" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18147">&#8211;</ix:nonFraction></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c55" decimals="0" format="ixt:fixed-zero" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18148">&#8211;</ix:nonFraction></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c56" decimals="0" format="ixt:fixed-zero" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18149">&#8211;</ix:nonFraction></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c57" decimals="0" format="ixt:fixed-zero" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18150">&#8211;</ix:nonFraction></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> </tr> </table></ix:continuation></ix:continuation></ix:continuation><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&#160;</p><div>
  </div><ix:continuation continuedAt="_PvpTableTextBlock-c0_cont_16" id="_PvpTableTextBlock-c0_cont_15"><ix:continuation continuedAt="_EqtyAwrdsAdjFnTextBlock-c0_cont_5" id="_EqtyAwrdsAdjFnTextBlock-c0_cont_4"><ix:continuation continuedAt="_AdjToPeoCompFnTextBlock-c0_alt_2_cont_9" id="_AdjToPeoCompFnTextBlock-c0_alt_2_cont_8"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><span style="font-size: 8pt"><span style="text-decoration:underline">Debra K. Osteen</span></span></p></ix:continuation></ix:continuation></ix:continuation><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><ix:continuation continuedAt="_PvpTableTextBlock-c0_cont_17" id="_PvpTableTextBlock-c0_cont_16"><ix:continuation continuedAt="_EqtyAwrdsAdjFnTextBlock-c0_cont_6" id="_EqtyAwrdsAdjFnTextBlock-c0_cont_5"><ix:continuation id="_AdjToPeoCompFnTextBlock-c0_alt_2_cont_9"><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 65%; font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Year</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Fair Value of Current Year Equity Awards at Year-End</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Change in Value of Prior Years&#8217; Awards Unvested at Year-End</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Change in Value of Prior Years&#8217; Awards That Vested in the Year</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"> <div>Equity Value</div> <div> Included in CAP</div> </td> <td style="padding-bottom: 1pt">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2024</td> <td style="text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c58" decimals="0" format="ixt:fixed-zero" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18151">&#8211;</ix:nonFraction></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c59" decimals="0" format="ixt:fixed-zero" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18152">&#8211;</ix:nonFraction></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c60" decimals="0" format="ixt:fixed-zero" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18153">&#8211;</ix:nonFraction></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c21" decimals="0" format="ixt:fixed-zero" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18154">&#8211;</ix:nonFraction></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2023</td> <td style="text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c61" decimals="0" format="ixt:fixed-zero" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18155">&#8211;</ix:nonFraction></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c62" decimals="0" format="ixt:fixed-zero" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18156">&#8211;</ix:nonFraction></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c63" decimals="0" format="ixt:fixed-zero" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18157">&#8211;</ix:nonFraction></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c24" decimals="0" format="ixt:fixed-zero" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18158">&#8211;</ix:nonFraction></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 19%; text-align: center">2022</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right"><ix:nonFraction contextRef="c64" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18159">9,972,986</ix:nonFraction></td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right"><ix:nonFraction contextRef="c65" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18160">7,341,244</ix:nonFraction></td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right">(<ix:nonFraction contextRef="c66" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18161">1,772,108</ix:nonFraction></td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right"><ix:nonFraction contextRef="c26" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18162">15,542,122</ix:nonFraction></td> <td style="width: 1%; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2021</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c67" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18163">23,567,139</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c68" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18164">3,215,353</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c69" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18165">166,885</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c28" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18166">26,949,377</ix:nonFraction></td> <td style="text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2020</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c70" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18167">13,014,224</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c71" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18168">533,148</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c72" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18169">1,759,927</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c30" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18170">15,307,298</ix:nonFraction></td> <td style="text-align: left">&#160;</td> </tr> </table></ix:continuation></ix:continuation></ix:continuation><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p><div>
  </div><ix:continuation continuedAt="_PvpTableTextBlock-c0_cont_18" id="_PvpTableTextBlock-c0_cont_17"><ix:continuation continuedAt="_EqtyAwrdsAdjFnTextBlock-c0_cont_7" id="_EqtyAwrdsAdjFnTextBlock-c0_cont_6"><ix:continuation continuedAt="_AdjToNonPeoNeoCompFnTextBlock-c0_alt_2_cont_7" id="_AdjToNonPeoNeoCompFnTextBlock-c0_alt_2_cont_6"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><span style="font-size: 8pt"><span style="text-decoration:underline">Average Non-CEO NEOs </span></span></p></ix:continuation></ix:continuation></ix:continuation><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><ix:continuation continuedAt="_PvpTableTextBlock-c0_cont_19" id="_PvpTableTextBlock-c0_cont_18"><ix:continuation id="_EqtyAwrdsAdjFnTextBlock-c0_cont_7"><ix:continuation id="_AdjToNonPeoNeoCompFnTextBlock-c0_alt_2_cont_7"><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 80%; font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Year</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Fair Value of Current Year Equity Awards at Year-End</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Change in Value of Prior Years&#8217; Awards Unvested at Year-End</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Change in Value of Prior Years&#8217; Awards That Vested in the Year</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Fair Value of Forfeited Awards at Prior Year-End</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"> <div>Equity Value</div> <div> Included in CAP</div> </td> <td style="padding-bottom: 1pt">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 14%; text-align: center">2024</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right"><ix:nonFraction contextRef="c73" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18171">679,492</ix:nonFraction></td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right">(<ix:nonFraction contextRef="c74" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18172">1,278,180</ix:nonFraction></td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right">(<ix:nonFraction contextRef="c75" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18173">19,593</ix:nonFraction></td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right">(<ix:nonFraction contextRef="c76" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18174">459,873</ix:nonFraction></td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right">(<ix:nonFraction contextRef="c32" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18175">1,078,154</ix:nonFraction></td> <td style="width: 1%; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2023</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c77" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18176">2,182,972</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(<ix:nonFraction contextRef="c78" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18177">89,974</ix:nonFraction></td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(<ix:nonFraction contextRef="c79" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18178">255,921</ix:nonFraction></td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(<ix:nonFraction contextRef="c80" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18179">1,543,681</ix:nonFraction></td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c34" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18180">293,396</ix:nonFraction></td> <td style="text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2022</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c81" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18181">5,228,345</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c82" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18182">3,399,089</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(<ix:nonFraction contextRef="c83" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18183">130,155</ix:nonFraction></td> <td style="text-align: left">)</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c84" decimals="0" format="ixt:fixed-zero" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18184">&#8211;</ix:nonFraction></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c36" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18185">8,497,279</ix:nonFraction></td> <td style="text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2021</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c85" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18186">5,891,861</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c86" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18187">1,147,507</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c87" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18188">138,972</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c88" decimals="0" format="ixt:fixed-zero" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18189">&#8211;</ix:nonFraction></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c38" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18190">7,178,340</ix:nonFraction></td> <td style="text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2020</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c89" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18191">4,691,771</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c90" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18192">419,942</ix:nonFraction></td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(<ix:nonFraction contextRef="c91" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-18193">48,996</ix:nonFraction></td> <td style="text-align: left">)</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c92" decimals="0" format="ixt:fixed-zero" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18194">&#8211;</ix:nonFraction></td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right"><ix:nonFraction contextRef="c40" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-18195">5,062,717</ix:nonFraction></td> <td style="text-align: left">&#160;</td> </tr> </table></ix:continuation></ix:continuation></ix:continuation><div>
  </div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>
  </div><ix:continuation continuedAt="_PvpTableTextBlock-c0_cont_20" id="_PvpTableTextBlock-c0_cont_19"><ix:continuation continuedAt="_NamedExecutiveOfficersFnTextBlock-c0_alt_0_cont_3" id="_NamedExecutiveOfficersFnTextBlock-c0_alt_0_cont_2"><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"> <tr style="vertical-align: top"> <td style="width: 0"/> <td style="width: 0.5in"><span style="font-size: 8pt">(4)</span></td> <td style="text-align: left"><span style="font-size: 8pt">The Named Executive Officers, other than the CEO, reflected in the Pay Versus Performance table represent the following individuals for each of the years listed below</span></td> </tr> </table></ix:continuation></ix:continuation><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><ix:continuation continuedAt="_PvpTableTextBlock-c0_cont_21" id="_PvpTableTextBlock-c0_cont_20"><ix:continuation id="_NamedExecutiveOfficersFnTextBlock-c0_alt_0_cont_3"><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; width: 94%; border-collapse: collapse; margin-left: 0.5in">

      <tr style="vertical-align: bottom">
        <td style="width: 23%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">2020</span></td>
        <td style="width: 20%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">2021</span></td>
        <td style="width: 19%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">2022</span></td>
        <td style="width: 19%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">2023</span></td>
        <td style="width: 19%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">2024</span></td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">David M. Duckworth</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">David M. Duckworth</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">David M. Duckworth</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Heather Dixon</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Heather Dixon</span></td>
      </tr>
      <tr style="vertical-align: top">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Christopher L. Howard</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Christopher L. Howard</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Christopher L. Howard</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Brian P. Farley</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Brian P. Farley</span></td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">John S. Hollinsworth</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">John S. Hollinsworth</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">John S. Hollinsworth</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">John S. Hollinsworth</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Nasser Khan, M.D.</span></td>
      </tr>
      <tr style="vertical-align: top">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Laurence L. Harrod</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Laurence L. Harrod</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Laurence L. Harrod</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">David M. Duckworth</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">John S. Hollinsworth</span></td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Laurence L. Harrod</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
      </tr>

  </table></ix:continuation></ix:continuation><div>
  </div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>
  </div><ix:continuation continuedAt="_PvpTableTextBlock-c0_cont_22" id="_PvpTableTextBlock-c0_cont_21"><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 8pt">(5)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">An investment of $100 is assumed to have been made in our Common Stock as of December&#160;31, 2019. TSR was calculated by multiplying the initial investment of $100 by the quotient of the
            closing price of our Common Stock on December&#160;31, 2020, 2021, 2022, 2023 and 2024, divided by our closing price on December&#160;31, 2019.</span></td>
      </tr>

  </table></ix:continuation><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><ix:continuation continuedAt="_PvpTableTextBlock-c0_cont_23" id="_PvpTableTextBlock-c0_cont_22"><ix:nonNumeric contextRef="c0" escape="true" name="ecd:PeerGroupIssuersFnTextBlock" id="ixv-14340"><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"> <tr style="vertical-align: top"> <td style="width: 0"/> <td style="width: 0.5in"><span style="font-size: 8pt">(6)</span></td> <td style="text-align: left"><span style="font-size: 8pt">Reflects the cumulative total stockholder return for the S&amp;P Health Care Services Select Industry Index (the &#8220;S&amp;P HC Index&#8221;). An investment of $100 is assumed to have been made in the S&amp;P HC Index as of December&#160;31, 2019. Peer Group TSR was calculated by multiplying the initial investment of $100 by the quotient of the closing price of the S&amp;P HC Index on December&#160;31, 2020, 2021, 2022, 2023 and 2024 divided by the closing price on December&#160;31, 2019, with dividends reinvested at the time they are paid.</span></td> </tr> </table></ix:nonNumeric></ix:continuation><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 8pt">&#160;</span></p><div>
  </div><ix:continuation id="_PvpTableTextBlock-c0_cont_23"><ix:nonNumeric contextRef="c93" escape="true" name="ecd:NonGaapMeasureDescriptionTextBlock" id="ixv-14353"><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"> <tr style="vertical-align: top"> <td style="width: 0"/> <td style="width: 0.5in"><span style="font-size: 8pt">(7)</span></td> <td style="text-align: left"><span style="font-size: 8pt"><ix:nonNumeric contextRef="c0" name="ecd:CoSelectedMeasureName" id="ixv-18196">Adjusted EPS</ix:nonNumeric> is a non-GAAP financial measure and one of the core long-term metrics we use for purposes of evaluating performance for our compensation program, as further described in the section above entitled &#8220;COMPENSATION DISCUSSION AND ANALYSIS &#8211; Components of Executive Compensation &#8211; Annual Non-Equity Incentive Compensation.&#8221;</span></td> </tr> </table></ix:nonNumeric></ix:continuation><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">57</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="margin: 0">&#160;</p><div>
  </div><p style="margin: 0"></p><div>
  </div><ix:nonNumeric contextRef="c0" continuedAt="_TabularListTableTextBlock-c0_cont_1" escape="true" name="ecd:TabularListTableTextBlock" id="ixv-14376"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i>Financial Performance Measures</i></p></ix:nonNumeric><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><div>
  </div><ix:continuation continuedAt="_TabularListTableTextBlock-c0_cont_2" id="_TabularListTableTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As further described in the section above entitled &#8220;COMPENSATION DISCUSSION AND ANALYSIS &#8211; Components of Executive Compensation,&#8221; the Company&#8217;s
    executive compensation program is heavily weighted to performance-based pay, with a significant emphasis on long-term performance and stockholder value creation. The Company primarily uses three core metrics across its long-term and short-term
    incentive awards: Adjusted EPS, Adjusted EBITDA and revenue. The Company uses Adjusted EPS, Adjusted EBITDA and revenue to determine annual cash incentive awards and performance-based equity awards because they are important measures of our performance
    and the performance of our management, they drive our success and growth and they are key criteria by which management plans and analyzes our business. In addition, the Company uses certain non-financial measures to determine annual cash incentive
    awards in order to incentivize and align achievement for certain key qualitative metrics. Therefore, the most important financial performance measures (and only financial measures used in current plans/awards) used by the Company to link compensation
    actually paid to the Company&#8217;s NEOs, for the most recently completed fiscal year, to the Company&#8217;s performance are as follows:</p></ix:continuation><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>
  </div><ix:continuation continuedAt="_TabularListTableTextBlock-c0_cont_3" id="_TabularListTableTextBlock-c0_cont_2"><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"> <tr style="vertical-align: top"> <td style="width: 20.9pt"/> <td style="width: 18pt">&#9679;</td> <td style="text-align: justify"><ix:nonNumeric contextRef="c93" name="ecd:MeasureName" id="ixv-18197">Adjusted EPS</ix:nonNumeric></td> </tr> </table></ix:continuation><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><ix:continuation continuedAt="_TabularListTableTextBlock-c0_cont_4" id="_TabularListTableTextBlock-c0_cont_3"><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"> <tr style="vertical-align: top"> <td style="width: 20.7pt"/> <td style="width: 18pt">&#9679;</td> <td style="text-align: justify"><ix:nonNumeric contextRef="c94" name="ecd:MeasureName" id="ixv-18198">Adjusted EBITDA</ix:nonNumeric></td> </tr> </table></ix:continuation><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><ix:continuation id="_TabularListTableTextBlock-c0_cont_4"><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"> <tr style="vertical-align: top"> <td style="width: 20.7pt"/> <td style="width: 18pt">&#9679;</td> <td style="text-align: justify"><ix:nonNumeric contextRef="c95" name="ecd:MeasureName" id="ixv-18199">Revenue</ix:nonNumeric></td> </tr> </table></ix:continuation><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Analysis of the Information Presented in the Pay versus Performance Table</i></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As described in more detail in the sections entitled &#8220;COMPENSATION DISCUSSION AND ANALYSIS&#8221; and &#8220;EXECUTIVE COMPENSATION,&#8221; our executive
    compensation program reflects a variable pay-for-performance philosophy, <span style="background-color: white">with a significant emphasis on long-term performance and stockholder value creation</span>. While we utilize several performance measures to
    align executive compensation with our performance, all of those measures are not presented in the Pay versus Performance table. Furthermore, while we are required to disclose our net income for each covered fiscal year, it is not a metric currently
    used in our executive compensation program. We generally seek to incentivize long-term performance, and therefore do not specifically align our performance measures with compensation that is actually paid (as computed in accordance with Item 402(v) of
    Regulation S-K) for a particular year. In accordance with rules adopted by the SEC, we are providing the following descriptions of the relationships between information presented in the Pay versus Performance table.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>
  </div><ix:nonNumeric contextRef="c0" continuedAt="_CompActuallyPaidVsTotalShareholderRtnTextBlock-c0_cont_1" escape="true" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock" id="ixv-14424"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Comparison of Compensation Actually Paid and Company TSR</i></p></ix:nonNumeric><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>
  </div><ix:continuation continuedAt="_CompActuallyPaidVsTotalShareholderRtnTextBlock-c0_cont_2" id="_CompActuallyPaidVsTotalShareholderRtnTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following graph reflects the relationship between our CEO and average non-CEO NEO &#8220;compensation actually paid&#8221; versus our cumulative TSR,
    assuming an initial fixed investment of $100 on December 31, 2019, for the years ended December 31, 2020, 2021, 2022, 2023 and 2024.</p></ix:continuation><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p><div>
  </div><ix:continuation id="_CompActuallyPaidVsTotalShareholderRtnTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="ny20042551x1_image04.jpg"/>&#160;</p></ix:continuation><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">58</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p><div>
  </div><ix:nonNumeric contextRef="c0" continuedAt="_CompActuallyPaidVsNetIncomeTextBlock-c0_cont_1" escape="true" name="ecd:CompActuallyPaidVsNetIncomeTextBlock" id="ixv-14451"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Comparison of Compensation Actually Paid and Net Income</i></p></ix:nonNumeric><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>
  </div><ix:continuation continuedAt="_CompActuallyPaidVsNetIncomeTextBlock-c0_cont_2" id="_CompActuallyPaidVsNetIncomeTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following graph reflects the relationship between our CEO and average non-CEO NEO &#8220;compensation actually paid&#8221; and our net income for the
    years ended December 31, 2020, 2021, 2022, 2023 and 2024.</p></ix:continuation><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p><div>
  </div><ix:continuation id="_CompActuallyPaidVsNetIncomeTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="ny20042551x1_image05.jpg"/>&#160;</p></ix:continuation><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p><div>
  </div><ix:nonNumeric contextRef="c0" continuedAt="_CompActuallyPaidVsCoSelectedMeasureTextBlock-c0_cont_1" escape="true" name="ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock" id="ixv-14468"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Comparison of Compensation Actually Paid and Adjusted EPS</i></p></ix:nonNumeric><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>
  </div><ix:continuation continuedAt="_CompActuallyPaidVsCoSelectedMeasureTextBlock-c0_cont_2" id="_CompActuallyPaidVsCoSelectedMeasureTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following graph reflects the relationship between our CEO and average non-CEO NEO &#8220;compensation actually paid&#8221; and our Adjusted EPS for the
    years ended December 31, 2020, 2021, 2022, 2023 and 2024.</p></ix:continuation><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>
  </div><ix:continuation id="_CompActuallyPaidVsCoSelectedMeasureTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="ny20042551x1_image06.jpg"/>&#160;</p></ix:continuation><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">59</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>
  </div><ix:nonNumeric contextRef="c0" continuedAt="_TotalShareholderRtnVsPeerGroupTextBlock-c0_cont_1" escape="true" name="ecd:TotalShareholderRtnVsPeerGroupTextBlock" id="ixv-14495"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Comparison of Company TSR and Peer Group TSR</i></p></ix:nonNumeric><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>
  </div><ix:continuation continuedAt="_TotalShareholderRtnVsPeerGroupTextBlock-c0_cont_2" id="_TotalShareholderRtnVsPeerGroupTextBlock-c0_cont_1"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following graph reflects the relationship between our TSR and the TSR of the peer group presented for this purpose, the S&amp;P HC Index.</p></ix:continuation><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>
  </div><ix:continuation id="_TotalShareholderRtnVsPeerGroupTextBlock-c0_cont_2"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="ny20042551x1_image07.jpg"/>&#160;</p></ix:continuation><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">60</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>
  </div><div><a id="a014"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>Director Compensation</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The table below sets forth the 2024 compensation earned by or paid to our non-management directors. Mr.&#160;Hunter does not receive any additional
    compensation for his service as a director.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif; margin-left: auto; margin-right: auto;">

      <tr style="vertical-align: bottom">
        <td style="text-align: center; border-bottom: Black 1pt solid">Name</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">Fees Earned or<br/>
            Paid in Cash<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></p>
        </td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">
          <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;">Stock<br/>
            Awards<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></p>
        </td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid">Total</td>
        <td style="padding-bottom: 1pt">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 55%; text-align: left; text-indent: 0.65pt; padding-left: 5.4pt">Jason R. Bernhard</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">$</td>
        <td style="width: 12%; text-align: right">101,990</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">$</td>
        <td style="width: 12%; text-align: right">159,976</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">$</td>
        <td style="width: 12%; text-align: right">261,966</td>
        <td style="width: 1%; text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; text-indent: 0.65pt; padding-left: 5.4pt">E. Perot Bissell</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">139,000</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">159,976</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">298,976</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; text-indent: 0.65pt; padding-left: 5.4pt">Michael J. Fucci</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">129,500</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">159,976</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">289,476</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; text-indent: 0.65pt; padding-left: 5.4pt">Vicky B. Gregg</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">137,000</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">159,976</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">296,976</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; text-indent: 0.65pt; padding-left: 5.4pt">William F. Grieco</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">139,500</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">159,976</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">299,476</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; text-indent: 0.65pt; padding-left: 5.4pt">Patrice A. Harris, M.D., M.A.</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">99,500</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">159,976</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">259,476</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; text-indent: 0.65pt; padding-left: 5.4pt">R. David Kelly</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">112,000</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">159,976</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">271,976</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; text-indent: 0.65pt; padding-left: 5.4pt">Wade D. Miquelon</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">129,500</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">159,976</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">289,476</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; text-indent: 0.65pt; padding-left: 5.4pt">Reeve B. Waud</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">241,952</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">159,976</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">401,928</td>
        <td style="text-align: left">&#160;</td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>
  </div><!-- Field: Rule-Page --><div>
  </div><div style="margin-top: 0; margin-bottom: 3pt; text-align: LEFT;">
    <div style="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&#160;</div>
  </div><div>
  </div><!-- Field: /Rule-Page --><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 9pt">(1)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">Includes annual retainers and fees associated with serving on a Board committee. Each of Messrs. Bernhard and Waud elected to receive shares of our Common Stock in lieu of his annual cash
            retainer on May 23, 2024. The grant date fair value of such stock awards is computed by multiplying the total number of shares subject to the award by the closing market price of our Common Stock on the date immediately preceding the date of
            grant ($66.27).</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"/>
        <td style="width: 0.5in"><span style="font-size: 9pt">(2)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">This column reflects the grant date fair value of time-vesting restricted stock awards granted to directors calculated in accordance with ASC 718. On May 23, 2024, each non-management
            director elected or continuing to serve as a member of the Board received an award of 2,414 shares of time-vesting restricted stock. The grant date fair value of time-vesting restricted stock awards is computed by multiplying the total number
            of shares subject to the award by the closing market price of our Common Stock on the date immediately preceding the date of grant ($66.27).</span></td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 9pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><span style="font-size: 9pt">As of December 31, 2024, each of Messrs. Bernhard, Bissell, Fucci, Grieco, Miquelon, and Waud, and Ms. Gregg
      held 4,669 shares of time-vesting restricted stock. As of December 31, 2024, Dr. Harris held 3,839 shares of time-vesting restricted stock, and Mr. Kelly held 4,594 shares of time-vesting restricted stock.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board of Directors adopted a compensation plan for non-management directors effective January 1, 2013, as amended in 2016, 2019, 2020 and 2023
    (the &#8220;Directors Plan&#8221;), which provides:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left">An annual cash retainer of $87,000;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left">An annual cash retainer of $15,000 for each member of the Audit and Risk Committee and $30,000 for the chair of the Audit and Risk Committee;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left">An annual cash retainer of $12,500 for each member of the Compensation Committee and $27,500 for the chair of the Compensation Committee;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left">An annual cash retainer of $10,000 for each member of the Nominating Committee and $22,000 for the chair of the Nominating Committee;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left">An annual cash retainer of $12,500 for each member of the Compliance Committee and $27,500 for the chair of the Compliance Committee;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left">An annual cash retainer of $15,000 for each member of the Finance Committee and $30,000 for the chair of the Finance Committee;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left">An annual cash retainer of $45,000 for the Lead Director (if applicable) and $125,000 for the Chairman of the Board (if held by a non-management director);</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">61</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left">Additional cash compensation to be approved by the Chairman of the Board and Chairman of the Compensation Committee for each director who, at the discretion of the Chairman of the Board and Chairman of the Compensation
          Committee, devotes extraordinary time and effort to the Company;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left">An initial grant of time-vesting restricted stock having a value equal to $160,000;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left">An annual grant of time-vesting restricted stock having a value equal to $160,000; and</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left">An annual director compensation limit of $600,000 earned in a given year, including both cash compensation and equity awards.</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">In addition to the compensation described above, we also reimburse our directors for travel and out-of-pocket expenses in connection with their
    attendance at meetings of our Board of Directors.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Under the Directors Plan, all annual retainers shall be paid on the date of our annual meeting of stockholders (the &#8220;Annual Meeting Date&#8221;). Each year
    as of the Annual Meeting Date, each non-management member of our Board who is re-elected or who otherwise continues to be a member of the Board immediately thereafter is automatically granted under the Directors Plan, without further action by us, our
    Board of Directors, the Compensation Committee or our stockholders, shares of our time-vesting restricted stock having a value equal to $160,000. The value of the restricted shares shall be based on the closing trading price of our Common Stock on the
    trading day immediately preceding the Annual Meeting Date. All restricted shares issued to non-management directors shall vest over three years with such shares to vest 33&#8531;% per year on the three successive anniversary dates of the grant of
    time-vesting restricted stock beginning on the first anniversary of the grant date.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Each non-management director may elect to have the Company pay all or a portion of his or her cash retainer(s) in shares of our Common Stock in lieu
    of cash. The number of shares issued shall be determined by dividing the dollar amount of the applicable retainer(s) by the fair market value of a share (based on the closing trading price of our Common Stock on the trading day immediately preceding
    the Annual Meeting Date), rounded down to the nearest whole share. In no case shall any fractional shares be issued. In lieu of any fractional shares, non-management directors shall be entitled to cash equal to the value of any fractional shares.
    Shares issued in lieu of cash shall be fully vested and unrestricted shares issued pursuant to the Company&#8217;s incentive compensation plan and shall be issued on the Annual Meeting Date or, if the shares cannot be delivered due to a Company blackout
    period, then the shares will be delivered on the first business day following the end of the blackout period. Any election by a non-management director to receive his or her retainer(s) in shares must be made no later than the expiration of the
    election period established by the Compensation Committee and can only be made during a period in which the Company is not in a quarterly or special blackout period pursuant to the Company&#8217;s insider trading policy and at a time in which the director
    does not have material, non-public information.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Each of our directors is a party to an Indemnification Agreement with the Company pursuant to which we have agreed to indemnify and advance expenses
    to such director in connection with his or her service as our director, officer or agent to the fullest extent permitted by law and as set forth in each such agreement and, to the extent applicable, to maintain insurance coverage for each such director
    under our policies of directors&#8217; and officers&#8217; liability insurance.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">62</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>
  </div><div><a id="a015"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>AUDIT AND RISK COMMITTEE REPORT</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Our management has primary responsibility for preparing our financial statements and implementing internal controls over financial reporting. Our
    independent registered public accounting firm, Ernst &amp; Young LLP, is responsible for expressing an opinion on the conformity of our audited financial statements with accounting principles generally accepted in the United States and the
    effectiveness of our internal control over financial reporting.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The role and responsibilities of the Audit and Risk Committee are set forth in a written charter adopted by our Board of Directors. The charter is
    available on our website, <i>www.acadiahealthcare.com</i>, under the webpage &#8220;Investors &#8211; Corporate Governance.&#8221; The Audit and Risk Committee reviews and reassesses the adequacy of the charter annually or more often as necessary and recommends any
    proposed changes to the Board. The Audit and Risk Committee acted in accordance with its charter in 2024. In fulfilling its responsibilities for fiscal year 2024, the Audit and Risk Committee:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left">Pre-approved all auditing and non-auditing services of Ernst &amp; Young LLP;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left">Reviewed and discussed with management our unaudited quarterly financial statements during 2024 and our audited financial statements for the fiscal year ended December 31, 2024, including a discussion of critical
          accounting policies used in such financial statements;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left">Reviewed and discussed with the internal auditor the quality and appropriateness of our internal controls and reporting procedures;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left">Discussed with Ernst &amp; Young LLP the matters required to be discussed by Statement on Auditing Standards No. 1301, as amended, as adopted by the Public Company Accounting Oversight Board in Rule 3200T, both with and
          without management present; and</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"/>
        <td style="width: 0.25in">&#9679;</td>
        <td style="text-align: left">Received the written disclosures and the letter from Ernst &amp; Young LLP as required by the applicable requirements of the Public Company Accounting Oversight Board regarding Ernst &amp; Young LLP&#8217;s communications
          with the Audit and Risk Committee concerning independence and discussed with Ernst &amp; Young LLP their independence from us and management.</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Based on the Audit and Risk Committee&#8217;s review of the audited financial statements and discussions with management and Ernst &amp; Young LLP as
    described above, and in reliance thereon, the Audit and Risk Committee recommended to our Board of Directors that the audited financial statements for the fiscal year ended December 31, 2024 be included in our Annual Report on Form 10-K for filing with
    the SEC.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">

      <tr style="vertical-align: top; text-align: left">
        <td style="width: 50%">&#160;</td>
        <td style="width: 50%">AUDIT AND RISK COMMITTEE:</td>
      </tr>
      <tr style="vertical-align: top; text-align: left">
        <td>&#160;</td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top; text-align: left">
        <td>&#160;</td>
        <td>William F. Grieco, Chairman</td>
      </tr>
      <tr style="vertical-align: top; text-align: left">
        <td>&#160;</td>
        <td>E. Perot Bissell</td>
      </tr>
      <tr style="vertical-align: top; text-align: left">
        <td>&#160;</td>
        <td>Michael J. Fucci</td>
      </tr>
      <tr style="vertical-align: top; text-align: left">
        <td>&#160;</td>
        <td>R. David Kelly</td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">63</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>
  </div><div><a id="a016"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">None.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><div><a id="a017"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>GENERAL INFORMATION</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Stockholder Proposals for 2026 Annual Meeting</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Pursuant to Rule 14a-8 under the Exchange Act, proper stockholder proposals intended to be presented at our 2026 annual meeting of stockholders must
    be received by us at our principal executive offices at 6100 Tower Circle, Suite 1000, Franklin, Tennessee 37067 no later than December 11, 2025 for the proposals to be included in the Proxy Statement and form of proxy card for that meeting.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">If a stockholder desires to bring a matter before our annual meeting of stockholders and the matter is submitted outside the process of Rule 14a-8,
    including with respect to nominations for election as directors, the stockholder must follow the procedures set forth in our Bylaws. Our Bylaws provide generally that stockholder proposals and director nominations to be considered at an annual meeting
    of stockholders may be made by a stockholder only if (1) the stockholder is a stockholder of record and is entitled to vote at the meeting, and (2) the stockholder gives timely written notice of the matter to our corporate secretary. To be timely, a
    stockholder&#8217;s notice must be received at our principal executive offices no later than the close of business on the 90th day nor earlier than the close of business on the 120th day prior to the first anniversary of the preceding year&#8217;s annual meeting
    of stockholders. However, in the event that our annual meeting is more than 30 days before or more than 70 days after the date of first anniversary of the preceding year&#8217;s annual meeting of stockholders, notice by the stockholder must be so delivered
    not earlier than the close of business on the 120th day prior to such annual meeting and not later than the close of business on the later of the 90th day prior to such annual meeting or the tenth&#160;day following the day on which public announcement of
    the date of such meeting is first made by the Company. Under our Bylaws, notice with respect to the 2026 annual meeting of stockholders must be received at our principal executive offices between the close of business on January 29, 2026 and the close
    of business on February 28, 2026, unless the 2026 annual meeting is called for a date that is more than 30 days before or more than 70 days after May 29, 2026. The notice must set forth the information required by the provisions of our Bylaws dealing
    with stockholder proposals and nominations of directors.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">In addition to satisfying the foregoing requirements under our Bylaws, to comply with the universal proxy rules, stockholders who intend to solicit
    proxies in support of director nominees other than our director nominees must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act no later than March 30, 2026.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>Annual Report on Form 10-K</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&#160;</p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-weight: normal">As indicated in the Notice of Internet Availability of Proxy Materials, a copy of this Proxy Statement and our
      2024 Annual Report to Stockholders has been posted on the website <i>www.proxyvote.com</i>.</span> Upon the written request of any stockholder entitled to vote at the Annual Meeting, we will furnish, without charge, a copy of our Annual Report on
    Form 10-K for the year ended December 31, 2024, as filed with the SEC. Requests should be directed to Acadia Healthcare Company, Inc., 6100 Tower Circle, Suite 1000, Franklin, Tennessee 37067, Attention: Brian P. Farley, Esq., Executive Vice President,
    General Counsel and Secretary, (615) 851-6000. <span style="font-weight: normal">Our Annual Report to Stockholders and Annual Report on Form 10-K are not proxy soliciting materials.</span></p><div>
  </div><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>Delivery of Documents to Stockholders Sharing an Address</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-weight: normal">Householding is a program adopted by the SEC that permits companies and intermediaries (e.g., brokers) to satisfy
      the delivery requirements for annual reports, proxy statements and the Notices of Internet Availability of proxy materials sent to multiple stockholders of record who have the same address by delivering a single annual report, proxy statement or
      Notice of Internet Availability of Proxy Materials to that address. Householding is designed to reduce a company&#8217;s printing costs and postage fees. Brokers with account holders who are stockholders of the Company may be householding the Company&#8217;s
      proxy materials. If your household participates in the householding program, you will receive one Notice of Internet Availability of Proxy Materials. If you are a beneficial holder, you can request information about householding from your broker,
      bank or other nominee. If at any time you no longer wish to participate in householding and would prefer to receive a separate proxy statement, annual report or Notice of Internet Availability of Proxy Materials, please notify your broker if your
      shares are held in a brokerage account or us if you are a stockholder of record. You can notify us by sending a written request to our General Counsel and Secretary at 6100 Tower Circle, Suite 1000, Franklin, Tennessee 37067, or by calling
      (615)&#160;861-6000. In addition, we will promptly deliver, upon written or oral request to the address or telephone number above, a separate copy of the annual report, proxy statement and Notice of Internet Availability of Proxy Materials to a
      stockholder at a shared address to which a single copy of the documents was delivered.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">64</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">If you receive more than one Notice of Internet Availability of Proxy Materials, this means that you have multiple accounts holding Common Stock with
    brokers and/or the Company&#8217;s transfer agent. Please vote all of your shares by following the instructions included on each Notice of Internet Availability of Proxy Materials. Additionally, to avoid receiving multiple sets of proxy materials in the
    future, the Company recommends that you contact Broadridge Financial Services, Inc. at <i>www.proxyvote.com</i> or (800) 579-1639 to consolidate as many accounts as possible under the same name and address. If you are a beneficial holder, please call
    your broker for instructions.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><b>Electronic Access to Proxy Statement and Annual Report to Stockholders </b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">We have elected to provide this Proxy Statement and our 2024 Annual Report to Stockholders over the Internet through a &#8220;notice and access&#8221; model. The
    Notice of Internet Availability of Proxy Materials provides instructions on how you may access this Proxy Statement and our 2024 Annual Report to Stockholders on the Internet at <i>www.proxyvote.com</i> or request a printed copy at no charge. In
    addition, the Notice of Internet Availability of Proxy Materials provides instructions on how you may request to receive, at no charge, all future proxy materials in printed form by mail or electronically by email. Your election to receive proxy
    materials by mail or email will remain in effect until you revoke it. Choosing to receive future proxy materials by email will save us the cost of printing and mailing documents to stockholders and will reduce the impact of our annual meetings on the
    environment.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">

      <tr style="vertical-align: top; text-align: left">
        <td style="width: 50%">&#160;</td>
        <td style="width: 50%">ACADIA HEALTHCARE COMPANY, INC.</td>
      </tr>
      <tr style="vertical-align: top; text-align: left">
        <td>&#160;</td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top; text-align: left">
        <td>&#160;</td>
        <td><img alt="" src="ny20042551x1_image02.jpg"/>&#160;</td>
      </tr>
      <tr style="vertical-align: top; text-align: left">
        <td>&#160;</td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top; text-align: left">
        <td>&#160;</td>
        <td>Christopher H. Hunter</td>
      </tr>
      <tr style="vertical-align: top; text-align: left">
        <td>&#160;</td>
        <td><i>Chief Executive Officer and Director</i></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">April 10, 2025</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">65</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Reconciliation of Adjusted EBITDA for Purposes of Compensation Plans</b>&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Unaudited)</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom">
        <td style="text-align: left; border-bottom: Black 1pt solid"><span style="font-size: 8pt">(in thousands)</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">2024</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">2023</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 74%; text-align: left; text-indent: -12pt; padding-left: 12pt">Net income (loss) attributable to Acadia Healthcare Company, Inc.</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">$</td>
        <td style="width: 10%; text-align: right">255,612</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">$</td>
        <td style="width: 10%; text-align: right">(21,667</td>
        <td style="width: 1%; text-align: left">)</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; text-indent: -12pt; padding-left: 12pt">Net income attributable to noncontrolling interests</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">8,872</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">6,006</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; text-indent: -12pt; padding-left: 12pt">Provision for (benefit from) income taxes</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">77,395</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">(9,699</td>
        <td style="text-align: left">)</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; text-indent: -12pt; padding-left: 12pt">Interest expense, net</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">116,368</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">82,125</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-bottom: 1pt; text-indent: -12pt; padding-left: 12pt">Depreciation and amortization</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
        <td style="border-bottom: Black 1pt solid; text-align: right">149,595</td>
        <td style="padding-bottom: 1pt; text-align: left">&#160;</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
        <td style="border-bottom: Black 1pt solid; text-align: right">132,349</td>
        <td style="padding-bottom: 1pt; text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; text-indent: -12pt; padding-left: 12pt">EBITDA</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">607,842</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">189,114</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; text-indent: -12pt; padding-left: 12pt">Adjustments:</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">&#160;</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; text-indent: -12pt; padding-left: 0.5in">Equity-based compensation expense (a)</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">37,113</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">32,289</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; text-indent: -12pt; padding-left: 0.5in">Transaction, legal and other costs (b)</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">46,753</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">62,026</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; text-indent: -12pt; padding-left: 0.5in">Legal settlements expense (c)</td>
        <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">394,181</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; text-indent: -12pt; padding-left: 0.5in">Loss on impairment (d)</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">17,276</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">9,790</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-bottom: 1pt; text-indent: -12pt; padding-left: 0.5in">Gain on sale of property (e)</td>
        <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
        <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td>
        <td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
        <td style="border-bottom: Black 1pt solid; text-align: right">(9,747</td>
        <td style="padding-bottom: 1pt; text-align: left">)</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; text-indent: -12pt; padding-left: 12pt">Adjusted EBITDA, as reported</td>
        <td>&#160;</td>
        <td style="text-align: left">$</td>
        <td style="text-align: right">708,984</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">$</td>
        <td style="text-align: right">677,653</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; text-indent: -12pt; padding-left: 0.5in">Severance and restructuring costs (f)</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">1,877</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">2,418</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-bottom: 1pt; text-indent: -12pt; padding-left: 0.5in">Other non-cash gains and charges (g)</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
        <td style="border-bottom: Black 1pt solid; text-align: right">433</td>
        <td style="padding-bottom: 1pt; text-align: left">&#160;</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
        <td style="border-bottom: Black 1pt solid; text-align: right">312</td>
        <td style="padding-bottom: 1pt; text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -12pt; padding-left: 12pt">Adjusted EBITDA for purposes of compensation plans</td>
        <td style="padding-bottom: 2.5pt">&#160;</td>
        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
        <td style="border-bottom: Black 2.5pt double; text-align: right">711,294</td>
        <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
        <td style="padding-bottom: 2.5pt">&#160;</td>
        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
        <td style="border-bottom: Black 2.5pt double; text-align: right">680,383</td>
        <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
      </tr>

  </table><div>
  </div><p style="margin-top: 0; margin-bottom: 0">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">66</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Reconciliation of Adjusted EPS for Purposes of Compensation Plans</b>&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Unaudited)</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom">
        <td style="text-align: left; border-bottom: Black 1pt solid"><span style="font-size: 8pt">(in thousands)</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">2024</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
        <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">2023</span></td>
        <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="width: 74%; text-align: left; text-indent: -12pt; padding-left: 12pt">Net income (loss) attributable to Acadia Healthcare Company, Inc.</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">$</td>
        <td style="width: 10%; text-align: right">255,612</td>
        <td style="width: 1%; text-align: left">&#160;</td>
        <td style="width: 1%">&#160;</td>
        <td style="width: 1%; text-align: left">$</td>
        <td style="width: 10%; text-align: right">(21,667</td>
        <td style="width: 1%; text-align: left">)</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td>&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">&#160;</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; text-indent: -12pt; padding-left: 12pt">Adjustments to income:</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">&#160;</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; text-indent: -12pt; padding-left: 0.5in">Transaction, legal and other costs (b)</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">46,753</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">62,026</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; text-indent: -12pt; padding-left: 0.5in">Legal settlements expense (c)</td>
        <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">394,181</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; text-indent: -12pt; padding-left: 0.5in">Loss on impairment (d)</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">17,276</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">9,790</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; text-indent: -12pt; padding-left: 0.5in">Gain on sale of property (e)</td>
        <td style="font-family: Times New Roman, Times, Serif">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td>
        <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">(9,747</td>
        <td style="text-align: left">)</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-bottom: 1pt; text-indent: -12pt; padding-left: 0.5in">Provision for (benefit from) income taxes</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
        <td style="border-bottom: Black 1pt solid; text-align: right">77,395</td>
        <td style="padding-bottom: 1pt; text-align: left">&#160;</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
        <td style="border-bottom: Black 1pt solid; text-align: right">(9,699</td>
        <td style="padding-bottom: 1pt; text-align: left">)</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; text-indent: -0.5in; padding-left: 0.5in">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">&#160;</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; text-indent: -13.5pt; padding-left: 13.5pt">Adjusted income before income taxes attributable to Acadia Healthcare Company, Inc.</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">397,036</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">424,884</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; text-indent: -0.5in; padding-left: 0.5in">Adjustments to income for purposes of compensation plans:</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">&#160;</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; text-indent: -12pt; padding-left: 0.5in">Severance and restructuring costs (f)</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">1,877</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">2,418</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; text-indent: -12pt; padding-left: 0.5in">Other non-cash gains and charges (g)</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">433</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">312</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; padding-bottom: 1pt; text-indent: -12pt; padding-left: 0.5in">Income tax effect of adjustments to income (h)</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
        <td style="border-bottom: Black 1pt solid; text-align: right">(93,481</td>
        <td style="padding-bottom: 1pt; text-align: left">)</td>
        <td style="padding-bottom: 1pt">&#160;</td>
        <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td>
        <td style="border-bottom: Black 1pt solid; text-align: right">(105,369</td>
        <td style="padding-bottom: 1pt; text-align: left">)</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -12pt; padding-left: 12pt">Adjusted income attributable to Acadia Healthcare Company, Inc. for purposes of compensation plans</td>
        <td style="padding-bottom: 2.5pt">&#160;</td>
        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
        <td style="border-bottom: Black 2.5pt double; text-align: right">305,865</td>
        <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
        <td style="padding-bottom: 2.5pt">&#160;</td>
        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
        <td style="border-bottom: Black 2.5pt double; text-align: right">322,245</td>
        <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="text-align: left; text-indent: -12pt; padding-left: 12pt">Weighted-average shares outstanding &#8211; diluted (i)</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">92,059</td>
        <td style="text-align: left">&#160;</td>
        <td>&#160;</td>
        <td style="text-align: left">&#160;</td>
        <td style="text-align: right">91,826</td>
        <td style="text-align: left">&#160;</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -12pt; padding-left: 12pt">Adjusted EPS for purposes of compensation plans</td>
        <td style="padding-bottom: 2.5pt">&#160;</td>
        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
        <td style="border-bottom: Black 2.5pt double; text-align: right">3.32</td>
        <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
        <td style="padding-bottom: 2.5pt">&#160;</td>
        <td style="border-bottom: Black 2.5pt double; text-align: left">$</td>
        <td style="border-bottom: Black 2.5pt double; text-align: right">3.51</td>
        <td style="padding-bottom: 2.5pt; text-align: left">&#160;</td>
      </tr>

  </table><div>
  </div><p style="margin: 0">&#160;</p><div>
  </div><!-- Field: Rule-Page --><div>
  </div><div style="margin-top: 0; margin-bottom: 0; text-align: LEFT;">
    <div style="font-size: 1pt; border-top: Black 1pt solid; width: 20%">&#160;</div>
  </div><div>
  </div><!-- Field: /Rule-Page --><div>
  </div><p style="margin: 0"></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">

      <tr style="vertical-align: top">
        <td style="width: 3%; text-align: left"><span style="font-size: 9pt">(a)</span></td>
        <td style="width: 97%; text-align: left"><span style="font-size: 9pt">Represents the equity-based compensation expense of Acadia.</span></td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left"><span style="font-size: 9pt">(b)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">Represents transaction, legal and other costs incurred by Acadia primarily related to the following categories: (i) government investigations, (ii) termination and restructuring costs; (iii)
            legal, accounting, and other acquisition-related costs, and (iv) management transition costs.</span></td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left"><span style="font-size: 9pt">(c)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">Represents legal settlements expense related to the Desert Hills Litigation (as defined in our Annual Report on Form 10-K for the year ended December 31, 2023). </span></td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left"><span style="font-size: 9pt">(d)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">Represents non-cash impairment charges related to the closure of certain facilities.</span></td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left"><span style="font-size: 9pt">(e)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">Represents gain on facility property sale. </span></td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left"><span style="font-size: 9pt">(f)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">Represents severance and restructuring costs not included in transaction, legal and other costs.</span></td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left"><span style="font-size: 9pt">(g)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">Represents non-cash gains and charges such as gain or loss on disposal of assets and other one-time charges.</span></td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left"><span style="font-size: 9pt">(h)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">Represents the income tax effect of adjustments to income based on tax rates of 23.4% and 24.6% for the year ended December 31, 2024 and 2023, respectively.</span></td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left"><span style="font-size: 9pt">(i)</span></td>
        <td style="text-align: left"><span style="font-size: 9pt">For the year ended December 31, 2023, approximately 0.9 million outstanding restricted stock units and shares of common stock issuable upon exercise of outstanding stock option awards have
            been included in the calculation of weighted-average shares outstanding-diluted. These shares are excluded from the calculation of diluted earnings per share in the condensed consolidated statement of operations because the net loss for the
            year ended December 31, 2023 causes such securities to be anti-dilutive.</span></td>
      </tr>

  </table><div>
  </div><p style="margin: 0"></p><div>
  </div><p style="margin: 0">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">67</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><!--PROfilePageNumberReset%Num%1%A-%%--><div>
  </div><p style="margin: 0; font: 10pt Times New Roman, Times, Serif">&#160;</p><div>
  </div><div><a id="a018"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><b><span style="text-decoration:underline">APPENDIX A</span></b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Amendment to the</b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><br/>
      <span style="text-transform: uppercase"><b>Acadia Healthcare Company, Inc.<br/>
      Incentive Compensation Plan</b></span></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This Amendment to the Acadia Healthcare Company, Inc. Amended and
      Restated Incentive Compensation Plan (the &#8220;Plan&#8221;) is adopted by Acadia Healthcare Company, Inc. (the &#8220;Company&#8221;), effective as of May 29, 2025.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHEREAS</b>, the Company has established the Plan through which the
      Company may grant awards of stock options, stock appreciation rights, restricted stock and other stock-based and cash-based awards to directors, officers and other employees of the Company and its subsidiaries, as well as other persons performing
      consulting or advisory services for the Company; and</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>WHEREAS</b>, the Company desires to amend the Plan to increase the
      total number of shares that may be granted pursuant to the Plan by 2,475,000 shares, resulting in a total of 15,175,000 shares that may be granted under the Plan.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOW, THEREFORE</b>, the Plan is hereby amended as follows:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0"/>
        <td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By deleting Section 4.1(a) in its entirety and inserting the following in its place and stead:</span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0.5in"/>
        <td style="width: 0.5in;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;<b>4.1</b></span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration:underline">Shares</span>.</b></span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The aggregate number of shares of Common Stock that
      may be issued or used for reference purposes or with respect to which Awards may be granted under the Plan shall not exceed 15,175,000 shares (subject to any increase or decrease pursuant to Section 4.2), which may be either authorized and unissued
      Common Stock or Common Stock held in or acquired for the treasury of the Company or both. The maximum number of shares of Common Stock with respect to which Incentive Stock Options may be granted under the Plan shall be 15,175,000 shares.
      Notwithstanding any provision of the Plan to the contrary, the following shares of Common Stock shall not be added to the shares authorized for grant under Section 4.1(a) and the individual share limitations of Section 4.1(b) and shall not be
      available for future grants of Awards: (i) shares of Common Stock tendered by a Participant or withheld by the Company in payment of the exercise price of an Option, (ii) shares of Common Stock tendered by a Participant or withheld by the Company to
      satisfy any tax withholding obligation with respect to an Award, (iii) shares of Common Stock subject to a Stock Appreciation Right that are not issued in connection with the stock settlement of the Stock Appreciation Right on exercise thereof and
      (iv) shares of Common Stock purchased by the Company with the cash proceeds from the exercise of Options. If any Option, Stock Appreciation Right or Other Stock-Based Awards granted under the Plan expires, terminates or is canceled for any reason
      without having been exercised in full, the number of shares of Common Stock underlying any unexercised Award shall again be available for the purpose of Awards under the Plan. If any shares of Restricted Stock, Performance Awards or Other Stock-Based
      Awards denominated in shares of Common Stock awarded under the Plan to a Participant are forfeited for any reason, the number of forfeited shares of Restricted Stock, Performance Awards or Other Stock-Based Awards denominated in shares of Common
      Stock shall again be available for purposes of Awards under the Plan. If a Tandem Stock Appreciation Right or a Limited Stock Appreciation Right is granted in tandem with an Option, such grant shall only apply once against the maximum number of
      shares of Common Stock which may be issued under the Plan. Any Award under the Plan settled in cash shall not be counted against the foregoing maximum share limitations. In no event will dividends or dividend equivalents be granted with respect to
      unvested Awards, except that the Committee may provide in the applicable Award Agreement at the time of grant that the payment of dividends shall be deferred until, and conditioned upon, vesting of the Award.&#8221;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="width: 0; font: 10pt Times New Roman, Times, Serif"/>
        <td style="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
        <td style="text-align: justify; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except as specifically amended hereby, the Plan shall remain in full force and effect and otherwise
            unmodified. All references in the Plan to the &#8220;Plan&#8221; shall mean the Plan as amended hereby.</span></td>
      </tr>

  </table><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">A-1</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN WITNESS WHEREOF, this Amendment is hereby executed by the undersigned
      officer of the Company, to be effective as of the date first written above.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table border="0" cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman,Times,serif; width: 50%;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
        <td colspan="2" style="font: 10pt Times New Roman,Times,serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ACADIA HEALTHCARE COMPANY, INC.</b></span></td>
        <td style="font: 10pt Times New Roman,Times,serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
        <td style="font: 10pt Times New Roman,Times,serif; width: 36pt;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
        <td style="font: 10pt Times New Roman, Times, Serif; width: 35%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
        <td style="font: 10pt Times New Roman,Times,serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman,Times,serif; width: 50%;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
        <td style="font: 10pt Times New Roman,Times,serif; width: 36pt;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
        <td style="font: 10pt Times New Roman,Times,serif; border-bottom: 1pt solid Black; width: 35%;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
        <td style="font: 10pt Times New Roman,Times,serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman,Times,serif; width: 50%;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
        <td style="font: 10pt Times New Roman,Times,serif; width: 36pt;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
        <td style="font: 10pt Times New Roman,Times,serif; width: 35%;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brian P. Farley</span></td>
        <td style="font: 10pt Times New Roman,Times,serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
      </tr>
      <tr style="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
        <td style="font: 10pt Times New Roman,Times,serif; width: 50%;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
        <td style="font: 10pt Times New Roman,Times,serif; width: 36pt;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
        <td style="font: 10pt Times New Roman,Times,serif; width: 35%;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Vice President, General Counsel and Secretary</span></td>
        <td style="font: 10pt Times New Roman,Times,serif;"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
      </tr>

  </table><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">A-2</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><!--PROfilePageNumberReset%Num%1%B-%%--><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div><a id="a019"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><b><span style="text-decoration:underline">APPENDIX B</span></b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ACADIA HEALTHCARE COMPANY, INC.<br/>
      __________________________________________</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMENDED AND RESTATED INCENTIVE COMPENSATION PLAN<br/>
      __________________________________________</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Article I<br/>
      PURPOSE</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acadia Healthcare Company, Inc. hereby amends and
      restates the Acadia Healthcare Company, Inc. Incentive Compensation Plan, effective as of the date set forth in Article XV to enhance the profitability and value of the Company for the benefit of its stockholders by enabling the Company to offer
      Eligible Individuals cash and stock-based incentives in order to attract, retain and reward such individuals and strengthen the mutuality of interests between such individuals and the Company&#8217;s stockholders.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Article II<br/>
      DEFINITIONS</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For purposes of the Plan, the following terms
      shall have the following meanings:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.1</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Acquisition Event</span>&#8221;&#160;</b>has the meaning set forth in Section&#160;4.2(d).</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.2</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Affiliate</span>&#8221;&#160;</b>means each of the following: (a)&#160;any Subsidiary; (b)&#160;any Parent; (c) any corporation, trade or business (including, without limitation, a partnership or limited liability
      company) which is directly or indirectly controlled 50% or more (whether by ownership of stock, assets or an equivalent ownership interest or voting interest) by the Company or one of its Affiliates; (d)&#160;any trade or business (including, without
      limitation, a partnership or limited liability company) which directly or indirectly controls 50% or more (whether by ownership of stock, assets or an equivalent ownership interest or voting interest) of the Company; and (e)&#160;any other entity in which
      the Company or any of its Affiliates has a material equity interest and which is designated as an &#8220;Affiliate&#8221; by resolution of the Committee; provided that, unless otherwise determined by the Committee, the Common Stock subject to any Award
      constitutes &#8220;service recipient stock&#8221; for purposes of Section&#160;409A of the Code or otherwise does not subject the Award to Section 409A of the Code.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.3</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Award</span>&#8221;&#160;</b>means any award under the Plan of any Stock Option, Stock Appreciation Right, Restricted Stock, Performance Award, Other Stock-Based Award or Other Cash-Based Award. All Awards
      shall be granted by, confirmed by, and subject to the terms of, a written agreement executed by the Company and the Participant.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.4</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Award Agreement</span>&#8221;&#160;</b>means the written or electronic agreement setting forth the terms and conditions applicable to an Award.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.5</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Board</span>&#8221;&#160;</b>means the Board of Directors of the Company.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.6</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Cause</span>&#8221;&#160;</b>means, unless otherwise provided by the Committee in the applicable Award Agreement, with respect to a Participant&#8217;s Termination of Employment or Termination of Consultancy,
      the following: (a)&#160;in the case where there is no employment agreement, consulting agreement, change in control agreement or similar agreement in effect between the Company or an Affiliate and the Participant at the time of the grant of the Award (or
      where there is such an agreement but it does not define &#8220;cause&#8221; (or words of like import)), termination due to a (i)&#160;willful or serious misconduct or gross negligence in the performance of the Participant&#8217;s duties to the Company; (ii) willful or
      repeated failure to satisfactorily perform the Participant&#8217;s duties to the Company or to follow the lawful directives of the Board or any executive or supervisor to which the Participant reports (other than as a result of death or due to Disability);
      (iii)&#160;commission of, indictment for, conviction of, or pleading of guilty or nolo contendere to, a felony or any crime involving moral turpitude; (iv)&#160;performance of any act of theft, embezzlement, fraud, malfeasance, dishonesty or misappropriation
      of the Company&#8217;s property; or (v)&#160;breach of, or failure to comply with, any material agreement with the Company, or a violation of the Company&#8217;s code of conduct or other written policy; or (b)&#160;in the case where there is an employment agreement,
      consulting agreement, change in control agreement or similar agreement in effect between the Company or an Affiliate and the Participant at the time of the grant of the Award that defines &#8220;cause&#8221; (or words of like import), &#8220;cause&#8221; as defined under
      such agreement; provided, however, that with regard to any agreement under which the definition of &#8220;cause&#8221; only applies on occurrence of a change in control, such definition of &#8220;cause&#8221; shall not apply until a change in control actually takes place
      and then only with regard to a termination thereafter. With respect to a Participant&#8217;s Termination of Directorship, &#8220;cause&#8221; means an act or failure to act that constitutes cause for removal of a director under applicable Delaware law.</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-1</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.7</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Change in Control</span>&#8221;&#160;</b>has the meaning set forth in 11.2.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.8</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Change in Control Price</span>&#8221;&#160;</b>has the meaning set forth in Section&#160;11.1.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.9</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Code</span>&#8221;&#160;</b>means the Internal Revenue Code of 1986, as amended. Any reference to any section of the Code shall also be a reference to any successor provision and any treasury regulation
      promulgated thereunder.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.10</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Committee</span>&#8221;&#160;</b>means any committee of the Board duly authorized by the Board to administer the Plan. If no committee is duly authorized by the Board to administer the Plan, the term
      &#8220;Committee&#8221; shall be deemed to refer to the Board for all purposes under the Plan.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.11</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Common Stock</span>&#8221;&#160;</b>means the common stock, $0.01 par value per share, of the Company.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.12</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Company</span>&#8221;&#160;</b>means Acadia Healthcare Company, Inc., a Delaware corporation, and its successors by operation of law.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.13</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Consultant</span>&#8221;&#160;</b>means any Person who is an advisor or consultant to the Company or its Affiliates.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.14</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Disability</span>&#8221;&#160;</b>means, unless otherwise provided by the Committee in the applicable Award Agreement, with respect to a Participant&#8217;s Termination, a permanent and total disability as
      defined in Section&#160;22(e)(3) of the Code. Notwithstanding the foregoing, for Awards that are subject to Section&#160;409A of the Code, Disability shall mean that a Participant is disabled under Section&#160;409A(a)(2)(C)(i) or (ii)&#160;of the Code.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.15</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Effective Date</span>&#8221;&#160;</b>means the effective date of the Plan as defined in Article&#160;XV.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.16</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Eligible Employees</span>&#8221;&#160;</b>means each employee of the Company or an Affiliate.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.17</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Eligible Individual</span>&#8221;&#160;</b>means any Eligible Employee, Non-Employee Director or Consultant.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.18</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Exchange Act</span>&#8221;&#160;</b>means the Securities Exchange Act of 1934, as amended. Reference to a specific section of the Exchange Act or regulation thereunder shall include such section or
      regulation, any valid regulation or interpretation promulgated under such section, and any comparable provision of any future legislation or regulation amending, supplementing or superseding such section or regulation.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.19</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Fair Market Value</span>&#8221;&#160;</b>means, for purposes of the Plan, unless otherwise required by any applicable provision of the Code or any regulations issued thereunder, as of any date and except
      as provided below, the last sales price reported for the Common Stock on the applicable date: (a)&#160;as reported on the principal national securities exchange in the United States on which it is then traded or (b)&#160;if the Common Stock is not traded,
      listed or otherwise reported or quoted, the Committee shall determine in good faith the Fair Market Value in whatever manner it considers appropriate taking into account the requirements of Section&#160;409A of the Code. For purposes of the grant of any
      Award, the applicable date shall be the trading day immediately prior to the date on which the Award is granted. For purposes of the exercise of any Award, the applicable date shall be the date a notice of exercise is received by the Committee or, if
      not a day on which the applicable market is open, the next day that it is open.</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-2</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.20</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Family Member</span>&#8221;&#160;</b>means &#8220;family member&#8221; as defined in Section&#160;A.1.(a)(5) of the general instructions of Form S-8.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.21</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Incentive Stock Option</span>&#8221;&#160;</b>means any Stock Option awarded to an Eligible Employee of the Company, its Subsidiaries and its Parents (if any) under the Plan intended to be and designated
      as an &#8220;Incentive Stock Option&#8221; within the meaning of Section&#160;422 of the Code.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.22</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Limited Stock Appreciation Right</span>&#8221;</b> means a Stock Appreciation Right described in Section 7.5 of the Plan.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.23</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Non-Employee Director</span>&#8221;&#160;</b>means a director or a member of the Board of the Company or any Affiliate who is not an active employee of the Company or any Affiliate.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.24</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Non-Qualified Stock Option</span>&#8221;&#160;</b>means any Stock Option awarded under the Plan that is not an Incentive Stock Option.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.25</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Non-Tandem Stock Appreciation Right</span>&#8221;&#160;</b>shall mean the right to receive an amount in cash and/or stock equal to the difference between (x)&#160;the Fair Market Value of a share of Common
      Stock on the date such right is exercised, and (y)&#160;the aggregate exercise price of such right, otherwise than on surrender of a Stock Option.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.26</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Other Cash-Based Award</span>&#8221;&#160;</b>means an Award granted pursuant to Section&#160;10.3 of the Plan and payable in cash at such time or times and subject to such terms and conditions as provided by
      the Committee in the applicable Award Agreement.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.27</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Other Stock-Based Award</span>&#8221;&#160;</b>means an Award under Article&#160;X of the Plan that is valued in whole or in part by reference to, or is payable in or otherwise based on, Common Stock,
      including, without limitation, an Award valued by reference to an Affiliate.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.28</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Parent</span>&#8221;&#160;</b>means any parent corporation of the Company within the meaning of Section 424(e) of the Code.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.29</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Participant</span>&#8221;&#160;</b>means an Eligible Individual to whom an Award has been granted pursuant to the Plan.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.30</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Performance Award</span>&#8221;&#160;</b>means an Award granted to a Participant pursuant to Article IX hereof contingent upon achieving certain Performance Goals.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.31</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Performance Goals</span>&#8221;&#160;</b>means goals established by the Committee as contingencies for Awards to vest and/or become exercisable or distributable based on one or more of the performance
      goals set forth in&#160;<span style="text-decoration:underline">Exhibit&#160;A</span>&#160;hereto.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.32</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Performance Period</span>&#8221;&#160;</b>means the period designated during which the Performance Goals must be satisfied with respect to the Award to which the Performance Goals relate.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.33</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Person</span>&#8221; </b>means an individual, a partnership, a corporation, a limited liability company, an association, a joint stock company, a trust, a joint venture, an unincorporated
      organization and a government or any branch, department, agency, political subdivision or official thereof.</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-3</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.34</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Plan</span>&#8221;&#160;</b>means this Incentive Compensation Plan, as amended from time to time.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.35</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Reference Stock Option</span>&#8221;&#160;</b>has the meaning set forth in Section&#160;7.1.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.36</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Restricted Stock</span>&#8221;&#160;</b>means an Award of shares of Common Stock under the Plan that is subject to restrictions under Article&#160;VIII.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.37</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Restriction Period</span>&#8221;&#160;</b>has the meaning set forth in Section&#160;8.3(a) with respect to Restricted Stock.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.38</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Rule&#160;16b-3</span>&#8221;&#160;</b>means Rule&#160;16b-3 under Section 16(b) of the Exchange Act as then in effect or any successor provision.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.39</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Section&#160;409A of the Code</span>&#8221;&#160;</b>means the nonqualified deferred compensation rules under Section&#160;409A of the Code and any applicable treasury regulations and other official guidance
      thereunder.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.40</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Securities Act</span>&#8221;&#160;</b>means the Securities Act of 1933, as amended and all rules and regulations promulgated thereunder. Reference to a specific section of the Securities Act or regulation
      thereunder shall include such section or regulation, any valid regulation or interpretation promulgated under such section, and any comparable provision of any future legislation or regulation amending, supplementing or superseding such section or
      regulation.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.41</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Stock Appreciation Right</span>&#8221;&#160;</b>shall mean the right pursuant to an Award granted under Article&#160;VII.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.42</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Stock Option</span>&#8221;&#160;</b>or&#160;<b>&#8220;<span style="text-decoration:underline">Option</span>&#8221;&#160;</b>means any option to purchase shares of Common Stock granted to Eligible Individuals granted pursuant to Article&#160;VI.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.43</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Subsidiary</span>&#8221;&#160;</b>means any subsidiary corporation of the Company within the meaning of Section 424(f) of the Code.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.44</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Tandem Stock Appreciation Right</span>&#8221;&#160;</b>shall mean the right to surrender to the Company all (or a portion) of a Stock Option in exchange for an amount in cash and/or stock equal to the
      difference between (i)&#160;the Fair Market Value on the date such Stock Option (or such portion thereof) is surrendered, of the Common Stock covered by such Stock Option (or such portion thereof), and (ii)&#160;the aggregate exercise price of such Stock
      Option (or such portion thereof).</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.45</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Ten Percent Stockholder</span>&#8221;&#160;</b>means a Person owning stock possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company, its Subsidiaries
      or its Parent.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.46</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Termination</span>&#8221;&#160;</b>means a Termination of Consultancy, Termination of Directorship or Termination of Employment, as applicable.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.47</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Termination of Consultancy</span>&#8221;&#160;</b>means: (a)&#160;that the Consultant is no longer acting as a consultant to the Company or an Affiliate; or (b)&#160;when an entity which is retaining a Participant
      as a Consultant ceases to be an Affiliate unless the Participant otherwise is, or thereupon becomes, a Consultant to the Company or another Affiliate at the time the entity ceases to be an Affiliate. In the event that a Consultant becomes an Eligible
      Employee or a Non-Employee Director upon the termination of such Consultant&#8217;s consultancy, no Termination of Consultancy shall be deemed to occur until such time as such Consultant is no longer a Consultant, an Eligible Employee or a Non-Employee
      Director. Notwithstanding the foregoing, the Committee may otherwise define Termination of Consultancy in the Award Agreement or, if no rights of a Participant are reduced, may otherwise define Termination of Consultancy thereafter, provided that any
      such change to the definition of the term &#8220;Termination of Consultancy&#8221; does not subject the applicable Award to Section&#160;409A of the Code.</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-4</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.48</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Termination of Directorship</span>&#8221;&#160;</b>means that the Non-Employee Director has ceased to be a director of the Company; except that if a Non-Employee Director becomes an Eligible Employee or a
      Consultant upon the termination of such Non-Employee Director&#8217;s directorship, such Non-Employee Director&#8217;s ceasing to be a director of the Company shall not be treated as a Termination of Directorship unless and until the Participant has a
      Termination of Employment or Termination of Consultancy, as the case may be.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.49</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Termination of Employment</span>&#8221;&#160;</b>means: (a)&#160;a termination of employment (for reasons other than a military or personal leave of absence granted by the Company) of a Participant from the
      Company and its Affiliates; or (b)&#160;when an entity which is employing a Participant ceases to be an Affiliate, unless the Participant otherwise is, or thereupon becomes, employed by the Company or another Affiliate at the time the entity ceases to be
      an Affiliate. In the event that an Eligible Employee becomes a Consultant or a Non-Employee Director upon the termination of such Eligible Employee&#8217;s employment, no Termination of Employment shall be deemed to occur until such time as such Eligible
      Employee is no longer an Eligible Employee, a Consultant or a Non-Employee Director. Notwithstanding the foregoing, the Committee may otherwise define Termination of Employment in the Award Agreement or, if no rights of a Participant are reduced, may
      otherwise define Termination of Employment thereafter, provided that any such change to the definition of the term &#8220;Termination of Employment&#8221; does not subject the applicable Award to Section&#160;409A of the Code.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2.50</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b>&#8220;<span style="text-decoration:underline">Transfer</span>&#8221;&#160;</b>means: (a)&#160;when used as a noun, any direct or indirect transfer, sale, assignment, pledge, hypothecation, encumbrance or other disposition (including the issuance of equity
      in any entity), whether for value or no value and whether voluntary or involuntary (including by operation of law), and (b)&#160;when used as a verb, to directly or indirectly transfer, sell, assign, pledge, encumber, charge, hypothecate or otherwise
      dispose of (including the issuance of equity in any entity) whether for value or for no value and whether voluntarily or involuntarily (including by operation of law). &#8220;Transferred&#8221; and &#8220;Transferable&#8221; shall have a correlative meaning.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Article III<br/>
      ADMINISTRATION</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.1</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b><span style="text-decoration:underline">The Committee</span></b>. The Plan shall be administered and interpreted by the Committee. To the extent required by applicable law, rule or regulation, it is intended that each member of the
      Committee shall qualify as (a)&#160;a &#8220;non-employee director&#8221; under Rule&#160;16b-3, and (b)&#160; an &#8220;independent director&#8221; under the rules of any national securities exchange or national securities association, as applicable. If it is later determined that one or
      more members of the Committee do not so qualify, actions taken by the Committee prior to such determination shall be valid despite such failure to qualify.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.2</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b><span style="text-decoration:underline">Grants of Awards</span></b>. The Committee shall have full authority to grant, pursuant to the terms of the Plan, to Eligible Individuals: (i)&#160;Stock Options; (ii)&#160;Stock Appreciation Rights;
      (iii)&#160;Restricted Stock; (iv)&#160;Performance Awards; (v)&#160;Other Stock-Based Awards; and (vi)&#160;Other Cash-Based Awards. In particular, the Committee shall have the authority:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to select the Eligible
      Individuals to whom Awards may from time to time be granted hereunder;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to determine whether and
      to what extent Awards, or any combination thereof, are to be granted hereunder to one or more Eligible Individuals;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to determine the number of
      shares of Common Stock to be covered by each Award granted hereunder;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(d) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to determine the terms and conditions, not inconsistent with the terms of the Plan, of any Award
    granted hereunder (including, but not limited to, the exercise or purchase price (if any), any restriction or limitation, any vesting schedule or acceleration thereof, or any forfeiture restrictions or waiver thereof, regarding any Award and the shares
    of Common Stock relating thereto, based on such factors, if any, as the Committee shall determine);</p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-5</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to determine the amount of
      cash to be covered by each Award granted hereunder;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to determine whether, to
      what extent and under what circumstances grants of Options and other Awards under the Plan are to operate on a tandem basis and/or in conjunction with or apart from other awards made by the Company outside of the Plan;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to determine whether and
      under what circumstances a Stock Option may be settled in cash, Common Stock and/or Restricted Stock under Section&#160;6.4(d);</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to determine whether a
      Stock Option is an Incentive Stock Option or Non-Qualified Stock Option;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to determine whether to
      require a Participant, as a condition of the granting of any Award, to not sell or otherwise dispose of shares acquired pursuant to the exercise of an Award for a period of time as determined by the Committee following the date of the acquisition or
      exercise of such Award;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to modify, extend or
      renew an Award, subject to Article&#160;XII and Section&#160;6.4(l), provided, however, that such action does not subject the Award to Section&#160;409A of the Code without the consent of the Participant; and</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;solely to the extent
      permitted by applicable law, to determine whether, to what extent and under what circumstances to provide loans (which may be on a recourse basis and shall bear interest at the rate the Committee shall provide) to Participants in order to exercise
      Options under the Plan.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>3.3</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Guidelines</span></b>.
    Subject to Article&#160;XII hereof, the Committee shall have the authority to adopt, alter and repeal such administrative rules, guidelines and practices governing the Plan and perform all acts, including the delegation of its responsibilities (to the
    extent permitted by applicable law and applicable stock exchange rules), as it shall, from time to time, deem advisable; to construe and interpret the terms and provisions of the Plan and any Award issued under the Plan (and any agreements relating
    thereto); and to otherwise supervise the administration of the Plan. The Committee may correct any defect, supply any omission or reconcile any inconsistency in the Plan or in any agreement relating thereto in the manner and to the extent it shall deem
    necessary to effectuate the purpose and intent of the Plan. The Committee may adopt special guidelines and provisions for Persons who are residing in or employed in, or subject to, the taxes of, any domestic or foreign jurisdictions to comply with
    applicable tax and securities laws of such domestic or foreign jurisdictions. Notwithstanding the foregoing, no action of the Committee under this Section&#160;3.3 shall impair the rights of any Participant without the Participant&#8217;s consent. To the extent
    applicable, the Plan is intended to comply with the applicable requirements of Rule&#160;16b-3, and the Plan shall be limited, construed and interpreted in a manner so as to comply therewith.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.4</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b><span style="text-decoration:underline">Decisions Final</span></b>. Any decision, interpretation or other action made or taken in good faith by or at the direction of the Company, the Board or the Committee (or any of its members)
      arising out of or in connection with the Plan shall be within the absolute discretion of all and each of them, as the case may be, and shall be final, binding and conclusive on the Company and all employees and Participants and their respective
      heirs, executors, administrators, successors and assigns.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.5</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b><span style="text-decoration:underline">Procedures</span></b>. If the Committee is appointed, the Board shall designate one of the members of the Committee as chairman and the Committee shall hold meetings, subject to the By-Laws of
      the Company, at such times and places as it shall deem advisable, including, without limitation, by telephone conference or by written consent to the extent permitted by applicable law. A majority of the Committee members shall constitute a quorum.
      All determinations of the Committee shall be made by a majority of its members. Any decision or determination reduced to writing and signed by all of the Committee members in accordance with the By-Laws of the Company, shall be fully effective as if
      it had been made by a vote at a meeting duly called and held. The Committee shall keep minutes of its meetings and shall make such rules and regulations for the conduct of its business as it shall deem advisable.</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-6</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0.5in"/>
        <td style="width: 0.5in; text-align: left"><b>3.6</b></td>
        <td><b><span style="text-decoration:underline">Designation of Consultants/Liability</span></b>.</td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Committee may
      designate employees of the Company and professional advisors to assist the Committee in the administration of the Plan and (to the extent permitted by applicable law and applicable exchange rules) may grant authority to officers to grant Awards
      and/or execute agreements or other documents on behalf of the Committee. In the event of any designation of authority hereunder, subject to applicable law, applicable stock exchange rules and any limitations imposed by the Committee in connection
      with such designation, such designee or designees shall have the power and authority to take such actions, exercise such powers and make such determinations that are otherwise specifically designated to the Committee hereunder.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Committee may employ
      such legal counsel, consultants and agents as it may deem desirable for the administration of the Plan and may rely upon any opinion received from any such counsel or consultant and any computation received from any such consultant or agent. Expenses
      incurred by the Committee or the Board in the engagement of any such counsel, consultant or agent shall be paid by the Company. The Committee, its members and any Person designated pursuant to sub-section (a)&#160;above shall not be liable for any action
      or determination made in good faith with respect to the Plan. To the maximum extent permitted by applicable law, no officer of the Company or member or former member of the Committee or of the Board shall be liable for any action or determination
      made in good faith with respect to the Plan or any Award granted under it.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.7 &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Indemnification</span></b>. To the
      maximum extent permitted by applicable law and the Certificate of Incorporation and By-Laws of the Company and to the extent not covered by insurance directly insuring such person, each officer or employee of the Company or any Affiliate and member
      or former member of the Committee or the Board shall be indemnified and held harmless by the Company against any cost or expense (including reasonable fees of counsel reasonably acceptable to the Committee) or liability (including any sum paid in
      settlement of a claim with the approval of the Committee), and advanced amounts necessary to pay the foregoing at the earliest time and to the fullest extent permitted, arising out of any act or omission to act in connection with the administration
      of the Plan, except to the extent arising out of such officer&#8217;s, employee&#8217;s, member&#8217;s or former member&#8217;s own fraud or bad faith. Such indemnification shall be in addition to any right of indemnification the employees, officers, directors or members
      or former officers, directors or members may have under applicable law or under the Certificate of Incorporation or By-Laws of the Company or any Affiliate. Notwithstanding anything else herein, this indemnification will not apply to the actions or
      determinations made by an individual with regard to Awards granted to such individual under the Plan.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Article IV<br/>
      SHARE LIMITATION</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0.5in"/>
        <td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.1</b></span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration:underline">Shares</span></b>.</span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The aggregate number of
      shares of Common Stock that may be issued or used for reference purposes or with respect to which Awards may be granted under the Plan shall not exceed 12,700,000 shares (subject to any increase or decrease pursuant to Section 4.2), which may be
      either authorized and unissued Common Stock or Common Stock held in or acquired for the treasury of the Company or both. The maximum number of shares of Common Stock with respect to which Incentive Stock Options may be granted under the Plan shall be
      12,700,000 shares. Notwithstanding any provision of the Plan to the contrary, the following shares of Common Stock shall not be added to the shares authorized for grant under Section 4.1(a) and the individual share limitations of Section 4.1(b) and
      shall not be available for future grants of Awards: (i) shares of Common Stock tendered by a Participant or withheld by the Company in payment of the exercise price of an Option, (ii) shares of Common Stock tendered by a Participant or withheld by
      the Company to satisfy any tax withholding obligation with respect to an Award, (iii) shares of Common Stock subject to a Stock Appreciation Right that are not issued in connection with the stock settlement of the Stock Appreciation Right on exercise
      thereof and (iv) shares of Common Stock purchased by the Company with the cash proceeds from the exercise of Options. If any Option, Stock Appreciation Right or Other Stock-Based Awards granted under the Plan expires, terminates or is canceled for
      any reason without having been exercised in full, the number of shares of Common Stock underlying any unexercised Award shall again be available for the purpose of Awards under the Plan. If any shares of Restricted Stock, Performance Awards or Other
      Stock-Based Awards denominated in shares of Common Stock awarded under the Plan to a Participant are forfeited for any reason, the number of forfeited shares of Restricted Stock, Performance Awards or Other Stock-Based Awards denominated in shares of
      Common Stock shall again be available for purposes of Awards under the Plan. If a Tandem Stock Appreciation Right or a Limited Stock Appreciation Right is granted in tandem with an Option, such grant shall only apply once against the maximum number
      of shares of Common Stock which may be issued under the Plan. Any Award under the Plan settled in cash shall not be counted against the foregoing maximum share limitations. <span style="background-color: white">In no event will dividends or dividend
        equivalents be granted with respect to unvested Awards, except that the Committee may provide in the applicable Award Agreement at the time of grant that the payment of dividends shall be deferred until, and conditioned upon, vesting of the Award</span>.</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-7</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 1in"/>
        <td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration:underline">Individual Participant Limitations</span>.</span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The maximum number of shares
      of Common Stock subject to any Award of Stock Options, or Stock Appreciation Rights, or shares of Restricted Stock, or Other Stock-Based Awards for which the grant of such Award or the lapse of the relevant Restriction Period is subject to the
      attainment of Performance Goals in accordance with Section&#160;8.3(a)(ii) which may be granted under the Plan during any fiscal year of the Company to any Participant shall be 750,000 shares per type of Award (which shall be subject to any further
      increase or decrease pursuant to Section&#160;4.2), and the maximum number of shares of Common Stock for all types of Awards does not exceed 1,500,000 shares (which shall be subject to any further increase or decrease pursuant to Section&#160;4.2) during any
      fiscal year of the Company. If a Tandem Stock Appreciation Right is granted or a Limited Stock Appreciation Right is granted in tandem with a Stock Option, it shall apply against the Participant&#8217;s individual share limitations for both Stock
      Appreciation Rights and Stock Options.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;There are no annual
      individual share limitations applicable to Participants on Restricted Stock or Other Stock-Based Awards for which the grant, vesting or payment (as applicable) of any such Award is not subject to the attainment of Performance Goals.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The maximum number of shares
      of Common Stock subject to any Performance Award which may be granted under the Plan during any fiscal year of the Company to any Participant shall be 750,000 shares (which shall be subject to any further increase or decrease pursuant to Section&#160;4.2)
      with respect to any fiscal year of the Company.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The maximum value of a cash
      payment made under a Performance Award which may be granted under the Plan with respect to any fiscal year of the Company to any Participant shall be $10,000,000.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The individual Participant
      limitations set forth in this Section&#160;4.1(b) (other than Section&#160;4.1(b)(iii)) shall be cumulative; that is, to the extent that shares of Common Stock for which Awards are permitted to be granted to a Participant during a fiscal year are not covered
      by an Award to such Participant in a fiscal year, the number of shares of Common Stock available for Awards to such Participant shall automatically increase in the subsequent fiscal years during the term of the Plan until used.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0.5in"/>
        <td style="width: 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.2</b></span></td>
        <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration:underline">Changes</span></b>.</span></td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The existence of the Plan
      and the Awards granted hereunder shall not affect in any way the right or power of the Board or the stockholders of the Company to make or authorize (i)&#160;any adjustment, recapitalization, reorganization or other change in the Company&#8217;s capital
      structure or its business, (ii)&#160;any merger or consolidation of the Company or any Affiliate, (iii)&#160;any issuance of bonds, debentures, preferred or prior preference stock ahead of or affecting the Common Stock, (iv)&#160;the dissolution or liquidation of
      the Company or any Affiliate, (v)&#160;any sale or transfer of all or part of the assets or business of the Company or any Affiliate or (vi)&#160;any other corporate act or proceeding.</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-8</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to the provisions
      of Section&#160;4.2(d), if there shall occur any such change in the capital structure of the Company by reason of any stock split, reverse stock split, stock dividend, subdivision, combination or reclassification of shares that may be issued under the
      Plan, any recapitalization, any merger, any consolidation, any spin off, any reorganization or any partial or complete liquidation, or any other corporate transaction or event having an effect similar to any of the foregoing (a &#8220;<span style="text-decoration:underline">Section&#160;4.2 Event</span>&#8221;),








      then (i)&#160;the aggregate number and/or kind of shares that thereafter may be issued under the Plan, (ii)&#160;the number and/or kind of shares or other property (including cash) to be issued upon exercise of an outstanding Award granted under the Plan,
      and/or (iii)&#160;the purchase price thereof, shall be appropriately adjusted. In addition, subject to Section&#160;4.2(d), if there shall occur any change in the capital structure or the business of the Company that is not a Section&#160;4.2 Event (an &#8220;<span style="text-decoration:underline">Other
        Extraordinary Event</span>&#8221;), including by reason of any extraordinary dividend (whether cash or stock), any conversion, any adjustment, any issuance of any class of securities convertible or exercisable into, or exercisable for, any class of stock,
      or any sale or transfer of all or substantially all of the Company&#8217;s assets or business, then the Committee, in its sole discretion, may adjust any Award and make such other adjustments to the Plan. Any adjustment pursuant to this Section&#160;4.2 shall
      be consistent with the applicable Section&#160;4.2 Event or the applicable Other Extraordinary Event, as the case may be, and in such manner as the Committee may, in its sole discretion, deem appropriate and equitable to prevent substantial dilution or
      enlargement of the rights granted to, or available for, Participants under the Plan. Any such adjustment determined by the Committee shall be final, binding and conclusive on the Company and all Participants and their respective heirs, executors,
      administrators, successors and permitted assigns. Except as expressly provided in this Section&#160;4.2 or in the applicable Award Agreement, a Participant shall have no rights by reason of any Section 4.2 Event or any Other Extraordinary Event.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fractional shares of
      Common Stock resulting from any adjustment in Awards pursuant to Section&#160;4.2(a) or 4.2(b) shall be aggregated until, and eliminated at, the time of exercise by rounding-down for fractions less than one-half and rounding-up for fractions equal to or
      greater than one-half. No cash settlements shall be made with respect to fractional shares eliminated by rounding. Notice of any adjustment shall be given by the Committee to each Participant whose Award has been adjusted and such adjustment (whether
      or not such notice is given) shall be effective and binding for all purposes of the Plan.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In the event of a merger
      or consolidation in which the Company is not the surviving entity or in the event of any transaction that results in the acquisition of substantially all of the Company&#8217;s outstanding Common Stock by a single person or entity or by a group of persons
      and/or entities acting in concert, or in the event of the sale or transfer of all or substantially all of the Company&#8217;s assets (all of the foregoing being referred to as an &#8220;<span style="text-decoration:underline">Acquisition Event</span>&#8221;), then the Committee may, in its sole discretion,
      terminate all outstanding and unexercised Stock Options, Stock Appreciation Rights, or any Other Stock-Based Award that provides for a Participant elected exercise, effective as of the date of the Acquisition Event, by (i)&#160;cashing-out such Awards
      upon the date of consummation of the Acquisition Event, or (ii)&#160;delivering notice of termination to each Participant at least 20&#160;days prior to the date of consummation of the Acquisition Event, in which case during the period from the date on which
      such notice of termination is delivered to the consummation of the Acquisition Event, each such Participant shall have the right to exercise in full all of such Participant&#8217;s Awards that are then outstanding (without regard to any limitations on
      exercisability otherwise contained in the Award Agreements), but any such exercise shall be contingent on the occurrence of the Acquisition Event, and, provided that, if the Acquisition Event does not take place within a specified period after giving
      such notice for any reason whatsoever, the notice and exercise pursuant thereto shall be null and void.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If an Acquisition Event occurs but the Committee
      does not terminate the outstanding Awards pursuant to this Section&#160;4.2(d), then the provisions of Section&#160;4.2(b) and Article&#160;XI shall apply.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>4.3</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b><span style="text-decoration:underline">Minimum Purchase Price</span></b>. Notwithstanding any provision of the Plan to the contrary, if authorized but previously unissued shares of Common Stock are issued under the Plan, such shares
      shall not be issued for a consideration that is less than as permitted under applicable law.</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-9</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Article V<br/>
      ELIGIBILITY</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.1</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b><span style="text-decoration:underline">General Eligibility</span></b>. All current and prospective Eligible Individuals are eligible to be granted Awards. Eligibility for the grant of Awards and actual participation in the Plan shall
      be determined by the Committee.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.2</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b><span style="text-decoration:underline">Incentive Stock Options</span></b>. Notwithstanding the foregoing, only Eligible Employees of the Company, its Subsidiaries and its Parent (if any) are eligible to be granted Incentive Stock
      Options under the Plan. Eligibility for the grant of an Incentive Stock Option and actual participation in the Plan shall be determined by the Committee.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.3</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b><span style="text-decoration:underline">General Requirement</span></b>. The vesting and exercise of Awards granted to a prospective Eligible Individual are conditioned upon such individual actually becoming an Eligible Employee,
      Consultant or Non-Employee Director, respectively.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Article VI<br/>
      STOCK OPTIONS</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.1</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b><span style="text-decoration:underline">Options</span></b>. Stock Options may be granted alone or in addition to other Awards granted under the Plan. Each Stock Option granted under the Plan shall be of one of two types: (a) an
      Incentive Stock Option or (b)&#160;a Non-Qualified Stock Option.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>6.2</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Grants</span></b>.
    The Committee shall have the authority to grant to any Eligible Employee one or more Incentive Stock Options, Non-Qualified Stock Options, or both types of Stock Options. The Committee shall have the authority to grant any Consultant or Non-Employee
    Director one or more Non-Qualified Stock Options. To the extent that any Stock Option does not qualify as an Incentive Stock Option (whether because of its provisions or the time or manner of its exercise or otherwise), such Stock Option or the portion
    thereof which does not so qualify shall constitute a separate Non-Qualified Stock Option.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>6.3</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b><span style="text-decoration:underline">Incentive Stock Options</span></b>. Notwithstanding anything in the Plan to the contrary, no term of the Plan relating to Incentive Stock Options shall be interpreted, amended or altered, nor
      shall any discretion or authority granted under the Plan be so exercised, so as to disqualify the Plan under Section&#160;422 of the Code, or, without the consent of the Participants affected, to disqualify any Incentive Stock Option under such
      Section&#160;422.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>6.4</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Terms






        of Options</span></b>. Options granted under the Plan shall be subject to the following terms and conditions and shall be in such form and contain such additional terms and conditions, not inconsistent with the terms of the Plan, as the Committee
    shall deem desirable:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(a) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Exercise Price</span>. The exercise price per share of Common Stock subject to a Stock Option shall
    be provided by the Committee in the applicable Award Agreement at the time of grant, provided that the per share exercise price of a Stock Option shall not be less than 100% (or, in the case of an Incentive Stock Option granted to a Ten Percent
    Stockholder, 110%) of the Fair Market Value of the Common Stock at the time of grant.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Stock Option Term</span>.
      The term of each Stock Option shall be fixed by the Committee, provided that no Stock Option shall be exercisable more than 10&#160;years after the date the Option is granted; and provided further that the term of an Incentive Stock Option granted to a
      Ten Percent Stockholder shall not exceed five years.</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-10</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Exercisability</span>.
      Unless otherwise provided by the Committee in accordance with the provisions of this Section&#160;6.4, Stock Options granted under the Plan shall be exercisable at such time or times and subject to such terms and conditions as shall be provided by the
      Committee in the applicable Award Agreement at the time of grant. If the Committee provides, in its discretion, that any Stock Option is exercisable subject to certain limitations (including, without limitation, that such Stock Option is exercisable
      only in installments or within certain time periods), the Committee may waive such limitations on the exercisability at any time at or after the time of grant in whole or in part (including, without limitation, waiver of the installment exercise
      provisions or acceleration of the time at which such Stock Option may be exercised), based on such factors, if any, as the Committee shall determine.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Method of Exercise</span>.
      Subject to whatever installment exercise and waiting period provisions apply under Section&#160;6.4(c), to the extent vested, Stock Options may be exercised in whole or in part at any time during the Option term, by giving written notice of exercise to
      the Company specifying the number of shares of Common Stock to be purchased. Such notice shall be accompanied by payment in full of the purchase price as follows: (i)&#160;in cash or by check, bank draft or money order payable to the order of the Company;
      (ii)&#160;solely to the extent permitted by applicable law, if the Common Stock is traded on a national securities exchange, and the Committee authorizes, through a procedure whereby the Participant delivers irrevocable instructions to a broker reasonably
      acceptable to the Committee to deliver promptly to the Company an amount equal to the purchase price; or (iii)&#160;on such other terms and conditions as may be acceptable to the Committee (including, without limitation, having the Company withhold shares
      of Common Stock issuable upon exercise of the Stock Option, or by payment in full or in part in the form of Common Stock owned by the Participant, based on the Fair Market Value of the Common Stock on the payment date as determined by the Committee).
      No shares of Common Stock shall be issued until payment therefor, as provided herein, has been made or provided for.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Non-Transferability of
        Options</span>. No Stock Option shall be Transferable by the Participant other than by will or by the laws of descent and distribution, and all Stock Options shall be exercisable, during the Participant&#8217;s lifetime, only by the Participant.
      Notwithstanding the foregoing, the Committee may provide in the applicable Award Agreement at the time of grant or thereafter that a Non-Qualified Stock Option that is otherwise not Transferable pursuant to this Section is Transferable to a Family
      Member or such other Person or entity in whole or in part and in such circumstances, and under such conditions, as specified by the Committee. A Non-Qualified Stock Option that is Transferred to a Family Member or such other Person or entity pursuant
      to the preceding sentence (i)&#160;may not be subsequently Transferred other than by will or by the laws of descent and distribution and (ii)&#160;remains subject to the terms of the Plan and the applicable Award Agreement. Any shares of Common Stock acquired
      upon the exercise of a Non-Qualified Stock Option by a permissible transferee of a Non-Qualified Stock Option or a permissible transferee pursuant to a Transfer after the exercise of the Non-Qualified Stock Option shall be subject to the terms of the
      Plan and the applicable Award Agreement.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Termination by Death
        and Disability</span>. Unless otherwise provided by the Committee in the applicable Award Agreement at the time of grant, or if no rights of the Participant are reduced, thereafter, if a Participant&#8217;s Termination is by reason of death or Disability,
      all Stock Options that are held by such Participant that are vested and exercisable at the time of the Participant&#8217;s Termination may be exercised by the Participant at any time within a period of one year from the date of such Termination, but in no
      event beyond the expiration of the stated term of such Stock Options; provided, however, that, following a termination by reason of Disability, if the Participant dies within such exercise period, all unexercised Stock Options held by such
      Participant shall thereafter be exercisable, to the extent to which they were exercisable at the time of death, for a period of one year from the date of such death, but in no event beyond the expiration of the stated term of such Stock Options.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Involuntary Termination
        Without Cause</span>. Unless otherwise provided by the Committee in the applicable Award Agreement at the time of grant, or if no rights of the Participant are reduced, thereafter, if a Participant&#8217;s Termination is by involuntary termination by the
      Company without Cause, all Stock Options that are held by such Participant that are vested and exercisable at the time of the Participant&#8217;s Termination may be exercised by the Participant at any time within a period of 90&#160;days from the date of such
      Termination, but in no event beyond the expiration of the stated term of such Stock Options.</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-11</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Voluntary Termination</span>.
      Unless otherwise provided by the Committee in the applicable Award Agreement at the time of grant, or if no rights of the Participant are reduced, thereafter, if a Participant&#8217;s Termination is voluntary (other than a voluntary termination described
      in Section&#160;6.4(i)(y) hereof), all Stock Options that are held by such Participant that are vested and exercisable at the time of the Participant&#8217;s Termination may be exercised by the Participant at any time within a period of 30&#160;days from the date of
      such Termination, but in no event beyond the expiration of the stated term of such Stock Options.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Termination for Cause</span>.
      Unless otherwise provided by the Committee in the applicable Award Agreement at the time of grant, or if no rights of the Participant are reduced, thereafter, if a Participant&#8217;s Termination (x)&#160;is for Cause or (y)&#160;is a voluntary Termination (as
      provided in Section&#160;6.4(h)) after the occurrence of an event that would be grounds for a Termination for Cause, all Stock Options, whether vested or not vested, that are held by such Participant shall thereupon terminate and expire as of the date of
      such Termination.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Unvested Stock Options</span>.
      Unless otherwise provided by the Committee in the applicable Award Agreement at the time of grant, or if no rights of the Participant are reduced, thereafter, Stock Options that are not vested as of the date of a Participant&#8217;s Termination for any
      reason shall terminate and expire as of the date of such Termination.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Incentive Stock Option
        Limitations</span>. To the extent that the aggregate Fair Market Value (determined as of the time of grant) of the Common Stock with respect to which Incentive Stock Options are exercisable for the first time by an Eligible Employee during any
      calendar year under the Plan and/or any other stock option plan of the Company, any Subsidiary or any Parent exceeds $100,000, such Options shall be treated as Non-Qualified Stock Options. Should any provision of the Plan not be necessary in order
      for the Stock Options to qualify as Incentive Stock Options, or should any additional provisions be required, the Committee may amend the Plan accordingly, without the necessity of obtaining the approval of the stockholders of the Company.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Form of Stock Options;
        No Re-Pricing</span>. Subject to the terms and conditions and within the limitations of the Plan, Stock Options shall be evidenced by such form of agreement or grant as is approved by the Committee.&#160;Except as provided in Section&#160;4.2 or Article XII,
      without stockholder approval the Committee shall not be permitted to (i) amend an outstanding Stock Option to lower or reduce the exercise price thereof; (ii) cancel an outstanding Stock Option when the exercise price per share exceeds the Fair
      Market Value of the underlying shares in exchange for cash or another Award for the purpose of re-pricing the Stock Option; or (iii) cancel or accept the surrender of an outstanding Stock Option in exchange for a Stock Option with an exercise price
      that is less than the exercise price of the cancelled or surrendered Award.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Deferred Delivery of
        Common Shares</span><i>.&#160;</i>The Committee may in its discretion permit Participants to defer delivery of Common Stock acquired pursuant to a Participant&#8217;s exercise of an Option in accordance with the terms and conditions established by the Committee
      in the applicable Award Agreement, which shall be intended to comply with the requirements of Section&#160;409A of the Code.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Early Exercise</span>. The
      Committee may provide that a Stock Option include a provision whereby the Participant may elect at any time before the Participant&#8217;s Termination to exercise the Stock Option as to any part or all of the shares of Common Stock subject to the Stock
      Option prior to the full vesting of the Stock Option and such shares shall be subject to the provisions of Article&#160;VIII and be treated as Restricted Stock. Unvested shares of Common Stock so purchased may be subject to a repurchase option in favor of
      the Company or to any other restriction the Committee determines to be appropriate.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Cashing-Out of Stock
        Options</span>. Unless otherwise provided in the Award Agreement, on receipt of written notice of exercise, the Committee may elect to cash-out all or part of the portion of the shares for which an Option is being exercised by paying the optionee an
      amount, in cash or shares of Common Stock, equal to the excess of the Fair Market Value of the shares of Common Stock over the exercise price multiplied by the number of shares of Common Stock for which the Option is being exercised on the effective
      date of such cash-out.</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-12</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Other Terms and
        Conditions</span>. The Committee may include a provision in an Award Agreement providing for the automatic exercise of a Non-Qualified Stock Option on a cashless basis on the last day of the term of such Option if the Participant has failed to
      exercise the Non-Qualified Stock Option as of such date, with respect to which the Fair Market Value of the shares of Common Stock underlying the Non-Qualified Stock Option exceeds the exercise price of such Non-Qualified Stock Option on the date of
      expiration of such Option, subject to Section&#160;14.4. Stock Options may contain such other provisions, which shall not be inconsistent with any of the terms of the Plan, as the Committee shall deem appropriate.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Article VII<br/>
      STOCK APPRECIATION RIGHTS</b></span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.1</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b><span style="text-decoration:underline">Tandem Stock Appreciation Rights</span></b>. Stock Appreciation Rights may be granted in conjunction with all or part of any Stock Option (a &#8220;<span style="text-decoration:underline">Reference Stock Option</span>&#8221;) granted under the
      Plan (&#8220;<span style="text-decoration:underline">Tandem Stock Appreciation Rights</span>&#8221;). In the case of a Non-Qualified Stock Option, such rights may be granted either at or after the time of the grant of such Reference Stock Option. In the case of an Incentive Stock Option, such rights
      may be granted only at the time of the grant of such Reference Stock Option.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.2</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b><span style="text-decoration:underline">Terms and Conditions of Tandem Stock Appreciation Rights</span></b>. Tandem Stock Appreciation Rights granted hereunder shall be subject to such terms and conditions, not inconsistent with the
      provisions of the Plan, as shall be provided by the Committee in the applicable Award Agreement at the time of grant, and the following:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Exercise Price</span>. The
      exercise price per share of Common Stock subject to a Tandem Stock Appreciation Right shall be provided by the Committee in the applicable Award Agreement at the time of grant, provided that the per share exercise price of a Tandem Stock Appreciation
      Right shall not be less than 100% of the Fair Market Value of the Common Stock at the time of grant.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Term</span>. A Tandem
      Stock Appreciation Right or applicable portion thereof granted with respect to a Reference Stock Option shall terminate and no longer be exercisable upon the termination or exercise of the Reference Stock Option, except that, unless otherwise
      provided by the Committee in the applicable Award Agreement at the time of grant, a Tandem Stock Appreciation Right granted with respect to less than the full number of shares covered by the Reference Stock Option shall not be reduced until, and then
      only to the extent that the exercise or termination of the Reference Stock Option causes, the number of shares covered by the Tandem Stock Appreciation Right to exceed the number of shares remaining available and unexercised under the Reference Stock
      Option.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Exercisability</span>.
      Tandem Stock Appreciation Rights shall be exercisable only at such time or times and to the extent that the Reference Stock Options to which they relate shall be exercisable in accordance with the provisions of Article&#160;VI, and shall be subject to the
      provisions of Section&#160;6.4(c).</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Method of Exercise</span>.
      A Tandem Stock Appreciation Right may be exercised by the Participant by surrendering the applicable portion of the Reference Stock Option. Upon such exercise and surrender, the Participant shall be entitled to receive an amount determined in the
      manner prescribed in this Section&#160;7.2. Stock Options which have been so surrendered, in whole or in part, shall no longer be exercisable to the extent that the related Tandem Stock Appreciation Rights have been exercised.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Payment</span>. Upon the
      exercise of a Tandem Stock Appreciation Right, a Participant shall be entitled to receive up to, but no more than, an amount in cash and/or Common Stock (as chosen by the Committee) equal in value to the excess of the Fair Market Value of one share
      of Common Stock over the Option exercise price per share specified in the Reference Stock Option agreement multiplied by the number of shares of Common Stock in respect of which the Tandem Stock Appreciation Right shall have been exercised, with the
      Committee having the right to determine the form of payment.</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-13</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Deemed Exercise of
        Reference Stock Option</span>. Upon the exercise of a Tandem Stock Appreciation Right, the Reference Stock Option or part thereof to which such Stock Appreciation Right is related shall be deemed to have been exercised for the purpose of the
      limitation set forth in Article&#160;IV of the Plan on the number of shares of Common Stock to be issued under the Plan.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Non-Transferability</span>.
      Tandem Stock Appreciation Rights shall be Transferable only when and to the extent that the underlying Stock Option would be Transferable under Section&#160;6.4(e) of the Plan.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.3</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b><span style="text-decoration:underline">Non-Tandem Stock Appreciation Rights</span></b>. Non-Tandem Stock Appreciation Rights may also be granted without reference to any Stock Options granted under the Plan.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.4</b></span></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><span style="font-family: Times New Roman, Times, Serif;"><b><span style="text-decoration:underline">Terms and Conditions of Non-Tandem Stock Appreciation Rights</span></b>. Non-Tandem Stock Appreciation Rights granted hereunder shall be subject to such terms and conditions, not inconsistent
      with the provisions of the Plan, as shall be provided by the Committee in the applicable Award Agreement at the time of grant, and the following:</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Exercise Price</span>. The
      exercise price per share of Common Stock subject to a Non-Tandem Stock Appreciation Right shall be provided by the Committee in the applicable Award Agreement at the time of grant, provided that the per share exercise price of a Non-Tandem Stock
      Appreciation Right shall not be less than 100% of the Fair Market Value of the Common Stock at the time of grant.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Term</span>. The term of
      each Non-Tandem Stock Appreciation Right shall be fixed by the Committee, but shall not be greater than 10&#160;years after the date the right is granted.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Exercisability</span>. In
      accordance with the provisions of this Section&#160;7.4, Non-Tandem Stock Appreciation Rights granted under the Plan shall be exercisable at such time or times and subject to such terms and conditions as shall be provided by the Committee in the
      applicable Award Agreement at the time of grant. If the Committee provides, in its discretion, that any such right is exercisable subject to certain limitations (including, without limitation, that it is exercisable only in installments or within
      certain time periods), the Committee may waive such limitations on the exercisability at any time at or after grant in whole or in part (including, without limitation, waiver of the installment exercise provisions or acceleration of the time at which
      such right may be exercised), based on such factors, if any, as the Committee shall determine.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Method of Exercise</span>.
      Subject to whatever installment exercise and waiting period provisions apply under Section&#160;7.4(c), Non-Tandem Stock Appreciation Rights may be exercised in whole or in part at any time in accordance with the applicable Award Agreement, by giving
      written notice of exercise to the Company specifying the number of Non-Tandem Stock Appreciation Rights to be exercised.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Payment</span>. Upon the
      exercise of a Non-Tandem Stock Appreciation Right a Participant shall be entitled to receive, for each right exercised, up to, but no more than, an amount in cash and/or Common Stock (as chosen by the Committee) equal in value to the excess of the
      Fair Market Value of one share of Common Stock on the date that the right is exercised over the Fair Market Value of one share of Common Stock on the date that the right was awarded to the Participant.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f) &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Termination</span>. Unless
      otherwise provided by the Committee in the applicable Award Agreement at the time of grant or, if no rights of the Participant are reduced, thereafter, subject to the provisions of the applicable Award Agreement and the Plan, upon a Participant&#8217;s
      Termination for any reason, Non-Tandem Stock Appreciation Rights will remain exercisable following a Participant&#8217;s Termination on the same basis as Stock Options would be exercisable following a Participant&#8217;s Termination in accordance with the
      provisions of Sections&#160;6.4(f) through 6.4(j).</span></p><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-14</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px">&#160;</p><div>
  </div><p style="margin: 0"></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(g)<span style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="text-decoration:underline">Non-Transferability</span>. No Non-Tandem Stock Appreciation
    Rights shall be Transferable by the Participant other than by will or by the laws of descent and distribution, and all such rights shall be exercisable, during the Participant&#8217;s lifetime, only by the Participant.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>7.5</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Limited






        Stock Appreciation Rights</span></b>. The Committee may grant Tandem and Non-Tandem Stock Appreciation Rights either as a general Stock Appreciation Right or as a Limited Stock Appreciation Right. Limited Stock Appreciation Rights may be exercised
    only upon the occurrence of a Change in Control or such other event as the Committee may designate at the time of grant or thereafter. Upon the exercise of Limited Stock Appreciation Rights, except as otherwise provided in an Award Agreement, the
    Participant shall receive in cash and/or Common Stock, an amount equal to the amount (i)&#160;set forth in Section&#160;7.2(e) with respect to Tandem Stock Appreciation Rights, or (ii)&#160;set forth in Section&#160;7.4(e) with respect to Non-Tandem Stock Appreciation
    Rights.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>7.6</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Cashing-Out






        of Stock Appreciation Rights</span></b>. Unless otherwise provided in the Award Agreement, on receipt of written notice of exercise, the Committee may elect to cash-out all or part of the portion of the shares underlying a Stock Appreciation Right by
    paying the holder an amount, in cash or shares of Common Stock, equal to the excess of the Fair Market Value of the shares of Common Stock over the base price multiplied by the number of shares of Common Stock for which the Stock Appreciation Right is
    being exercised on the effective date of such cash-out.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>7.7</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Other






        Terms and Conditions</span></b>. The Committee may include a provision in an Award Agreement providing for the automatic exercise of a Stock Appreciation Right on a cashless basis on the last day of the term of such Stock Appreciation Right if the
    Participant has failed to exercise the Stock Appreciation Right as of such date, with respect to which the Fair Market Value of the shares of Common Stock underlying the Stock Appreciation Right exceeds the exercise price of such Stock Appreciation
    Right on the date of expiration of such Stock Appreciation Right, subject to Section&#160;14.4. Stock Appreciation Rights may contain such other provisions, which shall not be inconsistent with any of the terms of the Plan, as the Committee shall deem
    appropriate. Except as provided in Section 4.2 or Article XII, and notwithstanding any other provision, without stockholder approval the Committee shall not be permitted to (i) amend an outstanding Stock Appreciation Right to lower or reduce the
    exercise price thereof; (ii) cancel an outstanding Stock Appreciation Right when the exercise price per share exceeds the Fair Market Value of the underlying shares in exchange for cash or another Award for the purpose of re-pricing the Stock
    Appreciation Right; or (iii) cancel or accept the surrender of an outstanding Stock Appreciation Right in exchange for a Stock Appreciation Right with an exercise price that is less than the exercise price of the cancelled or surrendered Award.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Article VIII<br/>
    RESTRICTED STOCK</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>8.1</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Awards






        of Restricted Stock</span></b>. Shares of Restricted Stock may be issued either alone or in addition to other Awards granted under the Plan. The Committee shall determine the Eligible Individuals, to whom, and the time or times at which, grants of
    Restricted Stock shall be made, the number of shares to be awarded, the price (if any) to be paid by the Participant (subject to Section&#160;8.2), the time or times within which such Awards may be subject to forfeiture, the vesting schedule and rights to
    acceleration thereof, and all other terms and conditions of the Awards.&#160;&#160;&#160;&#160;&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">The Committee may condition the grant or vesting of Restricted Stock upon the attainment of specified performance targets
    (including, the Performance Goals) or such other factor as the Committee may determine.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">Restricted Stock for which the grant is conditioned on Performance Goals or other factors may be referred to as &#8220;Restricted
    Stock Units.&#8221;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-15</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>8.2</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Awards






        and Certificates</span></b>. Eligible Individuals selected to receive Restricted Stock shall not have any right with respect to such Award, unless and until such Participant has delivered a fully executed copy of the agreement evidencing the Award to
    the Company, to the extent required by the Committee, and has otherwise complied with the applicable terms and conditions of such Award. Further, such Award shall be subject to the following conditions:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(a)<span style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="text-decoration:underline">Purchase Price</span>. The purchase price of Restricted Stock
    shall be fixed by the Committee. Subject to Section&#160;4.3, the purchase price for shares of Restricted Stock may be zero to the extent permitted by applicable law, and, to the extent not so permitted, such purchase price may not be less than par value.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(b)<span style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="text-decoration:underline">Acceptance</span>. Awards of Restricted Stock must be accepted
    within a period of 60 days (or such shorter period as the Committee may specify at grant) after the grant date, by executing a Restricted Stock agreement and by paying whatever price (if any) the Committee has designated thereunder.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(c)<span style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="text-decoration:underline">Legend</span>. Each Participant receiving Restricted Stock
    shall be issued a stock certificate in respect of such shares of Restricted Stock, unless the Committee elects to use another system, such as book entries by the transfer agent, as evidencing ownership of shares of Restricted Stock. Such certificate
    shall be registered in the name of such Participant, and shall, in addition to such legends required by applicable securities laws, bear an appropriate legend referring to the terms, conditions, and restrictions applicable to such Award, substantially
    in the following form:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; background-color: white">&#8220;The anticipation, alienation, attachment, sale, transfer, assignment, pledge, encumbrance or charge of the shares of stock
    represented hereby are subject to the terms and conditions (including forfeiture) of the Acadia Healthcare Company, Inc. (the &#8220;Company&#8221;) Incentive Compensation Plan (the &#8220;Plan&#8221;) and an Agreement entered into between the registered owner and the Company
    dated _________. Copies of such Plan and Agreement are on file at the principal office of the Company.&#8221;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(d)<span style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="text-decoration:underline">Custody</span>. If stock certificates are issued in respect of
    shares of Restricted Stock, the Committee may require that any stock certificates evidencing such shares be held in custody by the Company until the restrictions thereon shall have lapsed, and that, as a condition of any grant of Restricted Stock, the
    Participant shall have delivered a duly signed stock power or other instruments of assignment (including a power of attorney), each endorsed in blank with a guarantee of signature if deemed necessary or appropriate by the Company, which would permit
    transfer to the Company of all or a portion of the shares subject to the Restricted Stock Award in the event that such Award is forfeited in whole or part.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>8.3</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Restrictions






        and Conditions</span></b>. The shares of Restricted Stock awarded pursuant to the Plan shall be subject to the following restrictions and conditions:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 1in">(a)<span style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="text-decoration:underline">Restriction Period</span>.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in; background-color: white">(i)&#160;The Participant shall not be permitted to Transfer shares of Restricted Stock awarded under the Plan during the
    period or periods set by the Committee (the &#8220;<span style="text-decoration:underline">Restriction Period</span>&#8221;) commencing on the date of such Award, as set forth in the Restricted Stock Award Agreement and such agreement shall set forth a vesting schedule and any event that would
    accelerate vesting of the shares of Restricted Stock. Within these limits, based on service, attainment of Performance Goals pursuant to Section&#160;8.3(a)(ii) and/or such other factors or criteria as the Committee may determine, the Committee may
    condition the grant or provide for the lapse of such restrictions in installments in whole or in part, or may accelerate the vesting of all or any part of any Restricted Stock Award and/or waive the deferral limitations for all or any part of any
    Restricted Stock Award.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in; background-color: white">(ii)&#160;If the grant of shares of Restricted Stock or the lapse of restrictions is based on the attainment of
    Performance Goals, the Committee shall establish the objective Performance Goals and the applicable vesting percentage of the Restricted Stock applicable to each Participant or class of Participants in writing prior to the beginning of the applicable
    fiscal year or at such later date as otherwise determined by the Committee and while the outcome of the Performance Goals are substantially uncertain. Such Performance Goals may incorporate provisions for disregarding (or adjusting for) changes in
    accounting methods, corporate transactions (including, without limitation, dispositions and acquisitions) and other similar type events or circumstances.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in; background-color: white"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-16</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Rights as a Stockholder</span>. <span style="background-color: white">Except as provided in Section
      8.3(a) with respect to the Restriction Period and this Section 8.3(b) with respect to dividends or as otherwise provided by the Committee in the applicable Award Agreement at the time of grant, the Participant shall have, with respect to the shares
      of Restricted Stock, all of the rights of a holder of shares of Common Stock of the Company, including, without limitation, the right to vote such shares and, subject to and conditioned upon the full vesting of shares of Restricted Stock, the right
      to tender such shares. Notwithstanding the foregoing and any provision of the Plan to the contrary, in no event will dividends or dividend equivalents be granted with respect to unvested shares of Restricted Stock, except that the Committee may
      provide in the applicable Award Agreement at the time of grant that the payment of dividends shall be deferred until, and conditioned upon, vesting of the shares of Restricted Stock.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Termination</span>. Unless otherwise provided by the Committee in the applicable Award Agreement at
    grant or, if no rights of the Participant are reduced, thereafter, subject to the applicable provisions of the Award Agreement and the Plan, upon a Participant&#8217;s Termination for any reason during the relevant Restriction Period, all Restricted Stock
    still subject to restriction will be forfeited in accordance with the terms and conditions established by the Committee at grant or thereafter.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(d)<span style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="text-decoration:underline">Lapse of Restrictions</span>. If and when the Restriction
    Period expires without a prior forfeiture of the Restricted Stock, the certificates for such shares shall be delivered to the Participant. All legends shall be removed from said certificates at the time of delivery to the Participant, except as
    otherwise required by applicable law or other limitations imposed by the Committee.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Article IX<br/>
    PERFORMANCE AWARDS</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>9.1</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Performance






        Awards</span></b>. The Committee may grant a Performance Award to a Participant payable upon the attainment of specific Performance Goals. If the Performance Award is payable in shares of Restricted Stock, such shares shall be transferable to the
    Participant only upon attainment of the relevant Performance Goal in accordance with Article&#160;VIII. If the Performance Award is payable in cash, it may be paid upon the attainment of the relevant Performance Goals either in cash or in shares of
    Restricted Stock (based on the then current Fair Market Value of such shares), as provided by the Committee in the applicable Award Agreement at the time of grant. Each Performance Award shall be evidenced by an Award Agreement in such form that is not
    inconsistent with the Plan and that the Committee may from time to time approve.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>9.2</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Terms






        and Conditions</span></b>. Performance Awards awarded pursuant to this Article&#160;IX shall be subject to the following terms and conditions:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(a)<span style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="text-decoration:underline">Earning of Performance Award</span>. At the expiration of the
    applicable Performance Period, the Committee shall determine the extent to which the Performance Goals are achieved and the percentage of each Performance Award that has been earned.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Non-Transferability</span>. Subject to the applicable provisions of the Award Agreement and the
    Plan, Performance Awards may not be Transferred during the Performance Period.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Objective Performance Goals, Formulae or Standards</span>. The Committee shall establish the
    objective Performance Goals for the earning of Performance Awards based on a Performance Period applicable to each Participant or class of Participants in writing while the outcome of the Performance Goals are substantially uncertain. Such Performance
    Goals may incorporate provisions for disregarding (or adjusting for) changes in accounting methods, corporate transactions (including, without limitation, dispositions and acquisitions) and other similar type events or circumstances.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-17</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Dividends</span>. <span style="background-color: white">Amounts equal to dividends declared during
      the Performance Period with respect to the number of shares of Common Stock covered by a Performance Award will not be paid to the Participant, except that the Committee may provide in the applicable Award Agreement at the time of grant that the
      payment of dividends shall be deferred until, and conditioned upon, vesting of the Performance Award.</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Payment</span>. Following the Committee&#8217;s determination in accordance with Section 9.2(a), the
    Company shall settle Performance Awards, in such form (including, without limitation, in shares of Common Stock or in cash) as determined by the Committee, in an amount equal to such Participant&#8217;s earned Performance Awards.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Termination</span>. Subject to the applicable provisions of the Award Agreement and the Plan, upon a
    Participant&#8217;s Termination for any reason during the Performance Period for a given Performance Award, the Performance Award in question will vest or be forfeited in accordance with the terms and conditions established by the Committee at grant.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Accelerated Vesting</span>. Based on service, performance and/or such other factors or criteria, if
    any, as the Committee may determine, the Committee may, at or after grant, accelerate the vesting of all or any part of any Performance Award.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Article X<br/>
    OTHER STOCK-BASED AND CASH-BASED AWARDS</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>10.1</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Other






        Stock-Based Awards</span></b>. The Committee is authorized to grant to Eligible Individuals Other Stock-Based Awards that are payable in, valued in whole or in part by reference to, or otherwise based on or related to shares of Common Stock, including
    but not limited to, shares of Common Stock awarded purely as a bonus and not subject to restrictions or conditions, shares of Common Stock in payment of the amounts due under an incentive or performance plan sponsored or maintained by the Company or an
    Affiliate (including nonmanagement director compensation paid at the election of a director in shares of Common Stock in lieu of cash), stock equivalent units, restricted stock units, and Awards valued by reference to book value of shares of Common
    Stock. Other Stock-Based Awards may be granted either alone or in addition to or in tandem with other Awards granted under the Plan.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">Subject to the provisions of the Plan, the Committee shall have authority to determine the Eligible Individuals, to whom,
    and the time or times at which, such Awards shall be made, the number of shares of Common Stock to be awarded pursuant to such Awards, and all other conditions of the Awards. The Committee may also provide for the grant of Common Stock under such
    Awards upon the completion of a specified Performance Period.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">The Committee may condition the grant or vesting of Other Stock-Based Awards upon the attainment of specified Performance
    Goals as the Committee may determine. Such Performance Goals may incorporate provisions for disregarding (or adjusting for) changes in accounting methods, corporate transactions (including, without limitation, dispositions and acquisitions) and other
    similar type events or circumstances.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>10.2</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Terms






        and Conditions</span></b>. Other Stock-Based Awards made pursuant to this Article&#160;X shall be subject to the following terms and conditions:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Non-Transferability</span>. Subject to the applicable provisions of the Award Agreement and the
    Plan, shares of Common Stock subject to Awards made under this Article&#160;X may not be Transferred prior to the date on which the shares are issued, or, if later, the date on which any applicable restriction, performance or deferral period lapses.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Dividends</span>. <span style="background-color: white">The recipient of an Award under this
      Article X shall not be entitled to receive dividends or dividend equivalents in respect of the number of shares of Common Stock covered by the Award, except that the Committee may provide in the applicable Award Agreement at the time of grant that
      the payment of dividends shall be deferred until, and conditioned upon, vesting of the Award</span>.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-18</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Vesting</span>. Any Award under this Article&#160;X and any Common Stock covered by any such Award shall
    vest or be forfeited to the extent so provided in the Award Agreement.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration:underline">Price</span>. Common Stock issued on a bonus basis under this Article&#160;X may be issued for no cash
    consideration. Common Stock purchased pursuant to a purchase right awarded under this Article&#160;X shall be priced, as determined by the Committee.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>10.3</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Other






        Cash-Based Awards</span></b>. The Committee is authorized to grant to Eligible Individuals Other Cash-Based Awards in such amounts, on such terms and conditions, and for such consideration, including no consideration or such minimum consideration as
    may be required by applicable law. Other Cash-Based Awards may be granted subject to the satisfaction of vesting conditions or may be awarded purely as a bonus and not subject to restrictions or conditions, and if subject to vesting conditions, the
    Committee may accelerate the vesting of such Awards at any time. The grant of an Other Cash-Based Award shall not require a segregation of any of the Company&#8217;s assets for satisfaction of the Company&#8217;s payment obligation thereunder.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white">Subject to the provisions of the Plan, the Committee shall have authority to determine the Eligible Individuals, to whom,
    and the time or times at which, such Other Cash-Based Awards shall be made, the amounts to be awarded pursuant to such Awards, and all other conditions of the Awards. The Committee may also provide for the grant of Cash-Based Awards upon the completion
    of a specified Performance Period.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">The Committee may condition the grant or vesting of Other Cash-Based Awards upon the attainment of specified Performance
    Goals as the Committee may determine. Such Performance Goals may incorporate provisions for disregarding (or adjusting for) changes in accounting methods, corporate transactions (including, without limitation, dispositions and acquisitions) and other
    similar type events or circumstances.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Article XI<br/>
    CHANGE IN CONTROL PROVISIONS</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>11.1</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Benefits</span></b>.
    In the event of a Change in Control of the Company (as defined below), and except as otherwise provided by the Committee in an Award Agreement, a Participant&#8217;s unvested Award shall not vest automatically and a Participant&#8217;s Award shall be treated in
    accordance with one of the following methods as determined by the Committee:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Awards, whether or not then vested, shall be continued, assumed, have new rights substituted
    therefor or be treated in accordance with Section&#160;4.2(d) hereof, as determined by the Committee, and restrictions to which shares of Restricted Stock or any other Award granted prior to the Change in Control are subject shall not lapse upon a Change in
    Control and the Restricted Stock or other Award shall, where appropriate in the sole discretion of the Committee, receive the same distribution as other Common Stock on such terms as determined by the Committee; provided that the Committee may decide
    to award additional Restricted Stock or other Awards in lieu of any cash distribution. Notwithstanding anything to the contrary herein, for purposes of Incentive Stock Options, any assumed or substituted Stock Option shall comply with the requirements
    of Treasury Regulation&#160;Section&#160;1.424-1 (and any amendment thereto).</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Committee, in its sole discretion, may provide for the purchase of any Awards by the Company or
    an Affiliate for an amount of cash equal to the excess of the Change in Control Price (as defined below) of the shares of Common Stock covered by such Awards, over the aggregate exercise price of such Awards. For purposes of this Section&#160;11.1, &#8220;<span style="text-decoration:underline">Change








      in Control Price</span>&#8221; shall mean the highest price per share of Common Stock paid in any transaction related to a Change in Control of the Company.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notwithstanding any other provision herein to the contrary, the Committee may, in its sole
    discretion, provide for accelerated vesting or lapse of restrictions, of an Award at any time.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-19</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>11.2</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Change






        in Control</span></b>. Unless otherwise provided by the Committee in the applicable Award Agreement at the time of grant or other written agreement approved by the Committee, a &#8220;Change in Control&#8221; shall be deemed to occur if:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any &#8220;person,&#8221; as such term is used in Sections 13(d) and 14(d) of the Exchange Act (other than the
    Company, any trustee or other fiduciary holding securities under any employee benefit plan of the Company, or any company owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of
    Common Stock of the Company), becoming the beneficial owner (as defined in Rule&#160;13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing 50% or more of the combined voting power of the Company&#8217;s then outstanding
    securities;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;during any period of two consecutive years, individuals who at the beginning of such period
    constitute the Board, and any new director (other than a director designated by a person who has entered into an agreement with the Company to effect a transaction described in paragraph (a), (c), or (d)&#160;of this Section&#160;11.2 or a director whose initial
    assumption of office occurs as a result of either an actual or threatened election contest (as such term is used in Rule&#160;14a-11 of Regulation&#160;14A promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by
    or on behalf of a person other than the Board) whose election by the Board or nomination for election by the Company&#8217;s stockholders was approved by a vote of at least two-thirds of the directors then still in office who either were directors at the
    beginning of the two-year period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority of the Board;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a merger or consolidation of the Company with any other corporation, other than a merger or
    consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than 50%
    of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation; provided, however, that a merger or consolidation effected to implement a recapitalization of the
    Company (or similar transaction) in which no person (other than those covered by the exceptions in Section&#160;11.2(a)) acquires more than 50% of the combined voting power of the Company&#8217;s then outstanding securities shall not constitute a Change in
    Control of the Company; or</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a complete liquidation or dissolution of the Company or the consummation of a sale or disposition by
    the Company of all or substantially all of the Company&#8217;s assets other than the sale or disposition of all or substantially all of the assets of the Company to a person or persons who beneficially own, directly or indirectly, 50% or more of the combined
    voting power of the outstanding voting securities of the Company at the time of the sale.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white">Notwithstanding the foregoing, with respect to any Award that is characterized as &#8220;nonqualified deferred compensation&#8221;
    within the meaning of Section&#160;409A of the Code, an event shall not be considered to be a Change in Control under the Plan for purposes of payment of such Award unless such event is also a &#8220;change in ownership,&#8221; a &#8220;change in effective control&#8221; or a
    &#8220;change in the ownership of a substantial portion of the assets&#8221; of the Company within the meaning of Section&#160;409A of the Code.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Article XII<br/>
    TERMINATION OR AMENDMENT OF PLAN</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>12.1</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Termination






        or Amendment</span></b>. Notwithstanding any other provision of the Plan, the Board may at any time, and from time to time, amend, in whole or in part, any or all of the provisions of the Plan (including any amendment deemed necessary to ensure that
    the Company may comply with any regulatory requirement referred to in Article&#160;XIV or Section&#160;409A of the Code), or suspend or terminate it entirely, retroactively or otherwise; provided, however, that, unless otherwise required by law or specifically
    provided herein, the rights of a Participant with respect to Awards granted prior to such amendment, suspension or termination, may not be impaired without the consent of such Participant and, provided further, that without the approval of the holders
    of the Company&#8217;s Common Stock entitled to vote in accordance with applicable law, no amendment may be made that would (i)&#160;increase the aggregate number of shares of Common Stock that may be issued under the Plan (except by operation of Section&#160;4.2);
    (ii)&#160;increase the maximum individual Participant limitations for a fiscal year under Section&#160;4.1(b) (except by operation of Section 4.2); (iii)&#160;change the classification of individuals eligible to receive Awards under the Plan; (iv)&#160;decrease the
    minimum option price of any Stock Option or Stock Appreciation Right; (v)&#160;extend the maximum option period under Section&#160;6.4; (vi)&#160;alter the Performance Goals for Restricted Stock, Performance Awards, Other Stock-Based Awards or Other Cash-Based Awards
    as set forth in&#160;<span style="text-decoration:underline">Exhibit&#160;A</span>&#160;hereto; (vii) award any Stock Option or Stock Appreciation Right in replacement of a canceled Stock Option or Stock Appreciation Right with a higher exercise price than the replacement award, except in accordance with
    Section&#160;6.4(l); or (viii)&#160;require stockholder approval in order for the Plan to continue to comply with the applicable provisions of, to the extent applicable to Incentive Stock Options, Section&#160;422 of the Code. In no event may the Plan be amended
    without the approval of the stockholders of the Company in accordance with the applicable laws of the State of Delaware to increase the aggregate number of shares of Common Stock that may be issued under the Plan, decrease the minimum exercise price of
    any Award, or to make any other amendment that would require stockholder approval under the rules of any exchange or system on which the Company&#8217;s securities are listed or traded at the request of the Company. Notwithstanding anything herein to the
    contrary, the Board may amend the Plan or any Award Agreement at any time without a Participant&#8217;s consent to comply with applicable law including Section&#160;409A of the Code.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-20</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">The Committee may amend the terms of any Award theretofore granted, prospectively or retroactively, but, subject to
    Article&#160;IV or as otherwise specifically provided herein, no such amendment or other action by the Committee shall impair the rights of any holder without the holder&#8217;s consent.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Article XIII<br/>
    UNFUNDED STATUS OF PLAN</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">The Plan is intended to constitute an &#8220;unfunded&#8221; plan for incentive and deferred compensation. With respect to any payment
    as to which a Participant has a fixed and vested interest but which are not yet made to a Participant by the Company, nothing contained herein shall give any such Participant any right that is greater than those of a general unsecured creditor of the
    Company.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Article XIV<br/>
    GENERAL PROVISIONS</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>14.1</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Legend</span></b>.
    The Committee may require each Person receiving shares of Common Stock pursuant to a Stock Option or other Award under the Plan to represent to and agree with the Company in writing that the Participant is acquiring the shares without a view to
    distribution thereof. In addition to any legend required by the Plan, the certificates for such shares may include any legend that the Committee deems appropriate to reflect any restrictions on Transfer. All certificates for shares of Common Stock
    delivered under the Plan shall be subject to such stop transfer orders and other restrictions as the Committee may deem advisable under the rules, regulations and other requirements of the Securities and Exchange Commission, any stock exchange upon
    which the Common Stock is then listed or any national securities exchange system upon whose system the Common Stock is then quoted, any applicable federal or state securities law, and any applicable corporate law, and the Committee may cause a legend
    or legends to be put on any such certificates to make appropriate reference to such restrictions.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>14.2</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Other






        Plans</span></b>. Nothing contained in the Plan shall prevent the Board from adopting other or additional compensation arrangements, subject to stockholder approval if such approval is required, and such arrangements may be either generally applicable
    or applicable only in specific cases.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>14.3</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">No
        Right to Employment/Directorship/Consultancy</span></b>. Neither the Plan nor the grant of any Option or other Award hereunder shall give any Participant or other employee, Consultant or Non-Employee Director any right with respect to continuance of
    employment, consultancy or directorship by the Company or any Affiliate, nor shall there be a limitation in any way on the right of the Company or any Affiliate by which an employee is employed or a Consultant or Non-Employee Director is retained to
    terminate such employment, consultancy or directorship at any time.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-21</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>14.4</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Withholding






        of Taxes</span></b>. The Company shall have the right to deduct from any payment to be made pursuant to the Plan, or to otherwise require, prior to the issuance or delivery of shares of Common Stock or the payment of any cash hereunder, payment by the
    Participant of, any federal, state or local taxes required by law to be withheld. Upon the vesting of Restricted Stock (or other Award that is taxable upon vesting), or upon making an election under Section 83(b) of the Code, a Participant shall pay
    all required withholding to the Company. Any statutorily required withholding obligation with regard to any Participant may be satisfied, subject to the consent of the Committee, by reducing the number of shares of Common Stock otherwise deliverable or
    by delivering shares of Common Stock already owned. Any fraction of a share of Common Stock required to satisfy such tax obligations shall be disregarded and the amount due shall be paid instead in cash by the Participant.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>14.5</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">No
        Assignment of Benefits</span></b>. No Award or other benefit payable under the Plan shall, except as otherwise specifically provided by law or permitted by the Committee, be Transferable in any manner, and any attempt to Transfer any such benefit
    shall be void, and any such benefit shall not in any manner be liable for or subject to the debts, contracts, liabilities, engagements or torts of any Person who shall be entitled to such benefit, nor shall it be subject to attachment or legal process
    for or against such Person.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>14.6</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Listing






        and Other Conditions</span></b>.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unless otherwise determined by the Committee, as long as the Common Stock is listed on a national
    securities exchange or system sponsored by a national securities association, the issuance of shares of Common Stock pursuant to an Award shall be conditioned upon such shares being listed on such exchange or system. The Company shall have no
    obligation to issue such shares unless and until such shares are so listed, and the right to exercise any Option or other Award with respect to such shares shall be suspended until such listing has been effected.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If at any time counsel to the Company shall be of the opinion that any sale or delivery of shares of
    Common Stock pursuant to an Option or other Award is or may in the circumstances be unlawful or result in the imposition of excise taxes on the Company under the statutes, rules or regulations of any applicable jurisdiction, the Company shall have no
    obligation to make such sale or delivery, or to make any application or to effect or to maintain any qualification or registration under the Securities Act or otherwise, with respect to shares of Common Stock or Awards, and the right to exercise any
    Option or other Award shall be suspended until, in the opinion of said counsel, such sale or delivery shall be lawful or will not result in the imposition of excise taxes on the Company.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Upon termination of any period of suspension under this Section&#160;14.6, any Award affected by such
    suspension which shall not then have expired or terminated shall be reinstated as to all shares available before such suspension and as to shares which would otherwise have become available during the period of such suspension, but no such suspension
    shall extend the term of any Award.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;A Participant shall be required to supply the Company with certificates, representations and
    information that the Company requests and otherwise cooperate with the Company in obtaining any listing, registration, qualification, exemption, consent or approval the Company deems necessary or appropriate.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>14.7</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Stockholders






        Agreement and Other Requirements</span></b>. Notwithstanding anything herein to the contrary, as a condition to the receipt of shares of Common Stock pursuant to an Award under the Plan, to the extent required by the Committee, the Participant shall
    execute and deliver a stockholder&#8217;s agreement or such other documentation that shall set forth certain restrictions on transferability of the shares of Common Stock acquired upon exercise or purchase, and such other terms as the Board or Committee
    shall from time to time establish. Such stockholder&#8217;s agreement or other documentation shall apply to the Common Stock acquired under the Plan and covered by such stockholder&#8217;s agreement or other documentation. The Company may require, as a condition
    of exercise, the Participant to become a party to any other existing stockholder agreement (or other agreement).</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-22</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>14.8</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Governing






        Law</span></b>. The Plan and actions taken in connection herewith shall be governed and construed in accordance with the laws of the State of Delaware (regardless of the law that might otherwise govern under applicable Delaware principles of conflict
    of laws).</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>14.9</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Jurisdiction;






        Waiver of Jury Trial</span></b>. Any suit, action or proceeding with respect to the Plan or any Award Agreement, or any judgment entered by any court of competent jurisdiction in respect of any thereof, shall be resolved only in the courts of the
    State of Delaware or the United States District Court for the District of Delaware and the appellate courts having jurisdiction of appeals in such courts. In that context, and without limiting the generality of the foregoing, the Company and each
    Participant shall irrevocably and unconditionally (a)&#160;submit in any proceeding relating to the Plan or any Award Agreement, or for the recognition and enforcement of any judgment in respect thereof (a &#8220;<span style="text-decoration:underline">Proceeding</span>&#8221;), to the exclusive jurisdiction
    of the courts of the State of Delaware, the court of the United States of America for the District of Delaware, and appellate courts having jurisdiction of appeals from any of the foregoing, and agree that all claims in respect of any such Proceeding
    shall be heard and determined in such Delaware State court or, to the extent permitted by law, in such federal court, (b)&#160;consent that any such Proceeding may and shall be brought in such courts and waives any objection that the Company and each
    Participant may now or thereafter have to the venue or jurisdiction of any such Proceeding in any such court or that such Proceeding was brought in an inconvenient court and agree not to plead or claim the same, (c)&#160;waive all right to trial by jury in
    any Proceeding (whether based on contract, tort or otherwise) arising out of or relating to the Plan or any Award Agreement, (d) agree that service of process in any such Proceeding may be effected by mailing a copy of such process by registered or
    certified mail (or any substantially similar form of mail), postage prepaid, to such party, in the case of a Participant, at the Participant&#8217;s address shown in the books and records of the Company or, in the case of the Company, at the Company&#8217;s
    principal offices, attention General Counsel, and (e)&#160;agree that nothing in the Plan shall affect the right to effect service of process in any other manner permitted by the laws of the State of Delaware.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>14.10</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Construction</span></b>.
    Wherever any words are used in the Plan in the masculine gender they shall be construed as though they were also used in the feminine gender in all cases where they would so apply, and wherever words are used herein in the singular form they shall be
    construed as though they were also used in the plural form in all cases where they would so apply.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>14.11</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Other






        Benefits</span></b>. No Award granted or paid out under the Plan shall be deemed compensation for purposes of computing benefits under any retirement plan of the Company or its Affiliates nor affect any benefit under any other benefit plan now or
    subsequently in effect under which the availability or amount of benefits is related to the level of compensation.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>14.12</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Costs</span></b>.
    The Company shall bear all expenses associated with administering the Plan, including expenses of issuing Common Stock pursuant to Awards hereunder.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>14.13</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">No
        Right to Same Benefits</span></b>. The provisions of Awards need not be the same with respect to each Participant, and such Awards to individual Participants need not be the same in subsequent years.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>14.14</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Death/Disability</span></b>.
    The Committee may in its discretion require the transferee of a Participant to supply it with written notice of the Participant&#8217;s death or Disability and to supply it with a copy of the will (in the case of the Participant&#8217;s death) or such other
    evidence as the Committee deems necessary to establish the validity of the transfer of an Award. The Committee may also require that the agreement of the transferee to be bound by all of the terms and conditions of the Plan.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>14.15</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Section&#160;16(b)&#160;of





        the Exchange Act</span></b>. All elections and transactions under the Plan by Persons subject to Section&#160;16 of the Exchange Act involving shares of Common Stock are intended to comply with any applicable exemptive condition under Rule&#160;16b-3. The
    Committee may establish and adopt written administrative guidelines, designed to facilitate compliance with Section 16(b) of the Exchange Act, as it may deem necessary or proper for the administration and operation of the Plan and the transaction of
    business thereunder.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-23</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>14.16</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Section&#160;409A






        of the Code</span></b>. The Plan is intended to comply with the applicable requirements of Section&#160;409A of the Code and shall be limited, construed and interpreted in accordance with such intent. To the extent that any Award is subject to Section&#160;409A
    of the Code, it shall be paid in a manner that will comply with Section&#160;409A of the Code, including proposed, temporary or final regulations or any other guidance issued by the Secretary of the Treasury and the Internal Revenue Service with respect
    thereto. Notwithstanding anything herein to the contrary, any provision in the Plan that is inconsistent with Section&#160;409A of the Code shall be deemed to be amended to comply with Section&#160;409A of the Code and to the extent such provision cannot be
    amended to comply therewith, such provision shall be null and void. The Company shall have no liability to a Participant, or any other party, if an Award that is intended to be exempt from, or compliant with, Section&#160;409A of the Code is not so exempt
    or compliant or for any action taken by the Committee or the Company and, in the event that any amount or benefit under the Plan becomes subject to penalties under Section&#160;409A of the Code, responsibility for payment of such penalties shall rest solely
    with the affected Participants and not with the Company. Notwithstanding any contrary provision in the Plan or Award Agreement, any payment(s) of &#8220;nonqualified deferred compensation&#8221; (within the meaning of Section&#160;409A of the Code) that are otherwise
    required to be made under the Plan to a &#8220;specified employee&#8221; (as defined under Section 409A of the Code) as a result of such employee&#8217;s separation from service (other than a payment that is not subject to Section&#160;409A of the Code) shall be delayed for
    the first six (6)&#160;months following such separation from service (or, if earlier, the date of death of the specified employee) and shall instead be paid (in a manner set forth in the Award Agreement) upon expiration of such delay period.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>14.17</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Successor






        and Assigns</span></b>. The Plan shall be binding on all successors and permitted assigns of a Participant, including, without limitation, the estate of such Participant and the executor, administrator or trustee of such estate.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>14.18</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Severability






        of Provisions</span></b>. If any provision of the Plan shall be held invalid or unenforceable, such invalidity or unenforceability shall not affect any other provisions hereof, and the Plan shall be construed and enforced as if such provisions had not
    been included.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>14.19</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Payments






        to Minors, Etc</span></b>. Any benefit payable to or for the benefit of a minor, an incompetent person or other person incapable of receipt thereof shall be deemed paid when paid to such person&#8217;s guardian or to the party providing or reasonably
    appearing to provide for the care of such person, and such payment shall fully discharge the Committee, the Board, the Company, its Affiliates and their employees, agents and representatives with respect thereto.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>14.20</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Headings






        and Captions</span></b>. The headings and captions herein are provided for reference and convenience only, shall not be considered part of the Plan, and shall not be employed in the construction of the Plan.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"><b>14.21</b></p><div>
  </div><p style="background-color: #FFFFFF; margin: -12pt 0px 0pt; line-height: normal; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: left; text-indent: 1in;"><b><span style="text-decoration:underline">Company






        Recoupment of Awards</span></b>. A Participant&#8217;s rights with respect to any Award hereunder shall in all events be subject to (i)&#160;any right that the Company may have under any Company recoupment policy or other agreement or arrangement with a
    Participant, or (ii)&#160;any right or obligation that the Company may have regarding the clawback of &#8220;incentive-based compensation&#8221; under Section&#160;10D of the Exchange Act and any applicable rules and regulations promulgated thereunder from time to time by
    the U.S. Securities and Exchange Commission.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.25in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>Article XV<br/>
    EFFECTIVE DATE OF PLAN</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">The Plan originally became effective on September 7, 2011, and was amended and restated effective May 23, 2013. Following
    its adoption by the Board, this amendment and restatement of the Plan shall become effective as of May 18, 2023 upon receipt of the requisite approval of the stockholders of the Company at the 2023 Annual Meeting of Stockholders. In the absence of such
    stockholder approval, any outstanding Awards for which the terms have been established under this amended and restated Plan and subject to such stockholder approval shall be null and void.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-24</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Article XVI<br/>
    TERM OF PLAN</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No Award shall be granted pursuant to the Plan on or after the tenth anniversary of the earlier of the date that
    this amended and restated Plan is adopted or the date of stockholder approval, but Awards granted prior to such tenth anniversary may extend beyond that date.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-25</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>&#160;</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b>EXHIBIT A&#160;</b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"><b><span style="text-decoration:underline">PERFORMANCE GOALS</span></b></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">Performance goals shall be based on the attainment of certain target levels of, or a specified increase or decrease (as
    applicable) in one or more of the following performance goals:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;</p><div>
  </div><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; width: 100%">

      <tr style="vertical-align: top">
        <td style="width: 0.5in; text-align: left">&#160;</td>
        <td style="white-space: nowrap; width: 0.25in; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">earnings per share;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">operating income;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">gross income;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">net income (before or after taxes);</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">cash flow;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">gross profit;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">gross profit return on investment;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">gross margin return on investment;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">gross margin;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">operating margin;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">working capital;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">earnings before interest and taxes;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">earnings before interest, tax, depreciation and amortization;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">return on equity;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">return on assets;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">return on capital;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">return on invested capital;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">net revenues;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">gross revenues;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">revenue growth, as to either gross or net revenues;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">annual recurring net or gross revenues;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">recurring net or gross revenues;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">license revenues;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">sales or market share;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">total stockholder return;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">economic value added;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">specified objectives with regard to limiting the level of increase in all or a portion of the Company&#8217;s bank debt or other long-term or short-term public or private debt or other similar financial obligations of the
          Company, which may be calculated net of cash balances and/or other offsets and adjustments as may be established by the Committee;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">the fair market value of a share of Common Stock;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">the growth in the value of an investment in the Common Stock assuming the reinvestment of dividends;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">reduction in operating expenses; or</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="text-align: left">&#160;</td>
        <td style="white-space: nowrap; text-align: left"><b>&#8226;</b></td>
        <td style="text-align: left">other objective criteria determined by the Committee.</td>
      </tr>

  </table><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">The Committee may, in its sole discretion, also exclude, or adjust to reflect, the impact of an event or occurrence that the
    Committee determines should be appropriately excluded or adjusted, including:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;restructurings, discontinued operations, extraordinary items or events, and other unusual or
    non-recurring charges, and/or management&#8217;s discussion and analysis of financial condition and results of operations appearing or incorporated by reference in the Company&#8217;s Form 10-K for the applicable year;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;an event either not directly related to the operations of the Company or not within the reasonable
    control of the Company&#8217;s management; or</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a change in tax law or accounting standards required by generally accepted accounting principles.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">Performance goals may also be based upon individual participant performance goals, as determined by the Committee.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in"></p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-26</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">In addition, such performance goals may be based upon the attainment of specified levels of Company (or subsidiary,
    division, other operational unit, administrative department or product category of the Company) performance under one or more of the measures described above relative to the performance of other corporations. The Committee may also:</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;designate additional business criteria on which the performance goals may be based; or</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;adjust, modify or amend the aforementioned business criteria.</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white; text-indent: 0.5in">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageNumberArea" style="text-align: center;"><span class="BRPFPageNumber" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; color: rgb(0, 0, 0); font-weight: normal; font-style: normal;">B-27</span></div>
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 261pt; text-align: center; text-indent: -261pt"><span style="font-variant: small-caps">&#160;</span></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;<img alt="" src="ny20042551x1_image08.jpg"/></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 261pt; text-align: center; text-indent: -261pt">&#160;</p><div>
  </div><div class="BRPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
    <div class="BRPFPageBreak" style="PAGE-BREAK-AFTER: always">
      <hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000"/> </div>
  </div><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 261pt; text-align: center; text-indent: -261pt">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 261pt; text-align: center; text-indent: -261pt">&#160;</p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;<img alt="" src="ny20042551x1_image09.jpg"/></p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 261pt; text-align: center; text-indent: -261pt">&#160;</p><div>
  </div><!-- Field: Rule-Page --><div>
  </div><div style="margin-top: 0; margin-bottom: 0; text-align: LEFT;">
    <div style="font-size: 1pt; border-top: Black 2pt solid; width: 100%">&#160;</div>
  </div><div>
  </div><!-- Field: /Rule-Page --><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 261pt; text-align: center; text-indent: -261pt"><br/>
  </p><div>
  </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 261pt; text-align: center; text-indent: -261pt"> <br/>
  </p><div>
</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" id="hidden-fact-0" name="dei:DocumentType">DEF 14A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-18203">0001520697</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag" id="ixv-18204">false</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="achc-20250529.xsd" xlink:type="simple"/></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><xbrli:context xmlns="" id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-04-11</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-04-10</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c35">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c40">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c41">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c42">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c43">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c44">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c45">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c46">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c47">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c48">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c49">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uqgO9qQHmt9BQ98lPQIyw9cjUtWqGRtgbQaf1gYq0X4K9JiZyOo5BOU8+1dVRqQRfuQ546Z0u9PC55o4gk42ezj6sNilJDP6dALTHVH8VeCAxcxNwRqVpEAtj4BNITIHGSGA2swVleiB0e9V1phtxDzXZCUsZPmFHj81X/doZtdqw4vZSDvf5DXV7LrQk0TDL7VVbqC+xdvBxbkfYwwa+udMOCPdWStbT0FKDnClY4bdU6nXkL/JcZChJosyKKwqMKHNd8WiQ3ONm4fNsULyEwhhMDHWMnKBC6+49wzrSaA==] CSR-->
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c50">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c51">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c52">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c53">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c54">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c55">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c56">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c57">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c58">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c59">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c60">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c61">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c62">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c63">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c64">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c65">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c66">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c67">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c68">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c69">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c70">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c71">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c72">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c73">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c74">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c75">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c76">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c77">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c78">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c79">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c80">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c81">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c82">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c83">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c84">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2022-01-01</xbrli:startDate>
    <xbrli:endDate>2022-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c85">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c86">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c87">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c88">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2021-01-01</xbrli:startDate>
    <xbrli:endDate>2021-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c89">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c90">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c91">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c92">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2020-01-01</xbrli:startDate>
    <xbrli:endDate>2020-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c93">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ecd:MeasureAxis">
        <ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c94">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ecd:MeasureAxis">
        <ecd:MeasureAxis.domain>2</ecd:MeasureAxis.domain>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c95">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001520697</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:typedMember dimension="ecd:MeasureAxis">
        <ecd:MeasureAxis.domain>3</ecd:MeasureAxis.domain>
      </xbrldi:typedMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit><xbrli:unit xmlns="" id="usdPershares">
  <xbrli:divide>
    <xbrli:unitNumerator>
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unitNumerator>
    <xbrli:unitDenominator>
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unitDenominator>
  </xbrli:divide>
</xbrli:unit></ix:resources></ix:header>

</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>achc-20250529.xsd
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION - SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Apr 10 21:02:13 UTC 2025 -->
<xs:schema elementFormDefault="qualified" xmlns:achc="http://acadiahealthcare.com/20250529" targetNamespace="http://acadiahealthcare.com/20250529" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://xbrl.us/us-types/2009-01-31" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="achc-20250529_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="achc-20250529_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="achc-20250529_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uqgO9qQHmt9BQ98lPQIyw9cjUtWqGRtgbQaf1gYq0X4K9JiZyOo5BOU8+1dVRqQRfuQ546Z0u9PC55o4gk42ezj6sNilJDP6dALTHVH8VeCAxcxNwRqVpEAtj4BNITIHGSGA2swVleiB0e9V1phtxDzXZCUsZPmFHj81X/doZtdqw4vZSDvf5DXV7LrQk0TDL7VVbqC+xdvBxbkfYwwa+udMOCPdWStbT0FKDnClY4bdU6nXkL/JcZChJosyKKwqMKHNd8WiQ3ONm4fNsULyEWMNLO/R5/WLD28uJEAeXDw==] CSR-->
      <link:roleType roleURI="http://acadiahealthcare.com/role/AdditionalDimensions" id="achc_r_AdditionalDimensions">
        <link:definition>999000 - Disclosure - Pay vs Performance Disclosure - Additional Dimensions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:element name="ChristopherHHunterMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="achc_ChristopherHHunterMember"/>
  <xs:element name="DebraKOsteenMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="achc_DebraKOsteenMember"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>achc-20250529_def.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION - DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Apr 10 21:02:13 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly" roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly"/>
  <roleRef xlink:type="simple" xlink:href="achc-20250529.xsd#achc_r_AdditionalDimensions" roleURI="http://acadiahealthcare.com/role/AdditionalDimensions"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uqgO9qQHmt9BQ98lPQIyw9cjUtWqGRtgbQaf1gYq0X4K9JiZyOo5BOU8+1dVRqQRfuQ546Z0u9PC55o4gk42ezj6sNilJDP6dALTHVH8VeCAxcxNwRqVpEAtj4BNITIHGSGA2swVleiB0e9V1phtxDzXZCUsZPmFHj81X/doZtdqw4vZSDvf5DXV7LrQk0TDL7VVbqC+xdvBxbkfYwwa+udMOCPdWStbT0FKDnClY4bdU6nXkL/JcZChJosyKKwqMKHNd8WiQ3ONm4fNsULyE6yQ6cmh9c0kb2wnSOd8NOw==] CSR-->
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <loc xlink:type="locator" xlink:label="achc_ChristopherHHunterMember" xlink:href="achc-20250529.xsd#achc_ChristopherHHunterMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllIndividualsMember" xlink:to="achc_ChristopherHHunterMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="achc_DebraKOsteenMember" xlink:href="achc-20250529.xsd#achc_DebraKOsteenMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllIndividualsMember" xlink:to="achc_DebraKOsteenMember" order="4" xbrldt:closed="true"/>
  </definitionLink>
  <definitionLink xlink:role="http://acadiahealthcare.com/role/AdditionalDimensions" xlink:type="extended"/>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>achc-20250529_lab.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION - LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Apr 10 21:02:13 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="achc_ChristopherHHunterMember" xlink:href="achc-20250529.xsd#achc_ChristopherHHunterMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="achc_ChristopherHHunterMember_lbl" xml:lang="en-US">Christopher H. Hunter [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="achc_ChristopherHHunterMember" xlink:to="achc_ChristopherHHunterMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="achc_ChristopherHHunterMember_lbl0" xml:lang="en-US">Christopher H. Hunter.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="achc_ChristopherHHunterMember" xlink:to="achc_ChristopherHHunterMember_lbl0"/>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uqgO9qQHmt9BQ98lPQIyw9cjUtWqGRtgbQaf1gYq0X4K9JiZyOo5BOU8+1dVRqQRfuQ546Z0u9PC55o4gk42ezj6sNilJDP6dALTHVH8VeCAxcxNwRqVpEAtj4BNITIHGSGA2swVleiB0e9V1phtxDzXZCUsZPmFHj81X/doZtdqw4vZSDvf5DXV7LrQk0TDL7VVbqC+xdvBxbkfYwwa+udMOCPdWStbT0FKDnClY4bdU6nXkL/JcZChJosyKKwqMKHNd8WiQ3ONm4fNsULyEBFu+VOSr8f2Ke5sgha5C2w==] CSR-->
    <loc xlink:type="locator" xlink:label="achc_DebraKOsteenMember" xlink:href="achc-20250529.xsd#achc_DebraKOsteenMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="achc_DebraKOsteenMember_lbl" xml:lang="en-US">Debra K. Osteen [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="achc_DebraKOsteenMember" xlink:to="achc_DebraKOsteenMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="achc_DebraKOsteenMember_lbl0" xml:lang="en-US">Debra K. Osteen.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="achc_DebraKOsteenMember" xlink:to="achc_DebraKOsteenMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>achc-20250529_pre.xml
<DESCRIPTION>INLINE XBRL TAXONOMY EXTENSION - PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Thu Apr 10 21:02:13 UTC 2025 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"/>
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"/>
  <presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <loc xlink:type="locator" xlink:label="ChristopherHHunterMember" xlink:href="achc-20250529.xsd#achc_ChristopherHHunterMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="ChristopherHHunterMember" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="DebraKOsteenMember" xlink:href="achc-20250529.xsd#achc_DebraKOsteenMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="DebraKOsteenMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <loc xlink:type="locator" xlink:label="ChristopherHHunterMember" xlink:href="achc-20250529.xsd#achc_ChristopherHHunterMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="ChristopherHHunterMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="DebraKOsteenMember" xlink:href="achc-20250529.xsd#achc_DebraKOsteenMember"/>
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uqgO9qQHmt9BQ98lPQIyw9cjUtWqGRtgbQaf1gYq0X4K9JiZyOo5BOU8+1dVRqQRfuQ546Z0u9PC55o4gk42ezj6sNilJDP6dALTHVH8VeCAxcxNwRqVpEAtj4BNITIHGSGA2swVleiB0e9V1phtxDzXZCUsZPmFHj81X/doZtdqw4vZSDvf5DXV7LrQk0TDL7VVbqC+xdvBxbkfYwwa+udMOCPdWStbT0FKDnClY4bdU6nXkL/JcZChJosyKKwqMKHNd8WiQ3ONm4fNsULyEPnOP0LSWZZn+PBTgJFsdPQ==] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="DebraKOsteenMember" order="0.01" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <loc xlink:type="locator" xlink:label="ChristopherHHunterMember" xlink:href="achc-20250529.xsd#achc_ChristopherHHunterMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="ChristopherHHunterMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="DebraKOsteenMember" xlink:href="achc-20250529.xsd#achc_DebraKOsteenMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="DebraKOsteenMember" order="0.01" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <loc xlink:type="locator" xlink:label="ChristopherHHunterMember" xlink:href="achc-20250529.xsd#achc_ChristopherHHunterMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="ChristopherHHunterMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="DebraKOsteenMember" xlink:href="achc-20250529.xsd#achc_DebraKOsteenMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllIndividualsMember" xlink:to="DebraKOsteenMember" order="0.01" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <loc xlink:type="locator" xlink:label="ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <loc xlink:type="locator" xlink:label="us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_PayVsPerformanceDisclosureLineItems" xlink:to="us-gaap_ProfitLoss" order="101" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ny20042551x1_image01.jpg
<TEXT>
begin 644 ny20042551x1_image01.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ /P#5 P$1  (1 0,1 ?_$ ,    (" @,! 0$
M      D*!P@ !@$"!00+ P$  @(# 0$               <%!@$$" ,"$
M!@$# P($ P4$"04    ! @,$!08' !$((1(),1-!410*82(5<8$R0A?1<A88
MD:&Q8B,SMG<X)#4W*!D1  $"! ,%! 4&"0H'      $" P 1! 4A$@8Q05$3
M!V%QD2*!H3(4%;'!0E)RLM%B@B,S<S06"/#ADL)#8R1T-1>B4X.39)0E_]H
M# ,!  (1 Q$ /P!_C1!' ]0'KM^.B XB4 FY(^5DN%?+KQIX2IR423%%KJ8U
MS,;E=JS,ZC\JY7[%L/\ 9*J *\>C$!&MB.$RG*FJG/@90!%(@@S[1T_-UZ>5
MVIPE7OS;H+8W%IL'F2&_'$'\7MBGUNH_==2L68$<E2 %'@H^S!V"="@&VVP
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MM:)HIRJ:I;4*V^7\54H9.\<?.A'G_P !'669DK%KE*N5FW8\S+#L2$2;(WR
MK:@KS+)H'5M%6Z,<H22">P%2%P=(NX)Z2>LM*+T?JU-O3,T*EH<:)^H5;.\'
M G?*+Q8[N+S934J_3I0H+[Y;>XC&%ZOM32%_KORV4V_,&'\>D#Y=HW.5-Z>F
M^Y0TX_X@)?"[7^L7]U,4SIW^WUGV?ZT.Z%_F_O#KF"&Q';1!"_?EY1#EWR3X
M,^+E@_DDZ]F.\2>>^1!H%W]))QV&<6,)(S! '904^B4F9=-T*!CE$ <MT#
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MAY2:9NLM\M#+-\MDF"H;/&C&U/H:4;UG*M-=U:(>O8MN]>U1RF9445 !T60
MYB]_<(O?2%SLW4+1%5IRBI_=6&&BVEHK+DDR*D+"E8^U+'C%"O--6Z=O[-T<
M<YCRS.8&69V*!XS$SC#]])M\#D&GU:]U5^C*U>Z5Z&M5<DT#@=&0@[!&MI:*
M>)&*(@)'#)V0WKTWUR-44[M)4.4KX(>;64J' I,CZQ#B:=0\TEYLS;4D$>D1
M'_(\0+QYSP<?0N&<HF']@4>=$=M;-G3*\4I_\EO[Z8\:_P#8'Q_<K^Z84O\
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8F;#]89%0Z9BIHG,)!! -$$9H@C-$$?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ny20042551x1_image02.jpg
<TEXT>
begin 644 ny20042551x1_image02.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 0@"O P$1  (1 0,1 ?_$ *\   $$ P$! 0
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M1V-I;E[ZXC5F['#U'(]O&BKMNCBM;N9UQ_5>ZK?Q^:N&[!)OT[MDQVV_IZ
M=P_M'6#D:?>#(O*WG\EI72U80.2BSB;DFSRMR2Y"84KE?<.(#CW%XYC+/?DI
M)HZBW.3KLPEK!+X^(T13\]"7I]9)&N'AC*'((R*90 HE'?17FV.LMJM;Z?RS
M7)=1M,=+1@ZO)W# 9*';3A[W1<6J6GS[?I\=5"FK&8=NGCN'P^/N#3;FXZN0
M0F@S/C>1RQ29NDQ62+WB5_,IM@:WW&SV/CKE!JMG#=<@Q3V4CY1DDDLHF4%B
M'0.55/<IN@Z[M+H1W&HLUU[<DS, 0*F@*@'Q Y<6Z7X(Y1SQFUW'ST_QWL7)
MJE3MT<G9P+/*#'CA:K96XJ]K*(($CH=>_,X!$ZX-TQ;I/%CBF40Z:U?4&T16
MG4EO8V@/MRP1.(&.DR,:2/ N/_!4=I=S?:/<[RMUO'PR^-0%8!@W(3_*^(\6
MY+E:PYITED''U1O+VK/7(O'5;<6J%;2XPBSSRD =+1X./+.?RR=PEW[2[[!G
M;ZRCLMPE@9B6.(U5Y&BOX:26K)'>JB=_4==IH\XY<C,&8RMF4IFL7:Y1M0C"
MR3BL8XKCNWWF:\QXU8ILZ]6V/:O).A7=D,<1.FDBB!U5#D3(8P/V\/W$HA!
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M+%$.VN/)7/%J8XBXZ8^55$I9.]V+N;+7"9["K+I5''L6JI)2:HE\H$D@*<0
MV^IO3&Q.W>\==3X;;9L,LAYT^GGC2G^M$QNUTZVC!:2'G#P3Q</>-=<XI\><
M;87B'HV"0KL8\?6ZV+I"B^NU^L3UU/7>XR8=QE%GD]8Y!PH!EC*+%0\M,QS=
M@#J%U!NLN\[E+>>DGRM ^EK10 >&/?5=V-NS[7[EPJ0*A0^OS.6Y=<_Z9BA1
M,B_'C@P6O9GR29, <,;URAMC1\;%-&D@$!1\C&=8<'LZZ8@<P/G+$3"4Q=AM
MK,G8.GG78)&Z7K7,&6$1P>?^[*O:H+7NOI 3BUCL1VUXJV-)N0B@' H 81,8
M1#?<1,&QA'KU$VW76-82'&GU9J\A:YC*5P6YIQ.)L\MY(J.'Z%:<GWZ?1K5+
MH\$_L-CEW =Y&L='HF7.5%$H"LY>NS$!%NBD!U5UU")D*)C &G[2RFW*Z98V
MM3<.(-!G3CX9U/  IN:801&23^GEXJ /$VIVS+]OG^?_ ""K2]/L%^K2E=P'
MCJU-SH26!>. +'E2.YU!T84(O)>3E&Q9B?53!-5HT!DQ/_9. Z?>)(K>%O3^
MWD/#"-;VX&20\#QHTDM RP[%GX+9\-T;^7&-U/  4^27A426Y&99RMSMM<::
M-KUP:&PKQ:A70"=>.X_4VPNU)'(I!.4H(*YPM[8TJD!2E/\ A;5D!]]@U'WB
M3[+;V[#&-,S0))37%Q<*M&'!H^2FV#QN#GN/I#C0=@*M!()=@';IWB3YPW_A
MK'Q,>_S/-2<U<< !DM62<E9M_/,H"9"'*)CBHFD4"!N)Q$RH@F(%( CL80 =
MNHAIV&W>^6@RHN)96Q,U.50S+\.]2/-D9=9515YPAXI7Y\I5&K]-P2N\G.0-
M4.Y8.;V]27310FL-8:>@I^%*#_QY><(+HO>V0()M;!/)LMJ^*T;3<KAHH[ZF
M1Y$#,5<<^SC@%GYGMN7F>;S6T0(H:TJ<033'!0JX?XYLOJ/^I%DGU(\FMW(<
M;.,<_9<'\+*R][5XVQS]5D7<!:\LMFBY3HJMAE4G*K-PF/8HZ,B=,YB)  >D
M=4;S;]$]$VW25DX?N%_$V6Y>!B1)YF@]P\O<"J3;K)^ZW[KVZ_F0QG^6#]-.
M5/FOTK()$%%/N*.X%3'Z7T3;EV, B!1  'N\??KPJ,:265J :56[970*YT6P
M)@ 0#]>@RC6&#B5TEWW\!#]O[].H6%43AL!0$1V$=R@.W00W#H(CW" ]-<.C
M]PC&@"X>\MI0$U7S4A;JY%?>32EB@8Q-JH*;E21FXUF1J?8OV3D'#E($C? Q
M@'KITVKR!H;4$=J:^Y:/*<TVD_R&P56RKGG\W8C@ON[<5G R>1Z6S4;IF#Z*
MYT',Z"@I^[Z [Z<@VZ]N7^W QQ/ !I_6GZIN6[AC;J(;7O'Z5K^2[$'F3%EH
MJ,K?:[DRB3]%K[&1D9FXP-M@92N1,?%-%GDHYF99D_<L8Y&+8HG<.#K*) DF
M43"&P#HGVV_AN60&-P>YP%""*U-,.?@B*ZA?"Z1U"0"1X)T#B8"CU'P]H"(>
MSQ*'40U7,JZ[<QIHZBFM&()RJJQI>1'D_P ]V= (DN[P_P #8N%OUR5<D<'B
M[-R9R5"NCX^AA/Y7W.25Q)CY=277(F8YFDG+-2J 4Y UL8IV[5L$DI!^[NW!
MH(&(8T^<#_JXTS"I'1&YW+1G& 3V5'Y*9>=<U8_XYXJN68<D2@1=6I,:K)/T
M&Y3N).9?'.DUB:W 1J7<[F+39)%9%G'M$2**N7*I4RE$3:S]GMK]SW"-C*@N
M.9P:T<W9 #X54[[P63'-(!%/Q14(<5[1.Y&YV\CN?'-&_4ZC5?C+C2/Q'6:I
M/6B-C*CQTM][+^<+/C]H]D@CSR-YA<?J1Z4^[.!5C3+\[1 %"-RZ]KWJTC;T
MO8=+])-DFW2XG=)( PD2,HQH?J:/07-J*^6@)PQ6!VZ[=<[Y)=W!(:PZ:$X#
MCD5,./\ 7$X!V;#^7,H8]RZK,R^'<=6G),CB^Q5JP4:XRL=7WR4'$MXY&:C6
M\8Z;V*P23)!L"+PRJA72?V(=Q@#%6_\ B_JJ/=8[&>(B">0-=(WS1,<<P7Y
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MM(I%K);Y!!LUDK',KF.==_)O&[1)+S3"&R*)" 0@%#?FXNKVY<T2#RL%!B,
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'&A"-"%__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ny20042551x1_image03.jpg
<TEXT>
begin 644 ny20042551x1_image03.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ W0)8 P$1  (1 0,1 ?_$ ,4  0 " P$! 0$
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MD 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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M7'7I?,_H'[K 0QOU!6%O36X>F*1RRO3EFS1DDG4\2>96XUA 6D^6S_E'EO\
MU67_ &-9>:YQ^ZOX?>RVT/H?63=51VA ?3)9&'5CBT^D$A 9];/Y&'0%_FM'
M@\:G[>: VU3<M631L[3"[];FW_"L VT<L<K ^-P>T\G ZA ?2 ( @" ( @"
M( @" ( @.1]U_F!PFT_.Q6%Z,GN #I< =:]=Q_TKA[SA^H/KT5GH^6RN_-+"
M/F<E_5*&"Q95?<V[-P;GR3LEG+LERT[@TO/LL;SZ8V#V6M]0"]'9LPMJD50J
MIW)3=6:E;2 0! $ 0! 7-V+_ ,I=I_[HS^0KQ^M_>EUE[I_VUU&<N4W! $ 0
M! $![U+UFI)UPOZ=?>;X'Z0@)1C,S7N@,/X<X'%A\?W5@&P0! $ 0! $ 0!
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M89EG@RY#I'<B'@_3WA^R[F%IO6N"5"SY5S".JM*7U+-=)(5I+(( @" ( @"
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MRRP])&NOAJL S4 0! $ 0#EQ* ^8Y(Y&!\;@]CN+7-((/T$(#Z0! $ 0! $
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M35F;V''/FNFCG<CWU/*MO#84-Z!D60EGG=(UL89&[IZB=!J= I_TTZ5H<_\
MWVE<E%2JWT,IKGFO;G,BV37S!:F#]>)U$AU7K[7H74CGN>I]9@K80" ("8=G
MR!W0VSJ=/[_$/M*Y-?\ LRZC?I?W$7J7CR\" ( @.?\ >OM5%W(VBW$MM?!9
M&G.VWCK)&K!*UI;TR-'$M<UQ'#ES4<5)26<2::HT\F:7?_;S>7<7:N+VOFXJ
MF*AKSPS93(Q2FP9!"TM=\-'T,Z2_77VSP]:G)1E/BV;O<:H5C#AVTI4S]Z[6
M[ITI< [MQDZM?&X>%M>QA+VHCL,86AO5(&O/N#3P3C;FY/%,RHI0HLT;_);:
MM[I?@9MP4X:D>(M-R3ZC)?/ZK432(@']+!T-<[JUYD@<$5%+B6Q.G:'5QX7M
MS-+O; =W[O<#!7]L9NO2VI7#/S:C(/;>0]QD)'2[KZF:!OM#0K%K"3<O29N8
MPI'U&MW1VAR+.[&-[E[9DB=>C'E9?%SN,;;$99Y?7'* [I?T>#AH= EKY&]T
MA<^9+?$]=C]HK5'N=G^X^=?$,KE=8Z%" E[:T1:UA+I"&]4CFQ@<!IS6;?R0
M<5F\^^IBXN*2>[X4.@;E_/S@[;-OB'\XD9T4Y+)(BC>[AYCP 2X,UZNGQY*+
M5<*T)Q:6+Q/C:^W*NW\'!BX7NF<P%]FR_P#B3SR'JEF>?%SWDDJ4VG@LLNPA
M%-8O-G&).P6X\7@]Z[5P4]>3#;OLQ6*]R=Y8^FT/+I&/C#3YG Z-(/TJ"581
M@_I>?1\<"<IOCE-?4O''XG8MD;5J[3VGB]NU9#+#C8&PB5PT+W#BY^GAU.)*
MVW)\3J:X1HC=J!(PLX0,+?)&H%>74?T"I0S1HU/[4OX7Y%7%>GR(( @" F':
M7_WU1_<G_P!BY<VJ_;9=_P!N_P#,C_-Y,L JD^DA $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $!0[NI*9>X^XWGG\?./3[KR/YE[+1K_XQZBBU'K9%ETFD( @,
MC'L#[]9AY.E8/M<%B63,QS/Z'PQB.%D8X!C0T?4-%X5GHC[0! $ 0',;KCN3
MOM1J#VZ&RL>ZW/XM^.R/X<0_>;"QQ'TK-E>N?5%><O<+N48[_F?9@CD_S7PS
MGN=L)]II.*<]C#K[O5\4SS!Z/=(32_OX]'O,WOV>_P C[[U>?V][V;0RVSF?
ME[LZ8X\ECJC1'%:+; 8[S(VZ-<Z1LVFNG/CS32.MUVWZ73LK5>%*D=2Z6>)>
MI<7A1EGWV*[)&1/E8R63^'&YP#G:<] >:P9(%NKM=LK_ (F__P!#?=L[>S./
MC=):RM.6&-CXF,+7>>RQ'/$X='[.JBI*W5[-I)ISHNXY#\L^WKNXNY>Z.YT\
M<GY;-+8@QD\P#72OGD#G/&C6CV8QH=!S.BVVDX6L<Y?X^?D:[S4[F]1^%%X%
M@<QL39^8NNOY/%06;3XQ%-*X$>;$TAP9,&D"5@+0>E^H6M8$ZU(]B(&;MW(S
M,F(-VGMU[X<!  !'9N1ZQR7&M'#RXN,</KZG#P4DVDYO-K#H7QEY=9&27H62
MSZ]W9Y]1R%G=[>^X=H=PM[5,E+C7[:N0PX.A&&>2V'S-'>>QP/FN>WGU<O!0
M3<;<9/%RE\,/$V2A6[*&R*\<?@=Y[;[JFW9L7"[BGA$$^1K-EFB;KTA_%KNG
M7CIJ."W78J,J(TVY-K$DBUDP@.#[QWKNZMN3)THLG+'!!8D9$R/1H#.H](X#
M7@."M+-F#BG0^><TYIJ8:B<%-I*3I3<1:SG\[9U^(R-F4'F'RO(^PG1="MQ6
MQ%1/6WI9SD^UF I'*%D'W#*Z*5DK?>C<'-UY:@ZK#524).,DUL.6[XJNJ[SS
MU=PT,60M- ]0F=I^A6^G=;<7T(^AW52;ZS2+<:P@" W.R[K*&\<#>D/3'4R-
M2=Y] CG8X_R+5J(UMR6^+\B=ITDGTG] 5XD] $ 0! $ 0'G/8KUXC+8E9#$"
M 9)'!K07$-'$Z#B3H@,/+;BV_A_*_-\G4QWG:^3\7/'!U].G5T^8YNNFHUT6
M*F:.E3[Q>;PV6@?8Q5^MD((W=#YJLT<S&N !Z2Z,N .AY++5%4P8U#=^T\A;
M%+'YJA<N'72M!:AEE]GG[#'%W#Z$6(>&#/N+=&V9I;4,67I22T0778V6(G.A
M:TZ.,H#M6 'GU)7"NP4QIM/RQNO:U:E%>L9BC#2L$""U)9A;%(2.H!CRX-=P
MX\"C5'3:$>U3.X2Y=FHU,A6LW:XZIZL4T;Y8P?%[&DN;S\0@,Y $ 0&LW/';
MEV[DHJ<9EM2UI(X8VZ:ESVEHY_2IVZ<2J<NN4G8FHJLG%T*YW=N9^CJ;>/L0
M@<2YT;NG[=-%<*[%Y,^87=!?M^J$EV&N6PY @" G?9F'S-X]>G\&K*_[2UG^
M4N36/Y.T]%_;$:ZI]$'[CNJJSZ$$ 0! $!P[='<C>E+<>3IU<CY=:O9ECA9Y
M,#NEC7D :NC)/#TJTM:>#BFT?/\ 7\[U=N_.,9TC&32PCOZCHO;+-Y3,[;^-
MR4YL63/(TR%K6^RW30:,#1^A<>I@HRHCT_(M5<OV..XZRXG[8$CR>3H8NC+>
MOS-KU80#)*[D-2&@<.)))  ',KGJ7)AX[<V,O6V4XVV(;4D;YHX;->:!SHXR
MUKG#S&MX:R-64@;58!K,+N&EF)<E%6CEC?B[;J5@3,Z-9&-:\EG$DM(>-#XH
ML4GO#P=#'R^[\3BLI!B[$=N2[9A?8ACK59YPZ.,@//5$QP]DN&H]:+&O0'A3
MI,W"YO%YO',R&,G%BI(7,#P"TA\;BQ[7-< YKFN:000LM>)BO@9RP9" ( @"
M ( @" H%OWS/^.-PB0ESQDK8)<=3H)W:<_4O:Z;]N/4B@N^M]9HEN-80! 9.
M,(&2J$\A-&?[849Y,S',_H@UP<T.'(C4?6O#'HC]0! $ 0&AVSM"I@K^<R#)
MWV;F>NF[9ED !: P1QPMT^Y&UO!$Z14=U?$-5EQ="7<8O<+MQMC?F%&+SL+B
M(GB6I;A/1/!*/OQOT.GK!X%8IBI+!HS7!IY,UM;M10GW/B]S;BORYW+82 5\
M6Z9C(HHO$S&-@T=,3QZN7H"FI4;DLY>V!%JL5'Z48^\>R^$W3OW"[RM9&Y7M
MX8,$=6%X$3_+>Y[>?%G%WM=/,*-KY).6\S<^:/"9VZ.V5;=MCHW-E;EW"MD\
MQF"A<VK5< =6MG,0$TNG[4FGJ6(JCJ\7[;#,G546!+,?CZ..I0T:%>.K3KM#
M(*\+0QC&CD&M' *3;>+(I)9&)N;"R9O!VL2R[-CVW&>5+9KZ"41..DC6./NE
MS=6]7,>"BXIYY>9)2:Q69EX['4L;0KX^C$V"G5C;#!"W@&L8-  I2DY.K(QC
M14.=9/L+MJT,_4IVY\?AMT316<WC8&LZ7R1.Z]87D:Q=9/M :^K11BDDH_3%
MU7MN,R=6Y?4U3VZ3H6(Q./Q&,JXO'0BO1I1-AK0MY-8P: <>*G*3DZLQ&*2H
MC+43(0%:M[RLEW?F',Y"W*WZVN+3^D*YL*D$?+.;24M5<:_,_# TBW%<$ 0'
MZUKG.#6C5SCH /$E8,I-NB(=WQQSJ'=3<$1X"6<3M^B9C7_Y2L>7RK9B?2-4
MJ7&05=ASA $!^L>YCVO:='-(+3ZQQ1@_H!LO-1YO:6(RT;NH7*D,KC^T6#K!
M]8=J%XF_#@FX[F>@MRXHIFY6HF$ 0! $!SGN3T[FM/V?3Z;+X*S[N0KQV(XG
ML>1TU'/#R#TLD=YI]89Z5'?)?3ET2_P\R:=*)_5XQV^)I<KNW%[B[%YG,W)*
M[<W'B+>+NEKVN(MF,L?%&X'VA-(QKF=/O#313O4JG'TR<7XUI_+5D=.FG26<
M:_X]M$=!QUGHQM"[B*3+T=Z*%UBU#+&QI:V-K6O))]OV>'#T*5S";W5;-5KT
M+?1(Y0S(5K.?N9.YD:MC9N/W*ZY-)2;K9JV0V,5IYI@^4.JR/#FNZ(V^MQ;J
ML6G11;_53=BY8/L=5V&RZJN2_AKV)>37F9(N;:SF6[A0P90!MO)8F:K?Q_19
M+?*KUPR?I;UMEABG9^+X :ZZ*$$^%;&KDGT>G;UT9.XUQ;U]M+_-*O;BC]N9
MR5VU9G9.]BZMUV?QXCW'2Z11N/9+$[XID<CR"Z)C?Q0'ENK3Q]$FO33Y7\W^
MEX]39JEE+ZO3YY$M[=;AQCLIDL!?%>/>58QNREB-[7_'@Q@LL1.U+RWHTUC/
M\/ERT*S@U58*N*W/W]?8'5/%UPP?1[NKM)^HD@@" XM\R7<3.;6J86K@KSJ5
M^U+)-*^, DQ1 -T.H(T+GJVY7I8W')R54CCUEYP2H<IQ/S/]SJ1 LNIY%FHU
M%B#I=IX@.A=%^G564^467E5')'736>)*:_S*[.R8 W)LYAE/!T]=\<I(/C[;
M(W#^L5ROE,X^B9&Y.Q=_<MI]B-G6WS\N^7T$DEK#2N(:.MDH )];1,SZRM4M
M+JH_J..?*=!/8X]5?Q-M#V^V5F1U[:W=4M-Y>2Z2*5X/H<8WM(_J+2[]R/K@
MT<5S^U[<OV[G?CY4\B7]M]@Y#;=^[:N2PS":)L<#X23PZNIVNH'H:N;47U-*
MA8<EY//23DYM.J5*$^7*>B" ( @" K3O7_W=F?\ ?)_\<JZL^A=1\JYI_P F
MY_'+S.N=FO\ V</]YE_F5?K/6>T_MG_B_P S-EW$V_DLUA*S,<&R6J%^ID&U
M7N#&3BK*)'1.<=0-1Q;K]X!<BPG&7Y7[FO>>BSC*.]>]/W&/N>3.9G:N0BK;
M>F;<D@,<=:U-#'(XO<T/:TP3$%O3J2/-9U:=.HUU1K%=:\]WN$7GU/R\.O80
M>OL'<E?;SZ\&)/Q>,R=NUA:%B*E+0=#8+"UI@$S1 !J[I=$X.CXZ=6NCMBE3
MAWK!_P#D]O\ #3RH0IZEL='_ )4LOXJOQK4SX=M;@;NUN8_X>F;8_P"(OB?C
M1)5)9CWTFUY2UQFZQ&Z1H)8!J= >G58M45/YO%U1F;;3_E\,S?[TQV7L[PQ%
MNMC\E-1J4[<<UO&S5H7B2P^+H9^+-$X\(B3PTY*,7ZNFAF62Z_<17#;"W'%2
MQ];/X?\ -,!"_)_^#/?7EL]5J=DE6U:<][89)V-\SJ>UVH+M1Q1Y4^KA236Q
MK=V4Q,MYTRXJNNW#X[.K<8%_8.[6LMNGP]G+9.'&8F.ED'3P2?WZI8<^66$S
MSAT;F1.:WKZ6]6A]/&4725?UQ[J?-WXX=(>5/TR\?2NPVCMBY>#+QOK[?/EU
M]P6LE%;A?5A<RI>IN9((7=?6UWFD=0T&I /'FM?#\J6Z,X][?#3W;C+E5UZ8
M/M5*^\EO;7!YC"4[^/NU(H*<,S6XVPV**">:$,&KK$<#Y(C('Z^VWIZ^9:#S
MV-U73X;.[J-=,<,J?'OZR9*)(( @" ("B?=RF:?<O<<)_P#SLKQ]$AZ_\I>R
MT4JV8]11:A4FR(KI-(0! ?4;W1R-D;[S"'#Z0=4:!_0C;EYM_;^,O-(<VU5A
MF#AR/7&'?SKP]R-)-=)Z&+JDS8*!(( @" (#5;EW-B-MXIV4RTIBJ-?'$7-!
M<XND<&C1H]&NI] !*;4MK=!3!O<JF+NG>-/;E5]JS3MVZT-:6Y9EJLC<V*"#
M0O>\R/C_ %N ;J3QX+%<>[QR,I5RV^XS,)G&Y6*5_P %9I/B+=8K38PYS7L#
MVO:8WRL+2#^MS4FJ$4Z^9I:_<K$ON,KVJ-ZBQ]_\J%JPR(Q"Z?=A)BEE<.K4
M .+>GUI%5ITU\,_)F9_+7HIXY'T>Y&&9:S-::K;@?A)X*MESV1]+[%KH,$4)
M;([K=()6D<@->.BBG5)K:Z=NTS)4='NKV'M=WW3IU&SR8V^Z3XN*A)5$<8E9
M8L=/EM/7(QCFN+VCJ8YS?6I+%I;Z^!%NB;>PS<1N:#*9._1@I6HVX]P9+<D8
MP5GO(#NF*1KW=9;K[6@X'@>*PL54R\'3H-P@" (#\>]K&.>XZ-:"2?4.*&&Z
M%6LI9-K)V[1YSS22G^F\N_G5[!421\BU-SCN2EODWWLQ5(TA $!G8&N;&<Q\
M &OFV8F:>HO *A<=(OJ.G10XKT%ODO,\OFPV^ZMNW&9MC=(LC5\B0@?YVL[F
M3ZV2-^Q;^37*P<=S\SZ/KX?,F<,5P< 0! $!:CY5=V_';6N;;F?K/B93+6:3
MQ\B<EQT]39-?M7F^<6>&:G^8MM#<K&FX[DJ@[0@" ( @" ( @" ( @" ( @"
M I/WXW;_ ,2=Q\A+$_KIX[2A4T.HZ82>L_7(YQ7K>76?MVEO>)2ZNYQ3ZCGJ
M[CF" ( "6D$'0CB".8* NWV(Q-S'=K\/\8][[5UK[CR\EQZ9W%T0]K_5=*\C
MS":E>E3)8%YIHM052?KB-X0! $ 0$:N]M]EW;DURUCO,LV'NDF?YT[>I[CJ3
MHV0 <?0M\=1-*B957>2:2Y)RE"LI.KQE\3:X/ 8W!TW4\=&8JSI#((RXOZ2X
M#4 NU=IP\2M<[CDZLZ])H[>GCPVU2-:FP4#J" ( @" ( @" ( @" ( @" I]
M\S>#_+NYDEIH/EY6K%:!/+K'5"X#A_JP?K7J.4W.*S3\K*C6PI.N\Y,K,XP@
M" ("YGRZ;D_.>V-"&1W59Q+GT9?W6'JB_P#PW-'U+RG,[7!>?3B76DGQ6UT'
M3E7G2$ 0! $!"-UX+.;DSKZ#ZIK86I3E$=V=D%B&Q-99Y4@9&VS',Q[(G.:U
MSV <7>K6-*J7=[_-(E6CC3K_  9I!2W[;[*9#;V0P=J7<7P,N*@8^>CUV&F,
MQ167/;8=$WV"/,!?KKKH"IWI<34MK:;ZTTW^!&PE!M?2JTZMA.J\.=FQF-="
M\8R5D3/BZEF)EB34- +.J*;RVD:'B'."E<:XF\T0MJD4MISBIM;=+,S=W/\
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MI5Z<(TAK1LBC'H:QH:/T!>)DZNIZ!*A[K!D( @" ( @" ( @" ( @" ( @"
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MOJIO7:-3,Q%K;6GE9"!O^;L, ZQH>.A]YOJ*\=JM.[4W'N+VS=4XU)6N8VA
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M07ZI<Y@L5I631]3#HYO6PN;JT\"%BGB-M-QJ\7O3#9'.YC"Q.='9PHC=9DD
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M @)WV>[FV=A[E%EX=+B+O3%DZ[>98">F1O[4?42/3Q"XM=I%>A3ZED=&FO\
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MI4ZE0U0^4 0! $ 0! $ 0! $ 0! $ 0! $ 0&_V1LG.;QSL.'Q$75(_VIYW
M^7#'XR2$<@/T\EIU&HC:CQ2-EJTYNB+K=O\ 8>&V5MZ'$8UH<X:/MVR 'SRZ
M<7N_F'@%Y'4ZB5V?$R[M6U"-$25:#8$ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
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MV,:XGR<G "Z%P]#O&-WJ=]6J]+IM;;O+#![BIO:>4.HA2ZS0$ 0! $ 0! $
M0! $ 0'U'')+(V.-I?(\Z-8T$DD^  1N@2.V]L?EJS69,&3W7UXO%.T>VB/9
MM2MY@.!_A-/K]KU!5&KYK&.$,7OV'?9T3>,L$6=PF"Q&#QL6-Q-6.G1A&D<,
M8T'K)\23XDKSURY*;K)U99QBDJ(SE R$ 0! $ 0! $ 0! $ 0! $ 0! $ 0!
M $ 0! $ 0! $ 0! $ 0$7[@]NMO;XPSL?E8RV9@)IW8]!+"\^+2>8.GM-/-=
M&FU,K,JQ-=VTIJC*==PNV.YMC9(ULI#YE.0GX3(1 F&5OT_==Z6E>ITNKA>5
M5GN*:]8E!XY$274:0@" ( @" ( @" ( @" ( @" EW;SMCN;?.2%;&0^73C(
M^+R,H(AB'T_>=Z&A<NJU<+*J\]QNLV)7'AD7$[?]N]O['PPQV)C+I7Z&Y=DT
M\V=X^\XCP&OLM\%Y;4ZF5Z59%S:M*"HB4+G-@0! $ 0! $ 0! $!\3UX+$+X
M;$;9H9!TOCD:'-<#X$'@5E.F0.-;Z^6+:>9=+<V]*<)>?J[R0"^JYQ_8UUC!
M_9X#T*TT_-IPPE\R\3CNZ.,L5@S@>[.S?</:YD??Q;YZD?$W:FL\.GZQ+1U-
M'[S0KNSK[5S)X])7W--..PA*ZS0$ 0! $ 0! $![4J-V]995I5Y+5F0Z1P0L
M=(]Q]36@DK$I**JW1&5%O(ZQLOY:-\YN2.?,!N"QYT+C-[=AP_8A:>'](CZU
M67^:VX81^9^!UV]%*6>!838?9S9&S&B6A4^)R1 #\E:TDF_H:^S&/W0/7JJ/
M4:ZY=S>&XL;6GC#+,G"Y#<$ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0! $ 0
M! $ 0! $ 0! $ 0&'F,-BLSCIL=E:L=RE8:6RP2C4$'T>(/H(XA2A-Q=4Z,Q
M**:HRM?<KY8LGCS)D=FN=?I<7/QDA_O$8Y_AN/"0>HZ.^E7^EYLGA<P>\K;V
MB:QB<*M5;-2Q)6M1/@L0N+)89&EKVN',.:>(5S&2:JC@::P9Y+)@( @" ( @
M" ( @" (#UJU;-NS'6JQ/GL3.#(H8VESW./(-:.)6)225692;P1W7MK\L62O
MF/([S<ZC3X.9BXS_ 'B0<_Q'CA&/4-7?0J;5<V2PMXO>=]G1-XR+*8?#8O#8
M^''8NK'3I5VAL4$0T: /Y3Z2>)5!.;DZMU991BDJ(S%$R$ 0! $ 0! $ 0!
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64JUQ.Q4V&2HF0@" ( @" ( @" __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ny20042551x1_image04.jpg
<TEXT>
begin 644 ny20042551x1_image04.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@!"0'" P$1  (1 0,1 ?_$ ,,  0 " P$! 0
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MVB4^TX\CI+, 6T<;%6\%RH"*J*28XX<6*Z7?%:S_ !5JNQR9<M<-:K\-F^W
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MJORTM7_DY)M26X^ZU7_Q(?PBT/J2?IJV3<1M+]G&],Q6Y++R.E(GO.;LGF7
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MQ[= .VFCOCMNZ6Q[= .VFCOCMNZ6Q[= .VFCOCMNZ6Q[= .VFCOCMNZ6Q[=
M.VFCOCMNZ6Q[= .VFCOCMNZ6Q[= .VFCOCMNZ6Q[= .VFCOCMNZ6Q[= .VFC
MOCMNZ6Q[= .VFCOCMNZ6Q[= .VFCOCMNZ6Q[= .VFCOCMNZ6Q[= .VFCOCMN
MZ6Q[= .VFCOCMNZ6Q[= .VFCOCMNZ6Q[= .VFCOCMNZ6Q[= .VFCOCMNZ6Q[
M= .VFCOCMNZ6Q[= .VFCOCMNZ6Q[= .VFCOCMNZ6Q[= .VFCOCMNZ6Q[= .V
MFCOCMNZ6Q[= .VFCOCMNZ6Q[= .VFCOCMNZ6Q[= .VFCOCMNZ6Q[= .VFCOC
MMNZ6Q[= .VFCOCMNZ6Q[= .VFCOCMNZ6Q[= .VFCOCMNZ6Q[= .VFCOCMNZ6
MQ[= .VFCOCMNZ6Q[= .VFCOCMNZ6Q[= .VFCOCMNZ6Q[= .VFCOCMNZ6Q[=
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MQ]V'HH!U5:_P;'W8>B@'55K_  ;'W8>B@'55K_!L?=AZ* =56O\ !L?=AZ*
M=56O\&Q]V'HH!U5:_P &Q]V'HH!U5:_P;'W8>B@'55K_  ;'W8>B@'55K_!L
M?=AZ* =56O\ !L?=AZ* =56O\&Q]V'HH!U5:_P &Q]V'HH!U5:_P;'W8>B@'
M55K_  ;'W8>B@'55K_!L?=AZ* =56O\ !L?=AZ* =56O\&Q]V'HH!U5:_P &
MQ]V'HH!U5:_P;'W8>B@'55K_  ;'W8>B@'55K_!L?=AZ* =56O\ !L?=AZ*
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M!@H&*$!)@0JF**B\2HM <BU  :#\38-[8!&;'?$YO.;!,H"6Q,<$V)E7*?\
M+7?3_+RW7[JG)?\ QW3T,Z\)(0H0KB*IBBIQHM<!UB@% * 4 H!0"@% * 4
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M -S#5.'>-IC@G]I,4K?V_,X+SH,N=3BK!B\*M6+J+2<<Y!YKC"_[::G&I F
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MG:GK;"FL26I<>83C;C[$R:Y<2#,VF5!?<52PPX1XEK5O"-3,UGN7BRYU0L*
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MEY.[5,@_:%ALXEKO?^3E?FJ<GHYFRQTSJ'5W>@^A1O17 =8ZAU=WH/H4;T4
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M[1",?5)AM4Y2EL4$^LNU?IK7F>IF/+]*-RJ%SYD#/GRIGPPS8;</)C0'V@%
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M)!N3".BNX-29$5!<OVV9)39HB(BY<?)A4TKQ-):4^YM>*8M@FWH\(GIMP+G
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MAQ+-%RTM?6+]8(5U95,LEM",4^J:;#'\A5S\RG#9HWI;B4DK5"PH!0"@% *
M4 H!0"@*?==2Z<TYJ63)U%,6WI(:;&!(D$XD51%%SB*[6A<S<..U4PJ*M0UI
MDFR>#T&]H^]LWKK&= 4SLQOHEO?,2$7< 3>FVAHB[M3X%X%VX;*MPM)3T15M
M-X='T@L502* Y?XLFS)O=LMURDNQ+2D=R2AQ;8ER=-\3$<A*;4@&P05Q]7$O
M+LJE?4WJB-\SX%K>E1IF>Z/%EET#K")?+>$46GFI<1I$>1R(]#;44)0 @!T4
MPS"*%E15R\%;6QQZ3&)FL,.OLDM=4+"@(S4K5X=LLANT"!3CRH(F\4;$,R;Q
M!= '% U#'*N7AJ'W%JP5N??7X_A\W+MRR(SQNM1".6XK[[*G)1AU2=-3S*.*
MX%C5XXK56BT=D29U<*SC&L]I!-W.\/:HF:16YR6[= *2ZS-1TN<GNHT=UMHG
ML<Q;LWR)<5VI@B[*I,T=M-9\<_(NZPZK\4>>&_,U=-ZPU%<K= U%)E.I**YP
MK84 5RL$P^VVCAJTFS,9'O!+A1-B;*VK5.R_-Q;H3CL@I?#B4^B/'3UG7JR+
M$!(U>VR^XSU1=7-V9!O&XAD!95PQ$L=J+Q+0&/MJW\%N_0C]- .VK?P6[]"/
MTT!SG75P2??2D)'?BHK8)NI3:M.;$X<J\5>K[/T'#[CU'W0EQ2WWWG"QI$I-
MT8[J*VKKFW#;E3BI[ST#V_J)EQ<3)>#%5V+PUDC4FK%?QML4VU@39><U+/$8
M)X4V(F!*G M<W/S->7D27;5OX+=^A'Z:P-!VU;^"W?H1^F@';5OX+=^A'Z:
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M[(-X--*)!R,RY2R&I$.<>5E)<4QPK:^>.I>&6[(QIEAK?CGO)JJ%Q0"@% *
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MV_>T ZEUKWD;^7M^]H!U+K7O(W\O;][0#J76O>1OY>W[V@'4NM>\C?R]OWM
M.I=:]Y&_E[?O: =2ZU[R-_+V_>T ZEUKWD;^7M^]H!U+K7O(W\O;][0#J76O
M>1OY>W[V@'4NM>\C?R]OWM .I=:]Y&_E[?O: =2ZU[R-_+V_>T ZEUKWD;^7
MM^]H!U+K7O(W\O;][0#J76O>1OY>W[V@'4NM>\C?R]OWM .I=:]Y&_E[?O:
M=2ZU[R-_+V_>T ZEUKWD;^7M^]H!U+K7O(W\O;][0#J76O>1OY>W[V@'4NM>
M\C?R]OWM .I=:]Y&_E[?O: =2ZU[R-_+V_>T ZEUKWD;^7M^]H!U+K7O(W\O
M;][0#J76O>1OY>W[V@'4NM>\C?R]OWM .I=:]Y&_E[?O: =2ZU[R-_+V_>T
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MM=?B+I_?D>FO5X>5^7N//XN9M'/M=?B+I_?D>FG#ROR]PXN9M)/2TW69:FM
MR'[BK"S8Z/(X;Z@H*Z.;-BN&&'#C6?.KR^!QPY/47Y3OQ+/,Z5:94&UZIU1&
MU&TO.+M)$H!N-$X$F'NA$66R1%1<I9D4//7@4QI&F7/D^P]BV%YT0OF4F1=@
ML-WU&5GF/6=MZ\Y$C,LINT K4TBN*&0D54?;PQ_.1:7L_P!-0\8O_P!I73:3
M:.-?T><DS$O]_"#:VPOD@I5TL(RC64)$(S2-I"Y3;1&W]9.!<NTL-E7YZ2O=
M5R34=4O3U&/(;=:.V;5IZX\L>LU)UUU$5P@7N.=P;?ZFD#N<ZOAB,QH73#
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MG<N7.F...S#"J\Q4X7ED6H[2LR9GWS3K.H]:PKF/.4ELQF6X*-&Z3YHP2*V
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MYB("3KB\P=17&QW!J,PK@$6G[CE/<.O"WO%C/#GS;U Y28*F9$7#@K%2ZO\
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M51%11 *YXP6M.9-4XM.C41A>%\H'7 C7<4@2EBR)L9^,KI',@M VR\#@O-Y
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C * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ny20042551x1_image05.jpg
<TEXT>
begin 644 ny20042551x1_image05.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@! @'" P$1  (1 0,1 ?_$ ,@  0 " P$! 0
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M.S&LU+3_ ';-?PN"[B$]M9_BDIFDM9WP+9H*9<987&=<+K>C?9?$1=!T$DY
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M..V1$N8E4!557#+BNSM;* \I;;<C8MI%9X88Y X8Y4S;%P3#9C0&86F@;1H
M$6T3*@(B(*)VL*/$+ \N18S@ #C0&#:HH"0HJ"J;E1%W84V@^##B Z;PL-BZ
MZF#CB"*$2?K+ABM ?%A0U;X2L-JUFS\-0'+FQQS8888T!\;@06T!&X[0(VJD
MV@@*957>HX)L6@/918Q/C()H%?!,HNJ**:)VD+?0!V-'>!6WF@< E12 Q0D5
M4W*J+0'W@L\07.&/$%,HG@F9!7L(O:H#"=KMINFZ<1DG7$5#<5L%(D78N*X8
MK0'UJVVYG-PHK+><<IY&Q'$>TN";4H#TL*$K;;2QVU;:5%:!0'**IN44PV4!
MX>M=L><)QZ(RXX>&8S; E7#=BJI0'T;;;A:-H8K(M.+BXVC8H)+VU3#!: V$
M1$1$1,$38B)0"@% * 4 H!0"@% * 4 H!0"@% * 4!#-ZNLQRIT55>;?@-H^
M\#C+@9FB)1$VLR)Q$4A44R]FH3PDEK&.F&?8;+5\A+:7+J^+L*(R)FZLMLF#
M$0VJ1 :(6%3; BJEPB.\_=.K"ZRCCRDCRQUB(RYUE'$!'516<,_N:H>[N=M'
MAGTC/L"QZ:\NT]IKC312(K+<OBC,%DFI#8D3*=9]P0W43**N_F(J[:MPN8TD
M3A)/54D4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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M]6:^&\M;''][^J(\,=QUEH.&T 8XY!0<?63"H;EBJA0>J@D4 H!0"@% * 4
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M/0Y/I1/5@:"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M_3:SXLY((@]"  C !&#(HUL:Q8$D9)6_^61 JA^;A4\3EO2R(41H)FH)% *
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M 8Y7R9[V!?BJ5F0S\]N=V7KK7O(\P[5H7[*P/8+^\M>/[GUL]#D^E$]6!H*
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MK_,'Q':O*LCZOH!U_F#XCM7E61]7T Z_S!\1VKRK(^KZ =?Y@^([5Y5D?5]
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MH"!?TBCS[COAFZM\0B/AMRE$!S+C@*9=B)V* Q^9B>/+O\[7O: >9B>/+O\
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M@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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MDH$XR8N"ABN!"JBJIBG92@,] * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% *
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M3HXL7AZK3NXN(Q6CE?>K:U;)C<2&Y>+6ZVKIOW&=)"8VTRZR.)2 =ZMAQE)
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M * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4
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M?F^I]=H_AGX'/R5]"U\-6]_3R-S2W,BZ2PBNWJ&.6=;F+@RU;&),IQM73("
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*@% * 4 H!0'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ny20042551x1_image06.jpg
<TEXT>
begin 644 ny20042551x1_image06.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@!" '" P$1  (1 0,1 ?_$ ,(  0 " P$! 0
M       %!@,$!P(!" $!  ,! 0                $" P0%$  ! P(# @<)
M"PD&!0,% 0 " 0,$  41$@8A$S%!(A065@=1,M*35)34%95A<8'10B-3TU75
M%Y&AL5*R,W,U-L%R@K,D=&*BPD,TDD1DHZ0E=0@F$0 " 0$$!P8#!@8" P$
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M(XK8J68-@KCACB/%208WK+9WCSO08[AY][F-H"7>?KXJG?;.&B#/2VJUKO\
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M8O+S"/C()#D?-!\X2+BA'LY2X\:T!FBPH<0""*PW' B4R%H!!%)>$E043:M
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MUEY/(J*B*FU%X%J * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MI.2I**F'%E3WZ DJ YQ<[+=V^TX9E@BO02N$9T+Q-<$7(1HC: T^@YD7?@0
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MBDF00<%1+#%=B[,$IPVQLMPMN[_O$.+MV-E_;N+0)(0H0KB*IBBIQHM0$Y%
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M*4UCD%<5<7'E;=J)6KY5O,ES/<7FJ%Q0"@% * 4 H!0"@% * 4 H!0"@% *
M4!RCM3_G[7\ ?TK7J=%RG%U',1V@/ZJA_P"+]E:TZKD93)YD=HKQST!0"@%
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M&VD6ZK+<+;NV&(AZ+;;,;.V_ M@&)@)@N821%%4X%1=J4:@A.5)]J"10"@%
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M .@]E\INOMBZ^DT Z#V7RFZ^V+KZ30#H/9?*;K[8NOI- .@]E\INOMBZ^DT
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M0JOD<>/PQ+<+GA^?MYE^8>!]AMYM<6W10P7W"3%*5*'!6FJ5)[J"10"@% *
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M?74 Z-6[Z:=[0G?74 Z-6[Z:=[0G?74 Z-6[Z:=[0G?74 Z-6[Z:=[0G?74
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M'$Q%.%:BO)JI4M$TYE-5Q*5D7% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@%
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MO:;9C,JXUD:=)\%,'"%PD>-2)S,:*JD2XKQ[:TJ<VF:46,UTTU=@U/<[ZS=
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MUJSC K#Q).H)% * 4 H!0"@% <W[7/W]L_NO?I"O0Z&YG)U.!3]-_P!16O\
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M =-F?L:\>8NT Z;,_8UX\Q=H!TV9^QKQYB[0#ILS]C7CS%V@'39G[&O'F+M
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MC26RLITNTR;W4O56[?DB>D57ZU);Z;+'I[4=W@0B9?TK>,ZFI)E"(J8*B?\
MR:PS*E4[#6A0B3Z:3NJMZ\7#])K,L.FD[JK>O%P_2: Y5VD6G66H=1+<+?I6
MY\W5H ^<YH)8BFW9SA:]/I.KHRZ(9P]1T]5=4HP]GUDUI8=4QKG/TK<N;- Z
M);OFA%B;:BFSG"<:U/5=7170TB.GZ:JBJ6=;Z:3NJMZ\7#])KRSO-:YZMNK\
M!YEC2UZ%TQP!<D1-N/=YS5J'#M(:L*OZPU?U;O/Y8OI-='U:3+@99[9JVZQX
M#++^EKT3H#@:Y(B[<>ZLFN>MR[#5*PVNFD[JK>O%P_2:J2.FD[JK>O%P_2:
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MWMO,,1Y$2(C1H<I')KL4LJJXJ_."SG#*FS%*I0IC6Z5&B:4_"? TK4*S\_\
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M2*S'1!RHC38@B#CCAR439BN-)(@P+I^PJTK*VV*K1'O2;W+>53_75,N&;W:
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MR1!NU!(H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H!0"@% * 4 H#6FW&'!
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M$0N9E4"Q00++ARL*OPV[XWV/R:*S9WONGU3+95210"@% * 4 H!0"@% * 4
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5"@% * 4 H!0"@% * 4 H!0"@/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ny20042551x1_image07.jpg
<TEXT>
begin 644 ny20042551x1_image07.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@!%@'" P$1  (1 0,1 ?_$ +L  0 " P$! 0
M       $!0(#!@<!" $! 0$! 0$               (! P0%$   !@ "! H'
M!@,$"0,#!0   0(#! 41!B$2$Q8Q4Y/35)34E58'05%AD2(4%7$RTB/5%Z%"
M4H'!<C.Q8I*BLL)#)#2"@T2CLS6$Q"5EA1$!  $" P0'!0<#!0$!      $1
M B$Q T%181+P<8&1H;$$P=$B,A/A0E)B<J(4@I+"\;+2XC,CH__:  P# 0 "
M$0,1 #\ _5(
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MR(AF>#6Q41[1)>LM'I'IFV/BX<N&[;7JEYXF:6\9NQV83EUP]U'%U
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M+3)5&G,/)AKV<HT+2>S7CAJJPX#QT#(RKO)SHL
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MW93CD2Y1%CJPV;!Q4.&G01'\9K(STZ> 2IH^D9N\0(ZBWS@!](S=X@1U%OG
M#Z1F[Q CJ+?. 'TC-WB!'46^< /I&;O$".HM\X ?2,W>($=1;YP ^D9N\0(Z
MBWS@!](S=X@1U%OG #Z1F[Q CJ+?. 'TC-WB!'46^< /I&;O$".HM\X ?2,W
M>($=1;YP ^D9N\0(ZBWS@!](S=X@1U%OG #Z1F[Q CJ+?. 'TC-WB!'46^<
M/I&;O$".HM\X ?2,W>($=1;YP ^D9N\0(ZBWS@!](S=X@1U%OG #Z1F[Q CJ
M+?. 'TC-WB!'46^< /I&;O$".HM\X ?2,W>($=1;YP ^D9N\0(ZBWS@!](S=
MX@1U%OG #Z1F[Q CJ+?. 'TC-WB!'46^< /I&;O$".HM\X ?2,W>($=1;YP
M^D9N\0(ZBWS@!](S=X@1U%OG #Z1F[Q CJ+?. 'TC-WB!'46^< /I&;O$".H
MM\X ?2,W>($=1;YP ^D9N\0(ZBWS@!](S=X@1U%OG #Z1F[Q CJ+?. 'TC-W
MB!'46^< /I&;O$".HM\X ?2,W>($=1;YP ^D9N\0(ZBWS@!](S=X@1U%OG #
MZ1F[Q CJ+?. 'TC-WB!'46^< /I&;O$".HM\X ?2,W>($=1;YP ^D9N\0(ZB
MWS@"X@,S&8B&YD@I4A..N^2":)6)F9? 1J(L"T<(#>
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M ;[TO$6?=-GV8!;P)S$Z(B4PEU+3F.JE]EV.Y\)FD]9IY+;B=)>E.GAX &\
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MEPEK)X/_ $^_$=M3U$6QRZ>6]RLT9NGFOS>C)2E*22DB))%@1%H(B(>%ZWT
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M&<0A"5I22GR=6IMM;)$H\4J4VHOBP/1B9$01%8B=_NB?*:DX3TZO/!T8P
M                        ,R(L3T$7"8#SS,WF'.FV"LMY,;^<M5&:'YQ8
M&RQZ%&2ONF:?7P?:8]NEZ:(CGU,(>74UYF>6S&5IDOR\A42CL)SAV%\]BI^<
MYBK5,^$F\>#[>$QSU_4S?A&%J]+0BW&<;G7CS.X              .)\RLHR
MK**U=TV+68*K\V.XWH6XA.DV_:?]/N](]7IM:+9Y;OEEY]?2F8K'S0M<C9NC
M9GI$3$X(F-?E3H_ :'2+3H/^57"0YZ^C.G=38O1U8OMJZ$<74
M        !Q\:KSC L<T38<6$XNUE,/5VTDN)P0B.W'6;N#"M51;+6(BUO4-K
M\$1QGQ5=,3=$[K8CQF?:KI^1;N5%<89:BQ&[* 598HVSCALMI?6[M6U;)&U6
MHG5XD9(TGCZ MB(GA6V?[=B8F:<?B_=M3;W([ZH<X\O(8K9KBFU,*9-4<UGK
MI5(6MYI.NAQQ&LV2TD9I(S,N$3->G3?2>RBK:;=SJ*://CU$&/8OE)GLL-HE
MR"X''4H(EK]'WE:1=\Q-TTR<[(F(QS0+#)]3/F.2WW[)#KN!J3'M+*,T6!$7
MPM,2&VT\'\J2]8E2/N#1=*M^^[?M0!N#1=*M^^[?M0!N#1=*M^^[?M0!N#1=
M*M^^[?M0!N#1=*M^^[?M0!N#1=*M^^[?M0!N#1=*M^^[?M0!N#1=*M^^[?M0
M!N#1=*M^^[?M0!N#1=*M^^[?M0!N#1=*M^^[?M0!N#1=*M^^[?M0!N#1=*M^
M^[?M0!N#1=*M^^[?M0!N#1=*M^^[?M0!N#1=*M^^[?M0!N#1=*M^^[?M0!N#
M1=*M^^[?M0#1.RAE:!%<ES+"U8C-%K..KN[<B(NM#;;9F:0R9B(K+SR/7V.<
MK14?+#UG!R\T9HE6,RQL))/)/0:4M2)#J-/H+5Q]9EP#WVV6:,5NQOW/'-]V
MKA;A;O=[6>5.4ZUDD13L&7%$1/.L65A&VAD7WE(COM-X_8D>35UKKYK+TZ>G
M%D4A-W!HNE6_?=OVH<G0W!HNE6_?=OVH W!HNE6_?=OVH W!HNE6_?=OVH W
M!HNE6_?=OVH W!HNE6_?=OVH W!HNE6_?=OVH W!HNE6_?=OVH W!HNE6_?=
MOVH W!HNE6_?=OVH W!HNE6_?=OVH W!HNE6_?=OVH W!HNE6_?=OVH W!HN
ME6_?=OVH!Y]G+*+.3K6/=P%3E9?DK2W:QV9TQIXE'P+.0VZE]6)GC\:STCZ&
ME=&M9R3\T9/'J1].[GC*<W=PLG99FQ&9<6;;.QWT$XTX5W;X&E18E_\ *'@N
MMF)I+UQ-8K#=N#1=*M^^[?M0QIN#1=*M^^[?M0!N#1=*M^^[?M0!N#1=*M^^
M[?M0!N#1=*M^^[?M0!N#1=*M^^[?M0!N#1=*M^^[?M0!N#1=*M^^[?M0!N#1
M=*M^^[?M0!N#1=*M^^[?M0!N#1=*M^^[?M0!N#1=*M^^[?M0"ZKJ]BOAMQ&%
M/+::QU52'WI+IZRC4>L\^MQU6D]&LK06@M "2
M        "ES3FZFRU 5*L7<%F1[".G2XZKU)+^_@'72T;KYI#GJ:L6167#0<
MNYC\P);=KF;7KZ!L]:%4H,TJ<+^I? >G^H]/JP'KNU+=&*68W;WGBR[5FMV%
MNYZ;#AQ(49N+$90Q':(DMM-D24I(O41#P3=,S67KB(C"&X8T
M      &B?!BSX3T*6V3L:0@VW6U:2-*BP&VW3$UADQ$Q27FV49TK).9G,H6S
MAG4S%F[22UGBDC4?^7CZ,3T8?U?:/?K6QJV<]N<9O)I3.G=R3EL>H#Y[V
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M &\]WX1MN5JNW +BOE/RHC;[\1Z ZO'6BR#:4ZC!1D6L;#CS>DBQ+!9Z/;H
M2  !5HRMEA#D]Q%1"2Y:EJVBRC-$<HCQT2#U?S>$_OXC*84V-K-:[6XZ*D4<
M(SKXQG6Z:[%EO_M_AU?R-'Y?PZ/APT"JS6NUE,*;&V75ULR-(BRXC,B++_\
M+8=;0MMW02?S$J(R7H21:1C8EO;;;:;2VVDD-H(DH0DB)*4D6!$1%P$03-61
M%&0                   /BE)2DU*,DI26)F>@B(@'F]]GVVOIZ\OY'1MGB
MT2[;_I-)/1\"O^;W#W:?I[;(YM3N>2_6FZ>6SO=!DO(%7EILW\3F6[Q'\U8.
M:5J-6E1)QQU2Q]_I''7]1-_"W<ZZ6C%G6ZD>=V
M   'G?F1E^P@3F,[4"<+&!A]0:3HVS!%@9GAPX)T'[/L'M]-J1,?3NRG)Y=>
MR8GGMSAV.6\P0+^G8LX2L6GB^-!_>0LOO(5[2,>;5TYLNI+OIWQ=%868YK
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M6"B,R,C(P'E:G/VYSAK-KQRE=+^)..)1WOM]G_#]@^C_ .]GY[?%XO\ RO\
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M*MMF<F3,0JZ3-U7;R5QF$N-NI+62EPB+627JP-0Z:FA=9%91;J1<NQQ=
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M-9P)Z+(F1VG4&9$HM9"UI46)&1Z2&-1OW-\MO%E-WA%YP _<WRV\64W>$7G
M#]S?+;Q93=X1>< /W-\MO%E-WA%YP _<WRV\64W>$7G #]S?+;Q93=X1>< /
MW-\MO%E-WA%YP!/AYMRK-:VL*Y@RFN$EL267"]Z%&*BR9RADW1#7(SEEQG'&
M8E9EZ$$:O]!#I&A?.Q$ZEJIL/-'+D-LUJU]4OYW#0TC_ &EJ_N%QZ6[;,)^M
M&QSY^>-%)_\ $L*=HCX%/V,;^];8WZ5D9W'/=.4/G[D,2>'.&7H9'_\ V$0S
M+W+6%=*-\GQRRWARE(+_ +_S)K5$?WFV9\9*?_ND7^Z,^M;&5I].9SEDW*\F
MBQ-W-U:\H^%2K.+CCZ]"R"?57-^C#0V]Y3MDI3>>*U+V.+3A6$,C3[G-(V?5
M3N9]&&1^8]?5'^5G&CM8Z> EV$7:8>W%PC_B85TKORE+XXNAH_-#+MFPES:)
M2E6@GF5I?9/['$8C+O33G&+8U8VX+:;GG)< D?/W]=#-TL6RDRF6347L)Q23
M'"ZV8S=(F)1?W-\MO%E-WA%YP2T_<WRV\64W>$7G #]S?+;Q93=X1>< /W-\
MMO%E-WA%YP _<WRV\64W>$7G #]S?+;Q93=X1>< /W-\MO%E-WA%YP _<WRV
M\64W>$7G #]S?+;Q93=X1>< /W-\MO%E-WA%YP _<WRV\64W>$7G #]S?+;Q
M93=X1>< /W-\MO%E-WA%YP _<WRV\64W>$7G #]S?+;Q93=X1>< /W-\MO%E
M-WA%YP _<WRV\64W>$7G #]S?+;Q93=X1>< /W-\MO%E-WA%YP _<WRV\64W
M>$7G #]S?+;Q93=X1>< /W-\MO%E-WA%YP _<WRV\64W>$7G %!G;,/E9F>C
M=@NYLID2$8N0W_GXN+;I%H/_ #. ^ QVT-:=.ZKEJZ47VT1_+SS6HG:0XV8;
M>'$DP#)HI[TEI+$A' E:'E*)"CT8:#T\(Z^JT8CXK?EEST-6OPS\T.G_ '-\
MMO%E-WA%YP>1Z3]S?+;Q93=X1>< /W-\MO%E-WA%YP _<WRV\64W>$7G #]S
M?+;Q93=X1>< /W-\MO%E-WA%YP!>5MG6VD)N=62V9T)[6V4J,XAYI>JHTJU5
MH-23P4DR/ ^$!)   R(R,CX#T!(YW<#+7R\.-L7"8A(V*&R<7@XUM-KLW=/Y
MB=?XL#&\V->KPR[B<IC?7QS[TZWRU4VT63'FH4I,E32U+2HTK2IA1+:-M1:4
MZBTZQ8>D33ITX8-BZB97P(M? C0(B-G%B-(98;X=5#:22DL3]A"KKIF:RFVV
M(BD) QH   "/8O/,5\EYA.N\VTM;:.'%24F9$*MBLQ5DS@X"BS/G"9*<9BZD
MI9I-1DZDB2@L>'$C2/=J:.G$5G!YK-2Z5W\CG^3_ )LUB*1^A!:2]Q&./-I1
MLJZ4OG:R+)=@_P#_ )"ZD/)/A;;Q07\347\!G\B(RM@^E.V6]C(.76CQ4VX\
M?K<6?_+JC)]3>V-&U91\MT3&&S@LXEZ5))1_[V(YSJW3M7%D1L6"&T(224))
M*2X$I+ OX#FI]       !IEPH<MO9RF4/(_I6DCP^S'@&VW3&3)B)<_*R) V
MFWK'W:^27W5-F9I]V)'_ !'>/4SE=BYSI1LP:">SS5'^8TBUCIX31H<P]F&!
M_P #%4TKORLK?'%*A9[IWE[*42X+Y:%(>(\"/[2_O$W>FNC+%L:L.@9?8?;)
MUAQ+K:M*5H,E$?\ :0X3$QFZQ+,8                           \^\R<
MMSV7V<XT"31<5OQ2D(+2\PDOBQ+^;53P^M(]OIM6)^"[Y9>77TY^>W.'5Y5S
M)!S%2L6<118.%JO-8_$VX7WD*^S_ $#S:NE-EU)=]/4B^*PMAS6
M(UE91*V&N7+4HF6_0VVMYQ1^A*&FDK<6H_0E*3,QDRV(5AYWRN3,![YY)M69
M$J(X2'#3JFHD:SIDG\E.N9(Q<U2UOAX= JF-.G2=F_8S97IQ[MNYLK\X9=L$
M3%Q)>T3 <)J0>S=3\2E&A.IK)+:)4HC2E2,4F98$8R,8B=_3IPQ)PFBX
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M2\YBHU%K%&:CM?"1ZI:K9:"TXGI 2@
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MW0+7NR;S0!OI7= M>[)O- &^E=T"U[LF\T ;Z5W0+7NR;S0!OI7= M>[)O-
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MMMD24(21$E*2+ B(BX"()FJ8BC(&@
M                                     "-82W8L8W68SDMW'!N.SJDI
M1_XEFE*2]JCP&2V'-J\R*DHC$KY63LC9.1.T(QB-)>-A2GOBTZKB%%\&.@C/
M@%12O=^[)GGC^W-LI?,.IMU2$1V'D.M.(;8:5J&I\G5.)2ILDJ5A_DK,R5@9
M$6)Z B*Q$[_=$^4P3ATXT\W4C
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M(VCA\*UX<*O:$94V&VNU+
M                                                          5V
M8)UE!J)$FMA*L)R$_D14F1:RC/#$\3+07">&D7IVQ-U)FD(OF8BL167 [[>;
MGA-'N7^,>WZ&A^)YOK:OX7)4OF7YF/9C=8::.?(,UDJJ4V1)1JXX_=U5)U?:
M8]%_I=*+:Y<7"SU&IS;^#KV\Z^;9N))64T:IF1']].C'UFL\!YIT-'\;O]75
M_"C9^S.T5O'NHQ+=9RA)87826),;Y>.J0>REM24J?;<-1,.?#@VKXAX-.:75
M^[/P]?2ZG<]M]L\O+3&G-[O"O?U+&1G\E.6TD\P0X$:(9ICP]BF0ZJ.HFS9F
MH/:HQ;7KG\1EJ:2TZ-.Q$TQSK3JGFI3MAE<<,J=^'LGR<AF#S L+7+BXEE.3
M -@S7KDC5<FN1[)3"FD[)Q1$IMII*W$(-6.M_3P[ITF;+N-F'7G/?W=S=2W"
MZ(VQ?_MK'?7IBLY/F@<-M*X5C")[ZP^S)BQXZ$H=93-986MUQ3I:BD-/8JP(
MU&?Q:"&Z<5NMB=L1XS='G'2K+YPNG=7PMKT\,EKG%FK=\S(/R\BHCVATLTY:
M[!A,A:HVNWH4DGHZR3J&YI,S+#6]HY1E?NI%?'[/!TV6[^;!R^3\XV\"#ERG
MR\[20Z5N"U*?>>=4W\T:WGBEIB,LM/;5QK4UC23B3Q/XL2':Z:W3,Y1$==.6
M*3U5\I<8C##.9GSR[O8RGYW5:RJHG[=*GXMTRFKE%J1S>:DUCKA*..AUQ"R)
MW0G7TEP</#QQS^]$7QW6U]NQUBDQ=$Y?!/\ ^E/*)Z0QK,Z.U+C%H=^S,LGZ
MZD*:S(<0:GU2'7&U(2DUX-J)*^%*=)EB?I'74FDS$1][_'['#2K=3FPGE_R=
M#)\PYZ<E%;IOHQV<@D&F$S%0M<>4<=QU<)S7>0E*M9&'YF"M!EPF0YZWP9?%
M$5[8AUTHYOFCERPW8]."N_=#,DNFE6E?95CB2F189FI:68L1$F,V]M9$@DRU
M),EF;>)HU?80Z:EE)I'XKHK^F9\\''1U)NBLQCRVS3KS[E]F2=->H\K.9D=C
M+IY#Y[S/PUK7 6C8KV>NM26\8ZW,-;6223].@9,1STG*FW?A]M'2)GDK&=8R
MW=*5:[2]J*!MIO+$V-6U4]+\AB7@ER&Y(8:;2U%C8J2V272+0EL^$CU=.(F9
MNRW1AOG'OZ;E1$>SJS<]#\VKY];R95S6PWR?G,*B$A&NS\M!1+1CKN&9J)>L
MVK'_ $BKHB(K'X;I[K^7QC%%DS-W+/XK8_NMKYX)A>:-TIW;(M8+B<8CA0FF
M#<6<.5#2\])+5<4M11U*UC,L",BU=!F0S*9B=DW1U4BML]N7:WW6]L\W+,>W
M@A2?-NZ;3LDWD%M*7)VH_(:92Z\VQ 3+8624/*;)*E*U='"6' 8R9I6NRV>^
M+XCQA416;8_%=;'?$^4QTV]=1YKMIDYDY$]HJYUENX5-)#91DUSC.EO;?=Q2
M_P#S8_=+$7=;RW3'X:Q_Q\*]SG9=-UL3MNB/^WL[VKS7D98U\I2;5Z E'U9M
MR+(FFT;9)V*U&LC698IQU#/ _5[!-N%^Z[EN\O>N<;)VVUM\_=5S=/YMV<ER
M/&DW5>M,N-$D2+!I+9(A$\[(;<6I.NHM3\EO2L_AUM.@+:3PR\;:T[S[M?U>
M%T17NF>YZY4O*>K8SJI3<Y2VR,YC*=1MW_70DE+P(_\ $879LA+&-
M                                       !BEEI+BG$H23B_OK(B(SP
MX,3"HR                  %;74,2!96-@TX\M^T6AR2EQ>L@C;03:=1.'P
MEJD1!;%(IQJ3C->%%D ALU;#;TIXUNN.R\"<4M9XI0G'50@TX:J4ZQX8>L-E
M#;5*::;:;0TVDD-MD24(+01)(L"(ALS49#
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M&V>"M4G4H-1$>C6+1[1DQ1M4T8T
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M;$:=6=<E+2FC8CJ49H8-2G'3<V>.!*/ \!DW5B*YMB*3-,EX,:
M
3                      __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ny20042551x1_image08.jpg
<TEXT>
begin 644 ny20042551x1_image08.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@#H +0 P$1  (1 0,1 ?_$ )D  0 " P$! 0
M       $!0(#!@<!" $! 0                    $0  $$ 0,"! $&" L&
M @D "P(  0,$!1$2!B$3,2(4!T%1,B.45@AA0M*S%18V%W&1T9*R4]-T=78W
M@5)B,R15U)6AL7*"0S0E-5>35+3!\6,8X7.U)Q$! 0$
M  $1_]H # ,!  (1 Q$ /P#]4H" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M>)VBL= 8_+U ]'^35!Z(SZ]6\$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!YG[
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M^/20QY66>L,TL$D^C1"7D(B<M69F'7Y$'2VLOQ;'VL?QRS+7K39.,PQV-,6
M98XF;> "[;.C%\W_ -"#D:_[B,?CKW,*U/#PTL=9.M<RL50/)8 Q$A%QC<B?
M<3=09T&RSSGV8XUGY[IS5:6:RL4<TUV&I,4MF.46E!^]%$7<U'0M-70;[/*O
M:3-<IJQV7KW>0XPM:DTE.8Y*Y,#6/+,\6V-]GF^<R##BO-O9RO0RV0XW:I5:
MH%':RTE> X"(IS[83&#Q@9[C+3<S.@MX;7MY2Y[)3A&E!S7)5N]-LB8;4U<?
MB<C#U^9KHY:]-4%@'+^-'B;^6:_&V-QDDT%^T>H!%)6?;*);F;YK].G^Q!7\
M&L< +#V;O$8JU7&',<ELX("JB\K,SF9B81OKM_&=D%=)8]HN=8NUFYJU#/4L
M8Q>ILRU>\<; &]_*<?<=MC[AT;JW@@L*W+?;O"T*T-6Y3Q^.DHOE*XQ"T4#4
MV<6[WE%@%G<V9M>KOT;J@CM[P>W#XR7)CF0>I!*,,[M#.\D9FSD.^+M]T1)A
M?0G';^%!@WO+[;/CH<BV8UIV)GK02-7M.\DK1]UQ 6BW%Y'W:LVB#K,=D*F1
MH07Z9O)5L@TL)N) [B3:L^TV$F_VL@XKV;_^PYK_ #!E_P#]K-!TW)N6<=XQ
MCGR&<O1TZ^NT-[ZG(7P"*-M3,G^060>;YSC_ "/W7.I)/BVXMQZM(,]3*6HV
M_3LFU]6*L+.WHQ+Y3=R_X4'J^/IM2HP5&FEL- #!W[!]R4]K:;C-_G$_Q=!(
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MM-##W D+MC$(;B>-S%M79_BA7KR((" @(" @(" @(" @(" @(#,S-HS:-\B
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M2;Y6)M6= EL5X7C&64(WF+MQ,9,+F;L[[1U\7T9WT9!L0$! 0$! 0$! 0$!
M0$! 0$! 0<YR;/9#'7J\,+=BL\1SG8]-+:>4HWU], Q..PR#5]Q?[&=!S[<S
MYE!#=FM4@*Q2KVCL8Z.K8UC*$'>N;3,1-+WCVLP .NCZZ]'00*W/?<!Y:PV<
M>$--Q>.[DFIV"A$MY,T\8[VE(=G;=A<&UW:[FT<6#87N+R\9"BEQAP5V H(\
MD=&UVSF]2(#8[8D[C%Z8M[@[[MVK:].H:<A[A>X%9Y##$ZUP'9'.=.?25Q)B
M>5A"0C'="^[MD/3PW$[.R";9YURFK#&4M4Y!9B.":"A,;W08I&8AB>47KB(Q
MBY;G,O,SL.B"9^M?*/T-BYWB8;=RM):)WIR%W)@?4*8QA,;1&;:^<Y-/P?!@
MJI.><\&]MJT!R./")Y2NQTK$(G*0&_IA&23N,XE&PB>UV)WT+9XN&5OF7N35
MA.$\=')EXI@@;'Q5)#>2&5A=K;2M-V!V;]KQ=QV<A?SZ=4&T.;\YMRP58,?Z
M4I(( >[+1LG$5PYH1FT;?'I$ 2GKJ6NH/U=M-0DTN9\IGXS'D2A".Y//9%AL
M5)H@ABAC-P[@QR32:E)LZOH_5VV_%!KK\ZY,SF4E4IHW;;#_ -#8B?O%6<XX
M9//)ME*?RFS>06_&?7H&KCG-.=9*WB1GHL$%N:1L@95)(@@!C=@#<\Q$SN %
MH3A\[1G86=G086.?<M"6^459IFJ2$=.$:-G2[$QOO"&5S;1XHFU(B%M2\K"[
M-JX3).;\EFHS-2K,5R*N-C?Z.P0$(T^Z9 !%'N[EIVA -VYM"U01+7,O<*O9
MM4XZ<-BW ?9J_P#1V CLZB\3S[VD)HXXK(]6U=R!V=M/%!;\=Y5R+)9BG!<J
M/3@FCL%-6>M*TL90GVF>20R8  S B!V9W)G;HWBX=H@(" @(" @(" @(" @(
M" @(" @(" @IN98-\[Q?)8H#[<]F%_32L^CA.&APGK_PR"+H/,[O >9W<57O
M9+&QW\ID!R,V3Q8VACCK9"VT85+(2.^TFK10[-1\PZZCU08\K]ILK8;)VH,?
M7O9.7'X</7/V1*Q<K6B+(2.,A VLD+#NWNS'X:H-_/>$\AS_ !3BT.%QL4GI
M*]AI( >J 0E/6V0R1L,O:':;L3%$9;/$=4'1\6X);QO-;F4LL38\*T4N-K]U
MI(HKUIG;(R SZ'J?:C\Q-^,6GBZ#@9O:KW":6>U6B$9)"KUY:Q6 V2UGS%B[
M*3:%HTD0=DQU\6<A03^1>TU]KMNWB\#6E&3/O<:(1JGOH/CVCT[4TD4;MZIR
M?81-H_F01<A[1\NLVLT_IV"#-6I"8J\L<,D,;96O8$Y28_I7[$9%%_5NSC^,
M@E8WV[YH64X]9SN+AO#7LY8LK_\ +3@S7+\<L<HC-(#COB$BU!G(?#1!V?"^
M'9+C7'<C7Q-.EC\I9R5N8'E%SB*L5LR@W=DA+I7)F%M?+X(.;]RLC[HT^2F_
M%H[]JG'$%KM1P;H2LB'9],).W6,QD[KOKT,-->NB"GR][W:AR@U\4>9L8H0B
MB>U)5<92]6 16I'8@$M:G;>6+IUWZ-KH@VX_-^[-3E,CVJN8O<=KGK#I7VRS
MQTH2[#/N$7$KDDNDNO1MGP9T$:;D'NI=LYLZ-;.UX9)[00;Z[:"#V8'@&L+A
MJ!11--O(O*7335!OR&3]V!DR4..',N3D08^Y-7UCZ6 >K+V^VQ,(5Q-K D.L
MA/Y6^+!KAS/N98.Y#"V=A:G1BMUHYJIE(65>.-CI2R,&PX-82/<+[?I/%M-&
M"1%D_=&2Q5:S'F1]0T!SR1UW&"L,I&=Z&0-G<D,1-@@./5FT9]?E"-P[*^Z6
M&LXF.WCLS8Q./HO'8JRPO-)/.$<FX-Y/KK+*X%&;OY1Z%IU0;\AG/=26K,\%
M'.!<.S:,G"$1CVF)^@[+$+[8H7<?4 3;C^&Y!K/)>ZXWK=H1S9,TQS5X6K-V
M7TR$>P&!PW-&])Y7VD_R,_FT9!U',L=[LV<CDI>.V#CCD#7&%W88X A]*['%
M)%(W<]05C1Q/YK-XNVCLX6')<3[@1U./08"[-/:JZ_I*2S+$ 2.0LS26#':9
M,!:NP@#L7@_RH**3&^\C/A6JO.#0Q$.6.>U7D*6:03:4F87$6!BV%%H+NWQV
MZ=0E_JQ[D6^!\BPUZ[.>2M5:WZ*L%8C&;U#U8WM!W8M-H^I8Q;7X?@04Q\8]
MT</!DKF'G*E%>MY"U;AMV:^T(3>N4)[VU89C$96<]W3XZ=$'09S#\EN<3XU3
MS(Q9;)06&GR^&.6*$K\<<4K=H=2[9E&Y@9,[[2VH.5XS[?<QDS7'>16(M\-,
M,>,D9'MM!$,MMSB:61VD8:P2Q!(+M]*S=/!!OR/$.?U?<7D.8PU:,),BTWI9
M7L0Q2'7.&K&Y@S2=PCB.(MHF(B.OSO,@L*F#]Y2J#-D+UAY8@HQ35:\]8"FC
M&2;U91D[.P3.#0Z$Y,WSOB@V6L3[QED)3CL3>A>PY6XAL5F.6MZ@7A"D[M]"
M80>65Y'\S^'RH' ^-^Z&&N<;I6CC@P-*B$>0K#)')I+I+W!)A=M2(RC(3'5M
M&TZ=4%9RG >ZESDX6;+&6%AR36*<,-NM$8$/>BB],<Q:L1Q2MJ+BW75M/BJ+
M%\3[PSSA3GRXQ7?01O+-#-"T3$U1QT:';W.Z5X=7D^9LU;\"@D8[&^\SYO!V
M[E@(Z4KC8S%5I(S&N4DQG-6TU;N",+@$9"[Z.VOX4'J"#7+9K0G%'-*$9SEL
MA R87,M'+:+/\Y]&=]&0;$! 0$! 0$! 0$! 0$! 0<SS+FP<:*L/H9;[RQSV
M)PAUWQUZS"\ILS"3.[,>K;B%NC^;7HX5V2]RBQ^,:Q+C6EN>N*D]:&PQQN(0
M-8DF";9YA 'T+R]"U;7IJ@P/W3KA((^@WA.<0TW"9G(AG.2*,I1<6[6DD3=S
M5W8!)B=_@@G9WG4F)#,D6/:7]#A5(G[VC2%98B(1T R'ML+/U;KK\&ZH(^*]
MRZF7L1QXVO'/')D/0"WJ0[Q",822SA$ GY8M[[F(AZ-KXNPH.T0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 04_,,5;RO'+E"FXM9E8"B8GVL[
MQR#)MU^&[;IJ@X^UA>?0#8LXG_IK61FO3M6FF 887G$>UO>,G<Y_H]K-H0#N
M=]6=NH6-S \JN\,H5K4DI96O=@LRQQ3/#*\$=C=V2E:0F-VBZ.Y'YOB@I*W%
MO<W&X_%8[&V]E*O6I#-W)6D..R$3C+L\T;%"!,VL>[1_@R"]Y5QWDUWDT5W%
MS'7JE6B@LS12M%)H!S2.+?'3<4:"FBX[[G03;X+)!);M1VKTI3]P1-ZM<'<(
MWD >V$L<V^/P?<+LSZ= VGQ_W0BJ5CI9 WR 4ZP2>IL-)#Z@PM/;(QT?70R@
MVNS?#I\4%CP?!\MJ9N?(YZ2:0;-*.&*,I]XPE%/*6PP[LK&3A(.DC>/773XA
M!QW'><8\X:T4]AXPM2G!*=MCC%CNR32'.)DYR@=4A  _%)GZ-\Y!8YKCW)I.
M53WL?/.%.W^CFE<++Q@,=:69[ ;'=]KF)AU >K:H*BIA?=8@:2>X<9QD<L$0
MS@[,1R4]0/5Y.X#"UK9N+P=NC=&8-M3CON#+/ UF[;AJQG!&;O:9I9(7FF>S
M)*P%((R/&\>C 6C?BZ>#!LX3QKF5/-ULGR CDE**W'8:*=NTQRM5>.0XA<0)
MW[,C;M'?73X(,(J?N%;K6Y(K<QPQV[%>D.[T\IPQ"35;!O(P]&E/Z5OQQ%M&
M=NCT;*N)]R9<OCHKUF1J%::0LA9AG !L 4\LH; 'Z1A$"C#1]'Z:>'506O(,
M;S6;+67Q-OM8\ZO=B=S9G:TS]LH19V?02B=S8O!CZH.5O<1]Q2NSWJLTWJ)8
M7](4EH2]/L@O1P@;$Y#WF]1!K(+/KH^K_*$G*U><T<S!1ALW;-0[T'Z,>.5R
M,:[30'9.W([:&#Q]T1%WU;Y/!V"RY+@>;SY^[<P\[UZQPL4&R48W.>*K,T(R
M-IJX=\@U9^G^Q!6VN-<_EGFLP6+7J0AR%:K.5L1/=8. XI)(A,X186"00V_\
M+N(H)DN-]P@OM"YSRXBL=AI2"U&,]F&6V\D 1&Y"0''"XBY&XZZ.S/U9T$*K
MQ/F]*4?3E8*M&]QI];8E:E">V<T#132$3AM$HW+5V^:3?'J&Z7">Y@Q2S>NE
MLV)2F>2.&< B-XWKO7$-7C>&,R&;N.#[V%_CT9!=\RK\TM6L<W'R&)H# [9C
M*S-KW WQR"1!J#P[]K[2?=IT;Q0<ME>)>Y%G 3XN:Q/>AL4  HWM ,CWI( :
M4I)"TW0#(QZ@WRMHVB#J.58#.V^0U\KB93 JU">J6V9PU>6U6D,!%_*QG!'(
MPF[>4MK_  9T&_B&-Y37OY"QG+$DD!C&&-@*5C:.)B-])&'H4K"X"9_%VZ?*
MX<='QSW<*[9R%B6([8U):T3M(S:E+:@DF>$]^H-+#$[ V@;';\.J"SO<?YK8
MIQCD)[%B[6LT+ 3U[(U89(H"C>6+M-(VDKDQD^[42_WO@@TG@O<W]$Q0PY&5
M[AP0-);>R#CH4 M8C'5O^=ZK<8R,VW9Y?P()-' \YKYZ::T<UC$=UHQ&&P V
MCABFL/7(Y'<"(0"0-[.6I?AT=G";R_!<HR.?H2T]9*-:Q4L0_2B$,10E(4I3
M1OYI'?6/9IX:/X?$.9'A_N?--5R%J8'R4(Q.\N\&=GA.:3M[G>3<!R$SZ]-!
M+;HVBHM+&%]TYK<+/>>*J<-5[#12LQ,1V DMQ,6YMK@+FP&POJ+;=64%UQ>+
ME4F.S3SVB>9I)JN"ELB7_*AW-#/*)-N<B,_,^GF86=!!PW&N4%R7%93*22O6
MH#;$(I;#22"\\, OW-C[9&.4)"'_ '6T\/!@[Q 0$! 0$! 0$! 0$! 0$'-<
MRYCB.,-6EOTY;+VFD!R@ 2<8PT<][DXMIYFZ:]4'.![C\)[&.$L,P4XNU,&@
MU""H,LQQ#8 !D?6-NV4A2Q,[,/75!ODY[QNF-F>?C\L%>4=_?&.J7J9;$33C
M$P@;DYR@S.^YM/\ >=!LL>X/%K+PW"Q$ENH=X*=*^\<!M)?(?H&B8C[FL@NS
M!)HS=6ZLR"36Y9@K.8B:7!G'?KSC7M6C"L15;%B1X8QWB9$7<(>KQZZ-\[31
M!+R7N)B*&4O8PZ]B2SCQ:67:P;2A:%YI98W(FW#"VC'\6<F^5!(M\TJUH*<Y
MTK3QWHK5B'R@Q-#5B>7>0D0D/<'3:SMKU;=H@CMSV)VKFV+MO%8IUKN]G@U!
MKD@1QQR#W-PGJ?\ !Y2Z]$%MB,T^1M9&#TDD X^?T_?,HRCE)A8G>-P(G\NK
M,6YF=GZ?*@LT! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 04G-(<M-QB
M]'B >3(NP>G 79G=VD%W^<[-\W5!Q$N)]RYLCC+DYRV9J-%[,;S#5:,;\]?;
M+&X@#?\ +)M _"_SM$$^%O<VQ.;%/8KTWFJQUBV5.]Z8YYN_+,S@0M,T0Q,[
M,VWKT;7P#1ZKW:CBIQ=HY9I/133V'&MH)R"'K*[B+-H :GM+Q9V_&U01<#6]
MSZ,1QR-:E,8PC">?L2'+;C;0.\_1O3/J6XQ9C^;H@N*$GN3#B[!VGDGM]NG9
M%G"NQ,?K#]97C8&$7_Z4!V[NNI>.O@$3C69]P+G*)*]T+ 5X9Q>>"6*N,$=2
M5IS'<8-O>;3LZ,Q.WCK\4&I[7NW.X@P35RJTG>8VCJ;9[T4,SZ#JQ?1R2M$W
M33IX:(,,3A.;/SZA9R(69\=5MWIRL3%$X1A/%*T(Q[=K[&:1ATTZ.@MK_'\Z
M5#/1PE:>27.U+M#_ *@F<JX^D>5F??TB9QE^C\.G@@C\DPN9MY>.[4]>4Y0V
M:KRG'&S5HNY*_?KO&8Z3,),T;.+N8[=='U=!#+B_++?&Z]%V[+2YD9XXG[H#
M!1:!QU,.\\G_ #6<V#NOU=OX$%?D\%[B34\]5I-=>OF-DD4TTPA8B>G3@9F%
MA/0'MR#M+:^C.Q/^-JJ.GY=6RE_+\=L14)Y*52S9&[&0.;:LPC%*X1RQ]'<7
M<"?73Q<5!16S]VKU.] [6:QV?41U(H6K <?<K-H1678FTAFW,&@BY^.K:=0E
M49_=*;D-*O(,M;"#.#69C: I2JC7)XW_ .5H)G*VDWF=^K;6%M4&R3%<URG"
MLQC\V$EN_)C8)J)/VH9&OG ;RQ@\';9NW*P[=?E\708GB^>5,ID*V(*6EAXY
MH/0!&-<Q*,SK12OK,TA_1P]TF\.K?'P<-N%G]T;EJ>MEH6J0G1,0E @_YCPL
MP&&V-V&;O;MVXW'3304%-B:/NCB<;//3CLV;-R1GN0VWKM(W;IU0.<#8#^E(
MXY1'5B%]&\ORA99R'W!O8S%QS5Y)I&>G8D@K=H1.:"\,I-9.48R#2  =G 6\
M^[IIHR!QW+>Y$G):^/R;[*5DSG)I B::&M" %YF!G9VEFD*%B?3H&K(*ZI%[
MJXFG#1QE8_2A)8[SS]G6.62Q*<':V1S%)7(2%Y=?/\A#UT"72QWN'BILBU09
MCFMWK%FKY:Q0FYV3W^I-Q&1@:NP/#IU^#].B"QQ >Y4Y7:>1D((BQ3-!9=XA
ME>Y)7C?</;B8 ,)RE%]2=M&#1O%W"CQ-+W-Q.*EFI1V9[-R9RMPVGK-(S#3K
M 4XDP$_=*2.1AU8A?IY?E#HLE+[A_HVJ,3D-\L:Y,=4(G LCH^@V.\.HQZ::
M;1;S:ZZ=$&K&2<]GY.V2E@G&A(UN"OC[4D<$(1]Z$H9)>U'.>_M[]OR^#NR"
MBY1@O<//XD*]CU#'"TDA"#50?U;T;8F,>HFSP-,4+1$_GU)WUZ,[!:<GQG+X
MY,14QU66S1QKT)JT$/IXXSDKO(\WJ"<1V.VD>SMMM\>C_ *YB]VX^[>=K,LT
MD#P00_01@T8W')Y7C8)=L_IR;3H[/UZ(+SD4_N8$(MC!8K?H <7A")X'L]J3
MU#GW?.Q-)V^RW@_7=^ )&;K\[];7CQMR<:L=>F,DHA5=Y)9+31VC+>#]0KNY
MLPLS:_+X(.>?)>])"^^D(/VX>\P'&Q=MP#><.D,PM.TF_>Q.0[?FBWB@RI4/
M<\,PY3367>>8/461[!110SR4NXU9I!Z,(#/T('=M/E\0E<5Y!S:QRJCC<P1M
M*,$DF5JQ! 5>(>S%V2,PW2!,4I'J+EM?X=$'I" @(" @(" @(" @(" @((&0
MP&$R4\4]^C#:F@8AA.8!-Q8O%FU^71!'?B/%WL26'Q55YI@**4WB%]P&Q"0D
MVFCLXR$W\#N@WR<>P4D;1R8^N<8EW! HQ=F/L^GW,SMX]GZ/_P!GH@TGQ'BY
MF9GBJSE)$-<G>(>L0LPB'AX,(LS?P(-9<*XJ\L,HXR".:NP-#+&.PQ:,MXMN
M'1]-=?X=7^5T$R3!8668YI*,!S2#+')(48N1!886F%WTUTD[8[F^.C(-UC'4
M++B]BO'*XQR0CO%GTCE9FD!M?Q286U9!B.)Q@N3C5B9R..0G8&ZG"S-$7AX@
MPMM^1!MK5:U6%H:T0PQ,Y$P S"VIDY$^C?%R=W=!M0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$!!6\CM9*KB)9L=&\EIBC'R@\I!&4@C+(,8]3>.-R)
MA;QTT0>9U,K[E1XL\91JVPDDBR;M<FK&,C2'ZBQ6FC:07$=38(VC,]6W=!TT
M=!U'#>2<LMVIX\YCYX:K.$5>4J\D9N;D0B6UF?R'&+&1/IL)]KLR"'R:WSJM
MG[TN.JV+.+BL8V0&B,][@+&\\<,6S88F["TCO(.B"##RSW4]+8_^CE.8O))6
ME:N8.4,+#N9QE:!^X;S"X#M;786BHO[G)>24>!CG;%4?TE ;%)2)G YH>]L$
M6$MNR4XW8MO^]T905\'(O<&O-6]?1>6,)7'+=FK(_9 2((^QM<GG[H[3=PUV
M>#_@"7@,]S N'9C,9N%JM^O 4M2K) \+#VZ@RNY,3[BUE(F?Y--$%5C^3^XE
MH8I1@(L?Z<)GNO1D"0^X]=I"&$GW:P-+*XBS:R;&TU^(97>9<]HPRW+./VTZ
ME5K,FZ @>66,V<J[$Y>4I:^ACTZ2/V_%E1T5_)<FK4L.\D1-).#EE):T#SD$
MK")! ,;.^T3)R'N/T;3KIKJH.<I\E]S+$;G)0*O%'W3<BJR$91O)49O*31OO
MB">=]HCYWC\NK=7#=#/R^GP:C-5ALV,JV2NR2!)%*$A0E/:.,CBU8A F[>@O
MTT=D$G(2<PO\"S->S%(V8C((JDD,1Q'(+C#)O&-GU\I&8OH_XJ"LS7*?<^J4
ME:AC#L302SP-9>J;QS1_2=JP(AJWEV#N%S;7=Y=>NT,[E[G=O*T*5N"<*U3+
M5V:>"M(S6H(K,C'-(8OMA 8Q!]'Z%N_B"TS&<Y[!R;]'T<=WL84HQM>[1$(C
M9C;M2.^YFTKR12=W\! @H<=E/<S#XO'T(,?+=:08S>>:$V*!SEG;LROJY$S[
M(]Q^(L6NG@@ZCB62YE9G./-P]H)JKV(Y.P\30R]^2-H7U=]WT8@?7K_L=!14
M>6^XMVL-F&A&6]RBJ1QQO)'/)#+Z><BF9]L0>4IHR?YS:"@N\+R3DMG&Y>U:
MQT[24Z\#U(?3G#)+8],Q6!C&7;O89M1;3I\FJ"HQW)O<.2E*5J@8680E]"(U
M97&XXR&.XW(8GAVQL)B)"'<=]&0:CY3[AM-=&*E,=*LPO%:.E*$L\;%'H\$3
M"_TLNZ0=LC"P:,[]-707K7^5W>(<A<!E@S<+7 QLHP=O<31[H.S'*S$6CNP:
MDW4F?34='0<Q5R?N+B:,TE:K9R,=ZW=D=SJD$T -8BVS"!N.N\)#(8W9O#IX
M.@Z7,Y;G<6!Q4^/HQGEKL?9MP["DC@GDC8PE/J+M&+@3%^%V0<OR+.>YF3QD
M]:+#SUHKM(IXQ&,FEC8]Q,#N+[FGBV@SATW;G0=9+E^4-Q&Y=&,OTA#,352]
M-+W9ZXRLS$-9F(PD,-6%B;1GT<M&0<J>=]RZ4L]B.I<FAL=(JI5NX\ ^MN,4
MFNKNY=L8&V[M-I:BV@H.GY5GN84<3B9<9C7GR5CMG=AC Y8A)MG<AU$7)M=Y
M;2?:WEZNW@X<KFLO[F6>,VZ5FK,,MK&M-ZFM3E>7U,]?7T8Q@[N&T]S/)^*^
MC/XH.FYA'R6/D6.OXP))J].C:<H6B[D8S23UH^YT=G*0(#E( \2VNS>+H.8@
MGY^W,;66>E9>%J10Q2O%*T1!ZF$/4>G=_P#F^G8I>U\[7R_@06;\F]SVFBB'
M$]R,R9FL/ 0L\=EWAKR$.[R/&8=V<7ZB),RHE^X,'+ILKC(,58L!2E:'O-!!
MW0:>/(5"[DA#U%FA[A:.["[,[*#+CG(N>6N104LGBRKT!"09K)1. &(;V:82
M\VTR,!;MOIY7W-J@[I 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$%1RX\F''[18P#DO,\7:&+=O=GE#=IM=
MG^;J@Y"GF/<EWIPVXI=;,<!RR15-IA)9BD8@W%NB *Q@)'O=B?71G^#A#QV?
M]RZ>%::W!9MG'4E@ 2HD\Y7 H021&8@S$[%:*8'+1@\OC\4&>=R'N'-0BL1/
M<@M@=L+F.KU"V-K6E:JP3"+F8E(P/O _*3]=J";+E_<J?(#6B@>M 4DSV+'I
MM_9>..P4<,;D^V0#[<+]SY2V^/00^'>YUD^*9WNQ35<N$4,^/**MM:(W%C.*
M()QW221Z.SDVYM=-KZ]&"9B\USF6MD9"IE-/'4.6&&> JPA;8W:."-RV]X2C
M;<Y?!^FK:Z"%/!9Y])R*6=H;#Q68*U.N<E5PCFA:S.TD\HGY:\D<<F[:3>?0
M6TZZ((L.;]SABPE,:5NP,<-,<G8F@.(WF H"F/R#&.W4I(R;=UVZ[=KLY!=!
MG^85>%Y#(YFJ$E['M4LA'+$T7?$H()YX1%WTWC*<D0?'<S-XH,(,][CPRUWN
M4GD$)A_2HQ5B=HJ[3 PE7<=SSE)$9.3#JX[?!O!PSQ.7]Q+7&+UVW"=;*%/3
MBI5BJZ.$4G8]1*X.^I./=D\>C;4&&.S_ +A36BBR-*6C2:UVIK(5RFFC9NYH
MT<8 0R12;8_I&W;=SZZ-X!@V<]SY)F8*.UA@GFF$J^UFM!&[M4 G?S1L>W;*
MWS^K,_R!]X99Y9#G[$=L;<V,N6K<K'+4.N3Z /;E-Y!V !;=H@),6[KMVOT"
M-#R3W1E$Y6QQQA"4LT<4E<G.46:LXUS=VCVNQ2S#N%NNSHY-U<,ZWZ\VJG+;
M?_55LM+C*XT7:#MM';!K)'%7:34)=CD+-)^-T06F"S/-IAN/-5.>0*<\D<,]
M<JHC9C+2K&$A;>XTX>8_]Q^G3YK!5WL[[CQA-)0@GN0:5@$I:3P&QR!*<I/&
MX[B 9 CC?:+Z"3OJ_B@USY?W'+*",%&:GC:5J(NQ#!JQBP6(R@W;&UA,PA+>
M&NUBU)VT=A"P?D'N"W!?7%CC'/R3$$4(Q$Y #"Y"\T3 1:/(/;\@OT=BU9M2
M8-V!S'N"4,MC(TNY+-3O6(:;Q=EHK%>QLK5]^KZ]Z-]VI?)JR#FXLU[IQW'R
M'Z)E*:Y!7A(GC/:+Q26BC:2+;J&]R$92 7VCH_Q9T$_+Y3W(>>"S4>S#8%[4
M-C'!2[E<#>6(:[M(XZRCVMY[V/37H^G@@L+>3]Q#RP4:\915Y+?8L7'K,;05
MQ/2*6,G?9*\T;;S^$9=-$&'#\OSBS:B_3M:Q0BGG,RTKR2,1-'$+1%KO[$;^
M8MW1M=6U;3J"QG/<<+4X!1=XJTLE>N30.7JI8R8HG=V?Z.":.31Y/ 2!T%<%
MSW-KW[D,169]);##8FK;@:,);\L(1LVR,F,(ZX[V;7S,WCX!OQW+.79&WEZ,
MH.-R+$VYRH10DWI[8FP5HPG%]3*0'<G'Q8NB &;]RHF'NUY.R4CNX!4,YFCB
MF&-HP+21M\P%OWRMMZ>+>*#[A,G[C57)\AZBS6J680L]RGK*44MNPTQ1]MM9
M.W"$.G;9^A?%!HDS'N/>Q=:>8;F-N!/6.2K7I.?<J%IW#,G$]I[BVO&SL3,V
MOX4&^+,>YGIZ-<*APRR#2AL&<!2]F*0:[2V7,G\\F\Y1.-W\K#N?Y7#;E?UX
ML!@KPUSFNXXLJ4M8HF&*:6!CAIRR-^*\@MO'1VZOTT09-E/<>>;9$)Q56*I%
M#9.IH<D<UTXI;!QGIVRCKBQ.#LVGB_R(+?A69Y18A[7(ZLD=F7M'#(,!1BV^
ML$LH'IJP]N1R!G?Q?IXH.K0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$
M! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!A//!7A.>>0888V<I)9"81$6\7(
MGZ,R"-%F</-"4\-ZO)  =TY0E @:/5VWN3/HPZB[:_@08/G\"U:*T^2JM6G)
MQAG>:/MF0_.82W:$[:==$&,7)..RN#196G(\AM&##8B+<;MJPMH74OP()!93
M&!-/"5N$9JP=VS&\@,4<>FN\VUU$=/BZ#Z.2QQ2#&-J%Y#9G &D'<3$+F+LV
MO741=V_ R#5^F\+Z-[WKZWHF+8]KO1]IBUTV[]=NNOPU0?9,UAXI((Y;]<)+
M+;JP%*#/(+_$&=_,W\"#-\GC6* 7MPL5IF*J+R#K*S^#Q]?-X_!!IFS6 [WI
MIK]7O>8FA.6/=]&[[GVN^OD<'U^31!G'F\-+$\T5^O)$(=TI!E!Q:/7;O=V?
M3;JVFJ#;/D*%>2&*>S%#)9?;7"0Q$I"^0&=_,_\  @P#+XJ0[,<=V SIZO;
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M/O/I/%_RV;7?\[YOX4&[]+XGLO-ZV#LM&TSR]T-K1D^T3W:Z;7=M&=!N*W5
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MIRD0U'KP20QE'H$'GNG*T4G1OHFT\Q(.NQ? 9 YI0Y'8JUZD,>- ;./KR$4
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MYF#J.%Q9[$BV-RT-F89C$*DY$!C&$<.I,31F01Q"XL$;]"+7J+>+AUZ @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M8J7[%VYC#LVC8IP@:((B\T!M, #N9V\O;':XOUZMT8.[0$! 0$! 0$! 0$!
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M:_O<I"M/7)SA<[%G2-Q=R<Q+9%J_B(EK\B#H<9G^;!5RUC+U1A:&E9MUOHB
M(I89YXPBWN_TC%%&$FO1W9]?!T%7C.3^XUR".>.N4M)Z8V1M/3.(I3D>OO9H
MB?7Z$992 6ZR;>GRN&U\U[GRE,<<':B"1XJXO3)RDC&M/,,Y,Y,X%(<,8.'X
MKGIXZ((.-Y3[@9FE#9 9H(POA^D'AIDSPQPY'L25PW[GG9X6<I"!M1T_#H@P
MR>:]R<IQXXK>.FHG.6HC7@D.9S&6!W@+9_RQ'=)I+KH0BWQZ(.GY?F<])CL3
M?XH)VFL2F_<".0P[91&PF<;.&H[G9VW(.6Y/D/<>U&U?TUD9*-J7TQ5:TO\
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M"FYE@SSO%\EBHC>.Q8A?TLK/HX3AH<)Z_P##((N@\SN\#YI=Q=>]D\8U[)Y
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M@C'9$3]MJS^3S#H?1WT;1!+GF]Q9,S%#%W(:17B&[*,<#C'5:8NSZ<B8G+?
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M$.JXGE\A>HC'DXI0R /)W9"KR00FPR.#%%O9GVOIY6+0M.KM\4%Z@(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @QDEBB#?*8@&K-N)V9M7?1FU?Y7=!KDNTX]>Y/&&
MAM&^XQ;SDVK#U?YSL_@@TR9G$1R'%)>KA)'JT@%*#$.GCJSOT0;"R6."**4[
M4(Q3Z-!(\@L)Z^&Q]="_V(,QMU2<1&8"<R(09B9W<@^<S=?$?B@UG:QDP!OF
MAD!Y6"/4@)N\+]!;7\=G^'B@V>KJ;=_>CV,?;<MS:;V?3;KK\[7X(-D<@2 ,
MD9,8&S$)B^K.S]6=G9!]0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 04W,\-6S7%<GB[$HP!:@(0G-V%HY6\T4FK^&R1A)D'FUGVVY-9Q]
M:6_!CLGG[D.2/,T9IG&".UD7C"*Y"[@;EZ>.!HV\K/I\UV=!\Y/[66+4V0KU
M!H6LS-B\.$4\W:&S-+0N$=NP>^.3_F XMN)B8GZ%T02_<+V]Y)GN-\=JTZM6
M.?'06HKD4IUP")[%9XF(=L':\I=7>.,7;\71T%]Q7@+8SF%S.FT94Y:D#X^.
M.1SBCMS#ID)H@)O+W^U#YM7=^OROJ' ?N;YS5F@GJ^CEBHY5^04Z1S$(OD3N
MNY$1;'9A]*(Z=/G.Z"?C?:_F&%XY)C+]JC8IA>IYNQ?WR1,TX2G)?.09.XW5
MMKL3.S/IX,@]!X'Z_$<*Q%'.Q5Z,E""KCXI([#313;0CAC,2VQZ=P^@B@ZG5
MM6;7J_@R @(" @("#79LUZM>6S9D&&O !232F["( +:D1._@S,@V,[.S.SZL
M_5G0:K-JM5B[MF488MP!O-V%MTA, #J_Q(B9F_"@VH#.S^#ZH"#$)8C=V Q)
MQ=Q)A=GT<?%GT^1 CDCD 9(R8XS9G$Q=G9V?P=G9!@URJ]IZC3 ]H0[KP,3;
MV!R<=VWQTW,[(-J @,[.[LS]6\60$!!@<\ $0G((D(O(0N[,[ WXVGR?A0?*
M]B"S7BL5Y!E@F 9(90=G$@-M1(7;Q9V=!L0:FMU7MO4:4/5#&TKP:MO:-W<6
M/;XZ:L[:H-J @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M(3,3 PN[.Y.),^GX4$U 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M!=9CD.>HXRC;I\:N9.U:$7LT()J@25G<&)VD*::.,M"\OD)^OX$%-^OG-?\
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MU#V?3Q>I=W=YM@[]7%@=]VFOS69OX$%?FAXMC<(1Y:"M%AZY#N"2$2A$Y9&
M?HV%VU*23Y/%T%G!6K5Q(8(@A$B<R&,6%G(O$GT^+_*@V(" @USV:]<&.Q*$
M($0@)2$PLYF["(L[_$B?1F0;$'.0>X?#IZ-F_'D6]'5D&&2<HI@ I2,HQ")R
M!NZ3F#CI'N?5 L>XO#*^/KY"3)CZ6S-)6B(8Y3+O0BYRQE&($8$ B[DQ"VC>
M*"_JVJ]NM%:K2#-6G 989@=B$P-MPD+MXL[/JR#8@(" @(" @(" @(" @("
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MKQPA4*)K$5.T,,4SD[OVG /$7^=N_P"%!W: @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(/$O9'_ %;]V/\ $8?SME%KVU$4'N!^PO(?\.M?F20<S]WC_1KC
M/]WD_/R(5Z*@("#Q_P"[3^SW)_\ ,-_^FR%>P(" @(" @(""-DL;3R5*2E<!
MY*\NF\1(XW\I,3.Q@XDVCLW@Z#'%XK'8JC'1QT UJD6KA$'AJ3N1$[OJ[N1.
M[N[]7=!+0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!XE[(_P"K?NQ_B,/Y
MVRBU[:B*#W _87D/^'6OS)(.9^[Q_HUQG^[R?GY$*]%0$!!X_P#=I_9[D_\
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M\G7KU2>%S@>,Y#><A$"D>-]NS0.YHXD[%\=-'0=,@(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MWAJ]Z/NO'INWL&N[;IUUT0:1Y3QDJ@W!R])ZAR]@+#6(GC>9_P#X;'NV[_\
MA\4$VK<IVXRDJSQV(P,XC.(Q-FDC)P,'<7?S"3.Q-\'0;D! 0$! 0$! 0$!
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M_N3ZE_O$S.Z"]X][78S"9:IDX+DTDU26[-M(09C>\$($Q.+,^@-7;;_"@[1
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M'?1R02+O&(K7"Y^+E.[138XL:]K:SDS%!V>YLUTU^.FJ"FY![;QY5^.E':@
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MA=D$G]ZT+V<E"5!JI50ADQX79C@DN!8( CDC!H9/HR*3:VQS+=TVLZ#7PWW
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MDV2O99S'MOL[9#L9GW,?7Y/B@@TN>U7;+VLD56GCL59EJN03G/9W1V/3L4D
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M_P#5&$T8QR,<CB44C1[?'=IJJ*!O=3DDTL'((6@C,L+(4M":?94:2'+E4DG
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MMX,0L3-_&@^O#"X#&X"X#IM'1M&T\-&_ @^=F%OQ!Z:.W1OQ>C?Q( 0P@[N
M"+OXN+,VOQ^"#X->N([1B 1=]SBPLS;M==?X4&Q 0$! 0$! 0$! 0$! 0$!
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MYF86TUZ:OXH.MXGA9,'QG&8>609I*%:.N<H"X@3QBS.XB[OHWR,@M4! 0$!
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MC/<\K;I)#CV@[=EWVCN?:^OCJR"?QWFF3S>3MQ18^.*G%CXK4#G,_=>P4]B
MXCT!Q8=]9V8F_A^.C! P7N5>MXFG>NXM@#91;*30S,XQ2Y 0*+M1DS%(.DH.
M75M-=&W:.@9_FG)JO(;&-ITX"BKWL;7A^D^DG&Z,A2">X'&-F[?SFU=OPH)&
M+]SZ61R="A#0G<[(Q-:(6(^Q)-W&%BVBXN#/"3$>YM.GC\ K_P!YL47/;-&:
M[7?"!ZBB%<'![(W:4+699'%GWN!!OC9M/G!^%!8Y'W&+&XFMDKN.&*.TW?B@
M&PQS/4?9]+L "\S=QM1=V%O]_JR" ?N)D)\O0,*Y5<-=A"2L8E$<DS29&M5
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MWZ^"#J\7CZ^-QM7'UQ$(*L00QB L LP,S=!'HW\#()2 @(" @(" @(" @("
M@(""/;QN.N%$5RK#9* M\#S1B;@7RCN9]K_P(,I*-*2S':DKQG:A9QAG(!>0
M&+YS"3MJS/\ '1!H'!X01B$<?6$89'FA%H8V8)7\9!Z="?Y6ZH-[4:0LS#7C
M9F869F >C1EO!O#\4NK?(Z#3^AL1VIXO0U^U:T]5'V@VRZ>'<;30M/PH-]>K
M5KCMKPA".C-MC%A;0681\&;P9M&0:ZF,QM,)(ZE2&O'*[E*$48@Q$_BY,+-J
M_P#"@PK8?&UKMB[! (6+4<4,QMKH\<#$T8,/S1$=Y=&;XH-<''>/UXIHH,94
MBBLCLL1A!&(R"WXILPZ$W7P=!D> P4D\5@\=5.Q P#!,4,;F#1_,8"<=1V_#
M3P09P8?$UQ(:]*O")2-,31Q +/(+ZL;Z,WF9^NOB@EH" @(" @(" @(" @("
M @(" @(" @(" @(" @H/<#]A>0_X=:_,D@YG[O'^C7&?[O)^?D0KT5 0$'C_
M -VG]GN3_P"8;_\ 39"O8$! 0$%#G\?DVR^-S6/@&[)0"Q!+2(VC(@L]MW.(
MR\K&#PLWFTU%WZH.>RW&^47\O+="OV;-@ZTU6]ZI_P#HH8XQ:>KVQZ'W"8NK
M='W]?FL@JX. YW%U@MQ&0S58*;F36)9'UCJ2QWW9B=]7E-P_]K37X(*^APSF
M%SCV-FKQ%4J%7I%>Q96.^=N4:\C267*9V82<I(WVD[.^W5^K,@N X!R".N<Q
MS3SWY+,C3V6MN%B2B6.[# QZ=L2>P(E\W37S((U7A?-9+^,:>K5JTJD\6KPF
MS$]+>7?AF9G+Z202\PQ-VW^5!]QW ^24L31J%3"3'TJM&O:PH6GC"T]9K8RN
M)MY18CFBET?3=IH_@@F8'@O)J5B"];L=W(QY"M)WO42'MH#6&.6!MWSM";3J
MWFTW/U02.3^WUS-6N36)#<@NUHVQ=3>(PE:CK21!),VW?Y#DZ>;3XZ=$$"]P
MGF-[/6)Y>W!CYI(PM!#,4;3P!=KRB^HOO<FKQ2"6NG5W8?*Z#L>+4,GBZKXV
MQ$SU8YK9UIN[OV0E:,JT.C^;I 3?'IIH@O4! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 04'N!^PO(?\.M?F20<S]WC_ $:XS_=Y/S\B%>BH" @\?^[3^SW)_P#,
M-_\ ILA7L" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(""KY3GX..\<R6=GA.Q#C:\EF2"+3>;1MKM'<[-J_P"%T',M[O8 P@>O
M6LV#MTZ5JG%&P;Y9;]B2L%5A<FVR!) 6_=HS:>*#'+>Z9XJEDI;>!M!<PPQS
M9.B\M?<%>?5HIXSW[)!(A(?*^K.SZL@LJO-KLW(VP1X2:&S#6@N9&4IZ^RO'
M8.4!UT/61V[#N^Q!/L<RP,!T#*U'Z#(59;D.2[@-6[410@SO([Z>=[([4&=[
ME_':?'YN0278SQ,#.\EF)^XVK%MVMM^.[IH@U87FW',LUIH+D02TSL#/"<@;
MQ"K*412NS/T!]F[7Y';5!DW,^-OI(^1K-4(8GBL]^/:9S%((@PZ[M?H2TZ=>
MNG@Z#[R3E^%X_"+W9P]3(\;04V,6ED[DHQ,XB3MTW&@S@Y9Q^2%SDOUHI KA
M;L1]Z,NW$;"[$1"[CIYVZZ]=6^5!C^NG$^U)+^EZO;A$"E+NCY6E9G#=UZ;F
M)M&0:8^;\>GR4N/K6HYK%>2&.Q]( B+6(BE A(G9C\H_BH-K\UXBU7U7Z8J>
MG<WB:3O!HYL._:W7QV-N_@ZH)N1S6-Q^'GS-F<6QU>%[,DX^87B$=VX=/G:M
MX:(*S$<ZXYE,C/0@MQC8CV%"!F+%-')7"QW(QUUVL$G7^!T$^/DF DQDF4#(
MURQL+N,USNCV@=G9M"/71O%D&D>7\6(8B;+5=)PDDB?NAY@A?20O'P!V\S_!
M!G#RGC<\$=B+)UCAE%RC-I1T)F,8WTZ_ S$?X79!JK<NX_($337ZT%B2![+P
M%/&3M$S.[GN$G'31G?5!(EY'@HL6&5DO0AC9'T"V1LT;N[NVC/\ PLZ#3)S#
MBL8S$>6J,-=P:8N\&@O*VX&?KXD/5OP=4$FYG,-2]-ZN[# UPF&JYF(M(Y::
M;7=^NNYD$3*\RXUB\=)D;=^)JT8]PB F-W%I6@<F$>KLTA,+_A0:L3S?CF2]
M<(7(H9<><XV8I) 8ACKR/&\SMKTC?H[._P '9!G/S3C,= +D62JS#.$QU!::
M,>[V&UD82)V;R]-SOT'XH,FYEQ9_5,^5K,5$6*X+R"SQ,1;!<OP.3:-\KH-=
M[FF JW<?1"U'9MY&:**&&&0"-AG C"5VU^9M#75D ^<\4BM9&M8R4->3%RQP
M7.\31L,DH,8BSEX]'^""\CDCDC&2,F.,V8@,7U9V?JSL[?!!]0$! 0$! 0$!
M 0$!!0>X'["\A_PZU^9)!S/W>/\ 1KC/]WD_/R(5Z*@("#Q_[M/[/<G_ ,PW
M_P"FR%>P(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(*CEW'VY%QC)X)YWJMDJ\E9[##O<.XVF[;J.NG\*#D)/9JDV>RF8JY.2
MM)<.I9H0C$)#3M593F>0-2T(93E-S!V;YS]>J"3/[?AR##9V2WFQNY#D->*F
M63@A$88H*IDX1Q0M(?@9&Y:R/J[H)]W@9S\[_6R*S5[CUH*W9LTFL21M 4I;
MX)WE!XB/OZ/Y7\$&W,<(DS%?&C?OL5BE7[$TD< @$I/8JV")H]SL#.]/3;J_
MSOP(-UGAL4^&S^-]40-G)Y;#RL#?1%* "S,VOF9GCU^&J"NM^VD%VAZ6S>=B
MD?*%/)#'VMQY61Y2<?.3CVR\.KZH,<;[9P5,E!D3N,=B.>&U.P1R;998?5>=
MWGFL2:EZSQ<W^;^'H&>7XO!R@[%_&Y1H:EYZ]>\Q5^ZY/B[AFS1D91]OZ1C
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MN8;)P>NH-Z&S3Q$DSPF+M6GR<LL+?.9BD$C8/_9;5T%MQ'G=/DMB>.M5EBA
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MR!/),^[71V=B_P!B#L$!!S7-\[F\;%BJ>#&M^E,Q=:E7FNM(=>+2&2<S,(B
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MT>A&!:[&9VZ,Z@]'PE&2AAJ-&60YI*T$<1RRGW#)P%A=R-A#<_3QVMJ@FH"
M@(" @(" @(" @H/<#]A>0_X=:_,D@YG[O'^C7&?[O)^?D0KT5 0$'C_W:?V>
MY/\ YAO_ --D*]@0:+U&K>J25+0=RO*VAAJXZZ/JW479VZM\$&BC@\31:!JE
M<8FK-(,.CEJW>=GD=W=WW$3BSNY:N@G(*'/VJM;*4O3XT<CGK$<H4P(FC8*X
M$!3F<I,>P&)PUT%W=].B"IEI>WC6:5'*5*=3)Q,,@T=SD$4AR/9$7(6$'?NL
MYQL7QZBR#.EF/;"[;,ZDU*2S>G&](8B[/),$'T<Q/HVK]D/(_P",S/IJ@B@7
MM-/AREC>O-CXY&E.87F,]9H^AN;:R%&<0Z;M=CBVG@R#[R*;@%^ED.._I&I1
M'('#7R8B#$T@L$8-"SOI&)E#L8?'0>NGQ074_+,+5F.O(VF,B$H"N"SE%ZB.
M3M%4$!9R*1M'?:+/T9T%?>J>V54<1B+<-. (HQ?$U'%Q$89#81;1NG;(]K:'
MY7+37J@RRUSVZ*?(/D9(1L%+ -W=W0D*8'>. @VZ$YZBX"<?7IMU^""96Y3P
MB?$S1P7:\V-KQ!'-&VL@O'+K&([79WDW.SAHVO75O%!5!D_;_#V\12Q4,$UF
MU;C]*T).1 5N$Q:9S+=K]"SMMUUV^'1!<QYOAU$'P8V:\$501K/5?I&(N[1M
M'J[;>F\6)M>FK:^*"%4L>W48PU8)*K 4$$L.I.X]FB9SUWWETTB=B,-7\.K=
M$&W$9+@M(;%S'SQ5PF K,[ZR +1]S:YL!Z, O(?XK,SN^J"OAS7 <[GC:2&)
M[9O/CC*PQ1',<1E"4;Q$S#*/4MI/KIX()N%;V^*:M2Q;UI)B<KE=F<C(C>(H
M7/>6KD79(FT=]=GX$'.\PL^W@XDW@>*4L-8I=VE68F>3TY/6KQ;Q9W8(SFTW
MAKL?\/1!,Q>:X78RLD'HX*,/&VEBALD9Q$WIVA.5F!P#?&)V!ZD[^;KIJ[(+
M%Y_;DH(:VZ"$&J&T(MW(""L)=XAU\A!YH-^U]'\KO\$&6&#V[N9*M)B8ZYW*
M\,<M?M 8B$81]N(]-&!B[1:"[^;8_3RH-$4OMB4#40:NX2ZT@K.,F_:<G?VB
M#MO&-C\XDWE;Q9V02'_=W6MR<??TH60@.E-4?5W:&<>^<1D_QE;S^9]2ZOU0
M;K?*.!Y/'!!;O5IL?<B>8.[J,91AJ3'N=F8?F.X%KUTU'P0:Z5W@%3]&A7*"
M A>6>AN$Q,2EW!(9.;;A*3S#J?4OPH-&1Y=[?Y$<=++,.0:2U'7I'"$AN,EN
M,V O*S/VY(]S;OFE^%!G9N>W!U)XYI*KP1^GHR,.[<S5R-ZXAM\VD;[W$@\-
M"Z]'06W$<A2R/&<;?HPO7J6H E@A<M[B)-JS.77=_"@MT'*\TP?([.2PN;X\
MU2;(X@[#>DOR20PR1VHVC)^[$$Q"0;6=O(^J#5Q3"\L?D>0Y%R6.C5M6*L%"
MO3Q\LM@&C@DDE>0Y)8X'W$4VFUA\&\4'7H"#E^;8//W+&&RN :K)D\+9DF"K
M>.2*"4)X#@-GDC"4@<6DW-Y'01N,X7F$O*;'(^314*DS41QU6ICII; N'=>8
MI)))8H-'UT9A8?\ :@[% 0<SSC!YO(QXJ[@_3'D\-=:[!7N&<<$K/#) 8%)&
M,A!Y9M6=A?JR"%Q[#\TL\L_6'DT./IO7H24*M7'3S6=_>FCE.20Y8H-NWLLS
M,S/X^*#LT!!S7N1#=FX3E(Z02':V 40P@\DFHR@6H@/4G9FUT^*#D\ARCG@%
M$% CEH%-8&GE;-<HBG(&B>*.>*.M*0@Y'*.HQ@Y,+:$WQ"-%/RW"%DG@EM#+
M;MY&S6/T83E;MA8>.O5E((F<(2B%MIOIT\#9AT03<IGO<:O$$L1$+VKU^,>Y
M#I% U>;MTX2[=>>0HYAW$1Z,[Z-M(?B$GW6@S<G;"G/;:"QBLE 52M'W(3M.
MT)0L>T"/<[,;CYF^;HWB^H:,KG?<2E<]! 3RQQ7)H8LG/ XC,[1UY(8Y!AKS
M-L+O2CN 1UV?/9V?4+;G.1YA6O:8.22.&&A)9VA7&<9+#6(8QC)R%WT[9F^T
M79_C\$%/)R+W"AS4./\ -Z:*S)##=GA<6M,%EA=I6AKRLWT#ZBX=MG?KKHSL
M@ACF>>Y&$9;\]BA'5R%,[L-6)WEA9[)!-'H]41*!H]K]"D?XN6U]$$[C^4YV
M%:A/($@0!)C:GZ*:H$47;GH1'.;DP;Q[<Y.W1V$='9V^0-O&^4<KL6,M7.66
M]D*V&ANC0L56K-%D9'F8JX.PQN<;%&(MU?\ ]I]4'W&9GF%W,8ZG7NVIL5+-
M&][(S41@D$FK3R35V$XQ$0[D<?FVZMNV[G?J@W\YY-RFAFHJV%KV3V-#O!HF
M.&49C<9#'2&0G>(>K_2AITZ%J@K;O)N?87&A=LE+D!"OCY9@.L$1%8R030=H
M-@CTAM#"[M\YA)]7\%1;<SSG+,35Q=?'C/9R7:$[$L4(E!/(!1B<;LT4SLY,
M1%M9X^GX_310<SE\OR4^58BS9:62:&W-7GI35=M6MW<C5CKB%AP83*2%MPDY
M$^OF;3P06E'E7,P:&Q8>Q/5 Z9YISI%&]2221QLUH1$-TL8#H^]MSMX[GUZ
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MD_\ F&__ $V0KV! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MW>/]&N,_W>3\_(A7HJ @(/'_ +M/[/<G_P PW_Z;(5[ @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MVSA,+E:L,MX-X@3@)/)KY-!U;73S*BX?W!Y6<)RC#CZ\=>M#//),8/O[UJ>
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M;<54Y(*</TDIR1ELDDD=IOH 'Y^A"XD/A*@Z3];,T_"GS/:J176F>-BDEA:
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M @H/<#]A>0_X=:_,D@YG[O'^C7&?[O)^?D0KT5 0$'C_ -VG]GN3_P"8;_\
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ME3D%W)XYZ-?%W0A>N<3/8(G@@D'>(/()R%+-M!Q?1^B"!F>?'%D*D-+#2O<
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MGZD[_%W0;$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MM/\ KX_YX_RH'K:?]?'_ #Q_E0/6T_Z^/^>/\J!ZVG_7Q_SQ_E0/6T_Z^/\
MGC_*@>MI_P!?'_/'^5 ]93_KX_YX_P J!ZVG_7Q_SQ_E0/6T_P"OC_GC_*@>
MMI_U\?\ /'^5 ];3_KX_YX_RH'K:?]?'_/'^5!N9V=F=GU9^K.R @(" @("
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M5A_)0/U-XA_V/'_58?R4#]3>(?\ 8\?]5A_)0/U-XA_V/'_58?R4#]3>(?\
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/ZT4<FC_\0BQ(+A 0?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ny20042551x1_image09.jpg
<TEXT>
begin 644 ny20042551x1_image09.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@#I +0 P$1  (1 0,1 ?_$ (P  0 " P$! 0
M       $!0,&!P(!" $! 0                    $0  $$ 0,"! (%"08%
M P,#!0(  0,$!1$2!B$3,2(4!T$546$R(PAQ0K*3TY15%E:!,W4V=C=28B25
M%Y&A<H(T);%#4\%CA288$0$! 0                   1'_V@ , P$  A$#
M$0 _ /U2@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MB5MG@+M[M'!Q?JS/N;;X/J@N.9\J?CU,)P*IO=C-XK4QQF8QMJ[1#''*1/\
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M@NN,YCF%^><,]QT,)#&(O!*%Z.YW"=WW#M"./;HWQ0; @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M9B9Q=Q=V9^C]4$Y 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MI'8@KPC$;/YGB[  ["__  DY?E1&PH" @(" @(" @(" @(" @(" @(" @("
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MBQUM$$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M$! 0$! 0$! 0<@]E?]Q/=7_&(OT)$6NOH@@Y)^)'_+O%O]38[]&5%CK:(("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @I^9U;-OA^=JU8RFLSX^
MW%!"#:D9G 8B+-]+N^B#EGMGPC-\5Y!Q:S)0N6:N3P7I<C)<,K$F,N1,,FP'
M-R>"&5M1<!Z;F9%1O9/ RX:]3@R?'^1T\P,MYY+DTLK8A@EED,'[/?[>I1NW
M_P"U]KK]:#-4X-RB/W-?CKX\VX)#F2Y5%>T;LO,4+;:NG_+:=ST^K5!>TQY'
MP3E?)I@X_=SV'Y'<'(T[6-[4DL4YQB$D,X2'&["Q#J)]69D10Q^WO.:M&GRT
M,?'+R&+DEGD4_'&G!O\ I[<;P% ,S_=]X(WW:ZZ:]$59^X64YASGA\G&L+Q[
M)X6;,VHJ%RYD8@ (:I,YSROVY#?9H&SZ]4'KB7'_ '!XQ[BT2R<5:_B,MC!Q
M]JWBX)8HH9,<W_2G9:225]Q 1 Q-HWP^"#1.&<.Y75N8D:G'LO6Y#2SD]J6]
MD3UP\=&6P?=**&24@:4H2Z%'&QZ_%!OG#<AF^.<TY;3M\:RT]?.9Y[-/)5X
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M$! 0<@]E?]Q/=7_&(OT)$6NOH@@Y)^)'_+O%O]38[]&5%CK:((" @(" @("
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MYM-$'OBWN!Q;E,TT6$LRV>P+2/*5>>&(P=]&.*24 "0=?B#N@V) 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$'(/97_ '$]U?\ &(OT)$6NOH@@Y)^)'_+O%O\
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M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("#D'LK_ +B>ZO\
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MLRE./J3AF+8$A=3$C$=>K]>GPT8BDS4[7\!EZF.RUW)TY<#=L9@CED<H+L8
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M0:E+Q7E]&22YCZ+R6>.2G3XW'WA89J=PC[ANSOHS1#-&VC]?NNGPU#-=]O\
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M2;5G9^CL[.@^LS,VC=&;P9 0> KP!+),$8#+-IW9&%F(]K:#N=NKZ-X:H/:
M@(" @(" @(" @\E'&;BY"Q.#[@=V9]'T=M6^A]'=D'I 0$! 0$! 0$! 0$!
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M%HAGWC&),._N/&Y&S;MO1T&*?W(JP4VR$N,M#C;$<LV-M-VW:R$,;S'M%BW
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M;K5:F+.6>WE[H58),A8GM1Q&49R$9/(9'M8(BT 2;4M&Z(*HN7\K/,#@88Z
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M I,+D<44!$<(EW!9S-R$'?XHBPXYF,YDN6WBDL1-ABQF.MUJ7;+NQE:[[O\
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M7=Y=";1M/M;@P3YS.0RE=R]L;4&.Y):&&.O&43M!7QUB3MOK(>YGZ:-]/T_
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MGQCA>/SD$U>"&++QC(=2)Y2<XPE;27LPD;L %\6 6%!9VL)B;<EJ2S5CF*[
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M-7E9F=PD#$6R$FUU;H[((-G,Y_#]^L^3GM!-0H7;%V<8RDK>HM=BS-&( PL
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MZDI5SF:G8>".4 8R#U';[(NPDWY_U(+DH(2V[HQ+:^X=69]'?XM]:##=LX^
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ME6O9]JX#/%C!M#JWJ)&)O!V+[#$^C;M-.J"TO\XQE#/4\3;K6H@R$@5Z>3<
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M)Z<=ISFRKX:*(HQ8RE:-Y>^S;_[AXQ<V/Z/@@KN.>ZM2U%C*4\<^2S&3FO\
M:CIUPA8:]*Z=4I#&6=VT!V9GVFY%]K:S=&"WQON3@,AFH\9!%9&.Q//3I9(X
MV:I8LU-W?BBD8G)R#875Q9GT?:[Z()EKFF-@Y;#Q:.O8M9.2$;4[PB';@A,G
M #E(S!W9R!_L,3M\=$%)C/>/BUZ2%SKWJ-*Q-;JP9&W",=8IZ.]YHV,3-]=L
M)D/31V9^NO1!EK^[G%2IW+5R.WC8ZE(,F VX=AV*<A]N.: 0(W)C-V%A?0M7
M;5FU01\I[AWZ^1Q0ACK5;UE')6WP]FO'ZN1Z0Q.&D@V.W'_>?9?5R_Y7;J%#
MPSW/RQXGC&1Y+;>&+,TLEE+KSU8P%H*D4,S/!)#+Y88QE?:Y@1FWCM^)6RC[
MM\=:E8L6*=^I8A&K)!CYH!:S9"\?;K%  F3%W#Z:.3./YS,B/OM[RO*Y_,\M
MCN#)%7QF1BK4:D\812PQE3AD,)-NNY^X9/KJ_P!3Z(,O+^>7,!RCCF%@P]B_
M'G)I(I+,3QZ P1')H#$8;C'9N+71MFKL[OT04O!O=%[5N7%Y]YO56,OEJ./R
M'9".HX4)9"&'>+L^\:\>NKCH^CZOJ@V'C?N-@L_D8Z-:&U6DM5RNXV2U$T87
M*H&P%- [$3N+.8]"82T=GTT=!M* @Y![*_[B>ZO^,1?H2(M=?1!!R3\2/^7>
M+?ZFQWZ,J+'6T004?+>+1<CJ4*TM@JS4<C3R0D L3D5*89FC?7X&XZ.Z"DY-
M[75,]/R663(2P/R2I1IRL("79:A*<HD.K^9S[FCZH/&6]KAO#R$8\DT8<CN1
MW+835(+(B,=4:O; 9=6U\C&Q^+.@^<_X3?N>U<G$\%W+-F**E7JG/*/=<*T\
M3N922=')@C<NOBZ#Y)[51V+CY&_EY[>4DRF/RDULHH@W!BG=Z]9@!A%A\Y;B
M\=7=T&2W[65+%VT'S.<./Y#(#EK^#8(GCEMB8RN_>=NX,9R1L9A\7^+(,V/X
M%-BN36>50Y&>UD[83CDZ[L QVX]=U2)F=](O3:; )GZL[[O%!']J.#3<9I9.
MU;@>K;RUR2>.D\@S>DJ,9/7J,8^72/>1>7IJ3H/F6]K O0<AACR31Q\CO->N
M#-4ALB+-6"MVP&75F=NWN$_%G06'(?;^KE^#UN)QW[%6"HU)H;SZ36/^ADCD
M B<^A$7:;5W04U_V;Q^2&S;R>1.[GI[H7FR<U>N8,\4+UXX7K.+Q%&T1.SL_
M5WZZL@DM[44=:9-<:$ZN,R.+,:]:&",WR9 4DW;CV@+CV^C-X_%!@R7M%C;6
M,JU9[$MN.CQR;CHUVV1/,!]DFE[GFV'NK#IT=NJ#Q[<\5Y=6Y-E.2<D,VFM4
M:F.@CG. YG:J4AE(;5F[0,[R]&8G=^KOIX()>5]IL7F<SF\CEK9S!F*4F.>"
M"..OLAD(#U,P;6:0"B'ME)]GP08+_M*V4Q6=@RV:GNY7.U:]"7*/#%&\5:K(
M\D8!$&@Z[C)R=_%W^'@@RR>U406;&1HY::GF"R]G,TKPQ1GV"N0A!- \9ZC)
M&01_'1]4#)^U4&1;.R3Y69KN:L8V\-H8XV[%K%1QC%(P?9-B.%B(7Z?!!\N^
MTF-M<D+/'8B.S;>N>5">E6L--)6 08XBE$B@<Q#0F%W;Z-'ZH/,/M*$&6QUB
M',V!Q6*RLV9HXAXHGC"6R,O=#N:-(X[IR(?HU^*"UY5PFUFL[B,Y1R\N)OX>
M*W% 4<,<PDUP0$MXR:MY>V@U;,>TP3GP_ 4Z\CX; R%8OY:2:,2GCD)Y)ZIQ
M"V\O43,!GT8=/_1!NO,^*1<FQ$=)[1T;%:S!>I6XQ$WCL59&DB)P/RFVK=1?
MQ04>2]JZ]^ER.O-DY6/D=VE?L2C&'W9T1KCM$==':3TNK_1J@^T?:?$4>5RY
MRO)$\,]P\E)5EJ5I96M2NY$\=HA[P!O\["S]'\'TZ()',_;Z;D69I92OEY,7
M-5IV\?*T<,4W<@NO'W6^]U82TB;1]'05UWV:Q9UY*-#)VJ.*O4*N*S--FCE>
MW5I \43=TV<HS>,G B'Q;X,_5![M>T&-L<K'//D)=([U;)0UBBB,@FJB,8QC
M8)NZT';#1HF?1B=R09O_ !74'CHXJ+)316J^8FSV/R+1@Y06I;!SLW;+4#$>
MZ0:/XL@L>+<%APM'.U;EV3+?S!<FNWCG (W=[$,<)QLT>C;=(^B"%@?;,,;<
MQTMK+V,E7P=>6I@*TP1 U:*8&B)R(!8I3:,=C$^G3X?%!<<1XK#QOB%#C45@
MK,5"OZ8;)BPD3=?,XMT;Q0:YQ;VE'$18.#(9NQEJ?&V?Y+3***"&*1P<&FD8
M&<I9!$W87(M&U\$'OCWM%B\2&-AENR7:^/P=CC\D,@"#30V9@E.0G%^C^3;H
MWTH(^.]D\#6P^1PUF8+%"[4]#%)'4K5[4<3.Q,Y6(@8I39P%]2Z=.K(+27@>
M5L6,'D+O();&9P-B62O>>O"+25[ #'-!)$/E\P#]MNK/U01J/M33J7ZK_,IY
M,+C;=G(XG#D$;!7MVVD8S[K-W#$7L2. OX:]7=!BN>T\5CV_Q7"FR>F/Q]=J
ML\\E6&:64&#9OC>37L2,VNTPZL@N.5\&@SV#H8H;LM9L=+#-"9B%D)'@%P8;
M,4NH3"[/KH7YVA?!!4\;]I:."S./R4.0DD^7VLI;"#M11@3Y;M;@TC81%HNS
MY=K?%!$J>S,5"E4AQV=LU+4-.YC+5L8H2>>I=L':<-IL3 4<DK[2%%;+6X30
M#V_BX5/*5BE'C1Q13DS"9 ,+0]S1NC%TW?E1%#4]GJ,,O&9I<I8L38 Y);AF
M(:Y"0Y?4"4^GALL-W!T0>Q]I*;3Q3?,I=8\GE\JS=L.I9B"6 X_'PB:?47^.
MG5!96/;ZM/[8_P A/=D:O\L#%^OV#W-H1M'W-GV=>FNB"GN>S=#)QW#S>4FR
M>0F"G%4NRPP-Z>.@920CVF%XY-3,GDW-YM?@@VGB/%X>.XPJ8%#)++(\LTM>
MM#3 B=F9ONH68>C,S:^*#7*?LYQZ(.3P69Y;-/D<7I!KNP@U.IJ9]BN3:^5I
M92-M?B@^S>TU?(8_-PYW+V<G?S5"/%'?V10E%4A(CC$ C;;NWFY$3^+_ $,@
MQ7?:"I>RD>6MWHK.2FA@@R\UBA5F&SZ?5A, D$NP;@^U]CZ::=-4'W+>T<5R
M]9.MF;%/%V\K5SL^,"*(P>Y6.,G?N$V]@D[(ZCKT?K]2"WYAP&#DN2QUZ2Z4
M/H!EC*L<,-F"0)M-S]J<3 96VMMD9M6;5OB@JL5[1U*,G%-^2.:#B4 14Q:"
M*.:62,##<<X_>=LFD\T6NUW9G06_+.#1<DRF(MV;CP5\38CMC!'%'W2EAD:0
M-MEV[L0NXZ&(_:;H@U? ^UV5GR64ESMLXL4?)+.;K8@&A..?1Q*M*4C,\@MN
M;<X:^+-X()N%]E>.XR*Y1<HY\38JSTHJ[U*\=F.&RSB8O< 6E/0"<1U^'CJ@
MGXGV[N5,M@<A?SLV2?CL=J"@$D$43O!9BCB89"CTW$#0Z[M.J"$/L[B2P.!P
MEJ[)9I86Q?G-B 1>P.1"R$D9:/Y6%K;Z.WT(,5/V5PT6#R.'L61DAN01UZ]J
M"G5K68AA,98S.6(&>4VDC G<FT?3P06.,]O\S0NYO)CR6>3,YP: 37GK5V[8
MT'+5HXF;9I*$CB^OAXL@N<YQ:++9SC^6.P41X"Q-9CB$6=I7GK25W$G?PT:7
M=T0?.%\5AXMQBK@8K!6HZKS.TYBPD7>E.5]6;IT[FB#6*7LQAXL=B,=;NRVZ
M6+QN2Q4L9 (=^+*&)R$3M]EPV:-H@L,?[:@,TL^9R]C,3?+I<-3.0(H7@IS:
M=S^[%MTI[!W&_P!'@@ET^!UOY ?A66N29+'O4?']]P"&3TS#VXA\GEW #,V[
MXNVJ"KE]IJ]^AFH<[E[.3O9G'AB3ON$4)15(G(XQ (VVN6\W(B?Q?Z&0>,K[
M3OEX,PV1S,LMS-86'"6K(P1AHT,LDG?$&?;N+NZ;?#H@RE[2X=N4EGH9(M+$
M\5J]6GIUK#G-"(BQQ32"\D.[MBY,+^/5M$&=O;*HW#,CQELA,+W;MG(P9 1%
MI:]B>V5P#C;JVL4C]/I08\'[58S$<CQ>:AN2D.+QT=$*3B+1'/%'V6MOIU[C
MQ$0:>'5!!D]FZ\F%H80\L?R^G;L79':O#ZAY+%PKGW-AV>2!Q<]FX/%D$S >
MTV'P?(BRE0XBJM8GMPU9*E8IHYK#D1[;>WO;&*1W$==6\-=.B"QY'P4,]R/$
M9:S=[<&(FBLP5HX(FE>6$G)O^J=NZ,9?G@W0F0:=Q+V=N38FM6Y;:D.G5NY2
MU%@F[3Q,=Z2>,9.]'YW;L3N[!KT(G_(BK6A[*X.'"Y'#69QFJW*X5(9X:E:M
M:B",QD BGB!GE-C 2U)M'=O!$6G\@7;.3Q>4RV;DOWL96OU&E[$4+2!?&,?,
M(=&>/M?#QU006]GL1)BN.XJW<EL4L#B;F%,-H@]B&[#'"9D[?8(6BU;3Z4&"
MK[,8Z'$S4GO"-D3K2X[(UZ52O/!)2D[L)F\8-WBW,V[=T?Z&=!,Q?!.1X:]8
MM4,V]B;,Y>'(YVS/%&!O7BK-$4$( !#YWB!M>CB/QU\0N>4\2^=W<+D(+QT,
MA@[16JDP $HDTD10RQF!]'8XS=M?%O%!2U?:;'PRX\CO2314<MD\L\) +-+\
MT"8)("=GZ"#6'T=NKZ(,W"/:_&<2M]VK+%-!#"]>BSTZT5B.-W;I)9C$9)7T
M9FZ_VZN@W5 0<@]E?]Q/=7_&(OT)$6NOH@@Y)^)'_+O%O]38[]&5%CK:((-+
M]R.?3\3JC-6"K9EC@GNV*<QS-.=>NS.;Q!#%-IXZ;Y-H,^FK]4&GW^<9_&\S
MY9G<;7"[B*>#Q.3LU;5B2+MP.UF0^Q&PR#W3#\C>5F15Y9]UKS!>S-;'12<4
MQ=Z'&W;!RD-USE>(2EC@8'';&4[-M<M2ZZ(C/5]T+1VL9BYZ,<>9DM9"+-UQ
M,B&K6QC$4DX^74NXQ1=O737?]2#'[?>ZMCE61KPRX\8:F2J%>H30/.?; 7'2
M&R4D4<;2$![FV$[=';X:H(^9]U<]CLER FQ5:3"\<R=+'W)WG,;$D=Z.!]T4
M>QQW1G8;74F9V^M!*R'NC/3Y:6':&K:J2E<KUYJ\DQG'9I53M$$Y/$T+:M$0
MN(2.0OIK]04U7W=YG/2Q4_R.B,F;P<N=I"]N70 JA&<X2_=?G]T>WM_^I!DN
M^^1=Z L=C&G@CQ^/R5Z WG>R09&/NC%6&&*4"../S%O(=?!OI01N3\VSN:NX
M>6I"-3!5^85<4%B.>0;,I5S,)FEB81'M&6K,.[X:NW5%;?RSEW(Z'+<1QO!T
M*MNSE:=VWWKDQPA&]-XF9O($CON[VB(HZGO#<R'\ORT,6'ILOBK&8NG-*0O6
MBI2A'89F$2[C^9V#335]-=&02,9[B\INOBA/%4X3Y12GN<:9K!R:%#$TXQ7-
M(VV;XRUW!JS/T055SW.R&<X5<SE:L=&I!F,;C('@LL%@IGN00VV,A&06C:21
MP'_^0>O1B9%66.]W9KW+&QL./:;%GD9\2,L7?*R$M?>+SRB\30C"4D>S^\U;
M5G?Q1%U[?\TR/*,5>GM5H<?E*LKQR8DBE:Q5)QW!';&0(W8G\=0U%VZLZ#7*
MWO3)\UQ-2_0CK0'5,^12]QW>C;9YP"'31M1*2G(VY]/A]*"IY5S/.7<;*<PS
M8ZQ?X1D\J\%>R3112:Q]M]C"+O*(R=)-S:=>B*OO:2[=L9OE(6+$LXQ!A>T,
MID;#OQ$!GM8G?3<3N3Z>+]4'JK[M3N(!;H!';Q_S>3DD,9N;U8,1^?'T9R[V
M^/9K]+_0B//_ )$Y<\,5>?&TJE_,XJ?*X$QL231B, QF<5K2,=":.5G8@U%W
MZ(*+%>\7)ZW&N-QWJ]2[GLCB!S4\I/. 25WV#& C!#)I8E(GU;1@'Z716T<^
MY%8N<'PITWFH#RB[C*$DG6*>"#(2AW?H<#V:A]+:HC%E_<4L=R:OA'@JVL-8
MO084RKR63L12V!81[A]KL#H3Z$'=WLW7ZD%A[4Y&W8XU<I69CL%A,G?Q,5J4
MG.26&G8*.(C)_M/LT%W^.B#FO%^5<M'@E/)O;S Y+-7*^-+-WY()Z$0V;Y0E
M-6BW$3$ #M^\!FU^GXE;;F;^>XOG[&$AS%O)4\A@<ED(SN$!V*EFDP,,@R@
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M7=]>B"PO\'XOD+.1LW*33RY6&O7NN1R:%'3(CK[68M *,I'=B'0M?CT08I.
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M$$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$'(/97_
M '$]U?\ &(OT)$6NOH@@Y)^)'_+O%O\ 4V._1E18ZVB" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @("#D'LK_N)[J_XQ%^A(BUU]$$'
M)/Q(_P"7>+?ZFQWZ,J+'6T00$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0<@]E?]Q/=7_&(OT)$6NOH@@Y)^)'_+O%O]38[]&5%CK:
M((" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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M7>+?ZFQWZ,J+'6T00$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0<@]E?\ <3W5_P 8B_0D1:Z^B"#DGXD?\N\6_P!38[]&5%CK:(("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(.0>RO^XGN
MK_C$7Z$B+77T00<D_$C_ )=XM_J;'?HRHL=;1! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0
M$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!!R#V5_W$]U?\8B_0D1:Z^B"#DGXD?\
MN\6_U-COT946.MH@@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MA(BUU]$$')/Q(_Y=XM_J;'?HRHL=;1! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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M" @(" @(" @("#D'LK_N)[J_XQ%^A(BUU]$$')/Q(_Y=XM_J;'?HRHL=;1!
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M_1F9AEU=W^"+'7$00$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MD@?(?Q/_ -38#]U/]D@?(?Q/_P!38#]U/]D@?(?Q/_U-@/W4_P!D@?(?Q/\
M]38#]U/]D@?(?Q/_ -38#]U/]D@?(?Q/_P!38#]U/]D@?(?Q/_U-@/W4_P!D
M@?(?Q/\ ]38#]U/]D@?(?Q/_ -38#]U/]D@?(?Q/_P!38#]U/]D@?(?Q/_U-
M@/W4_P!D@?(?Q/\ ]38#]U/]D@?(?Q/_ -38#]U/]D@?(?Q/_P!38#]U/]D@
M?(?Q/_U-@/W4_P!D@?(?Q/\ ]38#]U/]D@?(?Q/_ -38#]U/]D@?(?Q/_P!3
M8#]U/]D@?(?Q/_U-@/W4_P!D@?(?Q/\ ]38#]U/]D@?(?Q/_ -38#]U/]D@?
M(?Q/_P!38#]U/]D@?(?Q/_U-@/W4_P!D@?(?Q/\ ]38#]U/]D@?(?Q/_ -38
M#]U/]D@?(?Q/_P!38#]U/]D@?(?Q/_U-@/W4_P!D@?(?Q/\ ]38#]U/]D@\R
M<7_$Q; JT_+L-5AE;;)8K52[P"_B\>L;-N^CJ@WCVX]OL9P;CS8JG,=NQ-*5
MG(7YO[VQ8D^W(7CIX:,W_P#5$;2@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
7(" @(" @(" @(" @(" @(" @(" @_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ACADIA HEALTHCARE COMPANY, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001520697<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 10, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance Disclosure, Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Pay Versus Performance</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The following table sets forth certain information regarding compensation actually paid to our Named Executive Officers during the past five fiscal
    years compared to certain measures of our financial performance:</p><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="color: rgb(33, 37, 41); text-align: center; padding-bottom: 2px;"></td> <td colspan="8" rowspan="1" style="color: rgb(33, 37, 41); border-bottom: 2px solid rgb(0, 0, 0); text-align: center; vertical-align: bottom;"><span style="font-size: 8pt;">&#160;&#160;Summary Comp. Table Total <br/> for CEO</span></td> <td style="padding-bottom: 2px; color: rgb(33, 37, 41);"><span style="font-size: 8pt">&#160;</span></td> <td colspan="7" rowspan="1" style="color: rgb(33, 37, 41); text-align: center; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"><span style="font-size: 8pt;">&#160;</span> <p style="font: 10pt Times New Roman,Times,serif; margin: 0pt 0px; color: rgb(33, 37, 41);"><span style="font-size: 8pt;">&#160;</span></p> <p style="font: 10pt Times New Roman,Times,serif; margin: 0pt 0px; color: rgb(33, 37, 41);"><span style="font-size: 8pt;">Comp. Actually Paid</span></p> <p style="font: 10pt Times New Roman,Times,serif; margin: 0pt 0px; color: rgb(33, 37, 41);"><span style="font-size: 8pt;">to CEO<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup>&#160;&#160;</span></p> </td> <td style="padding-bottom: 2px; color: rgb(33, 37, 41);"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); padding-bottom: 2px;"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" rowspan="2" style="color: rgb(33, 37, 41); text-align: center; border-bottom: 2px solid rgb(0, 0, 0);"><span style="font-size: 8pt; color: #212529">Average Summary Comp. Table Total for Non-CEO NEOs<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 2px; color: rgb(33, 37, 41);"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); padding-bottom: 2px;"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" rowspan="2" style="color: rgb(33, 37, 41); text-align: center; border-bottom: 2px solid rgb(0, 0, 0);"><span style="font-size: 8pt; color: #212529">Average Comp. Actually Paid to Non-CEO NEOs<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 2px; color: rgb(33, 37, 41);"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); padding-bottom: 2px;"><span style="font-size: 8pt">&#160;</span></td> <td colspan="6" style="color: rgb(33, 37, 41); text-align: center; border-bottom: 2px solid rgb(0, 0, 0);"><span style="font-size: 8pt">Value of Initial Fixed $100 Investment Based On:</span></td> <td style="padding-bottom: 2px; color: rgb(33, 37, 41);"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); padding-bottom: 2px;"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" rowspan="2" style="color: rgb(33, 37, 41); text-align: center; border-bottom: 2px solid rgb(0, 0, 0);"><span style="font-size: 8pt">Net Income (Loss) <br/> (in thousands)</span></td> <td style="padding-bottom: 2px; color: rgb(33, 37, 41);"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); padding-bottom: 2px;"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" rowspan="2" style="color: rgb(33, 37, 41); text-align: center; border-bottom: 2px solid rgb(0, 0, 0);"><span style="font-size: 8pt; color: #212529">Adjusted EPS<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(7)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 2px; color: rgb(33, 37, 41);"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Year</span></td> <td colspan="4" rowspan="1" style="padding-bottom: 1pt; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);"><span style="font-size: 8pt">&#160;&#160;</span><span style="font-size: 8pt; color: rgb(33, 37, 41);">Christopher H. Hunter<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 1pt; color: #212529; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="border-bottom: 2px solid rgb(0, 0, 0); color: rgb(33, 37, 41); text-align: center;"><span style="font-size: 8pt; color: #212529">Debra K. Osteen<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 1pt; color: #212529; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td colspan="4" rowspan="1" style="color: rgb(33, 37, 41); padding-bottom: 1pt; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);"><span style="font-size: 8pt">&#160;</span><span style="font-size: 8pt; color: #212529">Christopher H. Hunter<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup>&#160;&#160;</span><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="border-bottom: 2px solid rgb(0, 0, 0); color: rgb(33, 37, 41); text-align: center;"><span style="font-size: 8pt; color: #212529">Debra K. Osteen<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 1pt; color: #212529; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="border-bottom: 2px solid rgb(0, 0, 0); color: rgb(33, 37, 41); text-align: center;"><span style="font-size: 8pt; color: #212529">TSR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(5)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 1pt; color: #212529; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="border-bottom: 2px solid rgb(0, 0, 0); color: rgb(33, 37, 41); text-align: center;"><span style="font-size: 8pt; color: #212529">Peer Group TSR<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(6)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 1pt; color: #212529; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 9%; color: #212529; text-align: center"><span style="font-size: 8pt">2024</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 6%; color: #212529; text-align: right"><span style="font-size: 8pt">7,089,167</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 6%; color: #212529; text-align: right"><span style="font-size: 8pt; color: #212529">&#160;N/A</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 6%; color: #212529; text-align: right"><span style="font-size: 8pt">(241,669</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">)</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 6%; text-align: right"><span style="font-size: 8pt; color: #212529">N/A</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 6%; color: #212529; text-align: right"><span style="font-size: 8pt">2,238,478</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 6%; text-align: right"><span style="font-size: 8pt">(19,323</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">)</span></td> <td style="width: 1%; color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 6%; color: #212529; text-align: right"><span style="font-size: 8pt">119</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 6%; color: #212529; text-align: right"><span style="font-size: 8pt">126</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 6%; color: #212529; text-align: right"><span style="font-size: 8pt">264,484</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 6%; color: #212529; text-align: right"><span style="font-size: 8pt">3.32</span></td> <td style="width: 1%; color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: #212529; text-align: center"><span style="font-size: 8pt">2023</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">7,404,606</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt; color: #212529">&#160;N/A</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">8,352,752</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt; color: #212529">N/A</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">3,289,184</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">1,079,088</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">234</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">124</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">(15,661</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">)</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">3.51</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: #212529; text-align: center"><span style="font-size: 8pt">2022</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">6,415,224</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">2,620,043</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">8,482,132</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">17,102,308</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">3,040,751</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">9,817,787</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">248</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">118</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">280,033</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">3.19</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="color: #212529; text-align: center"><span style="font-size: 8pt">2021</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt; color: #212529">N/A</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">9,853,107</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt; color: #212529">N/A</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">29,812,731</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">3,656,112</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">8,870,858</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">183</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">147</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">195,562</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">2.70</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="color: #212529; text-align: center"><span style="font-size: 8pt">2020</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt; color: #212529">N/A</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">5,131,395</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt; color: #212529">N/A</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">17,648,915</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">2,604,425</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">6,550,425</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">151</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">134</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">(669,199</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">)</span></td> <td style="color: #212529"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="color: #212529; text-align: right"><span style="font-size: 8pt">2.81</span></td> <td style="color: #212529; text-align: left"><span style="font-size: 8pt">&#160;</span></td> </tr> </table><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"> <tr style="vertical-align: top"> <td style="width: 0"></td> <td style="width: 0.5in"><span style="font-size: 8pt">(1)</span></td> <td style="text-align: left"><span style="font-size: 8pt">Mr. Hunter was appointed Chief Executive Officer effective April 11, 2022.</span></td> </tr> </table><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"> <tr style="vertical-align: top"> <td style="width: 0"></td> <td style="width: 0.5in"><span style="font-size: 8pt">(2)</span></td> <td style="text-align: left"><span style="font-size: 8pt">Ms. Osteen retired as Chief Executive Officer effective April 11, 2022.</span></td> </tr> </table><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"> <tr style="vertical-align: top"> <td style="width: 0"></td> <td style="width: 0.5in"><span style="font-size: 8pt">(3)</span></td> <td style="text-align: left"><span style="font-size: 8pt">To calculate Compensation Actually Paid (&#8220;CAP&#8221;), the following amounts were deducted from and added to Summary Compensation Table (&#8220;SCT&#8221;) total compensation:</span></td> </tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in"><span style="font-size: 8pt"><b>CEO SCT Table to CAP Reconciliation: </b></span></p><table border="0" cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: 1pt solid Black; text-align: left; width: 20%; vertical-align: bottom;"><span style="font-size: 8pt;">Name</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="border-bottom: 1pt solid Black; text-align: center; width: 9%;"><span style="font-size: 8pt">Year</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="text-align: center; border-bottom: 1pt solid Black;"><span style="font-size: 8pt">SCT Total</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="text-align: center; border-bottom: 1pt solid Black;"><span style="font-size: 8pt">Deductions from SCT Total<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(a)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="text-align: center; border-bottom: 1pt solid Black;"><span style="font-size: 8pt">Additions to SCT Total<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(b)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="text-align: center; border-bottom: 1pt solid Black;"><span style="font-size: 8pt">CAP</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 20%; text-align: left; vertical-align: top;"><span style="font-size: 8pt;">Christopher H. Hunter</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 9%; text-align: center;"><span style="font-size: 8pt">2024</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 14%; text-align: right"><span style="font-size: 8pt">7,089,167</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 14%; text-align: right"><span style="font-size: 8pt">5,099,925</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 14%; text-align: right"><span style="font-size: 8pt">(2,230,911</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">)</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 14%; text-align: right"><span style="font-size: 8pt">(241,669</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">)</span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; width: 20%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center; width: 9%;"><span style="font-size: 8pt">2023</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); text-align: right; width: 14%;"><span style="font-size: 8pt">7,404,606</span></td> <td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">4,749,977</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">5,698,123</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">8,352,752</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; width: 20%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center; width: 9%;"><span style="font-size: 8pt">2022</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); text-align: right; width: 14%;"><span style="font-size: 8pt">6,415,224</span></td> <td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">4,500,022</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">6,566,930</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">8,482,132</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; width: 20%; vertical-align: middle;"><span style="font-size: 8pt;">Debra K. Osteen</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center; width: 9%;"><span style="font-size: 8pt">2024</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"><span style="font-size: 8pt">&#8211;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"><span style="font-size: 8pt">&#8211;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"><span style="font-size: 8pt">&#8211;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"><span style="font-size: 8pt">&#8211;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom"> <td style="text-align: center; width: 20%;"></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center; width: 9%;"><span style="font-size: 8pt">2023</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"><span style="font-size: 8pt">&#8211;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"><span style="font-size: 8pt">&#8211;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"><span style="font-size: 8pt">&#8211;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"><span style="font-size: 8pt">&#8211;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; width: 20%;"></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center; width: 9%;"><span style="font-size: 8pt">2022</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">2,620,043</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">1,059,857</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">15,542,122</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">17,102,308</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom"> <td style="text-align: center; width: 20%;"></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center; width: 9%;"><span style="font-size: 8pt">2021</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">9,853,107</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">6,989,753</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">26,949,377</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">29,812,731</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; width: 20%;"></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center; width: 9%;"><span style="font-size: 8pt">2020</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">5,131,395</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">2,789,779</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">15,307,298</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); text-align: right; width: 14%;"><span style="font-size: 8pt">17,648,915</span></td> <td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> </tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in"><span style="font-size: 8pt"><b>Average Non-CEO NEOs SCT Table to CAP Reconciliation:</b></span></p><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Year</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">SCT Total</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">Deductions from SCT Total<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(a)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">Additions to SCT Total<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(b)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">CAP</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 15%; background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 14%; text-align: center"><span style="font-size: 8pt">2024</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 14%; text-align: right"><span style="font-size: 8pt">2,238,478</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 14%; text-align: right"><span style="font-size: 8pt">1,179,647</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 14%; text-align: right"><span style="font-size: 8pt">(1,078,154</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">)</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 14%; text-align: right"><span style="font-size: 8pt">(19,323</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">)</span></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center"><span style="font-size: 8pt">2023</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">3,289,184</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">2,503,492</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">293,396</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">1,079,088</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center"><span style="font-size: 8pt">2022</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">3,040,751</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">1,720,243</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">8,497,279</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">9,817,787</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center"><span style="font-size: 8pt">2021</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">3,656,112</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">1,963,594</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">7,178,340</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">8,870,858</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center"><span style="font-size: 8pt">2020</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">2,604,425</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">1,116,717</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">5,062,717</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">6,550,425</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> </tr> </table><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.5in"><span style="font-size: 8pt">(a)</span></td> <td style="text-align: left"><span style="font-size: 8pt">Represents the grant date fair value of equity-based awards granted each year calculated in accordance with ASC 718.</span></td> </tr> </table><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.5in"><span style="font-size: 8pt">(b)</span></td> <td style="text-align: left"><span style="font-size: 8pt">Reflects the value of equity calculated in accordance with the SEC methodology for determining CAP for each year shown. The equity component of CAP is further detailed in the table below. For performance-vesting restricted stock unit awards, fair value amounts have been computed consistent with the methodology used in the Company&#8217;s Consolidated Financial Statements as of December 31, 2020, 2021, 2022, 2023 and 2024, respectively.</span></td> </tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in"><span style="font-size: 8pt"><b>Equity Component of CAP: </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><span style="font-size: 8pt"><span style="text-decoration:underline">Christopher H. Hunter</span></span></p><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 65%; font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Year</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"> <div>Fair Value of</div> <div> Current Year Equity Awards at Year-End</div> </td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Change in Value of Prior Years&#8217; Awards Unvested at Year-End</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Change in Value of Prior Years&#8217; Awards That Vested in the Year</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"> <div>Equity Value</div> <div> Included in CAP</div> </td> <td style="padding-bottom: 1pt">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 19%; text-align: center">2024</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right">2,975,019</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right">(5,148,737</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 17%; text-align: right">(57,192</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right">(2,230,911</td> <td style="width: 1%; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2023</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">6,050,233</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(321,521</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(30,589</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">5,698,123</td> <td style="text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2022</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">6,566,930</td> <td style="text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">6,566,930</td> <td style="text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2021</td> <td style="text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2020</td> <td style="text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> </tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><span style="font-size: 8pt"><span style="text-decoration:underline">Debra K. Osteen</span></span></p><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 65%; font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Year</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Fair Value of Current Year Equity Awards at Year-End</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Change in Value of Prior Years&#8217; Awards Unvested at Year-End</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Change in Value of Prior Years&#8217; Awards That Vested in the Year</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"> <div>Equity Value</div> <div> Included in CAP</div> </td> <td style="padding-bottom: 1pt">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2024</td> <td style="text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2023</td> <td style="text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 19%; text-align: center">2022</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right">9,972,986</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right">7,341,244</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right">(1,772,108</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right">15,542,122</td> <td style="width: 1%; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2021</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">23,567,139</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">3,215,353</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">166,885</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">26,949,377</td> <td style="text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2020</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">13,014,224</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">533,148</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">1,759,927</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">15,307,298</td> <td style="text-align: left">&#160;</td> </tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><span style="font-size: 8pt"><span style="text-decoration:underline">Average Non-CEO NEOs </span></span></p><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 80%; font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Year</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Fair Value of Current Year Equity Awards at Year-End</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Change in Value of Prior Years&#8217; Awards Unvested at Year-End</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Change in Value of Prior Years&#8217; Awards That Vested in the Year</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Fair Value of Forfeited Awards at Prior Year-End</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"> <div>Equity Value</div> <div> Included in CAP</div> </td> <td style="padding-bottom: 1pt">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 14%; text-align: center">2024</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right">679,492</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right">(1,278,180</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right">(19,593</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right">(459,873</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right">(1,078,154</td> <td style="width: 1%; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2023</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">2,182,972</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(89,974</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(255,921</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(1,543,681</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">293,396</td> <td style="text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2022</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">5,228,345</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">3,399,089</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(130,155</td> <td style="text-align: left">)</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">8,497,279</td> <td style="text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2021</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">5,891,861</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">1,147,507</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">138,972</td> <td style="text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">7,178,340</td> <td style="text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2020</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">4,691,771</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">419,942</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(48,996</td> <td style="text-align: left">)</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">5,062,717</td> <td style="text-align: left">&#160;</td> </tr> </table><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"> <tr style="vertical-align: top"> <td style="width: 0"></td> <td style="width: 0.5in"><span style="font-size: 8pt">(4)</span></td> <td style="text-align: left"><span style="font-size: 8pt">The Named Executive Officers, other than the CEO, reflected in the Pay Versus Performance table represent the following individuals for each of the years listed below</span></td> </tr> </table><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; width: 94%; border-collapse: collapse; margin-left: 0.5in">

      <tr style="vertical-align: bottom">
        <td style="width: 23%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">2020</span></td>
        <td style="width: 20%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">2021</span></td>
        <td style="width: 19%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">2022</span></td>
        <td style="width: 19%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">2023</span></td>
        <td style="width: 19%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">2024</span></td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">David M. Duckworth</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">David M. Duckworth</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">David M. Duckworth</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Heather Dixon</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Heather Dixon</span></td>
      </tr>
      <tr style="vertical-align: top">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Christopher L. Howard</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Christopher L. Howard</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Christopher L. Howard</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Brian P. Farley</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Brian P. Farley</span></td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">John S. Hollinsworth</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">John S. Hollinsworth</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">John S. Hollinsworth</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">John S. Hollinsworth</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Nasser Khan, M.D.</span></td>
      </tr>
      <tr style="vertical-align: top">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Laurence L. Harrod</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Laurence L. Harrod</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Laurence L. Harrod</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">David M. Duckworth</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">John S. Hollinsworth</span></td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Laurence L. Harrod</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
      </tr>

  </table><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 0"></td>
        <td style="width: 0.5in"><span style="font-size: 8pt">(5)</span></td>
        <td style="text-align: left"><span style="font-size: 8pt">An investment of $100 is assumed to have been made in our Common Stock as of December&#160;31, 2019. TSR was calculated by multiplying the initial investment of $100 by the quotient of the
            closing price of our Common Stock on December&#160;31, 2020, 2021, 2022, 2023 and 2024, divided by our closing price on December&#160;31, 2019.</span></td>
      </tr>

  </table><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"> <tr style="vertical-align: top"> <td style="width: 0"></td> <td style="width: 0.5in"><span style="font-size: 8pt">(6)</span></td> <td style="text-align: left"><span style="font-size: 8pt">Reflects the cumulative total stockholder return for the S&amp;P Health Care Services Select Industry Index (the &#8220;S&amp;P HC Index&#8221;). An investment of $100 is assumed to have been made in the S&amp;P HC Index as of December&#160;31, 2019. Peer Group TSR was calculated by multiplying the initial investment of $100 by the quotient of the closing price of the S&amp;P HC Index on December&#160;31, 2020, 2021, 2022, 2023 and 2024 divided by the closing price on December&#160;31, 2019, with dividends reinvested at the time they are paid.</span></td> </tr> </table><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"> <tr style="vertical-align: top"> <td style="width: 0"></td> <td style="width: 0.5in"><span style="font-size: 8pt">(7)</span></td> <td style="text-align: left"><span style="font-size: 8pt">Adjusted EPS is a non-GAAP financial measure and one of the core long-term metrics we use for purposes of evaluating performance for our compensation program, as further described in the section above entitled &#8220;COMPENSATION DISCUSSION AND ANALYSIS &#8211; Components of Executive Compensation &#8211; Annual Non-Equity Incentive Compensation.&#8221;</span></td> </tr> </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CoSelectedMeasureName', window );">Company Selected Measure Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Adjusted EPS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"> <tr style="vertical-align: top"> <td style="width: 0"></td> <td style="width: 0.5in"><span style="font-size: 8pt">(1)</span></td> <td style="text-align: left"><span style="font-size: 8pt">Mr. Hunter was appointed Chief Executive Officer effective April 11, 2022.</span></td> </tr> </table><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"> <tr style="vertical-align: top"> <td style="width: 0"></td> <td style="width: 0.5in"><span style="font-size: 8pt">(2)</span></td> <td style="text-align: left"><span style="font-size: 8pt">Ms. Osteen retired as Chief Executive Officer effective April 11, 2022.</span></td> </tr> </table><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"> <tr style="vertical-align: top"> <td style="width: 0"></td> <td style="width: 0.5in"><span style="font-size: 8pt">(4)</span></td> <td style="text-align: left"><span style="font-size: 8pt">The Named Executive Officers, other than the CEO, reflected in the Pay Versus Performance table represent the following individuals for each of the years listed below</span></td> </tr> </table><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; width: 94%; border-collapse: collapse; margin-left: 0.5in">

      <tr style="vertical-align: bottom">
        <td style="width: 23%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">2020</span></td>
        <td style="width: 20%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">2021</span></td>
        <td style="width: 19%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">2022</span></td>
        <td style="width: 19%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">2023</span></td>
        <td style="width: 19%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">2024</span></td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">David M. Duckworth</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">David M. Duckworth</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">David M. Duckworth</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Heather Dixon</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Heather Dixon</span></td>
      </tr>
      <tr style="vertical-align: top">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Christopher L. Howard</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Christopher L. Howard</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Christopher L. Howard</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Brian P. Farley</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Brian P. Farley</span></td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">John S. Hollinsworth</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">John S. Hollinsworth</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">John S. Hollinsworth</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">John S. Hollinsworth</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Nasser Khan, M.D.</span></td>
      </tr>
      <tr style="vertical-align: top">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Laurence L. Harrod</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Laurence L. Harrod</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Laurence L. Harrod</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">David M. Duckworth</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">John S. Hollinsworth</span></td>
      </tr>
      <tr style="vertical-align: top; background-color: #CCEEFF">
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">Laurence L. Harrod</span></td>
        <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-size: 8pt">&#160;</span></td>
      </tr>

  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeerGroupIssuersFnTextBlock', window );">Peer Group Issuers, Footnote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"> <tr style="vertical-align: top"> <td style="width: 0"></td> <td style="width: 0.5in"><span style="font-size: 8pt">(6)</span></td> <td style="text-align: left"><span style="font-size: 8pt">Reflects the cumulative total stockholder return for the S&amp;P Health Care Services Select Industry Index (the &#8220;S&amp;P HC Index&#8221;). An investment of $100 is assumed to have been made in the S&amp;P HC Index as of December&#160;31, 2019. Peer Group TSR was calculated by multiplying the initial investment of $100 by the quotient of the closing price of the S&amp;P HC Index on December&#160;31, 2020, 2021, 2022, 2023 and 2024 divided by the closing price on December&#160;31, 2019, with dividends reinvested at the time they are paid.</span></td> </tr> </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"> <tr style="vertical-align: top"> <td style="width: 0"></td> <td style="width: 0.5in"><span style="font-size: 8pt">(3)</span></td> <td style="text-align: left"><span style="font-size: 8pt">To calculate Compensation Actually Paid (&#8220;CAP&#8221;), the following amounts were deducted from and added to Summary Compensation Table (&#8220;SCT&#8221;) total compensation:</span></td> </tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in"><span style="font-size: 8pt"><b>CEO SCT Table to CAP Reconciliation: </b></span></p><table border="0" cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="border-bottom: 1pt solid Black; text-align: left; width: 20%; vertical-align: bottom;"><span style="font-size: 8pt;">Name</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="border-bottom: 1pt solid Black; text-align: center; width: 9%;"><span style="font-size: 8pt">Year</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="text-align: center; border-bottom: 1pt solid Black;"><span style="font-size: 8pt">SCT Total</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="text-align: center; border-bottom: 1pt solid Black;"><span style="font-size: 8pt">Deductions from SCT Total<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(a)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="text-align: center; border-bottom: 1pt solid Black;"><span style="font-size: 8pt">Additions to SCT Total<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(b)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="text-align: center; border-bottom: 1pt solid Black;"><span style="font-size: 8pt">CAP</span></td> <td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 20%; text-align: left; vertical-align: top;"><span style="font-size: 8pt;">Christopher H. Hunter</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 9%; text-align: center;"><span style="font-size: 8pt">2024</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 14%; text-align: right"><span style="font-size: 8pt">7,089,167</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 14%; text-align: right"><span style="font-size: 8pt">5,099,925</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 14%; text-align: right"><span style="font-size: 8pt">(2,230,911</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">)</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 14%; text-align: right"><span style="font-size: 8pt">(241,669</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">)</span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; width: 20%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center; width: 9%;"><span style="font-size: 8pt">2023</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); text-align: right; width: 14%;"><span style="font-size: 8pt">7,404,606</span></td> <td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">4,749,977</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">5,698,123</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">8,352,752</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; width: 20%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center; width: 9%;"><span style="font-size: 8pt">2022</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); text-align: right; width: 14%;"><span style="font-size: 8pt">6,415,224</span></td> <td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">4,500,022</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">6,566,930</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">8,482,132</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; width: 20%; vertical-align: middle;"><span style="font-size: 8pt;">Debra K. Osteen</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center; width: 9%;"><span style="font-size: 8pt">2024</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"><span style="font-size: 8pt">&#8211;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"><span style="font-size: 8pt">&#8211;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"><span style="font-size: 8pt">&#8211;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"><span style="font-size: 8pt">&#8211;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom"> <td style="text-align: center; width: 20%;"></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center; width: 9%;"><span style="font-size: 8pt">2023</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"><span style="font-size: 8pt">&#8211;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"><span style="font-size: 8pt">&#8211;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"><span style="font-size: 8pt">&#8211;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"><span style="font-size: 8pt">&#8211;</span></td> <td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; width: 20%;"></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center; width: 9%;"><span style="font-size: 8pt">2022</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">2,620,043</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">1,059,857</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">15,542,122</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">17,102,308</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom"> <td style="text-align: center; width: 20%;"></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center; width: 9%;"><span style="font-size: 8pt">2021</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">9,853,107</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">6,989,753</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">26,949,377</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">29,812,731</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; width: 20%;"></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center; width: 9%;"><span style="font-size: 8pt">2020</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">5,131,395</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">2,789,779</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right; width: 14%;"><span style="font-size: 8pt">15,307,298</span></td> <td style="text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> <td style="color: rgb(33, 37, 41); text-align: right; width: 14%;"><span style="font-size: 8pt">17,648,915</span></td> <td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"><span style="font-size: 8pt">&#160;</span></td> </tr> </table><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.5in"><span style="font-size: 8pt">(a)</span></td> <td style="text-align: left"><span style="font-size: 8pt">Represents the grant date fair value of equity-based awards granted each year calculated in accordance with ASC 718.</span></td> </tr> </table><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.5in"><span style="font-size: 8pt">(b)</span></td> <td style="text-align: left"><span style="font-size: 8pt">Reflects the value of equity calculated in accordance with the SEC methodology for determining CAP for each year shown. The equity component of CAP is further detailed in the table below. For performance-vesting restricted stock unit awards, fair value amounts have been computed consistent with the methodology used in the Company&#8217;s Consolidated Financial Statements as of December 31, 2020, 2021, 2022, 2023 and 2024, respectively.</span></td> </tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in"><span style="font-size: 8pt"><b>Equity Component of CAP: </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><span style="font-size: 8pt"><span style="text-decoration:underline">Christopher H. Hunter</span></span></p><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 65%; font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Year</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"> <div>Fair Value of</div> <div> Current Year Equity Awards at Year-End</div> </td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Change in Value of Prior Years&#8217; Awards Unvested at Year-End</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Change in Value of Prior Years&#8217; Awards That Vested in the Year</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"> <div>Equity Value</div> <div> Included in CAP</div> </td> <td style="padding-bottom: 1pt">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 19%; text-align: center">2024</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right">2,975,019</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right">(5,148,737</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 17%; text-align: right">(57,192</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right">(2,230,911</td> <td style="width: 1%; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2023</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">6,050,233</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(321,521</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(30,589</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">5,698,123</td> <td style="text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2022</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">6,566,930</td> <td style="text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">6,566,930</td> <td style="text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2021</td> <td style="text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2020</td> <td style="text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> </tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><span style="font-size: 8pt"><span style="text-decoration:underline">Debra K. Osteen</span></span></p><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 65%; font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Year</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Fair Value of Current Year Equity Awards at Year-End</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Change in Value of Prior Years&#8217; Awards Unvested at Year-End</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Change in Value of Prior Years&#8217; Awards That Vested in the Year</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"> <div>Equity Value</div> <div> Included in CAP</div> </td> <td style="padding-bottom: 1pt">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2024</td> <td style="text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2023</td> <td style="text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 19%; text-align: center">2022</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right">9,972,986</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right">7,341,244</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right">(1,772,108</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right">15,542,122</td> <td style="width: 1%; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2021</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">23,567,139</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">3,215,353</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">166,885</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">26,949,377</td> <td style="text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2020</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">13,014,224</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">533,148</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">1,759,927</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">15,307,298</td> <td style="text-align: left">&#160;</td> </tr> </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,238,478<span></span>
</td>
<td class="nump">$ 3,289,184<span></span>
</td>
<td class="nump">$ 3,040,751<span></span>
</td>
<td class="nump">$ 3,656,112<span></span>
</td>
<td class="nump">$ 2,604,425<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (19,323)<span></span>
</td>
<td class="nump">1,079,088<span></span>
</td>
<td class="nump">9,817,787<span></span>
</td>
<td class="nump">8,870,858<span></span>
</td>
<td class="nump">6,550,425<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"> <tr style="vertical-align: top"> <td style="width: 0"></td> <td style="width: 0.5in"><span style="font-size: 8pt">(3)</span></td> <td style="text-align: left"><span style="font-size: 8pt">To calculate Compensation Actually Paid (&#8220;CAP&#8221;), the following amounts were deducted from and added to Summary Compensation Table (&#8220;SCT&#8221;) total compensation:</span></td> </tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in"><span style="font-size: 8pt"><b>Average Non-CEO NEOs SCT Table to CAP Reconciliation:</b></span></p><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Year</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">SCT Total</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">Deductions from SCT Total<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(a)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">Additions to SCT Total<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(b)</sup>&#160;&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"><span style="font-size: 8pt">CAP</span></td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 15%; background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 14%; text-align: center"><span style="font-size: 8pt">2024</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 14%; text-align: right"><span style="font-size: 8pt">2,238,478</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 14%; text-align: right"><span style="font-size: 8pt">1,179,647</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 14%; text-align: right"><span style="font-size: 8pt">(1,078,154</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">)</span></td> <td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td> <td style="width: 14%; text-align: right"><span style="font-size: 8pt">(19,323</span></td> <td style="width: 1%; text-align: left"><span style="font-size: 8pt">)</span></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center"><span style="font-size: 8pt">2023</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">3,289,184</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">2,503,492</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">293,396</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">1,079,088</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center"><span style="font-size: 8pt">2022</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">3,040,751</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">1,720,243</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">8,497,279</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">9,817,787</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center"><span style="font-size: 8pt">2021</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">3,656,112</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">1,963,594</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">7,178,340</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">8,870,858</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="background-color: White"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: center"><span style="font-size: 8pt">2020</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">2,604,425</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">1,116,717</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">5,062,717</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> <td style="text-align: right"><span style="font-size: 8pt">6,550,425</span></td> <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td> </tr> </table><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.5in"><span style="font-size: 8pt">(a)</span></td> <td style="text-align: left"><span style="font-size: 8pt">Represents the grant date fair value of equity-based awards granted each year calculated in accordance with ASC 718.</span></td> </tr> </table><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.5in"><span style="font-size: 8pt">(b)</span></td> <td style="text-align: left"><span style="font-size: 8pt">Reflects the value of equity calculated in accordance with the SEC methodology for determining CAP for each year shown. The equity component of CAP is further detailed in the table below. For performance-vesting restricted stock unit awards, fair value amounts have been computed consistent with the methodology used in the Company&#8217;s Consolidated Financial Statements as of December 31, 2020, 2021, 2022, 2023 and 2024, respectively.</span></td> </tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in"><span style="font-size: 8pt"><b>Equity Component of CAP: </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><span style="font-size: 8pt"><span style="text-decoration:underline">Average Non-CEO NEOs </span></span></p><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 80%; font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Year</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Fair Value of Current Year Equity Awards at Year-End</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Change in Value of Prior Years&#8217; Awards Unvested at Year-End</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Change in Value of Prior Years&#8217; Awards That Vested in the Year</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Fair Value of Forfeited Awards at Prior Year-End</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"> <div>Equity Value</div> <div> Included in CAP</div> </td> <td style="padding-bottom: 1pt">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 14%; text-align: center">2024</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right">679,492</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right">(1,278,180</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right">(19,593</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right">(459,873</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right">(1,078,154</td> <td style="width: 1%; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2023</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">2,182,972</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(89,974</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(255,921</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(1,543,681</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">293,396</td> <td style="text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2022</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">5,228,345</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">3,399,089</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(130,155</td> <td style="text-align: left">)</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">8,497,279</td> <td style="text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2021</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">5,891,861</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">1,147,507</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">138,972</td> <td style="text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">7,178,340</td> <td style="text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2020</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">4,691,771</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">419,942</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(48,996</td> <td style="text-align: left">)</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">5,062,717</td> <td style="text-align: left">&#160;</td> </tr> </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Comparison of Compensation Actually Paid and Company TSR</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following graph reflects the relationship between our CEO and average non-CEO NEO &#8220;compensation actually paid&#8221; versus our cumulative TSR,
    assuming an initial fixed investment of $100 on December 31, 2019, for the years ended December 31, 2020, 2021, 2022, 2023 and 2024.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="ny20042551x1_image04.jpg"/>&#160;</p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Comparison of Compensation Actually Paid and Net Income</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following graph reflects the relationship between our CEO and average non-CEO NEO &#8220;compensation actually paid&#8221; and our net income for the
    years ended December 31, 2020, 2021, 2022, 2023 and 2024.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="ny20042551x1_image05.jpg"/>&#160;</p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock', window );">Compensation Actually Paid vs. Company Selected Measure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Comparison of Compensation Actually Paid and Adjusted EPS</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following graph reflects the relationship between our CEO and average non-CEO NEO &#8220;compensation actually paid&#8221; and our Adjusted EPS for the
    years ended December 31, 2020, 2021, 2022, 2023 and 2024.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="ny20042551x1_image06.jpg"/>&#160;</p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock', window );">Total Shareholder Return Vs Peer Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Comparison of Company TSR and Peer Group TSR</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following graph reflects the relationship between our TSR and the TSR of the peer group presented for this purpose, the S&amp;P HC Index.</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="ny20042551x1_image07.jpg"/>&#160;</p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TabularListTableTextBlock', window );">Tabular List, Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i>Financial Performance Measures</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As further described in the section above entitled &#8220;COMPENSATION DISCUSSION AND ANALYSIS &#8211; Components of Executive Compensation,&#8221; the Company&#8217;s
    executive compensation program is heavily weighted to performance-based pay, with a significant emphasis on long-term performance and stockholder value creation. The Company primarily uses three core metrics across its long-term and short-term
    incentive awards: Adjusted EPS, Adjusted EBITDA and revenue. The Company uses Adjusted EPS, Adjusted EBITDA and revenue to determine annual cash incentive awards and performance-based equity awards because they are important measures of our performance
    and the performance of our management, they drive our success and growth and they are key criteria by which management plans and analyzes our business. In addition, the Company uses certain non-financial measures to determine annual cash incentive
    awards in order to incentivize and align achievement for certain key qualitative metrics. Therefore, the most important financial performance measures (and only financial measures used in current plans/awards) used by the Company to link compensation
    actually paid to the Company&#8217;s NEOs, for the most recently completed fiscal year, to the Company&#8217;s performance are as follows:</p><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"> <tr style="vertical-align: top"> <td style="width: 20.9pt"></td> <td style="width: 18pt">&#9679;</td> <td style="text-align: justify">Adjusted EPS</td> </tr> </table><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"> <tr style="vertical-align: top"> <td style="width: 20.7pt"></td> <td style="width: 18pt">&#9679;</td> <td style="text-align: justify">Adjusted EBITDA</td> </tr> </table><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"> <tr style="vertical-align: top"> <td style="width: 20.7pt"></td> <td style="width: 18pt">&#9679;</td> <td style="text-align: justify">Revenue</td> </tr> </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
<td class="nump">234<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="nump">151<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeerGroupTotalShareholderRtnAmt', window );">Peer Group Total Shareholder Return Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 126<span></span>
</td>
<td class="nump">$ 124<span></span>
</td>
<td class="nump">$ 118<span></span>
</td>
<td class="nump">$ 147<span></span>
</td>
<td class="nump">$ 134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CoSelectedMeasureAmt', window );">Company Selected Measure Amount | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.32<span></span>
</td>
<td class="nump">3.51<span></span>
</td>
<td class="nump">3.19<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">2.81<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">Ms. Osteen<span></span>
</td>
<td class="text">Mr. Hunter<span></span>
</td>
<td class="text">Mr. Hunter<span></span>
</td>
<td class="text">Mr. Hunter<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Ms. Osteen<span></span>
</td>
<td class="text">Ms. Osteen<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_EqtyAwrdsAdjFnTextBlock', window );">Equity Awards Adjustments, Footnote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="width: 0in"></td> <td style="width: 0.5in"><span style="font-size: 8pt">(b)</span></td> <td style="text-align: left"><span style="font-size: 8pt">Reflects the value of equity calculated in accordance with the SEC methodology for determining CAP for each year shown. The equity component of CAP is further detailed in the table below. For performance-vesting restricted stock unit awards, fair value amounts have been computed consistent with the methodology used in the Company&#8217;s Consolidated Financial Statements as of December 31, 2020, 2021, 2022, 2023 and 2024, respectively.</span></td> </tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in"><span style="font-size: 8pt"><b>Equity Component of CAP: </b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><span style="font-size: 8pt"><span style="text-decoration:underline">Christopher H. Hunter</span></span></p><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 65%; font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Year</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"> <div>Fair Value of</div> <div> Current Year Equity Awards at Year-End</div> </td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Change in Value of Prior Years&#8217; Awards Unvested at Year-End</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Change in Value of Prior Years&#8217; Awards That Vested in the Year</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"> <div>Equity Value</div> <div> Included in CAP</div> </td> <td style="padding-bottom: 1pt">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 19%; text-align: center">2024</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right">2,975,019</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right">(5,148,737</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 17%; text-align: right">(57,192</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right">(2,230,911</td> <td style="width: 1%; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2023</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">6,050,233</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(321,521</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(30,589</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">5,698,123</td> <td style="text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2022</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">6,566,930</td> <td style="text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">6,566,930</td> <td style="text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2021</td> <td style="text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2020</td> <td style="text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> </tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><span style="font-size: 8pt"><span style="text-decoration:underline">Debra K. Osteen</span></span></p><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 65%; font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Year</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Fair Value of Current Year Equity Awards at Year-End</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Change in Value of Prior Years&#8217; Awards Unvested at Year-End</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Change in Value of Prior Years&#8217; Awards That Vested in the Year</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"> <div>Equity Value</div> <div> Included in CAP</div> </td> <td style="padding-bottom: 1pt">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2024</td> <td style="text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2023</td> <td style="text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 19%; text-align: center">2022</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right">9,972,986</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right">7,341,244</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right">(1,772,108</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 17%; text-align: right">15,542,122</td> <td style="width: 1%; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2021</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">23,567,139</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">3,215,353</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">166,885</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">26,949,377</td> <td style="text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2020</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">13,014,224</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">533,148</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">1,759,927</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">15,307,298</td> <td style="text-align: left">&#160;</td> </tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><span style="font-size: 8pt"><span style="text-decoration:underline">Average Non-CEO NEOs </span></span></p><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 80%; font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; text-align: center">Year</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Fair Value of Current Year Equity Awards at Year-End</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Change in Value of Prior Years&#8217; Awards Unvested at Year-End</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Change in Value of Prior Years&#8217; Awards That Vested in the Year</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;">Fair Value of Forfeited Awards at Prior Year-End</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td style="padding-bottom: 1pt; border-bottom: Black 1pt solid">&#160;</td> <td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"> <div>Equity Value</div> <div> Included in CAP</div> </td> <td style="padding-bottom: 1pt">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 14%; text-align: center">2024</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right">679,492</td> <td style="width: 1%; text-align: left">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right">(1,278,180</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right">(19,593</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right">(459,873</td> <td style="width: 1%; text-align: left">)</td> <td style="width: 1%">&#160;</td> <td style="width: 1%; text-align: left">$</td> <td style="width: 14%; text-align: right">(1,078,154</td> <td style="width: 1%; text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2023</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">2,182,972</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(89,974</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(255,921</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(1,543,681</td> <td style="text-align: left">)</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">293,396</td> <td style="text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2022</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">5,228,345</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">3,399,089</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(130,155</td> <td style="text-align: left">)</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">8,497,279</td> <td style="text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center">2021</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">5,891,861</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">1,147,507</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">138,972</td> <td style="text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">7,178,340</td> <td style="text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center">2020</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">4,691,771</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">419,942</td> <td style="text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">(48,996</td> <td style="text-align: left">)</td> <td style="font-family: Times New Roman, Times, Serif">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: right">&#8211;</td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">&#160;</td> <td>&#160;</td> <td style="text-align: left">&#160;</td> <td style="text-align: right">5,062,717</td> <td style="text-align: left">&#160;</td> </tr> </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 264,484,000<span></span>
</td>
<td class="num">$ (15,661,000)<span></span>
</td>
<td class="nump">$ 280,033,000<span></span>
</td>
<td class="nump">$ 195,562,000<span></span>
</td>
<td class="num">$ (669,199,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=1', window );">Measure:: 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Adjusted EPS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonGaapMeasureDescriptionTextBlock', window );">Non-GAAP Measure Description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"> <tr style="vertical-align: top"> <td style="width: 0"></td> <td style="width: 0.5in"><span style="font-size: 8pt">(7)</span></td> <td style="text-align: left"><span style="font-size: 8pt">Adjusted EPS is a non-GAAP financial measure and one of the core long-term metrics we use for purposes of evaluating performance for our compensation program, as further described in the section above entitled &#8220;COMPENSATION DISCUSSION AND ANALYSIS &#8211; Components of Executive Compensation &#8211; Annual Non-Equity Incentive Compensation.&#8221;</span></td> </tr> </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=2', window );">Measure:: 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Adjusted EBITDA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=3', window );">Measure:: 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Revenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=achc_ChristopherHHunterMember', window );">Christopher H. Hunter [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,089,167<span></span>
</td>
<td class="nump">7,404,606<span></span>
</td>
<td class="nump">6,415,224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(241,669)<span></span>
</td>
<td class="nump">8,352,752<span></span>
</td>
<td class="nump">8,482,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=achc_DebraKOsteenMember', window );">Debra K. Osteen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,620,043<span></span>
</td>
<td class="nump">9,853,107<span></span>
</td>
<td class="nump">5,131,395<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">17,102,308<span></span>
</td>
<td class="nump">29,812,731<span></span>
</td>
<td class="nump">17,648,915<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Christopher H. Hunter [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,099,925)<span></span>
</td>
<td class="num">(4,749,977)<span></span>
</td>
<td class="num">(4,500,022)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Christopher H. Hunter [Member] | Equity Awards Adjustments, Excluding Value Reported in Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,230,911)<span></span>
</td>
<td class="nump">5,698,123<span></span>
</td>
<td class="nump">6,566,930<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Christopher H. Hunter [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,975,019<span></span>
</td>
<td class="nump">6,050,233<span></span>
</td>
<td class="nump">6,566,930<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Christopher H. Hunter [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,148,737)<span></span>
</td>
<td class="num">(321,521)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Christopher H. Hunter [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57,192)<span></span>
</td>
<td class="num">(30,589)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Debra K. Osteen [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,059,857)<span></span>
</td>
<td class="num">(6,989,753)<span></span>
</td>
<td class="num">(2,789,779)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Debra K. Osteen [Member] | Equity Awards Adjustments, Excluding Value Reported in Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">15,542,122<span></span>
</td>
<td class="nump">26,949,377<span></span>
</td>
<td class="nump">15,307,298<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Debra K. Osteen [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,972,986<span></span>
</td>
<td class="nump">23,567,139<span></span>
</td>
<td class="nump">13,014,224<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Debra K. Osteen [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,341,244<span></span>
</td>
<td class="nump">3,215,353<span></span>
</td>
<td class="nump">533,148<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Debra K. Osteen [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,772,108)<span></span>
</td>
<td class="nump">166,885<span></span>
</td>
<td class="nump">1,759,927<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,179,647)<span></span>
</td>
<td class="num">(2,503,492)<span></span>
</td>
<td class="num">(1,720,243)<span></span>
</td>
<td class="num">(1,963,594)<span></span>
</td>
<td class="num">(1,116,717)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Equity Awards Adjustments, Excluding Value Reported in Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,078,154)<span></span>
</td>
<td class="nump">293,396<span></span>
</td>
<td class="nump">8,497,279<span></span>
</td>
<td class="nump">7,178,340<span></span>
</td>
<td class="nump">5,062,717<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">679,492<span></span>
</td>
<td class="nump">2,182,972<span></span>
</td>
<td class="nump">5,228,345<span></span>
</td>
<td class="nump">5,891,861<span></span>
</td>
<td class="nump">4,691,771<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,278,180)<span></span>
</td>
<td class="num">(89,974)<span></span>
</td>
<td class="nump">3,399,089<span></span>
</td>
<td class="nump">1,147,507<span></span>
</td>
<td class="nump">419,942<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,593)<span></span>
</td>
<td class="num">(255,921)<span></span>
</td>
<td class="num">(130,155)<span></span>
</td>
<td class="nump">138,972<span></span>
</td>
<td class="num">(48,996)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (459,873)<span></span>
</td>
<td class="num">$ (1,543,681)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CoSelectedMeasureAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CoSelectedMeasureAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CoSelectedMeasureName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CoSelectedMeasureName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_EqtyAwrdsAdjFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br> -Sentence B<br> -Clause 1<br> -Subclause ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_EqtyAwrdsAdjFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonGaapMeasureDescriptionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonGaapMeasureDescriptionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeerGroupIssuersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeerGroupIssuersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeerGroupTotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeerGroupTotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TabularListTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TabularListTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnVsPeerGroupTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=achc_ChristopherHHunterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=achc_ChristopherHHunterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=achc_DebraKOsteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=achc_DebraKOsteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Award Timing Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgDiscLineItems', window );"><strong>Award Timing Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiDiscTextBlock', window );">Award Timing MNPI Disclosure</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Equity Award Grant Practices</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company does not generally grant stock options to its employees. The Compensation Committee did not take material nonpublic information into account when determining the timing and terms of equity awards in 2024, and the Company does not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiCnsdrdFlag', window );">Award Timing MNPI Considered</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock', window );">Award Timing, How MNPI Considered</a></td>
<td class="text">The Compensation Committee did not take material nonpublic information into account when determining the timing and terms of equity awards in 2024, and the Company does not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MnpiDiscTimedForCompValFlag', window );">MNPI Disclosure Timed for Compensation Value</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgDiscLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgDiscLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgHowMnpiCnsdrdTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiCnsdrdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiCnsdrdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiDiscTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiDiscTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MnpiDiscTimedForCompValFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MnpiDiscTimedForCompValFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>96</ContextCount>
  <ElementCount>33</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>11</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>2</UnitCount>
  <MyReports>
    <Report instance="ny20042551x1_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ny20042551x1_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ny20042551x1_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995443 - Disclosure - Award Timing Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure</Role>
      <ShortName>Award Timing Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ny20042551x1_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>achc-20250529.xsd</File>
    <File>achc-20250529_def.xml</File>
    <File>achc-20250529_lab.xml</File>
    <File>achc-20250529_pre.xml</File>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="ny20042551x1_def14a.htm">ny20042551x1_def14a.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>ny20042551x1_image01.jpg</File>
    <File>ny20042551x1_image02.jpg</File>
    <File>ny20042551x1_image03.jpg</File>
    <File>ny20042551x1_image04.jpg</File>
    <File>ny20042551x1_image05.jpg</File>
    <File>ny20042551x1_image06.jpg</File>
    <File>ny20042551x1_image07.jpg</File>
    <File>ny20042551x1_image08.jpg</File>
    <File>ny20042551x1_image09.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="5">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="181">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>25
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ny20042551x1_def14a.htm": {
   "nsprefix": "achc",
   "nsuri": "http://acadiahealthcare.com/20250529",
   "dts": {
    "schema": {
     "local": [
      "achc-20250529.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_def.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_lab.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_pre.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "achc-20250529_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "achc-20250529_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "achc-20250529_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ny20042551x1_def14a.htm"
     ]
    }
   },
   "keyStandard": 33,
   "keyCustom": 0,
   "axisStandard": 4,
   "axisCustom": 0,
   "memberStandard": 9,
   "memberCustom": 2,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 96,
   "entityCount": 1,
   "segmentCount": 11,
   "elementCount": 269,
   "unitCount": 2,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2024": 181,
    "http://fasb.org/us-gaap/2024": 5,
    "http://xbrl.sec.gov/dei/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20042551x1_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20042551x1_def14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20042551x1_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20042551x1_def14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
     "longName": "995443 - Disclosure - Award Timing Disclosure",
     "shortName": "Award Timing Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20042551x1_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20042551x1_def14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20042551x1_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "b",
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ny20042551x1_def14a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r185"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r185"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r183"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r92",
      "r103",
      "r119",
      "r154"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r95",
      "r106",
      "r122",
      "r157"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r96",
      "r107",
      "r123",
      "r149",
      "r158",
      "r162",
      "r170"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r87",
      "r99"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r87",
      "r99"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r87",
      "r99"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r99"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "achc_ChristopherHHunterMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acadiahealthcare.com/20250529",
     "localname": "ChristopherHHunterMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Christopher H. Hunter [Member]",
        "documentation": "Christopher H. Hunter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "achc_DebraKOsteenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://acadiahealthcare.com/20250529",
     "localname": "DebraKOsteenMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debra K. Osteen [Member]",
        "documentation": "Debra K. Osteen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r111",
      "r112",
      "r126"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r111",
      "r112",
      "r126"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r87",
      "r99"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r87",
      "r99",
      "r150"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r87",
      "r99",
      "r150"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r190"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r190"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r188"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r190"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r92",
      "r103",
      "r119",
      "r154"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r89",
      "r100",
      "r116",
      "r151"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r187"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r187"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r96",
      "r107",
      "r123",
      "r158"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r96",
      "r107",
      "r123",
      "r158"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r96",
      "r107",
      "r123",
      "r158"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r96",
      "r107",
      "r123",
      "r158"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r96",
      "r107",
      "r123",
      "r158"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r110"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r87",
      "r99"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r96",
      "r107",
      "r123",
      "r149",
      "r158",
      "r162",
      "r170"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r174"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r174"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r174"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r112",
      "r113",
      "r114",
      "r115"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r54",
      "r55",
      "r59",
      "r60",
      "r63",
      "r65",
      "r66",
      "r67",
      "r70",
      "r194"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r112",
      "r113",
      "r114",
      "r115"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r96",
      "r107",
      "r123",
      "r149",
      "r158"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r94",
      "r105",
      "r121",
      "r156"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r97",
      "r108",
      "r124",
      "r159"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r97",
      "r108",
      "r124",
      "r159"
     ]
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r7",
      "r8",
      "r9",
      "r14",
      "r15",
      "r16",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r62",
      "r64",
      "r65",
      "r66",
      "r67",
      "r68",
      "r69",
      "r71",
      "r193",
      "r194"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r89",
      "r100",
      "r116",
      "r151"
     ]
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r90",
      "r101",
      "r117",
      "r152"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r91",
      "r102",
      "r118",
      "r153"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r160"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r93",
      "r104",
      "r120",
      "r155"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r184"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r193": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r194": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>26
<FILENAME>0001140361-25-013294-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-25-013294-xbrl.zip
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MK-62V5VMTD#G]Z1]TFSX^7&#]>O+;_=WC7I3ZQ2T^[J=.X]OOY7QT$Y*I1_
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MK$S.R+#MP2U?]EK=W77[=S!#_ 502P,$%     @ 38B*6I?(8_!+!   /!D
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MBWD]XD8.DA&VM?\+:&YZ?S\DD1D07 D3Z7'?+!VTE%_+/],XD</I,T,;^/;
MO*U;!WURDKQ?YWJ?@/I']T\DTHZXDC%>,!*[ <D@-YZU[O3;UX>OWA?T!#]'
MM(3P V[W_=*P7?>%U%:2V'I(C+-+'B53%@*M14!PT/[C4-WA)E'=EHK5>YA
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MNF PW23TOC&TK"6^XL38AF&89B2HU4!O0B0Z!D9E3^# P\,H'>.X)@06A,=
M:-$ H(DAOU9*89QF:1:L%#&-DPB?GWULIN_D<(B$G3_,#Y0E/P4^7;@ 2@8M
MW8A!",\&86)VA*0W\';,;X42!1HCH"BIV-Q#00>_HX)-2XDK9Y9W$%)#(XZ6
MH]D6&+'BF-W(9 1:.L%,338)N\*N'E35,P?I&L.QUUH]Y:IP>H7=GZJE#@,U
M<P8"3VWQW Z/A$^Z%O001BI$R<U]466-/JQ^H%)P$.(W"K]!:ZC!J$6]D;ZO
M)AB$3 R'. FMR85I0MDV]"8X&SMTB%>EY(B!U/DUES[!?(8FOP9I;XHZ]>0]
MS#EF-SH*OT_5$/IJKFH.'$BK;_0TTU'LT$AQAI#J"@PGQT809 6ZDM@;%2'3
M?AS]5@!L4Y^A0LF#V8YF<7&W\388-OJ'HY=J@O?,78T&,L-?Z^OEKQ_ZE&:F
M(.T+TO88-+.!5C;G3BF=D9.+CIM@QJ:8L=F%3*Z9ZD.F%WJ8M;M-VJZ$1/5\
MP2.#4%13VDO"B2%I_8D!/M"'FP%%58MS"Q 5DSON5QC^]^(N:-2C'T&C3N"3
MO3Y^M,>',$^#1GU?!$?5B!)MTR>65+ 5#E@T!X,TC(M J[.@V_D<E^:K9R\_
M+L>/;GR6+4P<!I_)('5C?LO<89NF-[=0'=&\&/28&!41S!A&)H3P1@E_3^VD
M6&0R2.%K$_>-#?$@2.'&;C175$5=@:#57)T3;$!ZXD!'@X/.ZL'='_VJF=9-
MWEK^C51H#!]CID^R&\ O:)^ UGP)_PX$3T85U/C('$!:7@2_CL-K[E>58F9&
M@CH;:I!:8PR#.>W0D5&NQ2RR@JL]JR]7V<KYV"H+DK'A?)719> B$DV2-K,?
MV+K=@R69UF[/L.;H:Y&2XM 5?@CWBX%0&U)A#16R]F76GF,1#*>GS3(KVY,#
MS1_= ?"Z5B0K&=D>'07Z,WCXN^"U=W#I?@;J?A>8]0XNW2:AV!]B>;<.H+X9
M9+(S.="T,K]5Z!AC KKEQ#T$D.4^1[*V5=DU&KR7--SM_/KAGYZ(QJSU?2(Q
MPX*"J-1?Y0[]9N[W@V.$RE/P%$&*)0$^80)<(RY0>B,N?/:O*CM)/4]N!G-=
M'XKSU4ZA."V>$"V$418^ =*Q*R:)P4/6]Q54CW8TPS'F(V\,<K.%R7>2E.QP
MQ\(/$1FFLE0MBJ]I?1=>2CYI%_Z9?U<'<-2.=#3-V\JB))NY=YM92B@3 O)6
MMW"D(%7H>S8(N;$-!F*3,);*S&BS61U4G47 6*<%.%9N47T!>3]4"$UN-MBS
M_41GUR3+8IQW!6.91E\@J"'W/F$),;JC[\MXI$V_7KCGX?)I+*XR5"($5M =
MEYT@&@)1G%Z(L 1MN85/DS00[&A_7X,>J1%E7?410.N8;.WT<S.?BV5:BJ$\
M\<-$?&-MA6NCB"^%.3W_H]MZQTYZ_WY193D*GW< W:CBE<N ?&J7UH[DRTV<
M+<TG6G&^O:(:9?1 AORKL($0$Q<*R%643L)]),%8)3W[X:1(.\5XD0F5$3N/
M'K'S -)M,U=AIPAMC0H$!QX.G*L!TIU'D81'SZK'5?R[L6M8XE=%2.+MU?V.
M([-G*BR!Q/6>IT")("XG\=0;2=S?.+%^TV:X=Z(BNW.24$7HHCJ6Z7*..B;.
M! ;B4,UEQS&J\C.J3YW4DC8I8U='3&!8.4RZ,?@S#;P$8ZR'ROF-*0_-*)68
M_"1&'!1,E))=FPXU 9TTA >^!C"N*$9(IHX2@ 8H#AK$J4ZTGG73]&5 $=*-
M.(8EX(';\TRLRFJC. LC,0I1UYCOOLIF]^-$H&_<1GV8]*&V*^GAR$(0_:3+
MF9B=QF7#A.RH%5P8'I4EV9SMP\2&%[9_9MNW2KE6J>&:4$ 5H$W:#M2[A+"]
MF,A0#EB/Q]]0"04>8EH[U*W5<FNR,!6F!=OU5%R-Q1/#2N1:N)N>"L2";G_,
M8:^@GU9/;72/&_]YQ[Y^ZK9AB2]6TU47J*KY3?]Y7141'C;JQ#E3KM:).0RD
ME_H<4_MKE,G$H2I"V&84[+0"0_,'\>YJF =E]LU=@3R^^A'(8YF LTRF6>*"
M2ES0=BQ=B0LJ<4$E+JC$!95FR-(,N96$ML8R27P@V'&5G<F_4N&'P8Y=35\5
MN3Y^<$*/GDH9.UEW)B*S[RQGYG%29+H%7"Y]/J42B%DI)%U3J"]XFDSS1BRF
M#2#:(2KC-,KER*0H%.6#1F_Q?$69>=>Z+K1TH)SJ=NP+K'.5A995%0N42R&S
MP)CUKXO&^?F,_0H_>V'->O\*]QI!D"7[F4W'PIB*$K+V._0-DUN=]XW1R(OX
M$ 3Q1* [,IGBK+GT,;FD"K/!0@XJ-+HYXA/,.EFKL3X/OD7I)/&F:FE4Z:SZ
M(;7X+QZD/*+5.GHQ5Z4G5^-()[F$A;(U-G,+E2W?3(4A7!Z:O-.^SE(TLP+J
ML9E^%_196=PACB;[K1WHU*N4H0D7YW?N7T681;49:MS#O]!#CP6H<&R-]"J-
M:=AH*\V*/[W*5:FZR>$J"D:P<*W@;$_C,)B9^TD8#HP)M*!8TBP17T:AE^B5
M_\S'>-&7^.4U.; S< 6F90J\2/"8<A&(> *?RK[T57XI6^&LPAJQY&HC4\RQ
M6BWHUEITN:ZGFIV&W\(H"2G5;:.MBZ'%Z62"F5A'7 ;9L?TBYC*4L1_(I>2D
M4C)4T_!5H3?V*0R3V&9EQ>Q'['2*9XB@+,MR*%DWS+FAE\.]+U06RY/^\L1&
M+H>\S<P\,_L?375$=N0L]RBL\B3M^\@K/"_$P$1,UV$1#*)Z/S>)>Y8^<\%O
MFP)<7&=5JFW,E;H),/350.BO-P6$7E:DWUAJWK8+?$E*NT%*:TRA 'JCB,*$
M?9)Q+'Q_$QA>"0Y:=JG6&U5<JR PU11L)0G"V5S)&53X?,+<TZ:]=.+CYI$E
M>6:Q+*K29-6]V^;&B.%^0RGF=%'71&>DD!9<;*]'-7T],K=N,SF5+?;,%,UP
M$O"Z@ZOFWIF]=&K,>@$(*K<6;E%GH 5=UI8&W(*?KJ;L-(0^@4M8BT3 A/K&
M-]^P@5,,VC,I)0QTYL!@VVV^W>R*5CQZNAFZL/M+Z<,AM2-!"J$""&I?*!<=
M36$086ERK<*+[Q/?9*[#>Q7<MN; \:H1&JD;6U"KZR0E_TK]*<UA[DI;FZUG
MO,@@@K>R,_X=+DJ7(HE"7R#@W992Q@08$T%9,.:7=5DEX#RM."1B,^0:.LE-
MNC&91$+#I^PP&%;P&"&8# T?9OT*"+ZB<3C.+FH WARQ+KO.8Z;DT\NL+@IW
M[#-._EXU]Z6G?GGE8>Z/!]S/$WPW]%.5+7$Q.9L2,VJZ3<P9Q2[Z?T++V9*Y
M9-=H,_PY1'^/:ES?Q>%8! DG<AASS-ZBYH9?CB4EP&8>\ K"M>$R3ZSU3@;#
MB .[2#U,#9U?A;L58,[-_H1RR6"Y4KQ@=X$AP; (\O Y"F^2$26W=NQQ)YWN
M9PNIJ]<,NUI^K3?CO,<:(P6A#0LC$N;@?T^@9',)&ML9T-CK$C16@L9*T-C&
MXS)*T%@)&BM!8_>]O"5HK 2-K:A29V5OCW[9!/NS'<_KVX=S[W:YK*#LV\U:
MG.+A[!!9KO-D_R:];U.L3?<Y$E=7.W:-?;U&@-D&[)6JH7P>7ELCXV&%G<5Z
M[V:*L64AK7.UE!U3W^=4#L(@7S795K%5Z3<HTPA:]JCX0\!X%'$J_J&M>U@9
M%[.-S(6ZDIVZNY*%$UK[Y*>B&85Q3#]U1U)7S^B) $TP0@=29M"I_0.6C*(P
MO5*92$0PT."A>C5;E)_(Z/&?%"V@QY)?!:$RZF6E3& V.K''\>?_OJBP5N3S
MX HFHJ* M=5/.PE^DV2FRRS.Z"L8O.R_Y.QLVIH*#)9<: RSN_M#IK#<]%>,
MJ9RUA\%SFU!7]S%L8$59D79*CCR^U"Z+Z2X:PTX1VOJ.97.$F1O""?*E+U7V
M)<5EWC'6<[1;Z=B4WJ+*TM9J%?3_U)4+4NW>C.:"I0=(4<A)KSFE0?M3,X4
M,RQHA4"#B='AE.M(=T*8W0 =HGZ62"Q#[X+<_9)BTK29*K\XN!S 6CUEL>-4
M=17Z0Y@O#ND?? QGLVL=D\HE:CUOT-I, TH]ZIH$67:B,(/<6N1GXXZJ@A!E
MY54\X]$W@8A<U-MZD?Q_(@&UH9FKBI?'A>OA5.=6;(7ZL4X2$N-!!@4H"GW0
M$O80%R]\]@7+B7P) WP-AGD5\?%R-Z >PPSX8LT>P26JS]V3D^T&_\$#6KK_
M=L7]]Z9T_VVZ^X_^XDP.?GW&]_</@:9>\H_K+"][WX;PR\[%Y46W<<KJ[UCC
M$G[[#7Z^.&&-L];Y,?S?8[V+?/I+&@](NB!&G,P[EDXF(O)X+)Y]G"LUE!49
MHD"=!A8<U.E!.Y@O%.[CFL99^[P)O;5_:P'!G%VVSKN-7OOBG%V>-L[ON8+O
M?2_QPY<?6[,'X5,F71^R$MR]A\8\=*6K^F'U:+WR'FN6_<BAPV^P@.VU6PP,
MU"JE7E[ZV+6/U7*Y\W)D7E9A(@?L.>J/&CIK&Z2W,_"L+>",RBPHCD$2V\IR
M+)QH.)[ZE3L 15,'V$!SNXU.G+6*0XDDU4'3K]K::_2[#JDC.RB/1^;7&PR%
MJV;>T8JN3!<YQ=OT@HCQQ ^G3O8VNZB@LMX@Q TO/-2C*< '_R)'1'W<R](\
MH^W5(),-[)06(]\H56N65](4^M5+I>S ^&A^@56YNDD*=X+8UA+./X*&1]"S
M3;UF:;[4:CJ5".0),'*$-E)H;. 8G".!BP6:-%S*G(F9]:ID%XF*LU9YPW.,
M1855__@N#'&LZCH3A!(N,8)N6PB.Q U%NL(KI ^*_UZ"@4FZK""NH><2J-I.
M=;61D1D?@0*QDG;J#S466'V?"^.4(C;UI/7JKU+@>'M8P@YRN08=0FV&("O$
M$8&/X<S<X%]AFF ^3"*R10?F,2L</OPFKP^5]F9-H#1;ZUC?>]4-;D4K:4')
MW6:SU3HY61-^[<VK7V8OYOO5^I$,[C*_6XA@3[6X5ND?HI=*U:R_4**4761G
MX3;;AL$='MX!YY.?)LGH]48M'55>O7E<[\VVTL%7\OX*I>1IY4C3QNHTL2%T
M4*N\J;^MU ^+@MCN0@GWQCAVCT@PO_"=V,>&D$I]'XCEU9N29?P -8 "/$:
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M\$9578S3\1A!$GH'QW#6(L0O(SXB+MY7 SG'8VY>SP6AP:%&6S^^ A)IBLI
M)(8BHIK/6DN:XP_Y/HRRL(17?"IYQ19/"7=R, 9EA:I^2RQA(3\NN@ES_:3
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M=3P,YCR"EJ<D2L9\8'@>+UB@6?E8T/O?:]0W_E\>KPV?$ARO%N61PEQ'4R+
M2T-B*"?5:3NC0@269N>#*HS^YB:[@@<70M%G,E@!'6'N763*M_'K&97*)--R
MF[)G)+$*S;RI;S9#$!*NB!,YYOK$H5A!S>,[?82U78_P5&5SRK*!F=F[J:R4
MV9(2><45E;>6/!Z*,P0(=PG"8,^TE@'XRR.SX5/"2P^QPH;!$:A#TL@S[<41
M(](W$'NM6OE*R<.\:_ HJ3HS2 4;;1/@14.%:C!*!(WVD8H*_#&IV]"Z@V?7
MP'XK#A8JRX5GE& ?;@")-JB1KF7 45:%LL8S%SXUVXF3N,WH8-P#Q4_8 &\]
M9ZWE<<UQX%E,,:*2Q9G3/W^=T?<3^!GF@K61E?9M(5YX8XPLKLN1DC;44ITT
MNFSB<;2H,X- 780]W2G:W<WCF,L<D.F'"V#!>'-0M T,V*+<S4U4WPY1C*18
MZ3H62P/NPDSRY(6=_=CE\IK[V]R*=^V.PH4+^ZPNFS'E;LS#+&?543/]@DX=
MG9FPD&K,%0OAP)=R7V06&<<XDHB %,28/8>3.\3)JU^-R8&KQ)14E\@LCYOV
M,Z<-P][_PBCMI>")R>*IHIY>J)&9RZ2*^U:?&483>R,Q2&'YGDLR1[PPVHO6
MV95=8#YVPIEEE9V'BP8*XW(I*_\E+LN(HZ(3S(P1CDM,R3;5@@RYQ#%0M+FC
MJR^.7=<Q7*#"T/>:?4>5VU<X1_NKKG.%U>C+H;J6SPVW:G/,$?GU1<;Y8>6Y
M=N>JT4;TKSHX;@0M/5&$Z+T# \>NU%J8[9V50$-[.;3;:TU]5H:5<F++IV3E
M1,--&]RAM,&KRPP3,MSHQ,8JIU/4NJ>\DK=*6\.68N N[2O*UD%45*LBT3!X
MGVA.GTDJ9)&=GN?<A*#WX'4QQO%D,>AH7X1/,:[*ZD\Y'I2]?@[":;Z)*FO@
MKRJBC#*>Y&YHUE2 Y56,L#(\I,  B>:%.^E<%4R) 8P7VE><SZZ/2N\[7,P@
MT4:R-+T'OFE<$);_HMI;(#7P=JE;PUS6?5_&(Q6X5N!V=D/IS1!A$95@SLE)
M7-I%TE$]OG 8CC$4C@4V9)CKTM'KX<P2U8Q<8!DE$%6Z31<OMEW?7"3]S"JK
M%9GK+$]Z2_47LO7Z<:B;HAL+)B*$0UBQMO'8&3Y=;/(=Q/DSZ87CO$"BDYE.
M]-@SAT3N^J%V'J\?FIZ'1,PR<-Q7LP%J:($GP4+#5%<:'B\36#C"@8B!-9++
MHUBLJX3&Y&!;1?24F-A-PL36]DM0[*:#8K=3Q9G-T[J29J.,3;.B?+9H0I6U
M0%A-DCD7 "P7FJ(&Q'5-F8,;)8?((G6;AF[9KAH(<+G9OBOYV$#'<$9"BBY4
M](2J I&I/#K_SNR0,__B3$B@F;M1>J[#1+C>R(*QH:QT3&QH^L/Y4$2\8]I:
MW$ E&SJ-39#ED(2&&:-S*5+^^>PFI"MM6)->MC1\,O&EQZV!?6;8*)BP9-T0
M38A4*]=HMRJK@);8=M&M)6U^ :PAE+5SU#R?PQ!D<"*>?0R %VI9J(P3+@F9
M7R@QVC7ENHE=V,7L9J8F2?&R)1:*=LE0NESV6@A55@I#$6>VG#/6V6(9;;LR
MZC*5TS/SA+$J[6J ^)2(#,:)]"OYFZXFIHI+2,NIL<JT:.G80-I"HJ5ES]F?
M(Z%0 $:7"9E05?D"L@0LWG6U(:DN%$)%7V)-.@Y=6BR-,W[4335IN^J93A'!
M<'?B(?=,3A*XM^VYBKCKG;P*04/,W*Y>),EZ0_1$BJCZERH<JIX4G-P=HF.9
MIW(%E*TK9PHO.D3X #WNJ-GB&E_(-0Z7*;<."29ZXC(PA%$PE2542IMG5X(,
M[G2SR!CD#,$6-(^_ISZGE2'@BI,/S$)FLQ8, 6+Q+N@ E)/8',295"#YB=$J
M4Y?4T<R.*M-1T4APDW1&K3!-2%W7RSLW%T-&^&XBB9Q3^#+"8519%[N8?T?3
MF0$Z_8]SY%4@Z9 X46P="Q55F@?Q1]K)4='7 K)A<L_#L'3\:BR243@@MXN!
M45'],S7MG,2!#IQRI.@R1"A.;'PU3IDBC=,BGJDJW,C(2\<X9T^43L--GQ*H
M9A>TD:25[7TB3C +:%DLDZP&D#%GUV^GX1K9:?7Y344CZ#+FY5Q#<U6OYE(C
M!&$ <X(C3H?8EEO-)RCE<F#D'F5&U2?:*<_JFH?F;3'PK2]%2BX],A IAIK)
M?,2W)7D%QPHG]:QZ@*0.L@"0LS1YO*4CH@4/L A"A2\C4*CS!/H=T8ZA@&5+
M 73(K["4+74D@R&\1>P./0K&%.)H:[>:,O*>F(49*X*INV-ZE_3\YV6E<KB.
ML+"N8;V:!3*,@4+$3P'C1(YCOW=8O P')4O9\"E9EM+$DG5WY2@Y<[9VN\\<
MH*IJV>42F=J*A]L([XK.XV(MSOH[%W:PW.2EFK4'PV5&*G_AS 5H5H\PI.L>
M(7UF4$],(Z'J<'/6#X-4$7X0)M;Q8QN?14=D#:K4K7/U 5&O<]Z?'\A218YN
MW];%E'-2&J;"3690Y'6@+WB1T,"L':+EW3R>EP[#O>O)9-RHI',03+J.N4!0
M<VXS.TI>!=>W_'D!8"\X\YW(.790P?!8[=$BZ;^@N]P5:%[F:'N](Z1S>D*Q
MJ*_D[T[P/[Q.%OJDV#61LY[<!>[#/IF.8E5]LY*;@XT:,$H!\@A]U[SMI%=0
M7T*V1%$QM,N5Q:??L&;?-]EK<,N-9C"W824_V/ I 3]H6B]24WF1%#MHS_L3
M%WB<-$UD?J>[ID2<D3>.K)D/7UF"P841&_Q?92XJHR\LY"035VY9W/EQE9D9
MGVH@[F&=BGZL*12W]J8,Q5TEX48<IV-3[SI$HY4.FB0CFDQ27;4;;5K1@&2,
MXDHY \-[>.-)!NJ6Y[<\OX]Z?B\U5)ATV52GN@E,8E2%G2J$3*U4 XET>SS]
MN80Y<_K(0M"4&S$0EZ'\6Z*TK *_,@Y1HC<'&&O52!/5:]UA>7,*88^U[S2A
M:PQZ3,N;RX9/R2!G-9;"A<QJ1$@QZ&/.;^Y:&UWO>5 45KH,#)(W?V00D" T
M"!"R]2U#@"PQ^>= E@8=0][YV> B#20TWF[4EICN;]8G\*C "./B61T$L6[P
M@Y4E:P1!S-@]2@SD=F$@:R4&LL1 WDMT;E;6"MA(+\L8IV36>9@@H\RL7;;&
MF45_9.;7(OM:AIHJ#H97"E.FX*B":JH?E=_!JN/+TY9K\'B,?C5"&MED*3+1
MY7C\*96)BT)N"LT9"S7*XO=6&%= +MV 7(E4K' %&"V%FV5BV\"_4.S![=[$
M<\R !&>%>Y'MT05AYN7TC(S/!TS#[0'GJ,.^;!W&BEZ!6(?6.1D ;10%!FH-
M8'(QN?DHU906AV&:&,1D["*2G'%564?@S<480G,%J)&"**#@>;YR!/DN^ND4
MVX>7R%1Z0R%R)H#,O/G"CJ.H("3Y6:)P)/L8TE"JPAL^)> N/81R@;:BPP<1
M;ZD3 JP0^V]9AR&OB *$$]NF+RHVG96JNTEJH(49WM"Y&HC8,_QM@"679#]5
MQO@?T/!,N'Z2GQCVLS",-5XA+ 6/LH&@J/5F8Y5'I"3S#9\2!1)X83HQ/MU9
M[_4,66M2,EBL.Y66=3# )I^0AL)C6Y@,CGZC^]US^<)@W2C!F!WB)(3;"<F^
MYQ*>R6># (7R!B]<.!$=]V@#H#64PX6VZ2A(9\1=X:417$5@@G#A58:PAD<+
M4WM[<*C2N^BBJ6Y]8/=A&Y[I")9L*L[UBA)<:]3;5>IKA!^L\#CUK]PX9&=4
M^+3MC$YY3.+2'4RWU;3QG3M%K%M?>?-$#% HX,% F'./?T?_< SZ&&5$+.MN
M;A:]J5J$$U!D"7VB-T^JS4M@\PA\ZRB8\6RP!0A('QJT*C9P*BJZJ9K(V>^U
M33]+TV:L40NXJ5;+*14;F<X\(2>@XOX^HWNCLI],C0K^W%$YM(!_L;"/V^;F
MA5<!S&YN7BZ"1T]]<4!Q04X+F9G;M%F+PAZB0&2<5!=JRRX[=[,KYB;F4?[-
M;RI3AT$XJXZZ^K<W!\_[+[*[&R@]F ^I@_:[%!GQ0"@9\>:5*R/TY%WFC(]F
M ?PJ^QB04H9XLDNDE;KB)<IBZ*151@FMH4%7&'VM[FAP/- *EZH;"%GW'2'L
M\8E,X"O,KQE3-E"59E8/!MW$Q)W@3L/]!<,R.463412F5R.[\E5V0FJB-!J"
M3LL[.RX;;@9T(VV:F#R$/"90Y#P ;'9-%N6SR=8K3UD*ZWG+MLN8<B56S !S
M(+.E([BQ2!ZC<T?8Y^P97:Q]%UK %Y^\&X3+423-;#8)- SD^,U #DTX3U\D
M-T*_../B,_%!MV0%*$Q,DT\#)C#71&XJH]!^%R_+!I2/ $4K0+8 RM226X1*
M9KJ8->+CE3R>WR7R<B4@4W@,$[@)=;ZB(6AB15>?H;O"%+@3:#Z<>R-+M&17
M8*>DXPX*_-]%0;0DTF3BFS1)7ACAP0V517%>)[# O4&J6,@L?W#IT=)Q/$O$
M5?;%"#;#BVJOZL_'+S(6#"(G&R?%",5%.HH=B4(/S(?VT+2T=#(.,9-MS-R0
M$"2 -D[^G6XN1.SPWM]K<&?S?<J2U= 9.DG*V#29^>8PL72LH_3PT1LG5@#:
MMX*@.9)B"/<<N/<0/[A0Z3=1#5!?G<!:!1ZF[-)?5:@M/(@._-!M$H23L/F^
M0CCG([ALPL+9]4 )K+-\6D.)D^Z6++0W*KOGW*P"Y-)DU,1'RV.^X5,JL&N0
MWI&HBSVJ14 5)'! 3IOS=[C_MI$[?4GHN YL1B>3\RDV*-\P]0=T[9\:J\=R
MS;ZZN,<KI+Q G1D\BP9O:YVJ[NF&(ZFAY(;=J+"VS'AI563S!9;$LCEQ"QLU
M(.#LC"^.F':"]@8A;!!*;J7F3 V0"23C6,E1$IV+)J[#CDPCJ^P.QN3BPN<+
M*62+YJ:A@-G$81B8R"6K5P<A\\/@BE(T9&:K+)3(A"&S2,9D<X)9#4$!QR(*
M%' 7N,E3Z_N_$$-^KF+QAFFDPOV<]*KPK;H[4<!%!O2"IJD@+JRPJWKF==79
M%7A1>*,H0P@VS&[RH?^Q8QQROV$.DM((M%'4A<*"@V(0C3FQ:,H3HP^3<O%I
M!^B8_ZF*'<UE[BC(G&:,2J Z:%V("MCHCY7I%U.23XW^V @"O+R="9$H5_8@
MIYBJ4:GS#@.E;!XQY9#6BBMY(94&:KWF5:8L7,?"1[:@@\F1[0!KP];#8";K
M3LS'F+WT"D:BZOPH^!7U3C4Z@$%9AZ=:!SWMK  0C;T?A=\$94_=PY?C/+1+
MMVU2M.6S0LRT[TQGI^CN88^2 A.MF:_AT2D 3>"M9SPF6)CU7CH>\UB1T\E%
M9P$I,9>"5^26)2)LHQ!A]1(1]K008??"7[JMYM=.N]=N=5GC:^_+1:?]_UK'
MQ#C:W>[7QGFSQ6!96QW6^L_7=N\/V*^SR]9YM]%K7YRSR]/&>?<A=:WU+\&.
M:EO#T/?#&_+IJY16!G,@ XJ$5F8UTJR.A4= $W:@BKL<TJ4P2VMH#.QYJQ=<
MLG,P+\=%DGN01Q'ZV:DLA_&2Z8QBQ9764(=R2K>Y]=_*P->?"9S3WX/8H8"3
M=\S\=*?@MH<,ESNH9\,V44R??,2FU*#=./3EX"[Q@ 5BGLT.7G6SUO S-(TU
M>2*NPFAZ6\2<*9)[ISC'.\QK>6G>_1U8[G-;JL-!_"AC7)OJ/^;B],A&U+*)
MS8?LP@GLOS#NP]^)B>GL6BJ@I]S(^][(WTD)%H.]!O0%>FRV39?H5<UMX\YL
MW"XPO,(3V!%C+@/8G-R^-7*52$]2LOJV\Z5D6PI[XT)S/_0C9QGQ#S+9^$.<
M3A8*)5P*DDR^#,3>2-^P:KGQQW"S\NGR][SV @@EG7PL(!<5D#LG!N>#U/[6
M;+9:)R<_*PSO*E]SM\YYK48K$WN16@&*1S>?X1/JHW421,$.J@VCXB+A-5GJ
M<MOI!%"N=5?KBW?U?I:<%GFMBSFC-2Z80&XYC!FA^.AGNZ\CQ[_/T<C!_CR1
MT',_9?\HL&JHSZYY)'DP:_^8-8JL<YF??:Q7:G#]>7OT>IWD=O!4R&T19?WX
M'&9)\'!_S4SI[T>OJX='#[TSQ=)_@Y>I7MD_.JC4'&/CK8+P8:7=$I7G#O+N
M8<3=>9BL)O+63)5+UHA697,8QOWHOHO/RGIG_J9>J]\'K]R>_2M8]=7GM;O[
M4\SVG]8AV/1KT\J"Q.R+SN7UX/*E%R;<?V@1L6#Z#\]Y"@\'C84-PK3OW\&:
M_1CG([MG/-4-W.3=^3'AMS-;L_5GZ[:[RBYGT?L_>WOL1 I_\(YU4E_L(?:#
M[>T5 6X*IGI0,%7ZS-U&1(*\=Z$U[KST6/$=34?4\)SVDODHLCDM V@X\WJY
M;&(/MH.KO5:F15W=S[N_KHRH^]7ZD0P>YWPJE\$6Y$-M?:<:.+$!8"CGJ"3G
MJ'*("L<AZF8Z=Y/U+$B&/E>00/UQ@AF>9H[3\KCOVG&O;\EQ[QA ?(SA5,8?
MJX\[1A#E?+ R[WPMB*PJCV]Y?'?@^!YLR?%M!UI:U]_6*D>U-U9J(^I?UQ=R
M9?>M<GD^L!!?R<-I5*YR#/:E*'Y,QQ&G8Y4ABKK]OJA$7F3J&^F:"+[O-O13
MS*,,/]BH\(.#,OQ@T\,/Z"_.Y.#79WQ__PB(ZB7_6 R8[H?^8// ^9>=B\N+
M;N.4';QCYQ=P!-OGQ^WSSZQQ_%N[>]'Y@_UVT6NQBW/6^F^K^;77_JV5BT]8
M&2Z^F;-_H- $@W#?KY(TOK_0UD+VHL(5CL/!8.\DXL$W]CO*C&X",B-A'8'R
MA>Z;F.,M'0M3,^$R"A,=LZUS"];W:_NY+%%.FTY&028"E#(Q)=[)1<R9"- L
MTK."T9.< BS[4J<_'ES+.(RF*HU116?+=3S].J7/.<<D '/9-V)572_V(ME'
M#(#PPQN3K$DG.XBSF%23[LH-N3EN=YM?NUW\L7%^; )#SQNG?W3;79-J!!?,
M9%4L/!E5\^0GX?$4;OI3'#1-'U./Z$E2#4.;, @4#;,*.JBT("Y1)_TH3J1:
M(<TBPC2JF,)A(#R5/QH30YD\C7=M4Y44%*IHO5X.2:D-*$M$EAA@* >I)S$[
MS"#- HSOVMW2<L6X5$[JZ$A<2S@:E#X@3+06EOH:CIQ@LC3X;HQI"4)*N2PQ
M\8R*&,8<5&/^C?+C*%BL6:W8R=<I#'W97#%NZHK=X1Q/AA=>P"FTFSH3<16%
M5Q$?X_F\IG1S0#1P:/7.FS3$R+R2).)>4F%C(+IK/!@J/2JE%N8F9X_XCH6K
M,749D** =E6.+=5S7&6_8THS'PMD.]4ILB' ;2+UD"Z5F@^+&00J)R*F;IE,
MPBA1+-93.814CB_XO9_&<#G 7.J4#41UMCO[^F0HM3U?\,XFV3JT.53<G+X5
M=F-KVN U,2;N5B2&4<IXNL:KC P]V8Q2=Y*W6%33#V.3@Q](]Y)20G03Z$"%
MO_=&*JW\)(RYCSEO,!H1CLBW(+P)5'(&+4QC/MT#96#"IT9^9J]=(2D73(?2
MW.'X\<9-!Q2.'@@"F]20YHB2(C9R]2X3U,,WHAL%M9N$"00@]D7"T%8VEC!S
M*GF?2TK43Q,&XF>DS7XHJE$5NYMVHU,=3D82%CV<C$"'H&S3)N_R!%D3/)L5
M9S6ZT,+M:1"9 :U@]88;(IS%RAL&+B>Y^%>8?NBG;AJY?!J0=R7WN<.,U-^/
MQ',ZK>[%Z6^MXTH^8[^;HBY'%#DU7A/<795Y_&RI,I_G+_,CFJ%GR\7J^_6C
MV8PT6&_#G< DC= <3^'7;3RTA_MU?*AC<YVS[MZ_L8"P6VUC[B*AIW[[=>(G
M+A+;3G)/1G W?*RO<C52Q6?TA80(W;GYZ6Q$5&_#V(9_^O*WY!*G4_(^V'TI
M?U/:G3V_,Q5OIN5KQ:1'Q0F/-%T;H>^8<S0AHS38\@5:ITEJ%?(O?2\;Y7LY
M+'TOV^5[>;7%OI?#6WPOO2\M=M)I_>=KZ[SYAQN:?W%"WY6.FVW7*E9SW* ?
M1I=%C+'..AER"+Q0L94!K 3V!-;M!:$5R^\69%!\.2/!GJ]1-8Q4N1]KQE_\
MHH(S%FE]6.G#XPHMH8PPN3<K>?4"H1;>*(2;'B841C439:I&1#XM&T()AG(Q
M3'>#,&TH(&K!"?_'W]Z^>OWVUKB134!*+;KM*BZ@> WRF<6AB25^L3RRY9%]
M_!GDCJRM)%2>V_+<EN=V>\YM!OI]S\*H/+SEX2T/[P8?WEY(!2NH^G@4CK4#
MQD'F/*6#NVU7]B7V&9_*,<JLKN9B;SG:0JR;/+.P$%.GHFV)]EO7WC*N_-;C
M8K^U DG.>6?(13[DUV&DBKWDK#C9#:W*/O&L]FTL\EY <N[P&/UZ,SC:RB*W
MY(CGBHVJJNN%)B,]^>6&(]5 Z'DIM)T-&]$W5#DF-/5;)I$D6*HNS@733O4J
MXJ-RK,&D!2/6R#M3(3Z8L6DYG9+CM"^RGE79%QPS]C",L-B,[CH)F2Z[B#^Z
MVZ,)PNR]$ .J *\ .Y0X'M\GD%><HMM(4ITV(JN0B> *0_+5US.@' HCI"@D
MC4*T_6LWK]U>+-F6J+H\6(-PCZ:'&,5PH&8I@A%AS9PN"*N5!@@6PR56]7Y@
MN*H5SZ>:@S'"@6%U!-?E&]52A'WB=DX^_,P]* .,B8)',6Y2$FR#]\,T(3_:
M(GRFA3R5>,9-GM%&PB(*WC+<[L<1$_H17<"!ZBL2\!!X(+!.Z&A1G<_<(89#
M10<(3X&QORN65F'2U">&MS4HBVJH7Q/:;STEOQZLV!>5L0Y"PZ^SB=@ANGN%
MBZLG'U/A:U572W6JF]"9%0)3BRN%_GWEKP#R7NZT6)N;8W=.[E,'MU"]ST5:
MDY'=\(P&0+G$XLK,'.'\&.:X1(QL&V+DJ$2,;!=BY/46(T:.WK%.H]<^:3<5
MR/CBA#4N+R_:Y[VSUGD/?G51(NWSX]9E"_Z";SJMS^TN$%KKF%U^_73:;K)&
MLPD[U4/LR$F[<[;EK/_1BXV1C%ZW,&ND YGH$BOQ-S<T<V&,)5[)X8X<2E+=
M6E%@H2'_X./)>_9'F(+4.CV]I!IE((IP A-!LT LB(P3*A\_2?N^]"@2*57J
M*6J<K*#V/"A_) EGJYT=59G-D$.:*JF>-*+YL42D0PM*HZ&4.Z.6+E8ZLZ*L
ML.0SD4!CQ#3;8M@V1$#2NDV-EFY;@?ZR;#WYV[QK< #U("982I796PWBI(?F
MGJSCA")3,AE49UQCJ@@JU$6](V@X _9IZO,;R@#"N/[^N8X(4%^9P.H**N0A
MA@_=R!AC+J#%@IW'V,&TCP22A2OX.G L-->)XN57 8]YQ0AW.C<WKA1VJMX+
M'5^%(19?CV#9<6E,^-%CEKE=^QF\-ZYRBP-AK74H3X2(5ZPD^=3MR@_,WN=+
M2>IT8D/8,CJ P'J&(HY5G#UHL-<8X ?L!6U_;J6#XF-MF#4G,:*O'OHB/90!
M#SR)S1KN&-L7R+O(%$^:+V*)7 Q^.%"ULFFL,O#2*-)%)8E5%8YVR3CCU!NI
M?A^S%N6#<Y#U>3+?K*D2I3WTNAI1]16NR,-6IWS[PS7B_DQ!0 ^G\XF?:Y-%
MQ0+<TGZK=[J\E( S/>AKTROUXJEV2#1;I%M*^=5^*5YG2_6W5 )\TBM^<-N*
M+RCK4'CL[JW6PT^=PG6NF+H*D2[S,,4(%^(+-JWZRM\/*F^.WE3>[.\OFL5M
MYW'#9W?T^E7E56%=A[L<D5TZ!WL=X=,=4NGVVTN[MU0.VF;"O7.]GB?*V'O\
M^]K9^JK52#>9?FJ5HWJ]\NJPMHN'X^VKUY6ZHP)M'4M?H/BND<_[/KN@B_0J
M/'Y=6O2"C;\_U?H>JNSEV>XJUYD?N<.4*W['%=]^J3=C*ZJ]J;[*U:2[MQI3
M5)?N(?A OB+5MA/FWX\J!V]JE4-'A/X(-]#;>;_\8,=6_K!R= C7TC?[JW&%
M%2#O:YFH55\70@7*6E_WLM[W;LM?Z\7DH(Q!NF,,TOKBC\HJ8[<-]#*2L.'P
MZMW]>UF<!Z&;]1M_I3Q*1(0-FI<<6>/ )V+E\;.>/1W!0-$G7A@$&FQ X0K<
M^RN5,:4(9X-4L(&$=<.DR B=B&T"DY@E$;\6/C7LAX,K](9Z89PX/L6"UM4D
MT*^H@V34$IB1E:642HZT QQI6PJAS7 D_ITPS[Y4046&6U"><I4$&9Z8^,"H
M#)(+/T#PM//XTSS"&ZP463S1923V5-Y'C,<8*I B['M7[]R*6*--G>%N0HV\
M$<EX QQ=""S5(CW.\D#;1_4AG'EA##N P"5-$H(*DY$T-H<;HR7L!Y8;&)"G
MUB T4)(K6J(,8J;"2&7YB.,1-S!0PCR&/BI$R4B%/F4Y2BE1>S[:-'3[5$$@
M6$]!/3\P:I4) +'SR'@4.X%W$#U1H6G/*T8+(4\W(A+NL@U,E99%\T2UR2\8
M@VI)*72WMU*Q*N#"]015BS2S@24!/7^:5*R#6 BN9<>P>)H\5G4J$HFZB=7=
MQIQ2Z9. ()*$GA!?; /E,E2R)TS^;QC9(%4EB;#"GJ6I81JHM-PE]O2G9K1F
M.=$Q(.C?PD0\I%#8TCC=!Y8(:PDAU:SAH0))"5\OA*[ 0>ATQ>]TQ -A_!<'
M&:PWX$'/O2#LX2M5^#T6/K_!P ;XIT)!NWWH*M"7V)S,PE0"OKB"]G4\*V'M
M54CT%;#*6*U7#HZ_:)J*Q?>C\!N, >6%"D;,>@Q"TXM>VS!-@$=; ICM!3]S
MUDQ/^]:5HZ#?V;TQ\1'4A1A4W+TU@1B1& JZ]^M4!@LEE8K(C.A*H03@4Q8
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ML(>Y(C[&[!@DF0";<(;B.PE@E>0<@MSC[34>PZEPRX#-A*NQFUDL3)<VA6W
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MGC)F2ZI,5&3RDUWKL_N+X#S8H2GR,3O0[K^#D&H\W*R<,82!\A#K[.;"R*,
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M4L!WWUS/<R/K.KA',?[FQ%@L3Y5A^7;]31.S6_ /W6VY;>?,3R I7ROJ<.T
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MP#/Z>):.0M.K10UU3)WX!I3K?AQ(&"4"J-R 9MN-T)J @WX"1[^:>@.?22O
M]((SQ?TC#_=2K&:*TWPTE1S!!-3J/8A5;I-\<MH4FH;BS@V2R-/S@ZB(Q$?!
M%HQ/6&'?:):Z((D1V,8H/S_+6D=[1F[.8> //3#P&#7(]$K.=.JY0PH.$[]D
M!G<%RB2 S8*=7&Y="@A>>->-<+'G-+5X?!&4T8&F*&*N(+C&$#*0&!L!'EXR
M4E:I9-V+E)R9/Y1KL,(4&H #XID"04=+."SB"Y8;_[-"P9\=&B:9^MS2^'55
MO-K]M6%]D R85:>/O>J1HG!40D%<2,PR,!>Z<,A=N-SBTF$1"L(?(6\C(V!
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MP*/'KDA5D,S[6-E;I6MW%7LE/9+6?O,I!8)#$5D08'!(R_SZM[MG!A?!4SQ
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M"7W+ 3TEN17? K/6\  6V6R4Y(:ZF/TOL(<82>[#ZG$D9 !&U)=:?8?U4 >
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MPP1N0OJ&,OB,[L!R,//6$V?EP(!7#.&ND^P0X6#H62#F+'L4&26B,"_7S_&
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MCJHJZZAP64?9/O%Y]/[Q5X/"\D:I7,%,/./C6I>"%>3NOS[<W#U=/-_>WP'
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M2H'D^T0E[[UJ#O\ORK^%W;W/"9P!G?&,52"<N:60Y$)$.!&VQX;P(!ZRB&9
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MANT\$A2L%:R764%=;[6V6<I6=7+: R*J5*MZM:0L)R4<%6,="K*5Y:1(1\%
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M^Z0)JPU/)@ 20T4*MG;S@YDAK02_9XYOT#SRX9O_A%8P.N6G7O()P3W+&71
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M0CI&G@@#/DI =A"0&L.0%A+Q3]5222^52C3"3S7^!Q[>&&62[IF>\'&@ +1
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MA19HI49*&"8[2)E1"RC1K8X'D](O) 0*I<[]",ZT9_2:]V@/BXR.@5%)#/#
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M:6X4?!M2E%<E!-'2//U3^+L?8W\W]Z4?A\XKE418J778.$0Q2)[K\F;7NC?
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MT]9Q GS3:"G25O/PK<?P29+L1#"%CA7P@]U?DO21)(AQ$B0+S_>8A;/@D9O
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MR$E+^P69LZ'R?9-%]\9O25D?@:LJ)'2K1 G$9 \)W,D*$2E7^F9+,&[]1+W
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M#9[%DR""TT0"48]%(:<( *CKH:X44PI%91*^'7)?39@<YQ9*E2^(8_8$"-;
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M91>Y")LM0D:#!E6O[I@8CM/9MXY=7=K;U\;(AT:CO-#F%IR]+YR]BH>G@S&
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M6/G^%"@^/I[KO_VW[BL0)'22:%4DU= 8Z/P39 XW8*JM,.-5Q1:HM3$[4"&
MD@*HMSX!-+187XB?A+C)D"?XQN/UI39F_L@9@/K[_(9&(EB-H'*/31M6GA*3
MX&>1C/)&SJM=TI[@9=D+D*-C@PS$GO$%T].&@0O-4UN&:?'^L3]."#UF.:\E
M[0LT/&$N&:8PJO,7YOG8*4A4'^@6A^WY0$]D: JIJ:N"U1@[ 8K>D?&"C3*;
MQA+@BT"ZGNGY.*IPLNI$ R\:%/*38;]1X9;6)P_^MDG+HH7[8MHP.-.PM$<?
M/AB3K#<\G.L5ZS,T0+1:1=?0TTL_^>]5^EG3#'N O]1UG-4$=LI\8=9;I@R/
MN'>_9?K:TPQ5:MF2O;JJ9*_RAIH+2?;&>B1[6M^Y3X.L$63)<GEL9LO\_4L?
M]'/OXIH+G,N$P/FH+9,LJ4BH-)/!ZMD\F&W89-%8+2<MKHO;6_FX/>3/K>YW
M.9O\U2_IW0&#\YPG"PN@&1>3?9Q<7(Y<./><"9Z^7TO:UP =:"&-K,HB.V.(
M\D:2VE4:V92>K=%G47 ])Z7G=!9DTFY[(4IOK4<_S\Y,UHPRD[5S*^Y("J%.
MG0UG2$ 5ED@(QG-^)93RI;*S2&K=1%L9V6HX R4:#9OCS7_29B!"< V1J[Z@
MHOV[,"DXH_$OM,O =?'XQ;72Q*'<Y4X-@W]Z?FT/Y"OO?#$O1X;]S-#6D&NI
MW;LFF#ZX3IXP.N3R_6:C$80^(G4=BP7,O8!/(UBYW_D:"O.NX&C)T8)5:1EC
M#'UC]ZU@P)>,DE3EYMS$1#:=8*HS(X42SY*T2"*%&7NII,G(>B*MU7_,?+PU
M([W%7/3%FC/4S+ZPIU1$G59#+U?2XEX.<&'GIP:I;ST13*U*)1'J;;U52P.X
M++(89^M>W8QWEEOBK><9J($"W6CIE=0D SM=WS53;V7-\?\YEK;.<Y65]4XE
M+2IUF=7=<%D=F>4ET[^>V-!9&YR;:Q:6\MO*YE!K("RKW"C#1J;%I>[#2F7(
ME*W'\M::)Q>U:D5O5'.0_3Q)LH/%6G/4;([%:L%BE?5&.X<.L>VUFB]0MQ5@
M7&NC%M#LM/5*:D:PQ2:\*6U[AC"M[H>(F$_T:PZSF[V3'<*X-IMZIY86H[7L
MA&,@QIRW;TLWL8 NN&RCN39M7GS6T/S!!N?_9JZSTG[5RSBU=K52^92]6SM>
MP2/:V7DA(.O:V<JN=G;[Y]2V(E#!/EZC=-N&IE\I1.XBE-28%QZR+L:L%2)W
M!SL[SVFXKIVM%SN[@YV=Y[1<U\XVBIW=P<[.\Y6N:V>;N]G9+1NIY4(/6(CR
MYCD?UT5YK4*F[&!GY_E*U[6S[6)G=["S\[R5Z]K93K&S.]C9>=[+->UL8T>.
ML T&JATL_+29#3]='?3?R D_S1FZE@DH[2P$/VT?*M#ZBO5<0_NUI-UY/F/V
MD4"L=Q-PT,KF@^;*?-#,R0=I'+< 0:\IWK' 4Q\/^C*&I,Z-GG[?:U; I@O8
M],[7\-!AT[FATH55-L\JVP(\H;&S2^QWO;-;@"<TJL7.;G]GFUNXWVX4]]L[
MV-GJ%NZW&SNZW]Y32/Q[)K?F-LBMN'3?Q<YN 4[1V-&E^SO?V2W *1K%I?8N
M#O\MP!4:.[K4WF'L]'1DQR&$^,Z7 =N*J@,;\J*C=UI5O=-.JY)\= N[YAB\
MF0L+)MQ%2Z_5*WJUGE:_Z@ 7=G[ 7G/K 7N@W&*E4J#=2CFM.-$BB['[H.GY
M)\>V0OQ K;RH-/1&'1:UNFHD^B&$46P]"J:YK1@_T",OJC6]T6SIE=I2,:T[
M7ZIM!0S!<7M1TZM ^+7&OL:6SU^I-1<KFKU28.Q7FDV]W4XKC;+WZU3=&D6!
MZ5QMZIUZ1Z^U<F1,.7@8^M:WLK6MXDX@L"\J-;U<@46LYE#E]G"IMI6)J8D)
M FHU3!1TD.NTYKQ*L]>I0YIK RROZNK"80<K5=L6\P&7HSY:*[?T:F=UHMHC
M&.]T%G.75VJ:+L*S:!&@I9&,[6PD8VME)&,K)Y(Q&S.Y2,KR6 +EW&G.]PS"
MFA?=VP7] "LDP3S/+Z_OM-OK.T\K,+XK<$8GFS/:LY"WV0PQ#[*;F[ZW!-QM
MEPO@[KK:*H"[^[9F!7"W .[N? WCC/O%<8?,Q"6*V#5:TH+F#A_H+)WH]8/-
M#YT<>2YK>\TI=F?;D)63BV:KH]=73JV[)\LZ_R*NM?7\NBV\--*KK;9>:>?(
MM[4O%W'+K>[6D[@"GUQ4.GJCD^-FXK"7=NLWR, J%_5&1V^WCGUM:UM/&=_"
MFR*]C$*AL2H HDBZG>"4;=TAM_ :"Z0ZEE?(<7CN9*4RA,J:;_QR$'[KY**-
MF*JE[HIVF7.[M>9;Y!QKU0;Z:C3TSN$E*&^O^0HDQV+1K5&C7M.;[3U<KOGG
MS[8 C; M%]5.3:]U<L 9]^O6_1 RE+>W=94,'5TT]&JUK=?J!PDU:6_K,ADZ
MND!Z[^CEY4H7[/R,;F^]V$X;;:I:&533I6AK6MM_C^$,[2V$,[1W%,NXBR-R
M6QC?-EAF;;W>:>G5UNH"H\#U"F[85F1!NXDG8[M3T=O-I=3 G:_4U@@=D7MZ
MI=[2&^6#A%FUMV7GM]MX'K;79.6_ZT-Q"^E6VCM+;[K]0W%;@.T.Q6M56FAO
M[+)FR-'BM=O;"E'H@.58UYL=# T[R/.QLRUP;0<LQWJEHW?JA^G;[:S9&9%M
M-W; ;JS#,;F<<ZDP&VG7MI"YHO-^S,;ZUJ1% ^V.<K.JMRKKBFC:"!(_AJ^?
M!M-O #A?+6?#@SN9</9;V)O!]0_6#WSSA=T-AV:?N5X*Y%<T61.=+OI>=3U0
MX=4#'I3XAA,.+_[G2:5<_FD^1!B:285/E4\^I'[,0<=S8>.G];,0,YY)QG-;
M>AHQC?9#"S=$DSNB:XX_8J[FCPR.=;R\OM,UEPTMUE<0D/?&F_8[/!YXVCUS
MB9OM/M/XCKELXC(/<;SXZ-"Q+.<5-@3>!0(V!P$( 10 &C/Z(P0/XE-OB+S4
M+)-@ECT&;\0GNS@KYF&\]'W.3S8[0OIC@K8,5@9NGP'87YR#M\R)@B<ZB"&9
M _5/0^W_!ZPM_LL!WA=/:BG<6*W]E(4>_:1))*8(B&J4ZD@X\E,^*O%AFD$T
MEVZXM121_[RQEG<_UDK.L5)^G!V/M7I 8ZT=T%CK*6,EH9W-D2"*TYP,_W5Y
M>7W]Y4LZIVYR-E<&'%+:]Y)V%?3_>G5<?Y2U#\5H=C.:K\P@9>7*_.'8^SR0
M_)RP?7*_'+F@=3D3'/^WDO;5P0".72YF,:"L 7UV3?CROJ1],5R+O>WW4 [T
M%/@?9V1KC[C;EF7:WLYE73&>PQK/K>%Y("]^':&!\[UT53JP8^&;$;@,;7J4
M>(;K.CN5>,5H#D4GR\F'!WHJ)#PZ.UC?8@3[QG\SUX/3.+G[UNRWW,Z%037;
MRUC9?S=]#I_@S -6\=K/^SJ/][YQED6C"WKQN[9F4FZ',7K:G:'V#YBO9GH:
M*!X!.O=]1QL9+TSK,6;#,@THX8$3N-JE,QX#'3SZL)7P-+Y[Q?ILW&,N)Z):
M1=>JY4JGI#T]/FBO\ @L5C^P#'+.OVGCP/+-B?6&3GUTWINVZ9N&E38>>!J?
M^#MP?%-\#G^'T\=_?<OQL*6):_8IF<#4&.&7M %6R_23_UZEGS7-L ?X2UW7
MZ+*!#QA;3'23WB3,>4E&/N;KAEJV(*B&-\"W0'RPQ/$+8! (S.L;$R1S-V#J
M'>\]8^XO<+I/;H!NXS<1RM5NO58O[[^LV?:58'-=5X(/_(+/(V;M!V/D=;P6
M]!T?^-I#+APY%BREYC(_<&VZO\-G'_^?,9Y\NM>^,L/R1]JEX3)<OA?@,0]^
MP4:U&WL0>+[[AK^P']HIOH? AVKY4_CZ)?^2/JY\.BMIRXFWV)!$FQDB#NE/
M(P+<E+2;EG"IPUQ&RJE"+J6G64).![*%W>(OVP,/=M54\@1A2SZP O[RIN&6
M3@QS4(K3VO2-;,3\1R(@LX1>;;[0Z]1F2[U;Q_[%,";?F>&!+GL%C[GF!#M-
M%WZ-K=_"[K_P:ZU+^&4<7-&F73I<HK&!V#>\2X_CCYJ@F W^#(B3KN\?DWQ!
M DR##\Y_Z7;OM:%I&W8?A<F8-TB,[=BAD.@[\)GE@(T"=L@8GO*A%4][95K@
M,1+"D\"=.!XC$<=># M)%P6 @LK QT@#<L839GN<MB>N\^P:8QVEXS!PZ?IB
M0&38BV >'N-@+J/G@*0%B6;Z%GPKA/?EW??[Z]O'[M/-W:UV=?-X^=OC(_[:
MO;V"_W>__=_CS:,F$&ZHT$U@8K9/(XV )Y?JH.3#71M8T*+4D")CTHV-MECR
MA9(X+PY!,LVTSS8F"J>[@A]P1, )^L^3SP_W7^Z-9_;99<9?7?@12I+OW8=?
M;F[//]\]/=U]YUW!]GV[[CX0>F+T21-//-W=\Z^%\936/"P[G#ZQ]J<-[$^2
M05-?/HGQK<1 _G=B]O^M\]E[7'PI/,XGH$#7X4#%_YV)IUX9=PK8R"^6?!6[
M##\[N6BT0AH32YH^7UK.<,3WW5^NSS\_7'=_/>]^>;J&!32L5^/-"ZW-GT>A
MR/Q\]W!U_7#^[?K+T_D?-U=/7W'#?WS2OE[?_/+UZ:-6Q3_$0P_X4>PI\3M*
MXO IOH.QQR[OOMW!*/ZK3/]2M_6C5I_\X$^+=F"?8XU\[E[^^LO#W6^W5^?Q
M]DB8?Y@BN=FT/M]QD?9P^JD]1WK'C1PXR4&Q<[^9GC\+ SG[S)[Y<NRH;JTC
M(V\:B/=G\^)+>%ZHJ#MQ&'D@VJ*4N:K(6V\RW#6F><[>#NF#RK-QZYX:'N/F
M\"V9X)?K)MW].39U<0IRO"9\8=AO(HFE1W*&A:^EJ0"HDXR8\0)B5>.RD%M7
MB@IQWC,\^'!BO G+P: X!',(.AZ8.6P\&1D>- .-1LJ*JH*@6J-:D2^4.+(/
MPI*.<>TI&CG:+K I.)H ]1I_Y#*A"$GUQ^B[CN=I)BQ*U!UU,7)<G_ZD>9NA
MTF!05LJ/FJJ;Z<I?GV^>KKK4A,M>&-!G?$@TD-SOXN(-&(["M''JI,OT#6\T
M-2!Z:WJ=&==YQ#,]UC=0VPN-,1-(PO5QX876Z$FOF=(4+0 VCT2A;H5X%/Z
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M9&I**1;$"RC9A#ZD!OC(O:#W)Y9&$METJ:UD#1^@L;^8/[\L&CY/PS3'8S;
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MKD'0]T'D<T^0].KT6=K!,E,,F&[\75JM@"]BQ%P%9A!I];.*)YBU*^'&<A=
MB&.8IWXJ&X9$,*7\XO>S*)C?12;1BN0JQ&QP(LZ7L%Z8,FHN086N!19684W)
M,N2/1%3&NE1JNK#G>2UIU-BON+)_(/4%U_R+XXYA:\]_%0X&<D#@0H4PC,?K
MRW?MJMMZV=C\\Y'I;A<X8-+JT,TY3QKEW)7UZ-%9-Q4?ETC/G6.T"V1YWD*G
M4P5N]#!J:LLCF5>O;PO=SRNTMH7N9Y>VV&Y6[>)6?9NWZK7B5GUO;]7GT;MR
MG=[<SG7ZY?7#4_?F5GNX_M9]NKF[??QZ<__(#RW\Y/I*N[]^>+R[U9X>NK>/
MW4MZYGU=LM\Z]M["CA2":6V'8'ZYOKU^Z'[3;FZ_W#U\)YHY#G*@V3U&82':
M/5UY&A8W-,"*:"90OAN:]QZ0_+V"?21?6:5NG+>5>^WK'_P>6.OV?9TNAUDL
MID;<%^/BH=-8FGL8',5]:(P0L&B&T<)FA$8A@I@.H1Z+LG!3')!L1< WH WV
M@_4# G!S."$]TH2S1GMR7F%DEZ;;1T3C8P"6)9Y!<+Q^<0W[+S#W8/&8C1YO
ML%1KK7*SE8 KAW9EA=N5C= &C>;+IZD:F^35<9T?JK.32BF@O0E3G=!W?;2"
M>7-1:-Y>RIVM!5!2H(5"5 /FF2*BJ"?@W-S%#"L^)#Q#=I2==-V)%TU*ARX@
MLT[@(UY;;FA?7'U$'* +?).\G2,O"L(31%R,+?+JH8=E*#/-4XBL%R%>N8=$
MG1<!Y#E*/^J;[E'BT!;REKQ9QJM'8"OQN\QTK."6B(32V9$[@@0661TOI]N^
MPR'KG#\-.[&<,APGSIU&A+.GH &U9T+AFT/MM'(V-6^"9\<>'I*#2*39@*_5
M$!+,H"&S=8CA<"_4:76Z:0Q@]@A?#]U+%Z[M^"(B1Z$ X87JAT <CV$B$,-]
M*X'$P(GQ5J OFKW22^B($PW+0(>H4$"V<)J.AT O,PTR#.(0_L!.&<@  SIL
M0EN[EIGKM4I5O@?CX*$;<Z/AHL!!]*B%<\PFA)+V%20LM*9+J0=_X"$R$NN0
M8$W87T(AT11J91RB%W*RJWS7$M_Q2%(UK':U220GH,N-%)[Z*1Z%O?6<*.:&
M%@'C,U;:# [$CP^,(UC\W*3!GQ-S[^3J0AQ<B/0?<5$_'2N$GS@R/$7B-VW;
M">R^N+,;AKY1N274E[+%?(ND<% B+$K:;V%H )=DX?HGY2J^E5=/6)0!>\Q_
M96S.^LI\]56>D+X9'B'TM&0$]8TOK.?R5]K\%80$6OCEK(F85/8$!=V00BAI
M,8EOEF02*HTB!BSB)A49%9TJ' X0QA!-75;1V<*O#&2X.#]T!LRPI!S@(;\S
MCQOUE%%#/]ZW<A//#H%1;-XPK.*"V_OL\+!FY8HPF&(8#*W$7*MOT65>((2A
M)11+%]07C'%7&86B_4DQI\X)-N1+H.</DZ>1\(()OQH9)C0&+ %&:0$XY:F!
M2M$#1&A2-1'$Q_42QN]N,J@OU+HJG1F&1^+L_&ZX('EJ94'T[Y.XZ):F=S'[
M;FLKQOJJA4UZ0*8;O,6:JJ(3]ZI2*1UX!V_,(PON-E0>;P@&!2*TRR'B/,("
MON!&WG<1IPFCQ"HI$Z&3@"!/,P)E&@N-WU/&-PYX\U%E6PSPZ.%A!=+5CRZ*
M!3)= M.)[5%;EHAT6=I&^VTBWQ :,3(<97'@8=BJ#)^E>L=]()2UAH*1AX%K
MF]XH2MN!R.YGIBY"VJTK33Y^\XJ]S,='&JA66"JD#6]FH5&:#8:@.P$F;Y7Q
MM'P670+L:U]#Q+[41'38TGY)7]I+H&M=7$T481^US[#WMG9?TKZ 4LB@[6OO
M;VC[.E0\?D<RN@?MQD2JY";E+]QT@P$%MB?R^SQ*.T373IN5QIG6;E3.FY1A
M))N"[Z:6.DE+V,6<*W!<'M1 ^1DB3@B3*H,)\LY?,&FS[+Q[:7O%#0*B\2NG
M'_##.KG@F,Q A"YU!P,,9#H(6;Q#,?S5"3R&RR=49 .I\=DUQDGP'W _URUX
M^#.OD&?8IH!J$6Z5TFNX^-$I*ST#1_9<YR_8ES-%_1*2F,P9N:<Q!8RT<YGX
M"9G&TR6'Q+$VT8GAS3TR^,LA3VF>".T69?U87&V+_".HP(596#P#\XARFJ*<
M)WSLW$.&X7(47*6,>FK0FB-/H<6/.6Z@H;>(CP#= /%]0[_=LRWKNPX"!)")
M+8IR):"-1@*F[WAB$?&4H^ART"=+(%AIOV*1>YJJT%(H6&*YU(A^X:<:J:-+
MR=H@%B*Q,R7M9JB]X0D6OD^9!4RT*WVN,&-CL=8%N>KX(C\E9=(,QUY&HY"#
MH*D:,!F;@1&+L"@^9=X1)K^0![NJ71L]/)9C R0L'LV*<X,N)M^#DXY299&6
M+W1ZZIV\@B)U+7:&.K@#"KD+\_-&N,/*JN"BQ/K#77VELWGBLB&+Y1$!4L7X
M5'PM09UZG'IQ8,MH8\!.F $';9'AFSIK]$^^18J82%N":TPYX"FHD#^)U"A)
M#T81>.)5L2&IOLP2@NEH4T3/ 3$I<+J(\$@J8\(C.5<G6.520\>A]][(XR!-
M>(WK&/Q0:#>EHJ%8J9&F![LSGOA6*&=T+4"]4DX#R<:ES0JGPX,2N7Q"!8]9
M;#)"%A#)G"2D,** 2&_.%%VX+LM)+4-NN+)ME)>%*& 0#CG, !)*4W5X@_#$
M?T4WOW0.;K">Y&*:T>X/^@+;LT9L3[W ]NP=MF<OC9.9S+?%^UL\&N7Y'KFJ
MEU-^=.Y$&3/#%@AQ;)VGQI+:LCB;/4TJ'+&T>R&66ZC^>'1\D'5@$NJH#Z>G
MAQH*95LJ:?=<>>">$,QT*+1!F3HO>75BVI[O!GWN]0[1 (Y(OK2,ZA?53,#+
M2#R^7AQ35B4GRSRT&1@/)TD:%V:4-708^('+])A^K(3]A\N+D7Y&WT?EVQBX
MYN!95E]"I?-1A%5S_PD>G;,\4'CJG[;+Y3.MT>J<5YJU#O=<V^A8H,L. ^^1
M[;=H!S&7B>/QY!^1_Y=,'=L0=1-"BR-++1:J'VH\-'U5^1M24JYHMW;C.=X/
M3\8U A9<QS;[&'@D=)\TM^5\W]+[=FS\(?+$R43*:!.)>Y!Y;N \#F"1;9=%
M8L,?N4[PC*JIR#$BKEJ(/6@+93:1L0.Z*=T%_L>2AKXLJ1T7;@[:>*_$?VAA
M&X)N5IVI'9]GAG"1QH;!_0B8J 15=(,NB;@G&JT9FGEDT2SGU\^W#HKY(TY
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MO5K;$O[<<S^$LFF*BF:/+0- JK0*?\,<L#KV5#J6&/4=YB9NFPA%]>K$K9/
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MY*=,7<\[YPV8]\J$UV;=RYNK_%W/-?%7-NZCCK9OVQ_^4?G>M()&$2BV4ZT
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M YB(,=!#Z3ZV%#@%BA,ERM($@<>3 (<)<NDC"GTG=8BDERXOE@33AU@'EB(
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MCRW<:O!_G6"O^)37+BG723 LQ&(M3:HRKL 6JHXIB>#3SG$>?XVJ(JMC-:W
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M4&)"7HX8UW_#Q6UY,<E1#PA.)]BOHZ0LXB.U#V&^D#V*1G]-:>G5U^L]*OJ
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MRG;%9M)]0DO31 FR;!<AV!)Z9LF2^CAYF@N:K83JM*@#3>%SIO0%4][2&.O
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M1#2D=^AIG@B^&7F=*$%TG@:_4JXF1KR).MU3B:-X4&%[$P!%#N&?<#FT1$]
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M>[4:/R"!(A%I\% FNT.;( *]72<":8[8R-Z4C2H%9Q]^P4VJHV_8+UC,0)C
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M#E=!)>PK+M!DBSV,N?(L>VK.9U"L3NW#XX0X#W AE%O]<-Y]1!BB K"!6.,
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MG<I>7>F^MQFI3F6W1JC;5C/Q9"5S<)W*[J0;I7LEDW$M4-GO\DS)];N%HOU
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MHL/_=EWAK#VB*,]@.M2F\1M&0C9^>./XR/'2UR>7@2V,_WPKD$!IAY'1&R7
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M*']5C*I<S[9)/7.NIX\0# KC$1-'9SE?;_*#,"2JH$W>>K\AT(O,WXXZ'BK
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MI"OC?+![!Q!U/MC?KSHFV.P[M5'.+#-VEXQP(:LE)K+?P!-O5-0WB T1!2K
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M(#3C2KW)^3-_SZNS(4.ESMYLO9,>^Y&7F%R]7R69Z!'K40JWAF<HUWDQ&@2
M31U &*R)D@Y &#1AK;<[VOF]2:%84[+7/M;X0[PXJ+"@XG4)1>JN2+%8Z1=G
M*;QFYE0>.7&F"@S%K,VY#;N*ME;7:@L?>09<Z,ZJ5"A6W#L U=DX]F^WB,?P
M:I4<2R:C.I4YY1.#@#?YC\W@J>>8T+-5;FS .''+\L3F@U1WB/C']6)LZ3L)
M+I3'(\]LSZ#>_(@KCJ&V=!8;XR:[V+?ORM"M5V\]LB7'5K8*3,-6_=SGEK-8
M!?[?HE_UOK=$\A>O[=EB2%#W!SA6Y2_%FJK?BA]LVL^7J&8BLT&KK5$4E1.C
M_HP0S7FI\ZF /VCR0NMC' K59V69Q!$MDF:6-GO5K;IWQQSDX/S85V&626D?
M*X $Q@?G65HT-Y#-QE8L3<U[$J/2&^RH@MSDLXS->#8<!=%1Y(J!HW_D5\>G
MT;L\35 DK^AS(*Z.K'P_24$T]C5^:[MTUAX4)Z7(+$Q?2J]F^^.SQ[-6(<.;
M^:/AO#*@KH!&SBLG2(;^/IN)V0PS%G<.^:U0['LLW#O@ZCQAW/@P8![P7$GP
M*C+\4_LK&^U#;4BU[^L="+T7Z?+[2&./ARV_OI/+,-Y?2%3,XX_KIL$B4@V6
MD#*9<4^K [$@J_#G^3OB3I$GC309()'8 >,?.?DPMRUT,P;5DKXYB4[>SLC>
M4[V@#M?BI:6O2X>T(08X),,6X=688QUX=(D6PYA\0]M)HHM8\_8I451(N2BY
M2)(9453B%50H '@J10! ,P-HAAEF3R*XW\DQ8A4]^4B[OS8E.RFCR"OSXI3/
MH''-:IQ2V^4W=H+"[P/UFGG4EAGQ5I;*"$"6EC)5,,Q7=R=DQ9+S6X=-PT_+
M#*15&L>JB^&Y"))Y'.DQFU(Z-'='WSMEB/G4'U3<:=;X 9*4N^%66 *>I<QN
M0Z>]X,/+.D$.ZT%_(C$QK=Y0TQ#2')O-G_.H=,P3WSH-D9.KH#F(.NSX6<EG
M<4R>9Y_A<6=MD*>SS_0GYL?%2Y_7[I+SD^OQL\^N<7;.61;G0>K-H/&O=P#
MO^D AP(';5-0+Z9YAUS3NGWZUI3$O"XC<6#;K@OV"'V@<<@<7 B1&1> 94?;
MI(QG%E2.9V2XFX2WLCLWL5BX+3U6DSR7F:17T$JJH.HY9T26&#W++8B>:='[
M9M#H6XE.5>W<:^$.0XNS9E,6930+=!_A<2>!FQ?X%3HI,$>KV2*C0=Q!/*91
MIG_,7^4,2O,[YS'<F#0\2TG2D6DK<M)QT$9K#=_QN*#?Z:EUQ0V(N#C_&5U@
M4W)[9*A=W#YW):^HEJBPP<C,UNZ\(-3.UKE$*4[YY$[-H5O7P@+"#QXW74FD
MR^)"RB.B/CCS=RW)'8MFL^^6#7>("$2];>5B*Y(5#(GDJ+^7X-VB=N<"6F8$
MG :L&M8Y0[[N%2R9'_10>J1G1#)-0H(7FO14\VKUF#)9&RFK0")(&1QZB/VD
MUZ<3WW3TF,S$/"U_1>?&R<)>RO>:]:%N.#^!>@</VPR.W'NXRL8O<X1P&!=.
MK34]UB8$ +E\N,HSYWI0%O*6DGN6L1HS.H.4=A&>XCL5[-0=# 0F_B]T;JW:
MSV-TFMP9AYJ*"BA J]'QV4D!(L]XO].L!Y5O+$<^(N,].CH2(S&1GQ(+HI,B
M<@2A*NV'"*JR*MO#-<R17,KP7J:P\:250%]:T3S=C<M55/B1W9N_EUK5I&A7
M-!&#1#K?O8P<SMN[A%Q]NDLP&'HU131MY*_"U'^=GT\5> _(6YF2&K] 2(-3
M@IISH(%M>MPM4YU,?2G).05U E:SD"&.G[ *0WV<N$(Y(ZLJKO<!T?>J>2J.
M#A8=5-RSR<PQ=C/<F';&.A\]'1@_<:P[DMH50D8#PA![-41:AM\![NTX5GL:
MAZN(#7;%.=1*\#%$DS2</5+%S+T:?F^"N2MK'T"X,:%)3S$>^PN_"*;QGTNY
M"B)KLGU8Z$U&98?M^:J)5%2(2!6Y;AZM!:*OBV*;&%^V6(3FA(.25Y)C9Z_J
MP 6FD8PNI3^M4+9-O; -^>BU[>0NTM#?"OVI%8">2*0X. CEOX7"2[P&V8\#
MN6=&*R4V8GA HOL;--V*(=W04%73Q@FZG?; ^M?HI?#+]6VV*V_!T/W=;-+2
M0?<7A;IK2VRS3P+2X^+:R:@JHUF/F]N=,:H2Z4(5-JO6F9/3^XM6Z7;C$T'I
M^':@/?"9):Q1)5^A8+W3'<M&!\Z-JLX.;D6MHQL=DB&861,@P8-#B>T&-]JQ
M..76K5ZY!94T* / PJ)-PFKR" M -"SZ/=QI>-U"D70$-EW W5.,EJQ!L\.&
M7K>A%&OV!&T"1:V]+60DA#U=^F:T^1\,-18DM%,E/,/*$7:;I1>()]35'1+:
MLBOU?;ZV[!4<L\.700K:U#(8<5AEP>.W:1NOE7&\S(;X$(:,,(G1R]%8ZHWJ
MT67[1]AFHP;B7VH:C!U+G=KU.NEE_& %1AT%8:QKUH/L9)D1OJ)QPL9.$VSF
MU$PUCW (-2SY\ARQ0]:)%F?E2J:955 Y*<9^-(+(5SF^"IYH'=ID$*/!++D?
MSJ$M7)NPR.;$-V\-0A6\A&H6>(NQB"I3+1<=O83*GP$S66S?E&5&LFA-<*$N
MM4JTQZ7@3.EE(.!>Z)9!E[6W=_5/'[1!ICVWQ-YW]K.KIH+\9N)0CO!>G-,"
M="5@2$=&.Z,*E%%I%ME]3\C=GSQ<,#ZWY=/^XX[($6;?/K%(N7.A572/@=@*
M>;\MNA5K(9[X,X@J)8^!_'8L>/@W:]EM881#-:)\R0:QP7JCCY'*S[X<BY*C
M-7<69Q1#+>XTI%E)U:M>#8>&\J:Z4AWJ CLF.XA.QN4/'G/ %$SPMZ#IGP.O
M(G6C[P!JO%ZZ-8MQ? FY!_L_PW/#A5XF3/"6GSUM6T9G1HF6/)BU5QTL:6L
MQW$89!N..[T#5=ZBR%T.)%PFK$<IV2T*.Y*MGX%;%OD2I8VZ59]E>EL8 R1M
MF03[A@2&1),FQ+Q*\U-+^Q.O=NTY$>T/*]TZ+>*#@B-=@V53=!$6?E0_G6G"
M^+[PR> 5LNNSW"NUV4:8V"4_1.V-$T&+Y;4UILXXCKXPKPY^I"O(<N@(S/RD
M&"<[?OF<4CAAS#LZ:7'[:S^;?$+#E9LO7N6\@S])'40%H=/A0:Q!# Y<.AD@
ML58/&;(Y6@5R'AKU#R*M^5O()Q.PWD.NIKI7#JW.E9BFQ,@MD]:^BXC^^$C@
MQZ7JJ;4_+NAHX,VM/;[ME^U1$4GSB;3<7;W1.9L(())^'5'*P&(U$*U *JTE
M'4$S8*KAD+]36XWW(3NCN<@<"(G"0)9T X[3LW7&HRK)U/(/*Y!;.VLF8_N,
M#TVQVDZBC<4WZ+<A68DX)P(IM<XSZF3&SY5:3&Q^EM4OV$8+/WDB!>I8\!%I
MYPB[ 7PC6I!*8MTH[\Z$?(2FO'L[>B%')H$9>[H9=!*4&;E@.>;^/GY%47;<
M6SY>2%6EH48A'3,M3O@(FJSHW[#"P63$@K2KA1QR&U:ZJ2US.W]A-4^Y3FUN
M!(S6KWT? 7TKW'95MYP&HAEUB O7&L>L$<<%TOQ<&%JXP\1V)Q<UFWQ?.O@W
M"P?&4V)X2E3Z4=+$:0"5DUD"8YI3Y76L';(U\5&,-8+R3+2*GEO2I,\%OBRF
M\Z?3=C[U\,#46?#3!Z)3/A)*?0?D;^HHH"9FOI4/.0J2Y<O2RK5JNRP7A #
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MN(^<.N51GD?C0AAYW<J^5/]HGYCR2]@1$Y)E#IRB9,XP/%.2.6Q8[%U*,;W
M&1D (.T= ;,))^VW*FH^/=@[PU4IT6146((&&;?1:,2C65JU,IT<XVKNM+G"
M;S09$LJ(\UI+QJ;:1(W"* KUE^ZEI6.;EQZH/QM&2HCDM829;+QB8DM<GFSY
MB6M/W,M&NQI(:K &9HJ5FFQ,P"/DI.UW$JXP0IG"PD?X!7MA$6L704?VG\]?
M'FE0'F7B IRWP)G)W<6:N#C0>50\&.@. #W:1<"N?!SR!!%*15ZJN25XLQD>
M:>+'R0*__J"[6GJX=?%O&%I3!]XN01MT(VBXQ17IA0>N]"3 **HWF*5(O$^4
M\>B0#>^\B:+N5!XC@EETW;=OS"?T3>DG^G\I%1-G,/ 2Q&O;6L$333968*]7
ML&0GO-B7YE0=@+BB!F7"P;(V_B3*Z!T4-Y:Y:@?EV0%9JO_K;Q@)U1$7LDT
MR:HT2+&G03X1W/X0(*O<L>I>168,'Z_'<V!D?,M-3=:#C-&.SEQ?Z\LW1:HI
MKU\U1:OG@-/1UETY*!483] >0>_"RPM9R)&C&#Q:Y#6BU_FQ4+/.8'EH.-W2
M^\7L1%+F /]BH]I-1NF A_ZZKE,=J4X.(T-ZD%*<*Y9&_Z@<YU0.U$-GE.@-
M&)8,1#T0B'9MT&6L_6*='G-;@P#N:S9D('#&-(UVLA;>ZO/P*(V0X?HRS[\
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MQZ_7/IXSKE:47LXC\"<@V/-5WGO4HF=IIJ1:_S\'_Q#&3TO_ 5!+ P04
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M',VPS,1SD>BB6_'?/-']I.&[X2L'0J'2U&>4(E'("(#W+__W'<+5%G=N<2>
M/_8W)3<_YEJ-0U9:H.UW>=&QF4#."_XVF_#D_G>0Z8^#C#R2AVYC->.MX75[
MK1&9?KVEGH^ @:J/+4(M=U6A)Z?<<BHV-KRI0-!!."PPD_-;C<W:W@"PGS6>
MQD1Z> IGC%$3KLS;9MELY)I.4P1+@$M:%<%L5[HR'/E;Y?3N9LMH!GY4U>V
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MNV/0D;?-7-<&L(?$2!6S8E/6DK&M:.:#R95N0?J8WP9X:XMJ8;9]FN$'OM
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MO4L<79[V>0=EZ.30RB. Z[?X7>8#QN54PI!:\0RMCGK:92T1G;'W8"%XUO]
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M#TAO,ML[5^,QQ!63N=/4>#VQC_=*J@?,RP>7U5E?\F)7#7]"LN9?@*E$ ]X
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MX?#:/F7QAJZO(Y)4YV)Z7>0;K880"@K]L);R5U/LK6* ;,!DP#VMGV8Q7J"
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M8:S*1[)R%2\5?5)V(\<#5:3)H'PN5;PU"KJ)GQ&ZMLQ-IS\VU$=Q)*>B>LW
M;Z!3*K_QZU=Z+\A,9WLQN9I9+48F"Y^JKHBL<26!'N]OZDV.=O%32^^/BV.'
MIR3ZHA/7]/KO73O3!W<T[Q:--^34:%[I\7ZSBYFA^'0@C1"IBO^33+$V5K 8
M$,MN=HU!D.5DWNHR'G2D"S(0:JQ@S],+K?#UF&)_Z<F)7L-\O<[.J<:':AKE
MW\1)>E/<T6*&Q3&\7LC6CD(E*G5K%0]WP9T7O0>O O4A(?K[MC'H13N\(3%&
M16U=*;9M(CUUVMJ!8=X-UJ0"=ACS,1F4NO]QC5Y;5X%379+MJN&U_KI83:W+
MZ?[Q?'?S?!' U0-&-B/<I]-\67_W.@D)B;V;&J,QER_UPE)-YDR(W>E<EP[?
M3SA-#>$\%A:GFT#)'P-Z!B2"<3YL?>Y$_&SE%(8R'*'+0XF(*+"UFT"),15,
MT4(<C9_\D)"<>C'?+64C;M_F5ZPK7BUB]M1M[;G3V@P^.BOD*&K#1B&KN[TC
MQGM(S_CC1C]JPC9Q9K PM^N)DK5/=-[J1GUV3H)K+=R]Q]JI*Q*A=%)V:B+@
M_;/T:O7WF0R8FIJ[+9,GB^X8,/E9]M2)JIBDRC.WNZU1)DM&060485R=-_#3
M;9.:8<XBH[6-A!NO!%-@EM,40?1BWT\XUHRS,NO.D0Z>L]A,1IPT^/D[>?$J
M1H:BRH"\MY; Q+"]#AY6Z>#X8>?/IDBWL$R?,?XRB?.M(P3IJC=B],O^VY5V
M2A_[6[8K,FM]%33%&06#;7R55*#N,^P]3U$,TN!>@:%ULI+:XZF'I5Q]\ Y8
M&+"#)QFC&L)IV_G76Q_+"=+D?-7(0@SKU;+706'"^B(_;QOML&//1.Q,:GJT
M,3<VQIS+K"?CQ1CA=.$9H:VZK99SCK=76L?>AF7),@_D$E;,Y&&N3G7CGK<1
MF<+X5W]3&U_*^F2Q'O;0#>&T;CGO+0B?TJA^F/X08=CC>#(T?=+SSIXE 9H0
M0L !'Z7ADK6TK!/"N*.O[C[%W8Q]05$^34YZ7\;;:5B#B+SM^E<!TO]H9&./
ML31K$R+JX6A_KE $R.JM-UI!<3=WWG('I.OA&P'(0LE4WUI=HEM1T9($;H5S
M3-(=Z,Z9O'MGC^3C/<K4 I=N*B&E*<Y[*%2 Q=W]AA#M&W73-UO&Q&UF$6>V
M@VZE\(+P?2I%HTGR+^8.-^LYWP]K:GYG>]2)@@A%%C84X#9YWH65/"D,:T51
MXT_59=RASQO=-BE4)]4;BB#",J$8"W(S<$9AH77-83:5EP-J.!?3+I#\&+GQ
MO28;S8]!NRK6*]1^@KXI5(V?'O&W0OI*3Q:.I;7=9.=2'+;;> ,O;EE*XHI#
M!V&U#Y.R)C>AQ</%[/ D(VM79QVG#N TZWEW6E[;ACK/;JGS^VGC)6N(>AD#
M2M"0#\/#&KYG'?ECI)VOY5K>*-N5(IC/_/(L2^Z#V3);==<I/': .,JW_2YZ
MZ,8\:Y5)@XED/"]!8PXP[1<7W*P/4"U-(((0?H#(OK7#X/ RS:6O=I*R;N@:
M\>!D@0GJE]EX,Q.!/6T-:4 B?L)$T-B!_>[HMS!'P052<9S76//X^2;'U9[K
M[FZW5HY[1@,;[:"FR6D/G_"I6-8M5OJ_;J\P)E\DMX(@7QCAB30)_E'N:AK4
M47U D7"=+-/\^9LA^#I2;H))54R!U!5T\1N>_M[4PMZ_ITU \/G1AW$64XQ>
M_M/N!>)P9K$^.8N9!)A_TDAD>TB[2&02N] -ZJ)/)A70KEB;SJ1U3AE/'Y8E
M8<ZFA=7MA>S''E#L&9;2GRB%[QHY/>0O4+"L*ZSUU_&*LQX$\]/8G+2\X)67
M"FM@XRI^;'Q5G/-QM9<PKXDW77/&!9G6&Y\SRH@3Y(D6X7K3+FMA07[2R8S5
M-$%\UZ.<F ,]-):.ZT-/AUS);%D0'?3R=^C,1:>?./.0_!Y:._/)_Z%+Z$%Q
MSW57]9B?8O-I<.>RYT5OCTU/(U!:\ ]27'U<"Z4ZG@P79+V 4\H;K:)15&^I
M'62I[6;)[KW7I1A$9!P'_TE?)$K]:WDNR.CESSJJYJC[9)N<].R&YL8&FC7W
MBLE#UESU)FM!^S.7ZZ65V K5V\*["X1;'FI+\AI8Q@55KKMP?(N^3*N/UD"_
M>"/]^G_K"F4YBRN'I;0]O\E.Q_@F9C\W[=N12QOQ89 K^>Z.D3MSZ$3,[2AD
M,:#FP9K'!9GY3ZS>= A=E!TL.*;*\3T[L 8*;TSTNC+O+AEFBJ(7W#!^'47'
M940=\!_,+PNF6!R8JI\BH4S<[J-I#5UM%&V<7N4&DU*C99-RQ@*F\=6\_.V]
M-U0CT803N@8/,U)ZB1(GC'AW<"))"%BOH\<S+O"IL%!S!%)W8R\93*B]D5VC
MKZ+F\RPH;T:+*44F+=VV3UH1CU%C^J "$HF&90*)L(A*?B)IQ_0&_A::KI2D
M6ED(9/+_Q:>B@K1V IBP"]C4-_$ ZB(2:50XE[6AZB.)F;P5WC7>4_0<;M%N
M6K<L(Q%&@QN2$4H<):G:X94,32'%=4A%X@/K+AU#*^KE (SR4K#XGL$]3>7C
M.[=ON2L#Q/(L\^]>NQZ-)VVZ>#0FL#T3X"AD>Z]3=KBU++VIMK?"7B._4)]1
M"1,-:YC.A':D@:[_@EH7.< 2[T@1-?+!J@8TI9D:Q3)%A8*NH"[!7R629\L)
M T=Y&W7SE$_G^5@EJOO+-MB-V4R/&?FK%1;BF2H=WAZD/#E7]4BY(!-"79 -
M]EV0Z3I<D!4VUK;0GY=/_S*$+V95T=H_EHO%;HA>^5H6-3I0.$VS;,S9^02X
M'"KE>&>'(_4(AUL$) *IH'6!0Z+CE-]VV06EH]X5U6SLZ.ZIX88$_.==HX:G
M>F<AT;B=)+""H02S^^X'5IH0-9%5]CK5<DQFI3-76!=,"V#3[K,J\F>P#:1[
M/'VB[2/$V [CRIN?[I0E,6F$@*IOQP!3I8GGF7F5QXR,!P+[6>7"'Y>?ZT-?
M=4S#!<_'&Q<ZBO#HA\,5%!0TPYX9W\$8;W6W=/9DU^H56Z5(-DT"N*C)W'G1
M]35QN14DDBOORSS#*'%(AOW3,H@X"+;UGPNZ\V0"'4EX[H&<^?$BID!TF;F'
M]R []J17ICN_Q 3F;HL7D90 ;SQ2.C6L?"W9]%=P%N69];527,VF=V-1&#M'
M7F!W?25\)!UUM2.7L_WP6+<D,+'V'7\]FQ);KFIN^!Z#&F=T8U2]*.66=&5G
M+W_Z=3F'B9^S<F:(W_#&(#-'"SR0N*KXKX4=I,<O;,HGWP6%5R:F#)PNAY-!
M[T/-P;LH1G!'!LR^T@7#7'? 4C06WQ:LT#XFU4 XX;PQ"7D@ SZ6GJK:1H+)
MAO+;!I;M9AGC\?;6'KIQ,'O\V[PPX26Q?W/<_C:\K(TG^(J=?*ME=;L&42A<
M!E%?V>K('2YD/4@I94>[K;AK8_B*L%FZ:ZKVD6AC#'AQ/P?B*V9#PST)E&-&
M*C<I.\;A O!MX&^EQC:[$*5PP.T$ 9SD,PUL[/]2O_I##N_"&2=K*-AZP*>^
MH'Y"[OY"4&[C?0U2]H^#:YD_LWL71Y]I#?'$<+:E40@-/M8DO;@96'-/,O2Y
M/H/6^'YP1XM3\HYP_C.#Q#6!A "\$4WY0.Y]!@5"K_,MWUJD\6!+WMRT8VRQ
MPC_ P66>:E;TQ,EJ$F/6H6.VTV")QGW@"+@=Z J7L3HS$JP7+/<P8X*(3)<Q
M%:EF3+(-0L[BK,[-3<9:<2@>'C+!C\W]FW>G5CV'"W9KG)QJNZC8YG+VTU^O
M<J@5]?]SZMJ[YZK&:1F%W@$NCXC<^@W=+T,".+'[;0N%HDE/K0Y 9D]N;[!-
M<(Y7/O9^/_LN:&AMOU[NC?U1D660$'R?==]-G<A/9^N2R*](PW)'G%Y/TLV<
M68G*4FZ-Y\>G.=5?HX*JD')WZU0+1.:SSU1!_S&FOS<.PDG5$ A$JG5_/>'Q
MQ.NY'E*7O]8=5J2_7=D0^67*[/2JJ+-,=*HB)Z_3?5)PC.04A1 MCSWZ/,_S
M4YCN#_/X1LTI3S3:)TVPA#%>#Q[N,,)%$?U2Q9WY7W5:";^_W.<IOO,?':VD
M327:#^LBOX1:L&M.>V9DN*Y6NI07_)J$8"STV9@8Z:O.:@DG[%1"8XE=:/_@
MA7&17[9>)[V<WQS6J[Y[.VGDZ*,-&<6*'_$]>%W=\]_^%9>VI;SXY0\=%<<S
M8MT: ,SW1LEGY6;U=')DB<9K"Q'@15.!GGK>)C/_DAW9)P5+[&.C!M_/TLG[
MBT5.)UR:0,+;$J1E(K\>U2P<@_%KGEA4FFEI\(G;%K=W $KZEPFPJK/7]9>L
MKVV8=! ']2>'-)Y?4UT3^<>[A&MG>>PA==%F:GI6DDJ7^=UBH'NB7Q!EO(\*
MJEY:*]1%EY6?&XGW0I27NJ_.EBW)$\6KS)OW.< _SQY(5QJ^2R8$TQVA D:=
M%7AM \S%V&W%%+OMD!\UPSIHR7?T*A#.RP[KK3)N-&8%,5HEU9[BP7.M(^E/
MNX1=JJF__Q_=B*^R65*'=Q-SVJSMVUSC@Y%=E[->R^UZ!2YSAFH'39KJ9 D]
M^AWFT<E2)'\ZL"-NO,3]V,3DU"KDY(<EZB=N*]8G.OI8]SPAA>=C-]L.=C^L
MR,*E4-<17\;EH"5-28LK-[ "_\YAW8#<4'TAA'W>++B(:;[\[3^YY!A5.A(P
MK/9ETG!Z">%'EF#8)+%=-"O,X#=OM=%VONQI-G%:9E6:N/.\IS=+,S I(O*"
MS"L6=JH431?S>GA&/F<89O6U*F+:<WQ /#*"-Z398FOL$#I64S:$-LTHDZ,=
M^$*S((WPBI<#5$M6Z1DJ\O)Q"KUL_Y=,=L!N#_?#I1^Y)JINEG'7>U@X?^+E
M^=$@C= <K'&R)S4/<=NG):J)P!P/.B'X<I-3;KT1P/S:@L;(>*1/R%:Z=!7#
MC'/JI%DV*J!'BLI,(TCL@JP3LA5:.UN.+ZJ IUDHAQU[ 6DJW=M2F^UM$KX@
M6\'<1Q:D;)]=.0U3@)NAW>CQST+[Q1$?>-2[ 9-E(,O.\!1B]J;TU<"#J#PW
M=LOPOK/BM$W<.P67GN*=VLD5D\N-Y*:Y26X+/_Q>.7P&B6,&K>UL^Y6%&A\=
M5;.6J,F8U?K1RA_%[*?1&O'T9I5SMR^SC6A^9>=GQ;6Y-6Q7(A.A,G3WK7R.
MDVAM:= M4)/%473\ S<EA2N#;D5WA@F)UUY)F#CY4-VG\*:K+/% %<U*INW%
M?W==7USCT<EYJM7!HE#TKRSJW^$SQFF_BO':IEN3TU((@Y65Z/5W(>:!S2H4
M;&R!>:9W1/4%? Q+%O+Z1%S4IW9R<072*MB6Y1W=HS:]#MHQ\H'14W%V4'E)
MT:_01J,,$$Q^%)WJ":@4%[S:7+@(1=HI#V7\RH(9N6T[[*ZX[ 5F5E3YT^M&
MO"*F52N)V",'_[X.)Q>XCNM2D5@#"Y/-:;0D#;<X( O$**.!C#%\K-NU]:$H
M^>5/B'8':X2=;SZ)Q3G::< 'Z.3O7&@0ELOY>PEB*%!%P>:OT%+Y4D."L_Q,
M?MHOF_U1F_7#%RZ)^PH YU<)5J=J-&Q2VFQ /W+9?.?5$M-WSYYO3$0*OTR#
MI?P?G'W_/X-0.3OR]%FCT(X_X^:IDF9";FGIA\\.)E223A+I9Q=D<Q=DQA=D
MPH<R4<32^7-;D'YT(^6AT?EQY= %F>'N2)I,6)OGNE.N[2RTN\+O(RQF843\
MGHF7PQ45I?V<T$([*8UI&OIPD*TM'5N53M742WRG=2"015"R3,8!$C-O/$?:
MT-I\=YR<'-QZTDC/_M/#\QP<=T%V?"ASMIK T#/P>RXQV[-A\T=[_N^GC0B=
MUA&^QG<DO\HXE*#FM3[5EBG57Y"MJCQR<J[=?BB1>')ME*;;$0+PVAZ\$4>S
MWL5KQ+WW7 *H'G?RW"NZ[6OC8>-(7Y<_#=&=V1^ZZ+[G!=X&?2PE\:4I[:%T
MP0.'K-B&UDZ/<Q['MG/CK9[3VHY#4ZF8D)6=W3TW%UWM8NAS!K%_JMO07(S_
M%U!+ P04    " !-B(I:>EYM-K]O  ")>P  &    &YY,C P-#(U-3%X,5]I
M;6%G93 T+FIP9^R[=52<P;(O.@0+)!!L<)+@,%APEQ D. ,,.D!P'=P]$&QP
MU^"N"3"XN[L/[H% \*#)R][O[+W//FN_>\YY[YW[U^U9LU:M^OKK_E55=U5U
M3<_OQ=\; #QY&3D9 ,H3 ,#TSP?P^SL 7\K5Q,83@ )  P  (G]8)P#<MZ;V
MQF8 T\X_')3?2, G  8:&AHZ&@8Z.@86QI_OLZ<8&$^?/<?&?H:-_1SO^5\;
MWG/<%W@O<)\3$A(1$1)24E!04+[Z>T/!Q,3$>8Y#BH='2@[$!Y*_^N^VWYT
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M"\T,[()JFYOU%:U%8.VCO:)V<8;;S3D.X(+:RHEMP$DP7A4=*HI>%L4($61
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M[# 04V)ZB!E7O$-VLAX=>2+E^66/>KEQ6V-KL^RA#N&_LY.AIA?3/.=_1OU
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MY?.PJ3=272+E*@CQIOH(H9ZE'C'Q)Z 78>2!6Z@$V-W"PXG%IOVNX3C/5<,
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MYS#-^U;2LSF_WN9]/U$N'D31S%=WTIUO>C&J7XORZR=Y4,>[K?%S>.F;GE[
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M\D&)'U;S&>/97V[Z?Y6_?X,>>QJ5,@\Y\ALA'3A*@LZO\E$6.P#P?#SF.A
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MYO<F4#&Z1K1:?+\&GKM89:G1!SWE*HMO+PBUEA"]N*0%5C/]URD.HP>MVZ=
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M8?&^(RN3,GG<%M*]+?SP"+IEYW0"I'I_Y^&?NU[1O7M0@G"(ZGZ;'S&#1:/
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MI&)Y[Y'F:N[EX6F1H 7O$Y+=&0QA=A[QR0]Y?S9R0KMMP?.MB8"&,)IF/H8
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MJ0+',7A'QOG1X]-W/$(I>;HR>B<6T7-R"V#[W:B&^Z(L<CK+A,K,HN7UV"P
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MW=W=I;B[%0IM;W_[[E?V.>^^>Y][SO/<?^[*DR?SK'PSLM:L69^9R>_%WQL
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M>[;"!P%K*_G/M^]>M"C"BTZ#W[7YIF4*A[6K+U%M='A!Q9Z,2O\\#L4SH[]
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MZR<RA[+CWF57'$6Q]B]D5XN:'YM/+LRI&F6\<98S3-[WPF!A6-%4EJZ?]I2
M)'K)UP*DY.PYT.YZ0]GYT\TP'VT7TT9CUU,5G]86Y9KIM.+'*,23=X_#(T#.
M&IIA2Y+/@'P@ 242[9'O6AV#88+=#FW*@%OCW^ ^KY\>/]T'?*%6':\8J9V_
MQM&KVM3!=+QT]/U(*IT[QJ+%E'1]H)02S[L3UWAQS6VAT;]<YO:J.1-R:]O^
M?,2$*O#-CQP)OE6OI ^AD^@B.R14[ZR[OS99(DAH$%C_RV'SOT,BLW,?_?G
M'FF^6Z-1[Q<<U+44=T7/0/6J7RC]L%<F6&KM=I?^(1%M].-2#VZM8:E 2G2*
M9V_RAP'6B9*7U#\85R)+REP-=]=V<#X;-URB;U/*XE.*1S$S+^5:;[#1LUM\
MCB"CAM?68PE]VEVA$2$$<PO>!*#Z>Y N5NF%?A,LM__1ST&/0PW#?:XT!Q9I
MI6HE4N+;<EE:\W0T(S\8\+23-*^6'2CP2/#ZM2C9, J5N+XDXJ%4HY"C?K6W
M&&-@8VLQ%[3:R_U5+"\\5<;MZ:1. A\N)OSE>8,K72M+SE3TK\_&['GP?V7\
MIR;'=^+.0+;OK%.QPKG1V#QW5E%FK2T2L0:>-3:RAQ/4Q"3W6DD*<Z>#?,:0
MQD<6D3>2T4)M[S+7?<E75J=L(D8J6C<65(N&333%7<*90_IJN_@OJOH()N.)
M=-2/?R:N:3IID(_N=C1VD.;><,6=XYT[Q;B%'XC-;#"ED)'(ZBV_#'(::C.%
M"$R6Q>M$'15;_ ]EH6'NC!\?,/3$G2_\J)O%1Z@?_-IJ"#GS+,DM@KE%F$4J
MBDWG[M3G[8CCU@\YY*E-@4!"74?N6>--L;Y_M<ON+I9RDUK6B3],A]3UY3ZI
MAS3LGW:[[@ 5>W[*J2.!,IE0N[RW]32$)Z(#%-8Y$!*TT6\BA=E,0^[BMF7\
M&BQ:V*XM*%-\&)V5JS83<H5]0R0S<%#7%LM*T\"99L[]Y5"7CA\5RY"CCWU(
MXV?^].=NK6IM"G#2 14*_M *A@]\]]5H\U\\>.2! &7BFNF5YH0?;W2CS/(>
M;;QQ?AHZ.[YAJ*9U2#SE\TFT;S>Q5MH8F1V7%,P@&A_5!3A3.(_@)4DPCH65
M+!:G@%5/WIH&FI,0K3:(&KF=;4;P-N1YB?OL"SDJV;A4*.N8V 'Y<22U&%CJ
M-T.=NS+=U%?8:8!>YCZDAS%/VOH%+*>;9UN_ 4-I2=%&ZZ?>_:4OH"_154S,
MTL7YX?5NF+A3Z(\Y6QSO<%O$A?QT.G A98VR#_%VW/,SGOMV?ZZC(C 2\B]X
M3?MC#%5ZSO.\ N6UY;U%^KBM)FG&<+CW9UW4$RWRI][JWP"@S]78PD,:TAY3
M\GU)1Y)+Q^@D/A]G1Y_I4XW7+]OW?A$VO]C/=],KK@511E5Y+@T".=<"4[-I
M+(T"X2T/ML=/8X!KHI$G\+<18?,]>XR4)/.M\E]&S;\! M*^@7)&06'/;$QK
M,!&%OP&E:SXY@4W%1J$P/[&P(#8K4;_&#XV;B2X-7"EG??[]6&:(NX19MY<P
MRUW7UJLSR23Q[U%R;D:][.6U<WM'=M$<50I-',D7"]0_ZQK3$)T'%5)5D;V1
M@9"#![S2-R22*MZQBZ1G"]:_=N)L?L[9G"S?"L)_ ^*^J-10&(GF^ZG5/[X]
M9F!J.A0N*19+N7,3-0QT\I*@2MO;B99R&I+A(TYHWG.BG_MN,*0?*%JPZK7;
M4YV:P?@;0)EU9=\FQ'##?5TE@!%KC/N9NWDU/3Y_39SN&FU@=H,#G-FVNVY(
M9K8<*:&"294[>?<;\+E*3-A&Q$#UL\6Q!7UE _\$R+DH27E,('%9T<6E41B+
MXJ-T8X-)ZA9'JX%@XI*V25T\TYS$>&#Q0^#;J8K,"0UQ;HWTL;YT!TM(RAD@
M!WHW> ;:Q/:^O+TL7[YV&H,(=R^/J[J?CGA ZDC':,8CYO1_U;ED^2C)$)<J
MB(_-4=LG5ZK,-W@G-?FUIFOWB(F^[?-B_?*/+7)BD/D_O],2_^1(*"/-+)K5
M4\TW*R50$%QQ<[T\AYZM#@RV<7[%B&?AU2A9Q/T+=?>Z00DW1R'9U__8 _:9
MRFV1>Y#YPGP>.%"9F7962%\+@8SWQ#TM^/1H3 \Y[> E.%#X'S-#'@S9ATA\
M0J927<V"&8K#BO:$3!Y7)$@QZ]Z5Z?,0K>Q1Q]^7-/QEUP+%M,1_XMO$4RF8
ME\O1RZDH+[B"1&P/$=BOX1HB>;8FH%AVQ)T]YIIN4>[AHW@RRXJ!EC(E-$^/
M:EQ,&0!7F"+1,3T&U^467#GF1?B8JL186IZSCS#5B[P^[4%&4P1<'&(C"H'$
M5/Z2\/G9R(O3&/J,%G%]G0$!JG4[(SJ2AEW!8^_P$KK\IAMPC3^#X_98./W^
M03:"_DX%R%XL/']E?+EYR4,^H'^HN_'*N [B #O#4XOVWB^S#Q,*2U"1J7:%
M8X1OI; &!@Q'OBXL0-5QGC9V7U>(X=O:)5UM:%_K-D""?E;^(/$Y,3U$V7 7
M]SW"WG18[Z(I2LS;@O'5A-(8#VD,R^B*)3('C,9MT<&\!9G5"O>KGZ&.!_#P
MS6M23,D0<([N7*BD']&%X>FOE"RB+<805N7&G +6]IQ9U(G:_SLRZX@&@90E
MT=<<6'-AOF-;*)\$J/M0D,SP7FO+KD1&PIG)O1U+)",\#_-J1OROA9O<3Q:<
M\<0%Q!K=L[1A@YDR:@251,K'TR1=O"OW)4IQ1]>V3K,_[,UL"A"&_^K.1Q<U
M9WZS2+95;/1Y8O *Z@)QG9'ERZGG1C1NNJ@9.+*XH@U@_T"]D/#.S]R6OOJF
MR!1*M5!6-I2P@4BOV-KC@!>ZM]&>57"L>ISWSF[X4WU1]]4-_DE*I1S%P$?N
M(LZP6C\9CNT_R!H!B6I(G4R@^#MD\5 W'Q&-M2LOF.+VPADQ3*_LR9DY;(TE
M;NH+5/#F*3;-J'!+VVQGW=MSAUP:\.O*>O!3WR<M>+AV-7^,_G"Q>O 5X:I_
M^7/M5L.GP:O/2F>UW+T>']WT.&7U;Y8Q".'EU3@\^HTW*Y-2D$!R6\<"Y3'\
MN,PR&NPPR\X0^1F=* ;7K_3M/)9J[4E9V:J6,"-KEJP>V8X67*>&C,_<?T+6
M$L6B/F@:<X(N@IRB.7F?7YR%=RB/^)?!S,[&C>:,V8ODH_Z]N$28EH;R'8=D
M4:TO2B3+/LAB%$Q*+:O&3_&B*9EF7?:V1 IJ4J+<P3VY4V#L^8VW[(?_BIWA
M_.%D%\%N?Z);'/8TLQF5FV $G1FTE0\R+-K@_.J@+;[U^_G5U/*HJ)=CU0R/
MU"DZ1P?[F8%]#6><]8#MX/:U7>_GY505"H'.:R1!V:#80E,&HG&$ROM=-3[C
M^3&WNJ,"DS+V-T3G@M7Z+N[U@2/=VQ62(25BWK_*5I,.>NVLCX0PDY'@UXA5
MW[$!YMC^P50:.O9R&Z+!B&A,U=#E1D=2BK9[I;#!-&']K,V/"Y'W3X.WDY2I
M2P3G^!D\N$8Z OH%,@/^+6/]<L@LJ_HU@IH?2BJE[]_5E%S6KB5Y3]3DGBWK
MAN%1XVC<7*U1G"Y:FAF:I:DX4=\C?.YWR;38XL.COBJ[RU(Y QKA$A[/\)G%
M<:A3'=FW..X*OMQ>]B $XYUA,[>!>KZ*I=[43)6**P3JW>%LQ_066JLA7V6.
MLF/_;8=%\\\5C@9N&=/KVE=L6*9-W"U6=SF*!17R:$+=@,,X07AZIB.O0"V/
M(V:T%CXS^47#6.79F)OB<"-%^EB!GB[^75UY[G61V<:/,ZI7K 5&;%K*IFO-
MR%G"1NM<#5A5+J1]C)@*4A1R2ODT6F[&^NO0;(&QB*^>A#"U-<1'N/\"_JUF
MB*6:9?V$I^]0O5@K^92KHPJ>8LH*5WIP)69$C1XD![,@7-FHF1V>3EIF@\N4
M'OW40*@D(,IV-AJ)^\Y;=-^"G--O<.5HJK:<3'\SSR(AVFXDW?Z+&N]9VZNP
MA-*$\8/['/X)-<6'WX"^E-<>FMU\*<WR(1%VP.#5:[<+OP9N;'I6Y(B$V!R8
MP.DMXHE=7\2H^^3+Q>ZKQQ*!IMHGBD $D:413!L,W%!0A\-5'NPQ(!'GI[\F
M?QDC+="_>0RL?9GTWFOPRZ]OI_B[V=3N+!T-CW+_S8<P<;T0]$:"^=V^S:@'
MM665K,J(<M$IZG7$?"L<9LH@!;UW7.KRW.&/<56B^NZ TR=TLM'2T=Q6[U>G
M]&;RRBHT.9CY .L%-VM>>-OT0M39.^>;)JD$S;_)*<7]W]:4K?E:QM"+E[&?
M41CYOG_Q>H61"*Q>%&VC!]:8/G]UL/,8IB90'",<5S8O<ZAAIU$'B5<[_JAH
MAYRMU&P)G\EI05.+M_TV_6N5P\RN01\"::VCF,F8V6RWTSB.E?S9L4P[ E'2
M^ALI+;:C&>AZ%W8UB==$_&WEY]>G6I1R^>]_0(I](!>2]L+;B1J'T#CQ5_$5
M^"RUL@X>[%:5X#XU]YP[8O\%)9:5ENTXOKWK1/_A\:S)^#K@H!!->P)>2V7.
MTN34<ZAP=DK.B?Q/VN4RUS,@&3Y/[7AKLEU?0$^Q,#V*>B2T<1*$]?[]YQQZ
M%@M"CO CR?^U1>+/^4I/4,[:HJWKGO\_I0C ,:M <1%Y9FR9D7=J]#U1%#:P
M,4(R-CAK40[+OAVM>94VMX4C,V]RQ99UU9&1NVD$\J4K!WA=%8V)'H9V.8P=
M;+;XG$]MJ"JPO7RZ7Q"8:?U3[W/C9LT[)/TPB_G+G;$X@Q:GF"%-!X\N5SH\
MM%/+H]O;<0![(Z;U<N/V8DZ7M-_0E6)LW&V]0NI N@B98-SIW*430Z;-KBP9
M1=<H$FJ'D'Q;DOAR7$\H0[E=@8P=#\5$22@NW^[.Q=ORKSZHL^52%2TPPY(N
M;7UT85R&RRIYQ2X@'\S?Q,<Y=YA4PRX@ %LLS(R/L#F VW^"X,&$%%,I" ^&
M]MD_52T4NN^U_YJUA#G&E@25"=6 .+2I!5LH@ ?A):JJ3[B6'<;MM6QSG,S3
MEYSVE5%@F4.Q_;+U-G3U>#PN/9I*$3,\ J;#I-4'-O"?I)'HG?P5O2)E1]OZ
M!^#9!RI!LP1BUK7P^01?YM9/I Z<LV*DI-%.K=B-;G]/0!E5QS\XK=F#/0XC
M[3&'W7@O78O\W 5<$\O]$'=^R BX^@,=O_ZDKG\[_M)/VGW-ZW6EJ=!IA>H2
MU&VS@00;/+58M6R?R#N6$(Y&ADJRML)^?G<<'/WC0HE%_*BZ&%,V^!5K"CTW
MYI<<@VSW3 /E0RXV<4VY1- (LEXRFF],&T4R%2=0UX$ 4>;[:W]^0BG^4'[@
M[[HE!F7_:S7^]^U#*O':K8]H7,G\L!%>A396=*)H8M'%N*HLS= R5R;Z=D5[
MF"W N#K4O?%.7]3+XR@MK0_]LF"GL14'T6,S8*)CNI/';M:(^#&WY&B04=!H
MN*??P-;37PBN/W2!K'X5 N'&S=%S#*4VR#)Z*?P&!#=RZ6<(E G.YMK]0YE@
M39:O-ZS(J8>/AN\+&%7QQ.CIO<'N6E0#NA,S!@Z[A8(TJ?6C&:I)"F-T2OII
MZB.)>KR_ ?R_L$]W'[W ?:-=CJ*NX]"+&?ZEKP_B!2>\L,8!VWTW7[>WF<XJ
M00I/_<N,PQ%'FT;7;2/M.-C)N^Y F&_UT#_L]W@>\[_O#6J5/82++A+>?4D4
MA-""=!(" $FGO +O7ZT 0E9\S_^Q<!Y_E,E59-ZAD4(Z-$ Q\"[_<O;Z!4@Y
M)[/7^P=NP=@0N!RS+C*0VU*2LAO:/B5X,.1#Z Y;PW?+V68;3SU;;6G0K_?E
MK@#90;ZI8T;/$?% );:OO#PHH:%(U(9?J0N'GC,,HFZVP,LMEZ;4'TL$[4=
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M*,QYVR@L%C5@-@:N9HO\N=54#_V,R^4FO4*SGLL7#NUXN? I&&/@\,?@XKM
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MX&U:(<\ E$5NIR(9 -4;#5CX,T ?_)?UTNMDN_\KE\(0F'5+NT;(=;E:>@W
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M#GE<SO/SJXC@K:)(5RJ#B[F2-+H=V/19\D*%Y]5XK&W'T1N7K(9<_9$W5<^
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M)NQUC0_YO>5I>X$?RP5D+GT6DOMV/<";%'H)1?1A5H,/R'BGK3S PQTI4\^
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MKRC%)L^>#<I?YKEF^E;=ZXM_$:7_POF:S<Q=!:2NOJIUR?$(F!XA[MSP:H)
MG$7WB!\!5\,;5MEWI:95'".E68J")G1T/)A\\-\(Z6Y_<C9AKN7: D-DYNZ<
MF:PW.KY7>+\L5^:+V<G::"=PL'%UZ5F[PZ^"+_U\3U2 '_]U5_5_MP:-YN?&
MGE# 16:#9>KX824S;@Q#,2<QS!6-H*1.;^T.26P*&U*T3?8;["4CL9!D7BP\
M4FB&QX+D5]JW:9V2B(B5.G62#\N<<:.5))DWZ==.WBTA(M,NRQX! P]2F9N.
M?+$WQ!.R][,RN]8?3VM.)]>!V70QXU74MQZ!+%H/)7G.B2LJ+V8:D?$DXCU&
M&GJ2(]U,_[!;73?T6342+]GT9X!Z,!X?QU+RDO?SX7.O3^7_3C&^]O=8^W.<
MA(U%I.+.9?)+2N-@*YP7Q*R<&,#4J=I-S]!12:U$GEB=+;=R!VT&/PM%Y&[H
M.*$,<2Z?O-89I@J$4P"4VLDT>,E?'\JE)&F^"6S=RKT=%Q[^-?M05HRKJ'77
M@E+NG4)Z;5RY;5PTB*^FXKCJC".A)7,]W]4'5 3AS/1KMQ3U)^P1;P-BQAK&
MT6?*F>$#\(]T$'J?_X#V\[@#ZE+<5DV*BU7J:J6DEN=3UTQ&31CT7'X>29#=
MO=QWR[$L)G!JX0YJZM+WDUHW-Y[[F[_>!X%K,+&)6M4C>'H#R?;[KRS,=#$O
M[@(@U<WI>4?_\K("3?="[[.ATS]@'\3VBW_)O_Z;&!L'FF;*HX Z[K4OQQ=\
M^8,^XFT>EFEXJ$%2;:F*Q 'P$_E;'.6.T-<I;^9(,;])DP,E(,\4DP,\L<5-
M_F9WOZPIJ7Z\?8:T(VKE@G2Z?J(UQU'J"-G;;U[_8,N5K&472XP.:E7WU,S%
MYQ[YG_8/"NI:%65.\</Y*)S3@Z-R>"<80=)Q2B+S Z  AD^>:)_0U1?]BERX
M"C8'$4*INM&1[OPA2*2RI\J"C::S*:(>7P?S=54!W8 ]8I[J37Q>]O,1SHL)
M5MT/Q.BZMR[6VO6R[;=&-$VZO,0UN"5"0LBS<=]$[6HN=CO;E[.OATWJ5 R3
MZY?< Z9H2*)FV0K2B'GY/BC.K 82BS34K28I?0&%.HRK^1=[ZWHTX"4<V+JE
MLC/SD0AU->;$51V .#4#_>1NBE9D#(LLXE_A<,Y'\*EG:!N%NDJ%:N5<=D?^
MFE1T+83*7_A^)RO]DZ!3:;RR)ND@ K* :!.S;MNP;%/*?H*0>I.I&[1W_F3U
MU#ZQ3JB C)M]-UZ?_&[A7+604C?W<T&;F&2+&P^C].PC$:O8<SZK*2IB1!Q\
M4E9P M>V\+?E7E>&#?QG,G0GFT+$C"RFM'Y4VD;Z%6=C03+Z F?[4_6EI'T5
M?JW[P]\TH.6=:F?75*BH%H+=%%PIP[J+X4AE<S*,N6E2\+.:"@_^H7."K@?1
M8C,8"OVT>E\1J5>:PL5B3:GMY&RUD_]47U6_+"&X7->&17DN,Y'FU:_D!+EB
MO_?K_'Z;/6.EC/Y)FY*Z2? 0(W-/S[C+CE?6+"P2KBAZ-H^E2[M$XH0U3CH/
M0_D+0P@(VL7R=?8\O(FU;8W"N/W,2YLA6^%-W1WGP0R5V<6 [7:FE)NKSJ[
MQ?90TW,F$?Z:XND7GQ:>]U!_(9=>?QI<Z)DW2J]0%%I=7I@%16JL00^*JO:_
M@+3::C<CKJX2BPJ!7W^3A-L7V:3$'!G:P-.3:V:'/EJRA,EJ4%F3PR<\"=Q5
M.-=6$W%1M@H6$%[HM'#64-/Q$AO6H'E[DVQ#/M(4T4!)<DZFL/2SU[U)_"\V
M%@DZ,$KH=&B$F8K*1_!9IXN!ZL^_#M6B$2GUL0V:W([05P0U9S<OL_'\%)J
M9B!%V47XO^54RAK'O"!N)&7&ED/%$!K%$[L8(!7@>+8.F6\99Z#0H&,_QOE2
MCD3,:#)3D#WV.+=>E8"<WA07]?/A8D;CX2381X4DEZ9_(4.#W,F@OKJCE?+0
MU4*$*LK5U;XDZT4*@MZ8:1 GBZJTH<O,L']>>[T6HE6NF^HZ8?\6.G)F,21F
MVN2?&UJFD+]Q3BIPB!B=<W^OHP%0IK.EZHW WLU5C!-@TF#B :X'#IZC1]@:
M3MV4'KO5:2>GF]E\(:_\&<9CJ('O)\2(QX3=%Q22DTXEALO"'M*OD:KW849K
M&O%E4F<8M3RN7071"P$I1"75?73>.F=A'B]BM1M$KS!Q0VTYUJ.SK=>:;E;^
MXP%L@1X((Z.M&;S&%\O:LQC*$OL/:@Z>L9K"JF7C\!<49(W75ICLV]%[HX@Y
MZ=2[<31H%E^I1>0OY-.T^(+[H$.7M-R,HZ5E&DS166B:*ZY)-L.5&: "G/(_
MO%X&7 K]WWY9Q.*XY!M1U",L]F!BD^_P:?",D4U?[/<YY:>GM^N_L!-J^W7D
MV;R .V=KN#FDP1]><H4^:%,X5=$8$\^TY*IH5A5[+=9G=EL"KUB\]?V[]<+#
MMC'K?_SW%\)#K"G+$-TC?A9YGN*#X6]@!<Y :[DU?,Z@@I.HQH*D+<4D;XH0
MQ8)BI#MR@RT@9?>HR-NKZR)ETJ/T3,6@X(/A#N[OU(EB%N6WY>$QV(9]Q_:=
M$SM/$X[GJW!(=M[@'43<ZU3?]=005@^[-&=((!_N/9$+JQ12QOM'O1@1>:!*
MC2 LF%VKPP]PH2\FHX AZF*G(VXH[Y9H??H/ZQ29]9']*=#:8^G:Q3UIL"ML
M_E*3WJDJI;# W\2>DKT\*2OZ*1FII!K5C L7HE[ ZK!8^?C-(R!4=U,WQLJ6
M]*P[K!?!GSQ-EJ(2&IJPPI*U\'R9+@<HA4^X$B4GPWQ622.8JMP;3J@T(<\B
MM2.9K@V=AMALBM7:4"I]A[S^#_M%*/CG!RC9\A3'''\,:/Y,[Z;BLGY5GI3,
MC+&&:+*D9"Q2E)PPH%1L\JJKC$XRR/K2FB_UX2W0D/DY->'@3%N)"9E%OR<P
M4X4HK<TZV  7N=D<ND=5HM4N]+E-=KCCT.%/,.GT[*<_:MGDL^1G<Z1MX('N
M;_LBK5OP#'<);_J7Z46R7<:EV%]#;0>(&'4X]1(F081ZK<P,.M_)]L++\W\%
MKHI:\2'(CMF)526?Z)7O!%\<?/S2()LVD'>$Q_NG&Z-CK+*X.NQ[#4OIUD6%
M@@=3+;(^3D5S;MGZ"WI%]7[$Q=UP0@F/W3=$&>GO-]5GGE76_!.!W#7P<V,0
MW&U!;;"B;7!$J8O,Q;24>>\ZO]4=R)K7^X^K!FIUP#\270UA.FFF=-QO@\EG
MC&_]Y,L7X$/E,Y@%I1@YLP9S!:5N,2?TY"-J0%0^UFZXLW@,^+W M@6Q*>&K
M'.\9$1,%SI>_T993O7CA_K7L2<T]#&N;>W]+,QP'D;J?[&7@]@C=.<N5?MO.
M]:X@\;G.^,0PK/G(1LNU*+IL_[6S!FPDB5X)GMC;R5,Z\ZFTLDQ%#*3.#^G:
M7Y'/A9BYB,M-<G01<03H7 ]]J=JPJ#AZPR)9W7%M;>>\8R^4;-I$:Y,<>="(
M-!020_+>7X+/>6%I:N3BE<T[I"),14/]LHZD:[R"O?V@3&&!SG*OZ;KW0)AB
M=QS7F2[L!_S<NF?N&)6;:A20^G-N,7#2#J%C]G\ $TFZ95RGY8R&&%<CJ^LR
M?6;N%PT+5*H7V+=+]2P&8)+M2S*&8H7\#N9@Q<CC1>OQ+_W00*_487(U!0'S
MA$$W!=A%TPE&-.1_^+$$;=)T"5N$P>UJV6AI@6;4L<(/VB0+QN=VHXFS4^;@
MTP9)BQZU[+\K 6:H7#1,^GTUW#@Z*SJ"46YM?1>",*^L*3Q2:BCWXF:>F"SQ
M(6?'C*!TG90E0G>4L["HT:HMY,[GXV]_!5WYNN!LH,UM3J'R04-O(%F;9FK!
M!RW_C/F!_,AFB55+,1W9[?!M,5$1QG:3<NGFXJG<W<C"'/U<J ;.\J0=#[Z6
M0BOM\QX\AH*"A\UKP,K&3@=F#>FIG^2:^+A%AW@X*8B(0C:XW4>[%S%K42M/
M)80)9+/:)_^Z1:B)+_XRAZG4.Q!E)?<&-#/2=$U:C6Q0WDG7AQN[)-:_#E\B
MZOO;FP;SU' 46[]T=^$K@?WDY;+NZEE7A=VL8$(!O=< *09ZH]929X?VES2X
M.:V@WD!1>E9Y6P-F,W*6+.R/P!7>IZO'5 02_)SO!U!PV"L77@.::2JP;0&H
M= >70ZBC5C)1L'")(.W@EX#]9(#Y<KN 86E3,IB1L@A*!+GC69H_-N8#NTQ3
M]VJTTA136#I7/@*^U(L*%N(LZ<)7PP@FLRRTT> $, W8\"A1=U:J3V5PIYM+
M\PD\/-^8YK>6[0E'R:#-;^H&N]<A$@+&ZVV9I]RBW?@?[,&&)>R8GQ(<V!+0
M)&ST!OQS]EDJT9)&T[Z9VO?L&I'P'(:6!F/4SZ&,?]"G<JZ\3>7JA*K94UR9
M%571",2L>>I=YJ]8]XWQUUU *I7K.EB,OS*:(BF><,N-,F*P$O2X^C=5@O@.
M#&0[^;-HC?[L@"#(!"_AF_>6 /PG3V: 04$962IU=&\_><'L9IM_Q#3D.'7L
MD2^2P+;R&;H<:P&KW5#B;!^<]9#Z"^/MO/]"8E+T\(L6'J6P5<0&8B42RL8G
M-%]@FZB1ST>7VAZ.XO(3JE9D$0^/8&<I-=O.6PJ!/_1!_N(P; 'N&J_$T\!F
MN('\843OX]21D!!*;G]#3?0(2/EQ2?4>LV,VI!K% &$=[_KH$93TI2G]22()
M[L(''16I12OWF3XC"D+!#L8XR:F>@1JL#(,9>C\CI/5\!"J](C'T )?QMP:1
M#Y%RX'/A(Q:V.;^!!9UA=9>-^8H>=IR/4E'D85<B8<^,UW/\9+!80D,7F6_B
M/A67%*Y7Q_VQTK8J@GJ;+   :$_PQ57P)?F!C!UR@7VY+^8()7;3)6F5M=+J
M1.8:XGSSYB7??[ ?$T=38_-+3K0L@4Y%I/9#9&EI=;#F5T69ET[5C,L=%@,%
M:'$#_66['?,PWH\348%C2@^N+ 9@; ^PV[O/PW%7,3ZA0*'E@0NSS^W@VA#/
M.W1?:BIKWY68V7KT3J4@YF>6.2Q(L,NN@*?ZT+:W>;).AFZ)._FWY)I\<3U#
MGB$)<VV6U-TL)F(]IV0"7DA',&[EP+<Z\$11OW:&SIBW.?^K$B5J74[^<\:J
M4&-W'<TA^14IP=/X7&6+H+D5FY6FL8L < G$+$+3:#K:W(:>Y$0JK-1T=BTV
MLK&]T.*5>Z -O2]V)1D<!O87+BE@]FN*GU7#>Y,1CFJE=+*8L>Z:5ID\1&^C
M+*>!;VG&!(H;CO6W(PBBRAQVV!4\T2L\G9FKEN<J(MK>M+E:+>9#33**9/ZM
M_4X@-&]OTJN!;1^W$Q$H=5#%0(E?LQHQ8OK^><<]>L$H6M3+'?+^_!R+:(-
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MB?J\8>&/*Y0U$DSIAZ55":0PA)BW>9BA6<Y3[RIVG?.%3_!KIY/WL/':- F
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M/"S#Y,BOL[6OM43P'</MC!JH0.A3<@NFPS&6>Q]F6&SDS<,EN5V9C;XCU'1
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M06%N=L".,M+>WB8M6(E-B,Y@4H_ZYEB()*12[\!V"6N=!N22UP._^DFP[DQ
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MSB5X%EO(K%<T6)NPUKY2Z<7RQY@Q;J46@G7KV"#X:@55-^=-/VRJ6O"V*.T
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M:- BX?<)-WRB\YO-&PTM)\+Z"(V6Y9;<QH'"G;S#^!/>.MVS.^5*6BF?XT=
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ML"@ V!18.!18M]V SM]B8^-@86$!_AIX^#BX=[!_4V(!</XU_K<FV#BX>.0
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M<7,-,63$M>KY9>%DJM&2P^SA24SJ-V:ZFG??S2ON_;"5.C-&1PQBB6JT4Y?
M-)5%VL]<6!847F2*RU_IN;9[N))JX7'7IF$SU+OM=_'),/46O-W18[-8E<@J
M%!3I>F-D;_]XX<?T:)]!H <?\^Z/FG9N04RKZLP5W?=:%HU8=HSF5QIF)3O&
M)37;H&^HK+ ";YNCLW).7Y<9+OWK?;,$<Y0 G+K]RZY@H\'#"4^/T7[520-#
M\R=+%&_TF *H_+C(N'*IPM4R8'X&.WI[99,I:)#7X8<O6A:%%ST'4'/?GIPU
M?$TCFGEO'9-5+2_A>(EP@KB([T:;X03[MJ',DH85@BGVYQ)+1_8IPNG(EL;U
MR)"6MN4I2\O%)'IHKTI\O*?OJG/M'4;#+%%:@/07/'+!M:$PX3*#K3DM1M>A
MZ:RTOHSD$^<CU'A"V^6[<MY4AT3>TA,S4FD7=)=3!E#9=^=* +!M;N!E?6QX
M/?1K\.-/9[.LK 6/Q8*OAE=3Y,8U05.&M9PZ#^L2\C3=HOQH04U3(S1;KT&C
MQL?RJ[[$%"S]9>&P/NIJ\Q6-AAI^KGJ_ZVD?.XP%E:\E(MXU^B+IM\=I:.+J
M3->S9W:^D!_QJPE'?I80ZN?':F;?%A/C:30;=D&[5;?L61DV^HI,IQ[ OUFO
MVF!6M>G1K>=/G]ZEA<ISZKA6L7NB>7C[7Y6SF]DJ&';<MRZ>MRC?>7&VE&BP
M:I%N*$DT?0L  I]A8H4#32=@]P.1C17L<2_<OD-+;!:6$D D*UZH@,,/ P6V
MD:SYS0@#B)?#:KD=>Y]E'-XM@'UC5QBY5O#M\P^KB+*/B] T97528N9EY[HQ
MY]8RI5@:N88EBTGE%P'CJ7M?JCR4C+#P&/M3[)##&,6//L]>&VP(7*=A+C/3
M^*B>UBZZ?8U;<VM>@G.#G$S<KV=7JAB:D035F=QBFW:0RLRXL6\N3)X[F=SJ
M'Y$NLP/%,7,"0"T:!N9"7PLJ+X:<Y*8QNK@.=9*\2J.A@%5P^7IT0#6\C;@W
MY6D/214)LISFSXS]KY+W7V"7G&M/$R9?8B/!IIZI+TVX=\H&UW69G1KRG-X:
M*WUVR,%XY]X35>-1FI->8&Z_ZO=NB2<51^/JD3ZSV52*#.;R(FPB(G&38$I/
M2GY+ZES0>4YH@W/)$27KH_.^(TJ+5/<A%6J,^!PM7KYS<126$6ETA89;D7YN
M>'&)8:+=ER9;^&P<KA?\=.4QT3A71LF@B,&60$L#'V?O%T,5#*+I\.0E"@8<
MIS&3%]4BZ8]"K>7AZS5AHJ8#\NNT05&LT?-E#J2AZ+4XUAYU?/'*)O]XZ7%;
M=.!5<VPN^\KS#^#LRU'Z!V.:+HW5MP Z-P&I6\#@]?OKS^MN6T]%8A[8<J:G
MNC[B!,Y[VO8B5$%(/AR[_'><%$H+<D]Y@&\+LFQ0O<9'S!>]L-1IPK$YW2X\
M ;^0P>6FI<6ZJAX[FH=;<?GSQ5^,'+!"O?17"A/N=#5B&-T6O5CQ,1'MGH3O
M=3EE+73UG8,;V+Z*F4DT\;TA6)_/BPP5(>"*\]^-BAB\MEC$Z<H,^K2>(>D6
M[;*:*U'8Y5+(&II;S=I(!;:6"VQ8H&]*VA1B3OK@&=7P3-Z?+X&;E=2.O".W
M#TNY#W<A%C+/5 TY6JR*&R*L[K(>B/UUI"Y&M+O6\;+<07M(IY+D H1Q3W39
MC*QL<^$B<A=C:];U?K!>VBJ(42)Y7E1O<WI&\*V?3?*^R'T)-70>\ZC>1F\#
MOM/[O&YL@DIQ1H+D?E,L7#U+2@-J:(7<,XE:: F]F%QF,#"PD5I7U))Q()PX
MOE4-G[K!5'>620W"6IO$ZTB1.SQ_A>79_=L8ZZ!^(6\"R:7'[K/^$:Q%;Q&"
M/_7,Q8I7\'(?-MK6-9#A&'X;>=49NAO#ET^7#P91@N!*?7&))'55L]=NQ)3Y
MC2PA!CK.XU2X!JL&E,K09*0CQ6MFPRD7DZ<7UN_K'PZ-PG)7UL+I'+O$[[3*
M*>V3WK5M6V3#D&LL+C4-1'P.X6W8$UH',V@48J+>ODVC[EI>*Y^!S!_Q*;NG
M@<\"L\5MW$F,E?$BTE_W]\;%BY%Q-7"%OHH"?=DL%BWRE2KWE5[(%OE:F(H_
M+Q=*YH$MK; >?@B1T_7RW.JA:K\"%\4_KFAZTNFMXAES"XA&OK^N%D N#'SC
M?O-J;1'NR)J5)4:D0=[\T;!#6^(+Y4BX1 GE! [C$&F<*V8O=;?.LHOT8+AI
M[4D687J"X5LV8&BW37]*"S>)QP\?0S,##_='<=J<'EY);I&?YE/PJ7NOO#90
M+(T=!DQ8@CVTU/-J;<1R#A042A1*\M#(J%J*OXUG.>6XXKJJ@2&7-GF^II$M
M6GK?]X88<Y*74UANIS5D>N9@CMYS*IJBPODP_S AEB'7( SI1GKA^W/[#BH@
M;\TKNX((9CJ#5NHZ((JB\B";_^SNH^DZ-D??C ;KGWNL^Z6#3;/0C?SUZ$T=
MH$*'9UD$%4;[+9EK%1@#::FO%_O&4RHW51RRR*PL7A=ZI$PJ5":90N&GQQ>;
M(^Z_^C!GUE(;E)\/ABNOFH;\O?#_.4B@,RMV1Y3">?LS:S,J6@*$B9ZG!S2W
M<GH=38PLY-GW,8*=H64<1;1(SYJF#-2]WT97WDO]$268IW#=B! FXK9.06BM
M3_,8K"K6=N2W;&BRJ -SHD8H8#,ZOGA>.8?^=@6OT/1;UVU^7];R&[5=U>,P
M FQPH^!GLT+]H>OH^<PF)SDX'=W7J*9UK"A.S\1BHF)W \H_!:1V;NHK=MDY
MBL)V-NME_7I4:[>ZH2>O*^X,S!<:BBY>:M9!7T[KDV_O;$.A(X)!?;JG(G=L
M]J[][%P,G.9>^<GD"_>T27R"@+=$]4#DPSRA-L;!TU5295&95: ((,+:^@ZM
MUCY[6^<TOQF3<ZN(I@\H1!(V-\@M^T&L3XP(%!\=SH.".^V;:]5T'TW8!7[$
M9ITO_2'LCG2^!=RG,N6/G9[]A@HQQF-9AN(K&783P$!2-\=T!8/EZ=@XN^4%
M<=.=%<PS2AN:.7M'GZ;B?XV5K2TS[9B\[NP+[_;E'1QZLICFSY5O>UWN6F[F
M(*)/793[)IO6.*N$B'1RJ5O98%GD9_M5%G67NR.^*\@L."1%;YO9ON;#0F,P
MO_:*"$Z&ZW$3W'(HZ2H6L&UZ<X@TJMO\^;OF2_UPXS#SI5DV8)SL_R?^?Y 8
MJ]4EOHS>9_;@,6-3LJ<;J,N/F\6VLW"SC*LL@L;@:I<0C)-E_@7E=Z-U+Y6@
M1I[GM:/"B6@'+0L]JQ/IXU<9M,]Q 1*@.&MH^W2FI(N^8Q7*[X1/OWEEVM_U
M)/YEFJKSLJKU]&*HTKD[Y!Y?]^_C 2L5VUJ^O?#UP-T:3C'.^+MWF]4S6<^"
M*(R$@K@O[' 66?4EQ)IZ*6X!OZQG@BE9AJ0)J_KE/=R7S.!&*1'@*BA"KT)/
MM[E&+Z/A1&,2\TU Q:K!CG#X^^+3)B+P,D=R<8%DN*?'@Y =>9@2^T <W8Q>
MM!YF?<A@NVQAU7C_?V[G^<^WIGM2HS-D3TN3%A-(6!]Z-6,.[:U[,[L"JA+!
M:>Q&+Y4%UWOS)"UJV2MB8[2*4$LVZ@DI\_:$, [59"ZRQI"=[@GJ)#QF/7A9
M>8\$!;2:@K[/*95SXP.\D=U.M)GC085-(AMN"DO<!G;12YSR!7N8P:JY9YD/
M^A U.(&9&I9>?)R%3Q?8&'@YTOA<KX&@;2)!U&TY,5K]K7R'+J^@14P];@EI
M;=T27^O'8_+UP_F%%^[KXVRON130T<5<9;TQ.E0)_Q5ML8A?S 8Y:J.'C (/
M>WQ_5C49)X ]'0RH84I7A@T%X/)J99[A8N0"'[,BI2T*)!UZ<)< /95;FB^G
M'ID(]LPOTBWESTC,_3]P)5IUK=#,+%N6&M)N^>'#DL"+(PSXUL1_!-3U=EQ&
MLW>$3T,0"WI)+IYG[29+4 UI"W&&6;@J_1Z'N6XL!UNZ"]>!'G*Y/*KX@6UH
M(E?:UE&10HN:GX3HY@$!1:KS1V8YQ=>EQ.)</%HMQ;$%O*LN:Q+%I5P9 4Y5
M9NZSD&<ML1CV4_9U%K4X?A'X/6&0<'_H@58\@017861K0&I1I4]*HD+N;]L0
M<=0TN:0ZIO0^+D:233J>G>0K.VB\)UCT+WB[_$@3:$X1$  N'QJ2=F<+?O1\
M]Z+%6BL-'. =MIU8(D*Q(E97/&.G0TW%Z#G,U5C0["S<L\L'T^L,V5Y\IV8I
MRK2RQ<%XCR91H@0XY_!AH%Y0[O5&!?3]>1B\K6-P^$'[A&DT+\H4424;EI8$
M>]\H*I7IM.BP[/?,@VRT23W\LI+?C<0Q;KV+IH"+-5$=I>8)NG^CX=HHV.5.
MI9<I(?:11^R;*U%I1=0:\2$KZQX<=B#1$GMC$G-I/&XMZ'K'MJ(ND47V@V^=
MD6Z"HNJ43YP$3ZVW?854&E4%??8B;[RX>Y6][1]YY+RD/?.+$]3((]X'?ZVP
MI/&1^+J:CF\A ;]:X [YLOY#D)O\#UJ?<).D5Z2-C#QA]FO<HT._QN@$^HZ_
M)[C'"Z ZM2K(I%0BNWW,^X=L5NPW!KG2?[ED[J>N)$EQKQ7QX4)^/MQL=E?7
MG!D4DBAM#6=V,V6DH$J,7@ _-RVSM<JK\0T_V2%]!@/LNBY;MP5V6<'DI.BO
MC#V8/>=F=,C"VV<9^K)$+PQP_B\1ZC4FI;DR#8-ZVY>6L.&D!I])$+ KANK1
M=R6P,L?'[JY%'17%CBO5J.('[4'-..X;Z6%?^VQL>Y?-I(N*,^TITG+V/:V^
M_[F8$>'D_WH)_TE(5[@7OB%6/3!]I<*@1>6E_T VQ50C&<E25^\Y+46/_?9C
MM;N2[2E](+-5\/8\>#$'*;CJ<+9KG'(VNR614B5AFK/M4AZZ)S$%%VB-%G&]
M]JQZX<PXPBJ[- 9V.R,;P<QT:C (LYENU-QY]'8@;F4WDN'=Z4QB?PDSJ!YI
M6$!6\$7;:ID-)09;D1FT3<?IW4<&4D@\-&_57]68$Z@<*E+0<;2"FC799;U:
M>/RQ4=FYPK":0P>/RE/!93Z-G@QL_N[K+,Q7TE?:6<0$6%$NPI^IC;ILAGR^
M7@1M) J/B&EDC^4X-_PX7^\/$)'P3N7.K'HNK/C+FG+_&R>A(%^*P#7N9-Z6
M76LYY[X#SYY0<6,:T,!]V 5=GGW:=*#%N<6!U![3O5%O*=0^ GTW:26V<E)G
M8)Y)VU7]E,=*HAL<TV+?_>/":&*;EZUNWXD#9.D#J9-WM!C3LP0E8MVXQ3I\
M#YK%2_6]2^G"E[HL0.9:47UWHZ,UO>-Y^(&XIE&!LIX#]UO>K\4H?,M:M"#?
MDK@;8Y-2&C-I](S&4%F96H2I%EO"7QXSX/T[W^+_S._VVXGM;![-SO(ZVD*3
M$1SV4<@#,'(:.M2$LV93,J6" 8VF%@[2"2,"5&&SDFU-W9[P!K@Y+:4">32H
M],&6UBV@61+.;G#E.K- 95'F?&H\]D8):6JX[/O*J]62<D:,6C-!J,PQ\=RQ
ML. ZV>*%1']@ DEY5G*@'T=WGSUWF#;9AZVK0QY]][*9SQ@$@^^D$>&9_1+<
MT)^/F%DI$ ]OXPVKYW.VMV_C"?I\M_LDHJ,9HMGCGZ9SB%(_IGM.S^N\WP>A
M,H5Q:J6\\''M0M?M'MCW/ES:&;.VD?5+U9ND>'NOC@@;&Q^:@'J7$+W%KNU7
M#$IN^A:^-3J&W:/S>_>7O 4X-]V0!-M0-:E4QVNE?# ^?JS;T==3^6I0>=$.
M%/H@BP?67(1:_\5> _UR0_(SL=5-6F0-I11!&+[%=?1$C1MJ^]8(B$!LP1>C
M3#_ V@:\97JV2\W_@^S%6- HNW/X O!"8ZYLPBO+0E60*5>V/.\6$'-IV+#?
M? ^28^<7?3(F]T>:LYBE/^TH7+ [<@@>(&I--6/L57O$<\PA6FT(A2TY9F26
MMH7Y-XT EF@VS[J$1?J0Q';51%>$$K(R+BV/!B*Y;S)!IXRM3BWF,1P94WHE
M-FCBT?R8%\FZ^J=55I=1W@8)VDOB@_&O^]Q16]V?8THV*)\?-C#> HBJST^N
MHL".H&Q1@I$*W</J;B)$P6*\SDC.^EJZ&1OU5;UD6]\IN^HQ:VIRQ&%)1I,I
MGT7JKK2#7KR3TS)IZ<&^-HW,YRP]I6^4M15EU14+59+4O,3"% 7O"4A$2+'=
MY+'DM4>,41SO[4K_NW&>/L2!D.@DH<MBL9C$H7O7G05"R_=.+*+#QP4N8;/V
M&MNP\1Q<ZM'^&^G4K%9A> V%D'MCQ"=<;M/J"D$;AU.N '*]8)S): U/1^W0
MBD\/=LDY?^6.W )$G5H63]23G_%)J(\UWK&EG\F6>]-!A58$43NL.W#E/R)L
MZT$HW_=J.?W>(@%_OUU37!$]I#W>-'^L@E)^<X:<R[!O6O)]KDN0S_T4G+(Y
MO943K1,;':K\;WPJ&5XJHR'5HH1.C3D_<N00ZI+P6G3'$@(LM. Q]6&H]+HG
M#%Y%O/0SL$>C/#H[9RI8C:)\)E'<5/F//4PL:KFD2A/NJ[P=HE;0MQB@\TH)
M;G2JI4::B.NHY?(<N;JZTBJ_$GJ4_@3ZZ(;J'4VO=!Z3H#\H+Z'8 #.$U2-6
M+$HXOQ*C'J,WN1'8ZOX!Q3_M+[[>BOV0J/E-Z)-II-)(-HUT31R=O]%]K^*/
M\$W](S_RDQO5AL<<+&0VD"&F_O<$IJJ%*#Z(,2++8GE+U*WUC!'M];[,I_V,
M@?<=RU:)UIVD0Z$.-&V&C4$(O@;DW(VAEY4/#;WWX;7M2CHE&-]^(9J#P9EF
M_Q_%7!-=9!!?T[#;X4?L>7P.["?-KQ.H81) 6A?=4A9)O6>E;/\F''"2_4I^
M_*Q9O;MG>B'%KQ]3NLW:<.?"0/;D^>!LMA$K=])PW(2EY.X_[@QA )XP&SE3
MH1(:Q/FA 4]<QZ\YO[(8DER$Y/+S#G"*2W5?3^7BOG8M$"BJKGS0V_;=F8>G
MX@8V$X JJ<*Q?_V4RAZ\W=6:'G&I[.I1E*(JG&I_(<RSI6.#]KL7V/9>2, T
M;\]?:9X-GE0%J)[!4A"Q&HAHU]<V+MLJ[@3O61BU:OJ]_=(*<=XE%=DTY!?N
M,(@+_A*:F?@KG^9I9)9ZK#5R>L9L/+;NE+N(%E?I]^B@>DG9/!+V']:O>-;9
M@5@_+3BU5"/8-R+2V4>P@,ZHB=Q ^B%D8"-*V=M^*'HM3I1;7)N&V;]&P447
MH\[J, VW8!^)?+_9F8 GST0(6G2@I7KXMD)E'Z[%;L"VH?&&+>(I!?NBY3N\
M8&DOI3O4D>LAI4,LOG2Z\2_+*(_5\80?;'1U-!5QK L@',:_9'0^%>#XXC\_
M%WG4,J75YR==V%U:D\M:)24!CG(?^+1J8*Z4PDW#61@+2?B'T[#OZ^_3S=)Q
M/S8O3; 1S[#T<NW_5)IO&Y+AUILW0Y)<>%(B"F^ZN9>6#O]6_"VAKKL7^LH3
MRU,?SB@_*JWOXJ_?:N3383#04@8**:<R352^V//F?2,U!#C0(;4GRF]21Y'K
MS+M[@JN[M</SD5DK _Y5^ W/9,!\^;#2)X5^ M4M_"IQ+M!.VGL&>LI#*;IJ
M?OE/D'YZY0XY3!\1U.B*&&O@?247NV:5CX^GB#T;^L+(J!]X YZ"J#!=K+J?
M@-TO$M.]/"M01[ZV^J@6&1.*0P-KZ/+Y+2#ZH>!";_XKYLTE>^L=46K5?//(
M6"5;JF.I=?1*CQ&Y\@5CZ^_H,C8'QZ?J9Z?]#/O6?@O0DUE\]&&JJ#M.,+^>
M$69@@N4&"X#A4<C65<'T,)..RH^X^7#-#SE=D=P#VK((6B8#/1I^?X+#8L((
M]F(K>.WJ-2N,UWI7)FW0_<-\RW<HX)\@UMKRO2?V!;Y[:2J+<.K8KK9E7&4J
ME_+RP?ED-7HQI$I4&VN,:YL6LL5 U9]V**-THR.:K5JJW0 &W2>:,O474LV]
MM.)NN;$YV!-5Z/H+%L'Y'P#O/#K$GJ/'^,,C=QYTF"KT0M*V<L 5MP O^9:
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M^&IMY+P@1:')%RIT"Z@^DGIN736Z]+C&-R(G'$I?L3#?!?"!"<6=40^6-FK
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M+8!KR4EYIB75ONFGX-"KD=;"!?$'D32ZJ=#'N]M/]:]*GRR*AYZLES55**9
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M.=?)UGC#(HO_X\F86/4]9_/]WYG.ZAS2[) 6''S<S-UJOA%#K_C?VOO.J":
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MLP* *W>4R\.9W3(Y]ED'J,^.8+W^ZW.&MRB=/]ZMQP<=GX8<2HU[SV28D'*
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M&R3L8(_E#] ?N,)?&SWTZU U577QR1C:U\]0OU8IQRG&#)#>Q*U?)O"2C"G
MVB(SM-\=UDSQ-GH.N=6FRS[T#=X/313A9 %>S?[IEE?I7/DYPE2HN&]4)CS;
MM''1F9FXI=T/<S5>$5"['%;@-^Z9_.)B=3>>.:3A1Y<$/M8K\_^N<J [GB-
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M.6Y&6/_@,+Y!-;Z.&D8R-Y-^%Q.]R/&E-Q9-3U'W-(-+ TS%<V<D]RE U0]
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M2 #W2'#ND^#<=0&:?IE][SX.#@[@3\)]<.\^WD,<?)R_T7__ W /YS[N@Z<
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M>PZJ8E4R=B/">X4?/\G6D#9#+ 7T$S7]42RXQYLKK$ORK -+2@N79!Q G$;
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MQES,D'!,F&9?6.DKK.H2^;+=2&DEY3+5UZ(<C/>[_6>^Z<#3I,D*-"];G5V
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M40;? 83>73SQ&)W*?%&R7IK_;%XN4$!R*L?CPZHEK9<S:SO0NK"%+:^*B8Y
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MMAZAK:%0G$9R<_*]=\I.\B'233B0MFUR\IIS]DJH5OMP/Y=TP8H3;.)!JIM
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M[ML]/1[A0J ;E)TLT=5B[MACBFD\CS[IQUO8< P=U6?T!EQ,XN@JED3[:_Y
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M\H D\Z'X__S:]?_FU/?Y?P%02P,$%     @ 38B*6IX>L-=38P$ JI ! !@
M  !N>3(P,#0R-34Q>#%?:6UA9V4P."YJ<&?LNV50G%^4[ML$#^[N'B0TC3<.
MP3T)[N[20#<>@@5W]P!1/+@[C;O3$*"Q((U# @3.?^;#J9JY<^?<.W/.M_/;
M]7Y9]5;MM>NMVL^SUKOWT_+3)H!875E-&8#V# "P^V< GHX!)$I^MJX! #0
M!@  D/HGA (0RMMYVM@#['K^B: ]K0$B 5@8&!B8&%B8F%BX6/\\>#A86#AX
M^,^?XSU_CD^,_Z\0XQ,2$1,1XI.1D9.3D='3T='1,_U/T+"QL0GP":B)B:EI
M*4@H:)G^__+4 R#!02]Y-HV.1@)X1H*&3H+V- #(_2?M9^AH:&B _PD&YC-T
M+&PTG'\3_%?0B %H&&CHSS#0_LD=ZQDN .\9  T= Y.$%(N%#,A*CBVO)\26
M88!CK3!;3T$I2N6=.I/VX_6<KQ]4[+V^#8C][7SFQSI(N*(PAXAA^IN&WG-;
MZBV?1BZ2_\=,:"1/JP!\]']2(T$G <@"_NJ'_5_^+_][B#BW9+T%;8RT<CI>
M.9B^>+/=[4*M7"F@&S8(Q EK4=;:=;![\^ I=DLKGWZ5S;/;&!N;1QE!#@(2
M+D(@"+V#8Y.F8JXWY&GW'T['U-T)#:6\@6!E>Z.! K^+]GKE.W!S_QO&^UN'
M741]JG?'',2TWKQ9X0E@ _K!)Q36H:"$689WQ?6."8-W>0;C_P2,CL=$QT.P
MA\',ASLB33GYG8VA=[>GD.[Q1=G286E[-#3L(LC+8/]JMI05Y+63/6A%DF\J
ME.^52L/"]5QY<HN,19MK*=[G6U#,!WP/:\@(\FQR3^"65=S!&3 JEOQ#JW-B
MF$G9X3 B,^*48H#]1$> "6Q*!L09S,UG=-=L;A?L]E(M5EGZ.\^0++V?(T,$
M+Y_< W]YPXZC\&*;@^\#VT'?,R6"B^[D".;[GC^39/G>R_7+H9L+*9.LT5"2
M+%#BE3>05-3Q+#1Y\X#GMTY' 3A['R+.%Z!ERIL$(JURDV-T2"C WUIU;(U:
MJXEXQ" [MT!:"P6?\O9M1@_O HD3XT'4$7(*0;Y6G&)B[\H]2>P(W5'X4MKJ
M[SF)7N9<NWD,QGZ]R9/.>S<1TM]LODX,$;?L<&2<4.U/0$HE+<.B.](5E>R3
M)!A6&E+*,II^5==\%^"[?+P[QW=P&2)-U,QF'7G]"XK/;]@TW>Y:0>.!MM E
M"3Z(C=\@0.F0[S7NI^-:%0TJK$$2P_S=^G3F?K$)=!-1+J3XX>#@2)VBG5HR
MM&?4)4PH"A!:M3LDTF6UZ3?Y??(O+*V;IG[HE+MZE_Z&,6:JQN!,[K^/_%YH
MS^.XX[MQ8\NIDJL!#$:M8\<G0.@M[\.$[1U?Q*(N,7&HV_YR@@%7'D1&K[?U
MVD-VQ)I5:I'T.(),@QM/=9MA G9Z< S&;7Q'^>J-3[7.B$1V$X(N?]_[5("7
M)D-LJA_0_HI/;_@9Z/BH).?]A^'))T 4=IO:*5$C>G32Y854@'Z.DFVU$*[Z
ML3F&--B53;9?A5PE,VAK)!^(*J9'ZB$]]KS-O")X<N%(JR"RW*S(9^?U]4XL
MC<6&[F)MO$SV$AI6?Y<FO<N&-OJL6R6*5 @4>= 7\R0^Z+-8P:"KBJWY*N_R
M?I+3-V/>;#\!.".R'?U/PC^-^S]"U,XI7UTYT[UF#7MD?!?Q!*B[ Y?\DH[<
M"2!4.77D'-OY'DB?L3R==**RT*2#.TB>6';M*>A:]IO%LCQ^K_N,58H7-4A_
M<4YH3(^]5G#1I,PCNRZ6F*/Q-RE*[KX-X@$:\#;N HZZ]T;N4OP@'0NHR>FY
M1(^I35=CBV=,FCK_?73^J@KQS%]"; ,$'O7O^C1D]>F7Y\\$,ZLZ^P'3T4<,
ME&+[$P!F&4<4JD1,'-#=1)U@81GK>/Y'/=6\3"9(0&BQ@%:.\]IQ>R#L03;/
MJR_@MW3W; OP,%B'BT>F]P\W@A_.M(DKPK0I'S(H/8Q\B!Y!6K;'[1"+-M4:
MHQV;)N]Z4X6P$_U&PNP8])_]=R$"W6#?V((?;48?0[ _,S-?>-K*WM^V6NZY
M,LW8,6;G3MK4-I8U9M0NN&H(^T7KVWBCQC5)ZL3K3Q#:$Q57\E@>GH/6PXPR
MFF$BPR?P9/&;X3N3+*X<%D1_L\_06D=@L.Y;O=MW:Q4SY L_CM_VE#XK*/E!
MXBJ5B/].U3O&25]FW6\&0^"56#T-G81KP.'O]J;?5RGPS*S ?N%:-9E$XNR4
MF()&!P>&4"4&_LIN2O@J_'Q,:*E*5!N$#Q4>#+-/XG3??'927T8U\028CDBM
MN8^!(VM\GL^?G<W"C267A.K>$'&$ 4E)O!.'B[W%=!WE?TQ)W-@F.NZW^;S]
ME#<Z2#]G'ET^R)^S2YG!U$G^"C'ORR_B2W=\4>,,,OM<";7HW%!,X'?1XI!(
M4M_I692JES*U#2GR+!@6W.Y86QF]$EHA%'/)-"G16QU3LT /B_DBLZQI=?Z^
M",DO!I+$\W</"M H&M$F^80M,F)PJO6#D^ZU(5/L</_2GFM95J>(O!5]=R(C
MYZ-QS= RPBY=/G3F$(T\L]BMU#2WR_7JU^, Q0,M', GG=^A_&+!^P-PQ&TS
M['O\Z/BD@XTUW5'S>6&*H9KMJH!??&-^7B/^-9\MU;=Z?HOSH1ZZGZ/>MPQ-
M,ELS;<WA>,\1S6L=_,^G%UIUF)+2XG=Y$Q1FY.97!MLW]*PH8:(.2Q7=RH?A
MX*#>DWXDQTB2'6,Y:0*H71$\0I,O0?B[/62&U#H$%^ZY)1\1-'92C_PXW&1K
M N4,G%9=. &/\*JL>Z,Y-5.EWKI,E!+6,Z1\2_V(>>=P\?8' 1_GMAR*?;7^
M1)34\^8'(>]*]V-_WA- T/X)\+=RVA>1G^6] 4P*CH9<^1X=-8AU?6$)?L:]
M]EKH78HQ=OZ^^!. [=;L4$V&OZ69L8IYZC6/B^A?,.?20EQM?7,9Z1\M1/>6
M_.'O.W?U! I:9S=A0._/VI 1'5?GEHE';]G!:=7_]N:Z6S1@489--XFQR!KS
M!#""U#2,O[HZ?4@ZD.:Z:N)] BPQ/P&N/CY\9?I49_G8BOT$*"?:E=]]'*1F
M]$&D/[-YMM-$KVII /7VJ#R.F)40>);-TF/9M^X8N+3%K;4V8)8_:OL$(*:,
M_!F5XC4O_77D3<]YWJN4I$D-NLS@(8^'2M.J*78(?J2DV.1EO&@WEOS;WL[,
MX>W?-Z;)^Z9,_%*)5)]O#C7\]]@V=DCI??)[Z!ANQ=Q,*YCOHV^P7L#$!X\D
MJ(K6T7GI"SHF5\ $;,OABDOP1O#A6A>.9*CW2:&,Y0A0]"*1?#GPK7NOPS>)
MA$FH*'0GIE^KFI!1\C BA\A.J"M<BMY8M2Z'>-)T0E ?C4=)5<FYCT4*HE@>
M8M8,>A"6=WQ_TYV"M-H6_C+2[_*%=&2UJ*%\8'9$V>2B'\-N?)R?&=80(M5N
M6HK3V/EM1^1OSS@$C<^WX2*+JX!#PI/@J[)+5[&K$I:(1HVY)A/\-_$;VY"(
M2=NSIO.MS.CQ['/A QV1TCS#:!=H'HP6=;);J5@S\X"+F7GJV/JJ2$M6D/YL
ML-BM'/9MSHJJ?*'$HT?!X?PNT:(^)VMVK>*W)*ZO=/<^Q7<(/OT3H.34NV,A
M_^9>5'E%<]=K0PY75)QPAE]D;6GG,!P>>^9A';NYXL90N=FDL!]0!QFZ-(H+
M4Z/#\!Z"FGT&4AWMA19C4#S.!=F.BH>TNZ</&Q93")L8#,V#&;[:LWH@V[4J
MQEI>-;"%*.XE9V*(_XU.XE.&%!C+WL6+,=>]3]-%1:G/?PH2.:26R2]U3K@%
MR487L^+%26%GF(XX@A!QNTQSQGQZ6]][DY)T*^A?MN2I/5<)P$>,/0'\.HC?
M7A0[^ZQH<_5YB^R5B13Q$ZNX\3-\+2D<*OY\P>"89'T9D#\^7*."G'?3[=4M
ML[/!/9(C414D_T(F3IB'IKG+F[PEMK2K%$"%->[SA]>AEMZ09#GU,D""#R*5
M+SX;:=?@L1ZSIEC/68PU;;I] )X4.4EBHTEUVS 9Z/B0WAY0+T& 7[9T[JKP
M4\5,%B#:'34-Y<;Y;R-+#2FVDEXK3M\]?MN;<5UI7B=,AAEWS$7_(S461!ZN
M-=W%%U]=L3KE7/\;IQY]7+HS6X+C:X[W_L_/(<T.(;T?Q]?$P,VS8@8*+6SW
MG?<#>]I24'DJF#?36^,K]T#1SHTVEIKI8N@D^F@+C':T=_B["*^81\-T/P(7
MKPF(X\&5.&YJZ/C[HT5'#/._ P0235@5&_[/2HJ<W5R/MR:/HOB4DJ8BJU;I
M7-;18H0C="JK[GN8%2@?5C3^2AE&C_>*8BS[9X/:)O.>YJ(I#A/*?C8)K&?8
M%<:Q6VGR".V0&90OT^\VS.""^/6LZAF]CRXKA=:Y51,&U*IV%QD]Y\/7=VAH
M*G3!VV3K>ZN36ZYCEQO;AEFW!V9N45KM[OH]Z&J\(80_0@C[87=J*@I'EPP-
M\I5_F*23@3B4D@=;=OZ\C<TU]+.M&"4&7, /BI2"/^E<<>I].<_E2_&SVXD'
MW$1V6F;=4CCKZ($%[C^,XV3FK1E/Y$H):ZIO.!\!4RR%M\0<.+57->;EN@7
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M#09T_"+"MM-4(R=)K*U2%#T?!+:Y.342;W%>-@CXC,540FGU\?02;JRSUD8
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MSR"9//<S>8!'T!?\MS$;IB#J5\*-JR_Z3D%C@ID.*2IN>@TAI6Q V!,@MO&
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MX^/6%@KU8##F[L6J6_NHI_PE786$S)I-1B4U?0Q\2.!<1V^RCQC>Z6R)D-J
MVBTNT_L6SJ9M+T8QA6W,_,720+8E&( RENR_)BEE:\0%OMS4VV"MQS0<>6,L
M&%;I]0O W9ES%V>OA$NSQXH)P,?/HA>,4*1ED^YG[#X'-U_.E/ ZF^533&?
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MMZ[L'2MV;V5,7/K(+]/R)$'4:5'G ZB*"4#JB7096(P%0D?VG-3/R &-]OA
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M%G8)G*EDV'3Q3)>/D]+C;'9RZ8ND4CR@5F^?UCI[,1:"W>.X#W9U9 BBRO(
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MI$$5S."?B,>5VIZ19L,<X3_GUQ_T4':V'IXX9:3?UPC9^>9P0&_R1H;T=Z$
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MX1EA=V>,D,G;<W-:&GJRMFO*$F2QNOVVN-]>,%K->J!'6XYF7#V[4R\<:WE
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M72A9]<<T^&5/[I$VODBH+1^?2M447]/BHOT?T5=!_UH8Y7_0[X2+=4;_(+9
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ML?,I;\%((M?:%_WM#M!:WZB-M:M:QB;PM8_O(6>Z%D:DZA,FT ]AO/[@CAA
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M9SMENS/J_G+&-6E7+X>=Q.'V*/1>F"VBU"9PUO]W:=0(Q='AX^&3U5]/F?1
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M,W<%DD.8//QQN1[$,P0;JF_-\/IYYVJ !X-46'*(ERE43N>._]'-80TNGNR
MR[78,S*O@GS@#]L*?%-!E.H/M[2;&!2R@KY/*2D38\Z_P;JF3?R+\='D88!Y
M.^2$:7>.[O&$<V=3L8T:$Q,OX0_ZO5VS_%WD7XS+!<)K;#RHS\2B 63],KA]
M:^WC!OC:>:(YIM-V-7%_'M^&*$6#8B9Z5'AF/EO<*[A-9NP4XH2J73D,:9Q$
M?LY\67@I9.0N)L'(I,K&CD>E\U-(-+ZWR=)W[JPAO_1S9&#D4JFT*U!_-67:
M]FCM6,N[#[#9;,Y5D$S[Y+FFAAAYB[JT2NL*%^]FW^_H72&*R?(4AN!H1QR3
M&R'@29<B9<#7/J,*S*<NP0WO3AI[ZJ<&X332"8'U?K&T0@T>NHE6O6I\7"X8
M,LA(@+SZM5C_3ZJG<.?>IA!IBY'RB#0FQ(6C#..R/7.CR>;=W?%"U2SKU>2&
M;>.2&-&30!/KV(VVO-.Z_(4/ZV^_Z1CVU=&%UD,2$@1Y7Z%7W#I%SF3Q2Q?8
MZI-E3!M;7.94ETX*F6.=HL]-_;-S,'NR6>Q2YD8,1S.Z)GH-\ ]._.:UMX\U
M%B2N#Z'C>8800D;P\=2:*=)JR_2J9@9.^%B&R_;#T#F@A /K@+.(&6U2Y]18
M53G.)VC4X:8ZRUXG7P3MJ6_PG8%W*\G@L=?Z$ ZT9;!G8N!^[GO%WV9\SUQ<
MW/.GK]?R%U"'(3&.[Y/C&,X9S(,*[>]@(B2)Y/Z3?!'V*+;C%NP-<>B7^(O1
M_(K1\9#F7,C4R1N/3A.9AB@:C^<*5I(6&6< YQ3(:KT(#,)9^*77O'FKXQTH
M\WK]R*B8&/ \&! 1ST-C-H &IXO.JEKR>;M/=>LS7%-1'(?[E VE_7DF]I33
MMPX!'\(I2&EX0BFSXZB4UG[-R7PL;K@K'< M^JL[\(>^0+Q2/Z[E@0W]5FDS
M4TFN!I&)?.'&<3 FGDX52Z%C;\L;[%@&SR7TG  U4/*YI?_YZ8R#2VUCL8RG
M+"544LZWTA>MN\V$@(<1!KDN:\ZN9P(_KR@@M<-FWCH4V!?UTI8_9_/DZQ*_
MOIRX?%!%AYD3(7Y7RAC-"UU_)U>XHZ].(4=^AT1*U2%3Z#)[^EX.":.V0#_D
M7U+<XH2\C@TL3>P69<BF/:%UR=?';"12ELOCL ._I4UJZ?&.9*6\D%?;[ZTJ
MF.Q42N_NNTO?/$$7M 3-.\\,\3VMT-JV&L44J54"T/R$98DG1-7E5\+EW2]D
M[*BS?/K?7[TW#9@5RRFHEO7,%62PKZ7KO037N C:W?66UWK;4%F CHN"X%$Z
M!LZ&R:/T@0WYM8!_5LRLQ#G+HN>328V<6/O(\%\_X2%J9,?R!_I(<$,Q,;EH
M:_';\+I:)T=[Z3>[Z=+-K6 M%;%,V!3DEGG'V9W1/ZE+G=9J8(#$5,()HAFX
M;E"<6['X78WX@]@L%HB1A<U5V'%8EMSB--NWF?S\M_".;4;MV'YV>$(+=AA[
MQ9M YXL\Y\*$P4,P:9NO=#L"7DK=Z>_-SQ<F_3)G#VR<TC^$&IHB3;PYW%M,
MJK>6+R6(*)*GF?I"0F=.,'PN+#L<[-N=<SAR&.XN7_IYLIN?^1N!)ND6,#7Z
MXVO+Y9(_WG/?R+37J6U*>P4O-\OTV2LU6_'4HXO\S"5Z&&77-WL;M47GOA%Y
M,?J/"+;"=YJ,XB*ETDT^@F*;!4634@_:"C(I(\4$)7J>\3$YI;6;+9-#.CV8
MO 4\>+5YJ#<_DDF?]&]"4=FXN((W[!4_;<<!"Z'/3OD"G+Z0YBW5CABMGUL+
MSD#K/'EXO>+7..,WX&JS/1$"?S%(6E@5>Q\OOI.)=8P&=VX &.3X>T(BK]RD
M(+\^'%$WKS<S4.#G%FP&?&PK@E[05)Y.X'SU$/ \.K]5U)(YBHD)])SY5*XE
M0(1C^N&I!_DA0KN/POX1&CQ2N'^4'U0X\&>#%R%6/)CLPQM/QZ=+(]/SLTKA
MF:"CRVG43(K/G^V>1T8N:5=GFTVUKEUQMN2>C*;?2<O2+V6$7.F(=!##/=)>
MXUF%W\GXAB=OZ/TD0Y3/)'%)7YJL6J]%#6]&?#MT9-4C<@D=!:=LS RT<TEQ
M-3/]F-HL*"/7O1=SHH2 4"@&,09"%I],A=3?+]6(PY6V.=B@T]X072;V&S>_
M/[S^&P)F&6<>G2G2(MMTI!.SV8W1?=U_,?CU\-L#)9V:6[TA,Z>'8TV3=@YS
M0U/,W<.&[]P#4,"?U(IXE2R:RCI_=I(AL""?AQ_YES;4V7DB1CKR[WD%[^'%
M!)KCDA)@V*VD8%9="*CJ TIH)Q45\%TJV=&&6-^.A\(_P'X;0E7KM+ZH9YR_
MY=\H)B?*)T@_/K9O52<I,G6-GUGMNEL 2_;E2&G)Q],VPZ[8D>BT+&@R:%,:
MT6E-T\2HEFX-(Q>)!#..+H6SWJ<0R,WNWXN5\9S+;5KOF56__<(:8UP,I+H^
MW#,GO%*<CA"L)]U@(X[??/_1D.,4,J4_J-=DH%HQ(CPM%M/7YVLICIGB\L/^
M48EV[SQ_J]9\_^S@[DF%I:RZN:#$=NT_"I_'4W]\L;'(NAUWO+_>ET_&&$]-
M*=%*8#DW]05H2!1YC-M-XT/E-_ SRLC&4LR=$\_':O>/GGW_^3"I6,^X1<V;
M&/RB7*5DNDR^)+7E%)L6::@2T,6=TF-J%4[W.Z('$A;<;2VW/1\LFWN<A-%O
M<^9S4R/B07#L,^5JY@5)/?;O.T#9-?H()^-O@A,S#2I4&,QV<&N8W9M%0NPH
M?/GD\(5J1_V6J,RJ]TE?Z.-:90+6TG,&\3,=V.(:G"7IA:S0_"=?\,<#4WN*
M8Y[P4*GPKA&(>I3;CB!ZS':_^ "&]HBEHL0-;QWAK@>-M-,BK?Q"D/U(" &C
MW&+/14-)=VW\&IX87O"BJ1FYBJO;[5**]7J%YP)O1/H^ZGO]X>IYER>*I1:C
M1=42>"2/=^82=X]38I>X+MA)86/GUS)JEH^_F;[\H9'..4JK(<R;]9\S*O]C
M]);;EB2-$K4!)_?\+<_PC5>*3;5M-JKAM[2--%V>)Y-%RCJ<A#_PS:* $_L;
MAXU: ]MOFU39U[YJUE.U&A@]H\2V)<L,K7I:*3EG1A7:V'/F=#R.LXQ&T#@V
ME@\5313I^.!KBQ!4,#J(W$XW?;T*>K#.'#,7,&+,K\:;:A<.8 /C6?DKB+4<
MSR#_8MQ\Q_=O=Z<12'WY\_J)8AWY&&^$,&:<CC(G<UAL71PO<,N#9=RBI!V?
M]X[4\U(4</Z,+"!4DR0$RL=(N#-Q:#]L&@Y:&.N&S#SB\YPQW)#X;<1X!*3,
M<U[6 OI-^K1VL ;8\%PD.>);PJC2CJKZV>>WEZSPG09]18'NAKEEJ*>3#!]@
M _EN&$\X_1F85*?T 4.CMT4P_9CK F=+"1O\$D%H+:<CXQJ^1&^[+M>)S\S5
M'0A[&&$WL>4N(FWZ%T-30R1X!.WS6_ 3>J_PH&J$_)7%SBM(-/SP33X=KZU=
M3\*WVOEP<P)HP@^/>KM"VM+3Q;,I?=IL3R')"KZWZ3VGHDF^1RW'4'=.6G<^
MH%O[LG([7V%^+:33DYB?2?J8%M0'_=J=A H@CCO2'">N:?WIW6-SE/MED]6V
M<&]*G\E/AXDJ?">HE#;R*ZD\/?59'0EW/EA1J%\8G*5*CY\D2/I#W(S<-PI?
M0L<[NA?:7$W9"^7N?0_DLH$FQR?264JRQLB&OTS[H@.,U3;]0NR72T7RX89)
M,J[K51@P0<:6"$\SGUCP)L8)X]RG,]TH6R7CETZ9]#0V@W@38-C%(N7TP<"@
MU=?=QWE)<G>>)IF D!OZLKG/)!H64EG./(6J <C)'P</AQ#&!YG1G=;,YQ9+
M] %B+)',(A$ 8=*C-M$I?=#]OZT4U4;K9IMN2$;LN%6IC/NF,J?!+UHLGRIL
M#IN:Q:I-K8;!F;PE;>[P:]-OP8T[R6N&1..^,:WY@/-V][YAEQ.10$;Q"X?R
MQI%]./O*I=U&S_U/8MN4-*2TS4O?%B_"F7XGD%.['?]J7(]VR=QYQV==\B3Y
M5KKYO8Q#%)[E=R@=FW\PZ"_&1!\6@\BE;&#*#9,NV)MV(AK[JRRZO]M3&&?^
M0"\@:2XYSI1P*$R7W?TOQ@Q &X!B8T \>QK/^ N$=BS+=_669)_L[&>Q9Q/J
MZG\UGAF<2J_NL?5*XR>I'E5*([ )SSWGT8DRK.P&Z[,55IC5=QJ7^8]L&5%
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MZ]H1&NMXC-PD"-$-2$5D-BXW\JU7B^2+W.F!@^#$<=:!RCFM!VMN/-];?V.
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MZ9];:S(G35D[R@L]037<LE^'*<^VT/1%R9L4>-S"=8$,SW&<WPQ_<F?7@C=
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MBQW;8G?C/HD;< A)4EJ1N3?6!SD-^6Y(JT)\SMYFL+VFLK_'SAM06A\#>%Q
M21:]5JMNW]_337)-H]+:,'$I'55$H3S16ZLIC!B"$MA*XA_S#^D7\U9SS/L>
MT8RI[]<QCV?Q7#(=& U.\*[;!93UC"U9_=4%5TURU(7@5UX@FB\=^<6EF&0,
M+OK.*G(ZGU0!SK&,E)-H$8'RXO+&HU5M@[H U/533'^ DNW,O;,$?F7DC);$
M&KMYU-!7WFE*) P&)=MX('+XA#3)>$6:,3 SS&5NK$*?9/V*'H!J)B<5IPE
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MBM^Z"M R'1WL?WA+C;N9^ 4K+(,G$V\&1JB387E&LR"&%Z>>EU?PD.2PO^Y
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M[O[(!]/HL>Q_TWQFDM!BXL0]AZ4L!A9<4#)6F/0'DXBU7A0^2;,QN%>/2A.
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MFZP2E]0]VF^QO;+3UU37$,F4ZE>P9%$W$]%4KP([K&+LK-$=G*2\%%[Y*HF
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MEHFZG??TO#]M,;H"S,9T#:#O/SH-X']0=;5P8$_;)TBMBE,:HJ$9Y$1$PU,
M,76!Z:!ID/6%PGUR[!*K;1Y)KP"</[2R"^R"%E.>X.+GFC78Q,S&O[G2#?C
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M=UQ*'S=K4$2*;XS( \L_@-]!C_DFZCZ<IG5Q&*1O<[/^%.T3>L>582'GO)J
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MW]CS]KO90OFH^EHJX NT%P?CE/NU1CP^Z=I,]X#48K,.T_GN?.TO,8CE@,K
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MI;W59RLHX$YM:^[7,*+-6;4LQG6$7>"&(":)D.@A2[1,"IXHX6%']DG;K8.
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MUD B4V[BPQ&V/$@@3.++&.-B]_N#=$]X??O8VA_6YL?MYL7PQ"X]N$C OB:
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M->2&(G33#.LL$/9DKJZ:>R)9JF8;+E?SCP!&HO:\1"_^E=1RT9;0*"Z(#$F
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M\F,.W"/BBC1-BK&]4\ON23> CU4COV9]E%BT+_&T%A $ Y?;"\0/VQ,ZX@+
MCF>7MXP<P-V\UF<P-0.7;X'Z;<?1 #/*,/J7*8FDQPH_!RNK6S]MVT6GZ$PX
MSBYS DEJI0>7?R#QPIA1R79#SGCJ\!JNW$.X^<14;,C25<A*26NG<2PJ=,T:
M,.&H/N_L6Y*)RQ1AG8ZON2^%^$WL2#BAO?'>]Y,2/5FW!].(_[H&&S2+1:(C
M/F7P[TMG[Q]^8EL.4R_*!>+:)!-$3CJSF^>Q97V+/,=V6#C_RFULMZ$W8]HN
M<R@;75DGYB(T)[N1EC%3\5^'!8,3<$54J+!&3M^]MB4T;0+P:V ::O]":'&\
M=.=;,U/*B[H^_:3T3!>JY1*&3.L&+-M$(VV.E83\1%NCYU5WDZ(%9!L'MU:<
MP[\7O$^<V1(8AVU5!<>7H_-_WR(*MB-Y6"P0?=@7X3:[\663LP1+IN ^$1)!
MQU-*Q6T[[T2.$;Y[#=!XTEA-!8<->94;]Y7HG,MY[,  S2<-!89=5],7"+.!
M1$$ATQ IH;T" >XB'OWF%,&SQ8&*6*!U1WG.;:+[N[\B@@PN^-<^$33R%Q\;
M6E_$]F4I6GN+J^67_2EUOY7@9*40'Q;(=+:1<9)ZD\S+8MA&-K6<==3*<7+L
MPD2C;!ETUR\M)7P0.V:8YIW- /MXI0]XC(M/,F5$?\JN0D)=-9]$FD9TS>XO
M5Z6IL-H8Q/S7=:BGS-F]FE;$*X<,L[!76WE,;#B4!6TYMC8X&X:H)44-YE]N
M> L&?"='^3JI7[TUQF/CGG@4-NTE\F@@T1#+XLN\8*-_C;R2>!4$J,Q8'-&D
M*Z^!$R@4NC+"R+*+RGMWO4:V4%]OQE%KNXN;$=BRZ1<Z7Z5V4QQ@1IGI8&^+
MBNYO?[IV0NZ$XOEQ;/V6N%<]F#I[^S!7;[CNA+F&%R>ZKG(Q9ZUY1ICUTQ=6
M3!GMJ6)/H+ 'U^-U@LJ%<);&!L.<'5M XKC-\WM*;LS(EXU4W].DH&%X)]:R
MG*3^3B4<;'R[I-9[+62IHF-EU5&CT'0O/A.G/ ^CTV$>IE(AF\'M9K!X"$Y2
M>(5MVL#)N@(SC!81^<(*U0@#FGE'FC^H,,CWOU;%J*WA7M0IGW*1JIU>_05J
MN!3,%%C*+"7XULC K*AG%(0O'9/*9XUDETR#5Y2V;4[$?_U3L]4DOLS8;3-"
M%X3W0K@$U]0UZ>.8EEPSV&9E\MR#L"KY]44-%%4EH&=?UI#5R>W?E$[G"+RS
M4G6?.< F/'<5<02/U#U:FA!]#,!VQ_5J%>CPRDE#3,^7*^\&N*M1:36*VUL1
M<(L:8#A>(DM[+7YB]78\Y@2;$5BD_UT8CC*E*.+/H3XOM I\(57*A#!M?BAR
M,X<&;I;MCG8PSZZEGYA<&I@D1B,5F2M).^!TB9J25P3!$DY;X5_I0V':EGX:
M%N'KZL';"X#@^@Z[Z&_MB2),&9-C9'H!EX[7?^IR?8K&O\*[74)_0W@HJ(X_
ME J=T.VG:FV+!ERY:8UL.X!FZ_J@BL-C\,G4/EO*^828%]M(06;J0)'T$!V7
MCK;3QT@46/C\XO06B+R5\F4MSZ;>?!F9RR([IFAJI-VA0J.&=+CHLI<%:TG5
MG1]$:,,"WU+LURPHO$AHR4"TU)1AD&'UX(9M_MC@]TI4BYT\6BYE["%BV;NV
MY=)R:111>0OSP/4LIA=V?@D<U4;Z-6GS]3_3/Y]I23 *[(C7.C^I&ZNGC1GB
MYC18'RT%%%<NQ]>\(\$8$R,F"@2EW]_6-X7J+HG9%ZA\EO3\*[HV$67"^,%%
MRN/C7H-E\(R'E8VTI5:W<3:V&,NVKG?P_M_W<_B)F;9W3AM+_1\Z@=,$X*^C
M]QJKJWV+X.0^3.-:^^,+PR'#80UEW*:_<OR&E%FC. TD2XXWQ!3_T#K^TQGH
MPQ09>9S$T][M^C:9\Y4M(>A67FS0*6N7@2*IR-H)P_9.E.:N*Y1=^KS M*#)
MZ\S^5(% +CS Q].H!;O%#@.4%-[^90P/.Q)KE:='VAQ[?L)IV\W&BG/QR':H
M)6N_CN4D2G>7A)5R'P-HBVX3FIM]-8VL!LX1%:B9DJ2U<#58NSQ&JWGI8B]$
M_N@3;I\PR?UBH2R"DVCJL>P5(E$$RR@(,C;Y:S:LH?\J^]@',)WNF8#?#N7M
MENX&JP<%3]ZMA.!4$V(-!\@8"@.^LKR@D@>/VI8WX>;[8"")8498Y0D>>MRG
M][<E$A+_*Y2/P;Z@$9?1Q[OF/AJ3_\*O+S9[^U(5?30X":1/)1ZB$<'FV)Q=
ME1@JK'-<VK\="_C3H\5?B:T[(''&V1/@I,-/+Q)S+<.)A -$ 87\+)3V'J8U
M*3<63)0[8L*G0Z3MS=YD)C*HUV#Z>*(LB-S07_TQBSBA2KI,D1'<H1E<T@0=
M"D^E\I>LL^W4;0L1(I\%8P8'+(*A*3<5CF\C==5 ^NF1"8XJQ*J?[6@?97!8
M/V2V_)PV@0@0IV.&E2>6I,0,&H4KD]+*Q+C'"N01#Q.^5F;%O(>F"3;USAP?
M,!*JIV?'H20MYY5,. 6<N1NVLG8232T33F-;["CY.S25%6O>AU,@+8RKA['(
M4SH,&# .$;^WW%H*JQ]I2O 8P]%?HB>JTF:9F6<O+W?1*+ZAFC",VMZWH!FP
MHP;C'-T'9KIB9&?^2OY$,LRE^$09K&O\/K!Q/MZ(\62 4Z@$BV90JW/\F[(F
M,\N=Z0>J5:6UN.5\9-\S]W>B&#+0Q!"ZIE9S]G*AP3WMR[XZ-$GB(?0M+L9C
MKHG^->/<PW>7Y^Z,)]';#_8M+:$YOO>!0#]K)SKEQ" (8B)09!]T?AC>Q#U2
MOY2+1C&J"L83-S[6U%5F-C7M% M3H7'YAT8E@+,@;DF7S$'X%B$B[U,_7YV>
M[MI,)-G4R:>-\OO9)-G [QC!HOU^R,W.]6.TEPO:C%1JG@K 6QB,Y'6W)8%8
M+/PDGPGI):/<WLT+#6S<"*=YWV?9RLWUB9LF2_4^3*',9)0:TAEA8/?Z?+E&
M.; \SBDN3T_SXS'<!M>*-9W2++(T"ZT+MP>'2QD'LPW?AAG1/XA /)CV]3(!
M <24? ";=RN2>$V2@FTQ*G(Z^7N4KK2QG#O8L[1?B<,V*YU_D62>-#0, "*Z
MKV6_FNNJPNP:P.7=!C6\-'-B_5, \U;O'.+\%@K0YP9.EXZ6Q1(\DGB@-?$+
M$NPIJNSL[)YH.1JFN%)H'6T0_Q&9]P ?7R<DRD(O1Y8H N VC4U#P0^UX[#>
MB2K0*!::PD#K<IU?!5S=TY^9:L=R25K/M[9E-X<6<%]^/@VONW,@5G+<CZW)
M&"EI$$0HACKOP'':+,*H1$ID</CF=A\M_J%1A.IAU7_%)!ZQ^M%.XP0PS=%Z
M%Y64W]KIAOR.)T'^9X=]L??CBOK";]RB%!C\DSX>94\DXJ1:-J((Y4&2V*&N
M+L+Y8B[=3XTP5PFV%@<?JU3Q.]P@(T:F6Y6-RM"IX7/ECE V3VD !-)M=H$J
M'!%*3+%-G?5IEW+;!"-B>R;;\.2TD"\)P8JZ(Q3>!,@@*""<F\OTI_M++SE1
M7C"]<N6W3BH-4N+Z2,_\"!_P13V<,KOS65G.U/8KRKI8XZU^%\ID?6Z=G27'
MX>1H;0:(GAX49-E1U;H!B158WNT*Q.6X<0!#SH>N3A+U\T-:<:.Y9V.[Y%;9
M0+2#*S^)A.]$L-?M4% 5J85#]8\3H$KK38@NM@"1'O(XH3XM]/-<^$Y19.MI
MHH;+*:UQH<KGA!!'OK6FY"\,\;^'7H#DZG#4*F(8!-LC!&][,Z84$0Y\MR6U
MHJ* "_>W4W*8F2 _ DJ$;:2==&E'&WF.2)6 6F8_.=!'0(?$EII7EWQ#A7"9
ML#/[N?43L646JJF4I41<0EW8KLJWTD6' R\+]L=,\E21#N26KU(7CO??R0PY
M)%Z!9^6+4SUH<[?DNK1#VSL%$^($FYI::YZ('1R!3A:@1!-]MU?*H-63J]YX
M-#DTO%AE1A[3_*CL7#"D6X9=1L."RD8,8?QK>2EWX$2PZ1_:\0'[]UVQ(1I*
M7[F'#PWEY,)QL)T .YQ(96)D^QX_+=:E0XBO1T11\^!&:6C1I#X'8RSN+]L"
M7$[*]M;"M5'^M$^?BU_V]\]P-1LKK!L 8XMK"756DI*N!"F?QZC\Q?W_3&,;
M.<"1!1;3*D)S9<>CQXA=,@BZN\0CO77"/S1GH@Y<3B5UIQ,, /$+#6![PZ>D
MO$+ES\F*;\!W%GCT875YS:2$$OY#LP#?\OQM].3.'KDOS)Y3P6KWP+3X49NS
M018#7!L\!>8<+0/GARR 8MZ*+A'M2<59\\J?6DAXD$%-/_HT!G[@-=S%4>+V
MSR4P.:U#@]ZHD3SBM'AE1K-_8I-0$UFXW>P[UQ-]&&[I"E#U:YU=]'&:OD+-
MOQS>AO!9)1JA!>(D" J&*MO1H^.@F:'S$[.!&4 @!S *;$?"GZUNS&MT!?N'
M=G!":WR3(-(X4%&[+M%F,#UEU\8JDO4FP;Q*WA9""EW.#5!W UB=H5;M^H<%
MDDQ*-A5P^)57E/^SE-R71-JQTGEZ- E9N&(R1:>(>]F9E2(AKX8;2M/07/#!
MRI_MBE[YE\X\^V"K&R%DK_):Y?1W'"K GBQM8+?QD/95>V46G=BZEGQ5'(VC
M1%I/S"[(81YS.AP[;IL25B)M%N$B*'-&:WHD=ZSXSD@I2]%4F?P ,2R51YPE
M]I\!T_F&*R@I>7OE('?D>#A9ZCQ>*COU/X-Y(:6)ZK*WM-GP?VB*=%F*P52Y
MEK0R923%N;0IZ&+KD@R8E:29B9JO![5?$UFBOZ9PD*,&7#.Z9CCKDFH)%[<P
MZT<(1C>7X[ Y\-Y&[E@_P^6LER+:]?W@[2;NTC2&LP.&]U"5SKBA]6A5-P-<
MV^Q?Y11NHEUV0S3YS6 0@SLD7+-!B=TU'?O=YW%6!X\G6JQ/5.JB@N0-848[
M:=3 OT9 NF$U]@9\^=.'MNN1N$M:H<^T@< &=FL&+^#KU].K_[FZR_-_:+.*
M]-B4RO+I[TP4#D (A$[ES(%TT?^*6H'U4K3<>8^<_;#_O:8HZD(LPEF39#UR
MAW<8R'-V)4#P65J!=WW'/[9J4BHOVI^E.)#?(9S!T3I:^[CP></^MP_H<TO=
MU^\X$9'C2/CV[=C' CPQI"AK0SH_TJPT59*!1(5MOZO.RASV,]E\PP@$W^'2
ME0HU98"TR%<"!FGQDH""9 L@B7Y^0[?0JY:(4:WIU5P=2%C0.,H8D((Z+V6>
MGP!D:0G_W*8"D+0XP2;5E-_-ZEL?\FZ%1S]C,)BR##=Z0+BZVV+H]5L2&/=7
MH_I*VX #%&YQ2^;#_2*T]V[WQ(:;8OD/AE[S%[?[4D*&C0)PHZ+ JVA<E_ZI
MMHH EI.(@J<BQ7M9<ZI'##I1W%'T:R:FM$K0GDPM/3VV?IA@5^,X;=RJVOT1
MA^&<:LGGEMINM>P\*HCX,"AX2D5] .ZPETC;K312V:TZX)+0=*@7UBD[-1&_
MPF]/1#6R6_06;OG&AT$;7\D_9EC?Z NV2JPOR'I]4.4.]SE=*5FPW'TM6'4A
MLL+?>XXU(ZP%2>;30-4[QST_Y3,&,$S3T9$@5[89U:#]U<CW(5.TG72%(FS]
MS#]:)9[5'8F&%^&\)L-B;M^>$39J M>'9UG9]\84S@Y4]1\+:!Q.ROFAK G/
M9E&*!CO^I_XLU'"M#<AB4PKDAWXE]^^XG4R!'\R^OW/02:S6IW.=^_ZA\<;C
M3\+WHX-\0='/*KVFH/<"GX;=PS"M3I:R\SI1ZM;%[Y#-<S__3&-JM-.I>7/Y
MJREZM?_^8=--7IV<JE)G?RP)]Y9HF"2=2]_V8_#V7IXOU K,\%'!* P%L^3.
MD.E';3=@+?U1#5F1SGQ1:RCY5$38;7OR7WXC^J@:][PEY\+*E%!IR<(]CED<
M#_R'AFKJS)49^V\B2:UWL+5"'0)=TQ'M/84<%:GS+%O/EIL/ F[8IIG9@XC0
M @1WVT5NT;2'5ZU*ZK;0[2"90UT0D<&CSUI*%C"K_ >W?S05[65:SU]^V4?9
M_,42@@@,#UGE'I,UYPY)HUN.N+GR5/(KE6#P&83$C;;$;VGC_.@Z$-C>WQTJ
MKH$7V:HB\_Z_7+H1PWW#?K!F)6OM<@K<>76_#-7[B__AKWVCM_F0T6A+CA<,
M3EC?$6C*-0.6.C[Y,S[^J[.N4COG<AI3(N\]!XE.6H/N[B3$!V#1Y;M^E<4!
M<RV9?ZQ/$^I<;G8X/!T6J;547_M63V3R.J-ZMZ@ 3+YHIT!6HVSY7OR_N\<R
M]*/'1S0K.CT9&MP*/#!Q P=:71;;;Q]-^8&Q=<ISZR* U5]IANFHEQK@I@&.
MA '[32T/+(<K^C73!;T!JTXT6E+TI0<'WX1O)T=K40M#6V4YQ[Z'<!O)-Z-&
MUF#PF3&>XKV2%3A%K;:.)W%=6N]-,\K8Q(#=Z!O<=2R[/*Z7T#U@*9H&;!=X
MK'CA_G"3YI25=9O\U2 TMH8 LM/>SMJ1'/9]S.9V&^6)3_1.6D2]67>$^2-$
M+5YF_(M3?MP_-*%"Y?F7.MN97C-;TB)"6M]M8U$HDM9$B[13\[ZKD(%V\Y;[
M%, 1'JSIW KUZ(^Z(.1YPA$0)_<#.9[,AX6KEZT\?=NC3-;YKE..WLJ9FE\@
M2K,E+76[-PACJ=-4XO](:>NBZ5<@AQ.I6I;X>TG;Q&7SOL&4J*W9_7$ :% 8
MXDJ:2?J&Y^F$F;_P4]F]\(J>XC\T(PFFWZ9?)1'J@ I1!FQ)P-^^)/1J3@6N
M&!(5[@XVT!("E:)"ZH("A]8B^@RC\);&=!T:2<U"98=0:7/5M#EN^GU"Y7@J
M-,J[/>^MPV+\PIE/)41^%JT%N+LPQ??3YOGBGEE P]EMH@5R6R]D\I?1A-EP
MD A-:<N![>\$#O1F]9/A8Q_@.]Q3X>6'F;:!.XO26M^V\O?%Z)U"+E/H]F_=
M/<)QB)72JC624685(G^G:HC-1K0L.I9B]\ZDH'.GRA.,_#3\ZI8*@J()12W.
M(LY_"6[%+CRE;N*'/.8.EV8B2V84DC]GC*]B>'C4/9H3FUF,9YI&::0/ZG$.
MN%/XO]7DX656#,+)P[HA];L2(0]1^_D)+%?4-^2NAJ<51+ Q]'[R0X=VO>XQ
MW\);!"E :'@?2M-UG^M26[.S%;_2/0@S[O9XP]0JSQ7,9%VS.N!R]&N'F'+;
M@5:G,=1!NN;9FO:3>U6L7-0P/4&=SBX1H7NYL_(F&O"U0;EO!:3UR4(DO31!
MG^"3#2\ML7\F5\UJC3ATVUV$!Y<I\IL4ST(L=M=T1G3M/[2 7?%(D3\=RRWN
ML3P-PDU"[04FPU,!=>8%)ROMW]2^M$XRD'G1),N!Z6K'-\\JXU_58I!K4$%'
M >UWUK#5MTSJ;R^UTQ4XP,H!TN)C')"<EYYC6H$RA12O$(98/G?OUV#99%.[
MDQQKJP][0?@?'E9Z<QU3I$R>"J-C16O9;&Y&^#]=$"\!(HT.8[R-HRX#XJ4;
M\7)OAYF)NGN:J6%OC:DKE3<J,X^7 )E*C<*EU@&)[AT  UL*O_5M0,2LN5^'
MTV()D=EP8\!H>[5OU?A%;$7AGI"[7DX [CIW_?"'(9,+RCC)1TN5J=;+^?"B
MVVB;MS?'Z0:\N\X& Q!.1BLYSG1]281>1/8QZTLD6_8:LEBRI,GT]W2F#INJ
MYR#QVLY'7I-,]E8E:8I:?-,R E$\3;8NX=LK#P$FV*-!Z"2;N,L6=9;BS7?$
MN0%#@'.@>,GW?;<=)'NVD#L_9J@*RL_OD$;ZT??O=46PHZ' ,#E.=9*!1U=
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MF*C@E^S37W[%NM(CZ.9'.UDNJT6D]N.R0.4$@I?AN*Z!#4[ K2,VAODZ\\!
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ML+8Z7)X3)5KG5 LG[2I!YGA@M1D%L^AP$DFJW_8*^O;JP?@V2B[R]0F9R()
MI>FQ!D1""@J1$%ZUU^&GM\^VVL^Q/:V0\/$[BAQLEC+^9+2SK*TVC+_B^M;%
MKA#N_6[/[[L^I:J[*>+-Q,45F,W_Z*PT C?0VKDV,'?"@SFCR1L+E):Y'X&S
M75U'B?/2@-\=G/2"\22MP+$'"^]IILF -"^2)SO_U%C2J ,7FHBOUV[X?>A"
M^1F1D\2I -0?Y7\7P##*UJB'F4-))>[\;0^/SU%0_;R?\N;%#B/&E)1CV3 E
M1C@M_5O\@D9=>W-)EGO3[%.7 9'S%8IM2'_%6R^8/G]H*DC,),:ZM =[M'/&
MSATJ/TD; Q]OK@K4S4]W)1!*?R<'9TI3+?0FFLJT7#V8?BB\?-GP&<N<%D0S
M_KX?5%</=MJB8\_GSQ@:11+N)3###X<^'BQN12RF>^:85IPRBZOP\;(^T7%Y
MO='KI?FAY?E&(V"X/##82=AML*%'_/PWIL2%#/5S1I.NC!2GOE*X?"#;=R\\
M#SX]P6<%RK2R5W)MES(<Y*Q]*FHGM-2D%3U!Z2U]6MNU1LHI3)ZR'$V5<];]
MF'0:*VVWAU")2_M=NQU_9^M:]@%Z/Q_EEA/ HHJS-&_UE4OD";TSBB30HG7D
M0O%\TO-"WS"CV-G!51^1+.47$]Q-_?N8^P]]S]5!A(K@S0-$*:LXK?I3*KFP
MF1_JHL&S7Q2*5TWOVWEK]&J&=?K*AW0Q-+L_+Y!]:GBE**Y#OHI+4"M;W II
M]@:EB)QU9!_?9D-G1'E$RKZE.PF62Z@=&92ZQ_6!7[NE"<>QPR)<O@!A=C8Y
M;5-^O<JQ!<IL4+F<OVBD<W028F5U!DHNG2"W&UFFZ<@TLN(:[WJ_45T@W2%6
MXM80=T SYD<\%4FCW66!C3%R5D3 /EH"\EB!AHU:*$@$R7P008:]RC^P-JCA
MRF?WVAK;RBSSQ2S&F_DOF51,4 8R#JTB6IA.J<['?LQ!P%8-JI-1(4')IJ)?
MOJN$FI6;16MQ; M)W8_5VM]13*-H(B9 B:!T"7$OV&D882^,YJ"AH7*FH!PQ
MQ=!:LHA77NS![I0^(>-[1;'D@'B]<O>;%B[+(H 6J460%6&0E&M=="]RL*&.
M<W=F?RY<<T\CG!71C]<HC:^OHM\8K-<WT3=AQ(3%H96+><V;)U&'IQ9 9]0/
MHY,_8\@8<'P.,N5:#SJ/5[/JQO>68U'8O43[TW0T.8_A(C,W^RVL_/=(('_+
MJA]4+%<<PXWT9-698K)M? U(7LO\KBNZPW(*U'HB923=U>]9,GR8.+CH4C_Y
MV@2<H6NSW"F::M4'6SGA/QKB%;?&BI2._!Q'7;?@YE,SCIOY(2EYDQR+&JA1
MILD[6?7A?H6\!U.'^B8#CB>8.*R0E*+S:67$'$=23QGC'K*P.2,"((NOWUW9
M( %P!@N2OC!D''1TFVLDD,P<-1I@5]O_YM>SXKGBIHE)D](Y0V(T:AXU]=)C
MZZ?!B!&'2@*-GK;F#_OG> IKTVU '^2]'HFP='X1?CO8&9K!K?5._'4+F+%*
M7N'3'*Y.:?0HP1HM43"],T<#2NN2PS>1[=-(O5_O-S!#QO/$P1^L!7KA\#Q=
M4Y.;AX:GI;]HC-++5%VCS\E_W;ST=E*>OA4)S0MR_?(B.']\:GC0\S)0K2X0
M-R+7D'<4G^!PN]"!A7G%-F!G;BQ?:WQO<3/2>4O*BDX2QFFC.\Q=)U6O8=4@
MU!V[G-5Y1&9[,#9>'4< +:C/#6+8.3?--Q>ZI[%*<D7@"$MD9]UPI;KN.CLP
MNX>QRXR?"(=$RXH2^O,YLH4+RTOI;2R3O"95584#T1*:3M<ABO^S\:CP3Y*M
MO/A4E[Q;N1XWH>YD$\DG'$<*II8I,")&2]*H@;QLO)')=IY]2P]=G^Z'7J=6
M9M7JD'MP&4O*\#/%])P:B0UOM&AU1&@/'4E<A77IXX79=MOLM'+['O*FR;QS
M@)73\"]'O,G1FES)U<0R6EFU!\_G&-T5?N\/5M&'Y1J$J>Y%QKX!&)!%L.]E
MJ';W>DW(!JZRIHZ3(2R7\S"[N#>GH9HE3,B<1,P0K9@3&*"?WJ<X6CE)9-GO
MM(]W^W/,GY*#2./N1\OT@M=IGR3=MOKI6>IS*F.PHK8+5%Y5<JB.7>!!W">H
M[NH#&'(^W!C#MYE:E4;$42*<D^J<9_KM?G;1HV*9'=UD:5?H7K1A=!*%!;$W
MI[N:3=B,X9(B:G?'?H6%K^1(M,]-X\0R[=FOUMY,_4)HES&^K&])Z=[TS*@:
M!F>0]=^/QV!8=>_(#ZE1.CT9D34]2(;B  UNC G(7C)_K+6WC]X!+%:[O/!U
M-8VQ!68(BH.P K6^PG#7<E1F>S#A@JN_Q_%:VS,O3'?&]K'>:07^,H8L34'G
MBV)SP"E1<+[JC_$,K1->3G7+$[(9DIB 36XML%B4Z8IQ?D/ZFMI&K_(G?T5Z
M,6O2C_%><2T4%:1E1^T3LYDUR?[%XM9&D#S);(8%CF#@QWC:F$%S!$^;23M$
M@Y3;'IWVKBZ:C9&X>=ESN<@IHI?^I Q_9C)K=&E,Z^+0<V[B31QY1.Z*ORR"
M#,EQ3#OP%TTE M?GCM9C!_NGJ6N*?>V9'NK/+5JTCF;O:DQ(OF4W_CABZ^3[
MB];0DNJP:!>:4ZL)[1M'.HK4SI__$W.Y_V_,M7J(,K&APC\G!8P\:M\'"!(D
MCXWRC"V0T;PN9\:P+5+@3O'OH[PYY3W-"9%@&+&:^;F:EA%$R333AS+K, OR
MK1 ?QXFI[1>*N%! -/%J\FW/-\CE==25K0DR#Y@S\G>L-D'Y[3&4BJM!P0Z>
MA")'*_W,5P^Z=CV/AK ^J)25"W5*TA9J>OJ%-M,T#4IEV=6CU&J[3Y$JP%<.
M2P?\:_C#YRBIVM^=>0AR>[_JEV6!W!9<!=ZVRSOO^R?!FRA[8GZZ6=OSD)BZ
M=$*F[PMLS02FG$8<1=F]R72KP<&K%%_] 8M&YXO:,=R!])CXM\Q]#A7(DYZ8
M;"Y^(SA.MG'&*ZC'0RGD8, ZGV J"RNOKR.O582U$6+NHE!J=/I/AK">2&GZ
M?\T'IG;0YZW62B*P.G *+I@JG8*Y(C_B)?>:YH++H2UOHP-<C"I=&& #;YCR
M&1S3EKHU]-UI5WL SK_?^TWHD*>-@G>Z@BG-_BA_JB7A8;"F&!QCG,Z76>P=
M?$MDOGRLF%DE&=<,-2>I$<O)-"#X\A)$73.(FR49&D$6;S1[*!=174]QX"6H
M'_Q#1/&7!GQHL5B__5Q-7?N8U8-"-*!9$(*<?HKV(0:&$"?_K#9I5!"Y81W;
M_3FT[S9)8N-AQ3D.D,-!([I?9W /$DL<M"9JW972V/?W;,7AH\6/)IPV^\:/
MILXRHZ@[2OG^RD]L?-6:#"6G8;SB%B*P/72F)O06NBQ5_^,-]\SO*59<!C;'
M X8%>A5(]1?\->:5WXZOFI'EW 9R^'Q6\=(2TR9P4;_#UYE]]NE78$C7:GDA
M4O<_.#F*U+AE+M#I.X+-1U1FV44$-W&,>0OM6R$$<_J(^D7R)3Q2G00/RZ_E
M2C?V*7][".YFK;E[(F)*(_MVCN<;0:H(3TG3I$= S9#T[,NA=2-[P]T"WVI^
MJ[&%024VDO[UC]1^/2,*OA/&,>HFFS9>JY3:XXVC^K^^,$M;^_#05H!Y@X"#
M62D+\MQ(+P'&<G.*/GUM&4N-EGYR#TOAC6N&P9/;MB9Q(^5V@>T!JBS.#T%1
M4U+[J\^\9JA?L^@-S!#1[2UI(VD[J0H3LVZ-I>'#4'0W0V?^=F\V#7JH?^Y
M7_(Z'!M)$DSCK^Q';:F6M?I+CHOQ%'9U[VR[0M7T7=V8:S&[/95R$)QNT" G
M+J6%YS)-U!(%EW]PO<84MO8/S+VJ-?@-CQG.Z1G-^\H'L43CC'(4T[BU+D#2
MK6\\?:7D?=RQ/,"CA3EO)M(G#EN]6_>ODTM.; ,:48#2<+83Q\R'?,\]BC$@
M.N/UK>4M@2[RPOR&]Q\L=$W@@5ACQ19CK,X@6\ )I<N89"<5PE?)_7?])Z@$
M33-@X-R'<[4^O=1O(VAG$$?Y:IT5?($!?T2L,+$?!?=Z,_[NXL$W"7+KY!P
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MAH0]T13C9[;KD+$)I=+X?[5XZNW/@.B7 &]&OP;)$WO(:%*V<U-65/T[97>
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M57#+ IJ,$X#!_YL 4$L! A0#%     @ 38B*6C$@G'S:!   K X  !$
M         ( !     &%C:&,M,C R-3 U,CDN>'-D4$L! A0#%     @ 38B*
M6H-?",?Z P  )@P  !4              ( !"04  &%C:&,M,C R-3 U,CE?
M9&5F+GAM;%!+ 0(4 Q0    ( $V(BEKQ^Q-UV@,  (8,   5
M  "  38)  !A8VAC+3(P,C4P-3(Y7VQA8BYX;6Q02P$"% ,4    " !-B(I:
ME\AC\$L$   \&0  %0              @ %##0  86-H8RTR,#(U,#4R.5]P
M<F4N>&UL4$L! A0#%     @ 38B*6B]3A\\,'0( ;O$7 !<
M ( !P1$  &YY,C P-#(U-3%X,5]D968Q-&$N:'1M4$L! A0#%     @ 38B*
M6J9WOP.5,0  !#(  !@              ( ! B\" &YY,C P-#(U-3%X,5]I
M;6%G93 Q+FIP9U!+ 0(4 Q0    ( $V(BEHZUO)<S1X  'X?   8
M      "  <U@ @!N>3(P,#0R-34Q>#%?:6UA9V4P,BYJ<&=02P$"% ,4
M" !-B(I:;.@DE+%=   L8@  &               @ '0?P( ;GDR,# T,C4U
M,7@Q7VEM86=E,#,N:G!G4$L! A0#%     @ 38B*6GI>;3:_;P  B7L  !@
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M."YJ<&=02P$"% ,4    " !-B(I:F='29N $ 0#7+P$ &
M@ $@V04 ;GDR,# T,C4U,7@Q7VEM86=E,#DN:G!G4$L%!@     .  X PP,
' #;>!@    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>ny20042551x1_def14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:achc="http://acadiahealthcare.com/20250529"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="achc-20250529.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
        </entity>
        <period>
            <startDate>2022-04-11</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-04-10</endDate>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:ChristopherHHunterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">achc:DebraKOsteenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>2</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001520697</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>3</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-112">ACADIA HEALTHCARE COMPANY, INC.</dei:EntityRegistrantName>
    <ecd:AwardTmgMnpiDiscTextBlock contextRef="c0" id="ixv-6210">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Equity Award Grant Practices&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The Company does not generally grant stock options to its employees. The Compensation Committee did not take material nonpublic information into account when determining the timing and terms of equity awards in 2024, and the Company does not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.&lt;/p&gt;</ecd:AwardTmgMnpiDiscTextBlock>
    <ecd:AwardTmgHowMnpiCnsdrdTextBlock contextRef="c0" id="ixv-18027">The Compensation Committee did not take material nonpublic information into account when determining the timing and terms of equity awards in 2024, and the Company does not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.</ecd:AwardTmgHowMnpiCnsdrdTextBlock>
    <ecd:AwardTmgMnpiCnsdrdFlag contextRef="c0" id="ixv-18028">false</ecd:AwardTmgMnpiCnsdrdFlag>
    <ecd:MnpiDiscTimedForCompValFlag contextRef="c0" id="ixv-18029">false</ecd:MnpiDiscTimedForCompValFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c0" id="ixv-18030">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:PvpTableTextBlock contextRef="c0" id="ixv-12515">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;b&gt;Pay Versus Performance&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"&gt;The following table sets forth certain information regarding compensation actually paid to our Named Executive Officers during the past five fiscal
    years compared to certain measures of our financial performance:&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="color: rgb(33, 37, 41); text-align: center; padding-bottom: 2px;"&gt;&lt;/td&gt; &lt;td colspan="8" rowspan="1" style="color: rgb(33, 37, 41); border-bottom: 2px solid rgb(0, 0, 0); text-align: center; vertical-align: bottom;"&gt;&lt;span style="font-size: 8pt;"&gt;&#160;&#160;Summary Comp. Table Total &lt;br/&gt; for CEO&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 2px; color: rgb(33, 37, 41);"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="7" rowspan="1" style="color: rgb(33, 37, 41); text-align: center; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;span style="font-size: 8pt;"&gt;&#160;&lt;/span&gt; &lt;p style="font: 10pt Times New Roman,Times,serif; margin: 0pt 0px; color: rgb(33, 37, 41);"&gt;&lt;span style="font-size: 8pt;"&gt;&#160;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman,Times,serif; margin: 0pt 0px; color: rgb(33, 37, 41);"&gt;&lt;span style="font-size: 8pt;"&gt;Comp. Actually Paid&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman,Times,serif; margin: 0pt 0px; color: rgb(33, 37, 41);"&gt;&lt;span style="font-size: 8pt;"&gt;to CEO&lt;sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"&gt;(3)&lt;/sup&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt; &lt;/td&gt; &lt;td style="padding-bottom: 2px; color: rgb(33, 37, 41);"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); padding-bottom: 2px;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" rowspan="2" style="color: rgb(33, 37, 41); text-align: center; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;span style="font-size: 8pt; color: #212529"&gt;Average Summary Comp. Table Total for Non-CEO NEOs&lt;sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"&gt;(4)&lt;/sup&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 2px; color: rgb(33, 37, 41);"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); padding-bottom: 2px;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" rowspan="2" style="color: rgb(33, 37, 41); text-align: center; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;span style="font-size: 8pt; color: #212529"&gt;Average Comp. Actually Paid to Non-CEO NEOs&lt;sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"&gt;(3)&lt;/sup&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 2px; color: rgb(33, 37, 41);"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); padding-bottom: 2px;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="6" style="color: rgb(33, 37, 41); text-align: center; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;span style="font-size: 8pt"&gt;Value of Initial Fixed $100 Investment Based On:&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 2px; color: rgb(33, 37, 41);"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); padding-bottom: 2px;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" rowspan="2" style="color: rgb(33, 37, 41); text-align: center; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;span style="font-size: 8pt"&gt;Net Income (Loss) &lt;br/&gt; (in thousands)&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 2px; color: rgb(33, 37, 41);"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); padding-bottom: 2px;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" rowspan="2" style="color: rgb(33, 37, 41); text-align: center; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;span style="font-size: 8pt; color: #212529"&gt;Adjusted EPS&lt;sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"&gt;(7)&lt;/sup&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 2px; color: rgb(33, 37, 41);"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Year&lt;/span&gt;&lt;/td&gt; &lt;td colspan="4" rowspan="1" style="padding-bottom: 1pt; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&#160;&lt;/span&gt;&lt;span style="font-size: 8pt; color: rgb(33, 37, 41);"&gt;Christopher H. Hunter&lt;sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"&gt;(1)&lt;/sup&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; color: #212529; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: 2px solid rgb(0, 0, 0); color: rgb(33, 37, 41); text-align: center;"&gt;&lt;span style="font-size: 8pt; color: #212529"&gt;Debra K. Osteen&lt;sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"&gt;(2)&lt;/sup&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; color: #212529; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="4" rowspan="1" style="color: rgb(33, 37, 41); padding-bottom: 1pt; text-align: center; border-bottom: 2px solid rgb(0, 0, 0);"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;span style="font-size: 8pt; color: #212529"&gt;Christopher H. Hunter&lt;sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"&gt;(1)&lt;/sup&gt;&#160;&#160;&lt;/span&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: 2px solid rgb(0, 0, 0); color: rgb(33, 37, 41); text-align: center;"&gt;&lt;span style="font-size: 8pt; color: #212529"&gt;Debra K. Osteen&lt;sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"&gt;(2)&lt;/sup&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; color: #212529; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: 2px solid rgb(0, 0, 0); color: rgb(33, 37, 41); text-align: center;"&gt;&lt;span style="font-size: 8pt; color: #212529"&gt;TSR&lt;sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"&gt;(5)&lt;/sup&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; color: #212529; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: 2px solid rgb(0, 0, 0); color: rgb(33, 37, 41); text-align: center;"&gt;&lt;span style="font-size: 8pt; color: #212529"&gt;Peer Group TSR&lt;sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"&gt;(6)&lt;/sup&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; color: #212529; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 9%; color: #212529; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;2024&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 6%; color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;7,089,167&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 6%; color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt; color: #212529"&gt;&#160;N/A&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 6%; color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(241,669&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 6%; text-align: right"&gt;&lt;span style="font-size: 8pt; color: #212529"&gt;N/A&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 6%; color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;2,238,478&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 6%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(19,323&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 6%; color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;119&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 6%; color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;126&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 6%; color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;264,484&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 6%; color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;3.32&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="color: #212529; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;2023&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;7,404,606&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt; color: #212529"&gt;&#160;N/A&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;8,352,752&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt; color: #212529"&gt;N/A&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;3,289,184&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,079,088&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;234&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;124&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(15,661&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;3.51&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="color: #212529; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;2022&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;6,415,224&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;2,620,043&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;8,482,132&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;17,102,308&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;3,040,751&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;9,817,787&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;248&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;118&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;280,033&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;3.19&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="color: #212529; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;2021&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt; color: #212529"&gt;N/A&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;9,853,107&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt; color: #212529"&gt;N/A&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;29,812,731&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;3,656,112&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;8,870,858&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;183&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;147&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;195,562&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;2.70&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="color: #212529; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;2020&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt; color: #212529"&gt;N/A&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;5,131,395&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt; color: #212529"&gt;N/A&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;17,648,915&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;2,604,425&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;6,550,425&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;151&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;134&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(669,199&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;2.81&lt;/span&gt;&lt;/td&gt; &lt;td style="color: #212529; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0"&gt;&lt;/td&gt; &lt;td style="width: 0.5in"&gt;&lt;span style="font-size: 8pt"&gt;(1)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Mr. Hunter was appointed Chief Executive Officer effective April 11, 2022.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0"&gt;&lt;/td&gt; &lt;td style="width: 0.5in"&gt;&lt;span style="font-size: 8pt"&gt;(2)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Ms. Osteen retired as Chief Executive Officer effective April 11, 2022.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0"&gt;&lt;/td&gt; &lt;td style="width: 0.5in"&gt;&lt;span style="font-size: 8pt"&gt;(3)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;To calculate Compensation Actually Paid (&#x201c;CAP&#x201d;), the following amounts were deducted from and added to Summary Compensation Table (&#x201c;SCT&#x201d;) total compensation:&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;CEO SCT Table to CAP Reconciliation: &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: 1pt solid Black; text-align: left; width: 20%; vertical-align: bottom;"&gt;&lt;span style="font-size: 8pt;"&gt;Name&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: 1pt solid Black; text-align: center; width: 9%;"&gt;&lt;span style="font-size: 8pt"&gt;Year&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: 1pt solid Black;"&gt;&lt;span style="font-size: 8pt"&gt;SCT Total&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: 1pt solid Black;"&gt;&lt;span style="font-size: 8pt"&gt;Deductions from SCT Total&lt;sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"&gt;(a)&lt;/sup&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: 1pt solid Black;"&gt;&lt;span style="font-size: 8pt"&gt;Additions to SCT Total&lt;sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"&gt;(b)&lt;/sup&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: 1pt solid Black;"&gt;&lt;span style="font-size: 8pt"&gt;CAP&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 20%; text-align: left; vertical-align: top;"&gt;&lt;span style="font-size: 8pt;"&gt;Christopher H. Hunter&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 9%; text-align: center;"&gt;&lt;span style="font-size: 8pt"&gt;2024&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;7,089,167&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;5,099,925&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(2,230,911&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(241,669&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: center; width: 20%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; width: 9%;"&gt;&lt;span style="font-size: 8pt"&gt;2023&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;7,404,606&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;4,749,977&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;5,698,123&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;8,352,752&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: center; width: 20%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; width: 9%;"&gt;&lt;span style="font-size: 8pt"&gt;2022&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;6,415,224&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;4,500,022&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;6,566,930&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;8,482,132&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: left; width: 20%; vertical-align: middle;"&gt;&lt;span style="font-size: 8pt;"&gt;Debra K. Osteen&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; width: 9%;"&gt;&lt;span style="font-size: 8pt"&gt;2024&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: center; width: 20%;"&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; width: 9%;"&gt;&lt;span style="font-size: 8pt"&gt;2023&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: center; width: 20%;"&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; width: 9%;"&gt;&lt;span style="font-size: 8pt"&gt;2022&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;2,620,043&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;1,059,857&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;15,542,122&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;17,102,308&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: center; width: 20%;"&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; width: 9%;"&gt;&lt;span style="font-size: 8pt"&gt;2021&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;9,853,107&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;6,989,753&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;26,949,377&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;29,812,731&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: center; width: 20%;"&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; width: 9%;"&gt;&lt;span style="font-size: 8pt"&gt;2020&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;5,131,395&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;2,789,779&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;15,307,298&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;17,648,915&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Average Non-CEO NEOs SCT Table to CAP Reconciliation:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Year&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;SCT Total&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;Deductions from SCT Total&lt;sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"&gt;(a)&lt;/sup&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;Additions to SCT Total&lt;sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"&gt;(b)&lt;/sup&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;CAP&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 15%; background-color: White"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; background-color: White"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; background-color: White"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 14%; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;2024&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;2,238,478&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,179,647&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(1,078,154&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(19,323&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;2023&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;3,289,184&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;2,503,492&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;293,396&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,079,088&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="background-color: White"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="background-color: White"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="background-color: White"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;2022&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;3,040,751&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,720,243&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;8,497,279&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;9,817,787&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;2021&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;3,656,112&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,963,594&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;7,178,340&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;8,870,858&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="background-color: White"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="background-color: White"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="background-color: White"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;2020&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;2,604,425&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,116,717&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;5,062,717&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;6,550,425&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.5in"&gt;&lt;span style="font-size: 8pt"&gt;(a)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Represents the grant date fair value of equity-based awards granted each year calculated in accordance with ASC 718.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.5in"&gt;&lt;span style="font-size: 8pt"&gt;(b)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Reflects the value of equity calculated in accordance with the SEC methodology for determining CAP for each year shown. The equity component of CAP is further detailed in the table below. For performance-vesting restricted stock unit awards, fair value amounts have been computed consistent with the methodology used in the Company&#x2019;s Consolidated Financial Statements as of December 31, 2020, 2021, 2022, 2023 and 2024, respectively.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Equity Component of CAP: &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="text-decoration:underline"&gt;Christopher H. Hunter&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 65%; font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;Year&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt; &lt;div&gt;Fair Value of&lt;/div&gt; &lt;div&gt; Current Year Equity Awards at Year-End&lt;/div&gt; &lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Change in Value of Prior Years&#x2019; Awards Unvested at Year-End&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Change in Value of Prior Years&#x2019; Awards That Vested in the Year&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt; &lt;div&gt;Equity Value&lt;/div&gt; &lt;div&gt; Included in CAP&lt;/div&gt; &lt;/td&gt; &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 19%; text-align: center"&gt;2024&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 17%; text-align: right"&gt;2,975,019&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 17%; text-align: right"&gt;(5,148,737&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 17%; text-align: right"&gt;(57,192&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 17%; text-align: right"&gt;(2,230,911&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: center"&gt;2023&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;6,050,233&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(321,521&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(30,589&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;5,698,123&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: center"&gt;2022&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;6,566,930&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;6,566,930&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: center"&gt;2021&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: center"&gt;2020&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="text-decoration:underline"&gt;Debra K. Osteen&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 65%; font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;Year&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Fair Value of Current Year Equity Awards at Year-End&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Change in Value of Prior Years&#x2019; Awards Unvested at Year-End&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Change in Value of Prior Years&#x2019; Awards That Vested in the Year&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt; &lt;div&gt;Equity Value&lt;/div&gt; &lt;div&gt; Included in CAP&lt;/div&gt; &lt;/td&gt; &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: center"&gt;2024&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: center"&gt;2023&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 19%; text-align: center"&gt;2022&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 17%; text-align: right"&gt;9,972,986&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 17%; text-align: right"&gt;7,341,244&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 17%; text-align: right"&gt;(1,772,108&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 17%; text-align: right"&gt;15,542,122&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: center"&gt;2021&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;23,567,139&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;3,215,353&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;166,885&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;26,949,377&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: center"&gt;2020&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;13,014,224&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;533,148&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;1,759,927&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;15,307,298&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="text-decoration:underline"&gt;Average Non-CEO NEOs &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 80%; font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;Year&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Fair Value of Current Year Equity Awards at Year-End&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Change in Value of Prior Years&#x2019; Awards Unvested at Year-End&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Change in Value of Prior Years&#x2019; Awards That Vested in the Year&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Fair Value of Forfeited Awards at Prior Year-End&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt; &lt;div&gt;Equity Value&lt;/div&gt; &lt;div&gt; Included in CAP&lt;/div&gt; &lt;/td&gt; &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 14%; text-align: center"&gt;2024&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;679,492&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;(1,278,180&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;(19,593&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;(459,873&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;(1,078,154&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: center"&gt;2023&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;2,182,972&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(89,974&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(255,921&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(1,543,681&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;293,396&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: center"&gt;2022&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;5,228,345&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;3,399,089&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(130,155&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;8,497,279&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: center"&gt;2021&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;5,891,861&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;1,147,507&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;138,972&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;7,178,340&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: center"&gt;2020&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;4,691,771&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;419,942&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(48,996&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;5,062,717&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0"&gt;&lt;/td&gt; &lt;td style="width: 0.5in"&gt;&lt;span style="font-size: 8pt"&gt;(4)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;The Named Executive Officers, other than the CEO, reflected in the Pay Versus Performance table represent the following individuals for each of the years listed below&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; width: 94%; border-collapse: collapse; margin-left: 0.5in"&gt;

      &lt;tr style="vertical-align: bottom"&gt;
        &lt;td style="width: 23%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;2020&lt;/span&gt;&lt;/td&gt;
        &lt;td style="width: 20%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;2021&lt;/span&gt;&lt;/td&gt;
        &lt;td style="width: 19%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;2022&lt;/span&gt;&lt;/td&gt;
        &lt;td style="width: 19%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;2023&lt;/span&gt;&lt;/td&gt;
        &lt;td style="width: 19%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;David M. Duckworth&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;David M. Duckworth&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;David M. Duckworth&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Heather Dixon&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Heather Dixon&lt;/span&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style="vertical-align: top"&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Christopher L. Howard&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Christopher L. Howard&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Christopher L. Howard&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Brian P. Farley&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Brian P. Farley&lt;/span&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;John S. Hollinsworth&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;John S. Hollinsworth&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;John S. Hollinsworth&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;John S. Hollinsworth&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Nasser Khan, M.D.&lt;/span&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style="vertical-align: top"&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Laurence L. Harrod&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Laurence L. Harrod&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Laurence L. Harrod&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;David M. Duckworth&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;John S. Hollinsworth&lt;/span&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Laurence L. Harrod&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
      &lt;/tr&gt;

  &lt;/table&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt;

      &lt;tr style="vertical-align: top"&gt;
        &lt;td style="width: 0"&gt;&lt;/td&gt;
        &lt;td style="width: 0.5in"&gt;&lt;span style="font-size: 8pt"&gt;(5)&lt;/span&gt;&lt;/td&gt;
        &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;An investment of $100 is assumed to have been made in our Common Stock as of December&#160;31, 2019. TSR was calculated by multiplying the initial investment of $100 by the quotient of the
            closing price of our Common Stock on December&#160;31, 2020, 2021, 2022, 2023 and 2024, divided by our closing price on December&#160;31, 2019.&lt;/span&gt;&lt;/td&gt;
      &lt;/tr&gt;

  &lt;/table&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0"&gt;&lt;/td&gt; &lt;td style="width: 0.5in"&gt;&lt;span style="font-size: 8pt"&gt;(6)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Reflects the cumulative total stockholder return for the S&amp;amp;P Health Care Services Select Industry Index (the &#x201c;S&amp;amp;P HC Index&#x201d;). An investment of $100 is assumed to have been made in the S&amp;amp;P HC Index as of December&#160;31, 2019. Peer Group TSR was calculated by multiplying the initial investment of $100 by the quotient of the closing price of the S&amp;amp;P HC Index on December&#160;31, 2020, 2021, 2022, 2023 and 2024 divided by the closing price on December&#160;31, 2019, with dividends reinvested at the time they are paid.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0"&gt;&lt;/td&gt; &lt;td style="width: 0.5in"&gt;&lt;span style="font-size: 8pt"&gt;(7)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Adjusted EPS is a non-GAAP financial measure and one of the core long-term metrics we use for purposes of evaluating performance for our compensation program, as further described in the section above entitled &#x201c;COMPENSATION DISCUSSION AND ANALYSIS &#x2013; Components of Executive Compensation &#x2013; Annual Non-Equity Incentive Compensation.&#x201d;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c1" decimals="0" id="ixv-18031" unitRef="usd">7089167</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c1" decimals="0" id="ixv-18032" unitRef="usd">-241669</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c0" decimals="0" id="ixv-18033" unitRef="usd">2238478</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c0" decimals="0" id="ixv-18034" unitRef="usd">-19323</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c0" decimals="0" id="ixv-18035" unitRef="usd">119</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c0" decimals="0" id="ixv-18036" unitRef="usd">126</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:ProfitLoss contextRef="c0" decimals="-3" id="ixv-18037" unitRef="usd">264484000</us-gaap:ProfitLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="c0"
      decimals="2"
      id="ixv-18038"
      unitRef="usdPershares">3.32</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c2" decimals="0" id="ixv-18039" unitRef="usd">7404606</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c2" decimals="0" id="ixv-18040" unitRef="usd">8352752</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c3" decimals="0" id="ixv-18041" unitRef="usd">3289184</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c3" decimals="0" id="ixv-18042" unitRef="usd">1079088</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c3" decimals="0" id="ixv-18043" unitRef="usd">234</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c3" decimals="0" id="ixv-18044" unitRef="usd">124</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:ProfitLoss contextRef="c3" decimals="-3" id="ixv-18045" unitRef="usd">-15661000</us-gaap:ProfitLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="c3"
      decimals="2"
      id="ixv-18046"
      unitRef="usdPershares">3.51</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c4" decimals="0" id="ixv-18047" unitRef="usd">6415224</ecd:PeoTotalCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c5" decimals="0" id="ixv-18048" unitRef="usd">2620043</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c4" decimals="0" id="ixv-18049" unitRef="usd">8482132</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c5" decimals="0" id="ixv-18050" unitRef="usd">17102308</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c6" decimals="0" id="ixv-18051" unitRef="usd">3040751</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c6" decimals="0" id="ixv-18052" unitRef="usd">9817787</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c6" decimals="0" id="ixv-18053" unitRef="usd">248</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c6" decimals="0" id="ixv-18054" unitRef="usd">118</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:ProfitLoss contextRef="c6" decimals="-3" id="ixv-18055" unitRef="usd">280033000</us-gaap:ProfitLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="c6"
      decimals="2"
      id="ixv-18056"
      unitRef="usdPershares">3.19</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c7" decimals="0" id="ixv-18057" unitRef="usd">9853107</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c7" decimals="0" id="ixv-18058" unitRef="usd">29812731</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c8" decimals="0" id="ixv-18059" unitRef="usd">3656112</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c8" decimals="0" id="ixv-18060" unitRef="usd">8870858</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c8" decimals="0" id="ixv-18061" unitRef="usd">183</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c8" decimals="0" id="ixv-18062" unitRef="usd">147</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:ProfitLoss contextRef="c8" decimals="-3" id="ixv-18063" unitRef="usd">195562000</us-gaap:ProfitLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="c8"
      decimals="2"
      id="ixv-18064"
      unitRef="usdPershares">2.7</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c9" decimals="0" id="ixv-18065" unitRef="usd">5131395</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c9" decimals="0" id="ixv-18066" unitRef="usd">17648915</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c10" decimals="0" id="ixv-18067" unitRef="usd">2604425</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c10" decimals="0" id="ixv-18068" unitRef="usd">6550425</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c10" decimals="0" id="ixv-18069" unitRef="usd">151</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c10" decimals="0" id="ixv-18070" unitRef="usd">134</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:ProfitLoss contextRef="c10" decimals="-3" id="ixv-18071" unitRef="usd">-669199000</us-gaap:ProfitLoss>
    <ecd:CoSelectedMeasureAmt
      contextRef="c10"
      decimals="2"
      id="ixv-18072"
      unitRef="usdPershares">2.81</ecd:CoSelectedMeasureAmt>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="c0" id="ixv-13080">&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0"&gt;&lt;/td&gt; &lt;td style="width: 0.5in"&gt;&lt;span style="font-size: 8pt"&gt;(1)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Mr. Hunter was appointed Chief Executive Officer effective April 11, 2022.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0"&gt;&lt;/td&gt; &lt;td style="width: 0.5in"&gt;&lt;span style="font-size: 8pt"&gt;(2)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Ms. Osteen retired as Chief Executive Officer effective April 11, 2022.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0"&gt;&lt;/td&gt; &lt;td style="width: 0.5in"&gt;&lt;span style="font-size: 8pt"&gt;(4)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;The Named Executive Officers, other than the CEO, reflected in the Pay Versus Performance table represent the following individuals for each of the years listed below&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; width: 94%; border-collapse: collapse; margin-left: 0.5in"&gt;

      &lt;tr style="vertical-align: bottom"&gt;
        &lt;td style="width: 23%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;2020&lt;/span&gt;&lt;/td&gt;
        &lt;td style="width: 20%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;2021&lt;/span&gt;&lt;/td&gt;
        &lt;td style="width: 19%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;2022&lt;/span&gt;&lt;/td&gt;
        &lt;td style="width: 19%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;2023&lt;/span&gt;&lt;/td&gt;
        &lt;td style="width: 19%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;David M. Duckworth&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;David M. Duckworth&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;David M. Duckworth&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Heather Dixon&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Heather Dixon&lt;/span&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style="vertical-align: top"&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Christopher L. Howard&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Christopher L. Howard&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Christopher L. Howard&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Brian P. Farley&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Brian P. Farley&lt;/span&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;John S. Hollinsworth&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;John S. Hollinsworth&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;John S. Hollinsworth&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;John S. Hollinsworth&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Nasser Khan, M.D.&lt;/span&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style="vertical-align: top"&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Laurence L. Harrod&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Laurence L. Harrod&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Laurence L. Harrod&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;David M. Duckworth&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;John S. Hollinsworth&lt;/span&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Laurence L. Harrod&lt;/span&gt;&lt;/td&gt;
        &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
      &lt;/tr&gt;

  &lt;/table&gt;</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="c11" id="ixv-18073">Mr. Hunter</ecd:PeoName>
    <ecd:PeoName contextRef="c3" id="ixv-18074">Mr. Hunter</ecd:PeoName>
    <ecd:PeoName contextRef="c0" id="ixv-18075">Mr. Hunter</ecd:PeoName>
    <ecd:PeoName contextRef="c10" id="ixv-18076">Ms. Osteen</ecd:PeoName>
    <ecd:PeoName contextRef="c8" id="ixv-18077">Ms. Osteen</ecd:PeoName>
    <ecd:PeoName contextRef="c12" id="ixv-18078">Ms. Osteen</ecd:PeoName>
    <ecd:AdjToPeoCompFnTextBlock contextRef="c0" id="ixv-13106">&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0"&gt;&lt;/td&gt; &lt;td style="width: 0.5in"&gt;&lt;span style="font-size: 8pt"&gt;(3)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;To calculate Compensation Actually Paid (&#x201c;CAP&#x201d;), the following amounts were deducted from and added to Summary Compensation Table (&#x201c;SCT&#x201d;) total compensation:&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;CEO SCT Table to CAP Reconciliation: &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;table border="0" cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: 1pt solid Black; text-align: left; width: 20%; vertical-align: bottom;"&gt;&lt;span style="font-size: 8pt;"&gt;Name&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: 1pt solid Black; text-align: center; width: 9%;"&gt;&lt;span style="font-size: 8pt"&gt;Year&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: 1pt solid Black;"&gt;&lt;span style="font-size: 8pt"&gt;SCT Total&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: 1pt solid Black;"&gt;&lt;span style="font-size: 8pt"&gt;Deductions from SCT Total&lt;sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"&gt;(a)&lt;/sup&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: 1pt solid Black;"&gt;&lt;span style="font-size: 8pt"&gt;Additions to SCT Total&lt;sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"&gt;(b)&lt;/sup&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: 1pt solid Black;"&gt;&lt;span style="font-size: 8pt"&gt;CAP&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: 1pt solid Black; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 20%; text-align: left; vertical-align: top;"&gt;&lt;span style="font-size: 8pt;"&gt;Christopher H. Hunter&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 9%; text-align: center;"&gt;&lt;span style="font-size: 8pt"&gt;2024&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;7,089,167&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;5,099,925&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(2,230,911&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(241,669&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: center; width: 20%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; width: 9%;"&gt;&lt;span style="font-size: 8pt"&gt;2023&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;7,404,606&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;4,749,977&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;5,698,123&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;8,352,752&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: center; width: 20%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; width: 9%;"&gt;&lt;span style="font-size: 8pt"&gt;2022&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;6,415,224&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;4,500,022&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;6,566,930&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;8,482,132&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: left; width: 20%; vertical-align: middle;"&gt;&lt;span style="font-size: 8pt;"&gt;Debra K. Osteen&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; width: 9%;"&gt;&lt;span style="font-size: 8pt"&gt;2024&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: center; width: 20%;"&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; width: 9%;"&gt;&lt;span style="font-size: 8pt"&gt;2023&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;&#x2013;&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman,Times,serif; text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: center; width: 20%;"&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; width: 9%;"&gt;&lt;span style="font-size: 8pt"&gt;2022&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;2,620,043&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;1,059,857&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;15,542,122&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;17,102,308&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: center; width: 20%;"&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; width: 9%;"&gt;&lt;span style="font-size: 8pt"&gt;2021&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;9,853,107&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;6,989,753&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;26,949,377&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;29,812,731&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: center; width: 20%;"&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center; width: 9%;"&gt;&lt;span style="font-size: 8pt"&gt;2020&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;5,131,395&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;2,789,779&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;15,307,298&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); text-align: right; width: 14%;"&gt;&lt;span style="font-size: 8pt"&gt;17,648,915&lt;/span&gt;&lt;/td&gt; &lt;td style="color: rgb(33, 37, 41); text-align: left; width: 1%;"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.5in"&gt;&lt;span style="font-size: 8pt"&gt;(a)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Represents the grant date fair value of equity-based awards granted each year calculated in accordance with ASC 718.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.5in"&gt;&lt;span style="font-size: 8pt"&gt;(b)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Reflects the value of equity calculated in accordance with the SEC methodology for determining CAP for each year shown. The equity component of CAP is further detailed in the table below. For performance-vesting restricted stock unit awards, fair value amounts have been computed consistent with the methodology used in the Company&#x2019;s Consolidated Financial Statements as of December 31, 2020, 2021, 2022, 2023 and 2024, respectively.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Equity Component of CAP: &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="text-decoration:underline"&gt;Christopher H. Hunter&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 65%; font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;Year&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt; &lt;div&gt;Fair Value of&lt;/div&gt; &lt;div&gt; Current Year Equity Awards at Year-End&lt;/div&gt; &lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Change in Value of Prior Years&#x2019; Awards Unvested at Year-End&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Change in Value of Prior Years&#x2019; Awards That Vested in the Year&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt; &lt;div&gt;Equity Value&lt;/div&gt; &lt;div&gt; Included in CAP&lt;/div&gt; &lt;/td&gt; &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 19%; text-align: center"&gt;2024&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 17%; text-align: right"&gt;2,975,019&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 17%; text-align: right"&gt;(5,148,737&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 17%; text-align: right"&gt;(57,192&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 17%; text-align: right"&gt;(2,230,911&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: center"&gt;2023&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;6,050,233&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(321,521&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(30,589&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;5,698,123&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: center"&gt;2022&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;6,566,930&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;6,566,930&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: center"&gt;2021&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: center"&gt;2020&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="text-decoration:underline"&gt;Debra K. Osteen&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 65%; font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;Year&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Fair Value of Current Year Equity Awards at Year-End&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Change in Value of Prior Years&#x2019; Awards Unvested at Year-End&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Change in Value of Prior Years&#x2019; Awards That Vested in the Year&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt; &lt;div&gt;Equity Value&lt;/div&gt; &lt;div&gt; Included in CAP&lt;/div&gt; &lt;/td&gt; &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: center"&gt;2024&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: center"&gt;2023&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 19%; text-align: center"&gt;2022&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 17%; text-align: right"&gt;9,972,986&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 17%; text-align: right"&gt;7,341,244&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 17%; text-align: right"&gt;(1,772,108&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 17%; text-align: right"&gt;15,542,122&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: center"&gt;2021&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;23,567,139&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;3,215,353&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;166,885&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;26,949,377&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: center"&gt;2020&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;13,014,224&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;533,148&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;1,759,927&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;15,307,298&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</ecd:AdjToPeoCompFnTextBlock>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="c0" id="ixv-13107">&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0"&gt;&lt;/td&gt; &lt;td style="width: 0.5in"&gt;&lt;span style="font-size: 8pt"&gt;(3)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;To calculate Compensation Actually Paid (&#x201c;CAP&#x201d;), the following amounts were deducted from and added to Summary Compensation Table (&#x201c;SCT&#x201d;) total compensation:&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Average Non-CEO NEOs SCT Table to CAP Reconciliation:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 75%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Year&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;SCT Total&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;Deductions from SCT Total&lt;sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"&gt;(a)&lt;/sup&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;Additions to SCT Total&lt;sup style="vertical-align: text-top; line-height: 1; font-size: smaller;"&gt;(b)&lt;/sup&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td colspan="2" style="text-align: center; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;CAP&lt;/span&gt;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 15%; background-color: White"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; background-color: White"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; background-color: White"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 14%; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;2024&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;2,238,478&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,179,647&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(1,078,154&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(19,323&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;)&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;2023&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;3,289,184&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;2,503,492&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;293,396&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,079,088&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="background-color: White"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="background-color: White"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="background-color: White"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;2022&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;3,040,751&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,720,243&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;8,497,279&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;9,817,787&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;2021&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;3,656,112&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,963,594&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;7,178,340&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;8,870,858&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="background-color: White"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="background-color: White"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="background-color: White"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;2020&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;2,604,425&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,116,717&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;5,062,717&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;6,550,425&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.5in"&gt;&lt;span style="font-size: 8pt"&gt;(a)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Represents the grant date fair value of equity-based awards granted each year calculated in accordance with ASC 718.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.5in"&gt;&lt;span style="font-size: 8pt"&gt;(b)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Reflects the value of equity calculated in accordance with the SEC methodology for determining CAP for each year shown. The equity component of CAP is further detailed in the table below. For performance-vesting restricted stock unit awards, fair value amounts have been computed consistent with the methodology used in the Company&#x2019;s Consolidated Financial Statements as of December 31, 2020, 2021, 2022, 2023 and 2024, respectively.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Equity Component of CAP: &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="text-decoration:underline"&gt;Average Non-CEO NEOs &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 80%; font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;Year&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Fair Value of Current Year Equity Awards at Year-End&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Change in Value of Prior Years&#x2019; Awards Unvested at Year-End&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Change in Value of Prior Years&#x2019; Awards That Vested in the Year&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Fair Value of Forfeited Awards at Prior Year-End&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt; &lt;div&gt;Equity Value&lt;/div&gt; &lt;div&gt; Included in CAP&lt;/div&gt; &lt;/td&gt; &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 14%; text-align: center"&gt;2024&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;679,492&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;(1,278,180&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;(19,593&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;(459,873&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;(1,078,154&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: center"&gt;2023&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;2,182,972&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(89,974&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(255,921&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(1,543,681&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;293,396&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: center"&gt;2022&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;5,228,345&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;3,399,089&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(130,155&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;8,497,279&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: center"&gt;2021&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;5,891,861&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;1,147,507&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;138,972&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;7,178,340&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: center"&gt;2020&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;4,691,771&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;419,942&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(48,996&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;5,062,717&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c1" decimals="0" id="ixv-18079" unitRef="usd">7089167</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c13" decimals="0" id="ixv-18080" unitRef="usd">-5099925</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c14" decimals="0" id="ixv-18081" unitRef="usd">-2230911</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c1" decimals="0" id="ixv-18082" unitRef="usd">-241669</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c2" decimals="0" id="ixv-18083" unitRef="usd">7404606</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c15" decimals="0" id="ixv-18084" unitRef="usd">-4749977</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c16" decimals="0" id="ixv-18085" unitRef="usd">5698123</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c2" decimals="0" id="ixv-18086" unitRef="usd">8352752</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c4" decimals="0" id="ixv-18087" unitRef="usd">6415224</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c17" decimals="0" id="ixv-18088" unitRef="usd">-4500022</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c18" decimals="0" id="ixv-18089" unitRef="usd">6566930</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c4" decimals="0" id="ixv-18090" unitRef="usd">8482132</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c19" decimals="0" id="ixv-18091" unitRef="usd">0</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c20" decimals="0" id="ixv-18092" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c21" decimals="0" id="ixv-18093" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c19" decimals="0" id="ixv-18094" unitRef="usd">0</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c22" decimals="0" id="ixv-18095" unitRef="usd">0</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c23" decimals="0" id="ixv-18096" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c24" decimals="0" id="ixv-18097" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c22" decimals="0" id="ixv-18098" unitRef="usd">0</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c5" decimals="0" id="ixv-18099" unitRef="usd">2620043</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c25" decimals="0" id="ixv-18100" unitRef="usd">-1059857</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c26" decimals="0" id="ixv-18101" unitRef="usd">15542122</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c5" decimals="0" id="ixv-18102" unitRef="usd">17102308</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c7" decimals="0" id="ixv-18103" unitRef="usd">9853107</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c27" decimals="0" id="ixv-18104" unitRef="usd">-6989753</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c28" decimals="0" id="ixv-18105" unitRef="usd">26949377</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c7" decimals="0" id="ixv-18106" unitRef="usd">29812731</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt contextRef="c9" decimals="0" id="ixv-18107" unitRef="usd">5131395</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c29" decimals="0" id="ixv-18108" unitRef="usd">-2789779</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c30" decimals="0" id="ixv-18109" unitRef="usd">15307298</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c9" decimals="0" id="ixv-18110" unitRef="usd">17648915</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c0" decimals="0" id="ixv-18111" unitRef="usd">2238478</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c31" decimals="0" id="ixv-18112" unitRef="usd">-1179647</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c32" decimals="0" id="ixv-18113" unitRef="usd">-1078154</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c0" decimals="0" id="ixv-18114" unitRef="usd">-19323</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c3" decimals="0" id="ixv-18115" unitRef="usd">3289184</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c33" decimals="0" id="ixv-18116" unitRef="usd">-2503492</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c34" decimals="0" id="ixv-18117" unitRef="usd">293396</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c3" decimals="0" id="ixv-18118" unitRef="usd">1079088</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c6" decimals="0" id="ixv-18119" unitRef="usd">3040751</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c35" decimals="0" id="ixv-18120" unitRef="usd">-1720243</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c36" decimals="0" id="ixv-18121" unitRef="usd">8497279</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c6" decimals="0" id="ixv-18122" unitRef="usd">9817787</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c8" decimals="0" id="ixv-18123" unitRef="usd">3656112</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c37" decimals="0" id="ixv-18124" unitRef="usd">-1963594</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c38" decimals="0" id="ixv-18125" unitRef="usd">7178340</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c8" decimals="0" id="ixv-18126" unitRef="usd">8870858</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c10" decimals="0" id="ixv-18127" unitRef="usd">2604425</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c39" decimals="0" id="ixv-18128" unitRef="usd">-1116717</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c40" decimals="0" id="ixv-18129" unitRef="usd">5062717</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c10" decimals="0" id="ixv-18130" unitRef="usd">6550425</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:EqtyAwrdsAdjFnTextBlock contextRef="c0" id="ixv-13809">&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0in"&gt;&lt;/td&gt; &lt;td style="width: 0.5in"&gt;&lt;span style="font-size: 8pt"&gt;(b)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Reflects the value of equity calculated in accordance with the SEC methodology for determining CAP for each year shown. The equity component of CAP is further detailed in the table below. For performance-vesting restricted stock unit awards, fair value amounts have been computed consistent with the methodology used in the Company&#x2019;s Consolidated Financial Statements as of December 31, 2020, 2021, 2022, 2023 and 2024, respectively.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.5in"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Equity Component of CAP: &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="text-decoration:underline"&gt;Christopher H. Hunter&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 65%; font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;Year&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt; &lt;div&gt;Fair Value of&lt;/div&gt; &lt;div&gt; Current Year Equity Awards at Year-End&lt;/div&gt; &lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Change in Value of Prior Years&#x2019; Awards Unvested at Year-End&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Change in Value of Prior Years&#x2019; Awards That Vested in the Year&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt; &lt;div&gt;Equity Value&lt;/div&gt; &lt;div&gt; Included in CAP&lt;/div&gt; &lt;/td&gt; &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 19%; text-align: center"&gt;2024&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 17%; text-align: right"&gt;2,975,019&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 17%; text-align: right"&gt;(5,148,737&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 17%; text-align: right"&gt;(57,192&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 17%; text-align: right"&gt;(2,230,911&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: center"&gt;2023&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;6,050,233&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(321,521&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(30,589&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;5,698,123&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: center"&gt;2022&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;6,566,930&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;6,566,930&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: center"&gt;2021&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: center"&gt;2020&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="text-decoration:underline"&gt;Debra K. Osteen&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 65%; font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;Year&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Fair Value of Current Year Equity Awards at Year-End&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Change in Value of Prior Years&#x2019; Awards Unvested at Year-End&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Change in Value of Prior Years&#x2019; Awards That Vested in the Year&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt; &lt;div&gt;Equity Value&lt;/div&gt; &lt;div&gt; Included in CAP&lt;/div&gt; &lt;/td&gt; &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: center"&gt;2024&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: center"&gt;2023&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 19%; text-align: center"&gt;2022&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 17%; text-align: right"&gt;9,972,986&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 17%; text-align: right"&gt;7,341,244&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 17%; text-align: right"&gt;(1,772,108&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 17%; text-align: right"&gt;15,542,122&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: center"&gt;2021&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;23,567,139&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;3,215,353&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;166,885&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;26,949,377&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: center"&gt;2020&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;13,014,224&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;533,148&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;1,759,927&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;15,307,298&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"&gt;&lt;span style="font-size: 8pt"&gt;&lt;span style="text-decoration:underline"&gt;Average Non-CEO NEOs &lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; border-collapse: collapse; width: 80%; font: 8pt Times New Roman, Times, Serif; margin-left: 0.5in"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;Year&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Fair Value of Current Year Equity Awards at Year-End&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Change in Value of Prior Years&#x2019; Awards Unvested at Year-End&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Change in Value of Prior Years&#x2019; Awards That Vested in the Year&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt;Fair Value of Forfeited Awards at Prior Year-End&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 1pt; border-bottom: Black 1pt solid"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: left; border-bottom: 1pt solid Black; vertical-align: bottom;"&gt; &lt;div&gt;Equity Value&lt;/div&gt; &lt;div&gt; Included in CAP&lt;/div&gt; &lt;/td&gt; &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 14%; text-align: center"&gt;2024&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;679,492&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;(1,278,180&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;(19,593&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;(459,873&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 14%; text-align: right"&gt;(1,078,154&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: center"&gt;2023&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;2,182,972&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(89,974&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(255,921&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(1,543,681&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;293,396&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: center"&gt;2022&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;5,228,345&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;3,399,089&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(130,155&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;8,497,279&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: center"&gt;2021&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;5,891,861&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;1,147,507&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;138,972&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;7,178,340&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: center"&gt;2020&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;4,691,771&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;419,942&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(48,996&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&#x2013;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;5,062,717&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</ecd:EqtyAwrdsAdjFnTextBlock>
    <ecd:AdjToCompAmt contextRef="c41" decimals="0" id="ixv-18131" unitRef="usd">2975019</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c42" decimals="0" id="ixv-18132" unitRef="usd">-5148737</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c43" decimals="0" id="ixv-18133" unitRef="usd">-57192</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c14" decimals="0" id="ixv-18134" unitRef="usd">-2230911</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c44" decimals="0" id="ixv-18135" unitRef="usd">6050233</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c45" decimals="0" id="ixv-18136" unitRef="usd">-321521</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c46" decimals="0" id="ixv-18137" unitRef="usd">-30589</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c16" decimals="0" id="ixv-18138" unitRef="usd">5698123</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c47" decimals="0" id="ixv-18139" unitRef="usd">6566930</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c48" decimals="0" id="ixv-18140" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c49" decimals="0" id="ixv-18141" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c18" decimals="0" id="ixv-18142" unitRef="usd">6566930</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c50" decimals="0" id="ixv-18143" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c51" decimals="0" id="ixv-18144" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c52" decimals="0" id="ixv-18145" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c53" decimals="0" id="ixv-18146" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c54" decimals="0" id="ixv-18147" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c55" decimals="0" id="ixv-18148" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c56" decimals="0" id="ixv-18149" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c57" decimals="0" id="ixv-18150" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c58" decimals="0" id="ixv-18151" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c59" decimals="0" id="ixv-18152" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c60" decimals="0" id="ixv-18153" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c21" decimals="0" id="ixv-18154" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c61" decimals="0" id="ixv-18155" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c62" decimals="0" id="ixv-18156" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c63" decimals="0" id="ixv-18157" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c24" decimals="0" id="ixv-18158" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c64" decimals="0" id="ixv-18159" unitRef="usd">9972986</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c65" decimals="0" id="ixv-18160" unitRef="usd">7341244</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c66" decimals="0" id="ixv-18161" unitRef="usd">-1772108</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c26" decimals="0" id="ixv-18162" unitRef="usd">15542122</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c67" decimals="0" id="ixv-18163" unitRef="usd">23567139</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c68" decimals="0" id="ixv-18164" unitRef="usd">3215353</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c69" decimals="0" id="ixv-18165" unitRef="usd">166885</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c28" decimals="0" id="ixv-18166" unitRef="usd">26949377</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c70" decimals="0" id="ixv-18167" unitRef="usd">13014224</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c71" decimals="0" id="ixv-18168" unitRef="usd">533148</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c72" decimals="0" id="ixv-18169" unitRef="usd">1759927</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c30" decimals="0" id="ixv-18170" unitRef="usd">15307298</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c73" decimals="0" id="ixv-18171" unitRef="usd">679492</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c74" decimals="0" id="ixv-18172" unitRef="usd">-1278180</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c75" decimals="0" id="ixv-18173" unitRef="usd">-19593</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c76" decimals="0" id="ixv-18174" unitRef="usd">-459873</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c32" decimals="0" id="ixv-18175" unitRef="usd">-1078154</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c77" decimals="0" id="ixv-18176" unitRef="usd">2182972</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c78" decimals="0" id="ixv-18177" unitRef="usd">-89974</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c79" decimals="0" id="ixv-18178" unitRef="usd">-255921</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c80" decimals="0" id="ixv-18179" unitRef="usd">-1543681</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c34" decimals="0" id="ixv-18180" unitRef="usd">293396</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c81" decimals="0" id="ixv-18181" unitRef="usd">5228345</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c82" decimals="0" id="ixv-18182" unitRef="usd">3399089</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c83" decimals="0" id="ixv-18183" unitRef="usd">-130155</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c84" decimals="0" id="ixv-18184" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c36" decimals="0" id="ixv-18185" unitRef="usd">8497279</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c85" decimals="0" id="ixv-18186" unitRef="usd">5891861</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c86" decimals="0" id="ixv-18187" unitRef="usd">1147507</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c87" decimals="0" id="ixv-18188" unitRef="usd">138972</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c88" decimals="0" id="ixv-18189" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c38" decimals="0" id="ixv-18190" unitRef="usd">7178340</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c89" decimals="0" id="ixv-18191" unitRef="usd">4691771</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c90" decimals="0" id="ixv-18192" unitRef="usd">419942</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c91" decimals="0" id="ixv-18193" unitRef="usd">-48996</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c92" decimals="0" id="ixv-18194" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c40" decimals="0" id="ixv-18195" unitRef="usd">5062717</ecd:AdjToCompAmt>
    <ecd:PeerGroupIssuersFnTextBlock contextRef="c0" id="ixv-14340">&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0"&gt;&lt;/td&gt; &lt;td style="width: 0.5in"&gt;&lt;span style="font-size: 8pt"&gt;(6)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Reflects the cumulative total stockholder return for the S&amp;amp;P Health Care Services Select Industry Index (the &#x201c;S&amp;amp;P HC Index&#x201d;). An investment of $100 is assumed to have been made in the S&amp;amp;P HC Index as of December&#160;31, 2019. Peer Group TSR was calculated by multiplying the initial investment of $100 by the quotient of the closing price of the S&amp;amp;P HC Index on December&#160;31, 2020, 2021, 2022, 2023 and 2024 divided by the closing price on December&#160;31, 2019, with dividends reinvested at the time they are paid.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</ecd:PeerGroupIssuersFnTextBlock>
    <ecd:NonGaapMeasureDescriptionTextBlock contextRef="c93" id="ixv-14353">&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 0"&gt;&lt;/td&gt; &lt;td style="width: 0.5in"&gt;&lt;span style="font-size: 8pt"&gt;(7)&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;Adjusted EPS is a non-GAAP financial measure and one of the core long-term metrics we use for purposes of evaluating performance for our compensation program, as further described in the section above entitled &#x201c;COMPENSATION DISCUSSION AND ANALYSIS &#x2013; Components of Executive Compensation &#x2013; Annual Non-Equity Incentive Compensation.&#x201d;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</ecd:NonGaapMeasureDescriptionTextBlock>
    <ecd:CoSelectedMeasureName contextRef="c0" id="ixv-18196">Adjusted EPS</ecd:CoSelectedMeasureName>
    <ecd:TabularListTableTextBlock contextRef="c0" id="ixv-14376">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;i&gt;Financial Performance Measures&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;As further described in the section above entitled &#x201c;COMPENSATION DISCUSSION AND ANALYSIS &#x2013; Components of Executive Compensation,&#x201d; the Company&#x2019;s
    executive compensation program is heavily weighted to performance-based pay, with a significant emphasis on long-term performance and stockholder value creation. The Company primarily uses three core metrics across its long-term and short-term
    incentive awards: Adjusted EPS, Adjusted EBITDA and revenue. The Company uses Adjusted EPS, Adjusted EBITDA and revenue to determine annual cash incentive awards and performance-based equity awards because they are important measures of our performance
    and the performance of our management, they drive our success and growth and they are key criteria by which management plans and analyzes our business. In addition, the Company uses certain non-financial measures to determine annual cash incentive
    awards in order to incentivize and align achievement for certain key qualitative metrics. Therefore, the most important financial performance measures (and only financial measures used in current plans/awards) used by the Company to link compensation
    actually paid to the Company&#x2019;s NEOs, for the most recently completed fiscal year, to the Company&#x2019;s performance are as follows:&lt;/p&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 20.9pt"&gt;&lt;/td&gt; &lt;td style="width: 18pt"&gt;&#x25cf;&lt;/td&gt; &lt;td style="text-align: justify"&gt;Adjusted EPS&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 20.7pt"&gt;&lt;/td&gt; &lt;td style="width: 18pt"&gt;&#x25cf;&lt;/td&gt; &lt;td style="text-align: justify"&gt;Adjusted EBITDA&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;&lt;table cellpadding="0" style="border-spacing: 0; border-spacing: 0; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"&gt; &lt;tr style="vertical-align: top"&gt; &lt;td style="width: 20.7pt"&gt;&lt;/td&gt; &lt;td style="width: 18pt"&gt;&#x25cf;&lt;/td&gt; &lt;td style="text-align: justify"&gt;Revenue&lt;/td&gt; &lt;/tr&gt; &lt;/table&gt;</ecd:TabularListTableTextBlock>
    <ecd:MeasureName contextRef="c93" id="ixv-18197">Adjusted EPS</ecd:MeasureName>
    <ecd:MeasureName contextRef="c94" id="ixv-18198">Adjusted EBITDA</ecd:MeasureName>
    <ecd:MeasureName contextRef="c95" id="ixv-18199">Revenue</ecd:MeasureName>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="c0" id="ixv-14424">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Comparison of Compensation Actually Paid and Company TSR&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following graph reflects the relationship between our CEO and average non-CEO NEO &#x201c;compensation actually paid&#x201d; versus our cumulative TSR,
    assuming an initial fixed investment of $100 on December 31, 2019, for the years ended December 31, 2020, 2021, 2022, 2023 and 2024.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;img alt="" src="ny20042551x1_image04.jpg"/&gt;&#160;&lt;/p&gt;</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="c0" id="ixv-14451">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Comparison of Compensation Actually Paid and Net Income&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following graph reflects the relationship between our CEO and average non-CEO NEO &#x201c;compensation actually paid&#x201d; and our net income for the
    years ended December 31, 2020, 2021, 2022, 2023 and 2024.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;img alt="" src="ny20042551x1_image05.jpg"/&gt;&#160;&lt;/p&gt;</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock contextRef="c0" id="ixv-14468">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Comparison of Compensation Actually Paid and Adjusted EPS&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following graph reflects the relationship between our CEO and average non-CEO NEO &#x201c;compensation actually paid&#x201d; and our Adjusted EPS for the
    years ended December 31, 2020, 2021, 2022, 2023 and 2024.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;img alt="" src="ny20042551x1_image06.jpg"/&gt;&#160;&lt;/p&gt;</ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock>
    <ecd:TotalShareholderRtnVsPeerGroupTextBlock contextRef="c0" id="ixv-14495">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Comparison of Company TSR and Peer Group TSR&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;The following graph reflects the relationship between our TSR and the TSR of the peer group presented for this purpose, the S&amp;amp;P HC Index.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;img alt="" src="ny20042551x1_image07.jpg"/&gt;&#160;&lt;/p&gt;</ecd:TotalShareholderRtnVsPeerGroupTextBlock>
    <dei:DocumentType contextRef="c0" id="hidden-fact-0">DEF 14A</dei:DocumentType>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-18203">0001520697</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c0" id="ixv-18204">false</dei:AmendmentFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
